<SEC-DOCUMENT>0001683168-25-003842.txt : 20250519
<SEC-HEADER>0001683168-25-003842.hdr.sgml : 20250519
<ACCEPTANCE-DATETIME>20250519172308
ACCESSION NUMBER:		0001683168-25-003842
CONFORMED SUBMISSION TYPE:	S-4/A
PUBLIC DOCUMENT COUNT:		23
FILED AS OF DATE:		20250519
DATE AS OF CHANGE:		20250519

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-4/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287005
		FILM NUMBER:		25965166

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-4/A
<SEQUENCE>1
<FILENAME>radnet_s4a1.htm
<DESCRIPTION>AMENDMENT NO. 1 TO FORM S-4
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:RDNT="http://radnet.com/20250519">
<head>
     <title>RADNET, INC. S-4</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_RDNT_radnet.com_20250519 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20250519_20250519 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000790526 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-05-19" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-19" id="Fact000004" name="dei:EntityCentralIndexKey">0000790526</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rdnt-20250519.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-05-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-19</xbrli:startDate>
        <xbrli:endDate>2025-05-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As filed with the Securities and Exchange
Commission on May 19, 2025 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Registration No. 333-287005 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 0.75pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-size: 5pt">&#160;</span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-size: 7pt"><a href="#toc">Table of Contents</a></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549 </b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AMENDMENT NO. 1</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TO</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90A_edei--DocumentType_c20250519__20250519_zt0yI5zEm9kk"><ix:nonNumeric contextRef="AsOf2025-05-19" id="Fact000009" name="dei:DocumentType">S-4</ix:nonNumeric></span></b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REGISTRATION STATEMENT </b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNDER </b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE SECURITIES ACT OF 1933 </b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityRegistrantName_c20250519__20250519_zuTJdYRDRwX4"><ix:nonNumeric contextRef="AsOf2025-05-19" id="Fact000010" name="dei:EntityRegistrantName">RADNET, INC.</ix:nonNumeric></span> </b></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 33%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="width: 32%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="width: 33%">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20250519__20250519_zvMhQZofjjw9"><ix:nonNumeric contextRef="AsOf2025-05-19" format="ixt-sec:stateprovnameen" id="Fact000011" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b>8071</b></span></td>
    <td style="vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20250519__20250519_ztvUB2BRtm5k"><ix:nonNumeric contextRef="AsOf2025-05-19" id="Fact000012" name="dei:EntityTaxIdentificationNumber">13-3326724</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of incorporation</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">or organization)</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td>
    <td style="vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Primary Standard Industrial</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Classification Code Number)</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></td>
    <td style="vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt">(I.R.S. Employer Identification Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90F_edei--EntityAddressAddressLine1_c20250519__20250519_z2sQhR9PZ3Ag"><ix:nonNumeric contextRef="AsOf2025-05-19" id="Fact000013" name="dei:EntityAddressAddressLine1">1510 Cotner Avenue</ix:nonNumeric> </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityAddressCityOrTown_c20250519__20250519_zmYj0fxaGpy3"><ix:nonNumeric contextRef="AsOf2025-05-19" id="Fact000014" name="dei:EntityAddressCityOrTown">Los Angeles</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20250519__20250519_zd4HNQBbbpcb"><ix:nonNumeric contextRef="AsOf2025-05-19" format="ixt-sec:stateprovnameen" id="Fact000015" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_90A_edei--EntityAddressPostalZipCode_c20250519__20250519_zjwhO5fIB1O2"><ix:nonNumeric contextRef="AsOf2025-05-19" id="Fact000016" name="dei:EntityAddressPostalZipCode">90025</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--CityAreaCode_c20250519__20250519_zKEZJEeH7q8e"><ix:nonNumeric contextRef="AsOf2025-05-19" id="Fact000017" name="dei:CityAreaCode">(310)</ix:nonNumeric></span> <span id="xdx_907_edei--LocalPhoneNumber_c20250519__20250519_zc9lKfKioLG4"><ix:nonNumeric contextRef="AsOf2025-05-19" id="Fact000018" name="dei:LocalPhoneNumber">445-2800</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address, including zip code, and telephone number,
including area code, of registrant&#8217;s principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Howard G. Berger, M.D. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>President and Chief Executive Officer</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RadNet, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>1510 Cotner Avenue</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Los Angeles, California 90025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(310) 445-2800</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, including zip code, and telephone
number, including area code, of agent for service)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Copies to: </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 34%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="width: 30%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="width: 34%">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>Andrew Moore</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>Dana Brown</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>Jeffrey Baumel</b></span></td></tr>
  <tr>
    <td style="text-align: center"><span style="font-size: 10pt"><b>Jonathan S. Schulman</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>Chief Executive Officer</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>Ilan Katz</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>Christopher Wassman</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>iCAD, Inc.</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>Ira L. Kotel</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>Perkins Coie LLP</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>2 Townsend West, Suite 6</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>Dentons US LLP</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>1201 Third Avenue, Suite 4800</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>Nashua, New Hampshire 03063</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>1221 Avenue of the Americas</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>Seattle, Washington 98101</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>(603) 882-5200</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>New York, New York, 10020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>(206) 359-8000</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>(212) 768-6700</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>Approximate date of commencement of proposed
sale of the securities to the public: </b>As soon as practicable after this Registration Statement becomes effective and upon completion
of the merger of Trio Merger Sub, Inc., a wholly-owned subsidiary of RadNet, Inc., with and into iCAD, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If the securities being registered on this Form
are being offered in connection with the formation of a holding company and there is compliance with General Instruction G, check the
following box: <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If this Form is a post-effective amendment filed
pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company.
See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221;
and " emerging growth company" in Rule 12b-2 of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt"><span id="xdx_907_edei--EntityFilerCategory_c20250519__20250519_zGj5QAsVvePa"><ix:nonNumeric contextRef="AsOf2025-05-19" format="ixt-sec:entityfilercategoryen" id="Fact000019" name="dei:EntityFilerCategory">Large accelerated filer</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Accelerated filer</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td colspan="2">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">Non-accelerated filer</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Smaller reporting company</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntitySmallBusiness_c20250519__20250519_zSZVi1g283Hh"><ix:nonNumeric contextRef="AsOf2025-05-19" format="ixt:booleanfalse" id="Fact000020" name="dei:EntitySmallBusiness">&#9744;</ix:nonNumeric></span></span></td></tr>
  <tr>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td colspan="2">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Emerging growth company</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20250519__20250519_zLG3i566Ob79"><ix:nonNumeric contextRef="AsOf2025-05-19" format="ixt:booleanfalse" id="Fact000021" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If applicable, place an X in the box to designate
the appropriate rule provision relied upon in conducting this transaction:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Securities Exchange Act Rule 13e-4(i) (Cross-Border
Issuer Tender Offer) <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Securities Exchange Act Rule 14d-l(d) (Cross-Border
Third-Party Tender Offer) <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>The registrant hereby amends this Registration
Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which
specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933 or until the Registration Statement shall become effective on such date as the Commission acting pursuant to said Section
8(a), may determine. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #FF4338"><b>Information contained herein
is subject to completion or amendment. A registration statement relating to these securities has been filed with the Securities and Exchange
Commission. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.
The attached proxy statement/prospectus shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be
any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #FF4338">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #FF4338"><b>PRELIMINARY&#8212;SUBJECT
TO COMPLETION&#8212;DATED MAY 19, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #FF4338">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<img src="icad.jpg" alt="" style="height: 65px; width: 225px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="transprop"></span>TRANSACTION PROPOSED&#8212;YOUR VOTE IS VERY
IMPORTANT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Stockholders of iCAD, Inc.:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 15, 2025, iCAD, Inc. (&#8220;iCAD&#8221;),
RadNet, Inc. (&#8220;RadNet&#8221;) and Trio Merger Sub, Inc., a wholly-owned subsidiary of RadNet (&#8220;Merger Sub&#8221;), entered
into an Agreement and Plan of Merger (as it may be amended from time to time, the &#8220;Merger Agreement&#8221;), under which, upon the
terms and subject to the conditions set forth therein, if the Merger is completed, Merger Sub will merge with and into iCAD (the &#8220;Merger&#8221;),
with iCAD surviving as a wholly-owned subsidiary of RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If the Merger is completed, each issued and outstanding
share of common stock of iCAD, par value $0.01 per share (&#8220;iCAD Common Stock&#8221;) (excluding shares held by iCAD as treasury
stock or owned by RadNet or Merger Sub or any of their respective subsidiaries, in each case, immediately prior to the effective time
of the Merger), will be converted into the right to receive 0.0677 shares (the &#8220;Exchange Ratio&#8221;) of common stock of RadNet,
par value $0.0001 per share (&#8220;RadNet Common Stock&#8221;), and, if applicable, cash in lieu of fractional shares without interest.
This Exchange Ratio is fixed and will not be adjusted for changes in the market price of either iCAD Common Stock or RadNet Common Stock
between the date of signing of the Merger Agreement and consummation of the Merger. Because the share price of RadNet Common Stock will
fluctuate between the date of signing of the Merger Agreement and the completion of the Merger, and because the Exchange Ratio is fixed
and will not be adjusted to reflect changes in the share price of RadNet Common Stock or iCAD Common Stock, the value of the shares of
RadNet Common Stock to be received by iCAD stockholders in the Merger may differ from the implied value based on the share price on the
date of signing of the Merger Agreement or the date of the proxy statement/prospectus. Based on the closing price of RadNet Common Stock
on April 14, 2025, the trading day before the public announcement of the signing of the Merger Agreement, the Exchange Ratio would represent
approximately $3.61 in implied value for each share of iCAD Common Stock on a fully diluted basis. Based on the closing price of RadNet
Common Stock on [ ], 2025, the last practicable date before the date of the proxy statement/prospectus accompanying this notice, the Exchange
Ratio would represent approximately $[ ] in implied value for each share of iCAD Common Stock on a fully diluted basis. We urge you to
obtain current share price quotations for RadNet Common Stock and iCAD Common Stock. The iCAD Common Stock is listed on The Nasdaq Capital
Market under the symbol &#8220;ICAD.&#8221; The RadNet Common Stock is listed on The Nasdaq Global Market under the symbol &#8220;RDNT.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>The
                                            Merger cannot be completed without adoption of the Merger Agreement by the affirmative vote
                                            of the holders of a majority of all outstanding shares of iCAD Common Stock entitled to vote
                                            thereon.</b> Because of this, iCAD is holding a virtual special meeting of its stockholders
                                            on July 14, 2025 (the &#8220;Special Meeting&#8221;) to vote on the proposal necessary to
                                            complete the Merger. Information about the Special Meeting, the Merger, the Merger Agreement,
                                            and the other business to be considered by stockholders at the Special Meeting is contained
                                            in this proxy statement/prospectus. The iCAD board of directors (the &#8220;iCAD Board&#8221;)
                                            has fixed the close of business on May 16, 2025 as the record date for the determination
                                            of iCAD stockholders entitled to notice of, and to vote at, the Special Meeting. We urge
                                            you to read this proxy statement/prospectus and the annexes and documents incorporated by
                                            reference carefully. <b>You should also carefully consider the risks that are described in
                                            the section titled &#8220;<a href="#a_031">Risk Factors</a>&#8221; beginning on page 26 of
                                            this proxy statement/prospectus</b>.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>The iCAD Board has unanimously approved and
declared advisable the Merger Agreement and the transactions contemplated therein, including the Merger, on the terms and subject to the
conditions set forth therein, determined that the Merger Agreement and the consummation of the transactions contemplated thereby, (including
the Merger), are advisable and fair to, and in the best interests of, iCAD and the stockholders of iCAD, resolved to recommend the adoption
of the Merger Agreement to the stockholders of iCAD, on the terms and subject to the conditions set forth therein, and directed that the
Merger Agreement be submitted to the stockholders of iCAD for adoption at a special meeting of such stockholders. The iCAD Board unanimously
recommends that iCAD stockholders vote &#8220;FOR&#8221; the proposal to adopt the Merger Agreement, &#8220;FOR&#8221; the proposal to
approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to iCAD&#8217;s named executive officers
that is based on or otherwise related to the Merger and &#8220;FOR&#8221; the proposal to adjourn the Special Meeting to a later date
or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at
the time of the Special Meeting.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>Your vote is very important regardless of the
number of shares of iCAD Common Stock that you own. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>Whether or not you plan to attend the Special
Meeting virtually, please submit your proxy as soon as possible by following the instructions on the accompanying proxy card to make sure
that your shares are represented at the Special Meeting. If your shares are held in the name of a broker, bank or other nominee, please
follow the instructions on the voting instruction form furnished by the broker, bank or other nominee. You must provide voting instructions
by filling out the voting instruction form in order for your shares to be voted. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Special Meeting will be held in a virtual
meeting format only. You will not be able to attend the Special Meeting physically in person. iCAD believes that a virtual stockholder
meeting provides greater access to those who may wish to attend the meeting while improving efficiency and reducing costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Thank you for your continued support of iCAD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dana Brown</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer, President and Chairman</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">iCAD, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of the Merger or the other transactions described in this proxy statement/prospectus
or the securities to be issued in connection with the Merger or determined if this proxy statement/prospectus is accurate or complete.
Any representation to the contrary is a criminal offense. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">This proxy statement/prospectus is dated [ ],
2025, and, together with the enclosed form of proxy card, is first being mailed to stockholders of iCAD on or about [ ], 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="addlinfo"></span>ADDITIONAL INFORMATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The accompanying document is the proxy statement
of iCAD for the Special Meeting and the prospectus of RadNet for the shares of RadNet Common Stock to be issued to iCAD stockholders as
consideration in the Merger. The accompanying proxy statement/prospectus incorporates by reference important business and financial information
about iCAD and RadNet from documents that are not included in or delivered with the accompanying proxy statement/prospectus. You can obtain
the documents incorporated by reference into the accompanying proxy statement/prospectus (other than certain exhibits or schedules to
these documents), without charge, by requesting them in writing or by telephone from iCAD or RadNet at the following addresses and telephone
numbers, or through the Securities and Exchange Commission&#8217;s website at www.sec.gov:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt"><b>iCAD, Inc.</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>RadNet, Inc.</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt">2 Townsend West, Suite 6</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">1510 Cotner Avenue</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt">Nashua, New Hampshire 03063</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">Los Angeles, California 90025</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt">Attention: Investor Relations</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">Attention: Investor Relations</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt">(603) 882-5200</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">(310) 445-2800</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt">icad@imsinvestorrelations.com</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">investorrelations@radnet.com</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">In addition, if you have any questions concerning
the Merger Agreement or the Merger or the other transactions contemplated by the Merger Agreement, or the accompanying proxy statement/prospectus,
or if you would like additional copies of this proxy statement/prospectus or documents incorporated by reference herein, or if you need
help voting your shares of iCAD Common Stock, please contact iCAD&#8217;s proxy solicitor:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 100%; text-align: center"><span style="font-size: 10pt"><b><br/>
Campaign Management</b><br/>
15 West 38th Street, Suite #747,<br/>
New York, New York 10018<br/>
North American Toll-Free Phone:&#160;1-844-394-4517<br/>
Email: info@campaign-mgmt.com<br/>
Call Collect Outside North America: +1 (212) 632-8422</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>If you would like to request documents,
please do so no later than five business days before the date of the Special Meeting (which date is July 7, 2025).</b><b> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">We are not incorporating the contents of the website
of the Securities and Exchange Commission, iCAD, or RadNet or any other entity into the proxy statement/prospectus. We are providing information
about how to obtain certain documents that are incorporated by reference into this proxy statement/prospectus for your convenience only.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">See the section titled &#8220;<i><a href="#s4_060">Where You Can Find More Information</a></i>&#8221; beginning on page 125 of the accompanying proxy statement/prospectus for further information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&#160;<img src="icad.jpg" alt="" style="height: 65px; width: 225px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>iCAD, Inc.<br/>
2 Townsend West, Suite 6<br/>
Nashua, New Hampshire 03063</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTICE OF SPECIAL MEETING OF STOCKHOLDERS<br/>
TO BE HELD JULY 14, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To our Stockholders<i>:</i>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">You
                                            are hereby notified that a virtual Special Meeting of Stockholders of iCAD, Inc., a Delaware
                                            corporation (&#8220;iCAD&#8221;), will be held virtually at www.cstproxy.com/icad/sm2025
                                            at 9:00 a.m., Eastern Time (the &#8220;Special Meeting&#8221;), on July 14, 2025 for the
                                            following purposes:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt">1.</td><td>to vote on a proposal to adopt the Agreement and Plan of Merger, dated April 15, 2025, by and among RadNet, Inc., a Delaware corporation
(&#8220;RadNet&#8221;), Trio Merger Sub, Inc., a wholly-owned subsidiary of RadNet and a Delaware corporation (&#8220;Merger Sub&#8221;),
and iCAD (as it may be amended from time to time, the &#8220;Merger Agreement&#8221;), under which, upon the terms and subject to the
conditions set forth therein, Merger Sub will merge with and into iCAD (the &#8220;Merger&#8221;), with iCAD surviving as a wholly-owned
subsidiary of RadNet, which is further described in the section titled &#8220;<i><a href="#s4_021">The Merger Agreement</a></i>&#8221; beginning on page 79
of this proxy statement/prospectus, and a copy of which is attached as Annex A to the proxy statement/prospectus of which this notice
forms a part (the &#8220;Merger Agreement Proposal&#8221;);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt">2.</td><td>to hold a non-binding advisory vote to approve the compensation that may be paid or become payable to iCAD&#8217;s named executive
officers that is based on or otherwise related to the Merger (the &#8220;Advisory Compensation Proposal&#8221;); and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt">3.</td><td>to vote on a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional
proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the &#8220;Adjournment Proposal&#8221;).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD will transact no other business at the Special
Meeting except such business as may properly be brought before the Special Meeting or any adjournment or postponement thereof by or at
the direction of the iCAD board of directors (the &#8220;iCAD Board&#8221;). Please refer to the proxy statement/prospectus of which this
notice forms a part for further information with respect to the business to be transacted at the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">Only
                                            stockholders of record as of May 16, 2025 are entitled to notice of, and to vote at, the
                                            Special Meeting. The Special Meeting will be a virtual only meeting conducted exclusively
                                            via live webcast at www.cstproxy.com/icad/sm2025 starting at 9:00 a.m., Eastern Time (with
                                            log-in beginning at 8:45 a.m. Eastern Time), on July 14, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">If your shares are registered in your name with
Continental Stock Transfer &amp; Trust Company (&#8220;Continental&#8221;), iCAD&#8217;s transfer agent, and you wish to attend the online-only
virtual Special Meeting, go to www.cstproxy.com/icad/sm2025, enter the control number you received on your proxy card or notice of the
Special Meeting and click on the &#8220;Click here to preregister for the online meeting&#8221; link at the top of the page. Just prior
to the start of the Special Meeting you will need to log back into the Special Meeting site using your control number. Pre-registration
is recommended but is not required in order to attend.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Beneficial stockholders who wish to attend the
online-only virtual Special Meeting must obtain a legal proxy by contacting their account representative at the bank, broker, or other
nominee that holds their shares and e-mail a copy (a legible photograph is sufficient) of their legal proxy to proxy@continentalstock.com.
Beneficial stockholders who e-mail a valid legal proxy will be issued a meeting control number that will allow them to register to attend
and participate in the online-only virtual Special Meeting. After contacting Continental a beneficial holder will receive an e-mail prior
to the Special Meeting with a link and instructions for entering the virtual Special Meeting. Beneficial stockholders should contact Continental
at least five business days prior to the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">A list of stockholders of record will be available
for inspection at iCAD&#8217;s principal executive offices located at 2 Townsend West, Suite 6, Nashua, New Hampshire 03063, during ordinary
business hours during the 10-day period before the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Stockholders
attending the Special Meeting will be in a listen-only mode and will not be able to speak during the webcast. However, stockholders have
multiple opportunities to submit questions to iCAD for the virtual Special Meeting. Stockholders who wish to submit a question in advance
may do so at https://www.cstproxy.com/icad/sm2025. Stockholders may also submit questions online during the meeting at https://www.cstproxy.com/icad/sm2025.
Given time constraints, some questions may not be addressed during the Special Meeting. Please give yourself sufficient time to log-in
and ensure you can hear the streaming audio before the Special Meeting starts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Completion of the Merger is conditioned on adoption
of the Merger Agreement by iCAD stockholders, which requires the affirmative vote of the holders of a majority of all outstanding shares
of iCAD Common Stock entitled to vote thereon. Completion of the Merger is not conditioned on approval of the Advisory Compensation Proposal
nor the Adjournment Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>The iCAD Board has unanimously approved and
declared advisable the Merger Agreement and the transactions contemplated therein, including the Merger, on the terms and subject to the
conditions set forth therein, determined that the Merger Agreement and the consummation of the transactions contemplated thereby, (including
the Merger), are advisable and fair to, and in the best interests of, iCAD and the stockholders of iCAD, resolved to recommend the adoption
of the Merger Agreement to the stockholders of iCAD, on the terms and subject to the conditions set forth therein, and directed that the
Merger Agreement be submitted to the stockholders of iCAD for adoption at a special meeting of such stockholders. The iCAD Board unanimously
recommends that iCAD stockholders vote &#8220;FOR&#8221; the Merger Agreement Proposal, &#8220;FOR&#8221; the Advisory Compensation Proposal
and &#8220;FOR&#8221; the Adjournment Proposal. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>Your vote is very important regardless of the
number of shares of iCAD Common Stock that you own. If you plan to attend the Special Meeting virtually, please follow the instructions
as outlined in this proxy statement/prospectus. Whether or not you expect to attend the Special Meeting virtually, we urge you to submit
your vote in advance of the Special Meeting. If your shares are held in the name of a broker, bank or other nominee, please vote by following
the instructions on the voting instruction form furnished by the broker, bank or other nominee. If you hold your shares in your own name,
submit a proxy to vote your shares as promptly as possible by (i) visiting the internet site listed on the accompanying proxy card, (ii)
calling the toll-free number listed on the proxy card or (iii) submitting your proxy card by mail by using the self-addressed, stamped
envelope provided. Submitting a proxy will not prevent you from voting virtually at the Special Meeting, but it will help to secure a
quorum and avoid added solicitation costs. Any eligible holder of iCAD Common Stock may vote virtually at the Special Meeting, thereby
revoking any previous proxy. In addition, a proxy may also be revoked in writing before the Special Meeting in the manner described in
the proxy statement/prospectus of which this notice is a part. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The proxy statement/prospectus of which this notice
is a part provides a detailed description of the Merger and the Merger Agreement and the other matters to be considered at the Special
Meeting. We urge you to carefully read this proxy statement/prospectus, including any documents incorporated by reference herein, and
the annexes in their entirety. <b>In particular, we urge you to carefully read the section titled &#8220;</b><span style="color: #0000EE"><b><i><a href="#a_031">Risk Factors</a></i></b></span><b>&#8221; beginning on page 26 in this proxy statement/prospectus</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If you have any questions concerning the Merger
or this proxy statement/prospectus, would like additional copies or need help voting your shares of iCAD Common Stock, please contact
iCAD&#8217;s proxy solicitor:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 100%; text-align: center"><span style="font-size: 10pt"><b><br/>
Campaign Management</b><br/>
15 West 38th Street, Suite #747,<br/>
New York, New York 10018<br/>
North American Toll-Free Phone:&#160;1-844-394-4517<br/>
Email: info@campaign-mgmt.com<br/>
Call Collect Outside North America: +1 (212) 632-8422</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By order of the Board of Directors,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dana Brown</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer, President and Chairman</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">iCAD, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nashua, New Hampshire</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">[ ], 2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="about"></span>ABOUT THIS PROXY STATEMENT/PROSPECTUS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">This proxy statement/prospectus, which forms part
of a registration statement on Form S-4 filed with the SEC by RadNet, constitutes a prospectus of RadNet under the Securities Act with
respect to RadNet Common Stock to be issued to iCAD stockholders in connection with the Merger. This proxy statement/prospectus also constitutes
a proxy statement of iCAD under the Exchange Act. This proxy statement/prospectus also constitutes a notice of meeting with respect to
the Special Meeting. As permitted by SEC rules, this proxy statement/prospectus does not contain all of the information included in the
registration statement. The complete registration statement, including any amendments, schedules and exhibits, is available at the SEC&#8217;s
website, www.sec.gov, free of charge.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Information contained or incorporated by reference
in this proxy statement/prospectus regarding RadNet or Merger Sub has been provided by RadNet and information contained or incorporated
by reference in this proxy statement/prospectus regarding iCAD has been provided by iCAD. RadNet and iCAD have both contributed to the
information related to the Merger contained in this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">You should rely only on the information contained
or incorporated by reference in this proxy statement/prospectus. RadNet and iCAD have not authorized anyone to provide you with information
that is different from that contained or incorporated by reference in this proxy statement/prospectus. You should not assume that the
information contained in this proxy statement/prospectus is accurate as of any date other than the date of this proxy statement/prospectus
unless otherwise specifically provided herein. You should also assume that the information incorporated by reference in this proxy statement/prospectus
is accurate only as of the date of the incorporated document unless the information specifically indicates that another date applies.
Neither the mailing of this proxy statement/prospectus to iCAD stockholders nor the issuance by RadNet of RadNet Common Stock in connection
with the Merger will create any implication to the contrary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>This proxy statement/prospectus does not constitute
an offer to sell, or a solicitation of an offer to buy, any securities, or the solicitation of a proxy, in any jurisdiction to or from
any person to whom it is unlawful to make any such offer or solicitation in such jurisdiction.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Unless otherwise indicated or the context otherwise
requires, when used in this proxy statement/prospectus:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>2005 iCAD Plan</b>&#8221; means iCAD&#8217;s 2005 Stock Incentive Plan, as amended or restated from time to time.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>2012 iCAD Plan</b>&#8221; means iCAD&#8217;s 2012 Stock Incentive Plan, as amended or restated from time to time.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>2016 iCAD Plan</b>&#8221; means iCAD&#8217;s 2016 Stock Incentive Plan, as amended or restated from time to time.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>2024 iCAD Plan</b>&#8221; means iCAD&#8217;s 2024 Omnibus Equity Incentive Plan, as amended or restated from time to time.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Adjournment Proposal</b>&#8221; refers to a proposal for iCAD stockholders to adjourn the Special Meeting to a later date
or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at
the time of the Special Meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Advisory Compensation Proposal</b>&#8221; refers to a proposal for iCAD stockholders to approve, on a non-binding, advisory
basis, the compensation that may be paid or become payable to iCAD&#8217;s named executive officers that is based on or otherwise related
to the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Closing</b>&#8221; refers to the closing of the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Closing Date</b>&#8221; refers to the date of the closing of the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Code</b>&#8221; refers to the Internal Revenue Code of 1986, as amended.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Continental</b>&#8221; refers to Continental Stock Transfer &amp; Trust Company, iCAD&#8217;s transfer agent.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Dentons</b>&#8221; refers to Dentons US LLP.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>DGCL</b>&#8221; refers to the General Corporation Law of the State of Delaware.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Effective Time</b>&#8221; refers to the date and time when the Merger becomes effective under the DGCL.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Eligible iCAD Option</b>&#8221; refers to each iCAD Option (whether or not vested or exercisable) that (i) has been validly
granted under any iCAD Stock Incentive Plans with an exercise price per share of iCAD Common Stock that is less than $7.20 and (ii) is
outstanding and unexercised as of immediately prior to the Effective Time.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Exchange Act</b>&#8221; refers to the Securities Exchange Act of 1934, as amended.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Exchange Ratio</b>&#8221; refers to an amount equal to 0.0677 shares of RadNet Common Stock for each issued and outstanding
share of iCAD Common Stock (other than Excluded Shares).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Excluded Shares</b>&#8221; refers to shares of iCAD Common Stock (i) held in the treasury of iCAD or (ii) owned by RadNet
or Merger Sub or any of their respective subsidiaries, in each case, immediately prior to the Effective Time, which are to be automatically
cancelled and retired and cease to exist, and no consideration will be delivered in exchange therefor, at the Effective Time.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>GAAP</b>&#8221; refers to United States generally accepted accounting principles.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>HSR Act</b>&#8221; refers to the Hart-Scott-Rodino Antitrust Improvements Act of 1976.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>iCAD</b>&#8221; refers to iCAD, Inc., a Delaware corporation.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>iCAD Board</b>&#8221; refers to the board of directors of iCAD.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>iCAD Book-Entry Shares</b>&#8221; refers to book-entry shares representing shares of iCAD common stock.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>iCAD Bylaws</b>&#8221; refers to the amended and restated by-laws of iCAD, as amended and/or restated to date.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>iCAD Certificate of Incorporation</b>&#8221; refers to the certificate of incorporation of iCAD, as amended and/or restated
to date.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>iCAD Certificates</b>&#8221; refers to certificates representing shares of iCAD Common Stock.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>iCAD Common Stock</b>&#8221; refers to shares of common stock, par value $0.01 per share, of iCAD.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>iCAD ESPP</b>&#8221; refers to iCAD&#8217;s 2019 Employee Stock Purchase Plan, as it may be amended from time to time.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>iCAD Option</b>&#8221; refers to an option to purchase shares of iCAD Common Stock granted under any equity incentive plan,
program or agreement maintained by iCAD or to which iCAD is a party, including any of the iCAD Stock Incentive Plans.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>iCAD Record
                                            Date</b>&#8221; refers May 16, 2025, the record date for the Special Meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>iCAD Stock Incentive Plans</b>&#8221; refers to collectively, (i) the 2005 iCAD Plan, (ii) the 2012 iCAD Plan, (iii) the
2016 iCAD Plan, (iv) the 2024 iCAD Plan and (v) the iCAD ESPP.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>iCAD Stockholder Approval</b>&#8221; refers to the approval by iCAD stockholders of the Merger Agreement Proposal;&#8221;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Merger</b>&#8221; refers to the merger of Merger Sub with and into iCAD, with iCAD surviving as a wholly-owned subsidiary
of RadNet, as contemplated by, subject to and in accordance with the terms of the Merger Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Merger Agreement</b>&#8221; refers to the Agreement and Plan of Merger, dated as of April 15, 2025, as it may be amended
from time to time, by and among, RadNet, Merger Sub and iCAD, a copy of which is attached to this proxy statement/prospectus as Annex
A.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Merger Agreement Proposal</b>&#8221; refers to the proposal for iCAD stockholders to adopt the Merger Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Merger Consideration</b>&#8221; refers to the right to receive the Exchange Ratio (and, if applicable, cash in lieu of fractional
shares of iCAD Common Stock payable in accordance with the Merger Agreement).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Merger Sub</b>&#8221; refers to Trio Merger Sub, Inc., a wholly-owned subsidiary of RadNet, and a Delaware corporation.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Outside Date</b>&#8221; refers to September 30, 2025 (or December 31, 2025, if such date is automatically extended in accordance
with the terms of the Merger Agreement).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Piper Sandler</b>&#8221; refers to Piper Sandler &amp; Co., financial advisor to iCAD in connection with the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Perkins Coie</b>&#8221; refers to Perkins Coie LLP.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>RadNet</b>&#8221; refers to RadNet, Inc., a Delaware corporation.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>RadNet Board</b>&#8221; refers to the board of directors of RadNet.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>RadNet Bylaws</b>&#8221; refers to the amended and restated bylaws of RadNet, as amended and/or restated to date.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>RadNet Certificate of Incorporation</b>&#8221; refers to the certificate of incorporation of RadNet, as amended and/or restated
to date.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>RadNet Common Stock</b>&#8221; refers to common stock, par value $0.0001 per share, of RadNet.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Representatives</b>&#8221; refers to, when used with respect to any person, the directors, officers, employees, consultants,
financial advisors, accountants, legal counsel, investment bankers and other agents, advisors and representatives of such person.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>SEC</b>&#8221; refers to the U.S. Securities and Exchange Commission.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Securities Act</b>&#8221; refers to the Securities Act of 1933, as amended.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Special Meeting</b>&#8221; refers to the virtual special meeting of iCAD stockholders to vote on the Merger Agreement Proposal,
the Advisory Compensation Proposal and the Adjournment Proposal.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Surviving Corporation</b>&#8221; refers to iCAD, the surviving corporation in the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Voting and Support Agreement Stockholders</b>&#8221; refers to each of the members of the iCAD Board.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>Voting and Support Agreements</b>&#8221; refers to the voting and support agreements, dated as of April 15, 2025, entered
into by and among RadNet, Merger Sub and each of the Voting and Support Agreement Stockholders.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->viii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="toc"></span>TABLE OF CONTENTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Page</td></tr>
  <tr style="vertical-align: top">
    <td style="font-weight: bold">&#160;</td>
    <td style="text-align: right; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="width: 96%; font-weight: bold"><a href="#qna"><span style="font-weight: normal">QUESTIONS AND ANSWERS</span></a></td>
    <td style="text-align: right; width: 4%; font-weight: bold">1</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#summary">SUMMARY</a></span></td>
    <td style="text-align: right; font-weight: bold">13</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#comps">The Companies</a></span></td>
    <td style="text-align: right"><b>13</b></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#merger">The Merger</a></span></td>
    <td style="text-align: right; font-weight: bold">14</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#icadmtng">The iCAD Special Meeting</a></span></td>
    <td style="text-align: right; font-weight: bold">14</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_080">What iCAD Stockholders Will Receive in the Merger</a></span></td>
    <td style="text-align: right; font-weight: bold">16</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#nodissenters"><span style="font-weight: normal">No Dissenters&#8217; or Appraisal Rights</span></a></td>
    <td style="text-align: right; font-weight: bold">16</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#trtmnt"><span style="font-weight: normal">Treatment of iCAD Options</span></a></td>
    <td style="text-align: right; font-weight: bold">17</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#rec"><span style="font-weight: normal">Recommendation of the iCAD Board of Directors</span></a></td>
    <td style="text-align: right; font-weight: bold">17</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#opinion"><span style="font-weight: normal">Opinion of iCAD&#8217;s Financial Advisor</span></a></td>
    <td style="text-align: right; font-weight: bold">17</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#ownrship"><span style="font-weight: normal">Ownership of Shares of RadNet Common Stock After the Merger</span></a></td>
    <td style="text-align: right; font-weight: bold">17</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#interests"><span style="font-weight: normal">Interests of iCAD&#8217;s Directors and Executive Officers in the Merger</span></a></td>
    <td style="text-align: right; font-weight: bold">18</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_083">The Voting and Support Agreements</a> </span></td>
    <td style="text-align: right; font-weight: bold">18</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_082">Completion of the Merger is Subject to Certain Conditions</a></span></td>
    <td style="text-align: right; font-weight: bold">19</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#regapprovs"><span style="font-weight: normal">Regulatory Approvals</span></a></td>
    <td style="text-align: right; font-weight: bold">20</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_022">No Solicitation; Obligation to Recommend Approval of the Merger Agreement Proposal</a></span></td>
    <td style="text-align: right; font-weight: bold">20</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_023">Termination of the Merger Agreement</a></span></td>
    <td style="text-align: right; font-weight: bold">20</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_024">Specific Enforcement</a></span></td>
    <td style="text-align: right; font-weight: bold">22</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_025">Material U.S. Federal Income Tax Consequences of the Merger</a></span></td>
    <td style="text-align: right; font-weight: bold">22</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_026">Accounting Treatment</a></span></td>
    <td style="text-align: right; font-weight: bold">22</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#a_027"><span style="font-weight: normal">Rights of iCAD Stockholders Will Change As a Result of the Merger</span></a></td>
    <td style="text-align: right; font-weight: bold">22</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#a_028"><span style="font-weight: normal">Risk Factors</span></a></td>
    <td style="text-align: right; font-weight: bold">23</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#a_008">COMPARATIVE PER SHARE MARKET PRICE AND DIVIDEND INFORMATION</a></span></td>
    <td style="text-align: right; font-weight: bold">25</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#a_029"><span style="font-weight: normal">Market Prices</span></a></td>
    <td style="text-align: right; font-weight: bold">25</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_030">Dividends</a></span></td>
    <td style="text-align: right; font-weight: bold">25</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold"><a href="#a_031"><span style="font-weight: normal">RISK FACTORS</span></a></td>
    <td style="text-align: right; font-weight: bold">26</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#a_032">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="text-align: right; font-weight: bold">34</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold"><a href="#a_033"><span style="font-weight: normal">THE COMPANIES</span></a></td>
    <td style="text-align: right; font-weight: bold">35</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_035">RadNet, Inc.</a></span></td>
    <td style="text-align: right; font-weight: bold">35</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_036">iCAD, Inc.</a></span></td>
    <td style="text-align: right; font-weight: bold">35</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_037">Trio Merger Sub, Inc.</a></span></td>
    <td style="text-align: right; font-weight: bold">35</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold"><a href="#a_034"><span style="font-weight: normal">THE iCAD SPECIAL MEETING</span></a></td>
    <td style="text-align: right; font-weight: bold">36</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_039">General</a></span></td>
    <td style="text-align: right; font-weight: bold">36</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#a_040"><span style="font-weight: normal">Date, Time and Place of the Special Meeting</span></a></td>
    <td style="text-align: right; font-weight: bold">36</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#a_041"><span style="font-weight: normal">Purposes of the Special Meeting</span></a></td>
    <td style="text-align: right; font-weight: bold">36</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#a_042"><span style="font-weight: normal">Recommendation of the iCAD Board</span></a></td>
    <td style="text-align: right; font-weight: bold">37</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#a_043"><span style="font-weight: normal">Voting by Directors and Executive Officers</span></a></td>
    <td style="text-align: right; font-weight: bold">37</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#a_044"><span style="font-weight: normal">Attendance at the Special Meeting</span></a></td>
    <td style="text-align: right; font-weight: bold">37</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#a_045"><span style="font-weight: normal">Submitting Questions for the Virtual Special Meeting</span></a></td>
    <td style="text-align: right; font-weight: bold">37</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_046">Limitations on Submitting Questions for the Virtual Special Meeting</a></span></td>
    <td style="text-align: right; font-weight: bold">38</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_047">Record Date</a></span></td>
    <td style="text-align: right; font-weight: bold">38</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_048">Outstanding Shares and Voting Rights of iCAD Stockholders</a></span></td>
    <td style="text-align: right; font-weight: bold">38</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#stoclist">Stockholder List</a></span></td>
    <td style="text-align: right; font-weight: bold">38</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_049">Quorum; Abstentions and Broker Non-Votes</a></span></td>
    <td style="text-align: right; font-weight: bold">38</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_050">Adjournment</a></span></td>
    <td style="text-align: right; font-weight: bold">39</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_051">Vote Required</a></span></td>
    <td style="text-align: right; font-weight: bold">39</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_052">How to Vote</a></span></td>
    <td style="text-align: right; font-weight: bold">40</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_053">Record Holders</a></span></td>
    <td style="text-align: right; font-weight: bold">40</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_054">Beneficial Owners</a></span></td>
    <td style="text-align: right; font-weight: bold">40</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_055">Proxies and Revocation</a></span></td>
    <td style="text-align: right; font-weight: bold">41</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_056">Inspector of Elections; Tabulation of Votes</a></span></td>
    <td style="text-align: right; font-weight: bold">41</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_057">Solicitation of Proxies</a></span></td>
    <td style="text-align: right; font-weight: bold">41</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#a_058">Other Matters</a></span></td>
    <td style="text-align: right; font-weight: bold">42</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#householding">Householding of Proxy Statement/Prospectus</a></span></td>
    <td style="text-align: right; font-weight: bold">42</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#questaddlinfo">Questions and Additional Information</a></span></td>
    <td style="text-align: right; font-weight: bold">42</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#themerger">THE MERGER</a></span></td>
    <td style="text-align: right; font-weight: bold">43</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#gen">General</a></span></td>
    <td style="text-align: right; font-weight: bold">43</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#parties"><span style="font-weight: normal">The Parties</span></a></td>
    <td style="text-align: right; font-weight: bold">44</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_001">Voting and Support Agreements</a></span></td>
    <td style="text-align: right; font-weight: bold">45</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_002">Background of the Merger</a></span></td>
    <td style="text-align: right; font-weight: bold">45</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_003">Recommendation of the iCAD Board of Directors and Reasons for the Merger</a></span></td>
    <td style="text-align: right; font-weight: bold">53&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_004">RadNet&#8217;s Reasons for the Merger</a></span></td>
    <td style="text-align: right; font-weight: bold">59&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_005">Certain iCAD Unaudited Prospective Financial Information</a></span></td>
    <td style="text-align: right; font-weight: bold">63&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_006">Opinion of iCAD&#8217;s Financial Advisor</a></span></td>
    <td style="text-align: right; font-weight: bold">66&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_011">Miscellaneous</a></span></td>
    <td style="text-align: right; font-weight: bold">75&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_013">Regulatory Approvals</a></span></td>
    <td style="text-align: right; font-weight: bold">77&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_014">Nasdaq Global Market Listing</a></span></td>
    <td style="text-align: right; font-weight: bold">77&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_015">Other Governmental Approvals</a></span></td>
    <td style="text-align: right; font-weight: bold">77&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_016">Timing</a></span></td>
    <td style="text-align: right; font-weight: bold">77&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_017">No Dissenters&#8217; or Appraisal Rights</a></span></td>
    <td style="text-align: right; font-weight: bold">78&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_018">Material U.S. Federal Income Tax Consequences of the Merger</a></span></td>
    <td style="text-align: right; font-weight: bold">78&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_019">Accounting Treatment</a></span></td>
    <td style="text-align: right; font-weight: bold">78&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_020">Delisting and Deregistration of Shares of iCAD Common Stock</a></span></td>
    <td style="text-align: right; font-weight: bold">78&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#s4_021">THE MERGER AGREEMENT</a></span></td>
    <td style="text-align: right; font-weight: bold">79&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><a href="#s4_022"><span style="font-weight: normal">Explanatory Note</span></a></td>
    <td style="text-align: right; font-weight: bold">79&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_023">Structure of the Merger</a></span></td>
    <td style="text-align: right; font-weight: bold">79&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_024">Completion and Effectiveness of the Merger</a></span></td>
    <td style="text-align: right; font-weight: bold">79&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_025">Merger Consideration</a></span></td>
    <td style="text-align: right; font-weight: bold">80&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_026">Governance Matters Following Completion of the Merger</a></span></td>
    <td style="text-align: right; font-weight: bold">80&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_027">Procedures for Surrendering iCAD Stock Certificates</a></span></td>
    <td style="text-align: right; font-weight: bold">80&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_028">Treatment of iCAD Options</a></span></td>
    <td style="text-align: right; font-weight: bold">82&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_029">Treatment of iCAD Employee Stock Purchase Plan</a></span></td>
    <td style="text-align: right; font-weight: bold">82&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_030">Listing of Shares of RadNet Common Stock</a></span></td>
    <td style="text-align: right; font-weight: bold">82&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_031">Conditions to Completion of the Merger</a></span></td>
    <td style="text-align: right; font-weight: bold">82&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_032">Representations and Warranties</a></span></td>
    <td style="text-align: right; font-weight: bold">84&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_033">Definition of &#8220;Material Adverse Effect&#8221;</a></span></td>
    <td style="text-align: right; font-weight: bold">85&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_034">Conduct of Business Pending the Merger</a></span></td>
    <td style="text-align: right; font-weight: bold">86&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_035">Obligation to Call the Special Meeting</a></span></td>
    <td style="text-align: right; font-weight: bold">89&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_036">No Solicitation</a></span></td>
    <td style="text-align: right; font-weight: bold">89&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_037">Obligation to Recommend Approval of the Merger Agreement Proposal</a></span></td>
    <td style="text-align: right; font-weight: bold">91&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_038">Reasonable Best Efforts</a></span></td>
    <td style="text-align: right; font-weight: bold">92&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_039">Indemnification and Insurance</a></span></td>
    <td style="text-align: right; font-weight: bold">94&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_040">Employee Matters</a></span></td>
    <td style="text-align: right; font-weight: bold">95&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_041">Section 16 Matters</a></span></td>
    <td style="text-align: right; font-weight: bold">96&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_042">Other Agreements</a></span></td>
    <td style="text-align: right; font-weight: bold">96&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_043">Termination of the Merger Agreement</a></span></td>
    <td style="text-align: right; font-weight: bold">97&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_044">Exclusive Remedy</a></span></td>
    <td style="text-align: right; font-weight: bold">98&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_045">Other Expenses</a></span></td>
    <td style="text-align: right; font-weight: bold">99&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_046">Governing Law</a></span></td>
    <td style="text-align: right; font-weight: bold">99&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_047">Specific Enforcement</a></span></td>
    <td style="text-align: right; font-weight: bold">99&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-weight: bold"><span style="font-weight: normal"><a href="#s4_048">Amendments; Waivers</a></span></td>
    <td style="text-align: right; font-weight: bold">99&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#s4_049">MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE MERGER</a></span></td>
    <td style="text-align: right; font-weight: bold">100&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#s4_050">CERTAIN BENEFICIAL OWNERS OF iCAD COMMON STOCK</a></span></td>
    <td style="text-align: right; font-weight: bold">104&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#s4_051">INTERESTS OF iCAD&#8217;S DIRECTORS AND EXECUTIVE OFFICERS IN THE MERGER</a></span></td>
    <td style="text-align: right; font-weight: bold">105&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#s4_052">PROPOSAL I&#8212;ADOPTION OF THE MERGER AGREEMENT</a></span></td>
    <td style="text-align: right; font-weight: bold">113&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#s4_054">PROPOSAL II&#8212;NON-BINDING ADVISORY VOTE ON TRANSACTION-RELATED COMPENSATION FOR CERTAIN iCAD EXECUTIVE OFFICERS</a></span></td>
    <td style="text-align: right; font-weight: bold">114&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#s4_053">PROPOSAL III&#8212;ADJOURNMENT OF THE SPECIAL MEETING</a></span></td>
    <td style="text-align: right; font-weight: bold">115&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#s4_055">DESCRIPTION OF RADNET CAPITAL STOCK</a></span></td>
    <td style="text-align: right; font-weight: bold">116&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#s4_056">COMPARISON OF STOCKHOLDER RIGHTS</a></span></td>
    <td style="text-align: right; font-weight: bold">117&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#s4_057">EXPERTS</a></span></td>
    <td style="text-align: right; font-weight: bold">123&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-weight: bold"><a href="#s4_058"><span style="font-weight: normal">LEGAL MATTERS</span></a></td>
    <td style="text-align: right; font-weight: bold">123&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#s4_059">FUTURE iCAD STOCKHOLDER PROPOSALS</a></span></td>
    <td style="text-align: right; font-weight: bold">124&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-weight: bold"><a href="#s4_060"><span style="font-weight: normal">WHERE YOU CAN FIND MORE INFORMATION</span></a></td>
    <td style="text-align: right; font-weight: bold">125&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font-weight: bold">&#160;</td>
    <td style="text-align: right; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-weight: bold"><span style="font-weight: normal"><a href="#annexa">Annex A - Agreement and Plan of Merger</a></span></td>
    <td style="text-align: right; font-weight: bold"><span style="font-weight: normal">A-1</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt"><a href="#annexb">Annex B - Opinion of Piper Sandler &amp; Co.</a></span></td>
    <td style="text-align: right"><span style="font-size: 10pt">B-1</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt"><a href="#annexc">Annex C - Form of Voting and Support Agreement</a></span></td>
    <td style="text-align: right"><span style="font-size: 10pt">C-1</span></td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ix<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="qna"></span>QUESTIONS AND ANSWERS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><i>The following are some questions that you,
as a stockholder of iCAD, may have regarding the Merger and other matters being considered at the Special Meeting, and brief answers to
those questions. To better understand these matters, and for a description of the legal terms governing the Merger, iCAD urges you to
carefully read the remainder of this proxy statement/prospectus because the information in this section does not provide all the information
that might be important to you with respect to the Merger and the other matters being considered at the Special Meeting. Additional important
information is also contained in the annexes to this proxy statement/prospectus and the documents incorporated by reference in this proxy
statement/prospectus. See the section titled &#8220;<a href="#s4_060">Where You Can Find More Information</a>&#8221; beginning on page 125 of this proxy statement/prospectus.
</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 27pt"><b>Q:</b></td><td><b>Why am I receiving this document? </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 27pt"><b>A:</b></td><td>RadNet, Merger Sub and iCAD have entered into the Merger Agreement, providing for the Merger of Merger Sub with and into iCAD, with
iCAD surviving the Merger as a wholly-owned subsidiary of RadNet. In order to complete the Merger, iCAD stockholders must approve the
proposal to adopt the Merger Agreement and all other conditions to the Merger must be satisfied or waived.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">iCAD will hold the Special Meeting to obtain the iCAD Stockholder
Approval and approvals with respect to certain other related matters. This proxy statement/prospectus, which you should read carefully,
contains important information about the Merger and other matters being considered at the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">This document is being delivered to you as both a proxy statement
of iCAD and a prospectus of RadNet in connection with the Merger. It is the proxy statement by which the iCAD Board is soliciting proxies
from iCAD stockholders to vote at the Special Meeting, or at any adjournment or postponement of the Special Meeting, on the approval of
each of the (i) Merger Agreement Proposal, (ii) Advisory Compensation Proposal and (iii) Adjournment Proposal, each as described more
fully herein. In addition, this document is the prospectus by which RadNet will issue shares of RadNet Common Stock to iCAD stockholders
in the Merger in accordance with the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">Your vote is important regardless of the amount of shares
of iCAD Common Stock that you own. We encourage you to vote as soon as possible.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 27pt"><b>Q:</b></td><td><b>What is the purpose of the Special Meeting? </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 27pt"><b>A:</b></td><td>At the Special Meeting, holders of iCAD Common Stock will act upon all the matters outlined in the Notice of Special Meeting of Stockholders.
These include:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">1.</td><td><b>Merger Agreement Proposal</b>: a proposal to adopt the Merger Agreement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">2.</td><td><b>Advisory Compensation Proposal</b>: a proposal to approve, on a non-binding, advisory basis, the compensation that may be paid
or become payable to iCAD&#8217;s named executive officers that is based on or otherwise related to the Merger; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">3.</td><td><b>Adjournment Proposal</b>: a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to solicit
additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 27pt"><b>Q:</b></td><td><b>What is a proxy and how does it work? </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 27pt"><b>A:</b></td><td>The iCAD Board is asking for your proxy. A &#8220;proxy&#8221; is your legal designation of another person to vote the stock you own
in the manner you direct. If you designate someone as your proxy in a written document, that document is also called a proxy or a proxy
card. By giving your proxy to the persons named as proxy holders in the proxy card accompanying this proxy statement/prospectus, you authorize
them to vote your shares of iCAD Common Stock at the Special Meeting in the manner you direct. You may cast votes &#8220;<b>FOR</b>,&#8221;
&#8220;<b>AGAINST</b>&#8221; or &#8220;<b>ABSTAIN</b>&#8221; with respect to both, either or neither of the matters we are submitting
to a vote of holders of iCAD Common Stock at the Special Meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">If you complete and submit your proxy in one of the manners
described below, but do not specify how to vote, the proxy holders will vote your shares &#8220;<b>FOR</b>&#8221; each of the proposals
described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 27pt"><b>Q:</b></td><td><b>What will iCAD stockholders receive for their shares of iCAD Common Stock in the Merger? </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 27pt"><b>A:</b></td><td>At the Effective Time, each share of iCAD Common Stock issued and outstanding immediately prior to the Effective Time (other than
the Excluded Shares) will be converted into the right to receive 0.0677 shares of RadNet Common Stock. No fractional shares of RadNet
Common Stock will be delivered to any holder of shares of iCAD Common Stock upon completion of the Merger. Instead, all fractional shares
of RadNet Common Stock that a holder of shares of iCAD Common Stock would otherwise be entitled to receive as a result of the Merger will
be aggregated and, if a fractional share results from such aggregation, such holder will be entitled to receive the cash proceeds from
the sale of such fractional share by the exchange agent for the account of such holder, without interest, in accordance with the Merger
Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">This Exchange Ratio is fixed and will not be adjusted for
changes in the market price of either iCAD Common Stock or RadNet Common Stock between the date of signing of the Merger Agreement and
the Effective Time. <b>As a result, the value of the shares of RadNet Common Stock to be received by iCAD stockholders in the Merger may
differ from the implied value based on the share price on the date of signing of the Merger Agreement or the date of the proxy statement/prospectus.
</b>Based on the closing price of RadNet Common Stock on April 14, 2025, the trading day before the public announcement of the signing
of the Merger Agreement, the Exchange Ratio would represent approximately $3.61 in implied value for each share of iCAD Common Stock on
a fully diluted basis. Based on the closing price of RadNet Common Stock on [ ], 2025, the last practicable date before the date of the
proxy statement/prospectus accompanying this notice, the Exchange Ratio would represent approximately $[ ] in implied value for each share
of iCAD Common Stock on a fully diluted basis. The market price of RadNet Common Stock when iCAD stockholders receive those shares after
the Merger is completed could be greater than, less than or the same as the market price of shares of RadNet Common Stock on such date,
the date of this proxy statement/prospectus or at the time of the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 27pt"><b>Q:</b></td><td><b>What will holders of iCAD Options receive in the Merger? </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 27pt"><b>A:</b></td><td>In general, at the Effective Time, each Eligible iCAD Option will be assumed by RadNet and converted into an option (A) to purchase
that number of shares of RadNet Common Stock equal to the product of (1) the number of shares of iCAD Common Stock subject to such Eligible
iCAD Option immediately prior to the Effective Time and (2) the Exchange Ratio, rounded down to the nearest whole number of shares, and
(B) with an exercise price per share equal to (1) the exercise price per share of iCAD Common Stock of such Eligible iCAD Option immediately
prior to the Effective Time, divided by (2) the Exchange Ratio, rounded up to the nearest whole cent (each, an &#8220;Assumed Option&#8221;).
Each Assumed Option will continue to have, and will be subject to, the same terms and conditions (including the vesting and exercisability
conditions (including any acceleration provisions) and expiration date) that applied to the corresponding Eligible iCAD Option as in effect
immediately prior to the Effective Time, other than any terms that become inoperative by reason of the transactions contemplated pursuant
to the Merger Agreement. Each iCAD Option that is not an Eligible iCAD Option will not be assumed or otherwise substituted by RadNet and
will automatically terminate and cease to be outstanding as of the Effective Time. See the section titled &#8220;<i><a href="#s4_028">The Merger Agreement&#8212;Treatment of iCAD Options</a></i>&#8221; beginning on page 82 of this proxy statement/prospectus.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27pt"><b>Q:</b></td><td><b>If I am a holder of iCAD Common Stock, how will I receive the Merger Consideration to which I am entitled? </b></td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                <tr style="vertical-align: top">
<td><b>A:</b></td><td>If, at the Effective Time, you
hold your shares of iCAD Common Stock in book-entry form, whether through The Depository Trust Company, which is referred to as &#8220;DTC,&#8221;
or otherwise, you will not be required to take any specific actions to exchange your shares of iCAD Common Stock for shares of RadNet
Common Stock and, if applicable, cash consideration in lieu of any fractional shares. Such shares will, following the Effective Time,
be automatically exchanged for shares of RadNet Common Stock (in book-entry form) and cash in lieu of any fractional shares of RadNet
Common Stock to which you are entitled. If, at the Effective Time, you instead hold your shares of iCAD Common Stock in certificated form,
then, after receiving the proper documentation from you following the Effective Time, the exchange agent will deliver to you the shares
of RadNet Common Stock (in book-entry form) and cash in lieu of any fractional shares of RadNet Common Stock to which you are entitled.
See the section titled &#8220;<i><a href="#s4_027">The Merger Agreement&#8212;Procedures for Surrendering iCAD Stock Certificates</a></i>&#8221; beginning on
page 80 of this proxy statement/prospectus.</td></tr>
                                                                                                                                                                                                <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>Who will own RadNet Common Stock immediately following the transactions?</b></td></tr>
                                                                                                                                                                                                </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
                                                                             <tr style="vertical-align: top">
<td style="width: 27pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</td></tr>
                                                                             <tr style="vertical-align: top">
<td><b>A:</b></td><td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under
                                            the terms of the agreement, iCAD stockholders will receive 0.0677 shares of RadNet Common
                                            Stock for each share of iCAD Common Stock they hold at the Effective Time. Based on (i) the
                                            Exchange Ratio of 0.0677 and (ii) the number of shares of iCAD Common Stock and Eligible
                                            iCAD Options outstanding as of the iCAD Record Date, RadNet estimates that it will issue
                                            approximately 2,024,584 shares of RadNet Common Stock pursuant to the Merger Agreement, provided
                                            that if additional iCAD equity awards are granted to certain iCAD employees as permitted
                                            under the Merger Agreement, RadNet may be required to reserve additional shares of RadNet
                                            Common Stock for issuance (see the section titled &#8220;<i>The Merger Agreement&#8212;Treatment
                                            of iCAD Options</i>&#8221;). Based upon the foregoing and the estimated number of shares
                                            of common stock of each of iCAD and RadNet that are expected to be outstanding immediately
                                            prior to the consummation of the Merger, RadNet and iCAD estimate that, as of immediately
                                            following completion of the Merger, holders of RadNet Common Stock as of immediately prior
                                            to the Merger will hold approximately 97.4% and holders of iCAD Common Stock as of immediately
                                            prior to the Merger will hold approximately 2.6% of the outstanding shares of RadNet Common
                                            Stock on a fully diluted basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
</td></tr>
                                                                             </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">Because the Exchange Ratio is fixed, the relative ownership
interests of RadNet stockholders and former iCAD stockholders immediately following the Merger will depend on the number of shares of
RadNet Common Stock and iCAD Common Stock issued and outstanding immediately prior to the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>How important is my vote?</b></td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 27pt"><b>A:</b></td><td>Your vote &#8220;<b>FOR</b>&#8221; each proposal presented at the Special Meeting is very important regardless of the number of shares
of iCAD Common Stock that you own, and you are encouraged to submit a proxy or proxies as soon as possible.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                     <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>What vote is required to approve each proposal at the Special Meeting?</b></td></tr>
                                                                                                                     </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 27pt"><b>A</b>:</td><td>Approval of the Merger Agreement Proposal requires the affirmative
vote of the holders of a majority of all outstanding shares of iCAD Common Stock entitled to vote on the Merger Agreement Proposal. <b>Any
abstention by a holder of iCAD Common Stock, broker non-votes (described in more detail below in <i>&#8220;&#8212;If my shares are held
in &#8220;street name&#8221; by my broker, bank or other nominee, will my broker, bank or other nominee automatically vote my shares
for me?</i>&#8221; beginning on page 8 of this proxy statement/prospectus), or the failure of any holder of iCAD Common Stock to submit
a vote will have the same effect as voting &#8220;AGAINST&#8221; the Merger Agreement Proposal.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">Approval of the Advisory Compensation Proposal requires the
affirmative vote of a majority of votes present or represented by proxy at the Special Meeting and entitled to vote on such proposal.
Any abstention by a holder of iCAD Common Stock or the failure of any holder of iCAD Common Stock to submit a vote will have the same
effect as voting &#8220;<b>AGAINST</b>&#8221; the Advisory Compensation Proposal. Broker non-votes will have no effect on the outcome
of the Advisory Compensation Proposal. Because the Advisory Compensation Proposal is non-binding, if the Merger Agreement is adopted by
iCAD stockholders and the Merger is completed, the compensation that is the subject of the Advisory Compensation Proposal, including amounts
iCAD is contractually obligated to pay, would still be paid regardless of the outcome of the non-binding advisory vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">Approval of the Adjournment Proposal requires the affirmative
vote of a majority of votes present or represented by proxy at the Special Meeting and entitled to vote on such proposal. Any abstention
by a holder of iCAD Common Stock or the failure of any holder of iCAD Common Stock to submit a vote will have the same effect as voting
&#8220;<b>AGAINST</b>&#8221; the Advisory Compensation Proposal. Broker non-votes will have no effect on the outcome of the Adjournment
Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">See the section titled &#8220;<i><a href="#a_051">The iCAD Special Meeting&#8212;Vote Required</a></i>&#8221; beginning on page 39 of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>How does the iCAD Board recommend that I vote?</b></td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 27pt"><b>A:</b></td><td>At a meeting held on April 15, 2025, the iCAD Board unanimously (i) approved and declared advisable the Merger Agreement and the transactions
contemplated therein, including the Merger, on the terms and subject to the conditions set forth therein, (ii) determined that the Merger
Agreement and the consummation of the transactions contemplated thereby, (including the Merger), are advisable and fair to, and in the
best interests of, iCAD and the stockholders of iCAD, (iii) resolved to recommend the adoption of the Merger Agreement to the stockholders
of iCAD, on the terms and subject to the conditions set forth therein, and (iv) directed that the Merger Agreement be submitted to the
stockholders of iCAD for adoption at the Special Meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">Accordingly, the iCAD Board unanimously recommends that holders
of iCAD Common Stock vote &#8220;<b>FOR</b>&#8221; the Merger Agreement Proposal, &#8220;<b>FOR</b>&#8221; the Advisory Compensation Proposal
and &#8220;<b>FOR</b>&#8221; the Adjournment Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>Are there any iCAD stockholders who have already committed to voting in favor of the proposals
                                 at the Special Meeting?</b></td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>Yes. Pursuant to the Voting and Support Agreements, each
                                        Voting and Support Agreement Stockholder (who collectively beneficially own, in the aggregate,
                                        approximately 5.5% of the issued and outstanding shares of iCAD Common Stock as of the iCAD Record
                                        Date) has agreed to vote the shares of iCAD Common Stock beneficially owned by such Voting and
                                        Support Agreement Stockholder in favor of, among other things, the Merger Agreement Proposal.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">See the section titled &#8220;<i><a href="#s4_001">The Merger&#8212;Voting and Support Agreements</a></i>&#8221; beginning on page 45 of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 22.5pt"><b>Q:</b></td><td><b>Are RadNet stockholders voting on the Merger? </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 22.5pt"><b>A:</b></td><td>No. No vote of RadNet&#8217;s stockholders is required to complete the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 22.5pt"><b>Q:</b></td><td><b>Will RadNet Common Stock received at the time of completion of the Merger be traded on an exchange? </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>Yes. It is a condition to the consummation of the Merger that the shares of RadNet Common Stock to be issued to iCAD stockholders
in connection with the Merger be authorized for listing on The Nasdaq Global Market, subject to official notice of issuance.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                      <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>How will RadNet stockholders be affected by the Merger?</b></td></tr>
                                                                                                                                      </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 22.5pt"><b>A:</b></td><td>Upon completion of the Merger, each RadNet stockholder will hold the same number of shares of RadNet stock that such stockholder held
immediately prior to completion of the Merger. As a result of the Merger, RadNet stockholders will own shares in a larger consolidated
company with more assets. However, because RadNet will be issuing additional shares of RadNet Common Stock to iCAD stockholders in exchange
for their shares of iCAD Common Stock in connection with the Merger, each outstanding share of RadNet Common Stock, as of immediately
prior to the Merger, will represent a smaller percentage of the aggregate number of shares of RadNet Common Stock outstanding after the
Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>What are the material U.S. federal income tax consequences of the Merger to holders of iCAD Common Stock?</b></td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td><b>A:</b></td><td>Material U.S. federal income tax consequences that
may be relevant to you in respect of the Merger are discussed in more detail in the section titled &#8220;<i><a href="#s4_049">Material U.S. Federal Income Tax Consequences of the Merger</a></i>&#8221; beginning on page 100 of this proxy statement/prospectus. The discussion of the U.S. federal
income tax consequences contained in this proxy statement/prospectus is intended to provide only a general discussion and is not a complete
analysis or description of all the U.S. federal income tax considerations that are applicable to you in respect of the Merger, nor does
it address any tax considerations arising under U.S. state or local or non-U.S. tax laws. TAX MATTERS ARE COMPLICATED, AND THE TAX CONSEQUENCES
OF THE MERGER WILL DEPEND ON THE FACTS OF YOUR OWN SITUATION. YOU SHOULD CONSULT YOUR TAX ADVISOR AS TO THE SPECIFIC TAX CONSEQUENCES
OF THE MERGER TO YOU IN YOUR PARTICULAR CIRCUMSTANCES.</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>When do RadNet and iCAD expect to complete the Merger?</b></td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>RadNet and iCAD currently expect to complete the Merger in the second or third quarter of 2025, subject to timing of satisfaction
of closing conditions to the Merger. However, neither RadNet nor iCAD can predict the actual date on which the Merger will be completed,
nor can the parties provide any assurance that the Merger will be completed. See the sections titled &#8220;<i><a href="#a_031">Risk Factors</a></i>,&#8221;
and &#8220;<i><a href="#s4_031">The Merger Agreement&#8212;Conditions to Completion of the Merger</a></i>&#8221; beginning on pages 26 and 82, respectively,
of this proxy statement/prospectus.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                             <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>Is the completion of the Merger subject to any conditions?</b></td></tr>

<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>Yes. RadNet, Merger Sub and iCAD are not required to complete the Merger unless certain conditions are satisfied (or, to the extent
permitted by applicable law, waived). These conditions include, among others, the adoption of the Merger Agreement by holders of a majority
of iCAD Common Stock. For a more complete summary of the conditions that must be satisfied (or, to the extent permitted by applicable
law, waived) prior to completion of the Merger, see the section titled &#8220;<i><a href="#s4_031">The Merger Agreement&#8212;Conditions to Completion of the Merger</a></i>&#8221; beginning on page 82 of this proxy statement/prospectus.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                         <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>What happens if the Merger is not completed?</b></td></tr>

<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>In the event that the Merger Agreement is not adopted by iCAD&#8217;s stockholders at the Special Meeting or the Merger is not completed
for any other reason, iCAD&#8217;s stockholders will not receive any consideration for shares of iCAD stock they own. Instead, it is expected
that iCAD will remain an independent public company, iCAD Common Stock will continue to be listed and traded on The Nasdaq Capital Market
and registered under the Exchange Act, and iCAD will continue to file periodic reports with the SEC on account of the iCAD Common Stock.
If the Merger is not completed for any reason, including as a result of iCAD stockholders failing to approve the Merger Agreement Proposal,
the ongoing businesses of iCAD may be adversely affected, and the anticipated benefits of having completed the Merger will not be realized.
See the section titled &#8220;<i><a href="#failuretocomplete">Risk Factors&#8212;Failure to complete the Merger could negatively impact the stock price and the future business and financial results of iCAD</a></i>&#8221; beginning on page 31 of this proxy statement/prospectus.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                     <tr style="vertical-align: top">
<td>&#160;</td><td>Under specified circumstances, iCAD may be required to pay
a termination fee upon termination of the Merger Agreement, as described under the section titled &#8220;<i><a href="#s4_043">The Merger Agreement&#8212;Termination of the Merger Agreement</a></i>&#8221; beginning on page 97 of this proxy statement/prospectus.</td></tr>
                                                                                                                     </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>When and where is the Special Meeting?</b></td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>The Special Meeting will be a virtual only meeting conducted exclusively via live webcast
                                        at www.cstproxy.com/icad/sm2025 starting at 9:00 a.m., Eastern Time (with log-in beginning at
                                        8:45 a.m. Eastern Time), on July 14, 2025. If your shares are registered in your name with Continental,
                                        and you wish to attend the online-only virtual Special Meeting, go to www.cstproxy.com/icad/sm2025,
                                        enter the control number you received on your proxy card or notice of the Special Meeting and
                                        click on the &#8220;Click here to preregister for the online meeting&#8221; link at the top of
                                        the page. Just prior to the start of the Special Meeting you will need to log back into the Special
                                        Meeting site using your control number. Pre-registration is recommended but is not required in
                                        order to attend. Beneficial stockholders who wish to attend the online-only virtual Special Meeting
                                        must obtain a legal proxy by contacting their account representative at the bank, broker, or
                                        other nominee that holds their shares and e-mail a copy (a legible photograph is sufficient)
                                        of their legal proxy to proxy@continentalstock.com. Beneficial stockholders who e-mail a valid
                                        legal proxy will be issued a meeting control number that will allow them to register to attend
                                        and participate in the online-only virtual Special Meeting. After contacting Continental a beneficial
                                        holder will receive an e-mail prior to the Special Meeting with a link and instructions for entering
                                        the virtual Special Meeting. Beneficial stockholders should contact Continental at least five
                                        business days prior to the Special Meeting.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                   <tr style="vertical-align: top">
<td>&#160;</td><td>Because the Special Meeting is completely virtual and being
conducted via live webcast, stockholders will not be able to attend the Special Meeting in person.</td></tr>
                                                                   <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                   <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>Who can vote at, and what is the record date of, the Special Meeting?</b></td></tr>
                                                                   </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>All iCAD stockholders who hold shares of iCAD Common Stock of record at the close of business on the iCAD Record Date, are entitled
to receive notice of, and to vote, at the Special Meeting.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                    <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>How many votes may I cast?</b></td></tr>

<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>Each issued and outstanding share of iCAD Common Stock entitles its holder of record to one vote on each matter to be considered
                                        at the Special Meeting. As of the iCAD Record Date, there were 27,470,869 shares of iCAD Common Stock outstanding. The iCAD
                                        stockholders of record on the iCAD Record Date are the only iCAD stockholders that are entitled to receive notice of, and to vote
                                        at, the Special Meeting or any adjournments or postponements thereof.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                    <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>What constitutes a quorum at the Special Meeting?</b></td></tr>

<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>In order for business to be conducted at the Special Meeting, a quorum must be present. A quorum at the Special Meeting requires the
presence of the holders of a majority of the total issued and outstanding shares of iCAD Common Stock entitled to vote, present virtually
or represented by proxy, at the Special Meeting.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>Abstentions will count as votes present and entitled to
vote for the purpose of determining the presence of a quorum for the transaction of business at the Special Meeting. Since all of the
proposals currently expected to be voted on at the Special Meeting are considered non-routine and non-discretionary matters, shares held
in &#8220;street name&#8221; through a broker, bank or other nominee are not expected to be counted as present for the purpose of determining
the existence of a quorum if such broker, bank or other nominee does not have instructions to vote on any such proposal.</td></tr>
                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                          <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>What do I need to do now?</b></td></tr>

<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>After you have carefully read and considered the information contained in or incorporated by reference into this proxy statement/prospectus,
please submit your proxy via the internet or by telephone in accordance with the instructions set forth on the enclosed proxy card or
voting instruction form you received, or complete, sign, date and return the enclosed proxy card or voting instruction form in the self-addressed,
stamped envelope provided as soon as possible so that your shares will be represented and voted at the Special Meeting.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                 <tr style="vertical-align: top">
<td>&#160;</td><td>Additional information on voting procedures can be found
under the section titled &#8220;<i><a href="#a_034">The iCAD Special Meeting</a></i>&#8221; beginning on page 36 of this proxy statement/prospectus.</td></tr>
                                                                                                                                 </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>How will my proxy be voted?</b></td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>If you submit your proxy via the internet, by telephone or by completing, signing, dating and returning the enclosed proxy card or
voting instruction form, your proxy will be voted in accordance with your instructions. If you sign your proxy card and return it without
indicating how you would like to vote your shares, your proxy card will be voted in accordance with the recommendation of the iCAD Board.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                   <tr style="vertical-align: top">
<td>&#160;</td><td>Additional information on voting procedures can be found
under the section titled &#8220;<i><a href="#a_034">The iCAD Special Meeting</a></i>&#8221; beginning on page 36 of this proxy statement/prospectus.</td></tr>
                                                                                                                                                   <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                   <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>Who will count the votes?</b></td></tr>
                                                                                                                                                   <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>

<tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>A representative of Continental will tabulate the votes and may act as inspector of elections.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                              <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>How do I vote my shares if I am a stockholder of record?</b></td></tr>
                                                                                                                                                                              </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 22.5pt"><b>A:</b></td><td>iCAD stockholders of record at the close of business on May
                                            16, 2025 may vote in one of the following ways:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Internet</i></b>:
                                            iCAD stockholders of record may submit their proxy over the internet by following the instructions
                                            on the proxy card. Internet voting is available 24 hours a day and will be accessible until
                                            11:59 p.m., Eastern Time, on July 13, 2025. Stockholders will be given an opportunity to
                                            confirm that their voting instructions have been properly recorded. iCAD stockholders who
                                            submit a proxy this way need not send in their proxy card.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Telephone</i></b>:
                                            iCAD stockholders of record may submit their proxy by calling 1-(866)-894-0536. Telephone
                                            voting is available 24 hours a day and will be accessible until 11:59 p.m., Eastern Time,
                                            on July 13, 2025. Voice prompts will guide stockholders through the voting and allow them
                                            to confirm that their instructions have been properly recorded. iCAD stockholders who submit
                                            a proxy this way need not send in their proxy card.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Mail</i></b>: iCAD stockholders of record may submit their proxy by properly completing, signing, dating and mailing their proxy
card or voting instruction form in the self-addressed, stamped envelope (if mailed in the United States) included with this proxy statement/prospectus.
iCAD stockholders who vote this way should mail the proxy card early enough so that it is received prior to the closing of the polls at
the Special Meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Online During the Virtual Special Meeting</i></b>: iCAD stockholders of record may attend the virtual Special Meeting by entering
his, her or its unique control number and vote online; attendance at the virtual Special Meeting will not, however, in and of itself constitute
a vote or a revocation of a prior proxy.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">If you are a beneficial holder of iCAD Common Stock, you
must obtain a legal proxy by contacting your account representative at the bank, broker, or other nominee that holds your shares and e-mail
a copy (a legible photograph is sufficient) of their legal proxy to proxy@continentalstock.com. Beneficial stockholders who e-mail a valid
legal proxy will be issued a meeting control number that will allow them to register to attend and participate in the online-only virtual
Special Meeting. After contacting Continental, you will receive an e-mail prior to the Special Meeting with a link and instructions for
entering the virtual Special Meeting. You should contact Continental at least five business days prior to the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>How can I vote during the Special Meeting?</b></td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>All stockholders of record may vote online during the Special Meeting using the unique control number found on your proxy card or
notice of the Special Meeting. Street name holders may vote online during the Special Meeting if they have been issued a meeting control
number. If you do not have a control number, please contact your broker, bank or other nominee as soon as possible so that you can be
provided with a control number.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">Whether you plan to attend the Special Meeting or not, we
encourage you to vote by proxy as soon as possible.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>How can I submit a question at the Special Meeting?</b></td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td><b>A:</b></td><td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stockholders
                      attending the Special Meeting will be in a listen-only mode and will not be able to speak during the webcast. However,
                      stockholders have multiple opportunities to submit questions to iCAD for the Special Meeting. Stockholders who
                      wish to submit a question in advance may do so at https://www.cstproxy.com/icad/sm2025. Stockholders may also submit
                      questions online during the meeting at https://www.cstproxy.com/icad/sm2025. Given time constraints, some questions
                      may not be addressed during the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
</td></tr>
                                                                             <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                    <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>Who do I contact if I am encountering difficulties attending the Special Meeting online?</b></td></tr>

<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td><b>A:</b></td><td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you encounter
                      any difficulties during the check-in process or during the Special Meeting, please call (917) 262-2373, and a technician
                      will be ready to assist you starting at 8:45 a.m., Eastern Time, and until the Special Meeting has finished. Please
                      give yourself sufficient time to log-in and ensure you can hear the streaming audio before the Special Meeting
                      starts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
</td></tr>
                                                                             <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                  <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>What should I do if I receive more than one set of voting materials for the Special Meeting?</b></td></tr>

<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>You may receive more than one set of voting materials for the Special Meeting, including multiple copies of this proxy statement/prospectus
and multiple proxy cards or voting instruction forms. For example, if you hold your shares of iCAD Common Stock in more than one brokerage
account, you will receive a separate voting instruction form for each brokerage account in which you hold shares. If you are a holder
of record of iCAD Common Stock and your shares are registered in more than one name, you will receive more than one proxy card. Please
submit each separate proxy or voting instruction form that you receive by following the instructions set forth in each separate proxy
or voting instruction form. If you fail to submit each separate proxy or voting instruction form that you receive, not all of your shares
will be voted.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>

<tr style="vertical-align: top">
<td style="width: 27pt"><b>Q:</b></td><td><b>What&#8217;s the difference between holding shares as a stockholder of record and holding shares as a beneficial owner? </b></td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>

<tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>If your shares of iCAD Common Stock are registered directly in your name with iCAD&#8217;s transfer agent, Continental, you are considered,
with respect to those shares, to be the stockholder of record. If you are a stockholder of record, then this proxy statement/prospectus
and your proxy card have been sent directly to you by iCAD.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                     <tr style="vertical-align: top">
<td>&#160;</td><td>If your shares of iCAD Common Stock are held through a bank,
broker or other nominee, you are considered the beneficial owner of shares of iCAD Common Stock held in &#8220;street name.&#8221; In
that case, this proxy statement/prospectus has been forwarded to you by your bank, broker or other nominee who is considered, with respect
to <b>those</b> shares, to be the stockholder of record. As the beneficial owner, you have the right to direct your bank, broker or other
nominee how to vote your shares by following their instructions for voting, and you are also invited to attend the Special Meeting. However,
because you are not the stockholder of record, you may not vote your shares at the Special Meeting unless you obtain a legal proxy by
contacting your account representative at the bank, broker, or other nominee that holds your shares and e-mailing a copy (a legible photograph
is sufficient) of your legal proxy to proxy@continentalstock.com. Beneficial stockholders who e-mail a valid legal proxy will be issued
a meeting control number that will allow them to register to attend and participate in the online-only virtual Special Meeting.</td></tr>
                                                                     </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"><b>Q:</b></td><td><b>If my shares are held in &#8220;street name&#8221; by my broker, bank or other nominee, will my broker, bank or other nominee automatically
vote my shares for me? </b></td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>

<tr style="vertical-align: top">
<td><b>A:</b></td><td>No. If your shares are held in the name of a broker, bank or other nominee, you will receive separate instructions from your broker,
bank or other nominee describing how to vote your shares. The availability of the Internet or telephonic voting will depend on your broker&#8217;s,
bank&#8217;s or other nominee&#8217;s voting process. Please check with your broker, bank or other nominee and follow the voting procedures
provided by your broker, bank or other nominee on your voting instruction form.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">You should instruct your broker, bank or other nominee how
to vote your shares. Under the rules applicable to broker-dealers, your broker, bank or other nominee has discretionary authority to vote
on proposals that are considered routine but does not have discretionary authority to vote your shares on proposals that are considered
non-routine, and each of the proposals to be voted on at the Special Meeting is considered non-routine. As a result, no broker will be
permitted to vote your shares at the Special Meeting without receiving instructions from you, and, hence, we do not expect any broker
non-votes at the Special Meeting. Therefore, it is important that you cast your vote or instruct your broker, bank or other nominee on
how you wish to vote your shares of iCAD Common Stock. A so-called &#8220;broker non-vote&#8221; results when banks, brokers and other
nominees return a valid proxy but do not vote on a particular proposal because they do not have discretionary authority to vote on the
matter and have not received specific voting instructions from the beneficial owner of such shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">Therefore, if you are an iCAD stockholder whose shares of
iCAD Common Stock are held in street name and you do not instruct your broker, bank or other nominee on how to vote your shares:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>your broker, bank or other nominee may not vote your shares on the Merger Agreement Proposal, which will have the same effect as a
vote &#8220;<b>AGAINST</b>&#8221; such proposal;	</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>your broker, bank or other nominee may not vote your shares on the Advisory Compensation Proposal, which will have no effect on the
vote count for such proposal; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>your broker, bank or other nominee may not vote your shares on the Adjournment Proposal, which will have no effect on the vote count
for such proposal.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">A quorum at the Special Meeting requires the presence of
the holders of a majority of the total issued and outstanding shares of iCAD Common Stock entitled to vote, present virtually or represented
by proxy, at the Special Meeting. Abstentions will count as votes present and entitled to vote for the purpose of determining the presence
of a quorum for the transaction of business at the Special Meeting. Since all of the proposals currently expected to be voted on at the
Special Meeting are considered non-routine and non-discretionary matters, shares held in &#8220;street name&#8221; through a broker, bank
or other nominee are not expected to be counted as present for the purpose of determining the existence of a quorum if such broker, bank
or other nominee does not have instructions to vote on any such proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">Additional information on voting procedures can be found
under the section titled &#8220;<i><a href="#a_034">The iCAD Special Meeting</a></i>&#8221; beginning on page 36 of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>What do I do if I am an iCAD stockholder and I want to revoke my proxy?</b></td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>iCAD stockholders of record may revoke their proxies at any time before their shares of iCAD Common Stock are voted at the Special
Meeting in any of the following ways:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>delivering written
                                            notice of revocation of the proxy to iCAD&#8217;s corporate secretary at iCAD&#8217;s principal
                                            executive offices at 2 Townsend West, Suite 6, Nashua, New Hampshire 03063, by no later than
                                            11:59 p.m., Eastern Time, on July 13, 2025;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>delivering another
                                            proxy with a later date to iCAD&#8217;s corporate secretary at iCAD&#8217;s principal executive
                                            offices at 2 Townsend West, Suite 6, Nashua, New Hampshire 03063, by no later than 11:59
                                            p.m., Eastern Time, on July 13, 2025 (in which case only the later-dated proxy is counted
                                            and the earlier proxy is revoked);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>submitting another
                                            proxy again via the internet or by telephone at a later date, by no later than 11:59 p.m.,
                                            Eastern Time, on July 13, 2025 (in which case only the later-dated proxy is counted and the
                                            earlier proxy is revoked); or</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>attending the Special Meeting virtually, using his, her or its unique control number and voting their shares online during the Special
Meeting; attendance at the virtual Special Meeting will not, in and of itself, revoke a valid proxy that was previously delivered unless
you give written notice of revocation to the iCAD corporate secretary before the proxy is exercised or unless you vote your shares online
during the Special Meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">If an iCAD stockholder holds shares through a bank,
broker or other nominee, such stockholder may change or revoke his, her or its voting instructions before the Special Meeting by providing
instructions again through the means specified on his, her or its voting instruction form (with most having the option to do so by internet,
telephone or mail), which must be received before 11:59 p.m., Eastern Time, on July 13, 2025. Alternatively, an iCAD stockholder may
also revoke their proxy by attending the Special Meeting virtually, using his, her or its unique control number and voting his, her or
its shares online during the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">Additional information can be found under the section titled
&#8220;<i><a href="#a_034">The iCAD Special Meeting</a></i>&#8221; beginning on page 36 of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 22.5pt"><b>Q:</b></td><td><b>What happens if I sell or otherwise transfer my shares of iCAD Common Stock before the Special Meeting? </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 22.5pt"><b>A:</b></td><td>The iCAD Record Date is prior to the date of the Special Meeting. If you sell or otherwise transfer your shares of iCAD Common Stock
after the iCAD Record Date but before the Special Meeting, unless special arrangements (such as provision of a proxy) are made between
you and the person to whom you transfer your shares of iCAD Common Stock, you will retain your right to vote such shares at the Special
Meeting but will otherwise transfer ownership of and the economic interest in your shares of iCAD Common Stock.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 22.5pt"><b>Q:</b></td><td><b>What happens if I sell or otherwise transfer my shares of iCAD Common Stock before the completion of the Merger? </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 22.5pt"><b>A:</b></td><td>Only holders of shares of iCAD Common Stock at the Effective Time will become entitled to receive the Merger Consideration. If you
sell your shares of iCAD Common Stock prior to the completion of the Merger, you will not be entitled to receive the Merger Consideration
by virtue of the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 22.5pt"><b>Q:</b></td><td><b>Do any of the directors or executive officers of iCAD have interests in the Merger that may differ from or be in addition to my
interests as an iCAD stockholder? </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 22.5pt"><b>A:</b></td><td>In considering the recommendation of the iCAD Board that iCAD stockholders vote to approve each of the Merger Agreement Proposal,
the Advisory Compensation Proposal and the Adjournment Proposal, iCAD stockholders should be aware that iCAD&#8217;s directors and executive
officers have interests in the Merger that may be different from, or in addition to, the interests of iCAD stockholders generally. These
interests may include, among others:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>rights to continued indemnification and insurance coverage;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>payment to iCAD non-employee directors of the unpaid portion of their full annual cash retainer under iCAD&#8217;s non-employee director
compensation program for the service year in which the closing of the Merger occurs;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>issuance of options to receive shares of RadNet Common Stock in exchange for Eligible iCAD Options;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>acceleration of vesting of  unvested Eligible iCAD Options held by directors and executive officers;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>extension of the exercise period applicable to certain iCAD Options held by directors and executive officers;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>cash bonuses payable to iCAD&#8217;s Chief Executive Officer and Chief Financial Officer upon closing of the Merger; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>severance payments and benefits.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">The iCAD Board was aware of and considered these potential
interests, among other matters, in evaluating and negotiating the Merger Agreement and the transactions contemplated thereby, in approving
the Merger and in recommending the adoption of the Merger Agreement, the approval of the Advisory Compensation Proposal and the approval
of the Adjournment Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">For more information and quantification of these interests,
see the section titled &#8220;<i><a href="#interests">Interests of iCAD&#8217;s Directors and Executive Officers in the Merger</a></i>&#8221; beginning on page
18 of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>Where can I find voting results of the Special Meeting?</b></td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 22.5pt"><b>A:</b></td><td>iCAD intends to announce preliminary voting results at the Special Meeting and publish the final results in a Current Report on Form
8-K that will be filed with the SEC following the Special Meeting. All reports that iCAD and RadNet file with the SEC are publicly available
when filed. See the section titled &#8220;<i><a href="#s4_060">Where You Can Find More Information</a></i>&#8221; beginning on page 125 of this proxy statement/prospectus.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                               <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>Are there risks associated with the Merger that I should consider in deciding how to vote?</b></td></tr>

<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td><b>A:</b></td><td>Yes. There are a number of risks related to the Merger and the other transactions contemplated by the Merger Agreement that are discussed
in this proxy statement/prospectus and in the documents incorporated by reference into this proxy statement/prospectus. Please read carefully
the detailed description of the risks described in the section titled &#8220;<i><a href="#a_031">Risk Factors</a></i>&#8221; beginning on page 26 of this
proxy statement/prospectus.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                     <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>Do iCAD stockholders have dissenters&#8217; or appraisal rights?</b></td></tr>
                                     <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>

<tr style="vertical-align: top">
<td><b>A:</b></td><td>iCAD stockholders are not entitled to dissenters&#8217; or appraisal rights in connection with the Merger. See
the section titled &#8220;<i><a href="#s4_017">The Merger&#8212;No Dissenters&#8217; or Appraisal Rights</a></i>&#8221;
beginning on page 78 of this proxy statement/prospectus.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                         <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>How can I find more information about RadNet and iCAD?</b></td></tr>

<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td><b>A:</b></td><td>You can find more information about RadNet and iCAD from various sources described in the section titled &#8220;<i><a href="#s4_060">Where You Can Find More Information</a></i>&#8221; beginning on page 125 of this proxy statement/prospectus.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
                                                                                               <tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>Who will solicit and pay the cost of soliciting proxies?</b></td></tr>

<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td><b>A:</b></td><td>The iCAD Board is soliciting your proxy and iCAD will pay for the proxy solicitation costs related to the Special Meeting. In addition
to sending and making available these materials, some of iCAD&#8217;s directors, officers and other employees may solicit proxies by contacting
iCAD&#8217;s stockholders by telephone, by mail, by e-mail or online. iCAD stockholders may also be solicited by, among others, news releases
issued by iCAD and/or RadNet, postings on iCAD&#8217;s or RadNet&#8217;s websites and social media accounts and advertisements in periodicals.
None of iCAD&#8217;s directors, officers or employees will receive any extra compensation for their solicitation services. iCAD has also
retained Campaign Management as its proxy solicitor to assist in the solicitation of proxies. For these proxy solicitation services, Campaign
Management will receive an estimated fee of approximately $13,000, plus reasonable out-of-pocket expenses and fees for any additional
services. iCAD will also reimburse banks, brokers, and other nominees for their expenses in sending proxy solicitation materials to the
beneficial owners of shares of iCAD Common Stock and obtaining their proxies.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>

<tr style="vertical-align: top">
<td><b>Q:</b></td><td><b>Who can answer any questions I may have about the Special Meeting, the Merger or the transactions contemplated by the Merger Agreement?
</b></td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>

<tr style="vertical-align: top">
<td><b>A:</b></td><td>If you have any questions about the Special Meeting, the Merger or the other transactions contemplated by the Merger Agreement or
how to submit your proxy, or if you need additional copies of this proxy statement/prospectus or documents incorporated by reference herein,
the enclosed proxy card or voting instructions, you should contact iCAD or iCAD&#8217;s proxy solicitor:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>iCAD, Inc. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2 Townsend West, Suite 6<br/>
Nashua, New Hampshire 03063<br/>
Attention: Investor Relations<br/>
(603) 882-5200</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>or </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Campaign Management</b><br/>
15 West 38th Street, Suite #747,<br/>
New York, New York 10018<br/>
North American Toll-Free Phone:&#160;1-844-394-4517<br/>
Email: info@campaign-mgmt.com<br/>
Call Collect Outside North America: +1 (212) 632-8422</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="summary"></span>SUMMARY</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><i>This summary highlights selected information
from this proxy statement/prospectus. It may not contain all of the information that is important to you. You are urged to read carefully
the entire proxy statement/prospectus and the other documents referred to or incorporated by reference into this proxy statement/prospectus
in order to fully understand the Merger Agreement and the Merger. See the section titled &#8220;<a href="#s4_060">Where You Can Find More Information</a>&#8221;
beginning on page 125 of this proxy statement/prospectus. Each item in this summary refers to the page of this proxy statement/prospectus
on which that subject is discussed in more detail.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="comps"></span>The Companies (see page 35)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>RadNet, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet, Inc., which is referred to in this proxy
statement/prospectus as RadNet, is a leading national provider of diagnostic imaging services in the United States based on number of
locations and annual imaging revenue. RadNet has been in business since 1985. RadNet&#8217;s principal business segment is the provision
of diagnostic imaging services. As of December 31, 2024, RadNet operated, directly or indirectly through joint ventures with hospitals,
398 imaging centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, Texas and New York.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet Common Stock is traded on The Nasdaq Global
Market under the symbol &#8220;RDNT.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The principal executive offices of RadNet are
located at 1510 Cotner Avenue, Los Angeles, California 90025, its telephone number is (310) 445-2800 and its website is www.radnet.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">This proxy statement/prospectus incorporates important
business and financial information about RadNet from other documents that are not included in or delivered with this proxy statement/prospectus.
For a list of the documents that are incorporated by reference in this proxy statement/prospectus, see the section titled &#8220;<i><a href="#s4_060">Where You Can Find More Information</a></i>&#8221; beginning on page 125 of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>iCAD, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD, Inc., which is referred to in this proxy
statement/prospectus as iCAD, is a global leader in AI-powered cancer detection whose mission is to create a world where cancer can&#8217;t
hide. iCAD&#8217;s ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where
cancer may be hiding, and because cancer may be found earlier, it is likely more easily eliminated. The ProFound Breast Health Suite currently
offers solutions for breast cancer detection, breast density assessment, and one- or two-year breast cancer risk evaluation. Additionally,
iCAD is in the early stages of development of a product that can identify breast arterial calcification from mammogram images.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD Common Stock is traded on The Nasdaq Capital
Market under the symbol &#8220;ICAD.&#8221; Following the Merger, iCAD Common Stock will be delisted from The Nasdaq Capital Market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The principal executive offices of iCAD are located
at 2 Townsend West, Suite 6, Nashua, New Hampshire 03063, its telephone number is (603) 882-5200 and its website is www.icadmed.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Additional information about iCAD and its subsidiaries
is included in documents incorporated by reference into this proxy statement/prospectus. For a list of the documents that are incorporated
by reference in this proxy statement/prospectus, see the section titled &#8220;<i><a href="#s4_060">Where You Can Find More Information</a></i>&#8221; beginning
on page 125 of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Trio Merger Sub, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Trio Merger Sub, Inc., which is referred to in
this proxy statement/prospectus as Merger Sub, is a wholly-owned subsidiary of RadNet and a Delaware corporation. Merger Sub was formed
solely for the purpose of completing the Merger. Merger Sub has not carried on any activities to date, except for activities incidental
to its formation and activities undertaken in connection with the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Merger Sub was formed in the State of Delaware
on April 11, 2025. The principal executive offices of Merger Sub are located at 1510 Cotner Avenue, Los Angeles, California 90025, and
its telephone number is (310) 445-2800.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="merger"></span>The Merger (see page 43)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet, Merger Sub and iCAD have entered into
the Merger Agreement. Subject to the terms and conditions of the Merger Agreement and in accordance with applicable law, in the Merger,
Merger Sub will be merged with and into iCAD, with iCAD continuing as the Surviving Corporation. Following completion of the Merger, iCAD
will be a wholly-owned subsidiary of RadNet. In connection with the Merger, iCAD stock will be delisted from The Nasdaq Capital Market
and deregistered under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">A copy of the Merger Agreement is attached as
Annex A to this proxy statement/prospectus. <b>You should read the Merger Agreement carefully because it is the legal document that governs
the Merger</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="icadmtng"></span>The iCAD Special Meeting (see page 36)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b><i>Date,
Time and Location</i></b>. The Special Meeting will be a virtual only meeting conducted exclusively via live webcast at
www.cstproxy.com/icad/sm 2025 starting at 9:00 a.m., Eastern Time (with log-in beginning at 8:45 a.m. Eastern Time), on July 14,
2025. If your shares are registered in your name with Continental, iCAD&#8217;s transfer agent, and you wish to attend the
online-only virtual Special Meeting, go to www.cstproxy.com/icad/sm2025, enter the control number you received on your proxy card or
notice of the Special Meeting and click on the &#8220;Click here to preregister for the online meeting&#8221; link at the top of the
page. Just prior to the start of the Special Meeting you will need to log back into the Special Meeting site using your control
number. Pre-registration is recommended but is not required in order to attend. Beneficial stockholders who wish to attend the
online-only virtual Special Meeting must obtain a legal proxy by contacting their account representative at the bank, broker, or
other nominee that holds their shares and e-mail a copy (a legible photograph is sufficient) of their legal proxy to
proxy@continentalstock.com. Beneficial stockholders who e-mail a valid legal proxy will be issued a meeting control number that will
allow them to register to attend and participate in the online-only virtual Special Meeting. After contacting Continental a
beneficial holder will receive an e-mail prior to the Special Meeting with a link and instructions for entering the virtual Special
Meeting. Beneficial stockholders should contact Continental at least five business days prior to the Special Meeting. Because the
Special Meeting is completely virtual and being conducted via live webcast, stockholders will not be able to attend the Special
Meeting in person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b><i>Purposes of the Special Meeting</i></b>.
The Special Meeting is being held to consider and vote upon the following proposals:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Proposal 1&#8212;the Merger Agreement Proposal</i></b>: to adopt the Merger Agreement, a copy of which is attached as Annex
A to this proxy statement/prospectus and the material provisions of which are summarized in the section titled &#8220;<i><a href="#s4_021">The Merger Agreement</a></i>&#8221;
beginning on page 79 of this proxy statement/prospectus, pursuant to which, among other things, Merger Sub will merge with and into iCAD
and each outstanding share of iCAD Common Stock will be converted into the right to receive a number of shares of RadNet Common Stock
equal to the Exchange Ratio, as determined in accordance with the Merger Agreement and described herein.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Proposal 2&#8212;the Advisory Compensation Proposal</i></b>: to approve, on a non-binding, advisory basis, the compensation
that may be paid or become payable to iCAD&#8217;s named executive officers that is based on or otherwise related to the Merger, the estimated
value of which is disclosed in the table in the section titled &#8220;<i><a href="#quantification">Interests of iCAD&#8217;s Directors and Executive Officers in the Merger&#8212;Quantification of Potential Payments and Benefits to iCAD&#8217;s Named Executive Officers</a></i>&#8221; beginning on page
110 of this proxy statement/prospectus.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Proposal 3&#8212;the Adjournment Proposal</i></b>: to approve the adjournment of the Special Meeting to a later date or dates,
if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of
the Special Meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b><i>iCAD Record Date; Stockholders Entitled
to Vote</i></b>. The record date for the determination of iCAD stockholders entitled to notice of, and to vote at, the Special Meeting
is the close of business on May 16, 2025. Only iCAD stockholders who held iCAD Common Stock of record on the iCAD Record Date are entitled
to vote at the Special Meeting or any adjournments or postponements of the Special Meeting. Each issued and outstanding share of iCAD
Common Stock as of the iCAD Record Date entitles its holder of record to one vote on each matter to be considered at the Special Meeting.
As of the iCAD Record Date, there were 27,470,869 shares of iCAD Common Stock outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b><i>Quorum</i></b>. In order for business to
be conducted at the Special Meeting, a quorum must be present. A quorum at the Special Meeting requires the presence of the holders of
a majority of the total issued and outstanding shares of iCAD Common Stock entitled to vote, present virtually or represented by proxy,
at the Special Meeting. Abstentions will count as votes present and entitled to vote for the purpose of determining the presence of a
quorum for the transaction of business at the Special Meeting. Since all of the proposals currently expected to be voted on at the Special
Meeting are considered non-routine and non-discretionary matters, shares held in &#8220;street name&#8221; through a broker, bank or other
nominee are not expected to be counted as present for the purpose of determining the existence of a quorum if such broker, bank or other
nominee does not have instructions to vote on any such proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b><i>Required Vote; Treatment of Abstentions
and Failure to Vote</i></b><i>. </i>The votes required for each proposal are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Proposal 1&#8212;the Merger Agreement Proposal. </i></b>The affirmative vote of the holders of a majority of all outstanding
shares of iCAD Common Stock on the iCAD Record Date and entitled to vote thereon is required to approve the Merger Agreement Proposal.
The required vote on Proposal 1 is based on the number of outstanding shares&#8212;not the number of shares actually voted. The failure
of any iCAD stockholder to submit a vote (i.e., by not submitting a proxy and not voting at the Special Meeting) and any abstention from
voting by an iCAD stockholder will have the same effect as a vote &#8220;<b>AGAINST</b>&#8221; the Merger Agreement Proposal. Because
the Merger Agreement Proposal is non-routine, brokers, banks and other nominees do not have discretionary authority to vote on the Merger
Agreement Proposal, and will not be able to vote on the Merger Agreement Proposal absent instructions from the beneficial owner of any
iCAD shares held of record by them. As a result, a broker non-vote will have the same effect as a vote &#8220;<b>AGAINST</b>&#8221; the
Merger Agreement Proposal.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Proposal 2&#8212;the Advisory Compensation Proposal. </i></b>The affirmative vote of a majority of votes present or represented
by proxy at the Special Meeting and entitled to vote thereon is required to approve the Advisory Compensation Proposal. Any shares not
present virtually or represented by proxy (including due to the failure of an stockholder who holds shares in &#8220;street name&#8221;
through a bank, broker or other nominee to provide voting instructions with respect to any proposals at the Special Meeting to such bank,
broker or other nominee) will have no effect on the outcome of the Advisory Compensation Proposal, provided that a quorum is otherwise
present. An abstention by any shares present or represented by proxy on the Advisory Compensation Proposal will have the same effect as
a vote &#8220;<b>AGAINST</b>&#8221; the Advisory Compensation Proposal. Broker non-votes, if any, will have no effect on the Advisory
Compensation Proposal. While the iCAD Board intends to consider the vote resulting from the Advisory Compensation Proposal, the vote is
advisory only and therefore not binding on iCAD, and, if the proposed Merger is approved by iCAD stockholders and consummated, the compensation
that is the subject of the Advisory Compensation Proposal, including amounts iCAD is contractually obligated to pay, will be payable even
if the Advisory Compensation Proposal is not approved.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Proposal 3&#8212;the Adjournment Proposal.</i></b> The affirmative vote of a majority of votes present or represented by proxy
at the Special Meeting and entitled to vote thereon is required to approve the Adjournment Proposal. Any shares not present virtually
or represented by proxy (including due to the failure of an stockholder who holds shares in &#8220;street name&#8221; through a bank,
broker or other nominee to provide voting instructions with respect to any proposals at the Special Meeting to such bank, broker or other
nominee) will have no effect on the outcome of the Adjournment Proposal, provided that a quorum is otherwise present. An abstention by
any shares present or represented by proxy on the Adjournment Proposal will have the same effect as a vote &#8220;<b>AGAINST</b>&#8221;
the Adjournment Proposal. Broker non-votes, if any, will have no effect on the Adjournment Proposal.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">You should instruct your broker, bank or other
nominee how to vote your shares. Under the rules applicable to broker-dealers, your broker, bank or other nominee has discretionary authority
to vote on proposals that are considered routine but does not have discretionary authority to vote your shares on proposals that are considered
non-routine, and each of the proposals to be voted on at the Special Meeting is considered non-routine. As a result, no broker will be
permitted to vote your shares at the Special Meeting without receiving instructions from you, and, hence, we do not expect any broker
non-votes at the Special Meeting. Therefore, it is important that you cast your vote or instruct your broker, bank or other nominee on
how you wish to vote your shares of iCAD Common Stock. A so-called &#8220;broker non-vote&#8221; results when banks, brokers and other
nominees return a valid proxy but do not vote on a particular proposal because they do not have discretionary authority to vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b><i>Share
Ownership; Voting by iCAD&#8217;s Directors and Executive Officers</i></b><i>.</i> As of the iCAD Record Date, iCAD&#8217;s directors
and executive officers had the right to vote approximately 1,513,609 shares of the then-outstanding iCAD Common Stock, collectively representing
approximately 5.5% of the iCAD Common Stock outstanding and entitled to vote on that date. We currently expect that iCAD&#8217;s executive
officers will vote their shares &#8220;<b>FOR</b>&#8221; Proposal 1 (the Merger Agreement Proposal), &#8220;<b>FOR</b>&#8221; Proposal
2 (the Advisory Compensation Proposal) and &#8220;<b>FOR</b>&#8221; Proposal 3 (the Adjournment Proposal), although no executive officer
has entered into any agreement obligating him or her to do so. Please see the section titled &#8220;<i><a href="#s4_001">The Merger&#8212;The
Voting and Support Agreements</a></i>&#8221; on page 45 of this proxy statement/prospectus for information on the Voting and Support
Agreements that iCAD&#8217;s directors have entered into with RadNet and Merger Sub.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_080"></span>What iCAD Stockholders Will Receive in the Merger (see page 80)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">At the Effective Time, each share of iCAD Common
Stock issued and outstanding immediately prior to the Effective Time (other than the Excluded Shares) will be converted into the right
to receive 0.0677 shares of RadNet Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">No fractional shares of RadNet Common Stock will
be delivered to any holder of shares of iCAD Common Stock upon completion of the Merger. Instead, all fractional shares of RadNet Common
Stock that a holder of shares of iCAD Common Stock would otherwise be entitled to receive as a result of the Merger will be aggregated
and, if a fractional share results from such aggregation, such holder will be entitled to receive the cash proceeds from the sale of such
fractional share by the exchange agent for the account of such holder, without interest, in accordance with the Merger Agreement. <i>Example:
If you own 110 shares of iCAD Common Stock at the time the Merger is completed, you will be entitled to receive 7 shares of RadNet Common
Stock. In addition, you will be entitled to receive the cash proceeds from the sale of .447 of a share of RadNet Common Stock by the exchange
agent.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">This Exchange Ratio is fixed and will not be adjusted
for changes in the market price of either iCAD Common Stock or RadNet Common Stock between the date of signing of the Merger Agreement
and the Effective Time. Based on the closing price of RadNet Common Stock on April 14, 2025, the trading day before the public announcement
of the signing of the Merger Agreement, the Exchange Ratio would represent approximately $3.61 in implied value for each share of iCAD
Common Stock on a fully diluted basis. Based on the closing price of RadNet Common Stock on May [ ], 2025, the last practicable date before
the date of the proxy statement/prospectus accompanying this notice, the Exchange Ratio would represent approximately $[ ] in implied
value for each share of iCAD Common Stock on a fully diluted basis. The market price of RadNet Common Stock when iCAD stockholders receive
those shares after the Merger is completed could be greater than, less than or the same as the market price of shares of RadNet Common
Stock on such date, the date of this proxy statement/prospectus or at the time of the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><b>Because the share price of RadNet Common Stock
will fluctuate between the date of signing of the Merger Agreement and the completion of the Merger, and because the Exchange Ratio is
fixed and will not be adjusted to reflect changes in the share price of RadNet Common Stock or iCAD Common Stock, the value of the shares
of RadNet Common Stock to be received by iCAD stockholders in the Merger may differ from the implied value based on the share price on
the date of signing of the Merger Agreement or the date of the proxy statement/prospectus. We urge you to obtain current share price quotations
for RadNet Common Stock and iCAD Common Stock.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="nodissenters"></span>No Dissenters&#8217; or Appraisal Rights (see page 78)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD stockholders are not entitled to dissenters&#8217;
or appraisal rights in connection with the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="trtmnt"></span>Treatment of iCAD Options (see page 82)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">At the Effective Time, each Eligible iCAD Option
will automatically and without any action on the part of the holder thereof, be assumed by RadNet and converted into an option (A) to
purchase that number of shares of RadNet Common Stock equal to the product of (1) the number of shares of iCAD Common Stock subject to
such Eligible iCAD Option immediately prior to the Effective Time and (2) the Exchange Ratio, rounded down to the nearest whole number
of shares, and (B) with an exercise price per share equal to (1) the exercise price per share of iCAD Common Stock of such Eligible iCAD
Option immediately prior to the Effective Time, divided by (2) the Exchange Ratio, rounded up to the nearest whole cent (each, an &#8220;Assumed
Option&#8221;). Each Assumed Option will continue to have, and will be subject to, the same terms and conditions (including the vesting
and exercisability conditions (including any acceleration provisions) and expiration date) that applied to the corresponding Eligible
iCAD Option as in effect immediately prior to the Effective Time, other than any terms that become inoperative by reason of the transactions
contemplated pursuant to the Merger Agreement. Each iCAD Option that is not an Eligible iCAD Option will not be assumed or otherwise substituted
by RadNet and will automatically terminate and cease to be outstanding as of the Effective Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="rec"></span>Recommendation of the iCAD Board of Directors (see page 54)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>The iCAD Board unanimously recommends that
iCAD stockholders vote &#8220;FOR&#8221; the Merger Agreement Proposal, &#8220;FOR&#8221; the Advisory Compensation Proposal and &#8220;FOR&#8221;
the Adjournment Proposal. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In the course of reaching its decision for iCAD
to enter into the Merger Agreement and effect the Merger, the iCAD Board considered a number of factors in its deliberations. For a more
complete discussion of these factors, see the section titled &#8220;<i><a href="#s4_003">The Merger&#8212;Recommendation of the iCAD Board of Directors and Reasons for the Merger</a></i>&#8221; beginning on page 54 of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="opinion"></span>Opinion of iCAD&#8217;s Financial Advisor (see page 66 and <a href="#annexb">Annex B</a>)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.35pt">On April 15, 2025, Piper Sandler rendered its
oral opinion to the iCAD Board, which was subsequently confirmed in writing by delivery of Piper Sandler&#8217;s written opinion, dated
April 15, 2025, to the effect that, as of such date, and based upon and subject to the various assumptions and limitations set forth in
its written opinion, the Exchange Ratio was fair, from a financial point of view, to the holders of iCAD Common Stock who will receive
RadNet Common Stock in the Merger. Piper Sandler&#8217;s opinion was directed to the iCAD Board, and addressed solely the fairness, from
a financial point of view, to the holders of iCAD Common Stock of the Exchange Ratio and did not address any other terms or agreement
relating to the Merger or any other terms of the Merger Agreement. The summary of Piper Sandler&#8217;s opinion included in this proxy
statement/prospectus is qualified in its entirety by reference to the full text of its written opinion, which is included as Annex B to
this proxy statement/prospectus and sets forth the assumptions made, procedures followed, matters considered and limitations on the scope
of the review undertaken by Piper Sandler in preparing its opinion. However, neither Piper Sandler&#8217;s written opinion nor the summary
of its opinion and the related analyses set forth in this proxy statement/prospectus is intended to be, and they do not constitute, a
recommendation to any iCAD stockholder as to how such stockholder should act or vote with respect to the Merger or any other matter. For
more information, see Annex B to this proxy statement/prospectus and the section titled &#8220;<i><a href="#s4_006">The Merger&#8212;Opinion of iCAD&#8217;s Financial Advisor</a></i>&#8221; beginning on page 66 of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.35pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="ownrship"></span>Ownership of Shares of RadNet Common Stock After the Merger</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Under the
terms of the agreement, iCAD stockholders will receive 0.0677 shares of RadNet Common Stock for each share of iCAD Common Stock they
hold at the Effective Time. Based on (i) the Exchange Ratio of 0.0677 and (ii) the number of shares of iCAD Common Stock and Eligible
iCAD Options outstanding as of the iCAD Record Date, RadNet estimates that it will issue approximately 2,024,584 shares of RadNet Common
Stock pursuant to the Merger Agreement, provided that if additional iCAD equity awards are granted to certain iCAD employees as permitted
under the Merger Agreement, RadNet may be required to reserve additional shares of RadNet Common Stock for issuance (see the section
titled &#8220;<a href="#s4_028"><i>The Merger Agreement&#8212;Treatment of iCAD Options</i></a>&#8221; beginning on page 82 of this proxy
statement/prospectus). Based upon the foregoing and the estimated number of shares of common stock that are expected to be outstanding
immediately prior to the consummation of the Merger, RadNet and iCAD estimate that, as of immediately following completion of the Merger,
holders of RadNet Common Stock as of immediately prior to the Merger will hold approximately 97.4% and holders of iCAD Common Stock as
of immediately prior to the Merger will hold approximately 2.6% of the outstanding shares of RadNet Common Stock on a fully diluted basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Because the Exchange Ratio is fixed, the relative
ownership interests of RadNet stockholders and former iCAD stockholders immediately following the Merger will depend on the number of
shares of RadNet Common Stock and iCAD Common Stock issued and outstanding immediately prior to the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="interests"></span>Interests of iCAD&#8217;s Directors and Executive Officers in
the Merger (see page 105)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Directors and executive officers of iCAD
have interests in the Merger that may be different from, or in addition to, the interests of iCAD stockholders generally. These
interests may include, among others, rights to continued indemnification and insurance coverage, payment to iCAD non-employee
directors of the unpaid portion of their full annual cash retainer under iCAD&#8217;s non-employee director compensation program for
the service year in which the closing of the Merger occurs, issuance of options to receive shares of RadNet Common Stock in exchange
for Eligible iCAD Options, acceleration of vesting of unvested Eligible iCAD Options held by directors and executive officers,
 extension of the exercise period applicable to certain iCAD Options held by directors and executive officers; cash bonuses
payable to iCAD&#8217;s Chief Executive Officer and Chief Financial Officer upon closing of the Merger, and severance payments and
benefits. The iCAD Board was aware of and considered those interests, among other matters, in evaluating and negotiating the Merger
Agreement and the Merger, in approving the Merger Agreement, and in recommending the approval of each of the Merger Agreement
Proposal, the Advisory Compensation Proposal and the Adjournment Proposal. See the section titled &#8220;<i><a href="#s4_051">Interests of iCAD&#8217;s Directors and Executive Officers in the Merger</a></i>&#8221; beginning on page 105 of this proxy
statement/prospectus for a more detailed description of these interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_083"></span>The Voting and Support Agreements (see page 45)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In connection
with the Merger Agreement, RadNet and Merger entered into the Voting and Support Agreements with each of the Voting and Support Agreement
Stockholders. The Voting and Support Agreement Stockholders together beneficially own, in the aggregate, approximately 5.5% of the issued
and outstanding shares of iCAD Common Stock as of the iCAD Record Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Voting and Support Agreement Stockholders
have separately agreed, pursuant to their respective Voting and Support Agreements, among other things, to vote all shares of iCAD beneficially
owned as of April 15, 2025 and any additional shares of iCAD Common Stock acquired between April 15, 2025 and the earliest to occur of
(i) the valid termination of the Merger Agreement in accordance with its terms or (ii) the Effective Time:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>in favor of (i) the Merger Agreement Proposal; (ii) the Adjournment Proposal and any other matters necessary to effect the Merger;
(iii) each of the other transactions contemplated by the Merger Agreement; and (iv) any other transaction pursuant to which RadNet or
any subsidiary thereof proposes to acquire iCAD in which iCAD stockholders would receive aggregate consideration per share equal to or
greater than the consideration to be received by stockholders of iCAD in the Merger;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>against any action or agreement which is intended or would reasonably be expected to impede, delay, postpone, interfere with, nullify,
prevent or adversely affect in any material respect the Merger or such Voting and Support Agreement, including (i) any other extraordinary
corporate transaction, including any proposal of any person (other than RadNet and Merger Sub) to acquire iCAD or all or substantially
all of the assets thereof, (ii) any amendment to iCAD Certificate of Incorporation or iCAD Bylaws, (iii) any material change to the capitalization
of iCAD, (iv) any change in a majority of the directors of the iCAD Board and (v) any action, proposal, or agreement that would reasonably
be expected to result in the any breach of any covenant, representation or warranty or any other obligation or agreement under the Merger
Agreement or such Voting and Support Agreement; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>against any Alternative Transaction (as defined in the section titled &#8220;<i><a href="#s4_036">The Merger Agreement&#8212;No Solicitation</a></i>&#8221;
beginning on page 89 of this proxy statement/prospectus) and any action in furtherance of any Alternative Transaction.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Listing of Shares of RadNet Common Stock and Delisting and Registration
of iCAD Common Stock (see page 82)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet will use its reasonable best efforts to
cause the shares of RadNet Common Stock to be issued in connection with the Merger to be listed on The Nasdaq Global Market, where shares
of RadNet Common Stock are currently traded. If the Merger is completed, shares of iCAD stock will no longer be listed on The Nasdaq Capital
Market and will be deregistered under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_082"></span>Completion of the Merger is Subject to Certain Conditions (see
page 82)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">As more fully described in this proxy statement/prospectus
and in the Merger Agreement, the respective obligation of each of RadNet, iCAD and Merger Sub to complete the Merger is subject to the
satisfaction or waiver, in whole or in part (to the extent permitted by applicable law) of the following conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the obtainment of the iCAD Stockholder Approval;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the expiration or termination of any applicable waiting period (including extensions) under the HSR Act relating to the Merger or
the transactions contemplated by the Merger Agreement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the absence of any injunction or order or applicable law preventing or making illegal the consummation of the Merger;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the registration statement of which this proxy statement/prospectus is a part being declared effective under the Securities Act and
the absence of any stop order suspending the effectiveness of the registration statement; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the shares of RadNet Common Stock to be issued in the Merger having been approved for listing on The Nasdaq Global Market, subject
to official notice of issuance.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In addition, RadNet&#8217;s obligation to complete
the Merger is subject to the satisfaction or waiver, in whole or in part (to the extent permitted by applicable law, waiver) of the following
conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>accuracy of the representations and warranties made in the Merger Agreement by iCAD as of the date of the Merger Agreement and as
of the Closing Date, subject to certain materiality qualifiers;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>performance in all material respects by iCAD of the obligations required to be performed by it at or prior to the Closing Date;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the absence since the date of the Merger Agreement of a Material Adverse Effect (as defined in the section titled                                                                                                        &#8220;<i><a href="#s4_033">The Merger Agreement&#8212;Definition of &#8216;Material Adverse Effect&#8217;</a></i>&#8221; beginning on page
                                                                                                           85 of this proxy statement/prospectus) on iCAD;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>receipt of an officer&#8217;s certificate from iCAD as to the satisfaction of the conditions in the three preceding bullet points;
and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><span style="font-size: 10pt">the absence of (i) pending or threatened action by any governmental entity, or (ii) any statute, rule,
regulation or order issued by any court of competent jurisdiction or other governmental entity or other legal restraint or prohibition
in effect, in either case: (1) challenging or seeking to restrain or prohibit the consummation of the Merger or other transactions contemplated
by the Merger Agreement, or seeking to obtain any damages in connection therewith; or (2) seeking to prohibit or impose any limitations
on RadNet or the Surviving Corporation&#8217;s ownership or operation of all or any portion of iCAD&#8217;s business or assets or to compel
RadNet or any of its affiliates to dispose of or hold separate all or any material portion of the assets of iCAD as a result of the consummation
of the Merger or other transactions contemplated by the Merger Agreement. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In addition, iCAD&#8217;s obligation to complete
the Merger is subject to the satisfaction or waiver, in whole or in part (to the extent permitted by applicable law, waiver) of the following
conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>accuracy of the representations and warranties made in the Merger Agreement by RadNet as of the Closing Date, subject to certain materiality
thresholds;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>performance in all material respects by RadNet of the obligations required to be performed by it at or prior to the Closing Date;
and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>receipt of an officer&#8217;s certificate from RadNet as to the satisfaction of the conditions in the two preceding bullet points.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet and iCAD cannot be certain when, or if,
the conditions to the Merger will be satisfied (or, to the extent permitted by law, waived), or that the Merger will be completed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="regapprovs"></span>Regulatory Approvals (see page 77)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Under the Merger Agreement, the Merger cannot be
completed until all applicable waiting periods (and any extensions thereof) under the HSR Act have expired or been terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_022"></span>No Solicitation; Obligation to Recommend Approval of the Merger
Agreement Proposal (see pages 89 and 91)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Subject to certain exceptions, iCAD has agreed
that it will not, and it will cause its affiliates and its and their respective Representatives not to, directly or indirectly, (i)(A)
solicit, initiate or knowingly encourage, or take any other action to knowingly facilitate any Alternative Transaction or (B) fail to
terminate any direct or indirect solicitation, encouragement, discussions or negotiations with any persons (other than RadNet or Merger
Sub and their Representatives); (ii) participate in any discussions or negotiations, or cooperate in any way with any person, with respect
to any Alternative Transaction; or (iii) amend or grant any waiver of any standstill or similar agreement, subject to certain exceptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger Agreement includes certain
exceptions to the non-solicitation covenant such that, if, prior to obtaining the iCAD Stockholder Approval, iCAD receives a bona
fide written proposal that did not result from a breach of the non-solicitation covenant the consummation of which would constitute
an Alternative Transaction and the iCAD Board determines in good faith (after consultation with its outside counsel and financial
advisor) that such proposal constitutes a Superior Offer (as defined in the section titled &#8220;<i><a href="#s4_036">The Merger
Agreement&#8212;No Solicitation</a></i>&#8221; beginning on page 89 of this proxy statement/prospectus), subject to compliance with
certain procedures set forth in the Merger Agreement and summarized in the section titled &#8220;<i><a href="#s4_036">The Merger
Agreement&#8212;No Solicitation</a></i>&#8221; beginning on page 89 of this proxy statement/prospectus, iCAD and its Representatives
may furnish certain information to the person (or group of persons) making such proposal (and its Representatives) and participate
in discussions and negotiations regarding such proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Also, the iCAD Board may, subject to
complying with certain specified procedures set forth in the Merger Agreement and summarized in the section titled &#8220;<i><a href="#s4_037">The
Merger Agreement&#8212;Obligation to Recommend Approval of the Merger Agreement Proposal</a></i>&#8221; beginning on page 91 of this
proxy statement/prospectus, including providing RadNet with a good faith opportunity to negotiate, make an iCAD Recommendation
Change (as defined in the section titled &#8220;<i><a href="#s4_037">The Merger Agreement&#8212;Obligation to Recommend Approval of
the Merger Agreement Proposal</a></i>&#8221; beginning on page 91 of this proxy statement/prospectus) in response to an unsolicited
Superior Offer or an &#8220;Intervening Event&#8221; (as defined in the section titled &#8220;<i><a href="#s4_037">The Merger
Agreement&#8212;Obligation to Recommend Approval of the Merger Agreement Proposal</a></i>&#8221; beginning on page 91 of this proxy
statement/prospectus) that becomes known after the date of the Merger Agreement but prior to obtaining the iCAD Stockholder
Approval, in each case, to the extent failure to do so would be inconsistent with the iCAD Board&#8217;s fiduciary duties under
applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Notwithstanding the foregoing, iCAD&#8217;s obligation
to hold the Special Meeting will not be affected by the commencement, public proposal, public disclosure or communication to iCAD or any
other person of any Alternative Transaction or an iCAD Recommendation Change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_023"></span>Termination of the Merger Agreement (see page 97)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Merger Agreement may be terminated at any
time prior to the Effective Time, and whether before or (except, with respect to iCAD as set forth in the case of the fourth sub-bullet
of the second bullet below) after receipt of the iCAD Stockholder Approval:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by the mutual written consent of iCAD and RadNet;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by either iCAD or RadNet if:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the Merger has not been consummated by the Outside Date; provided that if the Closing has not occurred by such date but on that date
any of the conditions that relate to any approvals or injunctions or restraints are not satisfied or waived but all other conditions have
been satisfied or waived (other than those that by their terms are to be fulfilled at the Closing, provided that each such condition would
be capable of being fulfilled if the Closing were to occur on such date), then the Outside Date will automatically be extended to December
31, 2025, and such date will be the &#8220;Outside Date&#8221; under the Merger Agreement; provided, further, that the right to terminate
the Merger Agreement pursuant to this bullet point will not be available to any party if a material breach by such party of any of its
obligations under the Merger Agreement has been the principal cause of or principally resulted in the failure of the Closing to have occurred
on or before the Outside Date;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the iCAD Stockholder Approval has not been obtained at the Special Meeting or at any adjournment or postponement thereof;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>prior to the Effective Time, any governmental entity of competent jurisdiction has issued or entered any order that has the effect
of permanently restraining, enjoining or otherwise prohibiting the Merger, and such order has become final and non-appealable; provided
that the right to terminate the Merger Agreement under this bullet will not be available to a party if a material breach by such party
of any of its obligations under the relevant obligations under the Merger Agreement has been the principal cause of or principally resulted
in the issuance of such order or the denial of such expiration, termination, authorization or consent;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the other party has breached or failed to perform any of its representations, warranties, covenants or other agreements contained
in the Merger Agreement, which breach or failure to perform (i) would give rise to the failure of the applicable condition of the terminating
party&#8217;s obligations to complete the Merger and (ii) is incapable of being cured by such breaching party or is not cured by the earlier
of the Outside Date and 30 days after receiving written notice thereof; provided that the terminating party is not then in breach of any
representation, warranty, covenant or other agreement contained in the Merger Agreement, which breach would give rise to the failure of
an applicable condition of the other party&#8217;s obligations to complete the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by iCAD at any time prior to obtaining the iCAD Stockholder Approval, in order to accept a Superior Offer and enter into the Specified
Agreement (as defined below) relating to such Superior Offer, if (i) such Superior Offer has not resulted from any breach of the Merger
Agreement with respect to such Superior Offer, (ii) the iCAD Board, after satisfying all of the requirements set forth in the Merger Agreement,
has authorized iCAD to enter into a binding written definitive acquisition agreement providing for the consummation of a transaction constituting
a Superior Offer (a &#8220;Specified Agreement&#8221;) and (iii) iCAD has paid the Termination Fee (as defined below), and has entered
into the Specified Agreement, substantially concurrently with the termination of the Merger Agreement; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by RadNet, at any time prior to the Special Meeting, if the iCAD Board or any committee thereof has made an iCAD Recommendation Change.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If the Merger Agreement is terminated, the Merger
Agreement will become void, without liability or obligation on the part of any of the parties, except in the case of a willful breach
of the Merger Agreement. The provisions of the Merger Agreement relating to information provided or made pursuant to the Merger Agreement
which is governed by the confidentiality agreement between iCAD and RadNet, fees and expenses, effect of termination and certain general
provisions will continue in effect notwithstanding termination of the Merger Agreement and no such termination will relieve any party
from any liability or obligation under such provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger Agreement provides that iCAD will pay
RadNet a termination fee equal to (i) $1,000,000, plus (ii) the amount of all documented fees and expenses of RadNet and its affiliates
incurred in connection with the negotiation and performance of the Merger Agreement and the transactions contemplated thereby, up to an
amount of $2,000,000 (the &#8220;Termination Fee&#8221;) if the Merger Agreement is terminated:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by RadNet in response to an iCAD Recommendation Change;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by either RadNet or iCAD because the iCAD Stockholder Approval is not obtained at the Special Meeting or any adjournment or postponement
thereof and, immediately prior to the Special Meeting, RadNet would have been entitled to terminate the Merger Agreement in response an
iCAD Recommendation Change;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by iCAD at any time prior to obtaining the iCAD Stockholder Approval, in order to accept a Superior Offer and enter into the Specified
Agreement relating to such Superior Offer, subject to the conditions set forth in the Merger Agreement; or</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by either RadNet or iCAD as a result of (i) the Outside Date having passed or (ii) the iCAD Stockholder Approval not having been obtained
at the Special Meeting or any adjournment or postponement thereof, and, in each case, (A) at or prior to the Special Meeting in the case
of a termination as a result of clause (ii) of this bullet or, at or prior to the time of such termination, in the case of a termination
as a result of clause (i) of this bullet, there has been publicly made to the stockholders of iCAD generally or has otherwise become publicly
known, or any person has publicly announced an intention (whether or not conditional) to make, an offer or proposal for an Alternative
Transaction, and (B) iCAD enters into a definitive agreement with respect to any Alternative Transaction or consummates an Alternative
Transaction within 12 months of such termination.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For purposes of the foregoing, the term &#8220;Alternative
Transaction&#8221; will have the meaning as described in the section titled &#8220;<i><a href="#s4_036">The Merger Agreement&#8212;No Solicitation</a></i>&#8221;
beginning on page 89 of this proxy statement/prospectus, except that all references to &#8220;20%&#8221; will be replaced with &#8220;50%.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Termination Fee will be payable in immediately
available funds no later than the applicable date set forth in the Merger Agreement. If iCAD fails to promptly pay the Termination Fee,
iCAD will pay the costs and expenses (including legal fees and expenses) in connection with any action, including the filing of any lawsuit
or other legal action, taken to collect payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_024"></span>Specific Enforcement (see page 99)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Under the Merger Agreement, each of RadNet and
iCAD is entitled to an injunction (even if monetary damages are available) to prevent breaches of the Merger Agreement or to enforce specifically
the terms and provisions of the Merger Agreement, in addition to any other remedy to which that party may be entitled at law or in equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_025"></span>Material U.S. Federal Income Tax Consequences of the Merger (see
page 100)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt">The Merger is intended to qualify as a &#8220;reorganization&#8221; within
the meaning of Section 368(a) of the Code, and iCAD and RadNet intend to report the Merger consistent with such qualification. iCAD has
received a tax opinion from Dentons to the effect that the Merger will qualify as a &#8220;reorganization&#8221; within the meaning of
Section 368(a) of the Code. The tax opinion from Dentons is based on customary assumptions and representations, covenants and undertakings
of iCAD, RadNet and Merger Sub. If any of the assumptions, representations, covenants or undertakings is incorrect, incomplete, inaccurate,
or otherwise is violated, the validity of the tax opinion from Dentons may be affected and the U.S. federal income tax consequences of
the Merger could differ materially from those described in this proxy statement/prospectus. The receipt of a tax opinion from counsel
is not a condition to either party&#8217;s obligation to complete the Merger. iCAD and RadNet have not sought, and do not intend to seek,
any ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) regarding the qualification of the Merger as a &#8220;reorganization&#8221;
within the meaning of Section 368(a) of the Code. As a result, there can be no assurance that the IRS will agree with the tax opinion
from Dentons or would not assert, or that a court would not sustain, a position contrary to the treatment of the Merger as a &#8220;reorganization&#8221;
within the meaning of Section 368(a) of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Assuming the Merger qualifies as a &#8220;reorganization,&#8221;
a U.S. holder (as defined in the section titled &#8220;<i><a href="#s4_049">Material U.S. Federal Income Tax Consequences of the Merger</a></i>&#8221;
beginning on page 100 of this proxy statement/prospectus) of iCAD Common Stock generally will not recognize any gain or loss for U.S.
federal income tax purposes upon the exchange of iCAD Common Stock for RadNet Common Stock in the Merger, except with respect to cash
received by such holder in lieu of fractional shares of RadNet Common Stock. If the Merger does not so qualify, the exchange of iCAD
Common Stock for RadNet Common Stock in the Merger will be a taxable transaction for U.S. federal income tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">See the section titled &#8220;<i><a href="#s4_049">Material U.S. Federal Income Tax Consequences of the Merger</a></i>&#8221; beginning on page 100 of this proxy statement/prospectus, for a more complete
description of the material U.S. federal income tax consequences of the Merger. Please consult your tax advisors as to the specific tax
consequences to you of the Merger, including the consequences if the Merger were to fail to qualify as a &#8220;reorganization.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_026"></span>Accounting Treatment (see page 78)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger will be accounted for as an acquisition
of a business. RadNet will record the net tangible and identifiable intangible assets acquired and liabilities assumed from iCAD at their
respective fair values, unless prohibited by GAAP, as of the Closing Date of the Merger. Any excess of the purchase price over the net assets acquired will be recorded
as goodwill. The purchase price will be based on the Closing Date fair value of consideration paid by RadNet, primarily the RadNet Common
Stock to be issued to iCAD stockholders, in connection with the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_027"></span>Rights of iCAD Stockholders Will Change As a Result of the Merger
(see page 117)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD stockholders, whose rights are currently
governed by the iCAD Certificate of Incorporation, the iCAD Bylaws and Delaware law, will, upon completion of the Merger, become stockholders
of RadNet and their rights will be governed by the RadNet Certificate of Incorporation, the RadNet Bylaws and Delaware law. As a result,
iCAD stockholders will have different rights once they become RadNet stockholders due to differences between the governing documents of
iCAD and RadNet. These differences are described in detail in the section titled &#8220;<i><a href="#s4_056">Comparison of Stockholder Rights</a></i>&#8221;
beginning on page 117 of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_028"></span>Risk Factors (see page 26)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">You should also carefully consider the risks that
are described in the section titled &#8220;<i><a href="#a_031">Risk Factors</a></i>&#8221; beginning on page 26 of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Risks Relating to the Merger</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>The Exchange Ratio is fixed and will not be adjusted in the event of any change in either RadNet&#8217;s or iCAD&#8217;s stock price.
Therefore, iCAD stockholders cannot be sure of the value of the Merger Consideration they will receive.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>The market price of RadNet Common Stock after the Merger may be affected by factors different from those affecting the market price
of iCAD Common Stock.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>After completion of the Merger, RadNet may fail to realize the anticipated benefits of the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD may have difficulty attracting, motivating and retaining employees in light of the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Completion of the Merger is subject to certain conditions and if these conditions are not satisfied, waived or fulfilled in a timely
manner, the Merger may be delayed or not completed.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>If the Merger were to fail to qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code, iCAD stockholders
may be required to pay substantial U.S. federal income taxes.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>The financial forecasts are based on various assumptions that may not be realized.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>The opinion of iCAD&#8217;s financial advisor will not reflect changes in circumstances between the signing of the Merger Agreement
and the completion of the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>RadNet&#8217;s and iCAD&#8217;s business relationships may be subject to disruption due to uncertainty associated with the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD or RadNet may waive one or more of the closing conditions without re-soliciting stockholder approval.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Completion of the Merger may trigger change in control or other provisions in certain agreements to which iCAD is a party.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD&#8217;s directors and executive officers have interests in the Merger that may be different from, or in addition to, your interests
as a stockholder of iCAD or as a stockholder of RadNet.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>The Merger Agreement limits iCAD&#8217;s ability to pursue alternatives to the Merger and may discourage other companies from trying
to acquire iCAD for greater consideration than what RadNet has agreed to pay pursuant to the Merger Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Failure to complete the Merger could negatively impact the stock price and the future business and financial results of iCAD.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>The shares of RadNet Common Stock to be received by iCAD stockholders upon completion of the Merger will have different rights from
shares of iCAD Common Stock.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>After the Merger, iCAD stockholders, as a group, will have a significantly lower ownership and voting interest in RadNet than they
currently have in iCAD and will exercise less influence over management.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD stockholders are not entitled to appraisal rights in connection with the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Potential litigation against RadNet and iCAD could result in substantial costs, an injunction preventing the completion of the Merger
and/or a judgment resulting in the payment of damages.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>RadNet and iCAD will incur significant transaction and Merger-related costs in connection with the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD may not have discovered certain liabilities or other matters related to RadNet and RadNet may not have discovered certain liabilities
or other matters related to iCAD, which may adversely affect the future financial performance of RadNet following the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>The failure or delay by Former iCAD stockholders to surrender necessary documents, duly executed and on a timely basis, to the exchange
agent in order to receive their shares of RadNet Common Stock or their cash in lieu of fractional shares.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Risks Relating to RadNet and iCAD </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>See the section titled &#8220;<i><a href="#s4_060">Where You Can Find More Information</a></i>&#8221; beginning on page
                                                                                                           125 of this proxy statement/prospectus for a listing of documents incorporated by reference into this proxy
                                                                                                           statement/prospectus containing applicable risks to the businesses of each of RadNet and iCAD.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_008"></span>COMPARATIVE PER SHARE MARKET PRICE AND DIVIDEND
INFORMATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_029"></span>Market Prices</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The following table sets forth the closing price
per share of RadNet Common Stock and per share of iCAD Common Stock as reported on The Nasdaq Global Market and The Nasdaq Capital Market,
respectively, on April 14, 2025, the trading day prior to the date the Merger Agreement was publicly announced, and on [ ], 2025, the
most recent practicable trading day prior to the date of this proxy statement/prospectus for which this information was available. The
table also shows the implied value of the consideration for each share of iCAD Common Stock as of the same dates. These implied values
were calculated by multiplying the closing price of a share of RadNet Common Stock on the relevant date by the assumed Exchange Ratio.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>



<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>RadNet<br/>
Common<br/>
Stock</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>iCAD<br/>
Common<br/>
Stock</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Implied Per<br/>
Share Merger<br/>
Consideration</b></span></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt; width: 50%"><span style="font-size: 10pt">April 14, 2025</span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; width: 1%"><span style="font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; width: 13%"><span style="font-size: 10pt">53.36</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; width: 1%"><span style="font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; width: 13%"><span style="font-size: 10pt">1.82</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; width: 1%"><span style="font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; width: 13%"><span style="font-size: 10pt">3.61</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt">[&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;], 2025</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-size: 10pt">[&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;]</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-size: 10pt">[&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;]</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-size: 10pt">[&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;]</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The market prices of shares of RadNet Common Stock
and iCAD Common Stock have fluctuated since the date of the announcement of the Merger Agreement and will continue to fluctuate from the
date of this proxy statement/prospectus to the date of the Special Meeting and the date the Merger is completed. No assurance can be given
concerning the market prices of shares of RadNet Common Stock and shares of iCAD Common Stock before completion of the Merger or shares
of RadNet Common Stock after completion of the Merger. The Exchange Ratio is fixed, and therefore the value of the Merger Consideration
when received by iCAD stockholders after the Merger is completed could be greater than, less than or the same as shown in the table above.
Accordingly, iCAD stockholders are advised to obtain current market quotations for shares of RadNet Common Stock and shares of iCAD Common
Stock in deciding whether to vote for adoption of the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_030"></span>Dividends</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet has never declared or paid cash dividends
on its capital stock and does not expect to pay any dividends in the foreseeable future. RadNet currently intends to retain future earnings,
if any, to finance the growth and development of its business. RadNet&#8217;s current credit facilities place restrictions on our ability
to issue dividends. Payment of future dividends, if any, will be at the discretion of the RadNet Board and will depend on RadNet&#8217;s
financial condition, results of operations, capital requirements and such other factors as the RadNet Board deems relevant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD has not paid any cash dividends on its common
stock to date, and does not expect to pay cash dividends in the foreseeable future. Future dividend policy will depend on iCAD&#8217;s
earnings, capital requirements, financial condition, and other factors considered relevant by the iCAD Board. The terms of the Merger
Agreement limit iCAD&#8217;s ability to declare or pay additional dividends. For more information, see the section titled &#8220;<i><a href="#s4_034">The Merger Agreement&#8212;Conduct of Business Pending the Merger</a></i>&#8221; beginning on page 86 of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">After completion of the Merger, any former iCAD
stockholder who holds RadNet Common Stock into which shares of iCAD Common Stock have been converted in connection with the Merger will
receive whatever dividends are declared and paid on RadNet Common Stock , if any. However, no dividend or other distribution having a
record date after completion of the Merger will actually be paid with respect to any shares of RadNet Common Stock into which shares of
iCAD Common Stock have been converted in connection with the Merger until the iCAD Certificates have been surrendered (or the iCAD Book-Entry
Shares have been transferred), at which time any accrued dividends and other distributions on those shares of RadNet Common Stock with
a payment date prior to such date will be paid without interest. Any future dividends by RadNet will be made at the discretion of the
RadNet Board. Subject to the limitations set forth in the Merger Agreement, any future dividends by iCAD will be made at the discretion
of the iCAD Board. There can be no assurance that any future dividends will be declared or paid by RadNet or iCAD or as to the amount
or timing of those dividends, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_031"></span>RISK FACTORS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><i>In addition to the other information contained
in or incorporated by reference into this proxy statement/prospectus, including the matters addressed in the section titled &#8220;<a href="#a_032">Cautionary Note Regarding Forward-Looking Statements</a>&#8221; of this proxy statement/prospectus, the following risk factors should be considered carefully
in determining whether to vote for the adoption of the Merger Agreement. You should also read and consider the risk factors associated
with each of the businesses of RadNet and iCAD because these risk factors may affect the operations and financial results of RadNet following
the Merger. These risk factors may be found under Part I, Item 1A, &#8220;Risk Factors&#8221; in each of RadNet&#8217;s and iCAD&#8217;s
Annual Reports on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on March 3, 2025 and March 31, 2025, respectively,
and in RadNet&#8217;s and iCAD&#8217;s subsequent filings with the SEC, in each case, which are incorporated by reference into this proxy
statement/prospectus. For information on where you can obtain copies of this information, see the section titled &#8220;<a href="#s4_060">Where You Can Find More Information</a>&#8221; of this proxy statement/prospectus. </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Risks Relating to the Merger</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>The Exchange Ratio is fixed and will not be adjusted in the event
of any change in either RadNet&#8217;s or iCAD&#8217;s stock price. Therefore, iCAD stockholders cannot be sure of the value of the Merger
Consideration they will receive.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">If the Merger is completed, each share of iCAD
Common Stock outstanding immediately prior to the Merger (except for the Excluded Shares) will automatically be converted into the right
to receive 0.0677 shares of RadNet Common Stock, with any cash proceeds from the sale of fractional shares. This Exchange Ratio was fixed
in the Merger Agreement and will not be adjusted for changes in the market price of either RadNet Common Stock or iCAD Common Stock. Any
change in the market price of RadNet Common Stock prior to completion of the Merger could affect the value of the consideration that iCAD
stockholders will receive upon completion of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">It is impossible to accurately predict the market
price of RadNet Common Stock at the completion of the Merger and, therefore, impossible to accurately predict the market value of the
shares of RadNet Common Stock that iCAD stockholders will receive in the Merger. The market price for RadNet Common Stock has fluctuated
since the date of the announcement of the Merger Agreement and will continue to fluctuate from the date of this proxy statement/prospectus
to the date of the Special Meeting and the date the Merger is completed and thereafter. Stock price changes may result from a variety
of factors, including, among others, general market and economic conditions, changes in RadNet&#8217;s and iCAD&#8217;s respective businesses,
operations and prospects, market assessments of the likelihood that the Merger will be completed, the timing of the Merger and regulatory
considerations, the public&#8217;s response to press releases or other public announcements by RadNet, iCAD or third parties, announcements
relating to litigation and investor perceptions of the investment opportunity associated with shares of RadNet Common Stock and shares
of iCAD Common Stock relative to other investment alternatives. Many of these factors are beyond RadNet&#8217;s and iCAD&#8217;s control
and neither iCAD nor RadNet are permitted to terminate the Merger Agreement solely due to a decline in the market price. As a result,
the market value represented by the Exchange Ratio will also vary. Accordingly, at the time of the Special Meeting, iCAD stockholders
will not know or be able to determine the market value of the Merger Consideration they would be entitled to receive upon completion of
the Merger. You are urged to obtain current market quotations for each of the RadNet Common Stock and the iCAD Common Stock traded on
The Nasdaq Global Market and The Nasdaq Capital Market, respectively (trading symbols &#8220;RDNT&#8221; and &#8220;ICAD&#8221;, respectively).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>The market price of RadNet Common Stock after the Merger may
be affected by factors different from those affecting the market price of iCAD Common Stock. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Upon completion of the Merger, holders of shares
of iCAD Common Stock will become holders of shares of RadNet Common Stock. The businesses of RadNet differ from those of iCAD in important
respects, and, accordingly, the results of operations of RadNet after the Merger, as well as the market price of RadNet Common Stock ,
may be affected by factors different from those currently affecting the results of operations of iCAD. For further information on the
respective businesses of RadNet and iCAD and certain factors to consider in connection with those businesses, see the documents incorporated
by reference into this proxy statement/prospectus and referred to in the section titled &#8220;<i>Where You Can Find More Information</i>&#8221;
of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In addition, the market price of the RadNet Common
Stock may decline as a result of the Merger if, among other things, RadNet is unable to achieve the expected benefits and synergies of
the Merger, if the Merger is not completed within the anticipated timeframe, or if the transaction costs related to the Merger are greater
than expected. The market price of RadNet Common Stock also may decline if RadNet does not achieve the perceived benefits and expected
synergies of the Merger as rapidly or to the extent anticipated by financial or industry analysts or if the effect of the Merger on RadNet&#8217;s
financial position, results of operations or cash flows is not consistent with the expectations of financial or industry analysts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Additionally, the market price of RadNet Common
Stock may fluctuate significantly following completion of the Merger. Moreover, general fluctuations in stock markets could have a material
adverse effect on the market for, or liquidity of, RadNet Common Stock, regardless of RadNet&#8217;s actual operating performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>After completion of the Merger, RadNet may fail to realize the
anticipated benefits of the Merger. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If RadNet is not able to successfully combine
the businesses of RadNet and iCAD within the anticipated time frame, the anticipated benefits of the Merger may not be realized fully,
or at all, or may take longer to realize than expected. In addition, RadNet may not perform as expected and the value of RadNet Common
Stock (including the Merger Consideration to be received by holders of iCAD Common Stock) may be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet and iCAD have operated and, until completion
of the Merger, will continue to operate, independently, and there can be no assurances that their businesses can be integrated successfully.
It is possible that the integration process could result in the loss of key iCAD employees and expertise, the loss of clients, the disruption
of either company&#8217;s or both companies&#8217; ongoing businesses or in unexpected integration issues, higher than expected integration
costs and an overall post-completion integration process that takes longer than originally anticipated. Specifically, the following issues,
among others, must be addressed in integrating iCAD in order to realize the anticipated benefits of the Merger so that RadNet performs
as expected:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>integrating the companies&#8217; physical assets and technologies, including DeepHealth&#8217;s SmartMammo&#8482; solution suite with
iCAD&#8217;s complementary products;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>coordinating sales, distribution and marketing efforts;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>integrating and achieving anticipated synergies;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>succeeding in applying RadNet&#8217;s technologies to iCAD&#8217;s assets;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>harmonizing the companies&#8217; operating practices, employee development and compensation programs, internal controls and other
policies, procedures and processes;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>maintaining existing agreements with commercial counterparties and avoiding delays in entering into new agreements with prospective
commercial counterparties;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>identifying and eliminating redundant and underperforming functions and assets;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>combining certain of the companies&#8217; operations, financial, reporting and corporate functions;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>addressing possible differences in business backgrounds, corporate cultures and management philosophies;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>consolidating the companies&#8217; administrative and information technology infrastructure;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>managing the movement of certain businesses and positions to different locations; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><span style="font-size: 10pt">coordinating geographically dispersed organizations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">In addition, at times, the attention of certain
members of either company&#8217;s or both companies&#8217; business or management and resources may be focused on completion of the Merger
and the integration of the businesses of the two companies following the completion of the Merger and diverted from day-to-day business
operations, which may disrupt each company&#8217;s ongoing business and the business of RadNet following the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>iCAD may have difficulty attracting motivating and retaining
employees in light of the Merger. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">Uncertainty about the effect of the Merger on iCAD
employees may impair iCAD&#8217;s ability to attract, retain and motivate personnel prior to and following the Merger. Employee retention
may be particularly challenging during the pendency of the Merger, as employees of iCAD may experience uncertainty about their future
roles. In addition, pursuant to certain change-in-control provisions set forth in employment-related agreements with iCAD, each executive
officer and certain other key employees of iCAD are eligible to receive cash severance and continued health benefits and, under certain
agreements, accelerated vesting of all unvested Eligible iCAD Options and any other equity awards assumed by RadNet in the Merger, in
each case, in the event the employee resigns for &#8220;good reason&#8221; (as such term is defined in the applicable agreement) within
a certain period of time following the Merger. In general, such employees potentially could resign for &#8220;good reason&#8221; as a
result of certain changes to their job titles and/or a material diminution in their position, authority, duties and/or responsibilities
following the Merger if iCAD does not remedy the &#8220;good reason&#8221; condition pursuant to a process set forth in their agreements.
See the section titled &#8220;<i>Interests of iCAD&#8217;s Directors and Executive Officers in the Merger</i>&#8221; for a further discussion
of the interests of iCAD&#8217;s executive officers in the Merger. If employees of iCAD depart, the integration of iCAD may be more difficult
and RadNet&#8217;s business following the Merger may be harmed. Furthermore, RadNet may have to incur significant costs in identifying,
hiring and retaining replacements for departing employees and may lose significant expertise and talent relating to the businesses of
RadNet or iCAD, and RadNet&#8217;s ability to realize the anticipated benefits of the Merger may be adversely affected. In addition, there
could otherwise be disruptions to or distractions for the workforce and management associated with integrating employees into RadNet.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Completion of the Merger is subject to certain conditions and
if these conditions are not satisfied, waived or fulfilled in a timely manner, the Merger may be delayed or not completed. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The obligation of each of RadNet, iCAD and Merger
Sub to complete the Merger is subject to the satisfaction (or, to the extent permitted by applicable law, waiver) of a number of conditions,
as set forth in the section titled &#8220;<i><a href="#s4_031">The Merger Agreement&#8212;Conditions to Completion of the Merger</a></i>&#8221; of this proxy
statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Many of the conditions to completion of the Merger
are not within either iCAD&#8217;s or RadNet&#8217;s control, and neither company can predict when, or if, these conditions will be satisfied.
If any of these conditions are not satisfied or waived prior to the Outside Date, it is possible that the Merger Agreement may be terminated.
Although iCAD and RadNet have agreed in the Merger Agreement to cooperate with each other and use (and to cause their respective subsidiaries
to use) their respective reasonable best efforts to consummate the transactions contemplated by the Merger Agreement and cause the conditions
to the Merger to be satisfied as promptly as reasonably practicable, these and other conditions to the completion of the Merger may fail
to be satisfied. In addition, satisfying the conditions to and completion of the Merger may take longer, and could cost more, than iCAD
and RadNet expect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Furthermore, the requirements for obtaining the
required clearances and approvals could delay the completion of the Merger for a significant period of time or prevent the Merger from
occurring. Any delay in completing the Merger may adversely affect the cost savings and other benefits that iCAD and RadNet expect to
achieve if the Merger and the integration of the companies&#8217; respective businesses are not completed within the expected time frame.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">There can be no assurance that the conditions
to the Closing of the Merger will be satisfied, waived or fulfilled in a timely fashion or that the Merger will be completed. See &#8220;<i>&#8212;Failure
to complete the Merger could negatively impact the stock price and the future business and financial results of iCAD</i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>If the Merger were to fail to qualify as a &#8220;reorganization&#8221;
within the meaning of Section 368(a) of the Code, iCAD stockholders may be required to pay substantial U.S. federal income taxes.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">The Merger is intended to qualify as a &#8220;reorganization&#8221;
within the meaning of Section 368(a) of the Code, and iCAD and RadNet intend to report the Merger consistent with such qualification.
iCAD has received a tax opinion from Dentons to the effect that the Merger will qualify as a &#8220;reorganization&#8221; within the meaning
of Section 368(a) of the Code. The tax opinion from Dentons is based on customary assumptions and representations, covenants and undertakings
of iCAD, RadNet and Merger Sub. If any of the assumptions, representations, covenants or undertakings is incorrect, incomplete, inaccurate,
or otherwise is violated, the validity of the tax opinion from Dentons may be affected and the U.S. federal income tax consequences of
the Merger could differ materially from those described in this proxy statement/prospectus. The receipt of a tax opinion from counsel
is not a condition to either party&#8217;s obligation to complete the Merger. iCAD and RadNet have not sought, and do not intend to seek,
any ruling from the IRS regarding the qualification of the Merger as a &#8220;reorganization&#8221; within the meaning of Section 368(a)
of the Code. As a result, there can be no assurance that the IRS will agree with the tax opinion from Dentons or would not assert, or
that a court would not sustain, a position contrary to the treatment of the Merger as a &#8220;reorganization&#8221; within the meaning
of Section 368(a) of the Code. If the Merger were to fail to qualify
as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code, a U.S. holder (as defined in the section titled &#8220;<i><a href="#s4_018">Material U.S. Federal Income Tax Consequences of the Merger</a></i>&#8221; of this proxy statement/prospectus) of iCAD Common Stock generally would
recognize gain or loss for U.S. federal income tax purposes upon the exchange of iCAD Common Stock for RadNet Common Stock in the Merger.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">See the section titled &#8220;<i><a href="#s4_049">Material U.S. Federal Income Tax Consequences of the Merger</a></i>&#8221; of this proxy statement/prospectus for a more complete description of the material U.S.
federal income tax consequences of the Merger. Please consult your tax advisors as to the specific tax consequences to you of the Merger,
including the consequences if the Merger were to fail to qualify as a &#8220;reorganization.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>The financial forecasts are based on various assumptions that
may not be realized. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The financial estimates set forth in the forecasts
included under the section titled &#8220;<i>The Merger&#8212;Certain iCAD Unaudited Prospective Financial Information</i>&#8221; were
based on assumptions of, and information available to, iCAD&#8217;s management, when prepared, and these estimates and assumptions are
subject to uncertainties, many of which are beyond iCAD&#8217;s control and may not be realized. Many factors mentioned in this proxy
statement/prospectus, including the risks outlined in this &#8220;<i><a href="#a_031">Risk Factors</a></i>&#8221; section and the events or circumstances described
under the section titled &#8220;<i><a href="#a_032">Cautionary Note Regarding Forward-Looking Statements</a></i>,&#8221; will be important in determining RadNet&#8217;s
future results. As a result of these contingencies, actual future results may vary materially from iCAD&#8217;s estimates. Although, in
the view of iCAD&#8217;s management, the financial estimates set forth in the forecasts included under the section titled &#8220;<i>The Merger&#8212;Certain iCAD Unaudited Prospective Financial Information</i>&#8221; were prepared on a reasonable basis and reflected the
best estimates and judgments available to iCAD&#8217;s management, in view of these uncertainties, the inclusion of financial estimates
in this proxy statement/prospectus is not and should not be viewed as a representation that the forecasted results will necessarily reflect
actual future results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD&#8217;s financial estimates were not prepared
with a view toward public disclosure, and such financial estimates were not prepared with a view toward compliance with published guidelines
of any regulatory or professional body. Further, any forward-looking statement speaks only as of the date on which it is made, and iCAD
does not undertake any obligation, other than as required by applicable law, to update the financial estimates herein to reflect events
or circumstances after the date those financial estimates were prepared or to reflect the occurrence of anticipated or unanticipated events
or circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>The opinion of iCAD&#8217;s financial advisor will not reflect
changes in circumstances between the signing of the Merger Agreement and the completion of the Merger. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD has received an opinion from its financial
advisor in connection with the signing of the Merger Agreement as to the fairness of the Exchange Ratio from a financial point of view,
to the holders of iCAD Common Stock who will receive RadNet Common Stock in the Merger, as more fully described in the section titled
&#8220;<i><a href="#s4_006">The Merger&#8212;Opinion of iCAD&#8217;s Financial Advisor</a></i>&#8221;, but has not obtained any updated opinion from its financial
advisor as of the date of this proxy statement/prospectus. Changes in the operations and prospects of RadNet or iCAD, general market and
economic conditions and other factors that may be beyond the control of RadNet or iCAD, and on which iCAD&#8217;s financial advisor&#8217;s
opinion was based, may significantly alter the value of RadNet or iCAD or the prices of the shares of RadNet Common Stock or iCAD Common
Stock by the time the Merger is completed. The opinion does not speak as of the time the Merger will be completed or as of any date other
than the date of such opinion. The iCAD Board&#8217;s recommendation that iCAD stockholders vote &#8220;<b>FOR</b>&#8221; approval of
the Merger Agreement Proposal, &#8220;<b>FOR</b>&#8221; approval of the Advisory Compensation Proposal and &#8220;<b>FOR</b>&#8221; approval
of the Adjournment Proposal, is made as of the date of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For a description of the opinion that iCAD received
from its financial advisor, see the section titled &#8220;<i><a href="#s4_006">The Merger&#8212;Opinion of iCAD&#8217;s Financial Advisor</a></i>&#8221; of
this proxy statement/prospectus. A copy of the opinion of Piper Sandler is attached as Annex B to this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>RadNet&#8217;s and iCAD&#8217;s business relationships may be
subject to disruption due to uncertainty associated with the Merger. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Parties with which RadNet or iCAD does business
may experience uncertainty associated with the Merger, including with respect to current or future business relationships with RadNet
or iCAD. RadNet&#8217;s and iCAD&#8217;s business relationships may be subject to disruption as parties with which RadNet or iCAD does
business may attempt to negotiate changes in existing business relationships or consider entering into business relationships with parties
other than RadNet or iCAD. These disruptions could have an adverse effect on the businesses, financial condition, results of operations
or prospects of RadNet, including an adverse effect on RadNet&#8217;s ability to realize the anticipated benefits of the Merger. The risk,
and adverse effect, of such disruptions could be exacerbated by a delay in completion of the Merger or termination of the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>iCAD or RadNet may waive one or more of the closing conditions
without re-soliciting stockholder approval. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD or RadNet may determine to waive, in whole
or part, one or more of the conditions to Closing prior to being obligated to consummate the Merger. Any determination whether to waive
any conditions to Closing, or to re-solicit stockholder approval or to amend or supplement this proxy statement/prospectus as a result
of such a waiver, will be made by iCAD or RadNet, as applicable, at the time of such waiver based on the facts and circumstances as they
exist at that time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Completion of the Merger may trigger change in control or other
provisions in certain agreements to which iCAD is a party. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD is a party to certain commercial agreements
that give the counterparty certain rights following a &#8220;change in control,&#8221; including in some cases the right to terminate
such agreements. Under some such agreements, the Merger may constitute a change in control and therefore the counterparty may exercise
certain rights under the agreement upon the Closing of the Merger. Any such counterparty may request modifications of its respective
agreements as a condition to granting a waiver or consent under its agreement. There is no assurance that such counterparties will not
exercise their rights under the agreements, including termination rights where available and/or requiring payment of substantial financial
penalties. Under the terms of the Merger Agreement, iCAD has agreed to use commercially reasonable efforts to obtain all third-party
consents or approvals, and provide all notices to third-parties, in each case to the extent reasonably requested by RadNet in writing
and required in connection with the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b><i>iCAD&#8217;s directors
and executive officers have interests in the Merger that may be different from, or in addition to, your interests as a stockholder of
iCAD or as a stockholder of RadNet.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 24.5pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">In
considering the recommendation of the iCAD Board to vote for the adoption of the Merger Agreement, iCAD stockholders should be aware
that the directors and executive officers of iCAD have interests in the Merger that may be different from, or in addition to, the interests
of iCAD stockholders generally. In connection with the Merger, shares of iCAD Common Stock owned by the directors and executive officers
of iCAD will be converted into the right to receive a number of shares of RadNet Common Stock, and RadNet will assume Eligible iCAD Options
held by each of the directors and executive officers of iCAD at the time of the Merger. In addition, all unvested outstanding Eligible
iCAD Options held by each member of the iCAD Board immediately prior to the Effective Time will accelerate and automatically vest and
become exercisable as of immediately prior to the Effective Time, iCAD non-employee directors may receive the unpaid portion of their
full annual cash retainer under iCAD&#8217;s non-employee director compensation program for the service year in which the closing of
the Merger occurs, regardless of the time during such service year that such closing actually occurs, and certain cash bonuses will become
payable to iCAD&#8217;s Chief Executive Officer and Chief Financial Officer upon closing of the Merger. Moreover, pursuant to certain
change-in-control provisions set forth in an employment-related agreement with iCAD, each executive officer of iCAD is eligible to receive
cash severance, continued health benefits and accelerated vesting of all unvested stock options and any other equity awards assumed by
RadNet in the Merger in the event such executive officer&#8217;s employment is terminated without &#8220;cause&#8221; by iCAD or the
executive officer resigns for &#8220;good reason&#8221; (as such terms are defined in the applicable agreement), as applicable, within
a certain period of time following the Merger. The Merger Agreement also generally provides that, no later than 10 business days prior
to the Effective Time, the iCAD Board may approve an amendment to the exercise provisions applicable to certain iCAD Options, including
certain iCAD Options held by the directors and executive officers of iCAD, such that, effective as of immediately prior to the Effective
Time, the portion of all such iCAD Options that is vested and exercisable will be exercisable for a period of the greater of (a) one
year following the Closing Date and (b) the exercise period set forth in the applicable award agreement (after giving effect to any applicable
acceleration provisions), subject to certain limitations and exceptions (the &#8220;iCAD Option Extension Amendments&#8221;). On May
16, 2025, the iCAD Board approved the iCAD Option Extension Amendments relating to an aggregate of 1,828,124 iCAD Options that each have
an exercise price per share of iCAD Common Stock that is less than $7.20, which included an aggregate of 1,478,124 iCAD Options held
by iCAD directors and executive officers. The iCAD Board was aware of these interests and considered them, among other matters, in evaluating
and negotiating the Merger Agreement and approving the Merger, and in making its recommendation that iCAD stockholders vote to adopt
the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For more information, see the sections
titled &#8220;<i><a href="#interests">Interests of iCAD&#8217;s Directors and Executive Officers in the Merger</a></i>&#8221; and &#8220;<i><a href="#s4_050">Certain
Beneficial Owners of iCAD Common Stock</a></i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>The Merger Agreement limits iCAD&#8217;s ability to pursue alternatives
to the Merger and may discourage other companies from trying to acquire iCAD for greater consideration than what RadNet has agreed to
pay pursuant to the Merger Agreement. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">The Merger Agreement contains provisions that make
it more difficult for iCAD to be acquired by, or enter into certain alternative transactions with, a third party. The Merger Agreement
contains certain provisions that restrict iCAD&#8217;s ability to, among other things, solicit, directly or indirectly, solicit, initiate
or knowingly encourage, or take any other action to knowingly facilitate, any inquiries relating to, the submission of, or the making
of, any proposal the consummation of which would constitute an Alternative Transaction, or cooperate in any way with any person, with
respect to any Alternative Transaction or amend or grant any waiver of any standstill or similar agreement. In addition, following receipt
by iCAD of any Alternative Transaction proposal that constitutes a Superior Offer, RadNet will have an opportunity to offer to modify
the terms of the Merger Agreement before the iCAD Board may effect an iCAD Recommendation Change, as described further under the section
titled &#8220;<i>The Merger Agreement&#8212;Obligation to Recommend Approval of the Merger Agreement Proposal</i>&#8221; of this proxy
statement/prospectus. These provisions could discourage a potential third-party acquiror, strategic transaction partner or business combination
partner that might have an interest in acquiring or combining with all or a significant portion of iCAD or pursuing an Alternative Transaction
from considering or proposing such a transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">If the Merger Agreement is terminated and either
RadNet or iCAD determines to seek another business combination transaction, RadNet or iCAD may not be able to successfully negotiate a
transaction with another party on terms comparable to, or better than, the terms of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="failuretocomplete"></span>Failure to complete the Merger could negatively impact the stock
price and the future business and financial results of iCAD. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If the Merger is not completed for any reason,
including as a result of iCAD stockholders failing to adopt the Merger Agreement or any other condition not being satisfied or waived,
the ongoing businesses of iCAD may be adversely affected, and, without realizing any of the benefits of having completed the Merger iCAD
would be subject to a number of risks, including the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD may experience negative reactions from the financial markets, including negative impacts on its stock price;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD may experience negative reactions from its customers, vendors and other business partners, regulators and employees;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD will be required to pay certain costs relating to the Merger, such as legal, accounting, financial advisor and printing fees,
whether or not the Merger is completed;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the Merger Agreement places certain restrictions on the conduct of iCAD&#8217;s businesses prior to completion of the Merger, and
such restrictions, the waiver of which is subject to the written consent of RadNet, and subject to certain exceptions and qualifications,
may prevent iCAD from taking certain other specified actions or otherwise pursuing business opportunities during the pendency of the Merger
that iCAD would have made, taken or pursued if these restrictions were not in place (see the section titled &#8220;<i>The Merger Agreement&#8212;Conduct
of Business Pending the Merger&#8221; </i>of this proxy statement/prospectus for a description of the restrictive covenants applicable
to iCAD);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>matters relating to the Merger will require substantial commitments of time and resources by iCAD management, which would otherwise
have been devoted to day-to-day operations and other opportunities that may have been beneficial to iCAD as an independent company;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>in the event of a termination of the Merger Agreement under certain circumstances specified in the Merger Agreement, iCAD may be required
to pay a termination fee to RadNet of $1,000,000, plus up to $2,000,000 of all documented fees and expenses of RadNet incurred in connection
with the negotiation and performance of the Merger Agreement and the transactions contemplated thereby; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>litigation related to any failure to complete the Merger or related to any enforcement proceeding commenced against iCAD or RadNet
preventing the performance of their respective obligations pursuant to the Merger Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">There can be no assurance that the risks described
above will not materialize. If the Merger is not completed, these risks may materialize and may materially and adversely affect iCAD&#8217;s
businesses, financial condition, financial results, ratings, stock prices and/or bond prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>The shares of RadNet Common Stock to be received by iCAD stockholders
upon completion of the Merger will have different rights from shares of iCAD Common Stock. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Upon completion of the Merger, iCAD stockholders
will no longer be stockholders of iCAD, but will instead become stockholders of RadNet, and their rights as stockholders will be governed
by the RadNet Certificate of Incorporation and the RadNet Bylaws. The terms of the RadNet Certificate of Incorporation and the RadNet
Bylaws may be materially different than the terms of the iCAD Certificate of Incorporation and the iCAD Bylaws, which currently govern
the rights of iCAD stockholders. See the section titled &#8220;<i>Comparison of Stockholder Rights</i>&#8221; of this proxy statement/prospectus
for a discussion of the different rights associated with RadNet Common Stock .</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>After the Merger, iCAD stockholders, as a group, will have a
significantly lower ownership and voting interest in RadNet than they currently have in iCAD and will exercise less influence over management.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Under the
terms of the agreement, iCAD stockholders will receive 0.0677 shares of RadNet Common Stock for each share of iCAD Common Stock they
hold at the Effective Time. Based on (i) the Exchange Ratio of 0.0677 and (ii) the number of shares of iCAD Common Stock and Eligible
iCAD Options outstanding as of the iCAD Record Date, RadNet estimates that it will issue approximately 2,024,584 shares of RadNet Common
Stock pursuant to the Merger Agreement, provided that if additional iCAD equity awards are granted to certain iCAD employees as permitted
under the Merger Agreement, RadNet may be required to reserve additional shares of RadNet Common Stock for issuance (see the section
titled &#8220;<i>The Merger Agreement&#8212;Treatment of iCAD Options</i>&#8221; of this proxy statement/prospectus). RadNet has a significantly
larger market capitalization than iCAD. Based upon the foregoing and the estimated number of shares of iCAD Common Stock that are expected
to be outstanding immediately prior to the consummation of the Merger, RadNet and iCAD estimate that, as of immediately following completion
of the Merger, holders of RadNet Common Stock as of immediately prior to the Merger will hold approximately 97.4%, and holders of iCAD
Common Stock as of immediately prior to the Merger will hold approximately 2.6%, of the outstanding shares of RadNet Common Stock on
a fully diluted basis. Consequently, former iCAD stockholders, as a group, will have materially less influence over the management and
policies of RadNet than they currently have over the management and policies of iCAD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>iCAD stockholders are not entitled to appraisal rights in connection
with the Merger. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Appraisal rights are statutory rights that enable
stockholders to dissent from certain extraordinary transactions, such as certain mergers, and to demand that the corporation pay the fair
value for their shares as determined by a court in a judicial proceeding instead of receiving the consideration offered to stockholders
in connection with the applicable transaction. Under Delaware law, holders of shares of iCAD Common Stock will not have rights to an appraisal
of the fair value of their shares in connection with the Merger. See the section titled &#8220;<i><a href="#nodissenters">The Merger&#8212;No Dissenters&#8217; or Appraisal Rights</a></i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Potential litigation against RadNet and iCAD could result in
substantial costs, an injunction preventing the completion of the Merger and/or a judgment resulting in the payment of damages. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Securities class action lawsuits and derivative
lawsuits are often brought against public companies that have entered into merger agreements. Even if such lawsuits are unsuccessful,
defending against them can result in substantial costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Stockholders of iCAD may file lawsuits against
RadNet, iCAD and/or the directors and officers of either company in connection with the Merger. These lawsuits could prevent or delay
the completion of the Merger and result in significant costs to iCAD and/or RadNet, including any costs associated with the indemnification
of directors and officers. There can be no assurance that any of the defendants will be successful in the outcome of any potential lawsuits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>RadNet and iCAD will incur significant transaction and Merger-related
costs in connection with the Merger. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet and iCAD expect to incur a number of non-recurring
costs associated with the Merger and combining the operations of the two companies. The significant, non-recurring costs associated with
the Merger include, among others, fees and expenses of financial, legal, accounting and other advisors and representatives, certain employment-related
costs relating to employees of iCAD (which are described in the section titled &#8220;<i><a href="#interests">Interests of iCAD&#8217;s Directors and Executive Officers in the Merger</a></i>&#8221;) and filing fees and printing and mailing costs for this proxy statement/prospectus. Some of these costs
have already been incurred or may be incurred regardless of whether the Merger is completed, including a portion of the fees and expenses
of financial advisors and other advisors and representatives and filing fees for this proxy statement/prospectus. RadNet also will incur
transaction fees and costs related to formulating and implementing integration plans with respect to the two companies, including facilities
and systems consolidation costs. RadNet continues to assess the magnitude of these costs, and additional unanticipated costs may be incurred
in the Merger and the integration of the two companies&#8217; businesses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>iCAD may not have discovered certain liabilities or other matters
related to RadNet and RadNet may not have discovered certain liabilities or other matters related to iCAD, which may adversely affect
the future financial performance of RadNet following the Merger.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In the course of the due diligence review that
each of RadNet and iCAD conducted prior to the execution of the Merger Agreement, RadNet and iCAD may not have discovered, or may have
been unable to properly quantify, certain liabilities of the other party or other factors that may have an adverse effect on the business,
results of operations, financial condition and cash flows of RadNet following the Merger or on the market price of RadNet Common Stock
issued pursuant to the Merger Agreement after the consummation of the Merger, and neither RadNet stockholders nor iCAD stockholders will
be indemnified or otherwise compensated for any of these liabilities or other adverse effects resulting from other factors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Former iCAD stockholders may be required to surrender necessary
documents, duly executed and on a timely basis, to the exchange agent in order to receive their shares of RadNet Common Stock or their
cash in lieu of fractional shares, if any, and if such iCAD stockholders fail to surrender all necessary documents, duly executed and
on a timely basis, to the exchange agent, such former iCAD stockholders may experience a delay in receiving RadNet Common Stock or their
cash in lieu of fractional shares, if any.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Former iCAD stockholders that hold their iCAD
Common Stock as iCAD Certificates, or as iCAD Book-Entry Shares but not through The Depository Trust Company, are required to surrender
necessary documents, duly executed and on a timely basis, to the exchange agent in order to receive their RadNet Common Stock, or their
cash in lieu of fractional shares, if any. Former iCAD stockholders who are required to surrender all necessary documents, duly executed
and on a timely basis, to the exchange agent and who fail to do so may experience a delay prior to receiving their RadNet Common Stock,
or their cash in lieu of fractional shares, if any. Until the distribution of RadNet Common Stock to the individual stockholder has been
completed, the relevant holder of RadNet Common Stock will not be able to sell its RadNet Common Stock. Consequently, in case the market
price for RadNet Common Stock should decrease during that period, the relevant stockholder would not be able to stop any losses by selling
RadNet Common Stock. Similarly, the relevant former iCAD stockholder who is entitled to receive cash in lieu of fractional shares will
not be able to invest the cash until the distribution to the relevant stockholder has been completed, and they will not receive any interest
payments for this time period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Risks Relating to RadNet and iCAD</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet and iCAD are, and following completion
of the Merger RadNet will continue to be, subject to the risks described in (i) Part I, Item 1A, &#8220;<i>Risk Factors</i>&#8221; in
RadNet&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 3, 2025, as amended
by Amendment No. 1 on Form 10-K/A, filed with the SEC on April 28, 2025, (ii) Part I, Item 1A, &#8220;<i>Risk Factors</i>&#8221; in iCAD&#8217;s
Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 31, 2025, as amended by Amendment
No. 1 on Form 10-K/A, filed with the SEC on April 30, 2025, and (iii) RadNet&#8217;s and iCAD&#8217;s subsequent filings with the SEC,
in each case, which are incorporated by reference into this proxy statement/prospectus. See the section titled &#8220;<i><a href="#s4_060">Where You Can Find More Information</a></i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_032"></span>CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">This registration statement on Form S-4 of which
this proxy statement/prospectus forms a part contains certain &#8220;forward-looking statements&#8221; within the meaning of the safe
harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the
Exchange. Forward-looking statements can be identified by words such as: &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221;
&#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;outlook,&#8221;
&#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;possible,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;seek, &#8220;should,&#8221;
&#8220;target,&#8221; &#8220;will&#8221; or &#8220;would,&#8221; the negative of these words, and similar references to future periods.
Examples of forward-looking statements include statements regarding the anticipated benefits of the proposed transaction, the impact of
the proposed transaction on RadNet&#8217;s and iCAD&#8217;s business and future financial and operating results and prospects, the amount
and timing of synergies from the proposed transaction and the closing date for the proposed transaction are based on the current estimates,
assumptions and projections of RadNet and iCAD, and are qualified by the inherent risks and uncertainties surrounding future expectations
generally, all of which are subject to change. Actual results could differ materially from those currently anticipated due to a number
of risks and uncertainties, many of which are beyond RadNet&#8217;s and iCAD&#8217;s control. Forward-looking statements are neither historical
facts nor assurances of future performance. Instead, they are based only on management&#8217;s current beliefs, expectations and assumptions
regarding the future of RadNet&#8217;s and iCAD&#8217;s business, future plans and strategies, projections, anticipated events and trends,
the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict and many of which are outside of RadNet&#8217;s and iCAD&#8217;s control.
RadNet&#8217;s and iCAD&#8217;s actual results and financial condition following the proposed transaction may differ materially from those
indicated in the forward-looking statements as a result of various factors. None of RadNet, iCAD or any of their respective directors,
executive officers, or advisors, provide any representation, assurance or guarantee that the occurrence of the events expressed or implied
in any forward-looking statements will actually occur, or if any of them do occur, what impact they will have on the business, results
of operations or financial condition of RadNet or iCAD. Should any risks and uncertainties develop into actual events, these developments
could have a material adverse effect on RadNet&#8217;s and iCAD&#8217;s businesses, the proposed transaction and the ability to successfully
complete the proposed transaction and realize its expected benefits. Risks and uncertainties that could cause results to differ from expectations
include, but are not limited to: (1) the termination of or occurrence of any event, change or other circumstances that could give rise
to the termination of the merger agreement or the inability to complete the proposed transaction on the anticipated terms and timetable,
(2) the inability to complete the proposed transaction due to the failure to obtain approval of the stockholders of iCAD or to satisfy
any other condition to closing in a timely manner or at all, or the risk that a regulatory approval that may be required for the proposed
transaction is delayed, is not obtained or is obtained subject to conditions that are not anticipated, (3) the ability to recognize the
anticipated benefits of the proposed transaction, which may be affected by, among other things, the ability of RadNet or iCAD to maintain
relationships with its customers, patients, payers, physicians, and providers and retain its management and key employees, (4) the ability
of RadNet following the proposed transaction to achieve the synergies contemplated by the proposed transaction or such synergies taking
longer to realize than expected, (5) costs related to the proposed transaction, (6) the ability of RadNet following the proposed transaction
to execute successfully its strategic plans, (7) the ability of RadNet following the proposed transaction to promptly and effectively
integrate iCAD into its business, (8) the risk of litigation related to the proposed transaction, (9) the diversion of management&#8217;s
time and attention from ordinary course business operations to completion of the proposed transaction and integration matters, (10) the
risk of legislative, regulatory, economic, competitive, and technological changes, (11) risks relating to the value of RadNet&#8217;s
securities to be issued in the Merger, and (12) the effect of the announcement, pendency or completion of the proposed transactions on
the market price of the RadNet Common Stock and iCAD Common Stock. The foregoing review of important factors should not be construed as
exhaustive and should be read in conjunction with the other cautionary statements that are included elsewhere. Additional information
concerning risks, uncertainties and assumptions are described in the section titled &#8220;<i>Risk Factors</i>&#8221; and in RadNet&#8217;s
and iCAD&#8217;s respective filings with the SEC, including the risk factors discussed in RadNet&#8217;s and iCAD&#8217;s most recent
Annual Reports on Form 10-K, as amended, as updated by their respective Quarterly Reports on Form 10-Q and future filings with the SEC.
Forward-looking statements included herein are made only as of the date hereof and, except as required by applicable law, neither RadNet
nor iCAD undertakes any obligation to update any forward-looking statements, or any other information in this Current Report on Form 8-K,
as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent.
All forward-looking statements in this registration statement on Form S-4 of which this proxy statement/prospectus forms a part are qualified
in their entirety by this cautionary statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_033"></span>THE COMPANIES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_035"></span>RadNet, Inc.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet, Inc., which is referred to in this proxy
statement/prospectus as RadNet, is a leading national provider of diagnostic imaging services in the United States based on number of
locations and annual imaging revenue. RadNet has been in business since 1985. RadNet&#8217;s principal business segment is the provision
of diagnostic imaging services. As of December 31, 2024, RadNet operated, directly or indirectly through joint ventures with hospitals,
398 imaging centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, Texas and New York.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet Common Stock is traded on The Nasdaq Global
Market under the symbol &#8220;RDNT.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The principal executive offices of RadNet are
located at 1510 Cotner Avenue, Los Angeles, California 90025, its telephone number is (310) 445-2800 and its website is www.radnet.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">This proxy statement/prospectus incorporates important
business and financial information about RadNet from other documents that are not included in or delivered with this proxy statement/prospectus.
For a list of the documents that are incorporated by reference in this proxy statement/prospectus, see the section titled &#8220;<i><a href="#s4_060">Where You Can Find More Information</a></i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_036"></span>iCAD, Inc.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD, Inc., which is referred to in this proxy
statement/prospectus as iCAD, is a global leader in AI-powered cancer detection whose mission is to create a world where cancer can&#8217;t
hide. iCAD&#8217;s ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where
cancer may be hiding, and because cancer may be found earlier, it is likely more easily eliminated. The ProFound Breast Health Suite currently
offers solutions for breast cancer detection, breast density assessment, and one- or two-year breast cancer risk evaluation. Additionally,
iCAD is in the early stages of development of a product that can identify breast arterial calcification from mammogram images.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD Common Stock is traded on The Nasdaq Capital
Market under the symbol &#8220;ICAD.&#8221; Following the Merger, iCAD Common Stock will be delisted from The Nasdaq Capital Market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The principal executive offices of iCAD are located
at 2 Townsend West, Suite 6, Nashua, New Hampshire 03063, its telephone number is (603) 882-5200 and its website is www.icadmed.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Additional information about iCAD and its subsidiaries
are included in documents incorporated by reference into this proxy statement/prospectus. For a list of the documents that are incorporated
by reference in this proxy statement/prospectus, see the section titled &#8220;<i><a href="#s4_060">Where You Can Find More Information</a></i>&#8221; of this
proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_037"></span>Trio Merger Sub, Inc.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Trio Merger Sub, Inc., which is referred to in
this proxy statement/prospectus as Merger Sub, is a wholly-owned subsidiary of RadNet. Merger Sub was formed solely for the purpose of
completing the Merger. Merger Sub has not carried on any activities to date, except for activities incidental to its formation and activities
undertaken in connection with the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Merger Sub was formed in the State of Delaware
on April 11, 2025. The principal executive offices of Merger Sub are located at 1510 Cotner Avenue, Los Angeles, California 90025, and
its telephone number is (310) 445-2800.<br/>
</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_034"></span>THE iCAD SPECIAL MEETING</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_039"></span>General</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">This proxy statement/prospectus is being provided
to iCAD stockholders as part of a solicitation of proxies by the iCAD Board for use at the Special Meeting and at any adjournments or
postponements of such Special Meeting. This proxy statement/prospectus provides iCAD stockholders with important information about the
Special Meeting and should be read carefully in its entirety. In addition, this proxy statement/prospectus constitutes a prospectus for
RadNet in connection with the issuance by RadNet of shares of RadNet Common Stock pursuant to the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_040"></span>Date, Time and Place of the Special Meeting</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">The Special Meeting will be a virtual only meeting
conducted exclusively via live webcast at www.cstproxy.com/icad/sm2025 starting at 9:00 a.m., Eastern Time (with log-in beginning at
8:45 a.m. Eastern Time), on July 14, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">If your shares are registered in your name with
Continental, iCAD&#8217;s transfer agent, and you wish to attend the online-only virtual Special Meeting, go to www.cstproxy.com/icad/sm2025,
enter the control number you received on your proxy card or notice of the Special Meeting and click on the &#8220;Click here to preregister
for the online meeting&#8221; link at the top of the page. Just prior to the start of the Special Meeting you will need to log back into
the Special Meeting site using your control number. Pre-registration is recommended but is not required in order to attend.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Beneficial stockholders who wish to attend the
online-only virtual Special Meeting must obtain a legal proxy by contacting their account representative at the bank, broker, or other
nominee that holds their shares and e-mail a copy (a legible photograph is sufficient) of their legal proxy to proxy@continentalstock.com.
Beneficial stockholders who e-mail a valid legal proxy will be issued a meeting control number that will allow them to register to attend
and participate in the online-only virtual Special Meeting. After contacting Continental a beneficial holder will receive an e-mail prior
to the Special Meeting with a link and instructions for entering the virtual Special Meeting. Beneficial stockholders should contact Continental
at least five business days prior to the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Because the Special Meeting is completely virtual
and being conducted via live webcast, stockholders will not be able to attend the Special Meeting in person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_041"></span>Purposes of the Special Meeting</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Special Meeting is being held to consider
and vote upon the following proposals:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Proposal 1&#8212;the Merger Agreement Proposal</i></b>: to adopt the Merger Agreement, a copy of which is attached as Annex
A to this proxy statement/prospectus and the material provisions of which are summarized in the section titled &#8220;<i>The Merger Agreement</i>&#8221;
of this proxy statement/prospectus, pursuant to which, among other things, Merger Sub will merge with and into iCAD and each outstanding
share of iCAD Common Stock will be converted into the right to receive a number of shares of RadNet Common Stock equal to the Exchange
Ratio, as determined in accordance with the Merger Agreement and described herein.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Proposal 2&#8212;the Advisory Compensation Proposal</i></b>: to approve, on a non-binding, advisory basis, the compensation
that may be paid or become payable to iCAD&#8217;s named executive officers that is based on or otherwise related to the Merger, the estimated
value of which is disclosed in the table in the section titled &#8220;<i>Interests of iCAD&#8217;s Directors and Executive Officers in
the Merger&#8212;Quantification of Potential Payments and Benefits to iCAD&#8217;s Named Executive Officers</i>&#8221; of this proxy statement/prospectus.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Proposal 3&#8212;the Adjournment Proposal</i></b>: to approve the adjournment of the Special Meeting to a later date or dates,
if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of
the Special Meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_042"></span>Recommendation of the iCAD Board</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">At a meeting held on April 15, 2025, the iCAD
Board unanimously (i) approved and declared advisable the Merger Agreement and the transactions contemplated therein, including the Merger,
on the terms and subject to the conditions set forth therein, (ii) determined that the Merger Agreement and the consummation of the transactions
contemplated thereby, (including the Merger), are advisable and fair to, and in the best interests of, iCAD and the stockholders of iCAD,
(iii) resolved to recommend the adoption of the Merger Agreement to the stockholders of iCAD, on the terms and subject to the conditions
set forth therein, and (iv) directed that the Merger Agreement be submitted to the stockholders of iCAD for adoption at the Special Meeting.
<b>The iCAD Board unanimously recommends that the iCAD stockholders vote:</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Proposal 1: &#8220;FOR&#8221; the Merger Agreement Proposal; </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Proposal 2: &#8220;FOR&#8221; the Advisory Compensation Proposal; and</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Proposal 3: &#8220;FOR&#8221; the Adjournment Proposal.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">This proxy statement/prospectus contains important
information regarding these proposals and factors that iCAD stockholders should consider when deciding how to cast their votes. iCAD stockholders
are encouraged to read carefully this proxy statement/prospectus in its entirety, including the annexes to this proxy statement/prospectus
and documents incorporated by reference into this proxy statement/prospectus, for more detailed information regarding the Merger Agreement
and the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_043"></span>Voting by Directors and Executive Officers</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">As of the
iCAD Record Date, iCAD directors and executive officers, as a group, beneficially owned and were entitled to vote 1,513,609 shares of
iCAD Common Stock, or approximately 5.5% of the issued and outstanding shares of iCAD Common Stock. We currently expect that iCAD&#8217;s
executive officers will vote their shares &#8220;<b>FOR</b>&#8221; Proposal 1 (the Merger Agreement Proposal), &#8220;<b>FOR</b>&#8221;
Proposal 2 (the Advisory Compensation Proposal) and &#8220;<b>FOR</b>&#8221; Proposal 3 (the Adjournment Proposal), although no executive
officer has entered into any agreement obligating him or her to do so. Please see the section titled &#8220;<i>The Merger&#8212;Voting
and Support Agreements</i>&#8221; of this proxy statement/prospectus for information on the Voting and Support Agreements that iCAD&#8217;s
directors have entered into with RadNet and Merger Sub.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_044"></span>Attendance at the Special Meeting</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Only iCAD stockholders of record on the iCAD Record
Date, beneficial owners of iCAD Common Stock on the iCAD Record Date and holders of valid proxies for the Special Meeting may attend the
virtual Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_045"></span>Submitting Questions for the Virtual Special Meeting</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD stockholders
attending the virtual Special Meeting will be in a listen-only mode and will not be able to speak during the webcast. However, in order
to maintain the interactive nature of the virtual Special Meeting, stockholders who wish to submit a question in advance may do so at
https://www.cstproxy.com/icad/sm2025. Stockholders may also submit questions online during the meeting at https://www.cstproxy.com/icad/sm2025.
Given time constraints, some questions may not be addressed during the virtual Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_046"></span>Limitations on Submitting Questions for the Virtual Special Meeting</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD will answer questions during the Special
Meeting that are relevant to meeting matters, comply with the meeting rules of conduct and have been submitted prior to the start of the
Special Meeting, subject to time constraints. However, iCAD reserves the right to exclude questions that are not pertinent to meeting
matters or to edit profanity or other inappropriate language. Each stockholder is limited to a total of one question that must be related
to the business of the Special Meeting. Each question should cover only one topic and be as succinct as possible. If iCAD receives substantially
similar questions, iCAD will group such questions together and provide a single response to avoid repetition. The questions of all iCAD
stockholders are welcome. However, the purpose of the Special Meeting must be observed and questions that are not directly related to
the business of iCAD or are not otherwise in good taste, related to personal grievances or otherwise inappropriate (as determined by the
chairman of the meeting) will not be answered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_047"></span>Record Date</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The iCAD Board has fixed the close of business
on May 16, 2025 as the iCAD Record Date for the determination of the iCAD stockholders entitled to receive notice of, and to vote at,
the Special Meeting. The iCAD stockholders of record on the iCAD Record Date are the only iCAD stockholders that are entitled to receive
notice of, and to vote at, the Special Meeting or any adjournments or postponements of the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_048"></span>Outstanding Shares and Voting Rights of iCAD Stockholders</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On the iCAD
Record Date, there were 27,470,869 shares of iCAD Common Stock issued and outstanding, held by 88 holders of record. Each issued and
outstanding share of iCAD Common Stock entitles its holder of record to one vote at the Special Meeting.</p>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="stoclist"></span>Stockholder List</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">A complete list of registered iCAD stockholders
entitled to vote at the Special Meeting will be available for inspection at iCAD&#8217;s principal executive offices at 2 Townsend West,
Suite 6, Nashua, New Hampshire 03063, during ordinary business hours, for a period of no less than 10 days before the Special Meeting.
If an iCAD stockholder wants to inspect the stockholder list, such stockholder should call the iCAD corporate secretary at (603) 882-5200
to schedule an appointment or request access.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_049"></span>Quorum; Abstentions and Broker Non-Votes&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In order for business to be conducted at the Special
Meeting, a quorum must be present. A quorum at the Special Meeting requires the presence of the holders of a majority of the total issued
and outstanding shares of iCAD Common Stock entitled to vote, present virtually or represented by proxy, at the Special Meeting. Abstentions
will count as votes present and entitled to vote for the purpose of determining the presence of a quorum for the transaction of business
at the Special Meeting. An abstention also occurs when a stockholder does not attend the Special Meeting virtually and instead submits
a proxy with an &#8220;abstain&#8221; instruction. In accordance with applicable rules, brokers, banks and other nominees who hold shares
of iCAD Common Stock in &#8220;street name&#8221; for their customers do not have discretionary authority to vote the shares with respect
to the Merger Agreement Proposal, the Advisory Compensation Proposal or the Adjournment Proposal. Accordingly, if brokers, banks or other
nominees do not receive specific voting instructions from the beneficial owner of such shares, they may not vote such shares with respect
to these proposals. Under such circumstance, a &#8220;broker non-vote&#8221; would arise. &#8220;Broker non-votes,&#8221; if any, will
not be considered present at the Special Meeting for purposes of determining whether a quorum is present at the Special Meeting. We do
not expect any broker non-votes at the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_050"></span>Adjournment</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If a quorum is present at the Special Meeting
but there are insufficient votes at the time of the Special Meeting to approve the Merger Agreement Proposal, then iCAD stockholders may
be asked to vote on the Adjournment Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If a quorum is not present or if there are not
sufficient votes at the time of the Special Meeting to approve the Merger Agreement Proposal, iCAD expects that the Special Meeting will
be adjourned by the chair of the Special Meeting to solicit additional proxies. In addition, the holders of a majority of the voting power
of all shares of iCAD Common Stock entitled to vote at the Special Meeting who are present online or by proxy at the Special Meeting have
the power to adjourn such Special Meeting, whether or not a quorum is present.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">No notice of the reconvened Special Meeting is
required to be given if the date, time and place (including the means of remote communication) are announced at the Special Meeting or
displayed, during the time scheduled for the Special Meeting, on the same electronic network used to enable iCAD stockholders and proxy
holders to participate in the Special Meeting by means of remote communication, unless (i) the reconvened Special Meeting is more than
30 days after the date for which notice was originally given or <span style="background-color: white">(ii) </span>after the adjournment
the iCAD Board fixes a new record date for the reconvened meeting. At any reconvened Special Meeting at which a quorum is present, (i)
any business may be transacted that may have been transacted at the Special Meeting had a quorum been present and (ii) all proxies will
be voted in the same manner as the manner in which such proxies would have been voted at the original convening of the Special Meeting,
except for any proxies that have been validly revoked or withdrawn prior to the subsequent meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_051"></span>Vote Required</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The votes required for each proposal are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Proposal 1&#8212;the Merger Agreement Proposal. </i></b>The affirmative vote of the holders of a majority of all outstanding
shares of iCAD Common Stock on the iCAD Record Date and entitled to vote thereon is required to approve the Merger Agreement Proposal.
The required vote on Proposal 1 is based on the number of outstanding shares&#8212;not the number of shares actually voted. The failure
of any iCAD stockholder to submit a vote (i.e., by not submitting a proxy and not voting at the Special Meeting) and any abstention from
voting by an iCAD stockholder will have the same effect as a vote &#8220;<b>AGAINST</b>&#8221; the Merger Agreement Proposal. Because
the Merger Agreement Proposal is non-routine, brokers, banks and other nominees do not have discretionary authority to vote on the Merger
Agreement Proposal, and will not be able to vote on the Merger Agreement Proposal absent instructions from the beneficial owner of any
iCAD shares held of record by them. As a result, a broker non-vote will have the same effect as a vote &#8220;<b>AGAINST</b>&#8221; the
Merger Agreement Proposal.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Proposal 2&#8212;the Advisory Compensation Proposal. </i></b>The affirmative vote of a majority of votes present or represented
by proxy at the Special Meeting and entitled to vote thereon is required to approve the Advisory Compensation Proposal. Any shares not
present virtually or represented by proxy (including due to the failure of an stockholder who holds shares in &#8220;street name&#8221;
through a bank, broker or other nominee to provide voting instructions with respect to any proposals at the Special Meeting to such bank,
broker or other nominee) will have no effect on the outcome of the Advisory Compensation Proposal, provided that a quorum is otherwise
present. An abstention by any shares present or represented by proxy on the Advisory Compensation Proposal will have the same effect as
a vote &#8220;<b>AGAINST</b>&#8221; the Advisory Compensation Proposal. Broker non-votes, if any, will have no effect on the Advisory
Compensation Proposal. While the iCAD Board intends to consider the vote resulting from the Advisory Compensation Proposal, the vote is
advisory only and therefore not binding on iCAD, and, if the proposed Merger is approved by iCAD stockholders and consummated, the compensation
that is the subject of the Advisory Compensation Proposal, including amounts iCAD is contractually obligated to pay, will be payable even
if the Advisory Compensation Proposal is not approved.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Proposal 3&#8212;the Adjournment Proposal.</i></b> The affirmative vote of a majority of votes present or represented by proxy
at the Special Meeting and entitled to vote thereon is required to approve the Adjournment Proposal. Any shares not present virtually
or represented by proxy (including due to the failure of an stockholder who holds shares in &#8220;street name&#8221; through a bank,
broker or other nominee to provide voting instructions with respect to any proposals at the Special Meeting to such bank, broker or other
nominee) will have no effect on the outcome of the Adjournment Proposal, provided that a quorum is otherwise present. An abstention by
any shares present or represented by proxy on the Adjournment Proposal will have the same effect as a vote &#8220;<b>AGAINST</b>&#8221;
the Adjournment Proposal. Broker non-votes, if any, will have no effect on the Adjournment Proposal.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_052"></span>How to Vote</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD stockholders of record and beneficial owners
of iCAD Common Stock on the iCAD Record Date may vote their shares of iCAD Common Stock by submitting a proxy or may vote virtually online
at the Special Meeting by following the instructions provided on the proxy card or voting instruction form received. iCAD recommends that
iCAD stockholders entitled to vote submit a proxy prior to the Special Meeting even if they plan to attend the virtual Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD stockholders are encouraged to submit a proxy
promptly. Each valid proxy received in time will be voted at the Special Meeting according to the choice specified, if any. Executed but
uninstructed proxies (<i>i.e.</i>, proxies that are properly signed, dated and returned but are not marked to tell the proxies how to
vote) will be voted in accordance with the recommendations of the iCAD Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_053"></span>Record Holders</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD stockholders of record may vote in one of
the following ways:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Internet</i></b>:
                                            iCAD stockholders of record may submit their proxy over the internet by following the instructions
                                            on the proxy card. Internet voting is available 24 hours a day and will be accessible until
                                            11:59 p.m., Eastern Time, on July 13, 2025. Stockholders will be given an opportunity to
                                            confirm that their voting instructions have been properly recorded. iCAD stockholders who
                                            submit a proxy this way need not send in their proxy card.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Telephone</i></b>:
                                            iCAD stockholders of record may submit their proxy by calling 1-(866)-894-0536. Telephone
                                            voting is available 24 hours a day and will be accessible until 11:59 p.m., Eastern Time,
                                            on July 13, 2025. Easy-to-follow voice prompts will guide stockholders through the voting
                                            and allow them to confirm that their instructions have been properly recorded. iCAD stockholders
                                            who submit a proxy this way need not send in their proxy card.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Mail</i></b>: iCAD stockholders of record may submit their proxy by properly completing, signing, dating and mailing their proxy
card or voting instruction form in the self-addressed, stamped envelope (if mailed in the United States) included with this proxy statement/prospectus.
iCAD stockholders who vote this way should mail the proxy card early enough so that it is received prior to the closing of the polls at
the Special Meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Online During the Virtual Special Meeting</i></b>: iCAD stockholders of record may attend the virtual Special Meeting by entering
his, her or its unique control number and vote online; attendance at the virtual Special Meeting will not, however, in and of itself constitute
a vote or a revocation of a prior proxy.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_054"></span>Beneficial Owners</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD stockholders who hold their shares of iCAD
Common Stock beneficially in &#8220;street name&#8221; and wish to submit a proxy must provide instructions to the bank, broker or other
nominee that holds their shares of record as to how to vote their shares with respect to the Merger Agreement Proposal, the Advisory Compensation
Proposal and the Adjournment Proposal. Most beneficial owners will have a choice of voting before the Special Meeting by proxy over the
internet, by telephone or by using a voting instruction form. Each beneficial owner of iCAD Common Stock should refer to the voting instruction
form received to see what options are available and how to use them. iCAD stockholders who hold their shares of iCAD Common Stock beneficially
and wish to vote virtually at the Special Meeting may do so by obtaining a legal proxy by contacting their account representative at the
bank, broker, or other nominee that holds their shares and e-mail a copy (a legible photograph is sufficient) of their legal proxy to
proxy@continentalstock.com. Beneficial stockholders who e-mail a valid legal proxy will be issued a meeting control number that will allow
them to register to attend and participate in the online-only virtual Special Meeting. After contacting Continental a beneficial holder
will receive an e-mail prior to the Special Meeting with a link and instructions for entering the virtual Special Meeting. Beneficial
stockholders should contact Continental at least five business days prior to the Special Meeting. However, attendance at the virtual Special
Meeting will not, in and of itself, constitute a vote or a revocation of a prior proxy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In accordance with applicable rules, brokers,
banks and other nominees who hold shares of iCAD Common Stock in &#8220;street name&#8221; for their customers do not have discretionary
authority to vote the shares with respect to the Merger Agreement Proposal, the Advisory Compensation Proposal or the Adjournment Proposal.
Accordingly, if brokers, banks or other nominees do not receive specific voting instructions from the beneficial owner of such shares,
they may not vote such shares with respect to these proposals. Under such circumstance, a &#8220;broker non-vote&#8221; would arise. &#8220;Broker
non-votes,&#8221; if any, will not be considered present at the Special Meeting for purposes of determining whether a quorum is present
at the Special Meeting, will have the same effect as a vote &#8220;<b>AGAINST</b>&#8221; the Merger Agreement Proposal and, assuming a
quorum is present, will have no effect on the Advisory Compensation Proposal or the Adjournment Proposal. We do not expect any broker
non-votes at the Special Meeting. Thus, for shares of iCAD Common Stock held in &#8220;street name,&#8221; only shares of iCAD Common
Stock affirmatively voted &#8220;<b>FOR</b>&#8221; the Merger Agreement Proposal will be counted as a vote in favor of such proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_055"></span>Proxies and Revocation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD stockholders of record may revoke their proxies
at any time before their shares of iCAD Common Stock are voted at the Special Meeting in any of the following ways:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>delivering written
                                            notice of revocation of the proxy to iCAD&#8217;s corporate secretary at iCAD&#8217;s principal
                                            executive offices at 2 Townsend West, Suite 6, Nashua, New Hampshire 03063, by no later than
                                            11:59 p.m., Eastern Time, on July 13, 2025;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>delivering another
                                            proxy with a later date to iCAD&#8217;s corporate secretary at iCAD&#8217;s principal executive
                                            offices at 2 Townsend West, Suite 6, Nashua, New Hampshire 03063, by no later than 11:59
                                            p.m., Eastern Time, on July 13, 2025 (in which case only the later-dated proxy is counted
                                            and the earlier proxy is revoked);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>submitting another
                                            proxy again via the internet or by telephone at a later date, by no later than 11:59 p.m.,
                                            Eastern Time, on July 13, 2025 (in which case only the later-dated proxy is counted and the
                                            earlier proxy is revoked); or</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>attending the Special Meeting virtually, using his, her or its unique control number and voting their shares online during the Special
Meeting; attendance at the virtual Special Meeting will not, in and of itself, revoke a valid proxy that was previously delivered unless
you give written notice of revocation to the iCAD corporate secretary before the proxy is exercised or unless you vote your shares online
during the Special Meeting</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If an iCAD stockholder holds shares through
a bank, broker or other nominee, such stockholder may change or revoke his, her or its voting instructions before the Special Meeting
by providing instructions again through the means specified on his, her or its voting instruction form (with most having the option to
do so by internet, telephone or mail), which must be received before 11:59 p.m., Eastern Time, on July 13, 2025. Alternatively, an iCAD
stockholder may also revoke their proxy by attending the Special Meeting virtually, using his, her or its unique control number and voting
his, her or its shares online during the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_056"></span>Inspector of Elections; Tabulation of Votes</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">A representative of Continental will tabulate
the votes and may act as inspector of elections.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_057"></span>Solicitation of Proxies</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD will pay for the proxy solicitation costs
related to the Special Meeting. In addition to sending and making available these materials, some of iCAD&#8217;s directors, officers
and other employees may solicit proxies by contacting iCAD&#8217;s stockholders by telephone, by mail, by e-mail or online. iCAD stockholders
may also be solicited by, among others, news releases issued by iCAD and/or RadNet, postings on iCAD&#8217;s or RadNet&#8217;s websites
and social media accounts and advertisements in periodicals. None of iCAD&#8217;s directors, officers or employees will receive any extra
compensation for their solicitation services. iCAD has also retained Campaign Management as its proxy solicitor to assist in the solicitation
of proxies. For these proxy solicitation services, Campaign Management will receive an estimated fee of approximately $13,000, plus reasonable
out-of-pocket expenses and fees for any additional services. iCAD will also reimburse banks, brokers, and other nominees for their expenses
in sending proxy solicitation materials to the beneficial owners of shares of iCAD Common Stock and obtaining their proxies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a_058"></span>Other Matters</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">At this time, iCAD knows of no other matters to
be submitted at the Special Meeting other than those listed in the notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="householding"></span>Householding of Proxy Statement/Prospectus</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">One copy of this proxy statement/prospectus will
be sent to stockholders who share an address, unless they have notified iCAD that they want to continue receiving multiple packages. This
practice, known as &#8220;householding,&#8221; is designed to reduce duplicate mailings and save significant printing and postage costs.
If you received a household mailing and you would like to have additional copies of this proxy statement/prospectus mailed to you or you
would like to opt out of this practice for future mailings, iCAD will promptly deliver such additional copies to you if you submit your
request in writing to Corporate Secretary, 2 Townsend West, Suite 6, Nashua, New Hampshire 03063, or call (603) 882-5200.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD stockholders who hold shares in street name
may contact their broker, bank or other nominee to request information about householding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="questaddlinfo"></span>Questions and Additional Information</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD stockholders may contact iCAD&#8217;s proxy
solicitor with any questions about the Merger Agreement Proposal, the Advisory Compensation Proposal or the Adjournment Proposal or how
to vote or to request additional copies of any materials at:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 100%; text-align: center"><span style="font-size: 10pt"><b><br/>
Campaign Management</b><br/>
15 West 38th Street, Suite #747,<br/>
New York, New York 10018<br/>
North American Toll-Free Phone:&#160;1-844-394-4517<br/>
Email: info@campaign-mgmt.com<br/>
Call Collect Outside North America: +1 (212) 632-8422</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>iCAD stockholders should not return their stock
certificates or send documents representing iCAD Common Stock with the enclosed proxy card. If the Merger is completed, the exchange agent
for the Merger will send to iCAD stockholders a letter of transmittal and related materials and instructions for exchanging shares of
iCAD Common Stock.<br/>
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 52 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="themerger"></span>THE MERGER</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="gen"></span>General</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">This proxy statement/prospectus is being provided
to holders of iCAD Common Stock in connection with the solicitation of proxies to be voted at the Special Meeting and at any adjournments
or postponements of the Special Meeting. At the Special Meeting, iCAD will ask iCAD stockholders to consider and vote on each of the (i)
Merger Agreement Proposal, (ii) Advisory Compensation Proposal and (iii) Adjournment Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger Agreement provides for, among other
things, the merger of Merger Sub with and into iCAD, with iCAD continuing as the Surviving Corporation and a wholly-owned subsidiary of
RadNet. <b>The Merger will not be completed unless iCAD stockholders adopt the Merger Agreement. </b>A copy of the Merger Agreement is
attached as Annex A to this proxy statement/prospectus. You are urged to read the Merger Agreement in its entirety because it is the legal
document that governs the Merger. For additional information about the Merger, see the section titled &#8220;<i>The Merger Agreement&#8212;Structure
of the Merger</i>&#8221; and &#8220;<i>The Merger Agreement&#8212;Merger Consideration</i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">At the Effective Time, each share of iCAD Common
Stock issued and outstanding immediately prior to the Effective Time (other than the Excluded Shares) will be converted into the right
to receive 0.0677 shares of RadNet Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">No fractional shares of RadNet Common Stock will
be delivered to any holder of shares of iCAD Common Stock upon completion of the Merger. Instead, all fractional shares of RadNet Common
Stock that a holder of shares of iCAD Common Stock would otherwise be entitled to receive as a result of the Merger will be aggregated
and, if a fractional share results from such aggregation, such holder will be entitled to receive the cash proceeds from the sale of such
fractional share by the exchange agent for the account of such holder, without interest, in accordance with the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">This Exchange Ratio is fixed and will not be adjusted
for changes in the market price of either iCAD Common Stock or RadNet Common Stock between the date of signing of the Merger Agreement
and the Effective Time. Based on the closing price of RadNet Common Stock on April 14, 2025, the trading day before the public announcement
of the signing of the Merger Agreement, the Exchange Ratio would represent approximately $3.61 in implied value for each share of iCAD
Common Stock on a fully diluted basis. Based on the closing price of RadNet Common Stock on  [ ], 2025, the last practicable date before
the date of the proxy statement/prospectus accompanying this notice, the Exchange Ratio would represent approximately $[ ] in implied
value for each share of iCAD Common Stock on a fully diluted basis. The market price of RadNet Common Stock when iCAD stockholders receive
those shares after the Merger is completed could be greater than, less than or the same as the market price of shares of RadNet Common
Stock on such date, the date of this proxy statement/prospectus or at the time of the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><b>Because the share price of RadNet Common Stock
will fluctuate between the date of signing of the Merger Agreement and the completion of the Merger, and because the Exchange Ratio is
fixed and will not be adjusted to reflect changes in the share price of RadNet Common Stock or iCAD Common Stock, the value of the shares
of RadNet Common Stock to be received by iCAD stockholders in the Merger may differ from the implied value based on the share price on
the date of signing of the Merger Agreement or the date of the proxy statement/prospectus. As a result, the value of shares of RadNet
Common Stock that iCAD stockholders will receive in the Merger will not be known at the time that iCAD stockholders vote to adopt the
Merger Agreement Proposal. We urge you to obtain current share price quotations for RadNet Common Stock and iCAD Common Stock.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="parties"></span>The Parties</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>RadNet, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet, Inc., which is referred to in this proxy
statement/prospectus as RadNet, is a leading national provider of diagnostic imaging services in the United States based on number of
locations and annual imaging revenue. RadNet has been in business since 1985. RadNet&#8217;s principal business segment is the provision
of diagnostic imaging services. As of December 31, 2024, RadNet operated, directly or indirectly through joint ventures with hospitals,
398 imaging centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, Texas and New York.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet Common Stock is traded on The Nasdaq Global
Market under the symbol &#8220;RDNT.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The principal executive offices of RadNet are
located at 1510 Cotner Avenue, Los Angeles, California 90025, its telephone number is (310) 445-2800 and its website is www.radnet.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">This proxy statement/prospectus incorporates important
business and financial information about RadNet from other documents that are not included in or delivered with this proxy statement/prospectus.
For a list of the documents that are incorporated by reference in this proxy statement/prospectus, see the section titled &#8220;<i><a href="#s4_060">Where You Can Find More Information</a></i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>iCAD, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD, Inc., which is referred to in this proxy
statement/prospectus as iCAD, is a global leader in AI-powered cancer detection whose mission is to create a world where cancer can&#8217;t
hide. iCAD&#8217;s ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where
cancer may be hiding, and because cancer may be found earlier, it is likely more easily eliminated. The ProFound Breast Health Suite currently
offers solutions for breast cancer detection, breast density assessment, and one- or two-year breast cancer risk evaluation. Additionally,
iCAD is in the early stages of development of a product that can identify breast arterial calcification from mammogram images.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD Common Stock is traded on The Nasdaq Capital
Market under the symbol &#8220;ICAD.&#8221; Following the Merger, iCAD Common Stock will be delisted from The Nasdaq Capital Market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The principal executive offices of iCAD are located
at 2 Townsend West, Suite 6, Nashua, New Hampshire 03063, its telephone number is (603) 882-5200 and its website is www.icadmed.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Additional information about iCAD and its subsidiaries
are included in documents incorporated by reference into this proxy statement/prospectus. For a list of the documents that are incorporated
by reference in this proxy statement/prospectus, see the section titled &#8220;<i><a href="#s4_060">Where You Can Find More Information</a></i>&#8221; of this
proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Trio Merger Sub, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Trio Merger Sub, Inc., which is referred to in
this proxy statement/prospectus as Merger Sub, is a wholly-owned subsidiary of RadNet and a Delaware corporation. Merger Sub was formed
solely for the purpose of completing the Merger. Merger Sub has not carried on any activities to date, except for activities incidental
to its formation and activities undertaken in connection with the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Merger Sub was formed in the State of Delaware
on April 11, 2025. The principal executive offices of Merger Sub are located at 1510 Cotner Avenue, Los Angeles, California 90025, and
its telephone number is (310) 445-2800.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_001"></span>Voting and Support Agreements</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In connection with the Merger Agreement, RadNet
and Merger entered into the Voting and Support Agreements with each of the Voting and Support Agreement Stockholders. The Voting and Support
Agreement Stockholders together beneficially own, in the aggregate, approximately 5.5% of the issued and outstanding shares of iCAD Common
Stock as of the iCAD Record Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Voting and Support Agreement Stockholders
have separately agreed, pursuant to their respective Voting and Support Agreements, among other things, to vote all shares of iCAD beneficially
owned as of April 15, 2025 and any additional shares of iCAD Common Stock acquired between April 15, 2025 and the earliest to occur of
(i) the valid termination of the Merger Agreement in accordance with its terms or (ii) the Effective Time:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>in favor of (i) the Merger Agreement Proposal; (ii) the Adjournment Proposal and any other matters necessary to effect the Merger;
(iii) each of the other transactions contemplated by the Merger Agreement; and (iv) any other transaction pursuant to which RadNet or
any subsidiary thereof proposes to acquire iCAD in which iCAD stockholders would receive aggregate consideration per share equal to or
greater than the consideration to be received by stockholders of iCAD in the Merger;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>against any action or agreement which is intended or would reasonably be expected to impede, delay, postpone, interfere with, nullify,
prevent or adversely affect in any material respect the Merger or such Voting and Support Agreement, including (i) any other extraordinary
corporate transaction, including any proposal of any person (other than RadNet and Merger Sub) to acquire iCAD or all or substantially
all of the assets thereof, (ii) any amendment to iCAD Certificate of Incorporation or iCAD Bylaws, (iii) any material change to the capitalization
of iCAD, (iv) any change in a majority of the directors of the iCAD Board and (v) any action, proposal, or agreement that would reasonably
be expected to result in the any breach of any covenant, representation or warranty or any other obligation or agreement under the Merger
Agreement or such Voting and Support Agreement; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>against any Alternative Transaction and any action in furtherance of any Alternative Transaction.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_002"></span>Background of the Merger</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><i>The following chronology summarizes the key
meetings and events that led to the signing of the Merger Agreement. This chronology does not purport to catalog every conversation among
the iCAD Board, the RadNet Board, their respective representatives, or other parties.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The iCAD Board and iCAD&#8217;s senior management,
with the assistance of iCAD&#8217;s advisors, periodically review and evaluate strategic alternatives, including acquisitions, dispositions,
and other strategic transactions, as part of ongoing efforts to enhance stockholder value. Among other things, these reviews and discussions
focus on the opportunities and risks associated with iCAD&#8217;s products and product candidates, financial condition and its strategic
relationships and potential long-term strategic options. These reviews have included consideration of purchases and sales of assets and
businesses, proposed capital raises and other transactions with third parties that would further iCAD&#8217;s strategic objectives and
ability to create stockholder value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">As a result of this periodic strategic review,
in October 2023, iCAD sold substantially all of the assets and liabilities primarily related to its Xoft business to allow iCAD to focus
on artificial intelligence powered software-centric cancer detection solutions as a part of iCAD&#8217;s Profound AI Breast Health suite
of solutions and related products and proposed products. As a result of the Xoft sale, iCAD positioned itself to succeed as either a standalone
company focused on the innovation and growth of AI technologies and cancer detection or as a strategic partner with a company looking
to grow and integrate iCAD Profound AI and related products into an existing cancer detection platform.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 17, 2023, iCAD Board member Mike Klein
and iCAD&#8217;s Chief Executive Officer and Chairman of the iCAD Board, Dana Brown, had a conference call with Howard G. Berger, M.D.,
RadNet&#8217;s President and Chief Executive Officer and the Chairman of the RadNet Board, and Greg Sorensen, M.D., RadNet&#8217;s Chief
Science Officer, a member of the RadNet Board, and Chief Executive Officer of DeepHealth, Inc., a subsidiary of RadNet that is focused
on using AI and deep learning methods to advance medical care with a special emphasis on breast cancer imaging (&#8220;DeepHealth&#8221;),
to discuss a potential strategic transaction. This conversation was a follow-on to earlier discussions that Mr. Klein and Dr. Sorensen
had in 2021 about possible ways that iCAD, RadNet, and DeepHealth might work together, including, but not limited to, a strategic transaction
in 2021; those 2021 discussions concluded with a mutual agreement to stay in touch. During this April 2023 conversation, the representatives
of iCAD and RadNet agreed to continue discussions with respect to a potential strategic transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 19, 2023, iCAD and RadNet executed a
mutual nondisclosure agreement (the &#8220;Non-Disclosure Agreement&#8221;) that contained customary confidentiality provisions and appropriate
acknowledgments that restricted either party from using material non-public information to affect any trading of any securities of the
other party. The initial term of the Non-Disclosure Agreement was two years. Between April 19, 2023, and December 2, 2024, representatives
of iCAD and RadNet engaged in a number of high-level discussions regarding a potential acquisition of iCAD by RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In October of 2024, in light of the continued
interest expressed by RadNet and the potential for a strategic transaction involving iCAD, and in order to create an efficient committee
of the iCAD Board that would be well-positioned to respond to potential transaction developments, the iCAD Board formed a strategic committee
consisting of Ms. Brown and iCAD Board members Andrew H. Sassine and Michael J. Doyle (the &#8220;Strategic Committee&#8221;) to further
evaluate strategic alternatives and, if appropriate, negotiate the terms of a potential transaction with RadNet to be considered for approval
by the iCAD Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On October 11, 2024, Dr. Sorensen contacted Ms.
Brown over email to schedule a meeting at the Radiological Society of North America annual meeting that was scheduled to take place in
Chicago, Illinois on December 2, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Between November 2024 and January 2025, iCAD engaged
in conversations with a privately held third party regarding a number of potential strategic transactions between iCAD and such third
party (such party, the &#8220;Private Party&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On December 2, 2024, Ms. Brown, Dr. Berger and
Dr. Sorensen met in person at the Radiological Society of North America annual meeting to discuss if iCAD was open to a merger transaction
and, if so, the willingness to consider a stock-for-stock merger transaction with RadNet. Ms. Brown indicated interest in engaging in
further conversations regarding a transaction with RadNet and that Ms. Brown would discuss with the iCAD Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On December 5, 2024, during a telephone discussion
with the other members of the Strategic Committee (Mr. Sassine and Mr. Doyle), Ms. Brown recapped her earlier discussions with Dr. Berger
and Dr. Sorensen during the Radiological Society of North America annual meeting. During this discussion, Mr. Sassine and Mr. Doyle expressed
a willingness to continue discussions with RadNet and asked Ms. Brown to seek additional information regarding the proposed transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On December 9, 2024, Ms. Brown emailed the entire
iCAD Board to update them on the status of discussions with RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On December 11, 2024, Ms. Brown notified Dr. Berger
and Dr. Sorensen via email that the iCAD Strategic Committee was supportive of continuing discussions regarding a potential acquisition
by RadNet and the broader iCAD Board had been updated on the current status of discussions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On December 13, 2024, RadNet sent a proposed non-binding
letter of intent (the &#8220;RadNet December 13 LOI&#8221;) and a proposed exclusivity letter agreement, each drafted by representatives
of Perkins Coie, to iCAD. This proposal outlined the terms pursuant to which iCAD would be merged with a subsidiary of RadNet in an all-stock
transaction that valued iCAD at $80 million, but did not specify if the exchange ratio would be calculated on a floating or fixed basis.
The RadNet December 13 LOI also included a number of conditions, including, among others, a requirement that certain to-be-determined
iCAD employees agree to execute employment and non-competition agreements. The proposed exclusivity letter required iCAD to agree to exclusive
negotiations with RadNet for a period of 120 days. The RadNet December 13 LOI was shared by Ms. Brown with the iCAD Board on December
14, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On December 14, 2024, a special meeting of the
Strategic Committee was held. During this meeting, the Strategic Committee determined that in light of receipt of the RadNet December
13 LOI, that it would be prudent to interview potential financial advisors to assist the Company in its evaluation of strategic alternatives,
including the indication of interest received from RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In connection with ongoing, high-level discussions
with the Private Party between November 2024 and January 2025 regarding a potential strategic transaction, on December 18, 2024, iCAD
received a non-binding proposal from the Private Party (the &#8220;Private Party December 18 LOI&#8221;) outlining a potential 10% minority
investment in iCAD and an option to purchase up to another 10% of iCAD Common Stock. The proposal also contemplated a strategic collaboration
between iCAD and the Private Party with the stipulation that the Private Party could direct use of the investment funds for such collaboration.
Ultimately, the iCAD Board elected to pursue a transaction with RadNet instead of negotiating a strategic agreement with the Private Party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On December 19, 2024, a special meeting of the
iCAD Board was held with representatives of Dentons in attendance. Ms. Brown provided a report on her discussions with representatives
of RadNet and the Private Party and the iCAD Board discussed the RadNet December 13 LOI as well as the Private Party December 18 LOI.
During this discussion, the iCAD Board evaluated the opportunities and challenges associated with each potential transaction. The iCAD
Board then discussed the interviews the members of the Strategic Committee had conducted with different financial advisors, and following
a review of preliminary proposals received from such potential financial advisors and confirmation that Piper Sandler was not conflicted
due to any existing or prior relationship with RadNet, the Strategic Committee recommended the engagement of Piper Sandler. The iCAD Board
then unanimously approved the engagement of Piper Sandler as its financial advisor. The iCAD Board selected Piper Sandler to serve as
its financial advisor due to Piper Sandler&#8217;s qualifications, expertise, reputation, extensive knowledge of the industry and its
participants, and its knowledge of iCAD&#8217;s business and financial profile. Representatives of Dentons then led a presentation regarding
the role and obligations of the iCAD Board in connection with the consideration of a strategic transaction. The presentation covered fiduciary
duties, and the standards of review Delaware courts may apply upon review of applicable transactions. Following this presentation, representatives
of Piper Sandler joined the meeting at the invitation of the iCAD Board and discussed next steps, including a selective initial outreach
to specified parties who may be interested in engaging in a strategic transaction with iCAD. The iCAD Board discussed who should be included
in this initial outreach given prior conversations and the desire to be discrete, and subsequently authorized Piper Sandler to reach out
to nine strategic parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Later that day, Ms. Brown sent an email to Dr.
Berger and Dr. Sorensen advising them that iCAD had engaged Piper Sandler as its financial advisor and that Piper Sandler would work with
iCAD to evaluate and negotiate the RadNet offer with the understanding that iCAD would defer entry into an exclusivity letter until after
Piper Sandler competed its initial analysis and iCAD and RadNet reached an agreement on the valuation of iCAD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Between December 19, 2024 and December 27, 2024,
iCAD and Piper Sandler finalized an engagement letter to effect the engagement of Piper Sandler as iCAD&#8217;s financial advisor, which
was executed on December 27, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On January 6, 2025, representatives of iCAD, RadNet
and Piper Sandler held an in-person meeting at Piper Sandler&#8217;s offices in Boston that was scheduled following discussions between
Ms. Brown and Dr. Sorensen. Ms. Brown and Michelle Strong, iCAD&#8217;s Chief Operating Officer, attended the meeting on behalf of iCAD,
and Dr. Sorensen and Sanjog Misra, Chief Commercial Officer of Digital Health, attended on behalf of RadNet. During this meeting the parties
discussed iCAD&#8217;s growth projections and potential synergies with RadNet among other topics. Prior to the meeting, iCAD provided
RadNet with copies of certain preliminary non-public financial projections relating to iCAD&#8217;s business prepared by management of
iCAD for use in RadNet&#8217;s evaluation of the potential transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">From October 2024 to January 2025, iCAD engaged
in high-level and preliminary conversations with two privately held third parties regarding the potential acquisition by iCAD of such
third parties. These conversations did not result in the entry into any letters of intent or term sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On January 17, 2025, the iCAD Board held a regularly
scheduled meeting with representatives of Dentons and Piper Sandler in attendance. In addition to covering operational agenda items, the
iCAD Board discussed the recent discussions with RadNet and the Private Party, as well as other potential strategic initiatives. At this
meeting, representatives of Piper Sandler discussed their preliminary financial analysis regarding iCAD as well as the results of their
strategic outreach to the nine selected companies to determine their interest in discussing a strategic transaction with iCAD. This outreach
yielded no indications of interest from any of the nine selected parties regarding discussions to pursue a strategic transaction with
iCAD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">During January 2025, representatives of iCAD,
RadNet and Piper Sandler engaged in a number of discussions regarding the proposed transaction with RadNet and their views as to iCAD&#8217;s
implied equity value in any stock-for-stock merger transaction. At the request of the Strategic Committee on January 15, 2025, representatives
of Piper Sandler proposed during a telephone call an implied iCAD equity value of $120 million to RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On January 20, 2025, Dr. Sorensen and Ms. Brown
discussed the valuation via telephone, during which Dr. Sorensen communicated that RadNet would be willing to move forward with the proposed
stock-for-stock transaction at an implied iCAD equity value of $96 million. During this same time period, management of iCAD kept the
Strategic Committee and the iCAD Board informed regarding the conversations with RadNet and the valuations proposed by iCAD and RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On January 23, 2025, a special meeting of the
Strategic Committee was held. During this meeting, the Strategic Committee considered the implied valuation of iCAD contemplated by RadNet&#8217;s
recent proposal and discussed whether it was an appropriate basis upon which to advance discussions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On January 27, 2025, Mr. Sassine and Ms. Brown
participated in a video conference meeting with Dr. Berger and Dr. Sorensen regarding the proposed implied valuation of iCAD. During this
meeting, Dr. Berger reiterated RadNet&#8217;s interest in the transaction and asked representatives of iCAD to advise on the implied valuation
that would be needed to move forward with a transaction. The parties agreed that an implied equity value of $105 million was an appropriate
basis upon which to move the transaction forward on a non-binding basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On January 29, 2025, RadNet submitted an updated
non-binding letter of interest to acquire 100% of iCAD&#8217;s equity for a total purchase price of $105 million. The proposal was otherwise
the same as the RadNet December 13 LOI. RadNet also delivered an updated exclusivity letter agreement, which again proposed a 120-day
exclusivity period. During email and text correspondence over the course of the same day, RadNet conveyed that it believed the 120-day
period was necessary and appropriate for this type of transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Later that day, the Strategic Committee met telephonically
with representatives of Piper Sandler and Dentons to discuss the updated proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On January 30, 2025, after working with Piper
Sandler and Dentons to incorporate revised terms in the drafts, Ms. Brown e-mailed revised drafts of the non-binding proposal and exclusivity
letter to Dr. Sorensen, which drafts reflected a number of changes, including proposing that the $105 million would be a minimum implied
equity value and that the exchange ratio would be based on a floating exchange ratio based on the lower of the price of the RadNet Common
Stock on the date of announcement and the price of RadNet Common Stock on the day prior to closing. The iCAD proposal also eliminated
certain conditions relating to new employee non-competition and employment agreements and revised the deal protections to provide for
lower fee reimbursement and expanded fiduciary protections for the iCAD Board. The revised exclusivity letter proposed a 30-day exclusivity
period and added certain exceptions to the general prohibitions to allow iCAD to raise up to $5 million in aggregate proceeds through
the sale of equity pursuant to the terms of its existing at-the-market equity facility and to allow iCAD to continue discussions with
respect to potential strategic acquisitions by iCAD, subject to certain parameters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On January 31, 2025, a continuation of the January
17, 2025, iCAD Board meeting was held with representatives of Dentons in attendance. At this meeting, Ms. Brown updated the iCAD Board
on the strategic transactions discussed at the January 17, 2025, iCAD Board meeting, including the updated proposal from RadNet, and the
iCAD Board discussed in additional detail the presentation made by representatives of Piper Sandler at the January 17, 2025, iCAD Board
meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On February 3, 2025, RadNet submitted an updated
non-binding letter of interest to acquire 100% of iCAD&#8217;s equity based on an aggregate implied equity value of $105 million, which
would be reduced by an amount equal to 50% of iCAD&#8217;s incurred transaction expenses. The updated non-binding proposal provided that
the exchange ratio would be determined on a floating basis to be finalized based on the five-day RadNet average share price for the period
ending two days prior to closing. The revised proposal reversed iCAD&#8217;s proposed change to reduce the deal protection reimbursement
fee and proposed that RadNet would have matching rights before iCAD could terminate a definitive agreement with RadNet to execute a superior
agreement. RadNet also delivered an updated exclusivity letter agreement that proposed a 60-day exclusivity period and added notice rights
with respect to any alternative proposals to be received by iCAD during the exclusivity period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Following receipt of the RadNet updated February
3, 2025 proposed letter of interest, the Strategic Committee met later that day with representatives of Piper Sandler and Dentons to discuss
the terms of the proposal. The Strategic Committee and the advisors discussed a number of changes to the February 3, 2025 proposal and,
on February 4, 2025, Ms. Brown emailed Dr. Sorensen a revised proposal. In iCAD&#8217;s revised proposal, iCAD removed the provision providing
for a reduction to the valuation for 50% of iCAD&#8217;s transaction expenses and proposed that the exchange ratio would include a mechanism
to ensure that the final exchange ratio would be in an agreed upon range. iCAD revised the exclusivity letter to eliminate any notice
of alternative proposals and to reduce the initial exclusivity period to 30 days with an automatic 30-day extension if RadNet delivered
a draft merger agreement with terms consistent with the non-binding letter of interest during the initial 30-day period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On February 7, 2025, RadNet submitted a further
revised non-binding letter of interest, which reflected the terms of the prior February 5, 2025 revised non-binding letter of interest
proposed by iCAD, including a $105 million implied equity value for iCAD. RadNet proposed revisions to make any exchange ratio price collar
provisions symmetrical and added a note to indicate that iCAD&#8217;s transaction expenses would be assessed during the 30-day period
after the signing of the non-binding letter of interest. RadNet included the proposed exclusivity letter without any changes from the
last draft prepared by iCAD. Following receipt of the RadNet updated proposed letter of interest, the Strategic Committee met with representatives
of Piper Sandler and Dentons later that same day to discuss the terms of the updated proposal. During these discussions, the Strategic
Committee agreed that the updated non-binding proposal from RadNet was generally acceptable and agreed to update the full iCAD Board and
propose that the iCAD Board approve the entry into the non-binding letter of interest and the exclusivity letter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Between February 7, 2025 and February 8, 2025,
Ms. Brown had discussions with all of the members of the iCAD Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On February 8, 2025, the iCAD Board, following
a recommendation from the Strategic Committee, executed a unanimous written consent authorizing Ms. Brown to execute the non-binding letter
of interest and the exclusivity letter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On February 9, 2025, Dr. Sorensen delivered a
countersigned copy to Ms. Brown of the non-binding letter of interest and the exclusivity letter, and on February 10, 2025, Dr. Sorensen
sent Ms. Brown a preliminary due diligence request list, which was updated on February 12, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Between February 10, 2025 and February 16, 2025,
representatives of iCAD, Dentons and Piper Sandler held a number of telephonic and Zoom meetings to discuss the preparation and organization
of a virtual data room containing due diligence information and the process for furnishing access to such data room to RadNet and Perkins
Coie.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On February 11, 2025, representatives of Perkins
Coie delivered a request for legal due diligence materials to Piper Sandler, via representatives of RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On February 13, 2025, RadNet and its legal and
accounting advisors were provided access to the virtual data room.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On February 17, 2025, representatives of iCAD,
RadNet and their advisors took part in a call to discuss the status of the virtual data room, the diligence tracker being used to confirm
that all diligence was being provided or addressed and next steps in the process.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On February 21, 2025, representatives of Dentons
and Perkins Coie held an introductory call to discuss the general timeline of the transaction and certain high-level deal questions addressed
in part in the non-binding letter of interest delivered on February 7, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Over the course of February 2025 and March 2025,
RadNet and its advisors and representatives conducted due diligence with the assistance of members of iCAD management and representatives
of Piper Sandler and Dentons, which included multiple due diligence meetings and responses to several additional due diligence requests.
These meetings covered topics that included financial and tax matters, legal matters, product strategy, marketing, human resources, technology
and information security.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On March 8, 2025, representatives of Perkins Coie
delivered an initial draft of the merger agreement to representatives of Dentons. The draft was generally consistent with the terms of
the non-binding letter of interest and provided for an implied iCAD equity value of $105 million and a floating exchange ratio. The draft
did not include any price collars or adjustment provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On March 10, 2025, representatives of Dentons,
Piper Sandler and the Strategic Committee discussed the draft merger agreement and agreed to propose a limited number of changes to clarify
and correct certain representations and warranties, provide that the floating exchange ratio would be calculated using the treasury stock
method calculation and to add a termination right to execute a potential superior offer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On March 12, 2025, Dentons shared a proposed revised
draft of the merger agreement with the Strategic Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On March 14, 2025, representatives of Dentons
held a call with iCAD to discuss the shared markup of the draft merger agreement that it intended to deliver to Perkins Coie. Later that
day, representatives of Dentons delivered to representatives of Perkins Coie a revised draft of the merger agreement following feedback
from iCAD management and representatives of Piper Sandler. The markup reflected the changes discussed with the Strategic Committee and
Piper Sandler.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On March 17, 2025, representatives of Dentons
held a call with iCAD to discuss the preparation of the disclosure letter relating to the draft merger agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Between March 18, 2025 and March 25, 2025, representatives
of iCAD, RadNet, Dentons and Perkins Coie held various calls to discuss certain intellectual property, data privacy and healthcare regulatory
matters related to the proposed transaction and continued to attend to other supplementary due diligence requests and questions received.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On March 27, 2025, representatives of Perkins
Coie delivered to representatives of Dentons a revised draft of the merger agreement. The revised draft excluded changes proposed by Dentons
with respect to the calculation of the exchange ratio and the inclusion of a termination right to execute a superior offer. On March 31,
2025, representatives of Dentons and Perkins Coie held a call to discuss certain open issues in the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 1, 2025, representatives of Dentons delivered
to representatives of Perkins Coie a revised draft of the merger agreement, which again proposed to calculate the floating exchange ratio
using the treasury stock method. Also on April 1, 2025, representatives of Dentons delivered to representatives of Perkins Coie an initial
draft of the iCAD disclosure letter relating to the draft merger agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 2, 2025, Piper Sandler delivered a customary
relationship disclosure letter regarding its lack of relationship with RadNet to representatives of iCAD and Dentons.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 4, 2025, representatives of RadNet discussed
with representatives of iCAD updates to the potential timeline for the execution and announcement of the transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Between April 4, 2025 and April 7, 2025, representatives
of Piper Sandler and, iCAD and RadNet engaged in a number of discussions regarding the material open issues regarding the calculation
of the exchange ratio and the timeline for execution of the proposed transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 7, 2025, Dr. Sorensen, along with Kees
Wesdorp, Chief Executive Officer of DeepHealth, held a videoconference with Ms. Brown and a representative of Piper Sandler to discuss
the potential transaction. During this call, Dr. Sorensen and Mr. Wesdorp discussed the increase in the transaction&#8217;s implied premium
resulting from RadNet&#8217;s recent stock price decline and general market tensions and proposed that the terms be revised to provide
for a fixed exchange ratio at an implied equity value for iCAD of $105 million as of February 9, 2025, which would mean a then-current
implied equity value of closer to $85 million. During the call, the parties also discussed a potential all cash offer of $75 million.
Following this discussion, representatives of Piper Sandler and Dentons discussed the revised proposal and a proposed response.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Following discussions among representatives of
RadNet, iCAD, the Strategic Committee and Piper Sandler over the course of April 7, 2025 to April 11, 2025, RadNet confirmed on April
9, 2025, a revised proposal at an implied equity value of $105 million based on a fixed exchange ratio determined using the closing price
of RadNet&#8217;s common stock as of April 9, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 9, 2025, representatives of Perkins Coie
delivered to representatives of Dentons a revised draft of the merger agreement, which included the fixed exchange ratio previously discussed,
but contemplated that this exchange ratio would be determined based on the fully-diluted capital stock of iCAD, rather than the treasury
stock method. In addition, representatives of Perkins Coie shared an initial draft of the voting and support agreement to be delivered
by each director of iCAD concurrently with the execution of the merger agreement. The draft voting and support agreement contained customary
terms for an agreement of this nature, including transfer restrictions between signing and closing and agreement to vote in favor of the
proposed transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 10, 2025, representatives of Dentons
delivered to representatives of Perkins Coie a further revised draft of the merger agreement. Among other things, the draft provided for
a fixed exchange ratio calculated based on the treasury stock method, rather than a fully-diluted share count, and the assumption by RadNet
of all outstanding iCAD options, including options that were then-currently out-of-the-money. The draft also contemplated that RadNet
would assume and honor the terms of iCAD&#8217;s severance guidelines for any U.S. continuing employee that experienced a qualifying termination
of employment within four months following the closing of the proposed transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 10, 2025, representatives of Perkins
Coie delivered to representatives of Dentons an exclusivity extension letter, which would amend the expiration of the exclusivity period
under the existing exclusivity letter to expire on April 16, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Later on April 10, 2025, a special meeting of
the Strategic Committee was held. During this meeting, the members of the Strategic Committee discussed the revised draft merger agreement
that was shared by representatives of Dentons with representatives of Perkins Coie on April 10, 2025 and the open issues contained in
the draft merger agreement, including calculating the fixed exchange ratio using the treasury stock method and the treatment of iCAD options.
The Strategic Committee also discussed proposed the extension of exclusivity to April 11, 2025 and agreed that it would be prudent to
extend exclusivity in light of the current status of negotiations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 11, 2025, the exclusivity extension letter
was executed by iCAD and RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 11, 2025, a representative of Piper Sandler
and Dr. Berger engaged in a conversion regarding the methodology for calculating the exchange ratio and how in-the-money options and out-of-the
money options would be treated for purposes of calculating the exchange ratio.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Also on April 11, 2025, a special meeting was
held with the iCAD Board and representatives of Dentons and Piper Sandler. At this meeting, representatives of Piper Sandler led a brief
discussion on the status of negotiations and confirmed that the parties were aligned on all major business and economic points, other
than the process for calculating the exchange ratio and the treatment of iCAD options. Following robust discussion by the iCAD Board,
the iCAD Board directed representatives of Dentons to continue to push for changes to the draft merger agreement that would result in
a longer exercise period for the iCAD options to be assumed by RadNet to create potential upside for the out-of-the-money option holders.
Following discussions on the merger agreement, representatives of Dentons reviewed with the members of iCAD Board their fiduciary duties
and the applicable standards of review applied under Delaware law. Representatives of Dentons then provided an overview of the transaction
timeline and the process for filing a proxy statement/registration statement on Form S-4 with the SEC. Following this discussion, representatives
of Piper Sandler then reviewed and discussed Piper Sandler&#8217;s preliminary financial analyses of the proposed transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 11, 2025 and April 12, 2025, representatives
of Perkins Coie and representatives of Dentons shared several drafts of (i) the form of voting and support agreement to be executed by
iCAD directors concurrently with the execution of the merger agreement, (ii) the disclosure schedules accompanying the merger agreement,
(iii) a joint press release announcing the execution of the merger agreement, (iv) each of the parties&#8217; current reports on Form
8-K and (v) draft communications materials.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Between April 11, 2025, and April 14, 2025, representatives
of iCAD, RadNet, Piper Sandler, Dentons and Perkins Coie engaged in a number of conversations regarding the final open issues, including
the final exchange ratio, confirmation of certain stay bonuses proposed by iCAD, the treatment of unvested iCAD Board options and iCAD&#8217;s
ability to extend the exercise period of certain non-qualified stock options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 12, 2025, representatives of Perkins
Coie shared with representatives of Dentons a further revised draft of the merger agreement. Among other things, the revised draft provided
for the assumption by RadNet of iCAD options with an exercise price less than $7.20 and the cancellation of all other outstanding options
immediately prior to the effective time of the proposed merger. The draft merger agreement also provided for a to-be-agreed-upon fixed
exchange ratio that would not be adjusted between signing and closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Later on April 12, 2025, representatives of Dentons
shared with representatives of Perkins Coie a further revised draft of the merger agreement, which, among other things, provided for (i)
a one-year exercise period for the eligible iCAD options, subject to certain exceptions and limitations, (ii) an &#8220;outside date&#8221;
with respect to the closing of the proposed transaction of September 30, 2025, and (iii) subject to the terms and conditions under the
severance guidelines referenced in the merger agreement and set forth in the confidential disclosure schedules thereto, RadNet honoring
iCAD&#8217;s severance guidelines for any continuing U.S. employee that experiences a qualifying termination of employment within 90 days
following the closing of the proposed transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Later on April 12, 2025, representatives of Perkins
Coie delivered a further revised draft of the merger agreement, which eliminated the one-year exercise period for the eligible iCAD options
and preservation of the severance guidelines as outlined above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Over the course of April 13, 2025 and April 14,
2025, representatives of Perkins Coie and Dentons continued to trade drafts of the disclosure schedules, voting and support agreement,
press release, Form 8-Ks, communications materials and other transaction documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 14, 2025, Dr. Sorensen and Ms. Brown
engaged in a conversation with respect to all remaining open issues. During this conversation, Dr. Sorensen and Ms. Brown agreed that
the exchange ratio would be fixed at 0.0677 and resolved the remaining open issues related to stay-bonus payments and treatment of the
exercise period for certain non-qualified options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 14, 2025, representatives of Perkins
Coie shared with representatives of Dentons updates to the potential timeline for the execution and announcement of the transaction and
conference calls with RadNet and iCAD stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Also on April 14, 2025, representatives of Dentons
delivered a further revised draft of the merger agreement, which contemplated (i) a one-year exercise period for the eligible iCAD options
that were non-qualified stock options, subject to certain exceptions and limitations, and (ii) subject to the terms and conditions under
the severance guidelines referenced in the merger agreement and set forth in the confidential disclosure schedules thereto, preservation
of such severance guidelines for any eligible continuing U.S. employee that experienced a qualifying termination of employment within
60 days following the closing of the proposed transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 15, 2025, representatives of Perkins
Coie confirmed that the revised draft delivered by Dentons on the previous day was materially complete and final.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Later on April 15, 2025, the iCAD Board held a
special meeting, with representatives from Dentons and Piper Sandler in attendance, to consider the proposed transaction. At this meeting,
representatives of Dentons recapped their prior discussion with the members of the iCAD Board on their fiduciary duties. Representatives
of Dentons then summarized the principal terms and conditions of the Merger Agreement, as well as certain related transaction agreements.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">At the request of the iCAD Board, representatives
of Piper Sandler then reviewed and discussed Piper Sandler&#8217;s financial analyses relating to the proposed transaction. Thereafter,
at the request of the iCAD Board, representatives of Piper Sandler rendered an oral opinion of Piper Sandler to the iCAD Board (which
was subsequently confirmed in writing by delivery of Piper Sandler&#8217;s written opinion addressed to the iCAD Board dated April 15,
2025), to the effect that, as of such date and based on and subject to various procedures followed, assumptions made, qualifications and
limitations on the review undertaken and the other matters considered by Piper Sandler in connection with the preparation of its opinion,
the Exchange Ratio was fair, from a financial point of view, to the holders of iCAD Common Stock who would receive RadNet Common Stock
in the Merger. Following discussion and recommendation of the Strategic Committee, the iCAD Board unanimously (i) approved and declared
advisable the Merger Agreement and the transactions contemplated therein, including the Merger, on the terms and subject to the conditions
set forth therein, (ii) determined that the Merger Agreement and the consummation of the transactions contemplated thereby, (including
the Merger), are advisable and fair to, and in the best interests of, iCAD and the stockholders of iCAD, (iii) resolved to recommend the
adoption of the Merger Agreement to the stockholders of iCAD, on the terms and subject to the conditions set forth therein, and (iv) directed
that the Merger Agreement be submitted to the stockholders of iCAD for adoption at the Special Meeting. For the basis of the iCAD Board&#8217;s
determination in this regard, please see &#8220;&#8212;&#160;<i>Recommendation of the iCAD Board of Directors and Reasons for the Merger</i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Later that day on April 15, 2025, the Merger Agreement
was executed by iCAD and RadNet. Following the closing of trading on the U.S. public stock markets, RadNet and iCAD issued a joint press
release announcing the execution of the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">On April 17, 2025, iCAD and RadNet amended the
Non-Disclosure Agreement to extend the term to April 19, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_003"></span>Recommendation of the iCAD Board of Directors and Reasons for
the Merger</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">At a meeting held on April 15, 2025, the iCAD
Board unanimously (i) approved and declared advisable the Merger Agreement and the transactions contemplated therein, including the Merger,
on the terms and subject to the conditions set forth therein, (ii) determined that the Merger Agreement and the transactions contemplated
thereby, (including the Merger), are advisable and fair to, and in the best interests of, iCAD and the stockholders of iCAD, (iii) resolved
to recommend the adoption of the Merger Agreement to the stockholders of iCAD, on the terms and subject to the conditions set forth therein,
and (iv) directed that the Merger Agreement be submitted to the stockholders of iCAD for adoption at the Special Meeting. Accordingly,
the iCAD Board unanimously recommends that holders of iCAD Common Stock vote &#8220;<b>FOR</b>&#8221; the Merger Agreement Proposal, &#8220;<b>FOR</b>&#8221;
the Advisory Compensation Proposal and &#8220;<b>FOR</b>&#8221; the Adjournment Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In evaluating the Merger Agreement and the transactions
contemplated thereby, including the Merger, the iCAD Board consulted with its senior management and legal and financial advisor, and considered
and analyzed a range of factors. In the course of reaching its determination to approve the terms of the Merger Agreement and the Merger
and to recommend that stockholders approve the terms of the Merger Agreement and the Merger, the iCAD Board considered numerous factors,
including the following material factors and benefits, each of which the iCAD Board of Directors believed supported its unanimous determination
and recommendation:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Value of Consideration Received</i>. The value of the consideration to be received by iCAD stockholders as a result of the Merger,
including the fact that:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the fixed Exchange Ratio provides certainty to iCAD stockholders as to the number of shares of RadNet Common Stock to be issued to
iCAD stockholders in the Merger;&#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the stock consideration offers iCAD stockholders the opportunity to participate in any potential value accretion of RadNet following
the consummation of the Merger, as well as any additional premium that may be realized in the event RadNet is sold to a third party in
the future;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the fact that the Exchange Ratio represents an approximately 98% premium to iCAD stockholders based on iCAD&#8217;s closing stock
price on Monday, April 14, 2025, the trading day immediately prior to the announcement of the Merger Agreement; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the fact that the Merger will provide the iCAD stockholders with shares of RadNet Common Stock that are more widely held and actively
traded, which could provide greater liquidity and marketability for iCAD stockholders who wish to sell their shares.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Business, Financial Condition, Prospects and Execution Risks</i>. The iCAD Board considered iCAD&#8217;s then-current and historical
operating and financial performance, as well as its prospects and risks if it were to remain an independent company. The iCAD Board also
considered iCAD management&#8217;s business plans and strategies, including the potential opportunities that these plans and strategies
presented against, among other things, various execution and other risks to achieving these business plans, including:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>whether these business plans could be achieved in the face of operational and execution risks in the short and long term;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the impact of market, industry, regulatory and competitive trends on iCAD&#8217;s business; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>market volatility and the general risks related to market conditions that could reduce the price of the iCAD Common Stock. Among the
potential risks identified by the iCAD Board were: (i) its prospects and competitive position as an independent company; (ii) its size,
as well as its financial resources and access to capital on a cost-effective basis, relative to those of its competitors; (iii) the evolving
regulatory and care standards that characterize the industry that iCAD operates in; (iv) its ability to continue to drive adoption of
iCAD&#8217;s product offerings and AI-driven solutions, as well as demographic and epidemiologic trends that may affect the market for
its products; and (v) the scale, efficiencies and performance of its sales operations, including relative to its larger competitors, and
its ability to execute ongoing and planned operational initiatives.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Acceleration of Long-Term Vision and Strategy</i>. Integrating iCAD&#8217;s ProFound Breast Health Suite solutions with RadNet&#8217;s
product, engineering and commercial capabilities is expected to better position iCAD to (i) create a comprehensive portfolio of breast
screening AI, integrated viewing and reporting tools that complement RadNet&#8217;s portfolio of AI-powered cancer detection and screening
tools, (ii) scale and boost commercial and R&amp;D capabilities, (iii) provide its customers with access to a broader suite of viewing
and reporting and end-to-end screening solutions, and (iv) expand its customer reach.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><i></i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Risks of Continuing as a Stand-Alone Company</i>. The iCAD Board considered the risks of continuing to execute iCAD&#8217;s AI-driven
cancer detection and screening tools as a stand-alone company, including (i) challenges associated with effectively commercializing iCAD&#8217;s
cancer detection and screening tools; (ii) macroeconomic risks, including uncertainty in the AI industry and challenges associated with
broad market acceptance of AI-driven products; (iii) the fact that iCAD&#8217;s standalone business plan entailed years of negative cash
flow and the substantial funding necessary for iCAD&#8217;s operation and growth strategy, including the potential that iCAD may need
to raise additional capital in the future in order to fund its operations prior to achieving positive cash flow; (iv) the fact that iCAD
has paused sales of its ProFound AI Risk product pending regulatory clearance from the U.S. Food and Drug Administration (the &#8220;FDA&#8221;);
(v) increasing competition from both existing competitors and potential entry by large, well-capitalized technology and AI-driven platforms;
(vi) the ongoing costs associated with maintaining iCAD&#8217;s status as an independent public company and (vii) the other risk factors
related to iCAD&#8217;s business and prospects as set forth in iCAD&#8217;s Annual Report on Form 10-K filed with the SEC on March 31,
2025, as amended by Amendment No. 1 on Form 10-K/A, filed with the SEC on April 30, 2025.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><span style="font-size: 10pt"><i>Operating and Financial Performance. </i>iCAD&#8217;s operating and financial performance and its
prospects, including certain prospective forecasts for iCAD prepared by iCAD&#8217;s senior management, which reflect an application of
various assumptions of senior management, and the inherent uncertainty of achieving iCAD&#8217;s prospective forecasts, as set forth below
under the section titled &#8220;&#8212;<i>Certain iCAD Unaudited Prospective Financial Information</i>&#8221;, and that, as a result,
iCAD&#8217;s actual financial results in future periods could differ materially from senior management&#8217;s forecasts.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><i></i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Attractive Value</i>. The iCAD Board considered the fact that the Exchange Ratio represented compelling value for the shares of
iCAD Common Stock and believed that the Exchange Ratio represented the best value reasonably available for iCAD stockholders, including
compared to iCAD continuing to operate as a stand-alone company. The iCAD Board reviewed historical market prices, volatility and trading
information with respect to the shares of iCAD Common Stock, including the fact that the Exchange Ratio represents: (i) an approximately
98% premium to iCAD stockholders based on iCAD&#8217;s closing stock price on Monday, April 14, 2025, the trading day immediately prior
to the announcement of the Merger Agreement, and (ii) an approximately 103% premium to iCAD stockholders based on iCAD&#8217;s average
closing stock price over the four-week period immediately prior to the execution of the Merger Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Tax-Free Reorganization</i>. The fact that the Merger is intended to be treated as a tax-free reorganization under Section 368(a)
of the Code for U.S. federal income tax purposes, as more fully described in the section titled &#8220;<i>Material U.S. Federal Income
Tax Consequences of the Merger</i>&#8221; of this proxy statement/prospectus.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><i></i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Consideration of RadNet&#8217;s Business Plan</i>. The iCAD Board further considered the business of RadNet, including RadNet&#8217;s
plans to accelerate the growth and delivery of transformative, AI-driven healthcare solutions and commitment to increased investment in
R&amp;D and integration of iCAD&#8217;s technology and solutions.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Negotiation Process</i>. The iCAD Board considered the fact that the terms of the Merger, including the Exchange Ratio, were the
result of robust, arm&#8217;s length negotiations conducted by iCAD at the direction of the iCAD Board, and with the assistance of an
independent financial advisor and outside legal counsel. The iCAD Board believed that the Exchange Ratio represented the best value that
iCAD could reasonably obtain from RadNet for the shares of iCAD Common Stock, taking into account (i) RadNet&#8217;s statements, including
that this price was RadNet&#8217;s final offer; (ii) the iCAD Board assessment, after consultation with its financial advisor, that other
parties did not have the interest in, or capability to, acquire iCAD at a higher price; and (iii) the iCAD Board&#8217;s familiarity with
the business, operations, prospects, business strategy, assets, liabilities, and general financial condition of iCAD on a historical and
prospective basis and its assessment of associated risks, including execution risks with respect to iCAD&#8217;s business plan and growth
targets. The iCAD Board believed, after consultation with representatives of Piper Sandler, that further negotiations would have created
a risk of causing RadNet to abandon the proposed transaction altogether or materially delaying the entry into definitive transaction agreements
with respect to the proposed transaction, that it was unlikely that any other potential acquiror would be willing and able to acquire
iCAD at a price in excess of the Exchange Ratio, which as of April 14, 2025 represented an implied value of $3.61 per share of iCAD Common
Stock, even if iCAD were to conduct additional outreach, and that it was unlikely that any other potential counterparties would be willing
and able to consummate a transaction with iCAD that iCAD&#8217;s Board would view as more value-maximizing for iCAD stockholders than
the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Strategic Alternatives</i>. The iCAD Board considered the risks and potential benefits associated with other strategic alternatives
and the potential for stockholder value creation associated with those alternatives, including the continuation of iCAD&#8217;s business
plan as an independent public company. After a review of strategic alternatives and discussions with management and iCAD&#8217;s financial
and legal advisors, the iCAD Board determined that the Exchange Ratio is more favorable to iCAD stockholders than the potential value
that might result from other potentially available strategic options.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><i></i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Receipt of Opinion from Piper Sandler</i>. The written opinion of Piper Sandler was delivered to the iCAD Board on April 15, 2025,
to the effect that, as of such date and based on and subject to the assumptions made, procedures followed, matters considered and limitations
on the scope of the review undertaken by Piper Sandler, as described in its written opinion, the Exchange Ratio was fair, from a financial
point of view, to the holders of iCAD Common Stock who will receive RadNet Common Stock in the Merger, as more fully described below under
the section titled &#8220;<i>The Merger&#8212;Opinion of iCAD&#8217;s Financial Advisor</i>&#8221;, which full text of the written opinion
is attached as Annex B to this proxy statement/prospectus and is incorporated by reference in this proxy statement/prospectus in its entirety.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><i></i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Timing and Likelihood of Consummation</i>. The iCAD Board considered the timing and likelihood that the Merger would be consummated
based on, among other things (not in any relative order of importance):</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the limited conditions to RadNet&#8217;s obligation to consummate the Merger as provided by the Merger Agreement;&#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the absence of anticipated substantive issues expected in connection with obtaining the termination or expiration of the applicable
waiting period under the HSR Act; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the business reputation, capabilities and financial condition of RadNet.&#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Other Terms of the Merger Agreement</i>. The iCAD Board considered other terms of the Merger Agreement, as more fully described
under the section titled &#8220;<i>The Merger Agreement</i>&#8221; of this proxy statement/prospectus, including:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the provisions of the Merger Agreement that permit iCAD, in response to certain unsolicited written acquisition proposals, to furnish
information to and participate in discussions and negotiations with third parties prior to receipt of iCAD stockholder approval under
certain circumstances and, under certain conditions, to accept a Superior Offer, and the corresponding right to terminate the Merger Agreement
(subject to the payment by iCAD to RadNet of $1,000,000, plus up to $2,000,000 of all documented fees and expenses of RadNet incurred
in connection with the negotiation and performance of the Merger Agreement and the transactions contemplated thereby), and that the amount
of the termination fee payable by iCAD is reasonable, would not likely deter competing bids and would not likely be required to be paid
unless iCAD entered into a more favorable transaction;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the remedies available to iCAD under the Merger Agreement including the rights of iCAD to specific enforcement; &#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the scope of the representations, warranties, and covenants being made by iCAD and RadNet; and&#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 78.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the terms of the Merger Agreement provide iCAD with sufficient operating flexibility to conduct its business in the ordinary course
until the earlier of the consummation of the Merger or the termination of the Merger Agreement.&#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Opportunity of iCAD Stockholders to Vote</i>. The iCAD Board considered the fact that the Merger would be subject to the approval
of iCAD stockholders, and that iCAD stockholders would be free to evaluate the Merger and vote for or against the approval of the Merger
Agreement Proposal at the iCAD Special Meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>No Management Arrangements</i>. The iCAD Board considered the fact that RadNet did not require any member of iCAD management to
enter into an employment or other agreement or arrangement as a condition to entering into the Merger Agreement, which avoided potential
conflicts of interest in the negotiations and additional barriers to reaching an agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">In the course of reaching the determinations and
decisions and making the recommendation described above, the iCAD Board, in consultation with iCAD&#8217;s senior management, outside
legal counsel, and financial advisor, also considered the risks and potentially negative factors relating to the Merger Agreement, the
Merger, and the other transactions contemplated by the Merger Agreement, including the following material factors (which factors are not
necessarily exhaustive or presented in order of relative importance):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>No Ongoing Equity Interest in iCAD. </i>The iCAD Board considered the fact that iCAD&#8217;s public stockholders will have no ongoing
equity interest in the Surviving Corporation following the Merger, meaning that iCAD stockholders will cease to participate in iCAD&#8217;s
potential future earnings or growth and will not benefit from any future increase in the value of iCAD following completion of the Merger,
other than indirectly through their equity interest in RadNet.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Fixed Exchange Ratio</i>. The iCAD Board considered that because the Merger Consideration is based on a fixed Exchange Ratio, iCAD
stockholders bear the risk that the market value of the shares of RadNet Common Stock may decline before the Effective Time, reducing
the value of the Merger Consideration to be received by iCAD stockholders.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><i></i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Termination Fee and Expense Reimbursement</i>. The iCAD Board considered the fact that iCAD may be required to pay a termination
fee to RadNet of $1,000,000, plus up to $2,000,000 of all documented fees and expenses of RadNet incurred in connection with the negotiation
and performance of the Merger Agreement and the transactions contemplated thereby, under certain circumstances.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><i></i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Effect of Announcement</i>. The iCAD Board considered the potential effect of the public announcement of the Merger Agreement on
iCAD&#8217;s employees, operations and business partners, as well as its ability to attract and retain key personnel while the Merger
is pending.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Interim Operating Covenants</i>. The iCAD Board considered the fact that the Merger Agreement imposes restrictions on the conduct
of iCAD&#8217;s business prior to the consummation of the Merger, requiring iCAD to conduct its business according to its ordinary course
of business consistent with past practice and refrain from taking certain specified actions without RadNet&#8217;s prior written consent.
The iCAD Board considered that such restrictions may potentially delay or prevent iCAD from pursuing business strategies or opportunities
that may arise while the Merger is pending.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><i></i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Risks That the Merger May Not Be Approved by iCAD Stockholders</i>. The iCAD Board considered the possibility that the Merger Agreement
Proposal will not be approved by iCAD stockholders.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><i></i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Risks That the Merger Might Be Delayed or Not Be Completed at All</i>. The iCAD Board considered the fact that there can be no
assurance that all conditions to the parties&#8217; obligations under the Merger Agreement will be satisfied on a timely basis or at all.
Furthermore, the iCAD Board considered the risks and costs to iCAD if the Merger is not consummated in the anticipated timeframe or at
all, including the diversion of iCAD&#8217;s management and employees&#8217; attention; potential employee attrition; the potential effect
on vendors, partners and others that do business with iCAD; and the potential effect on the trading price of the shares of iCAD common
stock.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Risks Related to Integration</i>. The iCAD Board considered the potential challenges and uncertainties inherent in integrating
the operations of iCAD and RadNet, including the risk that the integration may be more complex, time-consuming, or costly than anticipated.
The iCAD Board also considered the possibility that the cost savings and operational synergies anticipated to result from the Merger may
not be fully realized or may take longer to realize than expected, and that the integration process could divert management&#8217;s attention
and resources from ongoing business operations, thereby adversely impacting RadNet&#8217;s business and financial results.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><i></i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Transaction Costs</i>. The iCAD Board considered the fact that significant costs have been and will continue to be incurred in
connection with the Merger, and that substantial time and effort of iCAD&#8217;s management and certain other key employees will be required,
potentially resulting in disruptions to the operation of iCAD&#8217;s business. If the Merger is not consummated, iCAD will be required
to pay its own expenses associated with the Merger Agreement, and the resulting public announcement of the termination of the Merger Agreement
could affect the trading price of iCAD common stock.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Potential Conflicts of Interest</i>. The iCAD Board considered the potential conflicts of interest created by the fact that iCAD&#8217;s
executive officers and directors may have interests in the Merger that may be different from or in addition to those of other stockholders,
as described in the section titled &#8220;<i>The Merger&#8201;-&#8201;Interests of iCAD&#8217;s Directors and Executive Officers in
the Merger</i>&#8221; of this proxy statement/prospectus.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Regulatory Approval Risks</i>. The iCAD Board considered the fact that the completion of the Merger requires termination or expiration
of the applicable waiting period under the HSR Act, which could subject the Merger to unforeseen delays and risk.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Risks of Pending Actions</i>. The iCAD Board considered the risk of litigation in connection with the execution of the Merger Agreement
and the consummation of the Merger and the other transactions contemplated therein.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">The iCAD Board believed that, overall, the potential
benefits of the Merger to iCAD stockholders substantially outweighed the risks and uncertainties of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<!-- Field: Page; Sequence: 68 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">The foregoing discussion of factors considered by
the iCAD Board contains the material factors considered by the iCAD Board, but is not in any way intended to be exhaustive. In light of
the variety of factors considered in connection with its evaluation of the Merger, the iCAD Board did not find it practicable to, and
did not, quantify or otherwise assign relative weights to the specific factors considered in reaching its determinations and recommendations.
Each member of the iCAD Board applied his or her own business judgment to the process and may have given different weight to different
factors. The iCAD Board did not undertake to make any specific determination as to whether any factor or any particular aspect of a factor
supported or did not support its ultimate determination. Rather, the iCAD Board based its recommendation on the totality of the information
presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_004"></span>RadNet&#8217;s Reasons for the Merger</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">After careful consideration, the RadNet Board
unanimously determined that the Merger and the related transactions contemplated thereby were advisable and in the best interests of RadNet
and its stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In making its determination, the RadNet Board
held a number of meetings, consulted with RadNet&#8217;s senior management and its outside legal advisors, Perkins Coie, and considered
the business, assets and liabilities, results of operations, financial performance, strategic direction and prospects of RadNet and iCAD.
The RadNet Board considered a number of factors, including the following (not necessarily presented in order of relative importance to
the RadNet Board):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><i>Strategic and Financial Factors.</i> The RadNet
Board believes that the Merger presents, and is expected to provide, a number of significant strategic and financial opportunities and
benefits to RadNet and its stockholders, including the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the expectation that the complementary nature of RadNet&#8217;s existing clinical infrastructure and AI technology and iCAD&#8217;s
AI tools will create greater growth potential across geographies and customers;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the belief that the Merger will enhance RadNet&#8217;s leadership position in the diagnostic imaging services industry and that RadNet&#8217;s
and iCAD&#8217;s complementary focus on AI-powered breast health solutions will enable RadNet to offer a more comprehensive suite of solutions,
better leverage data and accelerate its growth trajectory through its DeepHealth subsidiary;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the expectation that RadNet will, following the Merger, have enhanced commercial, product, research and development and innovation
capabilities and resources, which should allow RadNet, through its DeepHealth subsidiary, to improve patient outcomes, accelerate growth,
better serve customers, accelerate innovation and sustain investment in rapid product innovation and introduction;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the expectation of a stronger combined team by joining the significant strengths and quality of the workforce across both companies;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the expectation that iCAD will have sufficient financial resources and flexibility as a result of the Merger, even after taking into
account transaction-related expenses, to realize the full potential of its products, to engage in additional product development, and
to invest in other business development opportunities for sustainable long-term growth;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the expectation that the Merger will result in meaningful synergies by combining key assets, personnel, capabilities, intellectual
property, access to customers, and that the Merger is expected to create significant value opportunity for all stockholders; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the expectation that RadNet will successfully integrate iCAD into the DeepHealth business, and enhance RadNet&#8217;s future opportunity
and flexibility.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 69 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><i>Other Factors. </i>In addition to considering
the strategic and financial factors described above, the RadNet Board considered the following additional factors, all of which it viewed
as supporting its decision to approve the Merger:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the fact that the Exchange Ratio was the result of a series of robust arm&#8217;s length negotiations between the parties with the
assistance of independent financial advisors and outside legal counsels;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>that,
                                            based on (i) the Exchange Ratio of 0.0677, (ii) the number of shares of iCAD Common Stock
                                            and Eligible iCAD Options outstanding as of the iCAD Record Date, and the number of shares
                                            of RadNet Common Stock outstanding as of the iCAD Record Date, RadNet and iCAD estimate that,
                                            as of immediately following completion of the Merger, holders of RadNet Common Stock as of
                                            immediately prior to the Merger will hold approximately 97.4% of the outstanding shares of
                                            RadNet Common Stock on a fully diluted basis and, as a result, RadNet&#8217;s stockholders
                                            prior to the Merger will continue to own a significant portion of RadNet following the Merger,
                                            giving them the opportunity to meaningfully benefit from the expected synergies of the Merger;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>historical information concerning RadNet&#8217;s and iCAD&#8217;s respective businesses, financial condition, results of operations,
earnings, trading prices, competitive positions and prospects on a stand-alone basis and post-Merger basis;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the Outside Date under the Merger Agreement, taking into account the ability of the parties to extend the initial Outside Date in
specified circumstances to (as more fully described in the section titled &#8220;<i>The Merger Agreement&#8212;Termination of the Merger
Agreement</i>&#8221;), which is expected to allow for sufficient time to complete the Merger;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the results of the due diligence review of iCAD and its business, including with respect to legal, regulatory, intellectual property,
accounting, tax and human resources matters, conducted by RadNet and its advisors;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the current and prospective business environment in which RadNet and iCAD operate, including global and local economic conditions,
the competitive and regulatory environment, and the likely effect of these factors on RadNet;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the recommendation of RadNet&#8217;s senior management in favor of the Merger;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the fact that the Merger is intended to qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code
with the result that U.S. holders of iCAD Common Stock generally will not recognize any gain or loss for U.S. federal income tax purposes
upon receipt of the Merger Consideration, as more fully described in the section titled &#8220;<i>Material U.S. Federal Income Tax Consequences
of the Merger</i>&#8221; of this proxy statement/prospectus;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the review by the RadNet Board with its advisors of the structure of the Merger and the financial and other terms of the Merger Agreement,
including the likelihood of consummation of the proposed transactions contemplated by the Merger Agreement and the evaluation of the RadNet
Board of the likely time period necessary to complete the Merger; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the
                                            increased likelihood of obtaining the iCAD Stockholder Approval due to the fact that the
                                            Voting and Support Agreement Stockholders (who collectively beneficially own, in the aggregate,
                                            approximately 5.5% of the issued and outstanding shares of iCAD Common Stock as of the iCAD
                                            Record Date) have agreed to vote the shares of iCAD Common Stock beneficially owned by them
                                            in favor of, among other things, the Merger Agreement Proposal, and not to transfer, or enter
                                            into an agreement to transfer, their shares of iCAD Common Stock, with certain limited exceptions.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 70 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The RadNet Board also considered the following
specific aspects of the Merger Agreement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>that the Exchange Ratio is fixed, with no adjustment in the Merger Consideration to be received by iCAD stockholders as a result of
possible increases or decreases in the trading price of RadNet&#8217;s stock following the announcement of the Merger, which creates certainty
as to the number of shares of RadNet Common Stock to be issued in the Merger as well as the fact that the Merger Agreement does not provide
iCAD with a collar or a value-based termination right;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the nature of the closing conditions included in the Merger Agreement as well as the likelihood of satisfaction of all conditions
to completion of the transactions contemplated by the Merger Agreement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>that the representations and warranties of each of RadNet and iCAD, respectively, as well as the interim operating covenants in the
Merger Agreement requiring iCAD to conduct its business in the ordinary course prior to consummation of the Merger, subject to specific
limitations, are reasonable under the circumstances; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the restrictions in the Merger Agreement on iCAD&#8217;s ability to respond to and negotiate certain alternative transaction proposals
from third parties, subject to certain exceptions, and the requirement that iCAD pays RadNet the Termination Fee if the Merger Agreement
is terminated under certain circumstances.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The RadNet Board weighed these advantages and
opportunities against a number of uncertainties, risks and other potentially negative factors in its deliberations concerning the Merger
Agreement and the Merger, including (not necessarily presented in order of relative importance to the RadNet Board):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the dilution to existing RadNet stockholders as a result of the Merger and the potential dilution associated with the acceleration
or assumption of certain outstanding iCAD equity awards;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the risk that iCAD&#8217;s financial performance may not meet RadNet&#8217;s expectations;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the fact that projections of future results of operations and synergies are necessarily estimates based on assumptions, the risk of
not being able to realize all of the anticipated benefits of the Merger, including the synergies, cost savings, growth opportunities or
cash flows between RadNet and iCAD, or that such benefits may take longer than expected to be realized, if at all;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the difficulties and management challenges inherent in completing the Merger and integrating the businesses, operations and workforce
of two businesses of the size and scope of RadNet and iCAD and the possibility of encountering difficulties in achieving expected growth
and cost savings;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the current and prospective business climate in RadNet&#8217;s industry;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the costs, fees and expenses associated with completing the Merger and the other transactions contemplated by the Merger Agreement,
including those incurred regardless of whether the Merger is consummated;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the risks and costs to RadNet in connection with the Merger (including if the Merger is not completed), either during the pendency
of the Merger or following the consummation of the Merger, including the risks and costs associated with the potential diversion of management
and employee attention, potential management and employee attrition and the potential negative effect on RadNet&#8217;s and iCAD&#8217;s
respective relationships with employees, customers and suppliers;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the risk that the Merger may not be completed despite the combined efforts of RadNet and iCAD or that completion may be unduly delayed,
even if the iCAD Stockholder Approval is obtained at the Special Meeting;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 71 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the potential for litigation relating to the Merger and the associated costs, burden and inconvenience involved in defending those
proceedings;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the risk that iCAD stockholders may vote down the Merger Agreement Proposal at the Special Meeting;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the fact that the Merger Agreement permits iCAD, subject to certain conditions, to respond to and negotiate unsolicited acquisition
proposals prior to the time that the iCAD Stockholder Approval is obtained;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the fact that the Merger Agreement permits the iCAD Board, subject to certain conditions, to make an iCAD Recommendation Change to
the recommendation to iCAD stockholders that they approve the Merger Agreement Proposal if it would be inconsistent with the iCAD Board&#8217;s
fiduciary duties to its stockholders under applicable laws to fail to do so;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the risk that the Termination Fee to which RadNet may be entitled, subject to the terms and conditions of the Merger Agreement, in
the event the Merger Agreement is terminated in certain circumstances may not be sufficient to compensate RadNet for the harm it might
suffer as a result of such termination;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the fact that the Merger Agreement contains restrictions on RadNet&#8217;s conduct of business prior to the completion of the Merger,
which could delay or prevent RadNet from undertaking business opportunities that may arise, or taking other actions with respect to the
operations and strategy of RadNet that the RadNet Board and RadNet&#8217;s management might otherwise believe were appropriate or desirable;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD&#8217;s ability to specifically enforce RadNet&#8217;s obligations under the Merger Agreement; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the risks of the type and nature described in the section titled &#8220;<i>Risk Factors</i>&#8221; and the matters described in the
section titled &#8220;<i>Cautionary Note Regarding Forward-Looking Statements</i>&#8221; of this proxy statement/prospectus.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The RadNet Board considered all of these factors
as a whole and, on balance, concluded that it supported a favorable determination to enter into the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The foregoing discussion of the information and
factors that the RadNet Board considered is not intended to be exhaustive, but rather is meant to include the material factors that the
RadNet Board considered. The RadNet Board collectively reached the conclusion to approve the Merger Agreement, the Merger and the other
transactions contemplated by the Merger Agreement in light of the various factors described above and other factors that the members of
the RadNet Board believed were appropriate. In view of the complexity and wide variety of factors, both positive and negative, that the
RadNet Board considered in connection with its evaluation of the Merger, the RadNet Board did not find it practical, and did not attempt,
to quantify, rank or otherwise assign relative or specific weights or values to any of the factors it considered in reaching its decision
and did not undertake to make any specific determination as to whether any particular factor, or any aspect of any particular factor,
was favorable or unfavorable to the ultimate determination of the RadNet Board. In considering the factors discussed above, individual
directors may have given different weights to different factors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The foregoing description of RadNet&#8217;s consideration
of the factors supporting the Merger is forward-looking in nature. This information should be read in light of the factors discussed in
the section titled &#8220;<i>Cautionary Note Regarding Forward-Looking Statements</i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_005"></span>Certain iCAD Unaudited Prospective Financial Information</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">iCAD does not as a matter of course publicly disclose
long term projections as to future performance, operating income or other financial results. However, iCAD&#8217;s management prepared
projections for the years ending December&#160;31, 2025 through December 31, 2029 (the &#8220;Projections&#8221;) that were utilized in
connection with the Merger. The Projections are included in this proxy statement/prospectus only because (1)&#160;portions of the Projections
through the year ending December 31, 2029 were made available to RadNet in connection with RadNet&#8217;s due diligence review of
iCAD; (2)&#160;the Projections were made available to the RadNet Board in connection with its consideration of the Merger; and (3)&#160;the
Projections were made available to Piper Sandler, iCAD&#8217;s financial advisor, as more fully described below in the section titled
&#8220;<i>&#8212;&#8201;Opinion of iCAD&#8217;s Financial Advisor</i>.&#8221; The Projections are not included in this proxy statement/prospectus
to influence any stockholder to make any investment decision with respect to the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">The Projections are forward-looking statements.
Important factors that may affect actual results and cause the Projections not to be achieved include, but are not limited to, the risks
and uncertainties described below and those described in the sections titled &#8220;<i>Cautionary Note Regarding Forward-Looking Statements</i>&#8221;
and &#8220;<i>Risk Factors</i>&#8221; of this proxy statement/prospectus. Although the Projections are presented with numerical specificity,
they reflect numerous estimates and assumptions made by iCAD with respect to industry performance, general business, economic, regulatory,
market and financial conditions, geographical expansion and other future events, as well as matters specific to iCAD&#8217;s business,
all of which are difficult or impossible to predict accurately and many of which are beyond iCAD&#8217;s control. The Projections reflect
assumptions as to certain potential business decisions that are subject to change. For example, the Projections take into account the
impact of iCAD&#8217;s previously disclosed partnership with Google Health, and the transition of iCAD&#8217;s business to a platform-based
Software-as-a-Service (SaaS) company. The Projections also reflect assumptions regarding the completion of, and receipt of approval from
the FDA for, iCAD&#8217;s AI-driven Breast Arterial Calcifications (BAC) algorithm.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">The Projections cover a number of years and such
information by its nature becomes less reliable with each successive year. The Projections were prepared on a standalone basis without
giving effect to the Merger. Furthermore, the Projections do not take into account the effect of any failure of the Merger to be completed
and should not be viewed as accurate or continuing in that context.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">In the view of iCAD&#8217;s management, the information
in the Projections was prepared on a reasonable basis and reflected the best estimates and judgments available to iCAD&#8217;s management
at the time. However, this information is not fact and should not be relied upon as being necessarily indicative of future results. The
Projections reflect subjective judgments and assumptions in many respects and thus are susceptible to multiple interpretations and periodic
revisions based on actual experience and business developments. As such, the Projections constitute forward-looking information and are
subject to many risks and uncertainties that could cause actual results to differ materially from the results forecasted in the Projections,
including, but not limited to, the risk that the proposed transaction may not be completed in a timely basis or at all, that iCAD may
be adversely affected by other economic, business and/or competitive factors, and risks related to iCAD&#8217;s financial condition, results
of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties, and assumptions, including those described in the section titled &#8220;<i>Risk
Factors</i>&#8221; in iCAD&#8217;s annual report for the year ended December&#160;31, 2024, as filed with the SEC on March 31, 2025 and
incorporated by reference in this proxy statement/prospectus. Moreover, iCAD operates in a very competitive and rapidly changing environment.
New risks emerge from time to time. It is not possible for iCAD&#8217;s management to predict all risks, nor can iCAD assess the effect
of all factors on iCAD&#8217;s business or the extent to which any factor, or combination of factors, may cause actual results to differ
materially from those contained in any forward-looking statements iCAD may make. There can be no assurance that the Projections will be
realized or that actual results will not be significantly higher or lower than forecast. In addition, the Projections will be affected
by iCAD&#8217;s ability to achieve strategic goals, objectives and targets over the applicable periods. The Projections cannot, therefore,
be considered a guarantee of future operating results, and this information should not be relied on as such.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"></p>

<!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">The Projections were not prepared with a view toward
public disclosure nor were they prepared with a view toward compliance with GAAP, published guidelines of the SEC or the guidelines established
by the American Institute of Certified Public Accountants for preparation or presentation of prospective financial information. The inclusion
of the Projections should not be regarded as an indication that iCAD, Piper Sandler, any of their respective affiliates, officers, directors,
advisors or other representatives or anyone who received this information then considered, or now considers, them a reliable prediction
of future events, and this information should not be relied upon as such. The inclusion of the Projections herein should not be deemed
an admission or representation by iCAD that it views such Projections as material information. The inclusion of the Projections in this
proxy statement/prospectus should not be regarded as an indication that the Projections will necessarily be predictive of actual future
events given the inherent risks and uncertainties associated with such long-range forecasts. No representation is made by iCAD or any
other person regarding the Projections or iCAD&#8217;s ultimate performance compared to such information. The Projections should be evaluated,
if at all, in conjunction with the historical financial statements and other information about iCAD contained in its public filings with
the SEC. For additional information, see the section titled &#8220;<i>Where You Can Find More Information</i>&#8221; of this proxy statement/prospectus.&#160;<b>In
light of the foregoing factors, and the uncertainties inherent in the Projections, stockholders are cautioned not to place undue, if any,
reliance on the Projections.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">The Projections included in this document have been
prepared by, and are solely the responsibility of, iCAD&#8217;s management. Neither iCAD&#8217;s independent auditor, BDO USA, P.C., nor
any other independent accountant has compiled, examined or performed any procedures with respect to the Projections, nor have they expressed
any opinion or any other form of assurance on such information or its achievability, and assume no responsibility for, and disclaim any
association with, the Projections. The report of BDO USA, P.C. incorporated by reference relates solely to iCAD&#8217;s previously issued
financial statements. It does not extend to the Projections and should not be read to do so.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Some of the Projections are &#8220;non-GAAP financial
measures,&#8221; such as EBITDA and EBITDA Margin (as defined below), which are financial performance measures that are not calculated
in accordance with the published guidelines of the SEC regarding projections or GAAP. iCAD uses these non-GAAP financial measures to evaluate
operating performance and believes that these non-GAAP financial measures are useful to enable investors and other external parties to
understand iCAD&#8217;s projected performance. These non-GAAP financial measures should not be viewed as a substitute for GAAP financial
measures, and may be different from non-GAAP financial measures used by other companies. Furthermore, there are limitations inherent in
non-GAAP financial measures, because they exclude charges and credits that are required to be included in a GAAP presentation. Accordingly,
these non-GAAP financial measures should be considered together with, and not as an alternative to, financial measures prepared in accordance
with GAAP. The financial measures included in the Projections are not subject to SEC rules regarding disclosures of non-GAAP financial
measures, which would otherwise require a reconciliation of a non-GAAP financial measure to a GAAP financial measure. Reconciliations
of non-GAAP financial measures to the most directly comparable GAAP measure were not provided to or relied upon by the iCAD Board, Piper
Sandler, RadNet or the RadNet Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"></p>

<!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">The following table presents a summary of the Projections
(in millions):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-style: italic">($ in thousands)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">CY2025E</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">CY2026E</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">CY2027E</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">CY2028E</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">CY2029E</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; font-weight: bold">Revenue</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">21,671</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">23,440</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">30,957</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">41,463</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">50,926</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 9pt">Cost of Goods Sold</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,783</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,599</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,356</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,372</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,148</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Gross Profit</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">17,889</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">19,840</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">26,601</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">36,090</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">44,778</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 9pt">Engineering &amp; Product Development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,484</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,812</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,453</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,830</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: 9pt">Marketing &amp; Sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,432</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,242</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,080</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,704</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,549</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 9pt">General &amp; Administration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,260</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,378</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,794</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,023</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: 9pt">Depreciation &amp; Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">339</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">346</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">353</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">360</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">367</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: 9pt">Total Operating Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,515</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,778</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,458</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,497</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,769</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Operating Income (loss)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(5,626</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(4,937</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">1,143</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">9,594</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">17,008</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: 9pt"><span style="font-size: 10pt">Depreciation &amp; Amortization<sup>1</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">906</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">906</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">906</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">906</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">906</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold"><span style="font-size: 10pt"><b>EBITDA<sup>2</sup> </b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(4,721</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(4,032</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,048</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">10,499</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">17,914</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 10pt">Unlevered Free Cash Flow<sup>3</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,777</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(4,912</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">82</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,806</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11,187</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>Notes: </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(1): Includes depreciations and amortization expenses
from cost of goods sold and operating expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(2): EBITDA is a non-GAAP financial measure and
is defined as GAAP earnings before interest, taxes, depreciation and amortization . The figures presented reflect stock based compensation
as a cash expense.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(3): At the direction of iCAD management, Unlevered
Free Cash Flow was calculated by Piper Sandler using the prospective financial information included in the Projections and other financial
information provided by iCAD management, which calculation was reviewed and approved by iCAD management. Unlevered Free Cash Flow is a
non-GAAP financial measure and is defined as earnings before interest and taxes, less taxes, plus depreciation and amortization, less
increases in net working capital and capital expenditures. Unlevered Free Cash Flow should not be considered as an alternative to net
income, net cash provided by operating activities, or any other items calculated in accordance with GAAP, or as an indicator of iCAD&#8217;s
operating performance. The Unlevered Free Cash Flow figures presented in the column &#8220;CY2025E&#8221; are for the 9 months ending
December 31, 2025 only.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Except as required by applicable law, iCAD does not intend to update
or otherwise revise the Projections to reflect circumstances existing after the date when made or to reflect the occurrence of future
events, even in the event that any or all of the assumptions underlying such forecast are no longer appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 75 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_006"></span>Opinion of iCAD&#8217;s Financial Advisor</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">On April 15, 2025, Piper Sandler rendered its
oral opinion to the iCAD Board, which was subsequently confirmed in writing by delivery of Piper Sandler&#8217;s written opinion, dated
April 15, 2025, to the effect that, as of such date, and based upon and subject to the various assumptions and limitations set forth in
its written opinion, the Exchange Ratio was fair, from a financial point of view, to the holders of iCAD Common Stock who will receive
RadNet Common Stock in the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"><b>The full text of Piper Sandler&#8217;s written
opinion dated April 15, 2025, which sets forth, among other things, the assumptions made, procedures followed, matters considered and
limitations on the scope of the review undertaken by Piper Sandler in rendering its opinion, is attached as Annex B to this proxy statement/prospectus.
Piper Sandler&#8217;s opinion addressed solely the fairness, from a financial point of view, to the holders of iCAD Common Stock, of the
Exchange Ratio and does not address any other terms or agreement relating to the Merger or any other terms of the Merger Agreement. Piper
Sandler&#8217;s opinion was directed to the iCAD Board in connection with its consideration of the Merger and was not intended to be,
and does not constitute, a recommendation to any iCAD stockholder as to how such stockholder should act or vote with respect to the Merger
or any other matter. Piper Sandler&#8217;s opinion was approved for issuance by the Piper Sandler opinion committee.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">In connection with rendering the opinion described
above and performing its related financial analyses, Piper Sandler, among other things:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>reviewed and analyzed the financial terms of a draft labeled &#8220;Execution Copy&#8221; of the Merger Agreement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>reviewed and analyzed certain financial and other data with respect to iCAD and RadNet which was publicly available;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>reviewed and analyzed certain information, including  financial forecasts relating to the business, earnings, cash flow, assets,
liabilities and prospects of iCAD that were furnished to Piper Sandler by iCAD (see the section titled &#8220;&#8212;<i>Certain iCAD Unaudited
Prospective Financial Information</i>&#8221;);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>conducted discussions with members of senior management and representatives of iCAD and RadNet concerning the two immediately preceding
matters, as well as their respective businesses and prospects of iCAD and RadNet before and after giving effect to the Merger;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>reviewed the current and historical reported prices and trading activity of iCAD Common Stock and RadNet Common Stock;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>compared the financial performance of iCAD with that of certain other publicly-traded companies that Piper Sandler deemed relevant;
and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>reviewed the financial terms, to the extent available to Piper Sandler, of certain business combination transactions that Piper Sandler
deemed relevant.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">In addition, Piper Sandler conducted such other
analyses, examinations and inquiries and considered such other financial, economic and market criteria as Piper Sandler deemed necessary
in arriving at its opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">The following is a summary of the material financial
analyses performed by Piper Sandler in connection with the preparation of its fairness opinion and reviewed with the iCAD Board at a meeting
held on April 15, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 76 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">This summary includes information presented in
tabular format, which tables must be read together with the text of each analysis summary and considered as a whole in order to fully
understand the financial analyses presented by Piper Sandler. The tables alone do not constitute a complete summary of the financial analyses.
The order in which these analyses are presented below, and the results of those analyses, should not be taken as any indication of the
relative importance or weight given to these analyses by Piper Sandler or the iCAD Board. Except as otherwise noted, the following quantitative
information, to the extent that it is based on market data, is based on market data as it existed on or before April 14, 2025, and is
not necessarily indicative of current market conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Unless the context indicates otherwise, for purposes
of the financial analyses described below, Piper Sandler calculated enterprise value (&#8220;EV&#8221;); defined as the relevant company&#8217;s
common equity value, plus book value of preferred stock, plus debt, plus capital and operating leases, less cash and cash equivalents,
and less short and long term investments (&#8220;net debt&#8221;), plus, where applicable, book value of non-controlling interests).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Specifically, Piper Sandler calculated (a) EV for
each publicly traded company included in the selected public companies analysis, based on (i) the market value of the relevant company&#8217;s
common equity, using closing stock prices on April 14, 2025, and (ii) the relevant company&#8217;s net debt as of such company&#8217;s
most recently reported quarter end, and (b) EV for each target company included in the selected M&amp;A transactions analysis, based on
(i) the implied value of the relevant target company&#8217;s common equity using the implied purchase price paid for such target company&#8217;s
common equity in the relevant M&amp;A transaction and the relevant target company&#8217;s net debt as of such target company&#8217;s most
recently reported quarter end immediately prior to announcement of the relevant M&amp;A transaction (in the case of M&amp;A transactions
involving the acquisition of public companies), or otherwise (ii) the publicly announced EV for the target company at the time of announcement
of the relevant M&amp;A transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">References to (a) &#8220;LTM&#8221; or &#8220;last
twelve months&#8221; historical financial information are references to (i) for each publicly traded company included in the selected
public companies analysis (including iCAD), the last twelve-month period for which financial information was publicly available as of
April 14, 2025, based on such publicly available information, and (ii) for each target company included in the selected M&amp;A transactions,
the last twelve-month period for which financial information was (x) publicly available as of immediately prior to the announcement of
the relevant M&amp;A transaction, based on such publicly available information, or (y) available to Piper Sandler as of immediately prior
to the announcement of the relevant M&amp;A transaction, based on such internal non-public transaction information, (b) &#8220;FTM&#8221;
or &#8220;forward twelve months&#8221; projected financial information are references to (i) for each target company included in the selected
M&amp;A transactions analysis, the twelve-month period immediately following the LTM period, based on Wall Street consensus research estimates
(&#8220;Consensus Estimates&#8221;), disclosure by such target company or otherwise available to Piper Sandler, at the time of announcement
of the relevant transaction, and (ii) for iCAD, the twelve-month period immediately following the LTM period, based on estimates provided
to Piper Sandler by management of iCAD, and (c) &#8220;EBITDA&#8221; mean GAAP earnings before interest, taxes, depreciation and amortization.
For iCAD, diluted shares were calculated using the treasury stock method as of March 31, 2025. For all other publicly traded companies,
diluted shares were calculated using the treasury stock method and financial information that was publicly available as of April 14, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">For purposes of certain analyses described below,
the term &#8220;Implied Per Share Merger Consideration&#8221; refers to the implied per share value of the merger consideration of $3.61,
based on the Exchange Ratio of 0.0677 shares of RadNet Common Stock per share of iCAD Common Stock and the closing price per share of
RadNet Common Stock on April 14, 2025 of $53.36 (the &#8220;RadNet Closing Stock Price&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="s4_007"></span>Selected Public Companies Analysis</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Select Unprofitable Growth Medical Technology Companies</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Piper Sandler reviewed, among other things, historical
2024 financial information for iCAD, as well as projected financial data for iCAD prepared by iCAD management for the years ending December
31, 2025 and 2026 (see the section titled &#8220;<i>&#8212;Certain iCAD Unaudited Prospective Financial Information</i>&#8221;), and compared
such data to corresponding historical financial information and Consensus Estimates for the public companies that Piper Sandler considered
to be U.S. listed companies in the medical technology industry with (i) LTM revenue less than or equal to $500 million, (ii) projected
revenue growth in 2026 between 5% to 20%, (iii) LTM gross margin greater than or equal to 65%, and (iv) LTM EBITDA less than $0.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 77 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Piper Sandler selected the following companies:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>AtriCure, Inc.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Neuronetics, Inc.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>NeuroPace, Inc.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>OrthoPediatrics Corp.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Pulmonx Corporation</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Sanara MedTech Inc.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>SI-BONE, Inc.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Sight Sciences, Inc.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Treace Medical Concepts, Inc.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For this selected medical technology public companies
analysis, Piper Sandler compared, among other things, the implied (i) EV/revenue multiple for each of 2024, 2025 and 2026 for iCAD and
(ii) EV/gross profit multiple for each of 2024, 2025 and 2026 for iCAD, based on the Implied Per Share Merger Consideration, to the corresponding
multiple for the selected unprofitable growth medical technology public companies. The historical 2024 revenue and gross profit financial
information for each of iCAD and the selected public companies was based on historical financial information as described above, and the
projected 2025 and 2026 revenue and gross profit financial information for each of iCAD and the selected medical technology public companies,
was (i) for iCAD, based on estimates provided to Piper Sandler by iCAD management (see the section titled &#8220;<i>&#8212;Certain iCAD
Unaudited Prospective Financial Information</i>&#8221;) and (ii) for the selected medical technology public companies, based on Consensus
Estimates publicly available as of April 14, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This analysis indicated the following implied
multiples:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">EV/ Revenue</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">EV/ Gross Profit</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2025</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2026</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2025</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2026</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%">Maximum</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">4.9x</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">4.2x</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">3.6x</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">6.7x</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">5.7x</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">4.8x</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">75<sup>th</sup> Percentile</span></td><td>&#160;</td>
    <td style="text-align: right">4.0x</td><td>&#160;</td>
    <td style="text-align: right">2.9x</td><td>&#160;</td>
    <td style="text-align: right">2.7x</td><td>&#160;</td>
    <td style="text-align: right">5.5x</td><td>&#160;</td>
    <td style="text-align: right">4.2x</td><td>&#160;</td>
    <td style="text-align: right">3.7x</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Mean</td><td>&#160;</td>
    <td style="text-align: right">3.0x</td><td>&#160;</td>
    <td style="text-align: right">2.4x</td><td>&#160;</td>
    <td style="text-align: right">2.1x</td><td>&#160;</td>
    <td style="text-align: right">3.9x</td><td>&#160;</td>
    <td style="text-align: right">3.3x</td><td>&#160;</td>
    <td style="text-align: right">2.9x</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Median</td><td>&#160;</td>
    <td style="text-align: right">3.0x</td><td>&#160;</td>
    <td style="text-align: right">2.3x</td><td>&#160;</td>
    <td style="text-align: right">2.1x</td><td>&#160;</td>
    <td style="text-align: right">3.7x</td><td>&#160;</td>
    <td style="text-align: right">3.2x</td><td>&#160;</td>
    <td style="text-align: right">2.9x</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">25<sup>th</sup> Percentile</span></td><td>&#160;</td>
    <td style="text-align: right">2.2x</td><td>&#160;</td>
    <td style="text-align: right">2.0x</td><td>&#160;</td>
    <td style="text-align: right">1.7x</td><td>&#160;</td>
    <td style="text-align: right">2.8x</td><td>&#160;</td>
    <td style="text-align: right">2.5x</td><td>&#160;</td>
    <td style="text-align: right">2.2x</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Minimum</td><td>&#160;</td>
    <td style="text-align: right">0.6x</td><td>&#160;</td>
    <td style="text-align: right">0.6x</td><td>&#160;</td>
    <td style="text-align: right">0.6x</td><td>&#160;</td>
    <td style="text-align: right">0.6x</td><td>&#160;</td>
    <td style="text-align: right">0.7x</td><td>&#160;</td>
    <td style="text-align: right">0.6x</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">iCAD at Implied Per Share Merger Consideration</td><td>&#160;</td>
    <td style="text-align: right">4.3x</td><td>&#160;</td>
    <td style="text-align: right">3.9x</td><td>&#160;</td>
    <td style="text-align: right">3.6x</td><td>&#160;</td>
    <td style="text-align: right">5.0x</td><td>&#160;</td>
    <td style="text-align: right">4.7x</td><td>&#160;</td>
    <td style="text-align: right">4.2x</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 78 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Piper Sandler then applied such multiples to iCAD&#8217;s
(i) 2024 historical revenue and 2025 and 2026 projected revenue and (ii) 2024 historical gross profit and 2025 and 2026 projected gross
profit in order to derive implied enterprise values for iCAD, after which Piper Sandler derived implied per share values using the balance
sheet data and diluted share information described above. Piper Sandler did not take into account the net present value of current and
estimated future net operating losses (&#8220;NOLs&#8221;) available to iCAD in performing this analysis. Piper Sandler observed that
based on the mean and median for each analysis, the ranges of implied per share values for iCAD Common Stock, as compared to the Implied
Per Share Merger Consideration, were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Implied Per-Share Value of iCAD Common Stock</b></p> <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 74%">EV/2024 Revenue</td><td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 25%">$2.78&#8212;$2.78</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>EV/2025 Revenue</td><td>&#160;</td>
    <td style="text-align: center">$2.48&#8212;$2.56</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>EV/2026 Revenue</td><td>&#160;</td>
    <td style="text-align: center">$2.45&#8212;$2.48</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">EV/2024 Gross Profit</td><td>&#160;</td>
    <td style="text-align: center">$2.87&#8212;$2.99</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">EV/2025 Gross Profit</td><td>&#160;</td>
    <td style="text-align: center">$2.70&#8212;$2.76</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">EV/2026 Gross Profit</td><td>&#160;</td>
    <td style="text-align: center">$2.71&#8212;$2.71</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Implied Per Share Merger Consideration</td><td>&#160;</td>
    <td style="text-align: center">$3.61</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Based on the per share value reference ranges for
iCAD Common Stock described above, Piper Sandler then converted each of the mean and median per share values implied by the selected public
companies analysis to the corresponding implied exchange ratios derived from the RadNet Closing Stock Price. Piper Sandler observed that
based on the mean and median for each analysis, the ranges of implied exchange ratios, as compared to the Exchange Ratio, were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr>
    <td style="vertical-align: top; width: 74%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; width: 25%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Implied Exchange Ratio </b></p>
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/2024 Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0520&#8212;0.0521</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/2025 Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0464&#8212;0.0480</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/2026 Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0459&#8212;0.0465</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/2024 Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0538&#8212;0.0560</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/2025 Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0506&#8212;0.0517</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/2026 Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0508&#8212;0.0508</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Exchange Ratio</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0677</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="s4_008"></span>Selected M&amp;A Transactions Analysis</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Select Unprofitable Growth Medical Technology Companies</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Piper Sandler reviewed M&amp;A transactions announced
since January 1, 2014 involving those public and private target businesses for which Piper Sandler had access to sufficient financial
information and that Piper Sandler considered to be in the medical technology industry with (i) LTM revenue less than or equal to $500
million, (ii) projected FTM revenue growth between 5% and 20%, (iii) LTM gross margin greater than or equal to 65%, and (iv) LTM EBITDA
less than $0.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<!-- Field: Page; Sequence: 79 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Based on these criteria, the following 11 transactions
were selected:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 51%"><span style="font-size: 10pt"><b>Target</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 30%"><span style="font-size: 10pt"><b>Acquiror</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%"><span style="font-size: 10pt"><b>Date of Transaction Announcement</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Paragon 28, Inc.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Zimmer Biomet Holdings, Inc.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">January 28, 2025</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Silk Road Medical, Inc.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Boston Scientific Corporation</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">June 18, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Cardiovascular Systems, Inc.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Abbott Laboratories</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">February 8, 2023</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Misonix, Inc.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Bioventus Inc.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">July 29, 2021</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Integra LifeSciences Holdings Corporation &#8211; Extremity Orthopaedics Business</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Smith &amp; Nephew plc</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">September 29, 2020</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">K2M Group Holdings Inc.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Stryker Corp.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">August 30, 2018</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">The Spectranetics Corporation</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Koninklijke Philips N.V. (Royal Philips)</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">June 28, 2017</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">LDR Holding Corporation</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Zimmer Biomet Holdings, Inc.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">June 7, 2016</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Uroplasty, Inc.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Vision-Sciences, Inc.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">December 22, 2014</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Small Bone Innovations, Inc.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Stryker Corporation</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">June 30, 2014</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">AngioScore, Inc.</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">The Spectranetics Corporation</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">May 27, 2014</span></td></tr>
  </table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">____________________</td><td/></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">For this selected medical technology M&amp;A transactions
analysis, Piper Sandler compared, among other things, the implied (i) EV/revenue multiple for each of LTM and FTM and (ii) EV/gross profit
multiple for each of LTM and FTM for iCAD, to the corresponding multiples for each selected M&amp;A transaction. Piper Sandler compared
multiples for iCAD to the corresponding multiple for each selected M&amp;A transaction, based on the Implied Per Share Merger Consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">This analysis indicated the following implied
multiples:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">EV/ LTM Revenue</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">EV/ FTM Revenue</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">EV/ LTM Gross Profit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">EV/ FTM Gross Profit</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 52%">Maximum</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">7.8x</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">7.1x</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">10.5x</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">9.6x</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">75<sup>th</sup> Percentile</span></td><td>&#160;</td>
    <td style="text-align: right">7.2x</td><td>&#160;</td>
    <td style="text-align: right">6.6x</td><td>&#160;</td>
    <td style="text-align: right">10.0x</td><td>&#160;</td>
    <td style="text-align: right">8.9x</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Mean</td><td>&#160;</td>
    <td style="text-align: right">5.4x</td><td>&#160;</td>
    <td style="text-align: right">4.8x</td><td>&#160;</td>
    <td style="text-align: right">7.3x</td><td>&#160;</td>
    <td style="text-align: right">6.4x</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Median</td><td>&#160;</td>
    <td style="text-align: right">5.1x</td><td>&#160;</td>
    <td style="text-align: right">4.7x</td><td>&#160;</td>
    <td style="text-align: right">7.5x</td><td>&#160;</td>
    <td style="text-align: right">6.6x</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">25<sup>th</sup> Percentile</span></td><td>&#160;</td>
    <td style="text-align: right">3.1x</td><td>&#160;</td>
    <td style="text-align: right">2.7x</td><td>&#160;</td>
    <td style="text-align: right">4.4x</td><td>&#160;</td>
    <td style="text-align: right">3.8x</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Minimum</td><td>&#160;</td>
    <td style="text-align: right">2.8x</td><td>&#160;</td>
    <td style="text-align: right">2.5x</td><td>&#160;</td>
    <td style="text-align: right">3.2x</td><td>&#160;</td>
    <td style="text-align: right">2.8x</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">iCAD at Implied Per Share Merger Consideration</td><td>&#160;</td>
    <td style="text-align: right">4.3x</td><td>&#160;</td>
    <td style="text-align: right">3.9x</td><td>&#160;</td>
    <td style="text-align: right">5.0x</td><td>&#160;</td>
    <td style="text-align: right">4.7x</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 80 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Piper Sandler then applied such multiples to iCAD&#8217;s
LTM revenue, FTM revenue, LTM gross profit and FTM gross profit in order to derive implied enterprise values for iCAD, after which Piper
Sandler derived implied per share values using the balance sheet data and diluted share information described above. Piper Sandler did
not take into account the net present value of current and estimated future NOLs available to iCAD in performing this analysis. Piper
Sandler observed that based on the mean and median for each analysis, the ranges of implied per share values for iCAD Common Stock, based
on each of (i) all selected unprofitable growth medical technology M&amp;A transactions (since 2014), and (ii) selected unprofitable growth
medical technology M&amp;A transactions since 2020, as compared to the Implied Per Share Merger Consideration, were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>All Selected Unprofitable Growth Medical Technology M&amp;A Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr>
    <td style="vertical-align: top; width: 74%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; width: 25%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Implied Per-Share Value of iCAD
    Common Stock</b></p>
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/LTM Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$4.18&#8212;$4.34</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/FTM Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$4.26&#8212;$4.29</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/ LTM Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$4.87&#8212;$4.98</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/FTM Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$4.68&#8212;$4.79</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Implied Per Share Merger Consideration </span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$3.61</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Selected Unprofitable Growth Medical Technology M&amp;A Transactions
Since 2020</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr>
    <td style="vertical-align: top; width: 74%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; width: 25%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Implied Per-Share Value of iCAD
    Common Stock</b></p>
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/LTM Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$3.96&#8212;$4.02</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/FTM Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$3.77&#8212;$3.98</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/ LTM Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$4.35&#8212;$4.57</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/FTM Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$3.95&#8212;$4.39</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Implied Per Share Merger Consideration </span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$3.61</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Based on the per share value reference ranges for
iCAD Common Stock described above, Piper Sandler then converted each of the mean and median per share values implied by each of (i) all
selected unprofitable growth medical technology M&amp;A transactions analysis (since 2014) and (ii) selected unprofitable growth medical
technology M&amp;A transactions since 2020 analysis, to the corresponding implied exchange ratios derived from the RadNet Closing Stock
Price. Piper Sandler observed that based on the mean and median for each analysis, the ranges of implied exchange ratios, as compared
to the Exchange Ratio, were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>All Selected Unprofitable Growth Medical Technology Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr>
    <td style="vertical-align: top; width: 74%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; width: 25%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Implied Exchange Ratio </b></p>
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/LTM Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0784&#8212;0.0813</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/FTM Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0798&#8212;0.0803</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/ LTM Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0912&#8212;0.0934</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/FTM Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0877&#8212;0.0897</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Exchange Ratio </span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0677</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 81 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Selected Unprofitable Growth Medical Technology Transactions Since
2020</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr>
    <td style="vertical-align: top; width: 74%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; width: 25%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Implied Exchange Ratio</b></p>
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/LTM Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0741&#8212;0.0754</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/FTM Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0706&#8212;0.0745</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/ LTM Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0815&#8212;0.0857</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/FTM Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0740&#8212;0.0823</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Exchange Ratio </span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0677</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="s4_009"></span>Discounted Cash Flows Analysis</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Using a discounted cash flows analysis, Piper Sandler
calculated an estimated range of theoretical enterprise values for iCAD based on the net present value of (i) projected unlevered after
tax free cash flows from April 1, 2025 to December 31, 2029 (which included the present value impact of current and estimated future NOLs
usage available to iCAD through December 31, 2036 of approximately $10 million), discounted back to March 31, 2025, and (ii) a projected
terminal value at December 31, 2029 calculated using a terminal year revenue multiple ranging from 2.5x to 4.0x, discounted back to March
31, 2025. The after-tax free cash flows for each year were calculated based on estimates provided to Piper Sandler by iCAD management
(see the section titled &#8220;<i>&#8212;Certain iCAD Unaudited Prospective Financial Information</i>&#8221;). Piper Sandler calculated
the range of net present values for unlevered free cash flows for such periods, as well as the terminal value, based on a range of discount
rates of 19.6% to 20.4%, based on its estimation of iCAD&#8217;s weighted average cost of capital using the capital asset pricing model,
together with a size premium, in order to derive a range of implied enterprise values for iCAD. Piper Sandler then derived a range of
implied per share values for iCAD Common Stock using the balance sheet data and diluted share information described above. Piper Sandler
observed that based on the mean and median, the range of implied per share values for iCAD Common Stock, was $2.97&#8212;$4.15, as compared
to the Implied Per Share Merger Consideration of $3.61. Based on these per share value reference ranges for iCAD Common Stock, Piper Sandler
then converted each of the mean and median per share values implied by the discounted cash flow analysis to the corresponding implied
exchange ratios derived from the RadNet Closing Stock Price. Piper Sandler observed that based on the mean and median for the discounted
cash flow analysis, the ranges of implied exchange ratios, was 0.0557&#8212;0.0778, as compared to the Implied Exchange Ratio of 0.0677.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="s4_010"></span>Other Information </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Piper Sandler also noted for the iCAD Board, among
other things, the following additional information that was not relied upon in rendering its opinion but was provided for informational
purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Growth Men&#8217;s and Women&#8217;s Health. </i>Piper Sandler reviewed M&amp;A transactions announced since January 1, 2014 involving
those public and private target businesses for which Piper Sandler had access to sufficient financial information and that Piper Sandler
considered to be in the medical technology industry with (i) LTM revenue less than or equal to $500 million, (ii) projected FTM revenue
growth between 5% and 20%, and (iii) LTM gross margin greater than or equal to 65%. Based on these criteria, Piper Sandler reviewed five M&amp;A
transactions and compared, among other things, the implied (i) EV/revenue multiple for each of LTM and FTM and (ii) EV/gross profit multiple
for each of LTM and FTM for iCAD, to the corresponding multiples for each selected M&amp;A transaction. Piper Sandler compared multiples
for iCAD to the corresponding multiple for each selected M&amp;A transaction, based on the Implied Per Share Merger Consideration.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<!-- Field: Page; Sequence: 82 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">This analysis indicated the following implied multiples:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">EV/ LTM Revenue</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">EV/ FTM Revenue</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">EV/ LTM Gross Profit</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">EV/ FTM Gross Profit</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 52%">Maximum</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">7.2x</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">6.2x</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">10.2x</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">8.9x</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">75<sup>th</sup> Percentile</span></td><td>&#160;</td>
    <td style="text-align: right">6.7x</td><td>&#160;</td>
    <td style="text-align: right">5.8x</td><td>&#160;</td>
    <td style="text-align: right">8.8x</td><td>&#160;</td>
    <td style="text-align: right">7.8x</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Mean</td><td>&#160;</td>
    <td style="text-align: right">5.1x</td><td>&#160;</td>
    <td style="text-align: right">4.4x</td><td>&#160;</td>
    <td style="text-align: right">6.7x</td><td>&#160;</td>
    <td style="text-align: right">6.0x</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Median</td><td>&#160;</td>
    <td style="text-align: right">4.8x</td><td>&#160;</td>
    <td style="text-align: right">4.1x</td><td>&#160;</td>
    <td style="text-align: right">7.2x</td><td>&#160;</td>
    <td style="text-align: right">6.3x</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">25<sup>th</sup> Percentile</span></td><td>&#160;</td>
    <td style="text-align: right">3.5x</td><td>&#160;</td>
    <td style="text-align: right">3.1x</td><td>&#160;</td>
    <td style="text-align: right">4.4x</td><td>&#160;</td>
    <td style="text-align: right">4.1x</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Minimum</td><td>&#160;</td>
    <td style="text-align: right">2.8x</td><td>&#160;</td>
    <td style="text-align: right">2.5x</td><td>&#160;</td>
    <td style="text-align: right">3.2x</td><td>&#160;</td>
    <td style="text-align: right">2.8x</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">iCAD at Implied Per Share Merger Consideration</td><td>&#160;</td>
    <td style="text-align: right">4.3x</td><td>&#160;</td>
    <td style="text-align: right">3.9x</td><td>&#160;</td>
    <td style="text-align: right">5.0x</td><td>&#160;</td>
    <td style="text-align: right">4.7x</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Piper Sandler then applied such multiples to iCAD&#8217;s
LTM revenue, FTM revenue, LTM gross profit and FTM gross profit in order to derive implied enterprise values for iCAD, after which Piper
Sandler derived implied per share values using the balance sheet data and diluted share information described above. Piper Sandler did
not take into account the net present value of current and estimated future NOLs available to iCAD in performing this analysis. Piper
Sandler observed that based on the mean and median for each analysis, the ranges of implied per share values for iCAD Common Stock, as
compared to the Implied Per Share Merger Consideration, were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr>
    <td style="vertical-align: top; width: 74%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; width: 25%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Implied Per-Share Value of iCAD
    Common Stock</b></p>
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/LTM Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$3.97&#8212;$4.13</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/FTM Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$3.82&#8212;$4.00</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/ LTM Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$4.56&#8212;$4.83</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/FTM Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$4.41&#8212;$4.58</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Implied Per Share Merger Consideration</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$3.61</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Based on the per share value reference ranges for
iCAD Common Stock described above, Piper Sandler then converted each of the mean and median per share values implied by the selected growth
men&#8217;s and women&#8217;s health M&amp;A transactions analysis to the corresponding implied exchange ratios derived from the RadNet
Closing Stock Price. Piper Sandler observed that based on the mean and median for each analysis, the ranges of implied exchange ratios,
as compared to the Exchange Ratio, were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr>
    <td style="vertical-align: top; width: 74%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; width: 25%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Implied Exchange Ratio</b></p>
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/LTM Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0745&#8212;0.0775</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/FTM Revenue</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0716&#8212;0.0749</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">EV/ LTM Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0854&#8212;0.0906</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">EV/FTM Gross Profit</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0827&#8212;0.0858</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Exchange Ratio </span></td>
    <td>&#160;</td>
    <td style="text-align: center">
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">0.0677</p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<!-- Field: Page; Sequence: 83 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Premiums Paid Analysis. </i>Piper Sandler reviewed publicly available information for selected completed M&amp;A transactions to
determine the implied premiums paid in such M&amp;A transactions over recent trading prices of the relevant target companies at certain
dates immediately prior to announcement of the relevant transaction. Piper Sandler selected M&amp;A transactions announced since January
1, 2014 involving those public target companies with EVs less than or equal to $250 million that Piper Sandler considered to be in the
medical technology industry. Based on these criteria, Piper Sandler reviewed 12 M&amp;A transactions in the medical technology industry
and compared, among other things, the implied premiums paid in those selected M&amp;A transactions over certain time periods to the premium
that would be paid to the holders of iCAD Common Stock based on the Implied Per Share Merger Consideration. Such range of implied premiums
based on the dates one day and four weeks prior to announcement of the relevant transaction indicated the following implied premiums:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>



<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Premium <br/>1-Day Prior <br/>(to announcement of M&amp;A Transaction)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Premium <br/>4-Weeks Prior <br/>(to announcement of M&amp;A Transaction)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%">Maximum</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">89%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">111%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">75<sup>th</sup> Percentile</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Mean</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Median</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">25<sup>th</sup> Percentile</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Minimum</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">iCAD at Implied Per Share Merger Consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55%</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Piper Sandler observed that based on the mean and
median for each analysis, the ranges of implied per share values for iCAD Common Stock, as compared to the Implied Per Share Merger Consideration,
were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr>
    <td style="vertical-align: top; width: 74%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; width: 25%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Implied Per-Share Value of iCAD
    Common Stock</b></p>
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Premium 1 day prior (to announcement of Merger)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$2.50&#8212;$2.60</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Premium 4 weeks prior (to announcement of Merger)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$3.51&#8212;$3.73</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Implied Per Share Merger Consideration </span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">$3.61</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">Based on the per share value reference ranges for
iCAD Common Stock described above, Piper Sandler then converted each of the mean and median per share values implied by the premiums paid
analysis to the corresponding implied exchange ratios derived from the RadNet Closing Stock Price. Piper Sandler observed that based on
the mean and median for each analysis, the ranges of implied exchange ratios, as compared to the Exchange Ratio, were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top; width: 74%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; width: 25%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Implied Exchange Ratio </b></p>
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Premium 1 day prior (to announcement of Merger)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0469&#8212;0.0488</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Premium 4 weeks prior (to announcement of Merger)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0657&#8212;0.0698</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Exchange Ratio </span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0.0677</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 84 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Historical Trading Analysis&#8212;iCAD.</i> Piper Sandler reviewed, among other things, the historical closing prices and trading
volumes for iCAD Common Stock over the fifty-two week period ended April 14, 2025, which reflected low and high closing prices during
such periods ranging from $1.19 to $3.70 as compared to the closing price of iCAD Common Stock on April 14, 2025 of $1.82 and the Implied
Per Share Merger Consideration of $3.61.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Historical Trading Analysis&#8212;RadNet.</i> Piper Sandler reviewed, among other things, the historical closing prices and trading
volumes for RadNet Common Stock over the fifty-two week period ended April 14, 2025, which reflected low and high closing prices during
such periods ranging from $45.92 to $86.38, as compared to the closing price of RadNet Common Stock on April 14, 2025 of $53.36.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Historical Trading Analysis&#8212;Exchange Ratio.</i> Piper Sandler reviewed the implied exchange ratio (calculated as the closing
price of iCAD Common Stock divided by the closing price of RadNet Common Stock on a certain date) over the fifty-two week period ended
April 14, 2025, which reflected low and high exchange ratios during such periods ranging from 0.0188 to 0.0577, as compared to the Exchange
Ratio of 0.0677.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="s4_011"></span>Miscellaneous</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">The summary set forth above does not contain a complete
description of the analyses performed by Piper Sandler and reviewed with the iCAD Board. The preparation of a fairness opinion is not
necessarily susceptible to partial analysis or summary description. Piper Sandler believes that its analyses and the summary set forth
above must be considered as a whole and that selecting portions of its analyses or of the summary, without considering the analyses as
a whole or all of the factors included in its analyses, would create an incomplete view of the processes underlying the analyses set forth
in Piper Sandler&#8217;s opinion. In arriving at its opinion, Piper Sandler considered the results of all of its analyses and did not
attribute any particular weight to any factor or analysis. Instead, Piper Sandler made its determination as to fairness on the basis of
its experience and financial judgment after considering the results of all of its analyses. In addition, the ranges of valuations resulting
from any particular analysis described above should not be taken to be Piper Sandler&#8217;s view of the actual value of iCAD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">None of the selected companies or transactions used
in the analyses above is directly comparable to iCAD or the Merger. Accordingly, an analysis of the results of the comparisons is not
purely mathematical&#894; rather, it involves considerations and judgments concerning differences in historical and projected financial
and operating characteristics of the selected companies and target businesses in the selected transactions and other factors that could
affect the public trading values of such companies or transaction values of such businesses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Piper Sandler performed its analyses for purposes
of providing its opinion to the iCAD Board. Certain of the analyses performed by Piper Sandler were based upon the Projections furnished
to Piper Sandler by iCAD management, which are not necessarily indicative of actual future results and may be significantly more or less
favorable than actual future results. These financial projections are inherently subject to uncertainty because, among other things, they
are based upon numerous factors or events beyond the control of the parties or their respective advisors. Piper Sandler does not assume
responsibility if future results are materially different from projected financial results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Piper Sandler&#8217;s opinion was one of many factors
taken into consideration by the iCAD Board in making the determination to approve the Merger Agreement. While Piper Sandler provided advice
to the iCAD Board during iCAD&#8217;s negotiations with RadNet, Piper Sandler did not recommend any specific amount or type of consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<!-- Field: Page; Sequence: 85 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Piper Sandler relied upon and assumed, without assuming
liability or responsibility for independent verification, the accuracy and completeness of all information that was publicly available
or was furnished, or otherwise made available, to Piper Sandler or discussed with or reviewed by Piper Sandler. Piper Sandler further
relied upon the assurances of iCAD management that the financial information provided was prepared on a reasonable basis in accordance
with industry practice, and that iCAD management was not aware of any information or facts that would make any information provided to
Piper Sandler incomplete or misleading. Without limiting the generality of the foregoing, for the purpose of its opinion, Piper Sandler
assumed that with respect to financial forecasts, estimates and other forward-looking information reviewed by Piper Sandler, that such
information was reasonably prepared based on assumptions reflecting the best currently available estimates and judgments of iCAD management
as to the expected future results of operations and financial condition of iCAD to which such financial forecasts, estimates or forward-looking
information relate. Piper Sandler expressed no opinion as to any such financial forecasts, estimates or forward-looking information or
the assumptions on which they were based. Piper Sandler relied, with consent of the iCAD Board, on advice of the outside counsel and the
independent accountants to iCAD, and on the assumptions of iCAD management, as to all accounting, legal, tax and financial reporting matters
with respect to iCAD, RadNet and the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">In arriving at its opinion, Piper Sandler assumed
that the executed Merger Agreement would be in all material respects identical to the last draft of the Merger Agreement reviewed by Piper
Sandler. Piper Sandler relied upon and assumed, without independent verification, that (i) the representations and warranties of all parties
to the Merger Agreement and all other related documents and instruments that are referred to therein were true and correct, (ii) each
party to such agreements would fully and timely perform all of the covenants and agreements required to be performed by such party, (iii)
the Merger would be consummated pursuant to the terms of the Merger Agreement without amendments thereto and (iv) all conditions to the
consummation of the Merger would be satisfied without waiver by any party of any conditions or obligations thereunder. Additionally, Piper
Sandler assumed that all the necessary regulatory approvals and consents required for the Merger would be obtained in a manner that would
not adversely affect iCAD, RadNet or the contemplated benefits of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">In arriving at its opinion, Piper Sandler did not
perform any appraisals or valuations of any specific assets or liabilities (fixed, contingent or other) of iCAD or RadNet, and was not
furnished or provided with any such appraisals or valuations, nor did Piper Sandler evaluate the solvency of iCAD or RadNet under any
state or federal law relating to bankruptcy, insolvency or similar matters. The analyses performed by Piper Sandler in connection with
its opinion were going concern analyses. Piper Sandler expressed no opinion regarding the liquidation value of iCAD, RadNet or any other
entity. Without limiting the generality of the foregoing, Piper Sandler undertook no independent analysis of any pending or threatened
litigation, regulatory action, possible unasserted claims or other contingent liabilities, to which iCAD, RadNet or any of their affiliates
is a party or may be subject, and at the direction of iCAD and with its consent, Piper Sandler&#8217;s opinion made no assumption concerning,
and therefore did not consider, the possible assertion of claims, outcomes or damages arising out of any such matters. Piper Sandler also
assumed that neither iCAD nor RadNet is party to any material pending transaction, including without limitation any financing, recapitalization,
acquisition or merger, divestiture or spin-off, other than the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Piper Sandler&#8217;s opinion was necessarily based
upon the information available to it and facts and circumstances as they existed and were subject to evaluation on the date of its opinion.
Events occurring after the date of Piper Sandler&#8217;s opinion could materially affect the assumptions used in preparing its opinion.
Piper Sandler expressed no opinion as to the price at which shares of iCAD Common Stock or RadNet Common Stock may trade following announcement
of the Merger or at any future time. Piper Sandler did not undertake to reaffirm or revise its opinion or otherwise comment upon any events
occurring after the date of its opinion and does not have any obligation to update, revise or reaffirm its opinion. As the iCAD Board
was aware, the credit, financial and stock markets have been experiencing unusual volatility and Piper Sandler expressed no opinion or
view as to any potential effects of such volatility on iCAD, RadNet or the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Piper Sandler&#8217;s opinion addressed solely the
fairness, from a financial point of view, to the holders of iCAD Common Stock of the Exchange Ratio set forth in the Merger Agreement
and did not address any other terms or agreement relating to the Merger or any other terms of the Merger Agreement. Piper Sandler was
not requested to opine as to, and its opinion does not address, the basic business decision to proceed with or effect the Merger, the
merits of the Merger relative to any alternative transaction or business strategy that may be available to iCAD or any other terms contemplated
by the Merger Agreement or the fairness of the Merger to any other class of securities, creditors or other constituency of iCAD. Furthermore,
Piper Sandler expressed no opinion with respect to the amount or nature of compensation to any officer, director or employee of any party
to the Merger, or any class of such persons, relative to the RadNet Common Stock to be received by the holders of iCAD Common Stock in
the Merger or with respect to the fairness of any such compensation, including whether such payments are reasonable in the context of
the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<!-- Field: Page; Sequence: 86 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="s4_012"></span>Information about Piper Sandler</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">As a part of its investment banking business, Piper
Sandler is regularly engaged in the valuation of businesses in the medical manufacturing, medical technology and other industries and
their securities in connection with mergers and acquisitions, underwritings, secondary distributions of listed and unlisted securities,
private placements, and valuations for corporate and other purposes. The iCAD Board selected Piper Sandler to be its financial advisor
and render its fairness opinion in connection with the Merger on the basis of such experience and its familiarity with iCAD. See the section
titled &#8220;<i>&#8211; Background of the Merger</i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Piper Sandler acted as financial advisor to iCAD
in connection with the Merger and will receive a fee, currently estimated to be approximately $3.0 million, from iCAD, which is contingent
upon the consummation of the Merger, except for $750,000 of such fee which became payable to Piper Sandler for rendering its fairness
opinion and is creditable against the total fee. The opinion fee is not contingent upon the consummation of the Merger or the conclusions
reached in Piper Sandler&#8217;s opinion. iCAD has also agreed to indemnify Piper Sandler against certain liabilities and reimburse Piper
Sandler for certain expenses in connection with its services. In addition, in the ordinary course of its business, Piper Sandler and its
affiliates may actively trade securities of iCAD and RadNet for its own account or the account of its customers and, accordingly, may
at any time hold a long or short position in such securities. Piper Sandler may also, in the future, provide investment banking and financial
advisory services to iCAD, RadNet or entities that are affiliated with iCAD or RadNet, for which Piper Sandler would expect to receive
compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_013"></span>Regulatory Approvals</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Under the Merger Agreement, the Merger cannot
be completed until all applicable waiting periods (and any extensions thereof) under the HSR Act have expired or been terminated. SEC
Clearance of Registration Statement</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The completion of the Merger is conditioned on
the registration statement of which this proxy statement/prospectus is a part being declared effective and the absence of any stop order
suspending the effectiveness of the registration statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_014"></span>Nasdaq Global Market Listing</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Pursuant to the Merger Agreement, the shares of
RadNet Common Stock to be issued in the Merger must have been approved for listing on The Nasdaq Global Market, subject to official notice
of issuance prior to the completion of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_015"></span>Other Governmental Approvals</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet and iCAD are not aware of any material
governmental approvals or actions that are required for completion of the Merger other than those described above. If any such additional
governmental approvals or actions are required, RadNet and iCAD will use their respective reasonable best efforts, subject to certain
limitations, to obtain any such approvals or actions from any governmental authority that are required under applicable law in order to
consummate the transactions contemplated by the Merger Agreement. There can be no assurance, however, that any additional approvals or
actions will be obtained.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_016"></span>Timing</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Subject to certain conditions, either RadNet or
iCAD may terminate the Merger Agreement if the Merger is not completed on or before the Outside Date (September 30, 2025) in certain circumstances,
provided that such date may be automatically extended to December 31, 2025, as described under the section titled &#8220;<i>The Merger
Agreement&#8212;Termination of the Merger Agreement</i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 87 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_017"></span>No Dissenters&#8217; or Appraisal Rights</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In accordance with Section 262 of the DGCL, iCAD
stockholders are not entitled to dissenters&#8217; or appraisal rights in connection with the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_018"></span>Material U.S. Federal Income Tax Consequences of the Merger</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger is intended to be treated as a tax-free
reorganization under Section 368(a) of the Code for U.S. federal income tax purposes, as more fully described in the section titled &#8220;<i>Material
U.S. Federal Income Tax Consequences of the Merger</i>&#8221; of this proxy statement/prospectus. Please consult your tax advisors as
to the specific tax consequences to you of the Merger, including the consequences if the Merger were to fail to qualify as a &#8220;reorganization.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_019"></span>Accounting Treatment</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger will be accounted for as an acquisition
of a business. RadNet will record the net tangible and identifiable intangible assets acquired and liabilities assumed from iCAD at their
respective fair values, unless prohibited by GAAP, as of the Closing Date of the Merger. Any excess of the purchase price over the net assets
acquired will be recorded as goodwill. The purchase price will be based on the Closing Date fair value of consideration paid by RadNet,
primarily the RadNet Common Stock to be issued to iCAD stockholders, in connection with the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The financial condition and results of operations
of RadNet after completion of the Merger will reflect iCAD&#8217;s balances and results after completion of the transaction, but will
not be restated retroactively to reflect the historical financial condition or results of operations of iCAD. The earnings of RadNet following
the completion of the Merger will include the effect of changes in the carrying value of assets and liabilities. Goodwill and intangible
assets with indefinite useful lives will not be amortized, but will be tested for impairment at least annually, and all assets (including
goodwill) will be tested for impairment when certain indicators are present. If, in the future, RadNet determines that tangible or intangible
assets (including goodwill) are impaired, RadNet would record an impairment charge at that time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_020"></span>Delisting and Deregistration of Shares of iCAD Common Stock</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If the Merger is completed, shares of iCAD stock
will no longer be listed on The Nasdaq Capital Market and will be deregistered under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 88 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_021"></span>THE MERGER AGREEMENT</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><i>The following is a summary of the material
terms and conditions of the Merger Agreement. This summary may not contain all the information about the Merger Agreement that is important
to you. This summary is qualified in its entirety by reference to the Merger Agreement attached as Annex A to, and incorporated by reference
into, this proxy statement/prospectus. You are encouraged to read the Merger Agreement in its entirety because it is the legal document
that governs the Merger. </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_022"></span>Explanatory Note</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger Agreement and the summary of its terms
and conditions in this proxy statement/prospectus have been included to provide information about the terms and conditions of the Merger
Agreement. The Merger Agreement and the summary of its terms and conditions are not intended to provide any other factual information
about RadNet, Merger Sub, iCAD or any of their respective subsidiaries or affiliates. The representations, warranties, covenants and agreements
contained in the Merger Agreement: were made by RadNet, Merger Sub and iCAD only for purposes of the Merger Agreement and as of specific
dates; were made solely for the benefit of the parties to the Merger Agreement; may be subject to limitations agreed upon by the contracting
parties, including being qualified by confidential disclosures; may not have been intended to be statements of fact, but rather, as a
method of allocating contractual risk and governing the contractual rights and relationships between the parties to the Merger Agreement;
and may be subject to standards of materiality applicable to contracting parties that differ from those applicable to investors. Investors
should not rely on the representations, warranties, covenants and agreements or any descriptions thereof as characterizations of the actual
state of facts or condition of RadNet, Merger Sub, iCAD or any of their respective subsidiaries or affiliates. Moreover, information concerning
the subject matter of the representations, warranties, covenants and agreements may change after the date of the Merger Agreement, which
subsequent information may or may not be fully reflected in RadNet&#8217;s or iCAD&#8217;s public disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For the foregoing reasons, the representations,
warranties, covenants and agreements in the Merger Agreement and any description of those provisions in this proxy statement/prospectus
should be read only in conjunction with the other information provided elsewhere in this proxy statement/prospectus or incorporated by
reference into this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_023"></span>Structure of the Merger</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger Agreement provides for a transaction
in which Merger Sub will merge with and into iCAD, upon the terms and subject to the conditions set forth in the Merger Agreement. iCAD
will be the Surviving Corporation in the Merger and will, following completion of the Merger, be a wholly-owned subsidiary of RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">At the Effective Time, the iCAD Certificate of
Incorporation will be amended and restated as set forth in Exhibit A to the Merger Agreement and the iCAD Bylaws will be amended and restated
as set forth in Exhibit B to the Merger Agreement, in each case, until amended in accordance with the DGCL and such documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_024"></span>Completion and Effectiveness of the Merger</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Closing of the Merger is required to take
place on the second business day after satisfaction or waiver of the conditions to Closing set forth in the section titled <i>&#8220;&#8212;Conditions
to Completion of the Merger</i>&#8221; (other than those conditions that by their terms are to be fulfilled at the Closing, but subject
to the fulfillment or waiver of such conditions), or such other date as may be mutually agreed upon in writing by RadNet and iCAD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger will become effective at the time the
certificate of merger for the Merger is duly filed with the Secretary of State of the State of Delaware or at such later time as agreed
by the parties and specified in the certificate of merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 89 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_025"></span>Merger Consideration</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">At the Effective Time, each share of iCAD Common
Stock issued and outstanding immediately prior to the Effective Time (other than the Excluded Shares) will be converted into the right
to receive 0.0677 fully paid and nonassessable shares of RadNet Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">No fractional shares of RadNet Common Stock will
be delivered to any holder of shares of iCAD Common Stock upon completion of the Merger. Instead, all fractional shares of RadNet Common
Stock that a holder of shares of iCAD Common Stock would otherwise be entitled to receive as a result of the Merger will be aggregated
and, if a fractional share results from such aggregation, such holder will be entitled to receive the cash proceeds from the sale of such
fractional share by the exchange agent for the account of such holder, without interest, in accordance with the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_026"></span>Governance Matters Following Completion of the Merger</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">After the Effective Time, the directors and officers
of Merger Sub immediately prior the Effective Time will be the directors and officers, respectively, of the Surviving Corporation, in
each case, until their successors are duly elected or appointed and qualified in accordance with the charter and bylaws of the Surviving
Corporation and the DGCL, as applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_027"></span>Procedures for Surrendering iCAD Stock Certificates</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Prior to the Closing, RadNet is required to enter
into an exchange agreement with the transfer agent of RadNet, the transfer agent of iCAD or another nationally recognized financial institution
or trust company designated by RadNet and, in each case, reasonably acceptable to iCAD, for the payment of the Merger Consideration. At
or promptly following the Effective Time, RadNet is required to deposit or cause to be deposited with the exchange agent, for exchange
in accordance with the Merger Agreement through the exchange agent, book-entry shares representing the full number of whole shares of
RadNet Common Stock to be issued as Merger Consideration pursuant to the Merger Agreement and RadNet will, after the Effective Time on
the appropriate payment date, if applicable, provide or cause to be provided to the exchange agent any dividends or other distributions
payable on such shares of RadNet Common Stock pursuant to the Merger Agreement (such shares of RadNet Common Stock provided to the exchange
agent, together with any such dividends or other distributions with respect thereto, the &#8220;Exchange Fund&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">As promptly as practicable following the Effective
Time, and in no event later than the third business day thereafter, RadNet will cause the exchange agent to mail a letter of transmittal
to each holder of record of an iCAD Certificate that immediately prior to the completion of the Merger represented outstanding shares
of iCAD Common Stock. The letter of transmittal will specify that delivery of iCAD Certificates will be effected and risk of loss and
title to such iCAD Certificates will pass only upon proper delivery of such iCAD Certificates (or affidavits of loss in lieu of such certificates)
to the exchange agent and will be in the form and have such other provisions as are reasonably acceptable to RadNet and iCAD. The letter
of transmittal will be accompanied by instructions (in the form and having such provisions as are reasonably acceptable to RadNet and
iCAD) for use in effecting the surrender of the iCAD Certificates in exchange for (A) the number of shares of RadNet Common Stock (which
will be in book-entry form) representing, in the aggregate, the whole number of shares that such holder has the right to receive in respect
of such iCAD Certificates pursuant to the Merger Agreement, (B) any dividends or other distributions payable pursuant to the Merger Agreement
and (C) cash in lieu of fractional shares of RadNet Common Stock payable pursuant to the Merger Agreement, collectively referred to as
the &#8220;Exchange Payment.&#8221; Upon surrender of an iCAD Certificate (or affidavit of loss in lieu thereof) for cancellation to the
exchange agent, together with a letter of transmittal duly completed and validly executed in accordance with the instructions thereto,
and such other documents as may be reasonably required pursuant to such instructions, the holder of such iCAD Certificate will be entitled
to receive in exchange the Exchange Payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">No holder of record of an iCAD Book-Entry Share
will be required to deliver an iCAD Certificate or letter of transmittal or surrender such iCAD Book-Entry Shares to the exchange agent,
and in lieu thereof, upon receipt of an &#8220;agent&#8217;s message&#8221; by the exchange agent (or such other evidence, if any, of
transfer as the exchange agent may reasonably request), each holder of an iCAD Book-Entry Share will be entitled, upon or following the
Effective Time, to receive the Exchange Payment. No interest will be paid or accrued for the benefit of holders of iCAD Certificates or
iCAD Book-Entry Shares on the Merger Consideration or any cash payable pursuant to the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 90 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">As of the completion of the Merger, shares of
iCAD Common Stock will no longer be outstanding and will automatically be canceled and retired and will cease to exist. As of the completion
of the Merger, each holder of an iCAD Certificate or iCAD Book-Entry Shares will cease to have any rights with respect thereto, except
the right to receive the Merger Consideration as described above and subject to the terms and conditions set forth in the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Subject to applicable law, the holders of RadNet
Common Stock issued in exchange for iCAD Certificates or iCAD Book-Entry Shares as described above will receive, without interest, (i)
at the time of delivery of such RadNet Common Stock by the exchange agent pursuant to the Merger Agreement, the amount of dividends or
other distributions, if any, with a record date after the Effective Time theretofore paid with respect to such shares of RadNet Common
Stock, and (ii) at the appropriate payment date, the amount of dividends or other distributions, if any, with a record date after the
Effective Time, but before the delivery of RadNet Common Stock by the exchange agent pursuant to the Merger Agreement, and a payment date
subsequent to such delivery of such RadNet Common Stock by the exchange agent pursuant to the Merger Agreement, payable with respect to
such shares of RadNet Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Each of iCAD, RadNet, Merger Sub, the Surviving
Corporation and the exchange agent will be entitled to deduct and withhold from any amounts otherwise payable or issuable pursuant to
the Merger Agreement to any person such amounts as are required to be deducted and withheld with respect to the making of such payment
under the Code or any provision of applicable law. Any amounts so deducted and withheld will be treated for all purposes of the Merger
Agreement as having been paid to the person in respect of which such deduction and withholding was made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">All shares of RadNet Common Stock issued pursuant
to the Merger Agreement will be issued in book-entry form.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">No fractional share of RadNet Common Stock (or
certificate or scrip representing the same) will be issued upon the conversion or surrender for exchange of iCAD Certificates or iCAD
Book-Entry Shares, and such fractional share interests will not entitle the owner thereof to any RadNet Common Stock or to vote or to
any other rights of a holder of RadNet Common Stock. Each holder of shares of iCAD Common Stock converted pursuant to the Merger who would
otherwise have been entitled to receive a fraction of a share of RadNet Common Stock (after taking into account all iCAD Certificates
and iCAD Book-Entry Shares delivered by such holder) will receive, in lieu thereof, cash (without interest) in an amount equal to such
fraction as provided in this paragraph. As promptly as practicable following the Effective Time, the exchange agent will determine the
excess of (i) the number of full shares of RadNet Common Stock delivered to the exchange agent by RadNet for issuance to holders of iCAD
Certificates or iCAD Book-Entry Shares over (ii) the aggregate number of full shares of RadNet Common Stock to be distributed to holders
of iCAD Certificates or iCAD Book-Entry Shares (such excess being referred to as the &#8220;Excess Shares&#8221;). As soon as practicable
after the Effective Time, the exchange agent will sell the Excess Shares at then prevailing prices on The Nasdaq Global Market. The net
proceeds of any such sale or sales of Excess Shares to be distributed to the holders of iCAD Certificates or iCAD Book-Entry Shares will
be reduced by any and all commissions, transfer taxes and other out-of-pocket transaction costs, as well as any expenses, of the exchange
agent incurred in connection with such sale or sales. The exchange agent will determine the portion of such net proceeds to which each
holder of iCAD Certificates or iCAD Book-Entry Shares will be entitled, if any, by multiplying the amount of the aggregate net proceeds
by a fraction, the numerator of which is the amount of the fractional share interest to which such holder of iCAD Certificates or iCAD
Book-Entry Shares is entitled (after taking into account all iCAD Certificates and iCAD Book-Entry Shares then held by such holder) and
the denominator of which is the aggregate amount of fractional share interests to which all holders of iCAD Certificates or iCAD Book-Entry
Shares are entitled. As soon as practicable after the determination of the amount of cash, if any, to be paid to holders of iCAD Certificates
or iCAD Book-Entry Shares with respect to any fractional share interests, the exchange agent will promptly pay such amounts to such holders
subject to and in accordance with the Merger Agreement. The payment of cash in lieu of fractional share interests pursuant to the Merger
Agreement represents merely a mechanical rounding-off of the fractions in the exchange and is not separately bargained-for consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Any portion of the Exchange Fund which remains
undistributed to the holders of iCAD Certificates or iCAD Book-Entry Shares for one year after the Effective Time will be delivered to
RadNet or its designee upon demand, and any such holders prior to the Merger who have not theretofore complied with the Merger Agreement
will thereafter look only to RadNet as general creditor thereof for payment of their claims for Merger Consideration and any dividends
or distributions with respect to RadNet Common Stock. Any amounts remaining unclaimed by holders of any such iCAD Certificates or RadNet
Book-Entry Shares five years after the Effective Time, or at such earlier date as is immediately prior to the time at which such amounts
would otherwise escheat to, or become property of, any governmental entity, will, to the extent permitted by applicable law, become the
property of the Surviving Corporation free and clear of any claims or interest of any such holders (and their successors, assigns or personal
representatives) previously entitled thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 91 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_028"></span>Treatment of iCAD Options</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">At the Effective Time, each Eligible iCAD Option
will automatically and without any action on the part of the holder thereof, be assumed by RadNet and converted into an option (A) to
purchase that number of shares of RadNet Common Stock equal to the product of (1) the number of shares of iCAD Common Stock subject to
such Eligible iCAD Option immediately prior to the Effective Time and (2) the Exchange Ratio, rounded down to the nearest whole number
of shares, and (B) with an exercise price per share equal to (1) the exercise price per share of iCAD Common Stock of such Eligible iCAD
Option immediately prior to the Effective Time, divided by (2) the Exchange Ratio, rounded up to the nearest whole cent (each, an &#8220;Assumed
Option&#8221;). Each Assumed Option will continue to have, and will be subject to, the same terms and conditions (including the vesting
and exercisability conditions (including any acceleration provisions) and expiration date) that applied to the corresponding Eligible
iCAD Option as in effect immediately prior to the Effective Time, other than any terms that become inoperative by reason of the transactions
contemplated pursuant to the Merger Agreement. For the avoidance of doubt, continuous employment with iCAD or any of its subsidiaries
will be credited to the holder of an Assumed Option for purposes of determining the number of shares of RadNet Common Stock that are vested
and exercisable under such holder&#8217;s Assumed Option after the Effective Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Each iCAD Option that is not an Eligible iCAD
Option will not be assumed or otherwise substituted by RadNet, and all such iCAD Options that are not Eligible iCAD Options and that are
outstanding and unexercised as of immediately prior to the Effective Time will terminate and cease to be outstanding at the Effective
Time without any further action by the holder thereof in accordance with the terms of the applicable iCAD Stock Incentive Plan or any
award agreements, as applicable, without any consideration payable therefor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_029"></span>Treatment of iCAD Employee Stock Purchase Plan</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Prior to the Effective Time, and subject to the
prior review and approval of RadNet (which review and approval will not be unreasonably withheld or delayed), the iCAD Board or the appropriate
committee thereof will take, or cause to be taken, all reasonably necessary and appropriate action to provide that, subject to the consummation
of the Merger, the iCAD ESPP will terminate effective immediately prior to the Effective Time. In connection with the Merger Agreement,
the iCAD Board or the appropriate committee thereof adopted resolutions took, or caused to be taken, all necessary and appropriate action
to provide that the iCAD ESPP will continue to be suspended until terminated in accordance with the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_030"></span>Listing of Shares of RadNet Common Stock</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger Agreement obligates RadNet and iCAD
to use reasonable best efforts to cause the shares of RadNet Common Stock issuable pursuant to the Merger Agreement to be approved for
listed on The Nasdaq Global Market, subject to official notice of issuance, prior to the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_031"></span>Conditions to Completion of the Merger</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Conditions to Each Party&#8217;s Obligation to Effect the Merger</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The respective obligation of each of RadNet, iCAD
and Merger Sub to complete the Merger is subject to the satisfaction or waiver, in whole or in part (to the extent permitted by applicable
law), on or prior to the Closing Date of the following conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the obtainment of the iCAD Stockholder Approval;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the expiration or termination of any applicable waiting period (including extensions) under the HSR Act relating to the Merger or
the transactions contemplated by the Merger Agreement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the absence of any injunction or order or applicable law preventing or making illegal the consummation of the Merger;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the registration statement of which this proxy statement/prospectus is a part being declared effective under the Securities Act and
the absence of any stop order suspending the effectiveness of the registration statement; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the shares of RadNet Common Stock to be issued in the Merger having been approved for listing on The Nasdaq Global Market, subject
to official notice of issuance;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 92 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Additional Conditions to Obligations of RadNet </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In addition, RadNet&#8217;s obligation to complete
the Merger is subject to the satisfaction or waiver, in whole or in part (to the extent permitted by applicable law, waiver) of the following
conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>accuracy of the representations and warranties made in the Merger Agreement by iCAD as of the date of the Merger Agreement and as
of the Closing Date, subject to certain materiality qualifiers;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>performance in all material respects by iCAD of the obligations required to be performed by it at or prior to the Closing Date;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the absence since the date of the Merger Agreement of a Material Adverse Effect on iCAD that is continuing;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>receipt of an officer&#8217;s certificate from iCAD as to the satisfaction of the conditions in the three preceding bullet points;
and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the absence of (i) pending or threatened action by any governmental entity, or (ii) any statute, rule, regulation or order issued
by any court of competent jurisdiction or other governmental entity or other legal restraint or prohibition in effect, in either case:
(1) challenging or seeking to restrain or prohibit the consummation of the Merger or other transactions contemplated by the Merger Agreement,
or seeking to obtain any damages in connection therewith; or (2) seeking to prohibit or impose any limitations on RadNet or the Surviving
Corporation&#8217;s ownership or operation of all or any portion of iCAD&#8217;s business or assets or to compel RadNet or any of its
affiliates to dispose of or hold separate all or any material portion of the assets of iCAD as a result of the consummation of the Merger
or other transactions contemplated by the Merger Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Additional Conditions to Obligations of iCAD</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In addition, iCAD&#8217;s obligations to complete
the Merger is subject to the satisfaction or waiver, in whole or in part (to the extent permitted by applicable law, waiver) of the following
conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>accuracy of the representations and warranties made in the Merger Agreement by RadNet as of the Closing Date, subject to certain materiality
thresholds;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>performance in all material respects by RadNet of the obligations required to be performed by it at or prior to the Closing Date;
and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>receipt of an officer&#8217;s certificate from RadNet as to the satisfaction of the conditions in the two preceding bullet points.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 93 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_032"></span>Representations and Warranties</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger Agreement contains a number of representations
and warranties made by iCAD, on the one hand, and RadNet, on the other hand, made solely for the benefit of the other, and that are subject
in some cases to exceptions and qualifications, including, among other things, as to materiality and Material Adverse Effect (see the
section titled &#8220;<i>&#8212;Definition of &#8216;Material Adverse Effect&#8217;</i>&#8221;). Furthermore, the assertions embodied
in those representations and warranties are qualified by information in the confidential disclosure schedules that the parties have exchanged
in connection with signing the Merger Agreement. The confidential disclosure schedules to the Merger Agreement contain information that
modifies, qualifies and creates exceptions to the representations and warranties set forth in the Merger Agreement. The representations
and warranties made by the parties in the Merger Agreement relate to and include, as applicable to such party, among other things:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>organization, standing and corporate power;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>corporate authority and non-contravention;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>capital structure;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>subsidiaries;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>SEC documents, financial statements, and undisclosed liabilities;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>absence of certain changes or events;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>compliance with applicable laws and outstanding orders;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>regulatory matters and compliance with healthcare laws;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>corrupt practices;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>sanctions;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>litigation;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>benefit plans;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>labor and employment matters;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>taxes;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>intellectual property;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>information technology and data protection;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>certain contracts;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 94 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>environmental protection;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>real property;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>voting requirements;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>opinion of financial advisors;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>brokers; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Merger Sub.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">None of the representations, warranties or agreements
contained in the Merger Agreement or in any certificate, document or instrument delivered pursuant to the Merger Agreement will survive
the Effective Time, except for covenants and agreements which contemplate performance after the Effective Time or otherwise expressly
by their terms survive the Effective Time. For more information, see the section titled &#8220;&#8212;<i>Explanatory Note</i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_033"></span>Definition of &#8220;Material Adverse Effect&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Many of the representations and warranties in
the Merger Agreement are qualified by a &#8220;Material Adverse Effect&#8221; standard with respect to the party making such representations
and warranties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For purposes of the Merger Agreement, &#8220;Material
Adverse Effect&#8221; means, with respect to any person, any event, circumstance, development, occurrence, fact, condition, effect or
change (each, a &#8220;Change&#8221;) that is, or would reasonably be expected to become, individually or in the aggregate, materially
adverse to (i) the business, results of operations, condition (financial or otherwise) or assets of such person and its subsidiaries,
taken as a whole, or (ii) the ability of such person to timely perform its obligations under the Merger Agreement or consummate the transactions
contemplated thereby on a timely basis, except a Material Adverse Effect will not be deemed to include any Change (alone or in combination)
to the extent arising out of, relating to, or resulting from:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>changes generally affecting the economy, financial or securities markets, or political conditions (including the impacts of any tariffs
or trade wars);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the execution and delivery, announcement, or pendency of the transactions contemplated by the Merger Agreement (it being understood
that this clause will not apply to a breach of any representation or warranty related to corporate authority and non-contravention);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>any changes in applicable law or GAAP or other applicable accounting standards;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>geopolitical conditions, the outbreak or escalation of hostilities, any acts of war (whether or not declared), sabotage or terrorism,
or any escalation or worsening of any such acts of war, sabotage or terrorism underway as of the date of the Merger Agreement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>natural disasters, epidemics, pandemics, or other force majeure events;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>general conditions in the industry in which such person and its subsidiaries operate;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>any failure, in and of itself, by such person to meet any internal or published projections, forecasts, estimates, or predictions
in respect of revenues, earnings, or other financial or operating metrics for any period (it being understood that any Change underlying
such failure may be deemed to constitute, or be taken into account in determining whether there has been or would reasonably be expected
to become, a Material Adverse Effect, to the extent permitted by this definition and not otherwise excepted by another clause from the
definition of Material Adverse Effect);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 95 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>any change, in and of itself, in the market price or trading volume of such person&#8217;s securities (it being understood that any
Change underlying such change may be deemed to constitute, or be taken into account in determining whether there has been or would reasonably
be expected to become, a Material Adverse Effect, to the extent permitted by this definition and not otherwise excepted by another clause
from the definition of Material Adverse Effect);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>actions taken as required or specifically permitted by the Merger Agreement or actions or omissions taken with the prior written consent
of, in the case of RadNet, iCAD, and in the case of iCAD, RadNet;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">provided that the exclusions in the first, third,
fourth, fifth or sixth bullets above will be taken into account in determining whether a Material Adverse Effect has occurred or would
reasonably be expected to occur to the extent it has a disproportionate effect on such person and its subsidiaries, taken as a whole,
compared to other participants in the industries in which such person and its subsidiaries conduct their businesses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_034"></span>Conduct of Business Pending the Merger</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In general, except as required by applicable law,
as expressly contemplated or expressly permitted by the Merger Agreement, with the prior written consent of RadNet or subject to specified
exceptions set forth in the Merger Agreement, from the date of the Merger Agreement until the Effective Time (the &#8220;Pre-Closing Period&#8221;),
iCAD will, and will cause its subsidiaries to, (i) carry on their respective businesses in all material respects in the ordinary course
of business consistent with past practice and (ii) preserve intact its business organization and relationships with customers, suppliers,
licensors, licensees and other third parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Without limiting the generality of the preceding
paragraph, during the Pre-Closing Period and except as required by applicable law, as expressly contemplated or expressly permitted by
the Merger Agreement, with the prior written consent of RadNet or subject to specified exceptions set forth in the Merger Agreement, iCAD
and its subsidiaries have agreed not to take the following actions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>other than dividends and distributions by a direct or indirect subsidiary wholly-owned by iCAD payable to another direct or indirect
subsidiary wholly-owned by iCAD or payable to iCAD, declare, set aside or pay any dividends on, make any other distributions in respect
of, any of its capital stock;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>split, combine or reclassify any equity securities of iCAD or issue or authorize the issuance of any other securities in respect of,
in lieu of or in substitution for any equity securities of iCAD, other than, solely with respect to the capital stock or other securities
of iCAD&#8217;s wholly-owned subsidiaries, actions or transactions solely between iCAD and its wholly-owned subsidiaries, or among iCAD&#8217;s
wholly-owned subsidiaries;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>purchase, redeem or otherwise acquire any equity securities of iCAD (other than certain acquisitions of shares pursuant to an iCAD
Stock Incentive Plan), other than, solely with respect to the capital stock or other securities of iCAD&#8217;s wholly-owned subsidiaries,
actions or transactions solely between iCAD and its wholly-owned subsidiaries, or among iCAD&#8217;s wholly-owned subsidiaries;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>issue, deliver, sell, transfer, pledge or otherwise encumber or subject to any lien or otherwise authorize the issuance, delivery,
sale, transfer, pledge or encumbrance of any equity securities (other than (1) in connection with the settlement or exercise of iCAD Options
outstanding as of March 31, 2025 in accordance with their terms in effect on March 31, 2025 or issued as permitted by the Merger Agreement
in accordance with the terms governing the issuance of such type of iCAD Options in effect on March 31, 2025, (2) as required under the
terms of any iCAD benefit plan in effect on the date of the Merger Agreement, as permitted by or pursuant to the Merger Agreement and
(3) solely with respect to the capital stock or other securities of iCAD&#8217;s wholly-owned subsidiaries, transactions solely between
iCAD and its wholly owned subsidiaries, or among iCAD&#8217;s wholly-owned subsidiaries), or enter into any agreement with respect to
the voting of, any of iCAD&#8217;s capital stock;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 96 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>other than (including with respect to equipment and inventory) in the ordinary course of business consistent with past practice, (A)(1)
amend or waive any material provision of any material contract, (2) enter into any contract that would have been a material contract had
it been in effect as of the date of the Merger Agreement or (3) renew any material contract (other than on terms that are no less favorable,
in the aggregate, to iCAD), (B) other than the expiration of any material contract in accordance with the terms and conditions contained
therein, terminate any material contract or (C) acquire any material assets;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>acquire any equity interests in, or make any investment in or any capital contribution to, any person, or acquire a substantial portion
of the assets or business of any person (or any division or line of business thereof), including, in each case, by merger or consolidation;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>transfer, assign, sell, lease, license, mortgage, pledge, surrender, encumber (except for certain liens permitted under the Merger
Agreement), divest, cancel, abandon, allow to lapse or otherwise dispose of any material tangible or intangible assets (including any
material intellectual property) except (1) for transactions solely between iCAD and its wholly-owned subsidiaries, or among iCAD&#8217;s
wholly-owned subsidiaries and (2) the non-exclusive license of intellectual property in the ordinary course of business consistent with
past practice;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>create, incur or assume any indebtedness, or issue any debt securities or any right to acquire debt securities, assume, guarantee,
endorse or otherwise become liable or responsible for the indebtedness of another person, enter into any agreement to maintain any financial
statement condition of another person or enter into any arrangement having the economic effect of any of the foregoing, in each case,
except (1) for additional indebtedness incurred in the ordinary course of business consistent with past practice after the date of the
Merger Agreement under iCAD&#8217;s then-current borrowing agreements that does not, at any time, exceed $2,000,000 in the aggregate and
(2) for any inter-company indebtedness solely between iCAD and its wholly owned-subsidiaries, or among iCAD&#8217;s wholly-owned subsidiaries;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>other than any action with respect to taxes, settle, pay, discharge or satisfy any action, other than any settlement, payment, discharge
or satisfaction that (A) does not relate to any litigation related to the Merger and (B)(1) either (x) results solely in a monetary obligation
involving only the payment of monies by iCAD or its subsidiaries of not more than $250,000 individually or $1,000,000 in the aggregate
(as well as related non-substantive incidental provisions and other remedies or obligations that are not material in the context of the
applicable resolution), individually or in the aggregate for all such actions (excluding any settlements made under the following clause
(y)), or (y) results solely in a monetary obligation that is funded by an indemnity obligation to, or an insurance policy of, iCAD or
any of its subsidiaries and the payment of monies by iCAD and its subsidiaries that are not more than $250,000 individually or $1,000,000
in the aggregate (not funded by an indemnity obligation or through insurance policies) (as well as related non-substantive incidental
provisions and other remedies or obligations that are not material in the context of the applicable resolution), (2) is limited to actions
which arise in the ordinary course of business, consistent with past practice, and (3) does not involve any admission of guilt or impose
any non-de-minimis restrictions or non-de-minimis limitations upon the operations or business of or other conduct remedy or injunctive
relief applicable to iCAD or any of its subsidiaries, whether before, on or after the Effective Time;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>(A) make, change or revoke any material tax election, (B) change any tax accounting period or adopt or change any material method
of tax accounting, or (C) settle, adjust or compromise, or enter into any closing agreement with respect to, any audit, examination, investigation,
claim or other action relating to a material amount of taxes, (D) file any material amended tax return, (E) extend or waive (or request
to extend or waive) any statute of limitations period for the assessment or collection of any material tax, (F) surrender any claim for
a refund of a material amount of taxes or (G) prepare and file any material tax return in a manner materially inconsistent with past practice;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>except as set forth in the confidential disclosure letter delivered by iCAD to RadNet or as required under the terms of any iCAD benefit
plan or labor agreement applicable to iCAD or any of its subsidiaries, in each case, as in effect on the date of the Merger Agreement:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>increase the compensation or increase the benefits of any current or former officer, director, employee or other individual service
provider, other than in the ordinary course of business consistent with past practice with respect to individuals whose annualized base
compensation is less than $175,000 and which increase is no more than 5% of such individual&#8217;s current compensation (provided that
such increase does not result in an increase to such service provider&#8217;s equity or equity-based compensation or opportunities), or
grant or pay any bonus, incentive, change in control, retention, severance, termination, tax gross-up or profit-sharing award or payment;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 97 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>enter into, adopt, amend, terminate or modify any iCAD benefit plan (or any arrangement that would be an iCAD benefit plan if in effect
on the date of the Merger Agreement);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>accelerate the vesting or payment of any compensation or benefits of any current or former officer, director, employee or other individual
service provider;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>provide any funding for any rabbi trust or similar arrangement, or take any other action to fund or secure the payment of any compensation
or benefit;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>grant to any current or former officer, director, employee or other individual service provider any right to receive any severance,
change-in-control, retention, termination, transaction or similar compensation or benefits or increases therein, including adding participants
to any iCAD severance plan maintained for employees at the level of vice president and above;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>hire, promote or terminate any individual, except for new hires or terminations in the ordinary course of business consistent with
past practice with respect to individuals whose annualized base compensation is less than $175,000;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>forgive any loans or advances to any current or former officer, director, employee or other individual service provider, or any of
their respective affiliates, or change its existing borrowing or lending arrangements for or on behalf of any of such persons in accordance
with an employee benefit plan or otherwise, except in the ordinary course of business in connection with relocation activities to any
employees of iCAD or any subsidiary of iCAD; or</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>announce or commit to take any of the actions set forth in the items set forth above in this bullet point; provided that the foregoing
sub-bullets will not restrict iCAD or any of its subsidiaries from entering into, in the ordinary course of business, any offer letter
with any newly hired employee to fill a critical vacant position whose annualized base compensation will be less than $175,000, provided
that the compensation and benefits provided pursuant to such offer letter contains terms substantially similar to the terms provided to
similarly situated employees of iCAD and does not contain any change in control, equity or severance benefits;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>change any of its material financial accounting policies or procedures currently in effect, except (1) as required (or with respect
to permitted early adoption of changes required) by GAAP, Regulation S-X of the Exchange Act or a governmental entity or quasi-governmental
authority (including the Financial Accounting Standards Board or any similar organization) or (2) as required by applicable law;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>make any payment of, commitment for or accrual of aggregate capital expenditures for any 12-month period that are greater than $125,000
individually or $500,000 in the aggregate;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>voluntarily terminate, suspend, abrogate, amend or modify any iCAD permit in a manner materially adverse to iCAD and its subsidiaries;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>(A) amend the iCAD Certificate of Incorporation or the iCAD Bylaws or any similar organizational documents of iCAD subsidiaries, (B)
merge or consolidate with any person or (C) adopt or implement any plan of complete or partial liquidation, dissolution, consolidation,
restructuring, recapitalization or other reorganization;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>amend, modify, extend, terminate, or enter into any material labor agreement or recognize or certify any labor union, labor organization,
works council, or group of employees as the bargaining representative for any employees of iCAD or its subsidiaries; or</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>authorize, or commit or agree to take, any of the actions described in the bullet points above.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 98 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_035"></span>Obligation to Call the Special Meeting</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD is required to duly give notice of, convene
and hold the Special Meeting as promptly as practicable after the effectiveness of the registration statement of which this proxy statement/prospectus
forms a part, for the purpose of obtaining the iCAD Stockholder Approval. iCAD may only postpone or adjourn the Special Meeting (i) to
solicit additional proxies for the purpose of obtaining the iCAD Stockholder Approval, (ii) for the absence of a quorum and (iii) to allow
reasonable additional time for the filing or mailing of any supplemental or amended disclosure that iCAD has determined after consultation
with outside legal counsel is reasonably likely to be required under applicable law and for such supplemental or amended disclosure to
be disseminated and reviewed by stockholders of iCAD prior to the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD is required to use reasonable best efforts
to hold the Special Meeting as soon as reasonably practicable after the date of the Merger Agreement; provided that, with respect to postponements
or adjournments in accordance with the clauses (i) and (ii) of the previous paragraph, iCAD cannot postpone or adjourn the Special Meeting
without RadNet&#8217;s prior written consent for more than 10 business days after the date on which the Special Meeting was originally
scheduled or (y) 10 business days before the Outside Date. iCAD is required, if requested by RadNet (to the extent permitted by applicable
law), to adjourn or postpone the Special Meeting for the absence of quorum or to allow additional solicitation of votes in order to obtain
the iCAD Stockholder Approval; provided that iCAD will not be required pursuant to this sentence to adjourn the Special Meeting more than
two times or for more than 10 business days in the aggregate from the originally scheduled date of the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Subject to the terms and conditions of the Merger
Agreement, including those described in the section titled &#8220;<i>&#8212;Obligation to Recommend Approval of the Merger Agreement Proposal&#8221;,
</i>iCAD is required to use reasonable best efforts to (i) solicit from its stockholders proxies in favor of the iCAD Stockholder Approval
and (ii) take all other action necessary or advisable to secure the iCAD Stockholder Approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_036"></span>No Solicitation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Subject to certain exceptions, iCAD has agreed
that it will not, and it will cause its affiliates and its and their respective Representatives not to, directly or indirectly:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>(A) solicit, initiate or knowingly encourage (including by way of furnishing non-public information), or take any other action to
knowingly facilitate, any inquiries relating to, the submission of, or the making of, any proposal the consummation of which would constitute
an Alternative Transaction or (B) fail to terminate any direct or indirect solicitation, encouragement, discussions or negotiations with
any persons (other than RadNet or Merger Sub and their Representatives) that may be ongoing with respect to a proposal for an Alternative
Transaction, including terminating all access granted to any such person or its representatives to any physical or electronic dataroom;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>engage in, participate in, or otherwise continue any discussions or negotiations, or cooperate in any way with any person (or group
of persons), with respect to any inquiries relating to, or the making of, any proposal the consummation of which would constitute an Alternative
Transaction;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>amend or grant any waiver or release under, or fail to enforce, any standstill or similar agreement with respect to any class of equity
securities of iCAD or its subsidiaries (provided that iCAD is permitted on a confidential non-public basis to release or waive any explicit
or implicit standstill or similar agreement solely to the extent necessary to permit the relevant party thereto to submit a proposal for
an Alternative Transaction to the iCAD Board on a confidential non-public basis and solely to the extent the iCAD Board determines in
good faith that the failure to do so would be a breach of iCAD&#8217;s Board&#8217;s fiduciary duties under applicable law, so long as
iCAD promptly (and in any event within 24 hours) notifies RadNet in writing of any such waiver or release); or</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>approve, authorize, agree or publicly announce an intention to do any of the foregoing.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 99 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Notwithstanding these restrictions, the Merger
Agreement provides that, if, at any time prior to obtaining the iCAD Stockholder Approval iCAD receives a bona fide written proposal that
did not result from a breach of the restrictions set forth in the previous paragraph, the consummation of which would constitute an Alternative
Transaction, and the iCAD Board determines in good faith (after consultation with its outside counsel and financial advisor) that such
a proposal constitutes a Superior Offer, subject to compliance with the requirements of the following paragraph, iCAD and its Representatives
may (i) furnish information with respect to iCAD and its subsidiaries to the person (or group of persons) making such proposal (and its
Representatives) (provided that all such information has previously been provided to RadNet or is provided to RadNet prior to or concurrently
with the time it is provided to such person) pursuant to a customary confidentiality agreement containing substantive terms that are not
less favorable to iCAD than those contained in that certain confidentiality agreement between iCAD and RadNet executed in connection with
the transactions contemplated by the Merger Agreement (provided, however, that such confidentiality agreement (x) need not contain any
&#8220;standstill&#8221; or similar provision and (y) may not (A) include any provision calling for an exclusive right to negotiate with
iCAD or (B) provide for the reimbursement by iCAD or any of its subsidiaries of any of the counterparty&#8217;s costs or expenses) and
which does not prohibit iCAD from complying with its obligations under the Merger Agreement and (ii) participate in discussions or negotiations
regarding such proposal with the person (or group of persons) making such proposal and its Representatives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger Agreement also requires iCAD to promptly,
and in any event within 24 hours of receipt by a member of the iCAD Board or an executive officer of iCAD (or if received by another Representative
of iCAD, the time such person became aware thereof), advise RadNet orally and in writing of any request for information, proposal or inquiry
relating to an Alternative Transaction, the material terms and conditions of such request, proposal or inquiry (including any changes
thereto) and the identity of the person making such request, proposal or inquiry. In connection therewith, iCAD is also required to (i)
keep RadNet reasonably informed of the status and details (including amendments or proposed amendments) of any such request, proposal
or inquiry on a reasonably current basis and (ii) provide to RadNet as soon as reasonably practicable after receipt or delivery (but in
no event later than 24 hours after receipt or delivery) thereof copies of all correspondence and other written materials exchanged between
iCAD or its subsidiaries or any of their Representatives, on the one hand, and any person making such request or proposal or any of its
Representatives, on the other hand, in each case relating to any such request, proposal or inquiry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For purposes of the Merger Agreement, an &#8220;Alternative
Transaction&#8221; means any of (1) a merger, consolidation, share exchange, tender offer, share issuance or similar transaction pursuant
to which any person (or group of persons) other than RadNet and its subsidiaries (such person (or group of persons), an &#8220;iCAD Third
Party&#8221;), or the direct or indirect stockholders of such iCAD Third Party or the resulting company, acquires or would acquire, directly
or indirectly, beneficial ownership of, or would otherwise own or control, directly or indirectly, more than 20% of the outstanding shares
of iCAD Common Stock or other equity securities of iCAD representing 20% or more of the equity or voting power of iCAD (or the resulting
company), (2) any transaction or series of transactions pursuant to which any iCAD Third Party acquires or would acquire, directly or
indirectly, control of assets (including for this purpose the outstanding equity securities of subsidiaries of iCAD and any entity surviving
any merger or combination including any of them) or businesses of iCAD or any of its subsidiaries representing 20% or more of the revenues,
net income, earnings, or assets (in each case on a consolidated basis) of iCAD and its subsidiaries taken as a whole, or (3) any disposition
of assets to a iCAD Third Party representing 20% or more of the revenues, net income, earnings, or assets (in each case on a consolidated
basis) of iCAD and its subsidiaries, taken as a whole.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For purposes of the Merger Agreement, a &#8220;Superior
Offer&#8221; means any bona fide written proposal (on its most recently amended or modified terms, if amended or modified) made by an
iCAD Third Party to enter into an Alternative Transaction (with all references to 20% in the definition of Alternative Transaction being
treated as references to 50% for these purposes) that (A) did not result from a breach of the first paragraph of this subsection, (B)
is on terms that the iCAD Board determines in good faith (after consultation with its outside financial advisor and outside legal counsel)
to be superior from a financial point of view to iCAD&#8217;s stockholders than the transactions contemplated by the Merger Agreement,
taking into account all financial, regulatory, legal and other aspects of such proposal (including any changes to the Merger Agreement
that may be proposed by RadNet in response to such proposal to enter into an Alternative Transaction and the identity of the person making
such proposal to enter into an Alternative Transaction) and (C) is reasonably likely to be completed in accordance with its terms, taking
into account all financial, regulatory, legal and other aspects of such proposal, and is not subject to a diligence or financing condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 100 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_037"></span>Obligation to Recommend Approval of the Merger Agreement Proposal</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD has agreed under the Merger Agreement to
recommend to iCAD stockholders the approval of the Merger Agreement Proposal and to include such recommendation in this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger Agreement provides that, subject to
the exceptions described below, neither the iCAD Board nor any committee thereof, will (i) withdraw, qualify or modify, or propose publicly
to withdraw, qualify or modify, or fail to make, in each case in a manner adverse to RadNet, its approval or recommendation of the Merger
or the Merger Agreement, (ii) approve or recommend, or propose publicly to approve or recommend, any Alternative Transaction, (iii) fail
to include in this proxy statement/prospectus its recommendation in favor of the Merger Agreement Proposal, (iv) fail to publicly, within
five business days after the commencement of a tender or exchange offer relating to shares of its iCAD Common Stock (or, if earlier, at
least two business days prior to the Special Meeting), recommend the rejection of such tender or exchange offer by the holders of such
shares of iCAD Common Stock and reaffirm its recommendation of the Merger Agreement Proposal or (v) fail to publicly reaffirm its recommendation
of the Merger Agreement Proposal within five business days of RadNet&#8217;s written request to do so (or, if earlier, at least two business
days prior to the Special Meeting), following the public announcement of any Alternative Transaction (or any material amendment, including
any change to the price or form of consideration); provided that RadNet will not be entitled to make such written request, and iCAD Board
will not be required to make such reaffirmation, more than once with respect to any particular Alternative Transaction and each material
modification thereof) (any action or failure to act in clauses (i), (iii), (iv) and (v) is referred to as an &#8220;iCAD Recommendation
Change&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Notwithstanding the foregoing restrictions, in
the event that, prior to obtaining the iCAD Stockholder Approval, the iCAD Board determines in good faith, after consultation with its
financial advisor and outside legal counsel, that it has received a Superior Offer, the iCAD Board may effect an iCAD Recommendation Change
if (A) the iCAD Board determines in good faith, after consultation with its financial advisor and outside legal counsel, that the failure
to take such action would be inconsistent with its fiduciary duties under applicable law, (B) iCAD has notified RadNet in writing that
it intends to effect an iCAD Recommendation Change, (C) iCAD has provided RadNet with a copy of the proposed definitive agreements and
other proposed transaction documentation between iCAD and the person making such Superior Offer, and the identity of the person making
such Superior Offer, (D) for a period of five business days following the notice delivered pursuant to clause (B) above, iCAD has discussed
and negotiated in good faith and made its Representatives available to discuss and negotiate in good faith (in each case to the extent
RadNet desires to negotiate) with RadNet&#8217;s Representatives any proposed modifications to the terms and conditions of the Merger
Agreement or the transactions contemplated by the Merger Agreement so that the proposal no longer constitutes a Superior Offer (provided
that any amendment to any material term or condition of any Superior Offer will require a new notice and a new negotiation period that
will expire on the later to occur of (I) three business days following delivery of such new notice from iCAD to RadNet and (II) the expiration
of the original five business day period described above in this clause (D)) and (E) no earlier than the end of such negotiation period,
the iCAD Board has determined in good faith, after consultation with its financial advisor and outside legal counsel, and after considering
the terms of any proposed amendments or modifications to the Merger Agreement, that (x) the Alternative Transaction that is the subject
of the notice described in clause (B) above still constitutes a Superior Offer and (y) the failure to take such action would still be
inconsistent with its fiduciary duties under applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Neither the iCAD Board nor any committee thereof
will cause or permit iCAD or its controlled affiliates to enter into any letter of intent, memorandum of understanding, agreement in principle,
acquisition agreement or other similar agreement related to any Alternative Transaction, or requiring, or reasonably likely to cause,
iCAD to terminate, delay or fail to complete, or that would otherwise impede, interfere with or be inconsistent with, the completion of
the Merger (other than a confidentiality agreement or a Specified Agreement otherwise permitted by the Merger Agreement).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In addition, prior to obtaining the iCAD Stockholder
Approval, the iCAD Board may make an iCAD Recommendation Change with respect to an Intervening Event if and only if: (i) the iCAD Board
determines in good faith, after consultation with iCAD&#8217;s financial advisor and outside legal counsel, that the failure to make the
iCAD Recommendation Change would be inconsistent with the fiduciary duties of the iCAD Board under applicable law, (ii) iCAD has notified
RadNet in writing that it intends to effect an iCAD Recommendation Change pursuant to this paragraph, describing the Intervening Event
in reasonable detail, (iii) for a period of five business days following the notice delivered pursuant to the requirements of the Merger
agreement, iCAD has discussed and negotiated in good faith and made its Representatives available to discuss and negotiate in good faith
(in each case to the extent the RadNet desires to negotiate) with RadNet&#8217;s Representatives, with respect to any proposed revisions
to the Merger Agreement or other proposals made by RadNet, if any, that would obviate the requirement to make an iCAD Recommendation Change,
and (iv) after considering the results of negotiations with RadNet and taking into account the proposals made by RadNet, if any, after
consultation with its financial advisor and outside legal counsel, the iCAD Board has determined in good faith that the failure to make
the iCAD Recommendation Change would be inconsistent with its fiduciary duties under applicable law. The provisions of this paragraph
will also apply to any material change to the facts and circumstances relating to such Intervening Event (except that any reference to
five business days will instead be three business days).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 101 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For purposes of the Merger Agreement, an &#8220;Intervening
Event&#8221; means any material event, effect, condition, change, occurrence, development, circumstance or state of facts occurring or
arising after the date hereof that materially affects iCAD, and that was neither known to, nor reasonably foreseeable by, any member of
the iCAD Board as of or prior to the date hereof, and that becomes known to the iCAD Board after the date hereof and prior to the date
of the Special Meeting (as it may be adjourned or postponed in accordance with the Merger Agreement); provided that in no event will any
of the following constitute an Intervening Event: (i) the receipt, existence of or terms of an Alternative Transaction or any inquiry
or communications relating thereto or any consequences thereof; (ii) any event, effect, condition, change, occurrence, development, circumstance
or state of facts with respect to RadNet or any of its affiliates; (iii) any changes, in and of itself, in the market price or trading
volume of the shares of iCAD Common Stock or the fact, in and of itself, that iCAD meets or exceeds any internal or published industry
analyst projections or forecasts or estimates of revenues or earnings for any period ending on or after the date hereof (it being understood
and agreed that the facts and circumstances giving rise to any such change may be taken into account in determining whether there has
been an Intervening Event); or (iv) changes in general economic or geopolitical conditions, or changes in conditions in the global, international
or U.S. economy generally.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Notwithstanding the foregoing, the Merger Agreement
provides that iCAD&#8217;s obligation to hold the Special Meeting will not be affected by the commencement, public proposal, public disclosure
or communication to iCAD or any other person of any Alternative Transaction or the making of an iCAD Board recommendation change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">None of the foregoing will prohibit iCAD from
(i) taking and disclosing to its stockholders a position contemplated by Rule 14d-9 or Rule 14e-2(a) promulgated under the Exchange Act,
(ii) making any disclosure to its stockholders that is required by applicable law or (iii) issuing a &#8220;stop, look and listen&#8221;
statement or similar communication of the type contemplated by Rule 14d-9(f) under the Exchange Act pending disclosure of its position
thereunder; provided that any such disclosure or statement that constitutes or contains an iCAD Recommendation Change will be subject
to the restrictions in the second and third paragraphs of this section above; provided, further, that a &#8220;stop, look and listen&#8221;
communication by iCAD pursuant to Rule 14d-9(f) of the Exchange Act will not be deemed to be an iCAD Recommendation Change so long as
any such communication states that the recommendation of the iCAD Board in favor of the Merger Agreement Proposal continues to be in effect
(unless, prior to the time of such public disclosure, an iCAD Recommendation Change has been made in compliance with the terms of the
Merger Agreement).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_038"></span>Reasonable Best Efforts</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Subject to the terms and conditions of the Merger
Agreement, RadNet and iCAD have agreed to cooperate with each other and use (and to cause their respective subsidiaries to use) their
respective reasonable best efforts to consummate the transactions contemplated by the Merger Agreement and cause the conditions to the
Merger to be satisfied as promptly as reasonably practicable, including by using their respective reasonable best efforts to, as promptly
as reasonably practicable:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>obtain all actions, consents, approvals, registrations, waivers, permits, authorizations, orders, expirations or terminations of waiting
periods and other confirmations from any governmental entity that are necessary in order to consummate and make effective the Merger;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>prepare and make all registrations, filings, forms, notices, petitions, statements, submissions of information, applications and other
documents (including filings with governmental entities) that are necessary in order to consummate and make effective the Merger;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>defend any lawsuits or other actions, whether judicial or administrative, challenging the Merger Agreement or that would otherwise
prevent or delay the consummation of the transactions contemplated by the Merger Agreement, including the Merger, including seeking to
have any stay, temporary restraining order or injunction entered by any court of other governmental entity vacated or reversed; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>execute and deliver any additional instruments that are reasonably necessary, proper or advisable to carry out fully the purposes
of the Merger Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 102 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Each of RadNet and iCAD has agreed to, in consultation
and cooperation with the other party to make any filings required in connection with the HSR Act as promptly as reasonably practicable
after such determination that any such filings are required. Neither RadNet nor iCAD will withdraw any such filings or applications without
the prior written consent of the other party. Furthermore, neither RadNet nor iCAD, nor any of their respective subsidiaries, will be
required to (and iCAD will not, without RadNet&#8217;s prior written consent (which will not be unreasonably withheld, conditioned or
delayed)), pay any material consent or other similar fee, payment or consideration, make any other material concession or provide any
additional material security (including a guaranty) to any non-governmental entity third party in connection with seeking or obtaining
its consent to the transactions contemplated by the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Additionally, each of RadNet and iCAD has agreed
to jointly develop, and consult and cooperate in all respects with the other, and consider in good faith the views of the other, in connection
with the form and content of any analyses, appearances, presentations, memoranda, briefs, filings, arguments, opinions and proposals made
or submitted by or on behalf of any party in connection with any action, or seeking of any consent, approval, order or authorization,
under or relating to any antitrust law; provided, however, that if there is any disagreement regarding the foregoing, RadNet will ultimately
control strategy or decisions in connection with any action, or seeking of any consent, approval, order or authorization, under or relating
to any antitrust law. Each of RadNet and iCAD have agreed to (1) furnish to the other such necessary information and reasonable assistance
as the other may request in connection with the preparation of any governmental filings, submissions or other documents, (2) promptly
inform the other of any such filing, submission or other document and of any communication with or from any governmental entity regarding
the transactions contemplated by the Merger Agreement, and permit the other to review and discuss in advance, and consider in good faith
the views of the other in connection with, any such filing, submission, document or communication and (3) cooperate in making an appropriate
response as promptly as reasonably practicable to any investigation or other inquiry from a governmental entity or any action initiated
by a governmental entity or private party, including promptly notifying the other party of any such investigation, inquiry or action,
and consulting in advance before making any presentations or submissions to a governmental entity, or, in connection with any action initiated
by a private party, to any other person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Each of RadNet and iCAD has also agreed to (1)
promptly make an appropriate response to any request for information, documentation, other material, or testimony by any governmental
entity, including by using reasonable best efforts to promptly make an appropriate response to any request for additional information,
documents or other materials received by any party or any of their respective subsidiaries from any governmental entity in connection
with such filings, submissions or in connection with actions under or relating to any antitrust law, (2) and in connection with the transactions
contemplated by the Merger Agreement, promptly inform and consult with the other in advance of any meeting, conference or material communication
with any governmental entity, or, in connection with any action by a private party, with any other person, and to the extent not prohibited
by applicable law or by the applicable governmental entity, reasonably consult with the other party in advance of any such meeting, conference
or material communication, and give the other party a reasonable opportunity to attend and participate therein, and if the other party
does not participate, keep such party apprised with respect thereto and (3) subject to certain limitations (including with respect to
sensitive information of a party), furnish to the other copies of all filings (excluding any notification and report form under the HSR
Act and any attachments thereto, if required), submissions, correspondence and communications between it and its affiliates and their
respective Representatives, on the one hand, and any governmental entity (or any other person in connection with any action initiated
by a private party), on the other hand, with respect to the transactions contemplated by the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Notwithstanding the foregoing, neither RadNet
nor any of its subsidiaries or affiliates will be required, either pursuant to requirements of this subsection or otherwise, to (and,
without RadNet&#8217;s prior written consent, iCAD will not, nor will it permit any of its Representatives to) (i) negotiate, commit to
or effect, by consent decree, hold separate order or otherwise, the sale, lease, license, divestiture or disposition of any assets, rights,
product lines or businesses of RadNet, iCAD or any of their respective subsidiaries or affiliates, (ii) terminate any existing relationships,
contractual rights or obligations of RadNet, iCAD or any of their respective subsidiaries or affiliates, (iii) terminate any joint venture
or other arrangement of RadNet, iCAD or any of their respective subsidiaries or affiliates, (iv) create any relationship, contractual
rights or obligations of RadNet, iCAD or any of their respective subsidiaries or affiliates, (v) effectuate any other change or restructuring
of RadNet, iCAD or any of their respective subsidiaries or affiliates and (vi) otherwise take or commit to take any actions, including
agreeing to prior approval restrictions, with respect to the businesses, product lines or assets of RadNet, iCAD or any of their respective
subsidiaries or affiliates; provided that iCAD will only be required to take or commit to take any such action, or agree to any such condition
or restriction, if such action, commitment, agreement, condition or restriction is binding on iCAD only in the event the Closing occurs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD will use commercially reasonable efforts
to obtain all third-party consents or approvals, and provide all notices to third-parties, in each case to the extent reasonably requested
by RadNet in writing and required in connection with the Merger under any contract of the iCAD or any of its subsidiaries or affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 103 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_039"></span>Indemnification and Insurance</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet has agreed that all rights to indemnification
and exculpation from liabilities, including advancement of expenses, for acts or omissions or other matter occurring at or prior to the
Effective Time in favor of the current or former directors, officers, members, managers, employees or agents of iCAD or any of its subsidiaries
(the &#8220;Existing Indemnified Parties&#8221;) as provided in iCAD&#8217;s and its subsidiaries&#8217; organizational documents, and
indemnification contract between such directors or officers and iCAD (in each case, as in effect on, and, in the case of any indemnification
contracts, to the extent made available to RadNet prior to, the date of the Merger Agreement) will survive the Merger and will continue
in full force and effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For a period of six years following the Effective
Time, the Surviving Corporation will, and RadNet will cause the Surviving Corporation to, maintain in effect the exculpation, indemnification
and advancement of expenses provisions equivalent to the organizational documents of iCAD and any of its subsidiaries as in effect immediately
prior to the Effective Time with respect to acts or omissions or other matters occurring prior to the Effective Time and will not amend,
repeal or otherwise modify any such provisions in any manner that would adversely affect the rights thereunder of any Existing Indemnified
Parties; provided that all rights to indemnification in respect of any claim made for indemnification within such period will continue
until the disposition of such action or resolution of such claim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">From and after the Effective Time, RadNet will
and will cause the Surviving Corporation to, indemnify, defend and hold harmless, to the fullest extent permitted under applicable law,
the current or former directors or officers of iCAD or any subsidiary of iCAD (the &#8220;D&amp;O Indemnified Parties) against any costs
or expenses (including reasonable attorneys&#8217; fees and expenses), amounts paid in settlement, judgments, fines, losses, claims, damages
or liabilities incurred in connection with, arising out of or otherwise related to any actual or alleged action in connection with, arising
out of or otherwise related to matters existing or occurring or alleged to have occurred prior to or at the Effective Time, whether asserted
or claimed prior to, at or after the Effective Time, including actions to enforce this provision or any other indemnification or advancement
right of any D&amp;O Indemnified Party, and RadNet will, and will cause, the Surviving Corporation to also promptly advance reasonable
costs and expenses (including attorney&#8217;s fees) as incurred to the fullest extent permitted under applicable law (subject to the
execution of an undertaking by or on behalf of the D&amp;O Indemnified Party to repay such amount if it will ultimately be determined,
by final judicial decision from a court of competent jurisdiction which there is no further right to appeal, that the D&amp;O Indemnified
Party is not entitled to be indemnified under the Merger Agreement). In the event of any such actual or alleged action, RadNet and the
Surviving Corporation will cooperate with the D&amp;O Indemnified Party in the defense of any such actual or alleged action. None of RadNet,
the Surviving Corporation nor any of their respective affiliates will settle or otherwise compromise or consent to the entry of any judgment
with respect to, or otherwise seek the termination of, any action for which indemnification may be sought by the D&amp;O Indemnified Party
pursuant to the Merger Agreement unless such settlement, compromise, consent or termination includes an unconditional release of all D&amp;O
Indemnified Parties from all liability arising out of such action.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Surviving Corporation will (and RadNet will
cause the Surviving Corporation to), at its option, (i) during the period commencing at the Effective Time and ending on the sixth anniversary
of the Effective Time, maintain in effect iCAD&#8217;s current directors&#8217; and officers&#8217; liability insurance (&#8220;D&amp;O
Insurance&#8221;) in respect of acts or omissions occurring at or prior to the Effective Time on terms (including with respect to coverage,
conditions, retentions, limits and amounts) that are equivalent to or more favorable than those of the D&amp;O Insurance or (ii) purchase
a six-year prepaid &#8220;tail&#8221; policy with respect to the D&amp;O Insurance from an insurance carrier with a comparable credit
rating as iCAD&#8217; current directors&#8217; and officers&#8217; liability insurance carrier (the &#8220;Tail Policy&#8221;). The Surviving
Corporation will not be obligated to (A) pay an amount per year in excess of 300% of the amount paid by iCAD for coverage for its last
full fiscal year prior to the date of the Merger Agreement for the D&amp;O Insurance (the &#8220;Maximum Premiums&#8221;) or (B) incur
an aggregate cost for the Tail Policy in excess of the Maximum Premiums. If the annual premiums of such insurance coverage for the six-year
period exceed the Maximum Premiums or the aggregate cost for such Tail Policy exceeds the Maximum Premiums, then the Surviving Corporation
will only be obligated to obtain a policy with the greatest coverage available for an annual premium not exceeding the Maximum Premiums
or an aggregate cost for such Tail Policy not exceeding the Maximum Premiums from an insurance carrier with the same or better credit
rating as iCAD&#8217;s current directors&#8217; and officers&#8217; liability insurance carrier. In lieu of the foregoing obligations,
prior to the Effective Time, iCAD may and, at RadNet&#8217;s request, will use reasonable best efforts to, purchase the Tail Policy, provided
that the aggregate cost for such Tail Policy will not exceed the Maximum Premiums. If iCAD purchases the Tail Policy prior to the Effective
Time, the Surviving Corporation will (and RadNet will cause the Surviving Corporation to) maintain such Tail Policy in full force and
effect for a period of no less than six years after the Effective Time and continue to honor its obligations thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 104 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_040"></span>Employee Matters</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">With respect to each employee of iCAD that continues
as an employee of the Surviving Corporation, RadNet or any their respective subsidiaries (a &#8220;Continuing Employee&#8221; and, to
the extent such person resides in the United States, a &#8220;Continuing U.S. Employee&#8221;), solely for purposes of determining eligibility
to participate, vesting (other than vesting of future equity awards), future vacation accruals and severance amounts (but not (i) for
purposes of benefit accrual, other than with respect to vacation benefits, or (ii) to the extent that such credit would result in a duplication
of compensation or benefits) under each applicable RadNet benefit plan, service by such Continuing U.S. Employee with iCAD or any of its
subsidiaries will be treated as service with RadNet to the same extent that such service was taken into account for such purposes under
the analogous iCAD benefit plan immediately prior to the Effective Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger Agreement does not confer upon any
employee, officer, director or consultant of iCAD or any of its subsidiaries any right to continue in the employ or service of the Surviving
Corporation, iCAD, RadNet or any subsidiary or affiliate thereof, or will interfere with or restrict in any way the rights of the Surviving
Corporation, iCAD, RadNet or any subsidiary or affiliate thereof to discharge or terminate the services of any employee, officer, director
or consultant of iCAD or any of its subsidiaries at any time for any reason whatsoever, with or without cause. Nothing in the Merger Agreement
(i) establishes, amends, modifies or terminates any iCAD benefit plan or any other compensation or benefit plan, program, agreement or
arrangement, or (ii) alters or limits the ability of the Surviving Corporation or any of its subsidiaries or affiliates to establish,
amend, modify or terminate any iCAD benefit plan or any other benefit or employment plan, program, agreement or arrangement after the
Effective Time. The Merger Agreement does not confer upon any person other than the parties thereto, including any current or former employee,
officer, director or consultant of iCAD or any of its subsidiaries, any right (including any third-party right), benefit or remedy of
any nature whatsoever under or by reason of the Merger Agreement. If a RadNet benefit plan replaces a iCAD benefit plan that is a group
health plan providing medical benefits during the 12-consecutive-month period commencing on the Closing Date, then RadNet will use commercially
reasonable efforts to cause such RadNet benefit plan to (A) waive any limitations on benefits relating to preexisting conditions to the
same extent such limitations are waived under the iCAD benefit plan that is replaced by such RadNet benefit plan prior to the Effective
Time and (B) recognize, for purposes of annual deductible and out-of-pocket limits under its medical and dental plans, deductible and
out-of-pocket expenses paid by Continuing U.S. Employees in the calendar year in which the Effective Time occurs, in the case of each
of clause (A) and (B), with respect to the Continuing U.S. Employees who are covered by such iCAD benefit plan at the time it is replaced;
provided, however, that clause (B) will not apply with respect to any RadNet benefit plan that is a high-deductible health plan</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Prior to the Closing Date, iCAD will (a) amend
the iCAD 401(k) plan, with such amendment to be effective prior to the Closing Date, to eliminate future purchases of iCAD Common Stock
(or, following the Closing, RadNet Common Stock) by participants under the iCAD 401(k) plan, (b) if requested by RadNet at least five
business days prior the Closing Date, terminate the iCAD 401(k) plan and such other iCAD benefit plans as RadNet may request effective
prior to the Closing Date, (c) provide RadNet with evidence satisfactory to RadNet that the iCAD 401(k) plan has been so amended and,
if requested by RadNet, terminated effective prior to the Closing Date as described above pursuant to resolutions of the iCAD Board or
other applicable governing body and (d) provide RadNet with evidence satisfactory to RadNet that all other iCAD benefit plans that RadNet
has requested be terminated have been terminated effective prior to the Closing Date as described above pursuant to resolutions of the
iCAD Board or other applicable governing body (the form and substance of the resolutions and amendments referred will be subject to the
prior review and approval of RadNet, which approval will not be unreasonably delayed, denied or conditioned).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD and its subsidiaries will be liable for any
accrued but unused personal, sick, vacation time or other paid time off balances to which any Continuing Employee is entitled pursuant
to the policies or individual agreements, or other arrangements applicable to such Continuing Employee immediately prior to the Effective
Time (the &#8220;PTO Policy&#8221;) and, if required pursuant to such PTO Policy, or applicable law, pay out, prior to the Effective Time,
all such amounts accrued and owed to such Continuing Employee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Subject to the terms and conditions under the
severance guidelines referenced in the Merger Agreement and set forth in the confidential disclosure schedules thereto, RadNet will provide,
and will cause the Surviving Corporation and its respective affiliates to provide, cash severance to any applicable Continuing U.S. Employee,
provided that (1) there will not be any duplication of benefits and (2) RadNet may, in its discretion, condition any such severance payments
on the execution and non-revocation of a release of claims. Such severance guidelines provide that RadNet will honor the severance obligations
set forth in such guidelines for any eligible Continuing U.S. Employee that experiences a qualifying termination of employment within
60 days following the Closing, subject to the terms and conditions set forth therein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 105 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_041"></span>Section 16 Matters</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD will take all such steps as are reasonably
necessary to cause the transactions contemplated by the Merger Agreement, including any dispositions of equity securities of iCAD (including
derivative securities) or acquisitions of equity securities of RadNet (including derivative securities) in connection therewith, by any
individual who is a director or officer subject to the reporting requirement of Section 16(a) of the Exchange Act to be exempt under Rule
16b-3 promulgated under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_042"></span>Other Agreements</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger Agreement contains certain other covenants
and agreements, including covenants and agreements relating to, among other things, and subject to certain exceptions and qualifications
described in the Merger Agreement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>cooperation between RadNet and iCAD in the preparation of this proxy statement/prospectus;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>confidentiality and reasonable access by RadNet and their respective representatives to certain information about the other party
during the period prior to the completion of the Merger;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>consultation between RadNet and iCAD in connection with public announcements with respect to the Merger Agreement or the transactions
contemplated thereby;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>requirement for RadNet to use reasonable best efforts to cause the shares of RadNet Common Stock to be issued pursuant to the Merger
Agreement to be approved for listing on The Nasdaq Global Market, subject to official notice of issuance;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>taking actions to complete the Merger and eliminate or minimize the effects of any antitakeover or similar statute or regulation that
is or becomes applicable to the transactions contemplated by the Merger Agreement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>cooperation regarding certain tax matters;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>cooperation, consultation and consent rights between RadNet and iCAD in connection with respect certain litigation relating to the
Merger and the transactions contemplated by the Merger Agreement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD using its reasonable best efforts to facilitate the commencement of the delisting of iCAD and of the shares of iCAD Common Stock
from The Nasdaq Capital Market as promptly as practicable after the Effective Time;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD will, if requested by the SEC, deliver a tax opinion from its counsel to RadNet to the effect that the Merger qualifies as
                                                                                                            a tax-free reorganization within the meaning of Section 368(a) of the Code;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD promptly notifying RadNet of certain events, including with respect to alleged consent rights to the Merger, notices or communications
from any governmental entity in connection with the Merger Agreement, certain litigation related to the transactions contemplated by the
Merger Agreement and certain events, changes or effects related to material breaches of the Merger Agreement or the failure of any of
the closing conditions, subject to certain exceptions;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD being required to cause each director of iCAD or any director of any of iCAD&#8217;s subsidiaries to resign, effective as of
the Effective Time, and cause such persons that do not resign to be removed from such positions so requested pursuant to the applicable
governing documents and applicable law; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 27.35pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD will have complied with its obligations to make certain filings with respect to employee benefit plans as required by the Merger
Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 106 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_043"></span>Termination of the Merger Agreement</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Merger Agreement may be terminated at any
time prior to the Effective Time, and whether before or (except, with respect to iCAD as set forth in the case of the fourth sub-bullet
of the second bullet below) after receipt of the iCAD Stockholder Approval:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by the mutual written consent of iCAD and RadNet;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by either iCAD or RadNet if:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">o&#160;&#160;
</span>the Merger has not been consummated by the Outside Date; provided that if the Closing has not occurred by such date but on that
date any of the conditions that relate to any approvals or injunctions or restraints are not satisfied or waived but all other conditions
have been satisfied or waived (other than those that by their terms are to be fulfilled at the Closing, provided that each such condition
would be capable of being fulfilled if the Closing were to occur on such date), then the Outside Date will automatically be extended to
December 31, 2025, and such date will be the &#8220;Outside Date&#8221; under the Merger Agreement; provided, further, that the right
to terminate the Merger Agreement pursuant to this bullet point will not be available to any party if a material breach by such party
of any of its obligations under the Merger Agreement has been the principal cause of or principally resulted in the failure of the Closing
to have occurred on or before the Outside Date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the iCAD Stockholder Approval has not been obtained at the Special Meeting or at any adjournment or postponement thereof;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>prior to the Effective Time, any governmental entity of competent jurisdiction has issued or entered any order that has the effect
of permanently restraining, enjoining or otherwise prohibiting the Merger, and such order has become final and non-appealable; provided
that the right to terminate the Merger Agreement under this bullet will not be available to a party if a material breach by such party
of any of its obligations under the relevant obligations under the Merger Agreement has been the principal cause of or principally resulted
in the issuance of such order or the denial of such expiration, termination, authorization or consent;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>the other party has breached or failed to perform any of its representations, warranties, covenants or other agreements contained
in the Merger Agreement, which breach or failure to perform (i) would give rise to the failure of the applicable condition of the terminating
party&#8217;s obligations to complete the Merger and (ii) is incapable of being cured by such breaching party or is not cured by the earlier
of the Outside Date and 30 days after receiving written notice thereof; provided that the terminating party is not then in breach of any
representation, warranty, covenant or other agreement contained in the Merger Agreement, which breach would give rise to the failure of
an applicable condition of the other party&#8217;s obligations to complete the Merger.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by iCAD at any time prior to obtaining the iCAD Stockholder Approval, in order to accept a Superior Offer and enter into the Specified
Agreement (as defined below) relating to such Superior Offer, if (i) such Superior Offer has not resulted from any breach of the Merger
Agreement with respect to such Superior Offer, (ii) the iCAD Board, after satisfying all of the requirements set forth in the Merger Agreement,
has authorized iCAD to enter into a binding written definitive acquisition agreement providing for the consummation of a transaction constituting
a Superior Offer (a &#8220;Specified Agreement&#8221;) and (iii) iCAD has paid the Termination Fee (as defined below), and has entered
into the Specified Agreement, substantially concurrently with the termination of the Merger Agreement; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by RadNet, at any time prior to the Special Meeting, if the iCAD Board or any committee thereof has made an iCAD Recommendation change.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 107 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If the Merger Agreement is terminated, the Merger
Agreement will become void, without liability or obligation on the part of any of the parties, except in the case of a willful breach
of the Merger Agreement. The provisions of the Merger Agreement relating to information provided or made pursuant to the Merger Agreement
which is governed by the confidentiality agreement between iCAD and RadNet, fees and expenses, effect of termination and certain general
provisions will continue in effect notwithstanding termination of the Merger Agreement and no such termination will relieve any party
from any liability or obligation under such provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger Agreement provides that iCAD will pay
RadNet a termination fee equal to (i) $1,000,000, plus (ii) the amount of all documented fees and expenses of RadNet and its affiliates
incurred in connection with the negotiation and performance of the Merger Agreement and the transactions contemplated thereby, up to an
amount of $2,000,000 (the &#8220;Termination Fee&#8221;) if the Merger Agreement is terminated:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by RadNet in response to an iCAD Recommendation Change;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by either RadNet or iCAD because the iCAD Stockholder Approval is not obtained at the Special Meeting or any adjournment or postponement
thereof and, immediately prior to the Special Meeting, RadNet would have been entitled to terminate the Merger Agreement in response an
iCAD Recommendation Change;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by iCAD at any time prior to obtaining the iCAD Stockholder Approval, in order to accept a Superior Offer and enter into the Specified
Agreement relating to such Superior Offer, subject to the conditions set forth in the Merger Agreement; or</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>by either RadNet or iCAD as a result of (i) the Outside Date having passed or (ii) the iCAD Stockholder Approval not having been obtained
at the Special Meeting or any adjournment or postponement thereof, and, in each case, (A) at or prior to the Special Meeting in the case
of a termination as a result of clause (ii) of this bullet or, at or prior to the time of such termination, in the case of a termination
as a result of clause (i) of this bullet, there has been publicly made to the stockholders of iCAD generally or has otherwise become publicly
known, or any person has publicly announced an intention (whether or not conditional) to make, an offer or proposal for an Alternative
Transaction, and (B) iCAD enters into a definitive agreement with respect to any Alternative Transaction or consummates an Alternative
Transaction within 12 months of such termination</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For purposes of the foregoing, the term &#8220;Alternative
Transaction&#8221; will have the meaning as described in &#8220;&#8212;No Solicitation&#8221;, except that all references to &#8220;20%&#8221;
will be replaced with &#8220;50%.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Termination Fee will be payable in immediately
available funds no later than the applicable date set forth in the Merger Agreement. If iCAD fails to promptly pay the Termination Fee,
iCAD will pay the costs and expenses (including legal fees and expenses) in connection with any action, including the filing of any lawsuit
or other legal action, taken to collect payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_044"></span>Exclusive Remedy</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In the event that RadNet receives full payment
of the Termination Fee then, receipt of the Termination Fee will be deemed to be liquidated damages for any and all losses or damages
suffered or incurred by RadNet, Merger Sub, any of their respective affiliates or any other person in connection with the Merger Agreement
(and the termination hereof), the transactions contemplated thereby (and the abandonment thereof) or any matter forming the basis for
such termination, and none of RadNet, Merger Sub, any of their respective affiliates or any other person will be entitled to bring or
maintain any claim, action or proceeding against iCAD or any of its affiliates for damages or any equitable relief arising out of or in
connection with the Merger Agreement, any of the transactions contemplated by the Merger Agreement or any matters forming the basis for
such termination; provided that iCAD will not be relieved or released from any liabilities or damages arising out of its willful breach
of the Merger Agreement prior to the termination of the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 108 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_045"></span>Other Expenses</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Generally, all fees and expenses incurred in connection
with the Merger, the Merger Agreement and the transactions contemplated thereby will be paid by the party incurring such fees or expenses,
whether or not the Merger is consummated, except that each of RadNet and iCAD will bear and pay one-half of the costs and expenses (other
than the fees and expenses of each party&#8217;s attorneys and accountants, which will be borne by the party incurring such expenses)
incurred by the parties in connection with (a) the filing, printing and mailing of the registration statement of which this proxy statement/prospectus
forms a part and this proxy statement/prospectus (including SEC filing fees), (b) the filings of the premerger notification and report
forms (including filing fees) and (c) the filings and notices required to obtain the consents of certain governmental entities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_046"></span>Governing Law</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">The parties have agreed that the Merger Agreement
will be governed by and construed in accordance with the laws of the State of Delaware, regardless of the laws that might otherwise govern
under any applicable principles of conflicts of laws thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_047"></span>Specific Enforcement</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The parties have agreed that they will be entitled
to an injunction or injunctions to prevent breaches of the Merger Agreement and to enforce specifically the performance of its terms and
provisions, without proof of actual damages, in addition to any other remedy to which they are entitled at law or in equity. The parties
have further agreed not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to law or inequitable for
any reason, nor to assert that a remedy of monetary damages would provide an adequate remedy for any breach.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="s4_048"></span>Amendments; Waivers</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Subject to compliance with applicable law, the
Merger Agreement may be amended by mutual agreement of the parties in writing at any time before or after receipt of the iCAD Stockholder
Approval; provided that any amendment of the Merger Agreement that requires the approval by the stockholders of iCAD or approval by the
stockholders of RadNet under applicable law, will be subject to such approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Subject to the provision in the previous paragraph
and compliance with applicable law, at any time prior to the Effective Time, a party may, in writing, (1) extend the time for performance
of any obligation or act of the other parties, (2) waive any inaccuracy in any representation or warranty of the other party, (3) waive
compliance by the other party with any of the agreements or conditions for the benefit of such party contained in the Merger Agreement
or (4) waive the satisfaction of any of the conditions contained in the Merger Agreement. No extension or waiver granted by iCAD or RadNet
will require the approval of the stockholders of iCAD or RadNet, respectively, unless such approval is required by applicable law.<br/>
</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 109 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_049"></span>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES
OF THE MERGER</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">The following discussion
is a summary of the material U.S. federal income tax consequences of the Merger to U.S. holders (as defined below) of iCAD Common Stock
who exchange their shares of iCAD Common Stock for shares of RadNet Common Stock in the Merger. This discussion is based on the Code,
the Treasury Regulations issued under the Code, and administrative rulings and court decisions, in each case, in effect as of the date
of this proxy statement/prospectus, all of which may be subject to change at any time, possibly with retroactive effect, or differing
interpretations. Any such change or differing interpretation could affect the accuracy of the statements and conclusions set forth in
this discussion and could adversely affect a U.S. holder. There can be no assurance that the IRS or a court will not take a position contrary
to the discussion below. This discussion assumes that the Merger will be consummated in accordance with the Merger Agreement and as described
in this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">For purposes of this
discussion, the term &#8220;U.S. holder&#8221; means a beneficial owner of iCAD Common Stock that is, for U.S. federal income tax purposes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 2%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">an individual citizen or resident of the United States;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 2%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">a corporation (including any entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 2%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">a trust that (i)&#160;is subject to the primary supervision of a court within the United States and the control of one or more &#8221;United States persons&#8221; (within the meaning of Section 7701(a)(30) of the Code) or (ii)&#160;has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a United States person for U.S. federal income tax purposes; or</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 2%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">an estate that is subject to U.S. federal income tax on its income regardless of its source.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">A &#8220;non-U.S. holder&#8221;
means a beneficial owner of iCAD Common Stock (other than a partnership) that is not a U.S. holder. If a partnership (including any entity
or arrangement, domestic or foreign, treated as a partnership for U.S. federal income tax purposes) holds iCAD Common Stock, the tax treatment
of a partner in such partnership generally will depend on the status of the partners and the activities of the partnership. Any partnership
(including any entity or arrangement, domestic or foreign, treated as a partnership for U.S. federal income tax purposes) that holds iCAD
Common Stock and any partners in such partnership should consult their tax advisors regarding the tax consequences of the Merger to them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">This discussion applies
only to U.S. holders that hold their shares of iCAD Common Stock as &#8220;capital assets&#8221; within the meaning of Section 1221 of
the Code (generally, for investment). This discussion is not a complete description of all the tax consequences of the Merger and, in
particular, may not address U.S. federal income tax considerations that may be relevant to particular iCAD stockholders in light of their
individual circumstances, or to iCAD stockholders who are subject to special treatment under U.S. federal income tax law, including, without
limitation:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>non-U.S. holders;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>banks or other financial institutions&#894;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>partnerships, S corporations and other pass-through entities (and investors in partnerships, S corporations and other pass-through
entities)&#894;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>insurance companies&#894;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>tax-exempt organizations or governmental organizations&#894;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 110 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>dealers or brokers in securities or currencies&#894;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>traders in securities that elect to use a mark-to-market method of accounting&#894;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>regulated investment companies&#894;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>real estate investment trusts&#894;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>tax-qualified retirement plans&#894;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>persons that hold iCAD Common Stock as part of a straddle, hedge, constructive sale or conversion transaction&#894;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>individuals who are U.S. expatriates or former citizens or long-term residents of the United States&#894;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>holders who acquired iCAD Common Stock through the exercise of an employee stock option or right or otherwise as compensation&#894;
and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>persons that have a &#8220;functional currency&#8221; other than the U.S. dollar.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">This discussion does
not address the tax consequences of any transaction other than the Merger, whether or not such transaction is in connection with the Merger.
In addition, no information is provided with respect to the tax consequences of the Merger under applicable state, local or non-U.S. laws
or under estate, gift, excise or other non-income tax laws, the Medicare contribution tax on net investment income, or the alternative
minimum tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Tax Consequences of the Merger</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>General</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">The Merger is intended
to qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code, and iCAD and RadNet intend to report
the Merger consistent with such qualification. iCAD has received a tax opinion from Dentons to the effect that the Merger will qualify
as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code. The tax opinion from Dentons is based on customary
assumptions and representations, covenants and undertakings of iCAD, RadNet and Merger Sub. If any of the assumptions, representations,
covenants or undertakings is incorrect, incomplete, inaccurate, or otherwise is violated, the validity of the tax opinion from Dentons
may be affected and the U.S. federal income tax consequences of the Merger could differ materially from those described in this proxy
statement/prospectus. The receipt of a tax opinion from counsel is not a condition to either party&#8217;s obligation to complete the
Merger. iCAD and RadNet have not sought, and do not intend to seek, any ruling from the IRS regarding the qualification of the Merger
as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code. As a result, there can be no assurance that the IRS
will agree with the tax opinion from Dentons or would not assert, or that a court would not sustain, a position contrary to the treatment
of the Merger as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code. If the IRS were to successfully challenge
the &#8220;reorganization&#8221; status of the Merger, the U.S. federal income tax consequences would be as discussed below under the
section titled &#8220;<i>&#8212;Tax Consequences if the Merger Were to Fail to Qualify as a 'Reorganization&#8217;.</i>&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>You are urged to consult with your tax
advisors regarding the U.S. federal income tax treatment of the Merger, including with respect to its qualification as a &#8220;reorganization&#8221;
within the meaning of Section 368(a) of the Code in light of the uncertainties discussed above.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<!-- Field: Page; Sequence: 111 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Tax Consequences Assuming the Merger
Qualifies as a &#8220;Reorganization&#8221; </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">Subject to the limitations
and qualifications set forth under the section titled &#8220;<i>&#8212;General</i>&#8221; and elsewhere herein, in the opinion of Dentons,
(1) the Merger will qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code, and (2) the U.S. federal
income tax consequences of the Merger to a U.S. holder that exchanges shares of iCAD Common Stock for shares of RadNet Common Stock in
the Merger will be as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 2%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">A U.S. holder generally will not recognize any gain or loss upon the exchange of such U.S. holder&#8217;s shares of iCAD Common Stock for shares of RadNet Common Stock in the Merger, except with respect to cash received in lieu of a fractional share of RadNet Common Stock (as described below).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 2%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">The aggregate tax basis in the shares of RadNet Common Stock received by a U.S. holder in the Merger (including the basis in any fractional share deemed received and exchanged for cash) will be equal to the U.S. holder&#8217;s aggregate tax basis in the shares of iCAD Common Stock surrendered in the Merger.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 2%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">The holding period of the shares of RadNet Common Stock (including any fractional share deemed received and exchanged for cash) received by a U.S. holder in the Merger will include the U.S. holder&#8217;s holding period of the shares of iCAD Common Stock surrendered in the Merger.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 2%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">A U.S. holder that receives cash in the Merger in lieu of a fractional share of RadNet Common Stock generally will be treated as having received such fractional share in the Merger and then having sold such fractional share for cash, generally resulting in a recognition of gain or loss by such U.S. holder in an amount equal to the difference, if any, between the amount of cash received by such U.S. holder and such U.S. holder&#8217;s tax basis allocable to such fractional share. Such gain or loss generally will be capital gain or loss and will be long-term capital gain or loss if the U.S. Holder&#8217;s holding period of such fractional share (including the holding period of the shares of iCAD Common Stock deemed surrendered therefor) is more than one year at the Effective Time of the Merger. Long-term capital gains of certain non-corporate taxpayers, including individuals, generally are taxed at reduced U.S. federal income tax rates. The deductibility of capital losses is subject to limitations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">If a U.S. holder acquired
different blocks of shares of iCAD Common Stock at different times and at different prices, such U.S. holder&#8217;s tax basis and holding
period in the shares of RadNet Common Stock received in the Merger may be determined with reference to each block of the shares of iCAD
Common Stock deemed surrendered therefor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">A U.S. holder receiving
shares of RadNet Common Stock in the Merger who, immediately before the Merger, owned (i) at least five percent (by vote or value) of
the total outstanding shares of iCAD Common Stock or (ii) shares of iCAD Common Stock with a tax basis of $1 million or more is required
to attach a statement to such U.S. holder&#8217;s U.S. federal income tax return for the year in which the Merger is completed, which
statement must contain the information listed in Treasury Regulations Section&#160;1.368-3(b). Such statement must include such U.S. holder&#8217;s
tax basis in, and the fair market value of, the shares of iCAD Common Stock surrendered by such U.S. holder in the Merger. Such U.S. holder
must also retain permanent records of these facts relating to the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Tax Consequences if the Merger Were to
Fail to Qualify as a &#8220;Reorganization&#8221; </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">Notwithstanding the
discussion above, if the Merger were to fail to qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of
the Code, a U.S. holder that exchanges shares of iCAD Common Stock for shares of RadNet Common Stock in the Merger generally would be
treated as exchanging such shares of iCAD Common Stock in a fully taxable transaction. For U.S. federal income tax purposes, a U.S. holder
generally would recognize gain or loss in such taxable transaction in an amount equal to the difference, if any, between (i) the sum
of the fair market value, as of the Effective Time of the Merger, of the shares of RadNet Common Stock received by such U.S. holder in
the Merger and the amount of any cash received by such U.S. holder in the Merger in lieu of a fractional share of RadNet Common Stock
and (ii) such U.S. holder&#8217;s tax basis in the shares of iCAD Common Stock surrendered in the Merger. Such gain or loss generally
would be capital gain or loss and would be long-term capital gain or loss if the U.S. Holder&#8217;s holding period of the shares of
iCAD Common Stock surrendered in the Merger is more than one year at the Effective Time of the Merger. Long-term capital gains of certain
non-corporate taxpayers, including individuals, generally are taxed at reduced U.S. federal income tax rates. The deductibility of capital
losses is subject to limitations. In such taxable transaction, the aggregate tax basis of a U.S. holder in the shares of RadNet Common
Stock received in the Merger would equal the fair market value thereof, as of the Effective Time of the Merger, and such U.S. holder&#8217;s
holding period of the shares of RadNet Common Stock received in the Merger would begin on the day after the Effective Time of the Merger.
If a U.S. holder acquired different blocks of shares of iCAD Common Stock at different times and at different prices, then the amount
of gain or loss, and whether any such gain or loss would be long-term capital gain or loss, must be calculated or determined separately
for each such block of shares of iCAD Common Stock exchanged by such U.S. holder in the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"></p>

<!-- Field: Page; Sequence: 112 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Backup Withholding</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;<br/></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">Backup withholding (currently,
at a rate of 24%) will apply with respect to the cash received by a U.S. holder in the Merger in lieu of a fractional share of RadNet
Common Stock unless such U.S. holder delivers a properly completed IRS Form W-9, providing such U.S. holder&#8217;s correct taxpayer identification
number and certain other information, or otherwise establishes a basis for exemption from backup withholding. Backup withholding is not
an additional tax. Any amounts withheld from payments to a U.S. holder in the Merger under the backup withholding rules may be credited
against such U.S. holder&#8217;s U.S. federal income tax liability, and may entitle such U.S. holder to a refund, provided that the U.S.
holder timely furnishes certain required information to the IRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"><b>The foregoing discussion
of the material U.S. federal income tax consequences of the Merger is for general information only and is not tax advice. The foregoing
discussion is not intended to constitute a complete description of all tax consequences relating to the Merger. The tax consequences of
the Merger to an iCAD stockholder will depend upon the facts of the stockholder&#8217;s particular situation. Because individual circumstances
may differ, iCAD stockholders are urged to consult with their own tax advisor regarding the applicability of the rules discussed above
and the particular tax effects of the Merger, including the application of state, local and non-U.S. tax laws.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 113 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_050"></span>CERTAIN BENEFICIAL OWNERS OF iCAD COMMON STOCK</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth certain information
regarding the beneficial ownership of our common stock as of April 18, 2025, by (i) each person who is known to iCAD to own beneficially
more than 5% of the outstanding shares of iCAD, (ii) each of iCAD&#8217;s named executive officers, (iii) each of iCAD&#8217;s directors
and (iv) all current executive officers and directors of iCAD as a group. Unless otherwise indicated below, the address of each beneficial
owner is c/o iCAD, Inc., 2 Townsend West, Suite 6, Nashua, New Hampshire 03063.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name of Beneficial Owner</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Beneficially<br/> Owned<br/> (1)(2)(3)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Percentage<br/> of Class</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left">Dana Brown</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">369,351</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">1.35%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Michael Doyle</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64,908</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Dr. Hedvig Hricak</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">59,556</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Eric Lonnqvist</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">109,884</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Dr. Rakesh Patel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">313,127</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.14%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Andy Sassine</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,534,699</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.59%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Susan Wood</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">229,915</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Jonathan Go</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">317,812</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1.16%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">All current executive officers and directors as a group (8 persons)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,999,252</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9.84%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">*&#8195;&#8201;&#8201;Less than 1% ownership</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-size: 10pt">(1)</span></td>
    <td style="width: 97%"><span style="font-size: 10pt">Based on 27,445,869 shares of iCAD Common Stock issued and outstanding as of April 18, 2025. A person is deemed to be the beneficial owner of securities that can be acquired by such person within 60 days from April 18, 2025, upon (i) the exercise of options; (ii) vesting of restricted stock; (iii) warrants or rights; (iv) through the conversion of a security; (v) pursuant to the power to revoke a trust, discretionary account or similar arrangement; or (vi) pursuant to the automatic termination of a trust, discretionary account or similar arrangement. Each beneficial owner&#8217;s percentage ownership is determined by assuming that the options or other rights to acquire beneficial ownership as described above, that are held by such person (but not those held by any other person) and which are exercisable within 60 days from April 18, 2025, have been exercised.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 2%"><span style="font-size: 10pt">(2)</span></td>
    <td style="width: 98%"><span style="font-size: 10pt">Unless otherwise noted, we believe that the persons referred to in the table have sole voting and investment power with respect to all shares reflected as beneficially owned by them.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 2%"><span style="font-size: 10pt">(3)</span></td>
    <td style="width: 98%"><span style="font-size: 10pt">Includes exercisable and vested options to purchase shares of common stock (within 60 days of April 18, 2025) as follows:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name of Beneficial Owner</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercisable<br/> Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: left">Dana Brown</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">315,001</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Michael Doyle</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64,856</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Hedvig Hricak</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">59,556</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Eric Lonnqvist</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,001</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Dr. Rakesh Patel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">250,910</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Andy Sassine</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">336,317</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Susan Wood</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">229,915</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jonathan Go</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">129,087</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 114 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_051"></span>INTERESTS OF iCAD&#8217;S DIRECTORS AND EXECUTIVE
OFFICERS IN THE MERGER</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In considering the recommendation of the iCAD
Board that iCAD stockholders vote &#8220;<b>FOR</b>&#8221; each of the Merger Agreement Proposal, the Advisory Compensation Proposal and
the Adjournment Proposal, iCAD stockholders should be aware that the directors and executive officers of iCAD have interests in the Merger
that may be different from, or in addition to, those of iCAD stockholders generally.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">These interests are described below, and certain
of them are quantified below. The iCAD Board was aware of and considered these interests, among other matters, in evaluating and negotiating
the Merger Agreement and the Merger, in approving the Merger Agreement, and in recommending the approval of each of the Merger Agreement
Proposal, the Advisory Compensation Proposal and the Adjournment Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Indemnification and Insurance</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet has agreed that all rights to indemnification
and exculpation from liabilities, including advancement of expenses, for acts or omissions or other matter occurring at or prior to the
Effective Time in favor of the current or former directors, officers, members, managers, employees or agents of iCAD or any of its subsidiaries,
as provided in iCAD&#8217;s and its subsidiaries&#8217; organizational documents, and indemnification contracts between such directors
or officers and iCAD (in each case, as in effect on, and, in the case of any indemnification contracts, to the extent made available to
RadNet prior to, the date of the Merger Agreement) will survive the Merger and will continue in full force and effect. For a period of
six years following the Effective Time, the Surviving Corporation will, and RadNet will cause the Surviving Corporation to, maintain in
effect the exculpation, indemnification and advancement of expenses provisions equivalent to the organizational documents of iCAD and
any of its subsidiaries as in effect immediately prior to the Effective Time with respect to acts or omissions or other matters occurring
prior to the Effective Time and will not amend, repeal or otherwise modify any such provisions in any manner that would adversely affect
the rights thereunder of any Existing Indemnified Parties; provided that all rights to indemnification in respect of any claim made for
indemnification within such period will continue until the disposition of such action or resolution of such claim. From and after the
Effective Time, RadNet will, and will cause the Surviving Corporation to, indemnify, defend and hold harmless, to the fullest extent permitted
under applicable law, the current or former directors or officers of iCAD or any subsidiary of iCAD against any costs or expenses (including
reasonable attorneys&#8217; fees and expenses), amounts paid in settlement, judgments, fines, losses, claims, damages or liabilities incurred
in connection with, arising out of or otherwise related to any actual or alleged action in connection with, arising out of or otherwise
related to matters existing or occurring or alleged to have occurred prior to or at the Effective Time, whether asserted or claimed prior
to, at or after the Effective Time, including actions to enforce this provision or any other indemnification or advancement right of any
D&amp;O Indemnified Party, and RadNet will, and will cause, the Surviving Corporation to also promptly advance reasonable costs and expenses
(including attorneys&#8217; fees) as incurred to the fullest extent permitted under applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For more information, see the section titled &#8220;<i>The
Merger Agreement &#8211; Indemnification and Insurance</i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Annual Compensation of iCAD Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD non-employee directors may receive the unpaid
portion of their full annual cash retainer under iCAD&#8217;s non-employee director compensation program for the service year in which
the closing of the Merger occurs, regardless of the time during such service year that such closing actually occurs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Treatment of iCAD Equity Awards in the Merger</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Outstanding Options in General </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">In general, at the Effective Time, each Eligible
iCAD Option, including those held by iCAD directors and officers, will be assumed by RadNet and converted into an option (A) to purchase
a number of shares of RadNet Common Stock equal to the product of (1) the number of shares of iCAD Common Stock subject to such Eligible
iCAD Option immediately prior to the Effective Time and (2) the Exchange Ratio, rounded down to the nearest whole number of shares, and
(B) with an exercise price per share equal to (1) the exercise price per share of iCAD Common Stock of such Eligible iCAD Option immediately
prior to the Effective Time, divided by (2) the Exchange Ratio, rounded up to the nearest whole cent (each, an &#8220;Assumed Option&#8221;).
Each Assumed Option will continue to have, and will be subject to, the same terms and conditions (including the vesting and exercisability
conditions (including any acceleration provisions) and expiration date) that applied to the corresponding Eligible iCAD Option as in effect
immediately prior to the Effective Time, other than any terms that become inoperative by reason of the transactions contemplated pursuant
to the Merger Agreement. Each iCAD Option that is not an Eligible iCAD Option will not be assumed or otherwise substituted by RadNet and
will automatically terminate and cease to be outstanding as of the Effective Time. See the section titled &#8220;<i>The Merger Agreement&#8212;Treatment
of iCAD Options</i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<!-- Field: Page; Sequence: 115 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Options Held by iCAD Directors</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">All unvested outstanding Eligible iCAD Options
held by each member of the iCAD Board immediately prior to the Effective Time will accelerate and automatically vest and become exercisable
as of a time immediately prior to the Effective Time. See the section titled &#8220;<i>The Merger Agreement&#8212;Treatment of iCAD Options</i>&#8221;
of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Options Held by iCAD Executive Officers</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For a description of the treatment of Eligible
iCAD Options held by executive officers of iCAD see the section titled &#8220;<i>&#8212;Severance and Change in Control Arrangements</i>&#8221;
below. As a member of the iCAD Board, Ms. Brown is also eligible for accelerated vesting of her unvested Eligible iCAD Options as described
in the section titled &#8220;&#8212;<i>Options Held by iCAD Directors</i>&#8221; above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Certain iCAD Options Held by iCAD Directors and Executive Officers</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">The Merger
Agreement generally provides that, no later than 10 business days prior to the Effective Time, the iCAD Board may approve an amendment
to the exercise provisions applicable to certain iCAD Options, including certain iCAD Options held by the directors and executive officers
of iCAD, such that, effective as of immediately prior to the Effective Time, the portion of all such iCAD Options that is vested and
exercisable will be exercisable for a period of the greater of (a) one year following the Closing Date and (b)&#160;the exercise period
set forth in the applicable award agreement (after giving effect to any applicable acceleration provisions), subject to certain limitations
and exceptions. On May 16, 2025, the iCAD Board approved the iCAD Option Extension Amendments relating to an aggregate of 1,828,124 iCAD
Options that each have an exercise price per share of iCAD Common Stock that is less than $7.20, which included an aggregate of 1,478,124
iCAD Options held by iCAD directors and executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Severance and Change in Control Arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD and certain employees of iCAD, including
the executive officers of iCAD, have entered into certain severance and change in control agreements, or certain severance and option
acceleration rights are provided for in such officer&#8217;s executive employment agreement (collectively, the &#8220;Severance Arrangements&#8221;),
which provide that in the event of a termination without Cause or, in some cases, a resignation for Good Reason (as such terms are defined
in the applicable Severance Arrangement) within a specified period following a Change in Control (the &#8220;Post-Closing Protection Period&#8221;)
set forth below, with the Merger being deemed a Change in Control for such purpose, then all of the individual&#8217;s unvested Eligible
iCAD Options shall immediately vest and become exercisable and shall remain exercisable during the post-termination exercise period set
forth below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: Black 1pt solid; width: 17%; text-align: center"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 29%; text-align: center"><span style="font-size: 10pt"><b>Title</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 27%; text-align: center"><span style="font-size: 10pt"><b>Post-Closing Protection Period</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 27%; text-align: center"><span style="font-size: 10pt"><b>Post-Termination Exercise Period</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify"><span style="font-size: 10pt">Dana Brown</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">President and Chief Executive Officer </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">9 months</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">One Year</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify"><span style="font-size: 10pt">Eric Lonnqvist</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">Chief Financial Officer </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">6 months</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">One Year</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify"><span style="font-size: 10pt">Jonathan Go</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">Chief Technology Officer</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">6 months</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">180 days</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In addition, the Severance Arrangements with iCAD&#8217;s
named executive officers provide the following payments and benefits; provided that the executive executes and delivers (and does not
revoke thereafter) (a) the Severance Arrangement (including any agreements attached as exhibits thereto), which contains certain post-termination
restrictive covenants in favor of iCAD and its affiliates and (b) an effective general release of claims in favor of iCAD and its affiliates
and in a form acceptable to RadNet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 116 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><i>Dana Brown</i>. Severance payments due to Ms.
Brown following a termination without Cause (as defined in the Severance Arrangement with Ms. Brown) or resignation by Ms. Brown for Good
Reason during the Post-Closing Protection Period described above are as follows: (i) (a) base salary as then in effect for a period of
6 months from the termination, payable in equal installments on the iCAD&#8217;s normal payroll dates for the 6-month period following
the termination; and (b) an amount equal to the discretionary bonus which would otherwise have been payable for the employment year in
which the termination occurs, payable at such time the discretionary bonus, if any, would otherwise have been payable; and (c) iCAD shall
pay its share of the COBRA premiums necessary to continue the executive&#8217;s health insurance coverage in effect for the executive
and her eligible dependents (as of the termination date) for 18 months beyond the termination date, provided that the executive timely
elects continued coverage under COBRA following the termination; or (ii) except with regard to the payment of any amount that is a Section
409A Amount (as defined in the Severance Arrangement with Ms. Brown), iCAD, in its sole discretion, may elect to make a lump sum cash
payment equal to the present value of the payments otherwise due under this clause (i); and (d) the iCAD Option acceleration and exercisability
benefits described above. The Severance Arrangement with Ms. Brown provides that if any severance payment payable after a &#8220;change
in control&#8221; as defined in Section 280G of the Code, either alone or together with other payments or benefits, either cash or non-cash,
that Ms. Brown has the right to receive from iCAD which would constitute an &#8220;excess parachute payment&#8221; (as defined in Section
280G of the Code), then such severance payment or other payment or benefit will be reduced to the largest amount that will not result
in receipt by Ms. Brown of a parachute payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For purposes of the Severance Arrangement with
Ms. Brown:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>A &#8220;Change in Control&#8221; shall be deemed to occur (i) when any &#8220;person&#8221; as defined in Section 3(a)(9) of the
Exchange Act, and as used in Section 13(d) and 14(d) thereof, including a &#8220;group&#8221; as defined in Section 13(d) of the Exchange
Act, but excluding Ms. Brown, iCAD or any subsidiary or any affiliate of iCAD or any employee benefit plan sponsored or maintained by
iCAD or any subsidiary of iCAD (including any trustee of such plan acting as trustee), becomes the &#8220;beneficial owner&#8221; (as
defined in Rule 13(d)(3) under the Exchange Act) of securities of iCAD representing 50% or more of the combined voting power of iCAD&#8217;s
then outstanding securities; or (ii) the sale of all or substantially all of the assets of iCAD, or (iii) the occurrence of a transaction
requiring stockholder approval for the acquisition of iCAD by an entity other than iCAD or a subsidiary or an affiliated company of iCAD
through purchase of assets, or by merger, or otherwise.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;Good Reason&#8221; means Ms. Brown has complied with the &#8220;Good Reason Process&#8221; (as defined below) following the
occurrence of any of the following events: (a) iCAD changing Ms. Brown&#8217;s position such that she is no longer the Chief Executive
Officer and President of iCAD, or materially diminishing Ms. Brown&#8217;s authority, duties and/or responsibilities such that her authority,
duties and/or responsibilities are no longer commensurate with those customarily associated with the title of Chief Executive Officer
and President; (b) iCAD reducing Ms. Brown&#8217;s compensation below the base salary; (c) iCAD requiring Ms. Brown, without her consent,
to relocate more than 50 miles from iCAD&#8217;s principal office to which she reports; or (d) any material breach by iCAD of any of its
obligations under Ms. Brown&#8217;s employment agreement; or (e) iCAD demonstrably demanding Ms. Brown perform her duties in a manner
that violates any applicable laws, the iCAD Code of Business Conduct and Ethics, or any iCAD policies. &#8220;Good Reason Process&#8221;
means that (a) Ms. Brown reasonably determines in good faith that a Good Reason condition has occurred; (b) Ms. Brown notifies iCAD in
writing of the occurrence of the Good Reason condition within 45 days of the occurrence of such condition; (c) Ms. Brown cooperates in
good faith with iCAD&#8217;s efforts, for a period not less than 30 days following such notice (the &#8220;Good Reason Cure Period&#8221;),
to remedy the condition; (d) notwithstanding such efforts, the Good Reason condition continues to exist; and (e) Ms. Brown terminates
his/her employment within 30 days after the end of the Good Reason Cure Period.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 117 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><i>Eric Lonnqvist</i>. Severance payments due
to Mr. Lonnqvist following a termination without Cause (as defined in the Severance Arrangement with Mr. Lonnqvist) or resignation by
Mr. Lonnqvist for Good Reason during the Post-Closing Protection Period described above are as follows: (a) continuation of payments in
an amount equal to executive&#8217;s then current base salary for the 6-month period immediately following the termination of executive&#8217;s
employment less all customary and required taxes and employment-related deductions, in substantially equal installments in accordance
with iCAD&#8217;s normal payroll practices. The payments will commence within 90 days following both the date of the termination of the
executive&#8217;s employment and the date that the release of claims is effective and irrevocable. The first payment shall include those
installments that would have been paid as of the payment commencement date had the payments commenced in the first payroll period following
the termination date; (b) upon completion of the appropriate COBRA forms, continuation of executive&#8217;s participation in iCAD&#8217;s
health and dental insurance plans at iCAD&#8217;s cost (except for executive&#8217;s co-pay, if any, which shall be deducted from executive&#8217;s
severance compensation) for the 6-month COBRA eligibility period following such termination, to the same extent that such insurance is
provided to similarly situated iCAD executives; and (c) the iCAD Option acceleration and exercisability benefits described above. Mr.
Lonnqvist&#8217;s Severance Arrangement provides that, if any payment or benefit Mr. Lonnqvist would receive under the Severance Arrangement,
when combined with any other payment or benefit Mr. Lonnqvist receives pursuant to a Change in Control (for this purpose, a &#8220;Payment&#8221;)
would: (i) constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G of the Code; and (ii) but for this sentence,
be subject to the excise tax imposed by Section 4999 of the Code, then such Payment will be either: (x) the full amount of such Payment;
or (y) such lesser amount (with cash payments being reduced before stock option compensation) as would result in no portion of the Payment
being subject to the excise tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local employments
taxes, income taxes, and the excise tax, results in Mr. Lonnqvist&#8217;s receipt, on an after-tax basis, of the greater amount of the
Payment notwithstanding that all or some portion of the Payment may be subject to the excise tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For purposes of the Severance Arrangement with
Mr. Lonnqvist:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>A &#8220;Change in Control&#8221; shall mean (i)&#160;the stockholders of iCAD approve: (a) any consolidation or merger of iCAD where
the stockholders of iCAD, immediately prior to the consolidation or merger, would not, immediately after the consolidation or merger,
beneficially own, directly or indirectly, shares representing in the aggregate more than 50% of the combined voting power of all the outstanding
securities of the corporation issuing cash or securities in the consolidation or merger (or of its ultimate parent corporation, if any);
(b) any sale, lease, exchange or other transfer (in one transaction or a series of transactions contemplated or arranged by any party
as a single plan) of all or substantially all of the assets of iCAD; or (c) any plan or proposal for the liquidation or dissolution of
iCAD; or (ii)&#160;any &#8220;person,&#8221; as such term is used in Section 13(d) of the Exchange Act (other than iCAD, any employee
benefit plan of iCAD or any entity organized, appointed or established by iCAD for or pursuant to the terms of such plan), together with
all &#8220;affiliates&#8221; and &#8220;associates&#8221; (as such terms are defined in Rule 12b-2 under the Exchange Act) of such person,
shall become the &#8220;beneficial owner&#8221; or &#8220;beneficial owners&#8221; (as defined in Rules 13d-3 and 13d-5 under the Exchange
Act), directly or indirectly, of securities of iCAD representing in the aggregate 25% or more of either: (a) the then outstanding shares
of the iCAD Common Stock or (b) the combined voting power of all then outstanding securities of iCAD having the right under ordinary circumstances
to vote in an election of the iCAD Board (in either such case, other than as a result of acquisitions of such securities directly from
iCAD).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;Good Reason&#8221; shall mean any action by iCAD without Mr. Lonnqvist&#8217;s prior written consent which results in (i) any
requirement by iCAD that Mr. Lonnqvist perform Mr. Lonnqvist&#8217;s principal duties outside a radius of 25 miles from iCAD&#8217;s Nashua
location; (ii) any material diminution in Mr. Lonnqvist&#8217;s title, position, duties, responsibilities or authority; (iii) any breach
by iCAD of any material provision contained herein; or (iv) a material reduction in Mr. Lonnqvist&#8217;s base salary (unless such reduction
is effected in connection with a general and proportionate reduction of salaries for all similarly situated iCAD employees). Notwithstanding
the foregoing, &#8220;Good Reason&#8221; shall not be deemed to have occurred unless: (a) the executive provides iCAD with written notice
that executive intends to terminate executive&#8217;s employment for the grounds set forth above within 30 days of such reason(s) occurring;
(b) if such ground is capable of being cured, iCAD has failed to cure such ground within a period of 30 days from the date of such written
notice; and (c) the executive terminates his employment within 6 months from the date that Good Reason first occurs.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 118 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><i>Jonathan Go</i>. Severance payments due to
Mr. Go following a termination without Cause (as defined in the Severance Arrangement with Mr. Go) during the Post-Closing Protection
Period described above are as follows: (i) (a) base salary as then in effect for a period of 18 months from the termination, payable in
equal installments on iCAD&#8217;s normal payroll dates for the 18-month period following the termination; and (b) an amount equal to
the discretionary bonus which would otherwise been payable in accordance for the employment year in which the termination occurs, payable
at such time the discretionary bonus, if any, would otherwise have been payable; and (c) the remainder of any Non-Bonus Eligible Base
Salary (as defined in the Severance Arrangement with Mr. Go) not already paid; or (ii) except with regard to the payment of any amount
that is a Section 409A Amount (as defined in the Severance Arrangement with Mr. Go), iCAD, in its sole discretion, may elect to make a
lump sum cash payment equal to the present value of the payments otherwise due under this clause (i); and (d) the iCAD Option acceleration
and exercisability benefits described above. In the event of a resignation by Mr. Go for Good Reason, severance payments are as follows:
(i) (a) base salary as then in effect for a period of 12 months from the termination, payable in equal installments on iCAD&#8217;s normal
payroll dates for the 12-month period following the termination; and (b) an amount equal to a pro rata share of the discretionary bonus
which would otherwise have been payable for the employment year in which the termination occurs, payable at such time the discretionary
bonus, if any, would otherwise have been payable; and (c) iCAD shall pay its share of the COBRA premiums necessary to continue the executive&#8217;s
health insurance coverage in effect for the executive and her eligible dependents (as of the termination date) for 12 months beyond the
termination date, provided that the executive timely elects continued coverage under COBRA following the termination. The Severance Arrangement
with Mr. Go provides that if any severance payment payable after a &#8220;change in control&#8221; as defined in Section 280G of the Code,
either alone or together with other payments or benefits, either cash or non-cash, that Mr. Go has the right to receive from iCAD which
would constitute an &#8220;excess parachute payment&#8221; (as defined in Section 280G of the Code), then such severance payment or other
payment or benefit will be reduced to the largest amount that will not result in receipt by Mr. Go of a parachute payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For purposes of the Severance Arrangement with
Mr. Go:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>A &#8220;Change in Control&#8221; shall be deemed to occur (i) when any &#8220;person&#8221; as defined in Section 3(a)(9) of the
Exchange Act, and as used in Section 13(d) and 14(d) thereof, including a &#8220;group&#8221; as defined in Section 13(d) of the Exchange
Act, but excluding Mr. Go, iCAD or any subsidiary or any affiliate of iCAD or any employee benefit plan sponsored or maintained by iCAD
or any subsidiary of iCAD (including any trustee of such plan acting as trustee), becomes the &#8220;beneficial owner&#8221; (as defined
in Rule 13(d)(3) under the Exchange Act) of securities of iCAD representing 50% or more of the combined voting power of iCAD&#8217;s then
outstanding securities; or (ii) the occurrence of a transaction requiring stockholder approval for the acquisition of iCAD by an entity
other than iCAD or a subsidiary or an affiliated company of iCAD through purchase of assets, or by merger, or otherwise.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;Good Reason&#8221; means that Mr. Go has complied with the &#8220;Good Reason Process&#8221; (as defined below) following the
occurrence of any of the following events: &#160;(a) iCAD changing Mr. Go&#8217;s position such that he is no longer the Chief Technology
Officer of iCAD, or materially diminishing the Executive&#8217;s authority, duties and/or responsibilities such that his authority, duties
and/or responsibilities are no longer commensurate with those customarily associated with the title of Chief Technology Officer; (b) iCAD
reducing the Mr. Go&#8217;s compensation below the base salary; (c) iCAD requiring Mr. Go, without his consent, to relocate more than
50 miles from iCAD&#8217;s principal office to which he reports as of the Effective Date; (d) any material breach by iCAD of any of its
obligations under the agreement; or (e) iCAD demonstrably demanding Mr. Go perform his duties in a manner that violates any applicable
laws, the iCAD Code of Business Conduct and Ethics, or any iCAD policies. &#8220;Good Reason Process&#8221; means that (a) Mr. Go reasonably
determines in good faith that a Good Reason condition has occurred; (b) Mr. Go notifies iCAD in writing of the occurrence of the Good
Reason condition within 30 days of the occurrence of such condition; (c) Mr. Go cooperates in good faith with iCAD&#8217;s efforts, for
a period not less than 30 days following such notice (the &#8220;Good Reason Cure Period&#8221;), to remedy the condition; (d) notwithstanding
such efforts, the Good Reason condition continues to exist; and (e) Mr. Go terminates his employment within 30 days after the end of the
Good Reason Cure Period.&#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 119 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2025 Stay Bonuses of Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">On April 15, 2025, simultaneously
with the approval of the terms of the Merger, the iCAD Board unanimously approved the grant of cash bonuses to certain employees, including
Dana Brown, iCAD&#8217;s President and Chief Executive Officer, who will receive $200,000, and Eric Lonnqvist, iCAD&#8217;s Chief Financial
Officer, who will receive $62,500 (the &#8220;Stay Bonuses&#8221;), less applicable tax and other withholdings. The Stay Bonuses are payable
on or within 30 days following the Closing, subject to each individual&#8217;s continued employment with iCAD or an affiliate of iCAD
through the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="quantification"></span>Quantification of Potential Payments and Benefits to iCAD&#8217;s
Named Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">The information set forth
below is required by Item 402(t) of Regulation S-K regarding compensation that is based on or otherwise relates to the Merger
that the iCAD named executive officers could receive in connection with the Merger. The compensation that may be paid or become payable
to iCAD&#8217;s named executive officers in connection with the proposed Merger is subject to approval, on an advisory (non-binding) basis,
by iCAD stockholders, as described in the section titled &#8220;<i>Proposal II&#8212;Non-Binding Advisory Vote On Transaction-Related
Compensation For Certain iCAD Executive Officers</i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">Please note that such
amounts reported below are estimates based on multiple assumptions that may or may not actually occur, or be accurate on the relevant
date. For purposes of determining the potential payments in the table below, the following assumptions were used:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">(a)</td><td>the Effective Time is June 30, 2025, which is the assumed Closing Date solely for purposes of disclosure in this section;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">(b)</td><td>each iCAD Option will be treated as described in the section titled &#8220;<i>The Merger Agreement&#8212;Treatment of iCAD Options</i>&#8221;
of this proxy statement/prospectus;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">(c)</td><td>the value per share of iCAD Common Stock on consummation of the Merger is $3.12 (which, in accordance with SEC requirements, is equal
to the average closing price of a share of iCAD common stock over the first 5 business days following the first public announcement of
the Merger);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">(d)</td><td>each iCAD named executive officer experiences a qualifying termination immediately following consummation of the Merger (and iCAD
provides the requisite notice of such termination);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">(e)</td><td>each iCAD named executive officer has complied with all requirements necessary in order to receive all payments and benefits;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">(f)</td><td>each iCAD named executive officer&#8217;s base salary rate remains unchanged from that in effect as of April 15, 2025;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">(g)</td><td>the amount of each of Ms. Brown&#8217;s and Mr. Go&#8217;s annual discretionary bonus that otherwise would have been payable for 2025
is $0;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">(h)</td><td>as of June 30, 2025, Mr. Go will have received the entire amount of his Non-Bonus Eligible Base Salary (as defined in the Severance
Arrangement with Mr. Go), if any, for 2025;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">(i)</td><td>each named executive officer&#8217;s iCAD Equity Awards are those outstanding as of June 30, 2025 based on forecasted vesting, which
is purely time-based and not dependent on performance; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt">(j)</td><td>no named executive officer receives any additional iCAD Options or other equity awards on or prior to the Effective Time.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 120 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">The payments and benefits
described below are calculated based on, to the extent applicable, the terms of the Merger Agreement, each iCAD named executive officer&#8217;s
Severance Arrangement, and the terms of the potential Stay Bonuses to certain iCAD named executive officers upon consummation of the Merger.
See the sections titled &#8220;&#8212;<i>Treatment of iCAD Equity Awards in the Merger,</i>&#8221; &#8220;&#8212;<i>Severance and Change
in Control Arrangements</i>&#8221; and &#8220;&#8212;<i>2025 Stay Bonuses of Executive Officers</i>&#8221; above, for more information.
The actual amounts payable to each iCAD named executive officer will depend on whether he or she experiences a qualifying termination,
the date of such termination (if applicable) and the terms of the plans or agreements in effect at such time and may materially differ
from the amounts set forth below. In addition, while the calculations below assume the Merger occurred June 30, 2025 as required by SEC
rules, the Merger is expected to close at some time during the second or third quarter of 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Golden Parachute Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>



<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Cash</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>($)<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Equity<br/> Awards</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>($)<sup>(2)</sup></b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><b><b>Perquisites / </b>Benefits</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b>($)<sup>(3)</sup></b></p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Total</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>($)<sup>(4)</sup></b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 32%; text-align: left">Dana Brown</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">400,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right"><span style="font-size: 10pt">&#8201;145,499&#8201;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">55,951</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">601,450</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Eric Lonnqvist</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">187,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">283,815</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Jonathan Go</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">499,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,301</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">579,134</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(1)</td><td><b>Cash: </b>The amounts shown in this column reflect the total cash severance amount equal to 6 months for Ms. Brown&#8217;s and
Mr. Lonnqvist&#8217;s, and 18 months for Mr. Go&#8217;s base salary as of the Effective Time that is payable under the named executive
officer&#8217;s Severance Arrangement in the event the named executive officer experiences a termination without Cause (as defined in
the applicable Severance Arrangement) during the Post-Closing Protection Period. The payments in this column are all &#8220;double-trigger&#8221;
in nature, which means that payment of these amounts is conditioned upon a qualifying termination of employment during the Post-Closing
Protection Period. The Severance Arrangements generally provide for salary continuation of the named executive officer&#8217;s base salary
in effect at the time of the qualifying termination. See the section titled &#8220;<i>&#8212;Severance and Change in Control Arrangements</i>&#8221;
above. If a named executive officer will be eligible to receive a Stay Bonus in connection with the Merger, the amount of the Stay Bonus
is also shown in this column and is included under the &#8220;Stay Bonus&#8221; column below. See the section titled &#8220;&#8212;<i>2025
Stay Bonuses of Executive Officers</i>&#8221; above.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Base<br/> Salary<br/> Severance ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Stay<br/> Bonus ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 49%; text-align: left">Dana Brown</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">200,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">200,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">400,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Eric Lonnqvist</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">125,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">187,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Jonathan Go</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">499,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">499,500</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(2)</td><td><b>Equity Awards: </b>The amounts in this column reflect the aggregate value of the accelerated vesting of each named executive officer&#8217;s
unvested Eligible iCAD Options which would be assumed by RadNet. For this purpose, the value of each unvested Eligible iCAD Option is
an amount equal to (a) the assumed value per share of iCAD Common Stock of $3.12 (as described in more detail in the section titled &#8220;&#8212;<i>Quantification
of Potential Payments and Benefits to iCAD&#8217;s Named Executive Officers</i>&#8221; above) <i>minus</i> (b) the per share exercise
price of iCAD Common Stock of such Eligible iCAD Option (prior to conversion into an Assumed&#160;Option). The amount for Ms. Brown is
&#8220;single trigger&#8221; in nature, which means that accelerated vesting is conditioned upon the consummation of the Merger, as described
in more detail in the section titled &#8220;&#8212;<i>Options Held by iCAD Directors</i>&#8221; above. The amounts for Messrs. Lonnqvist
and Go are &#8220;double trigger&#8221; in nature, which means that the accelerated vesting is conditioned upon a qualifying termination
of employment during the Post-Closing Protection Period. The treatment of outstanding iCAD Equity Awards is described in more detail in
the section titled &#8220;&#8212;<i>Treatment of iCAD Equity Awards in the Merger</i>&#8221; above.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 121 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(3)</td><td><b>Perquisites/Benefits: </b>The amounts shown in this column represent the estimated value of 18 months of COBRA payments for Ms.
Brown, 6 months for Mr. Lonnqvist and 12 months for Mr. Go under his or her Severance Arrangement as set forth in the section titled &#8220;<i>&#8212;Severance
and Change in Control Arrangements</i>&#8221; above.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(4)</td><td><b>280G:</b> The amounts in this column do not reflect any potential reductions to such amounts that may occur pursuant to the Section
280G-related provisions included in each named executive officer&#8217;s Severance Arrangement as set forth in the section titled &#8220;&#8212;<i>Severance
and Change in Control Arrangements</i>&#8221; above.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 122 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_052"></span>PROPOSAL I&#8212;ADOPTION OF THE MERGER AGREEMENT</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">At a meeting held on April 15, 2025, the iCAD
Board unanimously (i) approved and declared advisable the Merger Agreement and the transactions contemplated therein, including the Merger,
on the terms and subject to the conditions set forth therein, (ii) determined that the Merger Agreement and the consummation of the transactions
contemplated thereby (including the Merger), are advisable and fair to, and in the best interests of, iCAD and the stockholders of iCAD,
(iii) resolved to recommend the adoption of the Merger Agreement to the stockholders of iCAD, on the terms and subject to the conditions
set forth therein, and (iv) directed that the Merger Agreement be submitted to the stockholders of iCAD for adoption at the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The iCAD Board accordingly unanimously recommends
that iCAD stockholders vote <b>&#8220;FOR&#8221; </b>the Merger Agreement Proposal, as disclosed in this proxy statement/prospectus, particularly
the related narrative disclosures in sections titled &#8220;<i>The Merger</i>&#8221; and &#8220;<i>The Merger Agreement</i>&#8221; of
this proxy statement/prospectus, and the copy of the Merger Agreement attached as Annex A to this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The Merger cannot be completed without the affirmative
vote of the holders of a majority of all outstanding shares of iCAD Common Stock on the iCAD Record Date and entitled to vote thereon.
The required vote is based on the number of outstanding shares&#8212;not the number of shares actually voted. The failure of any iCAD
stockholder to submit a vote (i.e., by not submitting a proxy and not voting at the Special Meeting) and any abstention from voting by
an iCAD stockholder will have the same effect as a vote &#8220;<b>AGAINST</b>&#8221; the Merger Agreement Proposal. Because the Merger
Agreement Proposal is non-routine, brokers, banks and other nominees do not have discretionary authority to vote on the Merger Agreement
Proposal, and will not be able to vote on the Merger Agreement Proposal absent instructions from the beneficial owner of any iCAD shares
held of record by them. As a result, a broker non-vote, if any, will have the same effect as a vote &#8220;<b>AGAINST</b>&#8221; the Merger
Agreement Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>IF YOU ARE AN iCAD STOCKHOLDER, THE iCAD BOARD
UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE MERGER AGREEMENT PROPOSAL.<br/>
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 123 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_054"></span>PROPOSAL II&#8212;NON-BINDING ADVISORY VOTE
ON TRANSACTION-RELATED COMPENSATION FOR CERTAIN iCAD EXECUTIVE OFFICERS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">As required by Section 14A of the Exchange Act
and the applicable SEC rules issued thereunder, iCAD is required to provide its stockholders with the opportunity to vote to approve,
on a non-binding, advisory basis, certain compensation that may be paid or become payable to iCAD&#8217;s named executive officers in
connection with the Merger, as disclosed in this proxy statement/prospectus, including the compensation table and the related narrative
named executive officer compensation disclosures set forth in in the section titled &#8220;<i>Interests of iCAD&#8217;s Directors and
Executive Officers in the Merger&#8212;Quantification of Potential Payments and Benefits to iCAD&#8217;s Named Executive Officers</i>&#8221;
of this proxy statement/prospectus. This vote is commonly referred to as a &#8220;golden parachute say on pay&#8221; vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Accordingly, the iCAD Board unanimously recommends
that iCAD stockholders vote &#8220;<b>FOR</b>&#8221; the adoption of the following resolution, on a non-binding, advisory basis, at the
Special Meeting:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#8220;RESOLVED, that iCAD&#8217;s stockholders
approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to iCAD&#8217;s named executive officers
in connection with the Merger, as disclosed pursuant to Item 402(t) of Regulation S-K in &#8220;<i>Interests of iCAD&#8217;s Directors
and Executive Officers in the Merger&#8212;Quantification of Potential Payments and Benefits to iCAD&#8217;s Named Executive Officers</i>&#8221;
of this proxy statement/prospectus (which disclosure includes the compensation table and related narrative named executive officer compensation
disclosures required pursuant to Item 402(t) of Regulation S-K).&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD stockholders should note that the Advisory
Compensation Proposal is merely an advisory vote, which will not be binding on iCAD, RadNet or their respective boards of directors. Further,
the underlying plans and arrangements are contractual in nature and not, by their terms, subject to stockholder approval. Accordingly,
regardless of the outcome of the advisory vote, if the Merger is consummated, the eligibility of the iCAD named executive officers for
such payments and benefits will not be affected by the outcome of the advisory vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The affirmative vote of a majority of votes present
or represented by proxy at the Special Meeting and entitled to vote thereon is required to approve the Advisory Compensation Proposal.
Any shares not present virtually or represented by proxy (including due to the failure of an stockholder who holds shares in &#8220;street
name&#8221; through a bank, broker or other nominee to provide voting instructions with respect to any proposals at the Special Meeting
to such bank, broker or other nominee) will have no effect on the outcome of the Advisory Compensation Proposal, provided that a quorum
is otherwise present. An abstention by any shares present or represented by proxy on the Advisory Compensation Proposal will have the
same effect as a vote &#8220;<b>AGAINST</b>&#8221; the Advisory Compensation Proposal. Broker non-votes, if any, will have no effect on
the Advisory Compensation Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>IF YOU ARE AN iCAD STOCKHOLDER, THE iCAD BOARD
UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE ADVISORY COMPENSATION PROPOSAL. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 124 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_053"></span>PROPOSAL III&#8212;ADJOURNMENT OF THE SPECIAL
MEETING</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">We are asking iCAD stockholders to approve a proposal
to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient
votes to adopt the Merger Agreement at the time of the Special Meeting. If iCAD stockholders approve the Adjournment Proposal, we could
adjourn the Special Meeting and any adjourned session of the Special Meeting and use the additional time to solicit additional proxies,
including proxies from iCAD stockholders that have previously returned properly executed proxies voting against adoption of the Merger
Agreement. Among other things, approval of the Adjournment Proposal could mean that, even if we had received proxies representing a sufficient
number of votes against adoption of the Merger Agreement such that the Merger Agreement Proposal would be defeated, we could adjourn the
Special Meeting without a vote on the adoption of the Merger Agreement and seek to convince the holders of those shares to change their
votes to vote in favor of adoption of the Merger Agreement. Additionally, we may seek to adjourn the Special Meeting if a quorum is not
present.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The affirmative vote of a majority of votes present
or represented by proxy at the Special Meeting and entitled to vote thereon is required to approve the Adjournment Proposal. Any shares
not present virtually or represented by proxy (including due to the failure of an stockholder who holds shares in &#8220;street name&#8221;
through a bank, broker or other nominee to provide voting instructions with respect to any proposals at the Special Meeting to such bank,
broker or other nominee) will have no effect on the outcome of the Adjournment Proposal, provided that a quorum is otherwise present.
An abstention by any shares present or represented by proxy on the Adjournment Proposal will have the same effect as a vote &#8220;<b>AGAINST</b>&#8221;
the Adjournment Proposal. Broker non-votes, if any, will have no effect on the Adjournment Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>IF YOU ARE AN iCAD STOCKHOLDER, THE iCAD BOARD
UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE ADJOURNMENT PROPOSAL.<br/>
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 125 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_055"></span>DESCRIPTION OF RADNET CAPITAL STOCK</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt">For a description of RadNet&#8217;s capital stock,
please see Exhibit 4.1 to RadNet&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on
March 3, 2025, as amended by Amendment No. 1 on Form 10-K/A, filed with the SEC on April 28, 2025. See the section titled &#8220;<i><a href="#s4_060">Where You Can Find More Information</a></i>&#8221; of this proxy statement/prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 126 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><br/>
</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_056"></span>COMPARISON OF STOCKHOLDER RIGHTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If the transactions contemplated by the Merger
Agreement are completed, iCAD stockholders will receive shares of RadNet Common Stock in connection with the Merger and become stockholders
of RadNet. The following is a summary of certain differences between (i) the current rights of iCAD stockholders under the iCAD Certificate
of Incorporation and the iCAD Bylaws and (ii) the current rights of RadNet stockholders under the RadNet Certificate of Incorporation
and the RadNet Bylaws.&#160;Both companies governed by the DGCL.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The following discussion summarizes certain material
differences between iCAD&#8217;s and RadNet&#8217;s respective governing documents. The following summary is not a complete statement
of the rights of stockholders of the two companies or a complete description of the specific provisions referred to below. This summary
is qualified in its entirety by reference to the DGCL and iCAD&#8217;s and RadNet&#8217;s governing documents (which we urge you to read
carefully and in their entirety). Copies of the respective companies&#8217; governing documents have been filed with the SEC. To find
out where copies of these documents can be obtained, see the section titled &#8220;<i>Where You Can Find More Information</i>&#8221; of
this proxy statement/prospectus. In addition, the identification of some of the differences in the rights of iCAD and RadNet stockholders
is not intended to indicate that other differences that are equally important do not exist. iCAD and RadNet urge you to carefully read
this entire proxy statement/prospectus, the relevant provisions of the DGCL and the other documents to which iCAD and RadNet refer in
this proxy statement/prospectus for a more complete understanding of the differences between the rights of an iCAD stockholder and a RadNet
stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Between the date of the Merger Agreement and the
Effective Time, iCAD has agreed not to amend its governing documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Certain Key Features of Stockholder Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>RadNet</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>iCAD</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Organizational Documents</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The rights of RadNet&#8217;s stockholders are governed by RadNet&#8217;s Certificate of Incorporation, dated June 19, 2008, as amended by the Certificate of Amendment to the Certificate of Designation, dated September 2, 2008, RadNet&#8217;s Amended and Restated Bylaws, and the DGCL.</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The rights of iCAD&#8217;s stockholders are governed by (a) iCAD&#8217;s Certificate of Incorporation, dated February 21, 1984, as amended by: (i) the Amendments to Certificate of Incorporation, dated May 31, 1984, August 22, 1984, October 21, 1987, September 28, 1999, June 28, 2002, July 18, 2007, August 10, 2012, May 31, 2013, June 16, 2015, and July 21, 2021, (ii) the Certificates of Designation dated December 22, 1999 and October 19, 2000, (iii) the Certificate of Ownership and Merger dated December 4, 2023; (b) iCAD&#8217;s Amended and Restated By-laws, and (c) the DGCL.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Authorized Capital Stock</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet is authorized to issue 200,000,000 shares
    of RadNet Common Stock having a par value of $0.0001 per share and 30,000,000 shares of preferred stock having a par value of $0.0001
    per share.&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The RadNet Certificate of Incorporation authorizes
    the RadNet Board to issue shares of RadNet preferred stock in one or more series.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">iCAD is authorized to issue 60,000,000 shares
    of iCAD Common Stock having a par value of $0.01 per share, and $1,000,000 shares of preferred stock having a par value of $0.01 per share.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The iCAD Certificate of Incorporation authorizes
the iCAD Board to issue shares of iCAD preferred stock in one or more series.</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 127 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Common Stock </i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet is authorized to issue 200,000,000 shares
    of RadNet Common Stock having a par value of $0.0001 per share.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each holder of RadNet Common Stock is entitled
to one vote per share on all matters submitted to a vote of stockholders, and may not cumulate votes for the election of directors.</p></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">iCAD is authorized to issue 60,000,000 shares
    of common stock having a par value of $0.01 per share.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each holder of iCAD Common Stock is entitled
to one vote per share on all matters submitted to a vote of stockholders, and may not cumulate votes for the election of directors.</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Preferred Stock </i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">RadNet is authorized to issue 30,000,000 shares of preferred stock having a par value of $0.0001 per share.&#160;No shares of RadNet&#8217;s undesignated preferred stock are currently outstanding.</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">iCAD is authorized to issue 1,000,000 shares of preferred stock having a par value of $0.01 per share.&#160;No shares of iCAD&#8217;s undesignated preferred stock are currently outstanding.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Number and Qualification of Directors</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The number of RadNet directors is to be determined from time to time by resolution of the RadNet Board, acting by the affirmative vote of a majority of the directors. The RadNet Board currently consists of six members. Whenever the authorized number of directors is increased between annual meetings of the stockholders, a majority of the directors then in office shall have the power to elect such new directors for the balance of a term and until their successors are elected and qualified. Any decrease in the authorized number of directors shall not become effective until the expiration of the term of the directors then in office unless, at the time of such decrease, there shall be vacancies on the board which are being eliminated by the decrease. </span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The number of iCAD directors is to be determined from time to time by resolution of the iCAD Board, acting by the affirmative vote of a majority of the directors. The iCAD Board currently consists of six members. Whenever the authorized number of directors is increased between annual meetings of the stockholders, a majority of the directors then in office shall have the power to elect such new directors for the balance of a term and until their successors are elected and qualified. Any decrease in the authorized number of directors shall not become effective until the expiration of the term of the directors then in office unless, at the time of such decrease, there shall be vacancies on the board which are being eliminated by the decrease. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Structure of Board of Directors; Term of Directors; Election of Directors</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">RadNet directors shall be elected at the annual meeting of stockholders by such stockholders as have the right to vote on such election. Election of directors need not be by written ballot. Each director shall hold office for a term of one year and until his or her successor is elected and qualified, or until such director&#8217;s earlier resignation or removal. All elections shall be determined by a plurality of the votes cast, except as otherwise required by law.</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">iCAD directors shall be elected at the annual meeting of stockholders by such stockholders as have the right to vote on such election. Election of directors need not be by written ballot. Each director shall hold office for a term of one year and until his or her successor is elected and qualified, or until such director&#8217;s earlier resignation or removal. All elections shall be determined by a plurality of the votes cast, except as otherwise required by law.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Removal of Directors </i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Any director or the entire board of directors may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors, except as set forth in the RadNet Bylaws relating to a classified board and cumulative voting, if any.</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Any director or the entire board of directors may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors, except as set forth in the iCAD Bylaws relating to a classified board and cumulative voting, if any.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 128 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Vacancies of Directors </i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 49%"><span style="font-family: Times New Roman, Times, Serif">The RadNet Certificate of Incorporation and RadNet Bylaws provide that vacancies shall be filled pursuant to a resolution adopted by a majority of the remaining members of our board of directors then in office, although less than a quorum, or by a sole remaining director. In addition, whenever the holders of any class or classes of stock or series thereof are entitled to elect one or more directors under the terms of the RadNet Certificate of Incorporation, vacancies and newly created directorships of such class or classes or series may be filled by a majority of the directors elected by such class or classes or series thereof then in office, or by a sole remaining director so elected. Each director shall hold office until his or her successor is elected and qualified, unless the director dies, resigns or otherwise leaves the board of directors before then.</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: justify; width: 49%"><span style="font-family: Times New Roman, Times, Serif">The iCAD Certificate of Incorporation and iCAD Bylaws provide that any vacancy occurring in the board of directors, including any vacancy created by reason of an increase in the number of directors, shall be filled for the unexpired term by the concurring vote of a majority of the directors then in office, whether or not a quorum, and any director so chosen shall hold office for the remainder of the full term of the class of directors in which the new directorship was created or the vacancy occurred and until such director&#8217;s successor shall have been elected and qualified. In addition, if any vacancy shall occur because of death, resignation, retirement, disqualification, removal, an increase in the authorized number of directors or any other cause, the board of directors shall have the authority to, at any meeting, by resolution adopted by the affirmative vote of a majority of the directors then in office, though less than a quorum, elect a director or directors to fill such vacancy or vacancies until the next election for which such director or directors shall have been chosen. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Shareholder Action by Written Consent</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Any action required or permitted to be taken at any annual or special meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if a consent in writing, setting forth the action so taken, is signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. Every written consent shall bear the date of signature of each stockholder who signs the consent, and no written consent shall be effective to take the corporate action referred to therein unless, within 60 days of the earliest dated consent delivered to RadNet, a written consent signed by a sufficient number of stockholders to take action are delivered to RadNet.</span></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The DGCL provides that, unless otherwise provided
    in a corporation&#8217;s certificate of incorporation or bylaws, any action required or permitted to be taken at any annual or special
    meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing,
    setting forth the action so taken, are signed by the holders of issued and outstanding stock having not less than the minimum number of
    votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present
    and voted.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither the iCAD Certificate of Incorporation
    or iCAD Bylaws provide that stockholders may not act by written consent in lieu of a meeting. As such, the holders of a majority of iCAD
    Common Stock may act by written consent in lieu of a meeting in accordance with the rules and requirements of the DGCL.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 4.5pt; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Quorum</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Except as otherwise provided by the DGCL, the holders of a majority of the voting power of all of the shares of stock entitled to vote at the meeting, present in person or by proxy, shall constitute a quorum for all purposes. Where a separate vote by a class or series is required, a majority of the voting power of the shares of such class or series, present in person or represented by proxy, shall constitute a quorum entitled to take action with respect to that vote on that matter. If a quorum shall fail to attend any meeting, the chairman of the meeting or the holders of a majority of the shares of stock entitled to vote who are present, in person or by proxy, may adjourn the meeting to another place, if any, date, or time. No other business shall be transacted at such meeting.</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Except as otherwise provided by the DGCL, the holders of a majority of the voting power of all of the shares of stock entitled to vote at the meeting, present in person or by proxy, shall constitute a quorum for all purposes. Where a separate vote by a class or series is required, a majority of the voting power of the shares of such class or series, present in person or represented by proxy, shall constitute a quorum entitled to take action with respect to that vote on that matter. If a quorum shall fail to attend any meeting, the chairman of the meeting or the holders of a majority of the shares of stock entitled to vote who are present, in person or by proxy, may adjourn the meeting to another place, if any, date, or time. No other business shall be transacted at such meeting.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 129 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Special Meetings of Shareholders</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 4.5pt; text-align: justify; width: 49%"><span style="font-family: Times New Roman, Times, Serif">Special meetings of the stockholders, for any purpose or purposes prescribed in the notice of the meeting, may be called by the RadNet Board or a delegated committee of the RadNet Board and shall be held at such place, date, and time as it shall fix. Only such business shall be conducted are those that have been properly brought before the meeting.</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: justify; width: 49%"><span style="font-family: Times New Roman, Times, Serif">Special meetings of the stockholders may be called by the iCAD Board, or the President or by the Secretary of iCAD at the request in writing of the holders of record of a majority of the outstanding stock of iCAD entitled to vote at a meeting. Any such request by stockholders shall comply with the provisions of the iCAD Bylaws and the DGCL, and only such business shall be conducted as to matters properly brought before the meeting. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 4.5pt; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Notice of Shareholder Meetings</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Except as otherwise provided by the DGCL or the RadNet Bylaws, notice of the place, if any, date, and time of all meetings of the stockholders, the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such meeting, and the record date for determining the stockholders entitled to vote at the meeting, shall be given not less than 10 days nor more than 60 days before the date of the meeting to each stockholder entitled to vote at such meeting as of the record date for determining the stockholders entitled to notice of the meeting.</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Except as otherwise provided by the DGCL or
    the iCAD Bylaws, notice of the place, if any, date, and time of all meetings of the stockholders, the means of remote
    communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such meeting, and
    the record date for determining the stockholders entitled to vote at the meeting, shall be given not less than 10 days nor more than
    60 days before the date of the meeting to each stockholder entitled to vote at such meeting as of the record date for determining
    the stockholders entitled to notice of the meeting.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Advance Notice Requirements for Stockholder Proposals</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nominations of persons for election to the RadNet
    Board may be made at an annual meeting or special meeting of stockholders, and the proposal of business to be considered by the stockholders
    may be made at an annual meeting of stockholders, by any RadNet stockholder who was a stockholder of record at the time of giving the
    stockholder&#8217;s notice, who is entitled to vote at the meeting and who complied with the notice procedures set forth in the RadNet
    Bylaws. Such notice must be received by RadNet no earlier than the close of business on the 120<sup>th</sup> day prior to, nor no later
    than the close of business of the 90<sup>th</sup> day prior to the first anniversary of the preceding year&#8217;s annual meeting.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that the number of directors to be
    elected to the RadNet Board is increased effective at the annual meeting and there is no public announcement by RadNet naming the nominees
    for the additional directorships at least 100 days prior to the first anniversary of the preceding year&#8217;s annual meeting, a stockholder&#8217;s
    notice shall also be considered timely, but only with respect to nominees for the additional directorships, if it is delivered to RadNet
    no later than the close of business on the 10<sup>th</sup> day following the day on which such public announcement is first made by RadNet.
    Any public announcement of an adjournment or postponement of an annual meeting would not commence a new time period (or extend any time
    period) for the giving of a stockholder&#8217;s notice as described above.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that the annual meeting is more than
    30 days before or more than 60 days after such anniversary date, and in case of a special meeting, notice must be received by RadNet no
    earlier than the close of business on the 120<sup>th</sup> day prior to, nor no later than the close of business on the later of (i) the
    90<sup>th</sup> day prior to such meeting and (ii) 10<sup>th</sup> day following the day on which public announcement is first made of
    the date of such meeting, and in case of a special meeting nomination, the public announcement is first made of the nominees proposed
    by the RadNet Board to be elected at such meeting.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders who wish to present proposals appropriate
    for consideration at annual meeting of stockholders must submit a notice containing the proposal in proper form consistent with the iCAD
    Bylaws no later than 120 days prior to the anniversary of the preceding year&#8217;s annual meeting in accordance with Rule 14a-8 of the
    Exchange Act, in order for the proposal to be considered for inclusion in the proxy statement and form of proxy relating to such annual
    meeting.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a stockholder submits a proposal after the
    deadline required under Rule 14a-8 of the Exchange Act but still wishes to present the proposal at an annual meeting of stockholders (but
    not in our proxy statement), the proposal, which must be presented in a manner consistent with the iCAD Bylaws and applicable law, must
    be submitted not less than 50 nor more than 75 days prior to the meeting unless less than 65 days&#8217; notice or prior public disclosure
    of the date of the meeting is given or made to stockholders, in which case, no less than the close of business on the tenth day following
    the earlier of the date on which the notice of the date of the meeting was mailed or other public disclosure of the date of the meeting
    was made.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any stockholder entitled to vote in the election
of directors generally may nominate one or more persons for election as directors at a meeting only if written notice of such stockholder&#8217;s
intent to make such nomination or nominations has been delivered personally to, or been mailed to and received by iCAD&#8217;s corporate
secretary not less than 50 days nor more than 75 days prior to the meeting; provided, however, that, in the event that less than 65 days&#8217;
notice or prior public disclosure of the date of the meeting is given or made to stockholders, notice by the stockholder to be timely
must be received not later than the close of business on the tenth day following the earlier of (i) the day on which such notice of the
date of the meeting was mailed or (ii) such public disclosure was made.</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 130 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Amendment of Certificate of Incorporation</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 49%"><span style="font-family: Times New Roman, Times, Serif">The RadNet Certificate of Incorporation provides that RadNet may amend or repeal any provision contained in the RadNet Certificate of Incorporation in the manner prescribed by DGCL and all rights conferred upon stockholders are granted subject to RadNet&#8217;s right. Certain amendments of the RadNet Certificate of Incorporation may require the affirmative vote of the majority of the outstanding shares of capital stock entitled to vote, and the affirmative vote of the majority of the outstanding shares of each class entitled to vote thereon as a class, at a duly constituted meeting of stockholders called expressly for such purpose pursuant to Section 242 of the DGCL.</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with Section 242 of the DGCL, the
    iCAD Certificate of Incorporation may be amended by affirmative vote of the majority of the outstanding shares of capital stock entitled
    to vote at a duly constituted meeting of stockholders called expressly for such purpose.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Amendment of Bylaws</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The RadNet Board is expressly empowered to adopt, amend or repeal the RadNet Bylaws. The stockholders also have power to adopt, amend or repeal the RadNet Bylaws by the affirmative vote of the majority of shares present in person or represented by proxy at the meeting and entitled to vote. </span></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The iCAD Board is expressly empowered to
adopt, amend or repeal the iCAD Bylaws. The stockholders also have power to adopt, amend or repeal the iCAD Bylaws by the affirmative
vote of the majority of shares present in person or represented by proxy at the meeting and entitled to vote on the subject matter shall
be the act of the stockholders.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Limitation on Director and Officer Liability</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Section 102(b)(7) of the DGCL authorizes corporations to limit or eliminate the personal liability of directors to corporations and their stockholders for monetary damages for breaches of directors&#8217; fiduciary duties. The RadNet Certificate of Incorporation contains a provision that eliminates the personal liability of a director to RadNet or RadNet stockholders for monetary damages for breach of fiduciary duty as a director to the fullest extent permitted by the DGCL. </span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Section 102(b)(7) of the DGCL authorizes corporations to limit or eliminate the personal liability of directors to corporations and their stockholders for monetary damages for breaches of directors&#8217; fiduciary duties. The iCAD Certificate of Incorporation contains a provision that eliminates the personal liability for a director to iCAD or iCAD stockholders for monetary damages for breach of fiduciary duty as a director, other than with respect to (i) any breach of the duty of loyalty; (ii) acts or omissions not in good faith or which involve intentional misconduct or knowing violation of law; (iii) actions under Section 174 of the DGCL; or (iv) transactions from which the director derived an improper personal benefit.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Indemnification</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The RadNet Certificate of Incorporation and Bylaws provide for indemnification of officers and directors to the fullest extent permitted by, and in the manner permissible under, applicable state and federal law, including the DGCL. RadNet has also entered into separate indemnification agreements with its officers and directors, pursuant to which RadNet agreed to indemnify the officer or director against all liabilities relating to his or her position as an officer or director of RadNet, or as an employee, agent, officer or director of any other entity if the officer or director is serving in that capacity at RadNet&#8217;s request, to the fullest extent permitted under applicable law. RadNet is not obligated to indemnify directors and officers (i) as to circumstances in which indemnity is expressly prohibited pursuant to the DGCL, or (ii) for any acts or omissions or transactions from which a director may not be relieved of liability pursuant to the DGCL.</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The iCAD Certificate of Incorporation and Bylaws provide for indemnification of officers and directors to the fullest extent permitted by, and in the manner permissible under, applicable state and federal law, including the DGCL. iCAD has also entered into separate indemnification agreements with its officers and directors, pursuant to which iCAD agreed to indemnify the officer or director against all liabilities relating to his or her position as an officer or director of iCAD, or as an employee, agent, officer or director of any other entity if the officer or director is serving in that capacity at iCAD&#8217;s request, to the fullest extent permitted under applicable law. iCAD is not obligated to indemnify directors and officers (i) as to circumstances in which indemnity is expressly prohibited pursuant to the DGCL, or (ii) for any acts or omissions or transactions from which a director may not be relieved of liability pursuant to the DGCL.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 131 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Conversion Rights</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 49%"><span style="font-family: Times New Roman, Times, Serif">RadNet does not currently have any outstanding shares of undesignated preferred stock.</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: justify; width: 49%"><span style="font-family: Times New Roman, Times, Serif">iCAD does not currently have any outstanding shares of undesignated preferred stock.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Preemptive Rights</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">RadNet stockholders do not have preemptive rights. Thus, if additional shares of RadNet Common Stock are issued, the current holders of RadNet Common Stock will own a proportionately smaller interest in a larger number of outstanding shares of RadNet Common Stock to the extent that they do not participate in the additional issuance.</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">iCAD stockholders do not have preemptive rights. Thus, if additional shares of iCAD Common Stock are issued, the current holders of iCAD Common Stock will own a proportionately smaller interest in a larger number of outstanding shares of iCAD Common Stock to the extent that they do not participate in the additional issuance.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Distributions to Stockholders</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The DGCL permits a Delaware corporation to declare
    and pay dividends out of surplus or, if there is no surplus, out of net profits for the fiscal year in which the dividend is declared
    and/or for the preceding fiscal year as long as the amount of capital of the corporation following the declaration and payment of the
    dividend is not less than the aggregate amount of the capital represented by the issued and outstanding stock of all classes having a
    preference upon the distribution of assets.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to any preferential dividend rights of
    any outstanding preferred stock and the provisions of the RadNet Certificate of Incorporation and applicable law, dividends may be declared
    and paid or set apart for payment upon RadNet Common Stock out of any assets or funds of RadNet legally available for the payment of dividends,
    but only when and as declared by the RadNet Board or any authorized committee thereof.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The DGCL permits a Delaware corporation to declare
    and pay dividends out of surplus or, if there is no surplus, out of net profits for the fiscal year in which the dividend is declared
    and/or for the preceding fiscal year as long as the amount of capital of the corporation following the declaration and payment of the
    dividend is not less than the aggregate amount of the capital represented by the issued and outstanding stock of all classes having a
    preference upon the distribution of assets.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to any preferential dividend rights
of any outstanding preferred stock and the provisions of the iCAD Certificate of Incorporation and applicable law, dividends may be declared
and paid or set apart for payment upon iCAD Common Stock out of any assets or funds of iCAD legally available for the payment of dividends,
but only when and as declared by the iCAD Board or any authorized committee thereof.</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Exclusive Forum</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">RadNet does not have an exclusive forum in place.</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">iCAD does not have an exclusive forum in place.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Registration Rights</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">RadNet does not have any registration rights in place.</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">iCAD does not have any registration rights in place.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>Stock Transfer Restrictions Applicable to Stockholders</i></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The RadNet Certificate of Incorporation contains provisions generally restricting any direct or indirect transfer of shares of RadNet Common Stock where the transferee(s), individually or collectively, is or would become a &#8220;5-percent shareholder,&#8221; as such term is defined in the U.S. Internal Revenue Service Treasury Regulation ss. 1.382-2T(g) (referred to herein as the Treasury Regulation), or would increase the ownership percentage of an existing 5-percent shareholder. </span></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither the iCAD Certificate of Incorporation
or iCAD Bylaws generally restrict direct or indirect transfers of shares of iCAD Common Stock.</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 132 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_057"></span>EXPERTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The consolidated financial statements of RadNet,
Inc. and subsidiaries appearing in RadNet, Inc.&#8217;s Annual Report (Form 10-K) for the year ended December 31, 2024, and the effectiveness
of RadNet, Inc. and subsidiaries&#8217; internal control over financial reporting as of December 31, 2024, have been audited by Ernst
&amp; Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated
herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on
the authority of such firm as experts in accounting and auditing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The consolidated financial statements of iCAD,
Inc. as of December 31, 2024 and 2023 and for each of the years then ended incorporated by reference in this proxy statement/prospectus
and in the registration statement have been so incorporated in reliance on the report of BDO USA, P.C., an independent registered public
accounting firm, given on the authority of said firm as experts in auditing and accounting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_058"></span>LEGAL MATTERS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The validity of the shares of RadNet Common Stock
to be issued to iCAD stockholders pursuant to the Merger will be passed upon by Perkins Coie LLP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 133 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_059"></span>FUTURE iCAD STOCKHOLDER PROPOSALS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If the Merger Agreement is approved by the requisite
vote of iCAD&#8217;s stockholders and the Merger is completed, iCAD will become a wholly-owned subsidiary of RadNet and, consequently,
will not hold subsequent annual meetings of its stockholders. After the completion of the Merger, iCAD stockholders would be entitled
to participate, as stockholders of RadNet following the Merger, in the annual meetings of the stockholders of RadNet. RadNet and iCAD
currently expect to complete the Merger in the second or third quarter of 2025, subject to timing of satisfaction of closing conditions
to the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If the Merger Agreement is not adopted by the
requisite vote of holders of iCAD Common Stock or if the Merger is otherwise not completed for any reason in 2025, iCAD intends to hold
an annual meeting of its stockholders in 2025. iCAD&#8217;s proxy statement for the 2024 annual meeting of iCAD stockholders contained
information regarding presentation of stockholder proposals under Rule 14a-8 or other business or nominations at a 2025 annual meeting
of iCAD stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">iCAD stockholders who wished to present proposals
appropriate for consideration at iCAD&#8217;s 2025 annual meeting of stockholders must have submitted a notice containing the proposal
in proper form consistent with the iCAD Bylaws, addressed to the attention of iCAD&#8217;s Corporate Secretary at 2 Townsend West, Suite
6, Nashua, New Hampshire 03063 and in accordance with applicable regulations under Rule 14a-8 of the Exchange Act, received by iCAD no
later than December 30, 2024 in order for the proposal to be considered for inclusion in iCAD&#8217;s proxy statement and form of proxy
relating to such annual meeting. In addition to satisfying all the requirements under the iCAD Bylaws, to comply with the SEC&#8217;s
universal proxy rules for iCAD&#8217;s 2025 annual meeting of stockholders, stockholders who intended to solicit proxies in support of
director nominees other than iCAD&#8217;s nominees must have provided notice that sets forth all of the information required by Rule 14a-19
under the Exchange Act, and the stockholder must have given timely notice of such proposal or nomination, in proper written form. If the
stockholder did not also comply with the requirements of Rule 14a-4(c)(2) under the Exchange Act, iCAD may exercise discretionary voting
authority under proxies that iCAD solicits to vote in accordance with iCAD&#8217;s best judgment on any such stockholder proposal or nomination.
To make a submission or to request a copy of the iCAD Bylaws, stockholders should contact iCAD&#8217;s Corporate Secretary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If an iCAD stockholder submits a proposal after
the deadline required under Rule 14a-8 of the Exchange Act but still wishes to present the proposal at iCAD&#8217;s 2025 annual meeting
of stockholders (but not in iCAD&#8217;s proxy statement), the proposal, which must be presented in a manner consistent with the iCAD
Bylaws and applicable law, must be submitted to iCAD&#8217;s Corporate Secretary in proper form at the address set forth above so that
it is received by iCAD&#8217;s Corporate Secretary not less than 50 nor more than 75 days prior to the meeting unless less than 65 days&#8217;
notice or prior public disclosure of the date of the meeting is given or made to iCAD stockholders, in which case, no less than the close
of business on the tenth day following the earlier of the date on which the notice of the date of the meeting was mailed or other public
disclosure of the date of the meeting was made. Any such notice must set forth as to each matter the stockholder proposes to bring before
the meeting: (i) a description of each item of business proposed to be brought before the meeting and the reasons for conducting such
business at the meeting; (ii) the name and record address of the stockholder proposing to bring such item of business before the meeting;
(iii) the class or series and number of shares of our stock which are held of record or owned beneficially and represented by proxy by
such stockholder as of the record date for the meeting (if such date then will have been made publicly available) and as of the date of
such notice; (iv) a description of all arrangements or understandings between such stockholder and any other person or persons (including
their names) in connection with the proposal of such business by such stockholder and any material interest of such stockholder in such
business; (v) a representation that such stockholder intends to appear in person or by proxy at the meeting to bring such business before
the meeting, and (vi) all other information which would be required to be included in a proxy statement filed with the SEC if, with respect
to any such item of business, such stockholder were a participant in a solicitation subject to Section 14 of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Any iCAD stockholder entitled to vote in the election
of directors generally may nominate one or more persons for election as directors at a meeting only if written notice of such stockholder&#8217;s
intent to make such nomination or nominations has been delivered personally to, or been mailed to and received by iCAD&#8217;s Corporate
Secretary at the address set forth above, not less than 50 days nor more than 75 days prior to the meeting; provided, however, that, in
the event that less than 65 days&#8217; notice or prior public disclosure of the date of the meeting is given or made to stockholders,
notice by the stockholder to be timely must be received not later than the close of business on the tenth day following the earlier of
(i) the day on which such notice of the date of the meeting was mailed or (ii) such public disclosure was made. To be in proper form,
each such notice must set forth: (i) the name and record address of the stockholder who intends to make the nomination and of the person
or persons to be nominated; (ii) the class or series and number of shares of our stock which are held of record, owned beneficially and
represented by proxy by such stockholder as of the record date for the meeting (if such date will then have been made publicly available)
and of the date of such notice; (iii) a representation that the stockholder intends to appear in person or by proxy at the meeting to
nominate the person or persons specified in the notice; (iv) a description of all arrangements or understandings between such stockholder
and each nominee and any other person or persons (naming such person or persons) pursuant to which the nomination or nominations are to
be made by such stockholder; (v) the name, age, business address and residence address of the nominee and such other information regarding
each nominee proposed by such stockholder as would be required to be included in a proxy statement filed pursuant to the proxy rules of
the SEC, had each nominee been nominated, or intended to be nominated by the iCAD Board; and (vi) the written consent of each nominee
to serve as a director if so elected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 134 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="s4_060"></span>WHERE YOU CAN FIND MORE INFORMATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">RadNet and iCAD file annual, quarterly and current
reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information
statements and other information regarding issuers that file electronically with the SEC, including both RadNet and iCAD, which you can
access at www.sec.gov, free of charge. In addition, you may obtain free copies of the documents RadNet and iCAD file with the SEC, including
the registration statement on Form S-4 of which this proxy statement/prospectus forms a part, by going to RadNet&#8217;s and iCAD&#8217;s
websites at www.radnet.com and www.icadmed.com, respectively. The websites of RadNet and iCAD are provided as inactive textual references
only. The information contained on or accessible through the websites of RadNet and iCAD (other than the documents listed below that are
incorporated by reference herein) does not constitute a part of this proxy statement/prospectus and is not incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">Statements
                                            contained or incorporated by reference in this proxy statement/prospectus regarding the contents
                                            of any contract or other document are not necessarily complete, and each such statement is
                                            qualified in its entirety by reference to the full text of that contract or other document
                                            filed as an exhibit with the SEC. The SEC allows RadNet and iCAD to &#8220;incorporate by
                                            reference&#8221; of this proxy statement/prospectus documents that RadNet and iCAD file with
                                            the SEC, including certain information required to be included in the registration statement
                                            on Form S-4 of which this proxy statement/prospectus forms a part. This means that RadNet
                                            and iCAD can disclose important information to you by referring you to those documents. The
                                            information incorporated by reference herein is considered to be a part of this proxy statement/prospectus,
                                            and later information that RadNet and iCAD file with the SEC will update and supersede that
                                            information. Each of RadNet and iCAD incorporates by reference the following documents and
                                            any documents subsequently filed by it pursuant to Section 13(a), 13(c), 14 or 15(d) of the
                                            Exchange Act (i) after the initial filing and prior to the effectiveness of the registration
                                            statement on Form S-4 of which this proxy statement/prospectus forms a part and (ii) after
                                            the date of this initial registration statement on Form S-4 of which this proxy statement/prospectus
                                            forms a part and before the date of the Special Meeting (other than, in each case, those
                                            documents, or the portions of those documents or exhibits thereto, deemed to be furnished
                                            and not filed in accordance with SEC rules). These documents contain important information
                                            about RadNet&#8217;s and iCAD&#8217;s businesses and financial performance.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">This proxy statement/prospectus incorporates by
reference the documents set forth below previously filed with the SEC:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000749660/000143774925010259/icad20241231_10k.htm">Annual Report
on Form 10-K for the fiscal year ended December 31, 2024</a>, filed with the SEC on March 31, 2025, as amended by <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000749660/000119380525000588/e664438_10ka-icad.htm">Amendment
No. 1 on Form 10-K/A filed with the SEC on April 30, 2025</a>.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                        <tr style="vertical-align: top">
<td>&#160;</td><td><span style="font-family: Symbol">&#183;</span></td><td>iCAD&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/749660/000143774925016489/icad20250331c_10q.htm">Quarterly
                                            Report on Form 10-Q for the quarterly period ended March 31, 2025</a>, filed with the SEC
                                            on May 13, 2025.</td></tr>
                                                                        </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>RadNet&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/790526/000162828025009481/rdnt-20241231.htm">Annual Report
on Form 10-K for the fiscal year ended December 31, 2024</a>, filed with the SEC on March 3, 2025, as amended by <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000790526/000168316825002860/radnet_10ka-2024.htm">Amendment
No. 1 on Form 10-K/A, filed with the SEC on April 28, 2025</a>.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>The Part III information contained in RadNet&#8217;s definitive proxy statement on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000790526/000168316825002862/radnet_idef14a.htm">Schedule
14A for RadNet&#8217;s 2025 annual meeting of stockholders, filed with the SEC on April 28, 2025</a>, that was incorporated into RadNet&#8217;s
<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/790526/000162828025009481/rdnt-20241231.htm">Annual Report on Form 10-K for the
fiscal year ended December 31, 2024</a>, filed with the SEC on March 3, 2025.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                       <tr style="vertical-align: top">
<td>&#160;</td><td><span style="font-family: Symbol">&#183;</span></td><td>RadNet&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/790526/000162828025024672/rdnt-20250331.htm">Quarterly
                                            Report on Form 10-Q for the quarterly period ended March 31, 2025</a>, filed with the SEC
                                            on May 12, 2025.</td></tr>
                                                                                       </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>iCAD&#8217;s Current Report on Form 8-K filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/749660/000119380525000483/e664385_8k-icad.htm">April
15, 2025</a>.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>The description of iCAD&#8217;s securities contained in&#160;<a href="http://www.sec.gov/Archives/edgar/data/749660/000143774923008815/ex_460076.htm">Exhibit&#160;4.1</a>
to iCAD&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000749660/000143774925010259/icad20241231_10k.htm">Annual Report
on Form 10-K for the fiscal year ended December 31, 2024</a>, filed with the SEC on March 31, 2025 and in any report filed for the purpose
of amending such description.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.5pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>The description of RadNet&#8217;s securities contained in&#160;<a href="https://www.sec.gov/Archives/edgar/data/790526/000168316822008645/radnet_s3asr.htm">Exhibit&#160;4.1</a>
to RadNet&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/790526/000162828025009481/rdnt-20241231.htm">Annual Report
on Form 10-K for the fiscal year ended December 31, 2024</a>, filed with the SEC on March 3, 2025, and in any report filed for the purpose
of amending such description.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 135 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Copies of this proxy statement/prospectus and
the documents incorporated by reference are available from RadNet or iCAD, as the case may be, without charge, excluding any exhibits
to those documents, unless the exhibit is specifically incorporated by reference into this proxy statement/prospectus. RadNet stockholders
or iCAD stockholders, as applicable, may obtain these documents incorporated by reference by requesting them in writing or by telephone
from the appropriate party at the following addresses and telephone numbers:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt"><b>iCAD, Inc.</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>RadNet, Inc.</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt">2 Townsend West, Suite 6</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">1510 Cotner Avenue</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt">Nashua, New Hampshire 03063</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">Los Angeles, California 90025</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt">Attention: Investor Relations</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">Attention: Investor Relations</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt">(603) 882-5200</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">(310) 445-2800</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt">icad@imsinvestorrelations.com</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">investorrelations@radnet.com</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><b>To obtain timely delivery of the documents,
you must request them no later than five business days before the date of the Special Meeting. Therefore, if you would like to request
documents from RadNet or iCAD, please do so by July 7, 2025 in order to receive them before the Special Meeting.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 136 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-size: 10pt"><b><span id="annexa"></span>Annex A<br/>
<br/>
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>



<p style="margin: 0"></p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-size: 0.5pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AGREEMENT AND PLAN OF MERGER</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: normal">by and among</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RADNET, INC.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TRIO MERGER SUB, INC.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: normal">and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">iCAD, INC.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: normal">dated as of April
15, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 2.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 2.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 2.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 2.5in">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-size: 0.5pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 137 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: underline">TABLE OF CONTENTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="text-decoration: underline">Page</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 90%; text-align: left; padding-top: 9pt; padding-bottom: 3pt; padding-left: 0in">ARTICLE I DEFINITIONS</td>
    <td style="width: 10%; text-align: right; padding-top: 9pt; padding-bottom: 3pt">1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 1.1&#160;&#160;&#160;Definitions</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 1.2&#160;&#160;&#160;Interpretation.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">13</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 9pt; padding-bottom: 3pt; padding-left: 0in">ARTICLE II THE MERGER</td>
    <td style="text-align: right; padding-top: 9pt; padding-bottom: 3pt">14</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 2.1&#160;&#160;&#160;The Merger</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">14</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 2.2&#160;&#160;&#160;Closing</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">14</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 2.3&#160;&#160;&#160;Effective Time</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">14</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 2.4&#160;&#160;&#160;Effects of the Transaction</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">14</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 2.5&#160;&#160;&#160;Intended Tax Treatment</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">14</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 2.6&#160;&#160;&#160;Organizational Documents; Merger Sub Arrangements</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">14</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 9pt; padding-bottom: 3pt; padding-left: 0in">ARTICLE III EFFECT OF THE MERGER ON THE CAPITAL STOCK OF COMPANY; EXCHANGE OF CERTIFICATES</td>
    <td style="text-align: right; padding-top: 9pt; padding-bottom: 3pt">15</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 3.1&#160;&#160;&#160;Effect of the Merger</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">15</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 3.2&#160;&#160;&#160;Exchange of Shares and Certificates.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">16</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 3.3&#160;&#160;&#160;Certain Adjustments</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">19</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 3.4&#160;&#160;&#160;Further Assurances</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">19</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 9pt; padding-bottom: 3pt; padding-left: 0in">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF COMPANY</td>
    <td style="text-align: right; padding-top: 9pt; padding-bottom: 3pt">20</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.1&#160;&#160;&#160;Organization, Standing and Corporate Power</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">20</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.2&#160;&#160;&#160;Corporate Authority; Non-contravention.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">20</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.3&#160;&#160;&#160;Capital Structure.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">21</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.4&#160;&#160;&#160;Subsidiaries.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">22</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.5&#160;&#160;&#160;SEC Documents; Financial Statements; Undisclosed Liabilities.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">22</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.6&#160;&#160;&#160;Absence of Certain Changes or Events.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">23</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.7&#160;&#160;&#160;Compliance with Applicable Laws; Outstanding Orders</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">24</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.8&#160;&#160;&#160;Regulatory Matters and Compliance with Healthcare Laws.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">24</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.9&#160;&#160;&#160;Corrupt Practices</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">25</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.10&#160;&#160;&#160;Sanctions</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">26</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.11&#160;&#160;&#160;Litigation</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">26</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.12&#160;&#160;&#160;Benefit Plans.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">26</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.13&#160;&#160;&#160;Labor and Employment Matters.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">28</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.14&#160;&#160;&#160;Taxes.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">29</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.15&#160;&#160;&#160;Intellectual Property</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">30</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.16&#160;&#160;&#160;Information Technology; Data Protection</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">33</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.17&#160;&#160;&#160;Certain Contracts.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">34</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.18&#160;&#160;&#160;Environmental Protection</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">36</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.19&#160;&#160;&#160;Real Property.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">36</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.20&#160;&#160;&#160;Voting Requirements</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">36</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.21&#160;&#160;&#160;Opinion of Financial Advisors</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">37</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.22&#160;&#160;&#160;Brokers</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">37</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 4.23&#160;&#160;&#160;No Other Representations.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">37</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 138 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 9pt; padding-bottom: 3pt; padding-left: 0in; width: 90%">ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT</td>
    <td style="text-align: right; padding-top: 9pt; padding-bottom: 3pt; width: 10%">38</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 5.1&#160;&#160;&#160;Organization, Standing and Corporate Power</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">38</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 5.2&#160;&#160;&#160;Corporate Authority; Non-contravention.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">38</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 5.3&#160;&#160;&#160;Capital Structure.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">39</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 5.4&#160;&#160;&#160;Subsidiaries.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">40</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 5.5&#160;&#160;&#160;SEC Documents; Financial Statements; Undisclosed Liabilities.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">40</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 5.6&#160;&#160;&#160;Absence of Certain Changes or Events.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">41</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 5.7&#160;&#160;&#160;Compliance with Applicable Laws; Outstanding Orders</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">41</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 5.8&#160;&#160;&#160;Sanctions</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 5.9&#160;&#160;&#160;Litigation</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 5.10&#160;&#160;&#160;Brokers</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 5.11&#160;&#160;&#160;Merger Sub</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 5.12&#160;&#160;&#160;No Other Representations.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 9pt; padding-bottom: 3pt; padding-left: 0in">ARTICLE VI COVENANTS RELATING TO CONDUCT OF BUSINESS</td>
    <td style="text-align: right; padding-top: 9pt; padding-bottom: 3pt">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 6.1&#160;&#160;&#160;Conduct of Business</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 6.2&#160;&#160;&#160;No Solicitation by Company</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">46</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 9pt; padding-bottom: 3pt; padding-left: 0in">ARTICLE VII ADDITIONAL AGREEMENTS</td>
    <td style="text-align: right; padding-top: 9pt; padding-bottom: 3pt">48</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.1&#160;&#160;&#160;Form S-4 and Company Proxy Statement; Stockholders Meetings.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">48</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.2&#160;&#160;&#160;Access to Information; Confidentiality</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">50</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.3&#160;&#160;&#160;Reasonable Best Efforts.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">50</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.4&#160;&#160;&#160;Indemnification, Exculpation and Insurance.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">52</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.5&#160;&#160;&#160;Fees and Expenses</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">53</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.6&#160;&#160;&#160;Public Announcements</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">53</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.7&#160;&#160;&#160;NASDAQ Listing</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">53</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.8&#160;&#160;&#160;Takeover Statutes</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">53</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.9&#160;&#160;&#160;Transfer Taxes</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">54</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.10&#160;&#160;&#160;Employee Matters.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">54</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.11&#160;&#160;&#160;Section 16 Matters</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">55</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.12&#160;&#160;&#160;Certain Litigation</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">55</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.13&#160;&#160;&#160;Stock Exchange Delisting; Deregistration</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">55</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.14&#160;&#160;&#160;Tax Matters.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">55</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.15&#160;&#160;&#160;Merger Sub Stockholder Consent and Other Transaction Consents</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.16&#160;&#160;&#160;Notices of Certain Events</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.17&#160;&#160;&#160;Resignations</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 7.18&#160;&#160;&#160;Forms 5500</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 9pt; padding-bottom: 3pt; padding-left: 0in">ARTICLE VIII CONDITIONS PRECEDENT</td>
    <td style="text-align: right; padding-top: 9pt; padding-bottom: 3pt">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 8.1&#160;&#160;&#160;Conditions to Each Party&#8217;s Obligation to Effect the Merger</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 8.2&#160;&#160;&#160;Conditions to Obligations of Parent</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">57</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 8.3&#160;&#160;&#160;Conditions to Obligations of Company</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">58</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 139 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 9pt; padding-bottom: 3pt; padding-left: 0in; width: 90%">ARTICLE IX TERMINATION, AMENDMENT AND WAIVER</td>
    <td style="text-align: right; padding-top: 9pt; padding-bottom: 3pt; width: 10%">58</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 9.1&#160;&#160;&#160;Termination</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">58</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 9.2&#160;&#160;&#160;Effect of Termination.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">59</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 9pt; padding-bottom: 3pt; padding-left: 0in">ARTICLE X GENERAL PROVISIONS</td>
    <td style="text-align: right; padding-top: 9pt; padding-bottom: 3pt">60</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.1&#160;&#160;&#160;Amendment</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">60</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.2&#160;&#160;&#160;Extension; Waiver</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">60</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.3&#160;&#160;&#160;Non-Survival of Representations and Warranties</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">60</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.4&#160;&#160;&#160;Notices</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">61</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.5&#160;&#160;&#160;Counterparts</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">61</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.6&#160;&#160;&#160;Entire Agreement; No Third-Party Beneficiaries</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">62</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.7&#160;&#160;&#160;Assignment</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">62</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.8&#160;&#160;&#160;GOVERNING LAW</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">62</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.9&#160;&#160;&#160;WAIVER OF JURY TRIAL</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">62</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.10&#160;&#160;&#160;Specific Enforcement</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">62</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.11&#160;&#160;&#160;Jurisdiction</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">62</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.12&#160;&#160;&#160;Headings, etc.</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">62</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 3pt; padding-left: 12.25pt">Section 10.13&#160;&#160;&#160;Severability</td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 3pt">63</td></tr>
</table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<!-- Field: Page; Sequence: 140 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AGREEMENT AND PLAN OF MERGER</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS AGREEMENT AND PLAN OF
MERGER, dated as of April 15, 2025 (this &#8220;<span style="text-decoration: underline">Agreement</span>&#8221;), by and among RadNet, Inc., a Delaware corporation (&#8220;<span style="text-decoration: underline">Parent</span>&#8221;),
Trio Merger Sub, Inc., a wholly owned subsidiary of Parent and a Delaware corporation (&#8220;<span style="text-decoration: underline">Merger Sub</span>&#8221;), and iCAD, Inc.,
a Delaware corporation (&#8220;<span style="text-decoration: underline">Company</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">W I T N E S S E T H:</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Parent Board
and the Company Board have deemed it advisable and in the best interests of their respective corporations and stockholders that Parent
and Company engage in the transactions contemplated by this Agreement, subject to the terms and conditions set forth herein;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Parent Board
has approved and declared advisable the transactions contemplated by this Agreement, including the Merger and the Parent Share Issuance,
on the terms and subject to the conditions set forth in this Agreement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company Board
has (a) approved and declared advisable this Agreement and the transactions contemplated by this Agreement, including the Merger, on the
terms and subject to the conditions set forth in this Agreement, (b) determined that this Agreement and the transactions contemplated
by this Agreement, including the Merger, are fair to, and in the best interests of, Company and the stockholders of Company, (c) resolved
to recommend the adoption of this Agreement to the stockholders of Company, on the terms and subject to the conditions set forth in this
Agreement, and (d) directed that this Agreement be submitted to the stockholders of Company for adoption at the Company Stockholders Meeting;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Board of Directors
of Merger Sub has approved and declared advisable this Agreement and the Merger and has resolved to recommend to its stockholder the adoption
of this Agreement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, concurrently with
the entry into this Agreement and as an inducement to Parent entering into this Agreement, the Company Board have delivered to Parent
duly executed voting and support agreements, agreeing to certain matters with respect to the Merger and the other transactions contemplated
by this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the representations, warranties, covenants and agreements set forth herein, the parties hereto agree as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE I<br/>
DEFINITIONS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 1.1</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Definitions</span>. For purposes of this Agreement, the following terms shall have the following meanings:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">2005 Company Plan</span>&#8221; means Company&#8217;s 2005 Stock Incentive Plan, as amended or restated from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">2012 Company Plan</span>&#8221; means Company&#8217;s 2012 Stock Incentive Plan, as amended or restated from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">2016 Company Plan</span>&#8221; means Company&#8217;s 2016 Stock Incentive Plan, as amended or restated from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">2024 Company Plan</span>&#8221; means Company&#8217;s 2024 Omnibus Equity Incentive Plan, as amended or restated from time
to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Action</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.11</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 141 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Affiliate</span>&#8221; means, with respect to any person, another person that directly or indirectly, through one or more
intermediaries, controls, is controlled by, or is under common control with, such first person, where &#8220;<span style="text-decoration: underline">control</span>&#8221; means
the possession, directly or indirectly, of the power to direct or cause the direction of the management policies of a person, whether
through the ownership of voting securities, by contract, as trustee or executor, or otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Agreement</span>&#8221; has the meaning given to it in the Preamble.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(h)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">AI Technology</span>&#8221; means any (i) techniques that enable computers to mimic human intelligence, including deep learning,
machine learning and other artificial intelligence (AI) technologies and algorithms, software, or systems that make use of or employ neural
networks, statistical learning algorithms or reinforcement learning, and (ii) software and hardware used to operate, train, test, improve,
develop, and deploy any such techniques, including, in each case, as may be incorporated into the Company Products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Alternative Transaction</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 6.2(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(j)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Anti-Corruption Laws</span>&#8221; means the U.S. Foreign Corrupt Practices Act of 1977, the U.S. Travel Act, the U.K. Bribery
Act 2010, the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions or any other Applicable
Law relating to anti-corruption or anti-bribery.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(k)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Antitrust Law</span>s&#8221; means the United States Sherman Antitrust Act of 1890, as amended, the United States Clayton
Act of 1914, as amended, the HSR Act, the United States Federal Trade Commission Act of 1914, as amended and all other Applicable Laws,
including foreign laws, designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization,
abuse of dominant position, restraint of trade, lessening of competition, or impeding effective competition through merger or acquisition,
or regulating foreign investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(l)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Applicable Law</span>&#8221; means all applicable federal, national, state, provincial, local or supranational laws (statutory,
common or otherwise), acts, statutes, constitutions, treaties, ordinances, guidance, codes, ordinances, rules or regulations promulgated,
administrative interpretation, policy, or decisions, directives or Orders or other similar requirements issued, enacted, adopted, promulgated,
implemented, applied or otherwise put into effect or enforced by any Governmental Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(m)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Assumed Option</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 3.1(b)(i)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(n)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Author</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.15(e)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(o)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Business Day</span>&#8221; means any day other than a Saturday, Sunday or federal holiday, or a day on which banks in New
York, New York are authorized or obligated by law to close.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(p)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">CE Mark Countries</span>&#8221; means the twenty-seven (27) member states of the European Union, the United Kingdom, Iceland,
Liechtenstein, Switzerland and Norway.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(q)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Certificate of Merger</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 2.3</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(r)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Change</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 1.1(vvvv)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(s)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Closing</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 2.2</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(t)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Closing Date</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 2.2</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 142 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(u)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Code</span>&#8221; means the Internal Revenue Code of 1986.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(v)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company</span>&#8221; has the meaning given to it in the Preamble.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(w)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company 401(k) Plan</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 7.10(c)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(x)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Balance Sheet</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.5(c)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(y)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Benefit Plan</span>&#8221; means each compensation or benefit plan, policy, program, arrangement or agreement, whether
or not written, including any &#8220;employee welfare benefit plan&#8221; within the meaning of Section 3(1) of ERISA (whether or not
such plan is subject to ERISA), any &#8220;employee pension benefit plan&#8221; within the meaning of Section 3(2) of ERISA (whether or
not such plan is subject to ERISA) and any bonus, commission, incentive, deferred compensation, vacation, stock purchase, stock or stock-based,
profit sharing, phantom stock, severance, retention, salary continuation, insurance, cafeteria, employment, personal services, sale, transaction,
change of control or fringe benefit plan, policy, program, arrangement or agreement that (i) is or has been sponsored, maintained or contributed
to by Company or any of its Subsidiaries or which Company or any of its Subsidiaries is obligated to sponsor, maintain or contribute to;
(ii) is or has been sponsored, maintained or contributed to by any ERISA Affiliate or which any ERISA Affiliate is obligated to sponsor,
maintain or contribute to, in each case for the benefit of any current or former employee, director, manager, contractor, consultant or
other service provider of or to Company; or (iii) with respect to which Company or any of its Subsidiaries has or could have any liability
(including any contingent liability, any liability by reason of at any time having an ERISA Affiliate and any liability under or with
respect to a terminated Company Benefit Plan).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(z)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Board</span>&#8221; means the Board of Directors of Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(aa)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Book-Entry Share</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section&#160;3.2(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(bb)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company CE Products</span>&#8221; means the Company Products that are sold in reliance upon the EU Medical Devices Directive
and relevant parts of the EU Medical Devices Regulation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(cc)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Certificate</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 3.2(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(dd)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Common Stock</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.3(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ee)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Data</span>&#8221; means Personal Data, Confidential Information, and any other proprietary information processed
by or on behalf of Company or any of its Subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ff)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Disclosure Letter</span>&#8221; has the meaning given to it in the first paragraph in <span style="text-decoration: underline">ARTICLE IV</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(gg)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company ESPP</span>&#8221; means Company&#8217;s 2019 Employee Stock Purchase Plan, as may be amended from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(hh)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Field Safety Notices</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.8(d)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Filed SEC Documents</span>&#8221; has the meaning given to it in the first paragraph in <span style="text-decoration: underline">ARTICLE IV</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(jj)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Financial Advisor</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.21</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(kk)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Foreign Plan</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.12(j)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 143 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ll)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company IP</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.15(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(mm)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Leased Real Property</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.19(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(nn)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Material Contracts</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.17(a)(xvii)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(oo)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Option</span>&#8221; means an option to purchase shares of Company&#160;Common Stock granted under any equity incentive
plan, program or agreement maintained by Company or to which Company is a party, including any of the Company&#160;Stock Incentive Plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(pp)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Options Capitalization Table</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.3(c)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(qq)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Owned IP</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.15(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(rr)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Permits</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.7</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ss)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Preferred Stock</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.3(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(tt)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Product</span>&#8221; means all products or services now or previously produced, marketed, licensed, sublicensed,
sold, distributed or performed by or on behalf of Company or any of its Subsidiaries and all products or services currently under development
by Company or any of its Subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(uu)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Proxy Statement/Prospectus</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.2(c)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Real Property Lease</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.19(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ww)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Recommendation Change</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 6.2(c)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xx)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Registered IP</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.15(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(yy)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company SEC Documents</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.5(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(zz)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Source Code</span>&#8221; means, collectively, any software source code or database specifications or designs, or
any proprietary information or algorithm contained in or relating to any software source code or database specifications or designs, of
any Company Owned IP or Company Products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(aaa)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Stock Incentive Plans</span>&#8221; means, collectively, (i) the 2005&#160;Company Plan, (ii) the 2012 Company Plan,
(iii) the 2016 Company Plan, (iv) the 2024&#160;Company Plan, and (v) the Company ESPP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(bbb)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Stockholder Approval</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.20</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ccc)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Stockholders Meeting</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 7.1(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ddd)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Termination Fee</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 9.2(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(eee)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company Third Party</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 6.2(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 144 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(fff)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Confidential Information</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.15(d)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ggg)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Confidentiality Agreement</span>&#8221; means the confidentiality agreement set forth on <span style="text-decoration: underline">Section 1.1(ggg)</span> of the
Parent Disclosure Letter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(hhh)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Continuing Employee</span>&#8221; means an individual who, immediately prior to the Effective Time, is an employee of Company
or any of its Subsidiaries and who, immediately after the Effective Time, continues as an employee of the Surviving Corporation, Parent
or any of their respective Subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Continuing U.S. Employee</span>&#8221; means a Continuing Employee who resides in the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(jjj)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Control</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 1.1(f)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(kkk)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">D&amp;O Indemnified Parties</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 7.4(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(lll)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">DFVCP</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 7.18</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(mmm)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">DGCL</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 2.1</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(nnn)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">DOL</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 7.18</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ooo)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Effective Time</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 2.3</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ppp)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Eligible Company Option</span>&#8221; means each Company Option (whether or not vested or exercisable) that (i) has been
validly granted under any Company Stock Incentive Plan with an exercise price per share of Company Common Stock that is less than $7.20
and (ii) is outstanding and unexercised as of immediately prior to the Effective Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(qqq)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Enforceability Exceptions</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.2(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(rrr)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Environmental Laws</span>&#8221; means all Applicable Laws relating to pollution or protection of the environment, natural
resources, including natural resource damages, or, as it relates to exposure to Hazardous Materials, public or worker health and safety,
including Applicable Laws relating to Releases of, or exposure to, Hazardous Materials, and to the manufacture, processing, distribution,
use, treatment, storage, transport or handling of Hazardous Materials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(sss)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Environmental Permits</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.18</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ttt)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">EPCRS</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.12(e)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(uuu)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Equity Securities</span>&#8221; means, with respect to any Person, (i) any shares of capital or capital stock (including
any ordinary shares) or other voting securities of, or other ownership interest in, such Person, (ii) any securities of such Person convertible
into or exchangeable for cash or shares of capital or capital stock or other voting securities of, or other ownership interests in, such
Person or any of its Subsidiaries, (iii) any warrants, calls, options or other rights to acquire from such Person, or other obligations
of such Person to issue, any shares of capital or capital stock or other voting securities of, or other ownership interests in, or securities
convertible into or exchangeable for shares of capital or capital stock or other voting securities of, or other ownership interests in,
such Person or any of its Subsidiaries, or (iv) any restricted shares, stock appreciation rights, restricted units, performance units,
contingent value rights, &#8220;phantom&#8221; stock or similar securities or rights issued by or with the approval of such Person that
are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any shares of capital or capital
stock or other voting securities of, other ownership interests in, or any business, products or assets of, such Person or any of its Subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 145 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vvv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">ERISA</span>&#8221; means the United States Employee Retirement Income Security Act of 1974.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(www)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">ERISA Affiliate</span>&#8221; means any trade or business (whether or not incorporated) or any other Person that, together
with Company or any of its Subsidiaries, is or, at the relevant time, was treated as a single employer pursuant to Section 414(b), (c),
(m) or (o) of the Code or Section 4001(a)(14) or 4001(b)(1) of ERISA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xxx)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Ex-Im Laws</span>&#8221; means all Applicable Laws relating to export, re-export, transfer or import controls (including
without limitation, the Export Administration Regulations administered by the U.S. Department of Commerce and customs and import laws
administered by U.S. Customs and Border Protection).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(yyy)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Excess Shares</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 3.2(g)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(zzz)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Exchange Act</span>&#8221; means the Securities Exchange Act of 1934, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(aaaa)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Exchange Agent</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 3.2(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(bbbb)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Exchange Fund</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 3.2(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(cccc)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Exchange Ratio</span>&#8221; has the meaning given to it in Section 3.1(a).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(dddd)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Existing Indemnified Parties</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 7.4(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(eeee)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">FDA</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.8(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ffff)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Form S-4</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.2(c)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(gggg)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">GAAP</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.5(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(hhhh)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Governmental Entity</span>&#8221; means any federal, national, state, provincial, local or supranational government, any
court, legislative, administrative, regulatory or other governmental agency, commission or authority or any accrediting body or non-governmental
self-regulatory agency, Notified Body, commission or authority, in each case, whether domestic or foreign.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iiii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Governmental Health Program</span>&#8221; means any federal health program as defined in 42 U.S.C. &#167; 1320a-7b(f), including
but not limited to Medicare, Medicare Advantage, Medicaid, Managed Medicaid and Medicaid waiver programs, TRICARE, CHAMPVA, any state
health plan adopted pursuant to Title XIX of the Social Security Act (42 U.S.C. 1395 et seq.), any health insurance program for the benefit
of federal employees, including those under chapter 89 of title 5, United States Code, and any other state or federal healthcare program
administered by a Governmental Entity and any successor programs thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(jjjj)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Harmful Code</span>&#8221; means any computer software viruses, time bombs, Trojan horses, ransomware, spyware, adware or
scareware or other similar software is designed to or otherwise does assault, vandalize, disrupt, damage, disable, hack into, incapacitate,
infiltrate, slow or shut down a computer system.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(kkkk)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Hazardous Materials</span>&#8221; means any material, substance, chemical or waste (or combination thereof) that is listed,
defined, designated, regulated or classified as hazardous, toxic, radioactive, dangerous, a pollutant, a contaminant, a per- or polyfluoroalkyl
substance, petroleum, oil, asbestos, or words of similar meaning or effect, or for which liability or standards of conduct may be imposed,
under any Environmental Law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 146 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(llll)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Healthcare Laws</span>&#8221; means all Applicable Laws relating to healthcare delivery, regulatory, and reimbursement matters,
including but not limited to: (i) Title XVIII of the Social Security Act, 42 U.S.C. &#167;&#167; 1395-1395hhh (the Medicare statute);
(ii) any joint federal or state health care or health insurance program, including, Title XIX of the Social Security Act, 42 U.S.C. &#167;&#167;
1396-1396v (the Medicaid statute); (iii) TRICARE, 10 U.S.C. &#167; 1071 et seq.; (iv) 42 U.S.C. &#167;&#167; 1320a-7, 7a, and 7b, which
are commonly referred to as the &#8220;<span style="text-decoration: underline">Federal Fraud Statutes</span>,&#8221; and their state law counterparts; (v) 42 U.S.C. &#167; 1395nn,
which is commonly referred to as the &#8220;<span style="text-decoration: underline">Stark Law</span>,&#8221; and its state law counterparts; (vi) 31 U.S.C. &#167;&#167; 3729-
3733, which is commonly referred to as the &#8220;<span style="text-decoration: underline">federal False Claims Act</span>&#8221;; (vii) the Program Fraud Civil Remedies Act,
31 U.S.C. &#167;&#167; 3801-3812; (viii) 41 U.S.C. &#167;&#167; 51-58 (the Anti-Kickback Act of 1986,); (ix) 18 U.S.C. &#167; 1952 (the
Travel Act); (x) HIPAA (as defined herein); (xi) Applicable Laws relating to submission of claims to Payors; (xii) the Sunshine/Open Payments
Law (42 U.S.C. &#167; 1320a-7h); (xiii) 18 U.S.C. &#167; 220 (the Eliminating Kickbacks in Recovery Act of 2018), the Federal Criminal
False Claims Act (18 U.S.C. &#167; 287), the False Statements Relating to Health Care Matters Law (18 U.S.C. &#167; 1035), the Federal
Health Care Fraud Law (18 U.S.C. &#167; 1347); (xiv) the Deficit Reduction Act of 2005; (xv) 21 U.S.C. &#167;&#167; 301 et seq. (the Food,
Drug, and Cosmetic Act) together with implementing regulations and any other rules, regulations, or guidance published or promulgated
thereunder; (xvi) all federal, state or local statute or regulations relevant to mail fraud, wire fraud, false statements or claims; (xvii)
all Applicable Law relating to advertising or marketing of healthcare items or services; and (xviii) the Beneficiary Inducement Statute
(42 U.S.C. &#167; 1320a-7a(a)(5)); (xix) all Applicable Laws concerning the administration, ordering, storage, security or prescribing
of controlled substances, the federal Controlled Substances Act, 21 U.S.C. 13 et seq.; (xx) ISO 13485:2016, EU Regulation 2017/745 of
the European Parliament and of the Council of 5 April 2017 on medical devices (&#8220;<span style="text-decoration: underline">EU Medical Devices Regulation</span>&#8221;), EU
Medical Devices Directive 93/42/EEC (&#8220;<span style="text-decoration: underline">EU Medical Devices Directive</span>&#8221;); (xxi) EU Member States anti-gift and transparency
laws; and (xxii) all similar or comparable foreign, state, local Applicable Law counterparts to the foregoing, and the rules and regulations
promulgated thereunder, each as may be amended from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(mmmm)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Healthcare Permits</span>&#8221; means any and all licenses, Permits, certifications, authorizations, exemptions, waivers,
Governmental Health Program enrollments, registrations, accreditations, letters of non-reviewability, certificates of need, permits of
approval, consents, supplier or provider numbers, qualifications, operating authority, approvals or clearances, in each case that are
issued or enforced by a Governmental Entity with jurisdiction over any Healthcare Law, including any clearance, approval, license, registration,
exemption or other authorization necessary for the development, manufacture or commercialization of the Company Products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(nnnn)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Healthcare Reform Laws</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.12(f)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(oooo)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">HIPAA</span>&#8221; means the following, as the same may be amended, modified or supplemented from time to time, any successor
statute thereto, and together with any and all rules or regulations promulgated from time to time thereunder: (i) Health Insurance Portability
and Accountability Act of 1996, (ii) the Health Information Technology for Economic and Clinical Health Act (Title XIII of the American
Recovery and Reinvestment Act of 2009); and (iii) for purposes of this Agreement, the applicable state laws regarding patient privacy
and the security, use and disclosure of healthcare record.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(pppp)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">HSR Act</span>&#8221; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(qqqq)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Intellectual Property</span>&#8221; means all intellectual and industrial proprietary and property rights, whether registered
or unregistered, including: (i) patents, patent applications, patent disclosures, invention disclosures and inventions (regardless of
whether patentable and regardless of whether reduced to practice) and any reissue, continuation, continuation-in-part, divisional, revision,
extension or reexamination certificate, post-issuance certificate thereof or based thereon; (ii) registered and unregistered trademarks,
service marks, trade names, trade dress, logos, slogans, company names, corporate names, or other source or business identifiers (and
all translations, adaptations, derivations and combinations of the foregoing), and registrations and applications for registration thereof,
together with all goodwill of the businesses associated with the foregoing; (iii) works of authorship, whether copyrightable or not, all
derivatives, translations and adaptations thereof, copyrights (whether registered or unregistered) therein and thereto and all applications,
registrations, renewals, extensions, restorations and reversions thereof, and all common law and moral rights therein; (iv) rights in
software and computer programs (in both source code and object code form), and all rights in any documentation and manuals therefor; (v)
databases and data compilations; (vi) trade secrets, know-how, processes, formulae, recipes, methods, techniques, procedures, algorithms,
specifications, inventions, ideas, marketing materials, customer and supplier lists, and other confidential or proprietary information;
and (vii) Internet domain names (whether or not trademarked), websites, web addresses, web pages, URLs, social media identifiers, and
the content thereon.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 147 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(rrrr)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Intended Tax Treatment</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 2.5</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ssss)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Intervening Event</span>&#8221; means any material event, effect, condition, change, occurrence, development, circumstance
or state of facts occurring or arising after the date hereof that materially affects Company, and that was neither known to, nor reasonably
foreseeable by, any member of the Company Board as of or prior to the date hereof, and that becomes known to the Company Board after the
date hereof and prior to the date of the Company Stockholders Meeting (as it may be adjourned or postponed in accordance with this Agreement);
provided that in no event shall any of the following constitute an Intervening Event: (i) the receipt, existence of or terms of an Alternative
Transaction or any inquiry or communications relating thereto or any consequences thereof; (ii) any event, effect, condition, change,
occurrence, development, circumstance or state of facts with respect to Parent or any of its Affiliates; (iii) any changes, in and of
itself, in the market price or trading volume of the shares of Company Common Stock or the fact, in and of itself, that the Company meets
or exceeds any internal or published industry analyst projections or forecasts or estimates of revenues or earnings for any period ending
on or after the date hereof (it being understood and agreed that the facts and circumstances giving rise to any such change may be taken
into account in determining whether there has been an Intervening Event); or (iv) changes in general economic or geopolitical conditions,
or changes in conditions in the global, international or U.S. economy generally.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(tttt)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Invention Assignment Agreements</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.15(e)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(uuuu)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">IRS</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.12(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vvvv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">IT Assets</span>&#8221; means all computers, software, firmware, computer hardware, middleware, servers, networks, workstations,
routers, hubs, switches, information, telecommunications systems, data communications lines, peripherals and computer systems, and other
information technology equipment, systems, or platforms used in or relied upon by Company or any of its Subsidiaries in connection with
their business as currently conducted and as proposed to be conducted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(wwww)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Knowledge of Company</span>&#8221; means the actual knowledge of the individuals set forth on <span style="text-decoration: underline">Section 1.1(uuuu)</span> of
the Company Disclosure Letter, after reasonable inquiry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xxxx)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Knowledge of Parent</span>&#8221; means the actual knowledge of the individuals set forth on <span style="text-decoration: underline">Section 1.1(vvvv)</span> of
the Parent Disclosure Letter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(yyyy)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Labor Agreement</span>&#8221; means any collective bargaining agreement or similar labor-related contract with any labor
union, labor organization, or works council.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(zzzz)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Liens</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.2(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 148 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(aaaaa)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Material Adverse Effect</span>&#8221; means, with respect to any Person, any event, circumstance, development, occurrence,
fact, condition, effect, or change (each, a &#8220;<span style="text-decoration: underline">Change</span>&#8221;) that is, or would reasonably be expected to become, individually
or in the aggregate, materially adverse to: (a) the business, results of operations, condition (financial or otherwise), or assets of
such Person and its Subsidiaries, taken as a whole; or (b) the ability of such Person to timely perform its obligations under this Agreement
or consummate the transactions contemplated hereby on a timely basis; <span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>, that, a Material Adverse Effect
shall not be deemed to include any Change (alone or in combination) arising out of, relating to, or resulting from: (i) changes generally
affecting the economy, financial or securities markets, or political conditions (including the impacts of any tariffs or trade wars);
(ii) the execution and delivery, announcement, or pendency of the transactions contemplated by this Agreement (it being understood and
agreed that this clause shall not apply with respect to any representation or warranty in <span style="text-decoration: underline">Section 4.2</span> of this Agreement); (iii)
any changes in Applicable Law or GAAP or other applicable accounting standards, (iv) geopolitical conditions, the outbreak or escalation
of hostilities, any acts of war (whether or not declared), sabotage or terrorism, or any escalation or worsening of any such acts of war,
sabotage or terrorism underway as of the date of this Agreement; (v) natural disasters, epidemics, pandemics, or other force majeure events;
(vi) general conditions in the industry in which such Person and its Subsidiaries operate; (vii) any failure, in and of itself, by such
Person to meet any internal or published projections, forecasts, estimates, or predictions in respect of revenues, earnings, or other
financial or operating metrics for any period (it being understood that any Change underlying such failure may be deemed to constitute,
or be taken into account in determining whether there has been or would reasonably be expected to become, a Material Adverse Effect, to
the extent permitted by this definition and not otherwise excepted by another clause of this proviso); (viii) any change, in and of itself,
in the market price or trading volume of such Person&#8217;s securities (it being understood that any Change underlying such change may
be deemed to constitute, or be taken into account in determining whether there has been or would reasonably be expected to become, a Material
Adverse Effect, to the extent permitted by this definition and not otherwise excepted by another clause of this proviso); or (ix) actions
taken as required or specifically permitted by the Agreement or actions or omissions taken with the prior written consent of, in the case
of Parent, Company, and in the case of Company, Parent; <span style="text-decoration: underline">provided further</span>, <span style="text-decoration: underline">however</span>, that any Change referred to in clauses
(i), (iii), (iv), (v), or (vi) immediately above shall be taken into account in determining whether a Material Adverse Effect has occurred
or would reasonably be expected to occur to the extent it has a disproportionate effect on such Person and its Subsidiaries, taken as
a whole, compared to other participants in the industries in which such Person and its Subsidiaries conduct their businesses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(bbbbb)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Maximum Premiums</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 7.4(c)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ccccc)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Measurement Date</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.3(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ddddd)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Merger</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 2.1</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(eeeee)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Merger Consideration</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 3.1(a)(i)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(fffff)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Merger Sub</span>&#8221; has the meaning given to it in the Preamble.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ggggg)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Merger Sub Stockholder Approval</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 5.11</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(hhhhh)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Merger Sub Written Consent</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 5.11</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iiiii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Multiemployer Plan</span>&#8221; means any plan that is a multiemployer plan, as defined in Section 3(37) or 4001(a)(3)
of ERISA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(jjjjj)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">NASDAQ</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 3.2(g)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(kkkkk)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Notified Body</span>&#8221; means an entity licensed, authorized or approved by the applicable government agency, department
or other authority to assess and certify the conformity of a medical device with the requirements of the EU Medical Devices Regulation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 149 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(lllll)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Open Source Software</span>&#8221; means any software that is distributed as &#8220;free software&#8221; or as &#8220;open
source software&#8221; or under any license that is a license now approved by the Open Source Initiative and listed at http://www.opensource.org/licenses,
including any software licensed under or subject to the GNU General Public License or the GNU Affero General Public License.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">(mmmmm)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Order</span>&#8221; means any order, writ, decree, judgment, award, injunction, ruling, settlement or stipulation issued,
promulgated, made, rendered or entered into by or with any Governmental Entity or arbitrator (in each case, whether temporary, preliminary
or permanent).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(nnnnn)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span> &#8220;<span style="text-decoration: underline">Outside Date</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 9.1(b)(i)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ooooo)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Owned Company Software</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.15(f)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ppppp)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Parent</span>&#8221; has the meaning given to it in the Preamble.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(qqqqq)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Parent Benefit Plan</span>&#8221; means each compensation or benefit plan, policy, program or arrangement, whether or not
written, including any &#8220;employee welfare benefit plan&#8221; within the meaning of Section 3(1) of ERISA (whether or not such plan
is subject to ERISA), any &#8220;employee pension benefit plan&#8221; within the meaning of Section 3(2) of ERISA (whether or not such
plan is subject to ERISA) and any bonus, commission, incentive, deferred compensation, vacation, stock purchase, stock or stock-based,
profit-sharing, insurance, cafeteria, severance, retention, salary continuation, sale, transaction, change of control or fringe benefit
plan, policy, program, arrangement or agreement that is sponsored, maintained or contributed to by Parent or any of its Subsidiaries or
which Parent or any of its Subsidiaries is obligated to sponsor, maintain or contribute and in which any Continuing Employee is eligible
to participate after the Closing, but excluding any Multiemployer Plan and any Company Benefit Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(rrrrr)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Parent Board</span>&#8221; means the Board of Directors of Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(sssss)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Parent Common Stock</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 5.3(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ttttt)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Parent Disclosure Letter</span>&#8221; has the meaning given to it in the first paragraph under <span style="text-decoration: underline">ARTICLE V</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(uuuuu)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Parent Equity Awards</span>&#8221; means the Parent Options, the Time-Based Parent Stock Awards, and the Performance-Based
Parent Stock Awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vvvvv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Parent Equity Incentive Plan</span>&#8221; means Parent&#8217;s Equity Incentive Plan, as may be amended or restated from
time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(wwwww)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Parent Option</span>&#8221; means an option to purchase shares of Parent Common Stock granted under any equity incentive
plan, program or agreement maintained by Parent or to which Parent is a party, including the Parent Equity Incentive Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xxxxx)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Parent Stock Award</span>&#8221; means an award of shares of Parent&#160;Common Stock or Parent Stock Units granted under
any equity incentive plan, program or agreement maintained by Parent or to which Parent is a party, including the Parent Equity Incentive
Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(yyyyy)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Parent Stock Units</span>&#8221; means a bookkeeping entry representing an amount equivalent to the fair market value of
one share of Parent Common Stock, payable in cash or shares of Parent Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(zzzzz)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Payor</span>&#8221; means any Governmental Health Program (including Medicare Advantage plan and Medicaid managed care plan)
and any other healthcare service plan, health maintenance organization, health insurer, physician hospital organization, or private, commercial,
or governmental third-party payor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 150 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(aaaaaa)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">PCI DSS</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.16(c)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(bbbbbb)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Performance-Based Parent Stock Award</span>&#8221; means a Parent Stock Award that is subject to performance-based vesting
(or a combination of time-based and performance-based vesting).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(cccccc)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Permitted Liens</span>&#8221; means: (i) Liens imposed by Applicable Law, such as and mechanics and materialmen Liens, in
each case for sums not yet overdue for a period or more than thirty days or being contested in good faith by appropriate proceedings or
such other Liens arising out of judgments or awards against Company, with respect to which Company shall then be proceeding with an appeal
or other proceedings for review if adequate reserves with respect thereto are maintained on the books of Company, in accordance with GAAP,
(ii) Liens for Taxes, assessments or other governmental charges not yet due and payable or which are being contested in good faith by
appropriate proceedings diligently conducted, if adequate reserves with respect thereto are maintained on the books of Company in accordance
with GAAP, (iii) Liens securing judgments for the payment of money so long as such Liens are adequately bonded and any appropriate legal
proceedings that may have been duly initiated for the review of such judgment have not been finally terminated or the period with which
such proceedings may be initiated has not expired, (iv) minor survey exceptions on existing surveys or which would be shown on a current
accurate survey, minor encumbrances, easements or reservations of, or rights of others for, licenses, rights-of-way, sewers, electric
lines, telegraph and telephone lines and other similar purposes (including, for the avoidance of doubt, operating agreements), (v) Liens
arising from non-exclusive licenses of Intellectual Property entered into in the ordinary course of business, (vi) Liens arising from
Uniform Commercial Code financing statement filings regarding operating leases entered into by Company, in the ordinary course of business,
(vii) leases, subleases, licenses and occupancy agreements by Company as landlord, sublandlord or licensor and (viii) with respect to
leased property, all Liens existing on the date of the applicable lease, and all mortgages and deeds of trust now or hereafter placed
on the leased property by the third-party landlord.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(dddddd)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Person</span>&#8221; or &#8220;<span style="text-decoration: underline">person</span>&#8221; means a natural person, corporation, partnership, limited liability
company, joint venture, association, trust, unincorporated organization or other entity, including any Governmental Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(eeeeee)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Personal Data</span>&#8221; means any information about an identifiable individual that alone or in combination with other
information could be used to identify an individual or household, or includes information that is defined as &#8220;personal data,&#8221;
&#8220;personally identifiable information,&#8221; &#8220;individually identifiable health information,&#8221; &#8220;protected health
information,&#8221; &#8220;personal information&#8221; or any similar terms applicable under any Privacy and Security Requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(ffffff)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Privacy and Security Requirements</span>&#8221; means, to the extent applicable: (i) all Applicable Laws concerning any
Processing of Company Data (including any Personal Data therein) and the privacy, confidentiality, security, or breach of such Company
Data, including: HIPAA; state privacy, data security, and breach notification laws, and state social security number protection laws;
the Federal Trade Commission Act; the Telephone Consumer Protection Act; the Controlling the Assault of Non-Solicited Pornography And
Marketing Act; the California Online Privacy Protection Act; the California Consumer Privacy Act and other state consumer privacy laws,
the EU General Data Protection Regulation 2016/679, and PCI DSS; (ii) the terms of all contracts, as entered into by Company or its Subsidiaries
or Parent or its Subsidiaries (as applicable), with any person relating to the Processing of Company Data; (iii) all written notices and
policies by which Company or its Subsidiaries is bound or purports to be bound, to the extent relating to privacy, security, data protection,
or any notifications of Security Breaches, other data security incidents or violations of (i) or (ii), and the Processing of Company Data;
and (iv) and any binding industry standards applicable to the industry in which each of Company or any of its Subsidiaries operates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(gggggg)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Process</span>&#8221; or &#8220;<span style="text-decoration: underline">Processing</span>&#8221; means the creation, collection, use (including for the purposes
of sending telephone calls, text messages and emails), analysis, storage, retention, structuring, recording, organization, consultation,
de-identification, re-identification, maintenance, processing, recording, distribution, transfer, sale, lease, transmission, receipt,
import, export, protection (including safeguarding, security measures and notification in the event of a breach of security), access,
disposal or disclosure or any other operation or set of operations performed on data or sets of data (including Personal Data), whether
electronically or in any other form or medium and whether or not by automatic means.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(hhhhhh)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">PTO Policy</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 7.10(d)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 151 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(iiiiii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Release</span>&#8221; means any release, spill, pumping, pouring, emptying, emission, leaking, injection, deposit, disposal,
discharge, dispersal, leaching or migration into the environment, including the atmosphere, soil, surface water, groundwater, drinking
water supply, or property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(jjjjjj)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Representatives</span>&#8221; means, when used with respect to any person, the directors, officers, employees, consultants,
financial advisors, accountants, legal counsel, investment bankers and other agents, advisors and representatives of such person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(kkkkkk)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Sanctioned Person</span>&#8221; means (i) any person listed in any Sanctions-related list of designated persons maintained
by OFAC or the U.S. Department of State, the United Nations Security Council, the European Union or His Majesty&#8217;s Treasury of the
United Kingdom, (ii) any person located, organized or resident in a country or territory which, at the applicable time, is the subject
or target of comprehensive Sanctions (at the time of this Agreement, Belarus, Cuba, Iran, North Korea, Russia, Syria, or the Crimea region
and so-called Donetsk People&#8217;s Republic and Luhansk People&#8217;s Republic of Ukraine) or (iii) any person 50% or more owned or
otherwise controlled by any such person or persons described in the foregoing clauses (i) and (ii).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(llllll)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Sanctions</span>&#8221; means economic or financial sanctions or trade embargoes imposed, administered or enforced from
time to time by the U.S. government through OFAC or the U.S. Department of State, the United Nations Security Council, the European Union,
His Majesty&#8217;s Treasury of the United Kingdom.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(mmmmmm)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Sarbanes-Oxley Act</span>&#8221; means the Sarbanes-Oxley Act of 2002.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(nnnnnn)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Securities Act</span>&#8221; means the Securities Act of 1933, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(oooooo)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Security Breach</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.16(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(pppppp)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Specified Agreement</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 9.1(e)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(qqqqqq)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Subsidiary</span>&#8221; means, with respect to any person, any person with respect to which such first person directly
or indirectly owns or purports to own, beneficially or of record, (i) an amount of voting securities or other interests in such second
person that is sufficient to enable such first person to elect at least a majority of the members of such second person&#8217;s board
of directors or comparable governing body or (ii) at least 50% of the outstanding equity, voting or financial interests in such second
person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(rrrrrr)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Superior Offer</span>&#8221; means any bona fide written proposal (on its most recently amended or modified terms, if amended
or modified) made by a Company Third Party to enter into an Alternative Transaction (with all references to 20% in the definition of Alternative
Transaction being treated as references to 50% for these purposes) that (A) did not result from a breach of <span style="text-decoration: underline">Section 6.2(a)</span>, (B)
is on terms that the Company Board determines in good faith (after consultation with its outside financial advisors and outside legal
counsel) to be superior from a financial point of view to Company&#8217;s stockholders than the transactions contemplated by this Agreement,
taking into account all financial, regulatory, legal and other aspects of such proposal (including any changes to this Agreement that
may be proposed by Parent in response to such proposal to enter into an Alternative Transaction and the identity of the person making
such proposal to enter into an Alternative Transaction) and (C) is reasonably likely to be completed in accordance with its terms, taking
into account all financial, regulatory, legal and other aspects of such proposal, and is not subject to a diligence or financing condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(ssssss)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Surviving Corporation</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 2.1</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(tttttt)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Tail Policy</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 7.4(c)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(uuuuuu)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Tax Opinion</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 7.14(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 152 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(vvvvvv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Tax Return</span>&#8221; means any return, declaration, statement, claim for refund, election, estimate, report, form or
information return, and any schedule or attachment thereto or amendment thereof, relating to any Tax that is filed or required to be filed
with a Governmental Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">(wwwwww) &#8220;<span style="text-decoration: underline">Taxes</span>&#8221;
or other derivations of &#8220;<span style="text-decoration: underline">Taxes</span>&#8221; means any and all taxes, charges, levies or other like assessments imposed by any Governmental
Entity, including any income, gross receipts, license, severance, occupation, premium, environmental, customs, duties, profits, disability,
alternative or add-on minimum, estimated, withholding, payroll, employment, unemployment insurance, social security (or similar), excise,
sales, use, value-added, occupancy, franchise, real property, personal property, business and occupation, mercantile, windfall profits,
capital stock, stamp, transfer, escheat or unclaimed property, workmen&#8217;s compensation or other taxes, charges, levies or other like
assessments imposed by any Governmental Entity, together with any interest, penalties, additions to tax or additional amounts imposed
by any Governmental Entity, whether disputed or not. The term &#8220;<span style="text-decoration: underline">Tax</span>&#8221; means any one of the foregoing Taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(xxxxxx)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Terminating Company Option</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 3.1(b)(ii)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(yyyyyy)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Time-Based Parent Stock Award</span>&#8221; means a Parent Stock Award that is subject to time-based vesting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(zzzzzz)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Transaction Litigation</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 7.12</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(aaaaaaa)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Transfer Taxes</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 7.9</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(bbbbbbb)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">WARN Act</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 4.13(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">(ccccccc)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Willful Breach</span>&#8221; has the meaning given to it in <span style="text-decoration: underline">Section 9.2(d)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 1.2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Interpretation</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>When a reference is made in this Agreement to an Article, Section or Exhibit, such reference shall be to an Article or Section
of, or an Exhibit to, this Agreement, unless otherwise indicated. Whenever the words &#8220;include,&#8221; &#8220;includes&#8221; or
&#8220;including&#8221; are used in this Agreement, they shall be deemed to be followed by the words &#8220;without limitation.&#8221;
The words &#8220;hereof,&#8221; &#8220;hereto,&#8221; &#8220;hereby,&#8221; &#8220;herein&#8221; and &#8220;hereunder&#8221; and words
of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement.
The term &#8220;or&#8221; is not exclusive. The word &#8220;extent&#8221; in the phrase &#8220;to the extent&#8221; shall mean the degree
to which a subject or other thing extends, and such phrase shall not mean simply &#8220;if.&#8221; All terms defined in this Agreement
shall have the defined meanings when used in any certificate or other document made or delivered pursuant hereto unless otherwise defined,
or except as otherwise expressly provided, therein. The phrase &#8220;made available&#8221; when used in reference to anything made available
by Company or any of its Representatives shall be deemed to include anything uploaded to the electronic dataroom maintained by or on behalf
of Company or its Representatives for the purpose of the Merger and the transactions contemplated hereby by 4:00 p.m., Eastern Time, on
the date hereof. The phrase &#8220;made available&#8221; when used in reference to anything made available by Parent, Merger Sub or any
of their respective Representatives shall be deemed to include anything uploaded to the electronic dataroom maintained by or on behalf
of Parent or its Representatives for the purpose of the Merger and the transactions contemplated hereby by 4:00 p.m., Eastern Time, on
the date hereof. Words in this Agreement describing the singular number shall be deemed to include the plural and vice versa, and words
in this Agreement denoting any gender shall be deemed to include all genders. Any statute defined or referred to herein or in any agreement
or instrument that is referred to herein shall mean such statute as from time to time amended (including the rules and regulations promulgated
thereunder), unless otherwise specifically indicated. References to a person are also to its permitted successors and assigns. Unless
otherwise specifically indicated, all references to &#8220;dollars&#8221; and &#8220;$&#8221; will be deemed references to the lawful
money of the United States of America.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Except with respect to <span style="text-decoration: underline">Section 7.6</span>, whenever a consent or approval of Company or Parent is required under this Agreement,
such consent or approval may be executed and delivered only in writing and only by an executive officer of such party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 153 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE II<br/>
THE MERGER</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 2.1</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">The Merger</span>. Upon the terms and subject to the conditions set forth in this Agreement and in accordance with the General
Corporation Law of the State of Delaware (the &#8220;<span style="text-decoration: underline">DGCL</span>&#8221;), Merger Sub shall be merged with and into Company (the &#8220;<span style="text-decoration: underline">Merger</span>&#8221;)
at the Effective Time. Following the Effective Time, the separate corporate existence of Merger Sub shall cease, and Company shall continue
as the surviving corporation in the Merger (sometimes referred to herein as the &#8220;<span style="text-decoration: underline">Surviving Corporation</span>&#8221;) and a wholly
owned subsidiary of Parent, and shall succeed to and assume all the rights, privileges, immunities, properties, powers and franchises
of Merger Sub in accordance with the DGCL.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 2.2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Closing</span>. The closing of the Merger (the &#8220;<span style="text-decoration: underline">Closing</span>&#8221;) shall take place via the electronic exchange of documents
and signature pages on the second (2nd) Business Day after satisfaction or waiver of all of the conditions set forth in <span style="text-decoration: underline">ARTICLE VIII</span>
(other than those conditions that by their terms are to be fulfilled at the Closing, but subject to the fulfillment or waiver of such
conditions); <span style="text-decoration: underline">provided</span> that the Closing may occur at such other time, date or place as may be agreed to in writing by Parent and
Company (the date of the Closing, the &#8220;<span style="text-decoration: underline">Closing Date</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 2.3</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Effective Time</span>. Upon the terms and subject to the conditions set forth in this Agreement, as soon as practicable on the
Closing Date, the parties shall cause the Merger to be consummated by filing with the Secretary of State of the State of Delaware a Certificate
of Merger (the &#8220;<span style="text-decoration: underline">Certificate of Merger</span>&#8221;) with respect to the Merger, duly executed and completed in accordance with
the relevant provisions of the DGCL, and shall make all other filings or recordings required under the DGCL with respect to the Merger.
The Merger shall become effective at the time when the Certificate of Merger has been duly filed with the Secretary of State of the State
of Delaware or such later time as may be mutually agreed by the parties and specified in the Certificate of Merger (the &#8220;<span style="text-decoration: underline">Effective
Time</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 2.4</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Effects of the Transaction</span>. The Merger shall have the effects set forth in the applicable provisions of the DGCL. Without
limiting the generality of the foregoing, and subject thereto, at the Effective Time all (a) of the property, rights, privileges, powers
and franchises of Company and Merger Sub will vest in the Surviving Corporation; and (b) debts, liabilities and duties of Company and
Merger Sub will become the debts, liabilities and duties of the Surviving Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 2.5</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Intended Tax Treatment</span>. Each of the parties hereto intends for U.S. federal income tax purposes that (a) this Agreement
will constitute a &#8220;plan of reorganization&#8221; within the meaning of Section 368 of the Code and the Treasury Regulations promulgated
thereunder, (b) the Merger will qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code and (c) Parent
and Company will each be a party to the reorganization within the meaning of Section 368(b) of the Code (clauses (a)-(c), the &#8220;<span style="text-decoration: underline">Intended
Tax Treatment</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 2.6</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Organizational Documents; Merger Sub Arrangements</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Subject, in all cases to <span style="text-decoration: underline">Section 7.4</span>, at the Effective Time, (i) the Certificate of Incorporation of Company shall be amended
and restated in the form attached hereto as <span style="text-decoration: underline">Exhibit&#160;A</span> and shall be the Certificate of Incorporation of the Surviving Corporation
until duly amended in accordance with the DGCL and such certificate of incorporation and (ii) the bylaws of Company shall be amended and
restated in the form attached hereto as <span style="text-decoration: underline">Exhibit B</span> and shall be the bylaws the Surviving Corporation until duly amended in accordance
with the DGCL and such bylaws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The directors of Merger Sub immediately prior to the Effective Time shall be the directors of the Surviving Corporation from and
after the Effective Time, in each case until such director&#8217;s successor is elected and qualified or such director&#8217;s earlier
death, resignation or removal, in each case in accordance with the charter and bylaws of the Surviving Corporation and the DGCL.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The officers of Merger Sub immediately prior to the Effective Time shall be the officers of the Surviving Corporation from and
after the Effective Time, in each case until such officer&#8217;s successor is elected and qualified or such officer&#8217;s earlier death,
resignation, retirement, disqualification or removal, in each case in accordance with the bylaws of the Surviving Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 154 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE III<br/>
EFFECT OF THE MERGER ON THE CAPITAL STOCK OF COMPANY; EXCHANGE OF CERTIFICATES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 3.1</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Effect of the Merger</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Conversion of Company Common Stock and Merger Sub Common Stock</span>. As of the Effective Time, by virtue of the Merger and without
any action on the part of Parent, Company, Merger Sub, or the holders of any securities of Parent, Company or Merger Sub:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Subject to the other provisions of this <span style="text-decoration: underline">ARTICLE III</span>, each issued and outstanding share of Company Common Stock (other than
any shares of Company Common Stock to be canceled pursuant to <span style="text-decoration: underline">Section 3.1(a)(ii)</span>) shall be converted into the right to receive
0.0677 fully paid and nonassessable shares of Parent Common Stock (the &#8220;<span style="text-decoration: underline">Exchange Ratio</span>&#8221;) and, if applicable, cash in
lieu of fractional shares of Company Common Stock payable in accordance with <span style="text-decoration: underline">Section 3.2(g)</span> (collectively, the &#8220;<span style="text-decoration: underline">Merger
Consideration</span>&#8221;). As of the Effective Time, all such shares of Company Common Stock shall no longer be outstanding and shall
automatically be canceled and retired and shall cease to exist. As of the Effective Time, each holder of a Company Certificate or Company
Book-Entry Share shall cease to have any rights with respect thereto, except the right to receive, upon the surrender thereof, the Merger
Consideration in accordance with <span style="text-decoration: underline">Section 3.2</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Each share of Company Common Stock (A) held in the treasury of Company, or (B) owned by Parent or Merger Sub or any of their respective
Subsidiaries, in each case, immediately prior to the Effective Time shall automatically be canceled and retired and shall cease to exist,
and no consideration shall be delivered in exchange therefor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Each share of common stock of Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted into
one fully paid and nonassessable share of the common stock of the Surviving Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Treatment of Company Options</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Each Eligible Company Option shall, as of the Effective&#160;Time, automatically and without any action on the part of the holder
thereof, be assumed by Parent and converted into an option (A) to purchase that number of shares of Parent&#160;Common Stock equal to
the product of (1) the number of shares of Company Common Stock subject to such Eligible&#160;Company&#160;Option immediately prior to
the Effective Time and (2) the Exchange Ratio, rounded down to the nearest whole number of shares, and (B) with an exercise price per
share equal to (1) the exercise price per share of Company&#160;Common Stock of such Eligible Company Option immediately prior to the
Effective Time, divided by (2)&#160;the Exchange Ratio, rounded up to the nearest whole cent (each, an &#8220;<span style="text-decoration: underline">Assumed&#160;Option</span>&#8221;).
Each Assumed Option shall continue to have, and shall be subject to, the same terms and conditions set forth in the applicable Company
Stock Incentive Plan and the award agreement and any other written agreement applicable to the Eligible&#160;Company Option (including
the vesting and exercisability conditions (including any acceleration provisions) and expiration date) as in effect immediately prior
to the Effective Time, other than any terms that become inoperative by reason of the transactions contemplated pursuant to this Agreement.
For the avoidance of doubt, continuous employment with Company or any of its Subsidiaries will be credited to the holder of an Assumed&#160;Option
for purposes of determining the number of shares of Parent Common Stock that are vested and exercisable under such holder&#8217;s Assumed
Option after the Effective Time. The conversion of Eligible Company Options into Assumed&#160;Options shall be effected in a manner intended
to satisfy the requirements of Treasury&#160;Regulations Section 1.424-1 and of Treasury&#160;Regulations Section 1.409A-1(b)(5)(v)(D),
in each case, to the extent applicable, and this <span style="text-decoration: underline">Section 3.1(b)(i)</span> shall be construed consistent with such intentions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Each Company Option that is not an Eligible Company Option shall not be assumed or otherwise substituted by Parent (a &#8220;<span style="text-decoration: underline">Terminating
Company Option</span>&#8221;), and all Terminating Company Options that are outstanding and unexercised as of immediately prior to the Effective
Time shall terminate and cease to be outstanding at the Effective Time without any further action by the holder thereof in accordance
with the terms of the applicable Company Stock Incentive Plan or any award agreements, as applicable, without any consideration payable
therefor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 155 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Prior to the Effective Time (and in any event prior to the time provided in the applicable Company Stock Incentive Plan), and subject
to the prior review and approval of Parent (which review and approval shall not be unreasonably withheld or delayed), the Company Board
or the appropriate committee thereof shall take, or cause to be taken, all reasonably necessary and appropriate action under the Company
Stock Incentive Plans and award agreements evidencing Company Options, as applicable, to (A) provide for and give effect to the treatment
of Company Options contemplated by this <span style="text-decoration: underline">Section 3.1(b)</span>, including (1)&#160;obtaining all reasonably necessary approvals and consents,
(2) delivering notice to each holder of Company&#160;Options of the treatment of Company Options contemplated by this <span style="text-decoration: underline">Section 3.1(b)</span>
and the specified period of time prior to the Effective Time that such holder will be permitted to exercise such holder&#8217;s outstanding
Company Options (to the extent then exercisable), and (3)&#160;delivering evidence satisfactory to Parent that all reasonably necessary
determinations by the Company Board or appropriate committee thereof to provide for and give effect to the treatment of Company Options
in accordance with this <span style="text-decoration: underline">Section 3.1(b)</span> have been made, (B)&#160;provide that exercisability of Company Options will not be accelerated,
including as a result of the Merger, this Agreement, or the transactions contemplated by this Agreement except for such acceleration as
is (x) specifically provided in the Company Stock Incentive Plan or award agreements under which Company Options were originally granted,
(y) set forth in <span style="text-decoration: underline">Section 3.1(b)(iii)</span> of the Company Disclosure Letter or (z) as consented to in writing by Parent in accordance
with <span style="text-decoration: underline">Section&#160;6.1(a)(ix)</span>, and (C)&#160;deliver copies of all consents, notices, amendments and other documents executed, adopted
or delivered, as applicable, in connection with the immediately preceding clauses (A) and (B).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>As soon as practicable after the Effective Time, Parent will use commercially reasonable efforts to prepare and file one or more
registration statements on Form S-8 (or another appropriate form) with the SEC with respect to the shares of Parent Common Stock issuable
with respect to Assumed Options. Parent will use commercially reasonable efforts to maintain the effectiveness of such registration statement
or registration statements for so long as shares are issuable with respect to Assumed&#160;Options. Parent will give holders of Assumed
Options written notice of their Assumed&#160;Options as soon as practicable after the Effective Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Treatment of ESPP</span>. Prior to the Effective Time, and subject to the prior review and approval of Parent (which review and
approval shall not be unreasonably withheld or delayed), the Company Board or the appropriate committee thereof shall take, or cause to
be taken, all reasonably necessary and appropriate action to provide that, subject to the consummation of the Merger, the Company ESPP
shall terminate effective immediately prior to the Effective Time. As soon as practicable following the date of this Agreement, the Company
Board or the appropriate committee thereof, shall adopt resolutions and shall take, or cause to be taken, all necessary and appropriate
action to provide that the Company ESPP will continue to be suspended until terminated in accordance with this <span style="text-decoration: underline">Section 3.1(c)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Appraisal Rights</span>. In accordance with Section 262 of the DGCL, no appraisal rights shall be available to holders of Company
Common Stock or Parent Common Stock in connection with the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 3.2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Exchange of Shares and Certificates</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Designation of Exchange Agent; Deposit of Exchange Fund</span>. Prior to the Closing, Parent shall enter into an exchange agreement
with the transfer agent of Parent, the transfer agent of Company or another nationally recognized financial institution or trust company
designated by Parent (the &#8220;<span style="text-decoration: underline">Exchange Agent</span>&#8221;) for the payment of the Merger Consideration as provided in <span style="text-decoration: underline">Section 3.1(a)(i)</span>.
At or promptly following the Effective Time, Parent shall deposit or cause to be deposited with the Exchange Agent, for exchange in accordance
with this <span style="text-decoration: underline">ARTICLE III</span> through the Exchange Agent, book-entry shares representing the full number of whole shares of Parent Common
Stock issuable pursuant to <span style="text-decoration: underline">Section 3.1(a)(i)</span> in exchange for outstanding shares of Company Common Stock and Parent shall, after
the Effective Time on the appropriate payment date, if applicable, provide or cause to be provided to the Exchange Agent any dividends
or other distributions payable on such shares of Parent Common Stock pursuant to <span style="text-decoration: underline">Section 3.2(c)</span> (such shares of Parent Common Stock
provided to the Exchange Agent, together with any such dividends or other distributions with respect thereto, the &#8220;<span style="text-decoration: underline">Exchange Fund</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 156 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Exchange Procedures</span>. As promptly as practicable following the Effective Time, and in no event later than the third (3rd)
Business Day thereafter, Parent shall cause the Exchange Agent to mail to each holder of record of a certificate (an &#8220;<span style="text-decoration: underline">Company
Certificate</span>&#8221;) that immediately prior to the Effective Time represented outstanding shares of Company Common Stock (i) a letter
of transmittal in customary form (which shall specify that delivery of Company Certificates shall be effected, and risk of loss and title
to the Company Certificates shall pass only upon proper delivery of the Company Certificates (or affidavits of loss in lieu thereof) to
the Exchange Agent, and which shall be in the form and have such other provisions as are reasonably acceptable to Parent and Company)
and (ii) instructions (which instructions shall be in the form and have such other provisions as are reasonably acceptable to Parent and
Company) for use in effecting the surrender of the Company Certificates in exchange for (A) the number of shares of Parent Common Stock
(which shall be in book-entry form) representing, in the aggregate, the whole number of shares that such holder has the right to receive
in respect of such Company Certificates pursuant to <span style="text-decoration: underline">Section 3.1(a)(i)</span>, (B) any dividends or other distributions payable pursuant
to <span style="text-decoration: underline">Section 3.2(c)</span> and (C) cash in lieu of fractional shares of Parent Common Stock payable pursuant to <span style="text-decoration: underline">Section 3.2(g)</span>. Upon
surrender of a Company Certificate (or affidavit of loss in lieu thereof) for cancellation to the Exchange Agent, together with a letter
of transmittal duly completed and validly executed in accordance with the instructions thereto, and such other documents as may be reasonably
required pursuant to such instructions, the holder of such Company Certificate shall be entitled to receive in exchange therefor (i) the
number of shares of Parent Common Stock (which shall be in book-entry form) representing, in the aggregate, the whole number of shares
that such holder has the right to receive in respect of such Company Certificate pursuant to <span style="text-decoration: underline">Section 3.1(a)(i)</span>, (ii) any dividends
or other distributions payable pursuant to <span style="text-decoration: underline">Section 3.2(c)</span> and (iii) any cash in lieu of fractional shares of Parent Common Stock
payable pursuant to <span style="text-decoration: underline">Section 3.2(g)</span>, and the Company Certificate (or affidavit of loss in lieu thereof) so surrendered shall be
forthwith canceled. Notwithstanding anything to the contrary in this Agreement, no holder of record of a book-entry share (an &#8220;<span style="text-decoration: underline">Company
Book-Entry Share</span>&#8221;) that immediately prior to the Effective Time represented outstanding shares of Company Common Stock shall
be required to deliver a Company Certificate or letter of transmittal or surrender such Company Book-Entry Shares to the Exchange Agent,
and in lieu thereof, upon receipt of an &#8220;agent&#8217;s message&#8221; by the Exchange Agent (or such other evidence, if any, of
transfer as the Exchange Agent may reasonably request), the holder of such Company Book-Entry Share shall be entitled, upon or following
the Effective Time, to receive in exchange therefor (x) the number of shares of Parent Common Stock (which shall be in book-entry form)
representing, in the aggregate, the whole number of shares that such holder has the right to receive in respect of such Company Book-Entry
Shares pursuant to <span style="text-decoration: underline">Section 3.1(a)(i)</span>, (y) any dividends or other distributions payable pursuant to <span style="text-decoration: underline">Section 3.2(c)</span> and (z)
any cash in lieu of fractional shares of Parent Common Stock payable pursuant to <span style="text-decoration: underline">Section 3.2(g)</span>. Until surrendered, in the case
of a Company Certificate, or exchanged for, in the case of a Company Book-Entry Share, in each case, as contemplated by this <span style="text-decoration: underline">Section
3.2(b)</span>, each Company Certificate or Company Book-Entry Share shall be deemed, from and after the Effective Time, to represent only
the right to receive the Merger Consideration as contemplated by this <span style="text-decoration: underline">Section 3.2(b)</span> and any dividends or other distributions payable
pursuant to <span style="text-decoration: underline">Section 3.2(c)</span>. The Exchange Agent shall accept such Company Certificates (or affidavits of loss in lieu thereof) and
make such payments and deliveries with respect to Company Book-Entry Shares upon compliance with such reasonable terms and conditions
as the Exchange Agent may impose to effect an orderly exchange thereof in accordance with normal exchange practices. No interest shall
be paid or accrued for the benefit of holders of the Company Certificates or Company Book-Entry Shares on the Merger Consideration or
any cash payable hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Distributions with Respect to Unexchanged Shares</span>. Subject to Applicable Law, there shall be paid to the holders of the Parent
Common Stock issued in exchange for Company Certificates or Company Book-Entry Shares pursuant to <span style="text-decoration: underline">Section 3.2(b)</span>, without interest,
(i) at the time of delivery of such Parent Common Stock by the Exchange Agent pursuant to <span style="text-decoration: underline">Section 3.2(b)</span>, the amount of dividends
or other distributions, if any, with a record date after the Effective Time theretofore paid with respect to such shares of Parent Common
Stock, and (ii) at the appropriate payment date, the amount of dividends or other distributions, if any, with a record date after the
Effective Time, but prior to such delivery of such Parent Common Stock by the Exchange Agent pursuant to <span style="text-decoration: underline">Section 3.2(b)</span>, and a
payment date subsequent to such delivery of such Parent Common Stock by the Exchange Agent pursuant to <span style="text-decoration: underline">Section 3.2(b)</span>, payable
with respect to such shares of Parent Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Certain Transfers of Ownership</span>. In the event of a transfer of ownership of Company Common Stock that is not registered in
the transfer records of Company, payment of the appropriate amount of Merger Consideration (and any dividends or other distributions with
respect to Parent Common Stock as contemplated by <span style="text-decoration: underline">Section 3.2(c)</span>) may be made to a person other than the person in whose name the
Company Certificate or Company Book-Entry Share so surrendered is registered, if such Company Certificate shall be properly endorsed or
otherwise be in proper form for transfer (and accompanied by all documents reasonably required by the Exchange Agent) or such Company
Book-Entry Share shall be properly transferred and the person requesting such payment shall pay any Transfer Taxes or other Taxes required
by reason of the payment to a person other than the registered holder of such Company Certificate or Company Book-Entry Share or establish
to the reasonable satisfaction of Parent that such Tax has been paid or is not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 157 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Lost Certificates</span>. If any Company Certificate shall have been lost, stolen or destroyed, then upon the making of an affidavit
of that fact by the person claiming such Company Certificate to be lost, stolen or destroyed and, if required by Parent or the Exchange
Agent, the posting by such person of a bond, in such reasonable amount as Parent may direct, as indemnity against any claim that may be
made against it with respect to such Company Certificate, the Exchange Agent will issue in exchange for such lost, stolen or destroyed
Company Certificate the Merger Consideration to which the holder thereof is entitled pursuant to this <span style="text-decoration: underline">ARTICLE III</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Further Ownership Rights in Company Common Stock</span>. All shares of Parent Common Stock (together with cash in lieu of fractional
shares of Parent Common Stock payable pursuant to <span style="text-decoration: underline">Section 3.2(g)</span>) issued upon the surrender for exchange of Company Certificates
or Company Book-Entry Shares in accordance with the terms of this <span style="text-decoration: underline">ARTICLE III</span> shall be deemed to have been issued (and paid) in
full satisfaction of all rights pertaining to the shares of Company Common Stock theretofore represented by such Company Certificates
or Company Book-Entry Shares. After the Effective Time, there shall be no registration of transfers on the stock transfer books of Company
of shares of Company Common Stock that were outstanding immediately prior to the Effective Time. If Company Certificates or Company Book-Entry
Shares are presented to Parent, the Surviving Corporation or the Exchange Agent for transfer following the Effective Time, they shall
be canceled against delivery of the applicable Merger Consideration for each share of Company Common Stock formerly represented by such
Company Certificates or Company Book-Entry Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Fractional Shares</span>. No fractional share of Parent Common Stock (or certificate or scrip representing the same) shall be issued
upon the conversion or surrender for exchange of Company Certificates or Company Book-Entry Shares hereunder, and such fractional share
interests shall not entitle the owner thereof to any Parent Common Stock or to vote or to any other rights of a holder of Parent Common
Stock. Each holder of shares of Company Common Stock converted pursuant to the Merger who would otherwise have been entitled to receive
a fraction of a share of Parent Common Stock (after taking into account all Company Certificates and Company Book-Entry Shares delivered
by such holder) shall receive, in lieu thereof, cash (without interest) in an amount equal to such fraction as provided in this <span style="text-decoration: underline">Section
3.2(g)</span>. As promptly as practicable following the Effective Time, the Exchange Agent shall determine the excess of (i) the number of
full shares of Parent Common Stock delivered to the Exchange Agent by Parent for issuance to holders of Company Certificates or Company
Book-Entry Shares over (ii) the aggregate number of full shares of Parent Common Stock to be distributed to holders of Company Certificates
or Company Book-Entry Shares (such excess being herein referred to as the &#8220;<span style="text-decoration: underline">Excess Shares</span>&#8221;). As soon as practicable
after the Effective Time, the Exchange Agent, as agent for such holders of Company Certificates and Company Book-Entry Shares, shall sell
the Excess Shares at then prevailing prices on the NASDAQ Stock Market (&#8220;<span style="text-decoration: underline">NASDAQ</span>&#8221;). The sale of the Excess Shares by
the Exchange Agent shall be executed on the NASDAQ and shall be executed in round lots to the extent practicable. Until the net proceeds
of any such sale or sales have been distributed to the holders of Company Certificates or Company Book-Entry Shares, the Exchange Agent
shall hold such proceeds in trust for such holders. The net proceeds of any such sale or sales of Excess Shares to be distributed to the
holders of Company Certificates or Company Book-Entry Shares shall be reduced by any and all commissions, Transfer Taxes and other out-of-pocket
transaction costs, as well as any expenses, of the Exchange Agent incurred in connection with such sale or sales. The Exchange Agent shall
determine the portion of such net proceeds to which each holder of Company Certificates or Company Book-Entry Shares shall be entitled,
if any, by multiplying the amount of the aggregate net proceeds by a fraction, the numerator of which is the amount of the fractional
share interest to which such holder of Company Certificates or Company Book-Entry Shares is entitled (after taking into account all Company
Certificates and Company Book-Entry Shares then held by such holder) and the denominator of which is the aggregate amount of fractional
share interests to which all holders of Company Certificates or Company Book-Entry Shares are entitled. As soon as practicable after the
determination of the amount of cash, if any, to be paid to holders of Company Certificates or Company Book-Entry Shares with respect to
any fractional share interests, the Exchange Agent shall promptly pay such amounts to such holders subject to and in accordance with this
<span style="text-decoration: underline">Section 3.2(g)</span>; <span style="text-decoration: underline">provided</span> that no cash payment in lieu of fractional shares shall be paid to any such holder pursuant to
this <span style="text-decoration: underline">Section 3.2(g)</span> until the surrender of such Company Certificates or Company Book-Entry Shares in accordance with this <span style="text-decoration: underline">ARTICLE
III</span>. The payment of cash in lieu of fractional share interests pursuant to this <span style="text-decoration: underline">Section 3.2(g)</span> represents merely a mechanical
rounding-off of the fractions in the exchange and is not separately bargained-for consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(h)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Termination of Exchange Fund</span>. Any portion of the Exchange Fund which remains undistributed to the holders of the Company
Certificates or Company Book-Entry Shares for one year after the Effective Time shall be delivered to Parent or its designee upon demand,
and any such holders prior to the Merger who have not theretofore complied with this <span style="text-decoration: underline">ARTICLE III</span> shall thereafter look only to
Parent as general creditor thereof for payment of their claims for Merger Consideration and any dividends or distributions with respect
to Parent Common Stock as contemplated by <span style="text-decoration: underline">Section 3.2(c)</span>. Any amounts remaining unclaimed by holders of any such Company Certificates
or Company Book-Entry Shares five (5) years after the Effective Time, or at such earlier date as is immediately prior to the time at which
such amounts would otherwise escheat to, or become property of, any Governmental Entity, will, to the extent permitted by Applicable Law,
become the property of the Surviving Corporation free and clear of any claims or interest of any such holders (and their successors, assigns
or personal representatives) previously entitled thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 158 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Liability</span>. None of Parent, Merger Sub, Company or the Exchange Agent shall be liable to any person in respect of any
shares of Parent Common Stock (or dividends or distributions with respect thereto) or cash held in the Exchange Fund delivered to a Governmental
Entity pursuant to any applicable abandoned property, escheat or similar Applicable Laws. If any Company Certificate shall not have been
surrendered or Company Book-Entry Share not paid, in each case, in accordance with <span style="text-decoration: underline">Section 3.2(b)</span>, immediately prior to the date
on which any Merger Consideration in respect of such Company Certificate or Company Book-Entry Share would otherwise escheat to or become
the property of any Governmental Entity, any such Merger Consideration in respect of such Company Certificate or Company Book-Entry Share
shall, to the extent permitted by Applicable Law, become the property of Parent free and clear of all claims or interest of any person
previously entitled thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(j)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Withholding Rights</span>. Each of Company, Parent, Merger Sub, the Surviving Corporation and the Exchange Agent shall be entitled
to deduct and withhold from any amounts or consideration otherwise payable or issuable pursuant to this Agreement to any person such amounts
as are required to be deducted and withheld under the Code or any provision of Applicable Law. Any amounts so deducted and withheld shall
be treated for all purposes of this Agreement as having been paid or issued to the person in respect of which such deduction and withholding
was made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 3.3</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Certain Adjustments</span>. Without limiting the other provisions of this Agreement, if at any time during the period between the
execution of this Agreement and the Effective Time:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any change in the number or type of outstanding shares of Company Common Stock shall occur as a result of a reclassification, recapitalization,
exchange, stock split (including a reverse stock split), combination or readjustment of shares or any stock dividend or stock distribution
with a record date during such period, the Merger Consideration and any other similarly dependent items, as the case may be, shall be
appropriately adjusted to provide the same economic effect as contemplated by this Agreement prior to such event; <span style="text-decoration: underline">provided</span> that
nothing in this <span style="text-decoration: underline">Section 3.3(a)</span> shall be construed to permit any party to take any action that is otherwise prohibited or restricted
by any other provision of this Agreement. For the avoidance of doubt, to the extent any adjustments may be required pursuant to this <span style="text-decoration: underline">Section
3.3(a)</span> with respect to Company Options, such adjustments will be made without duplication in a manner consistent with the relevant
adjustment provisions of the applicable Company Stock Incentive Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any change in the number or type of outstanding shares of Parent Common Stock shall occur as a result of a reclassification, recapitalization,
exchange, stock split (including a reverse stock split), combination or readjustment of shares or any stock dividend or stock distribution
with a record date during such period, the Merger Consideration and any other similarly dependent items, as the case may be, shall be
appropriately adjusted to provide the same economic effect as contemplated by this Agreement prior to such event; <span style="text-decoration: underline">provided</span> that
nothing in this <span style="text-decoration: underline">Section 3.3(b)</span> shall be construed to permit any party to take any action that is otherwise prohibited or restricted
by any other provision of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 3.4</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Further Assurances</span>. If, at any time after the Effective Time, any further action is determined by Parent or the Surviving
Corporation to be necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation or Parent with
full right, title and possession of and to all rights and property of Merger Sub and Company with respect to the Merger, the officers
of Parent shall be fully authorized (in the name of Merger Sub, Company, the Surviving Corporation and otherwise) to take such action.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE IV<br/>
REPRESENTATIONS AND WARRANTIES OF COMPANY</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as set forth in any
Company SEC Document filed with the SEC and publicly available prior to the date of this Agreement (as amended prior to the date of this
Agreement, the &#8220;<span style="text-decoration: underline">Company Filed SEC Documents</span>&#8221;) (excluding any disclosures in any risk factors section, in any section
related to forward-looking statements and other disclosures that are predictive or forward-looking in nature other than historical facts
included therein) or as disclosed in the disclosure letter delivered by Company to Parent upon the execution of this Agreement (the &#8220;<span style="text-decoration: underline">Company
Disclosure Letter</span>&#8221;) and making reference to the particular subsection of this Agreement to which exception is being taken (<span style="text-decoration: underline">provided</span>
that such disclosure shall be deemed to qualify that particular subsection and such other subsections of this Agreement to the extent
that it is reasonably apparent from the face of such disclosure that such disclosure also qualifies or applies to such other subsections),
Company represents and warrants to Parent as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 159 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.1</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Organization, Standing and Corporate Power</span>. Each of Company and its Subsidiaries is a corporation or other legal entity
duly organized, validly existing and in good standing (with respect to jurisdictions that recognize such concept) under the laws of the
jurisdiction in which it is organized and has the requisite corporate or other power, as the case may be, and authority to own, lease
and operate its assets and to carry on its business as now being conducted, except, as to Subsidiaries, for those jurisdictions where
the failure to be so organized, existing or in good standing, individually or in the aggregate, would not reasonably be expected to have
a Material Adverse Effect. Each of Company and its Subsidiaries is duly qualified or licensed to do business and is in good standing (with
respect to jurisdictions that recognize such concept) in each jurisdiction in which the nature of its business or the ownership, leasing
or operation of its properties makes such qualification or licensing necessary, except for those jurisdictions where the failure to be
so qualified or licensed or in good standing, individually or in the aggregate, would not reasonably be expected to have a Material Adverse
Effect on Company. The Certificate of Incorporation of Company and the bylaws of Company, in each case as amended through the date of
this Agreement, have been filed prior to the date of this Agreement with the Company Filed SEC Documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Corporate Authority; Non-contravention</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company has all requisite corporate power and authority to enter into this Agreement and, subject to the Company Stockholder Approval,
to perform its obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement
by Company, the performance by Company of its obligations hereunder and the consummation by Company of the transactions contemplated hereby
have been duly authorized by all necessary corporate action on the part of Company, subject, in the case of the Merger, to the Company
Stockholder Approval. The Company Board (at a meeting duly called and held) has, by the unanimous vote of all directors of Company, (A)
approved and declared advisable this Agreement and the transactions contemplated by this Agreement, including the Merger, on the terms
and subject to the conditions set forth in this Agreement, (B) determined that this Agreement and the transactions contemplated by this
Agreement, including the Merger, are fair to, and in the best interests of, Company and the stockholders of Company, (C) resolved to recommend
the adoption of this Agreement to the stockholders of Company, on the terms and subject to the conditions set forth in this Agreement,
and (D) directed that this Agreement be submitted to the stockholders of Company for adoption at the Company Stockholders Meeting, and,
as of the date of this Agreement, such resolutions have not been rescinded, modified or withdrawn in any way. This Agreement has been
duly executed and delivered by Company and, assuming the due authorization, execution and delivery of this Agreement by Parent and Merger
Sub, constitutes the legal, valid and binding obligation of Company, enforceable against Company in accordance with its terms, except
that (1) such enforcement may be subject to applicable bankruptcy, insolvency, examinership, fraudulent transfer, reorganization, moratorium
or other similar laws, now or hereafter in effect, affecting or relating to the enforcement of creditors&#8217; rights generally and (2)
equitable remedies of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and
to the discretion of the court before which any proceeding therefor may be brought (collectively, the &#8220;<span style="text-decoration: underline">Enforceability Exceptions</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The execution and delivery of this Agreement does not, and the consummation of the transactions contemplated hereby shall not,
conflict with, or result in any violation of, or default (with or without notice or lapse of time, or both) under, or give rise to a right
of termination, cancellation or acceleration of any obligation or loss of a benefit under, or result in the creation of any pledge, claim,
lien, charge, encumbrance or security interest of any kind or nature whatsoever (collectively, &#8220;<span style="text-decoration: underline">Liens</span>&#8221;) upon any of
the properties or assets of Company or any of its Subsidiaries under, (A) the Certificate of Incorporation of Company or the Bylaws of
Company or the comparable organizational documents of any of its Subsidiaries, (B) any loan or credit agreement, note, bond, mortgage,
indenture, trust document, lease or other agreement, instrument, permit, concession, franchise, license or similar authorization to which
Company or any of its Subsidiaries is a party or by which Company, any of its Subsidiaries or their respective properties or assets may
be bound, or (C) subject to the governmental filings and other matters referred to in <span style="text-decoration: underline">Section 4.2(b)</span>, any judgment, order, decree,
statute, law, ordinance, rule or regulation applicable to Company or any of its Subsidiaries or their respective properties or assets,
other than, in the case of clauses (A) (solely with respect to the certificate of incorporation and bylaws or comparable organizational
documents of Company&#8217;s Subsidiaries), (B) and (C), any such conflicts, violations, defaults, rights, losses or Liens that, individually
or in the aggregate, would not reasonably be expected to (1) have a Material Adverse Effect or (2) prevent, materially impair or materially
delay the ability of Company to consummate any of the transactions contemplated hereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 160 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>No consent, approval, order or authorization of, action by or in respect of, or registration, declaration or filing with, any Governmental
Entity is required by or with respect to Company or any of its Subsidiaries in connection with the execution and delivery of this Agreement
by Company, the performance by Company of its obligations hereunder or the consummation by Company of the transactions contemplated hereby,
except for (A) the filing or submission with the SEC, and, if applicable, effectiveness, of (1) a proxy statement relating to the Company
Stockholders Meeting (such proxy statement, as amended or supplemented from time to time, the &#8220;<span style="text-decoration: underline">Company Proxy Statement/Prospectus</span>&#8221;),
(2) the registration statement on Form S-4 to be filed with the SEC (the &#8220;<span style="text-decoration: underline">Form S-4</span>&#8221;) by Parent in connection with the
issuance of shares of Parent Common Stock in connection with the Merger (the &#8220;<span style="text-decoration: underline">Parent Share Issuance</span>&#8221;) and (3) such
reports under Section 13(a) or 15(d) of the Exchange Act, as may be required in connection with this Agreement and the transactions contemplated
hereby, (B) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware and appropriate documents with
the relevant authorities of other states in which Company or its Subsidiaries are qualified to do business, (C) the approvals, orders
or authorizations set forth in <span style="text-decoration: underline">Section 4.2(c)</span> of the Company Disclosure Letter, and (D) such other consents, approvals, orders
or authorizations the failure of which to be made or obtained, individually or in the aggregate, would not reasonably be expected to (1)
have a Material Adverse Effect on Company or (2) prevent, materially impair or materially delay the ability of Company to consummate any
of the transactions contemplated hereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.3</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Capital Structure</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The authorized capital stock of Company consists of 60,000,000 shares of common stock, par value $0.01 per share (the &#8220;<span style="text-decoration: underline">Company
Common Stock</span>&#8221;), and 1,000,000 shares of preferred stock, par value $0.01 per share (the &#8220;<span style="text-decoration: underline">Company Preferred Stock</span>&#8221;).
At the close of business on March 31, 2025 (the &#8220;<span style="text-decoration: underline">Measurement Date</span>&#8221;), (A) 27,365,682 shares of Company Common Stock
were issued and outstanding (for the avoidance of doubt, excluding shares of Company Common Stock held by Company in its treasury), (B)
no shares of Company Preferred Stock were issued and outstanding, (C) 185,831 shares of Company Common Stock were held by Company in its
treasury, (D) Company had reserved 600,000 shares of Company Common Stock for issuance pursuant to the 2005 Company Plan, of which 4,000
shares were subject to outstanding and unexercised Company Options, (E) Company had reserved 600,000 shares of Company Common Stock for
issuance pursuant to the 2012 Company Plan, of which 48,403 shares of Company Common Stock were subject to outstanding and unexercised
Company Options, (F) Company had reserved 4,700,000 shares of Company Common Stock for issuance pursuant to the 2016 Company Plan, of
which 3,010,775 shares of Company Common Stock were subject to outstanding and unexercised Company Options, (G)&#160;Company had reserved
2,000,000 shares of Company Common Stock for issuance pursuant to the 2024 Company Plan, of which no shares were subject to outstanding
awards, and (H)&#160;950,000&#160;shares of Company Common Stock were reserved for issuance pursuant to the Company ESPP, of which
no shares of Company Common Stock were subject to outstanding purchase rights under the Company ESPP. No shares of Company Common Stock
are owned by any Subsidiary of Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>All outstanding shares of capital stock of Company are, and all shares of capital stock of Company that may be issued as permitted
by this Agreement or otherwise shall be, when issued, duly authorized, validly issued, fully paid and nonassessable and not subject to
preemptive rights. Except as set forth in <span style="text-decoration: underline">Section 4.3(a)</span> and except for changes since the Measurement Date resulting from the issuance
of shares of Company Common Stock pursuant to the exercise of Company Options outstanding on the Measurement Date in accordance with their
terms in effect on the date of this Agreement or as expressly permitted by <span style="text-decoration: underline">Section 6.1(a)(ii)</span>, (A)&#160;there are no issued, reserved
for issuance or outstanding Equity Securities of Company, and (B) there are no outstanding obligations of Company or any of its Subsidiaries
to repurchase, redeem or otherwise acquire any Equity Securities of Company or to issue, deliver or sell, or cause to be issued, delivered
or sold, any Equity Securities of Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Section 4.3(c) </span>of the Company Disclosure Letter sets forth a true and complete list of all outstanding Company Options as
of the Measurement Date (the &#8220;<span style="text-decoration: underline">Company Options Capitalization Table</span>&#8221;), including, with respect to each outstanding and
unexercised Company Option, (A) the holder&#8217;s name and country of residence, (B) the type of service relationship with Company or
any of its Subsidiaries (e.g., employee, independent contractor or non-employee director), (C) the applicable Company Stock Incentive
Plan covering such Company&#160;Option, (D) the date of grant, (E) the type of the award (including whether such Company Option was granted
in a manner intended to qualify as an &#8220;incentive stock option&#8221; under Section 422 of the Code), (F) the vesting schedule (including
any acceleration provisions), whether subject to performance conditions, (G)&#160;the number of shares of Company Common Stock subject
to such Company Option (based on the aggregate number of shares granted on the grant date and vesting on the applicable vesting date and
assuming satisfaction of any performance vesting conditions at maximum levels), (H) the applicable per share exercise price and expiration
date, and (I) a description of any exercisability conditions or provisions that deviate from the standard forms of award agreements evidencing
Company Options under the applicable Company Stock Incentive Plan. Company shall provide Parent with an updated Company Options Capitalization
Table no later than five (5) Business Days prior to the Effective Time. All Company Options have been granted in compliance in all material
respects with the applicable Company Stock Incentive Plan and all Applicable Laws. Company has delivered or made available to Parent copies
of each Company Stock Incentive Plan covering Company Options outstanding and unexercised as of the Measurement Date and the forms of
all award agreements evidencing such Company Options. The terms of the Company Stock Incentive Plans and the underlying award agreements
permit the treatment of Company Options described in <span style="text-decoration: underline">Section 3.1(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 161 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>There are no stockholder agreements or voting trusts or other agreements or understandings to which Company or any of its Subsidiaries
is a party with respect to the voting, or restricting the transfer, of any Equity Securities of Company or any of its Subsidiaries. Neither
Company nor its Subsidiaries has granted any preemptive rights, anti-dilutive rights or rights of first refusal, registration rights or
similar rights with respect to any Equity Securities of Company or any of its Subsidiaries that are in effect. Neither Company nor any
of its Subsidiaries has any outstanding any bonds, debentures, notes or other debtor obligations the holders of which have the right to
vote (or convertible into or exchangeable or exercisable for securities having the right to vote) with the stockholders of Company or
any of its Subsidiaries on any matter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>As of the date of this Agreement, there is no stockholder rights plan, &#8220;poison pill&#8221; antitakeover plan or similar device
in effect to which Company or any of its Subsidiaries is subject, party or otherwise bound.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.4</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Subsidiaries</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>All Equity Securities of each Subsidiary of Company (A) have been validly issued and are fully paid and nonassessable, except as,
individually or in the aggregate, would not reasonably be expected to be material to Company and its Subsidiaries, taken as a whole, and
(B) are owned by Company or one of its wholly owned Subsidiaries, directly or indirectly, free and clear of any Lien (other than any restrictions
imposed by Applicable Laws) and free of preemptive rights, rights of first refusal, subscription rights or similar rights of any person
and transfer restrictions (other than transfer restrictions under Applicable Laws or under the organizational documents of such Subsidiary).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>There are no outstanding (A) Equity Securities of Company or any of its Subsidiaries convertible into or exchangeable or exercisable
for, or based upon the value of, shares of capital stock or other voting or equity securities or interests in any Subsidiary of Company
or (B) warrants, calls, options, preemptive rights or other rights to acquire from Company or any of its Subsidiaries, or any obligation
of Company or any of its Subsidiaries to issue, any Equity Securities in any Subsidiary of Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.5</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">SEC Documents; Financial Statements; Undisclosed Liabilities</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company has timely filed or furnished all required registration statements, prospectuses, reports, schedules, forms, statements,
certifications and other documents (including exhibits and all other information incorporated therein, regardless of when such exhibits
and other information were filed) with the SEC since January 1, 2022 (the &#8220;<span style="text-decoration: underline">Company SEC Documents</span>&#8221;). As of their respective
dates, the Company SEC Documents complied in all material respects with the requirements of the Securities Act, the Exchange Act and the
Sarbanes-Oxley Act, as the case may be, and the rules and regulations of the SEC promulgated thereunder applicable to the Company SEC
Documents, and none of the Company SEC Documents when filed and at their respective effective times, if applicable, contained any untrue
statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading. As of the date of this Agreement, there are no outstanding
or unresolved comments received from the SEC with respect to any of the Company SEC Documents, and, to the Knowledge of Company, none
of the Company SEC Documents is the subject of any outstanding SEC investigation. No Subsidiary of Company is required to file reports
with the SEC pursuant to the requirements of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The consolidated financial statements (including all related notes and schedules) of Company and its Subsidiaries included in the
Company SEC Documents were prepared in all material respects in accordance with United States generally accepted accounting principles
(&#8220;<span style="text-decoration: underline">GAAP</span>&#8221;) (except, in the case of unaudited statements, as permitted by the SEC) applied on a consistent basis during
the periods involved (except as may be indicated in the notes thereto) and fairly present in all material respects the consolidated financial
position of Company and its consolidated Subsidiaries as of the dates thereof and the consolidated results of their operations and cash
flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments which are not material
and to any other adjustments described therein, including the notes thereto). Since January 1, 2022, there has been no material change
in Company&#8217;s accounting methods or principles that would be required to be disclosed in Company&#8217;s financial statements in
accordance with GAAP, except as described in the Company Filed SEC Documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 162 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Except (A) as reflected or reserved against in Company&#8217;s audited balance sheet as of December 31, 2024 (or the notes thereto)
included in Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 31, 2025 (the &#8220;<span style="text-decoration: underline">Company Balance Sheet</span>&#8221;),
(B) for liabilities and obligations incurred in the ordinary course of business consistent with past practice since December 31, 2022,
and (C) for liabilities and obligations incurred in connection with or contemplated by this Agreement, neither Company nor any of its
Subsidiaries has any liabilities or obligations of any nature (whether accrued, absolute, contingent or otherwise) that would be required
by GAAP to be reflected on a consolidated balance sheet of Company and its Subsidiaries (or in the notes thereto) that, individually or
in the aggregate, would reasonably be expected to have a Material Adverse Effect on Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company maintains a system of &#8220;internal control over financial reporting&#8221; (as defined in Rules 13a-15(f) and 15d-15(f)
of the Exchange Act) sufficient to provide reasonable assurance (A) that transactions are recorded as necessary to permit preparation
of financial statements in conformity with GAAP, consistently applied, (B) that transactions are executed only in accordance with the
authorization of management and (C) regarding prevention or timely detection of the unauthorized acquisition, use or disposition of Company&#8217;s
properties or assets. Since January 1, 2022, none of Company, Company&#8217;s independent accountants, the Company Board or its audit
committee has identified or been made aware of any (1) &#8220;significant deficiency&#8221; in the internal controls over financial reporting
of Company, (2) &#8220;material weakness&#8221; in the internal controls over financial reporting of Company, (3) fraud, whether or not
material, that involves management or other employees of Company who have a significant role in the internal controls over financial reporting
of Company or (4) any bona fide complaints regarding a material violation of accounting procedures, internal accounting controls or auditing
matters, including from employees of Company or any of its Subsidiaries regarding questionable accounting, auditing or legal compliance
matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The &#8220;disclosure controls and procedures&#8221; (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) utilized
by Company are reasonably designed to ensure that all information (both financial and non-financial) required to be disclosed by Company
in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods
specified in the rules and forms of the SEC and that all such information required to be disclosed is accumulated and communicated to
the management of Company, as appropriate, to allow timely decisions regarding required disclosure and to enable the chief executive officers
and chief financial officer of Company to make the certifications required under the Exchange Act with respect to such reports.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Company nor any of its Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off-balance
sheet partnership or any similar contract (including any contract or arrangement relating to any transaction or relationship between or
among Company and any of its Subsidiaries, on the one hand, and any unconsolidated Affiliate, including any structured finance, special
purpose or limited purpose entity or person, on the other hand, or any &#8220;off-balance sheet arrangements&#8221; (as defined in Item
2.03(d) of Form 8-K or as defined in Item 303(a) of Regulation S-K under the Exchange Act)), where the purpose or intended effect of such
contract is to avoid disclosure of any material transaction involving, or material liabilities of, Company or any of its Subsidiaries
in Company&#8217;s or such Subsidiary&#8217;s published financial statements or other Company SEC Documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Since January 1, 2022, each of the principal executive officer and the principal financial officer of Company (or each former principal
executive officer and each former principal financial officer of Company, as applicable) has made all certifications required by Rule
13a-14 or 15d-14 under the Exchange Act and Sections 302 and 906 of the Sarbanes-Oxley Act with respect to the Company SEC Documents,
and the statements contained in such certifications are true and accurate in all material respects. For purposes of this Agreement, &#8220;principal
executive officer&#8221; and &#8220;principal financial officer&#8221; shall have the meanings given to such terms in the Sarbanes-Oxley
Act. Since January 1, 2022, Company has been in compliance with all of the other applicable provisions of the Sarbanes-Oxley Act and the
applicable listing and corporate governance rules of NASDAQ.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.6</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Absence of Certain Changes or Events</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>From December 31, 2024 through the date of this Agreement, other than with respect to or in connection with the transactions contemplated
hereby, (i) the businesses of Company and its Subsidiaries have been conducted in all material respects in the ordinary course of business
consistent with past practice and (ii) neither Company nor any of its Subsidiaries has taken any action that, if taken during the period
from the date of this Agreement through the Effective Time without Parent&#8217;s consent, would constitute a breach of <span style="text-decoration: underline">Section 6.1(a)(i)</span>
to <span style="text-decoration: underline">Section 6.1(a)(xv)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 163 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Since December 31, 2024 and through the date of this Agreement, there have been no Changes that, individually or in the aggregate,
have had or would reasonably be expected to have a Material Adverse Effect on Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.7</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Compliance with Applicable Laws; Outstanding Orders</span>. Except as, individually or in the aggregate, would not reasonably be
expected to have a Material Adverse Effect on Company, Company and its Subsidiaries hold all permits, licenses, accreditations, certifications,
qualifications, agreements, authorizations, easements, franchises, rulings, waivers, consents, variances, exemptions, orders, registrations
and approvals of all Governmental Entities or accreditation organizations, or the administrative agents thereof (&#8220;<span style="text-decoration: underline">Permits</span>&#8221;)
that are required for the operation of the businesses of Company and its Subsidiaries as currently conducted (the &#8220;<span style="text-decoration: underline">Company Permits</span>&#8221;),
and all such Company Permits are in good standing or, where applicable, a renewal application has been timely filed and is pending agency
approval. Company and its Subsidiaries are in material compliance with the terms of the Company Permits and Applicable Laws relating to
Company and its Subsidiaries or their respective businesses or properties, except where the failure to be in compliance with such Company
Permits or Applicable Laws would be material to the Company and its Subsidiaries, taken as a whole. Neither Company nor any of its Subsidiaries
is subject to any outstanding Order that, individually or in the aggregate, would reasonably be expected to (i) have a Material Adverse
Effect on Company or (ii) prevent, materially impair or materially delay the ability of Company to consummate any of the transactions
contemplated hereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.8</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Regulatory Matters and Compliance with Healthcare Laws</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company and its Subsidiaries are in compliance with all Healthcare Laws applicable to their respective businesses and the Company
Products. Neither Company nor any of its Subsidiaries has received any written notification of any pending or threatened, Action from
any Governmental Entity, including the U.S. Food and Drug Administration (&#8220;<span style="text-decoration: underline">FDA</span>&#8221;), state Governmental Entities, and
Notified Bodies, alleging noncompliance of Company under any applicable Healthcare Laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Each Healthcare Permit is in full force and effect and no suspension, revocation, cancellation or withdrawal of such Healthcare
Permit is pending or threatened. All submissions utilized as the basis for, or submitted by, Company and its Subsidiaries, in connection
with any Healthcare Permit currently held by the Company for the Company Products, when submitted to the applicable Governmental Entity,
were complete and correct as of the date of submission or were corrected or supplemented by a subsequent submission and any required updates,
changes, corrections or modifications to such submissions have been submitted to the applicable Governmental Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The Company has not received any notice that (i) any Action has been taken by any Governmental Entity or (ii) any Action is in
the process of being taken by any Governmental Entity that, if taken, would slow, halt or enjoin the development, manufacturing, or marketing
of the Company Products or the operation of the respective businesses of Company or its Subsidiaries, or subject the development, manufacturing,
or marketing of the Company Products or Company or its Subsidiaries to any Action.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Since January 1, 2021, (i) there have been no field notifications, field corrections, market withdrawals, recalls, or replacements,
safety alerts or other notice of action relating to an alleged lack of safety, efficacy, or regulatory compliance of the Company Products
(&#8220;<span style="text-decoration: underline">Company Field Safety Notices</span>&#8221;); (ii) the Company has implemented corrective and preventative actions for all complaints
received by the Company from any Governmental Entity, and there are no open complaints with respect to the Company Products that have
been received by the Company from any Governmental Entity; and (iii) the Company has implemented corrective and preventive actions for
all material complaints from any non-Governmental Entity (including from healthcare professionals, users, distributors, or patients),
and there are no open material complaints with respect to the Company Products that have been received by the Company from any non-Governmental
Entity. To the Knowledge of Company, there are no facts that would be reasonably likely to result in (x) a material Company Field Safety
Notice, (y) a material change in labeling of any of the Company Products; or (z) a termination or suspension of marketing or testing of
the Company Products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company and its Subsidiaries and, to the Knowledge of Company, its suppliers and contract manufacturers, are ISO 13485:2016 certified
and in good standing with the relevant Governmental Entity, and in material compliance with all applicable requirements of ISO 13485:2016
and Applicable Laws, rules, standards, and official guidance, including quality system regulation in 21 C.F.R. Part 820, EU Medical Devices
Directive, and the EU Medical Devices Regulation, as applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 164 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The Company CE Products are in compliance with the EU Medical Devices Directive and relevant parts of the EU Medical Devices Regulation
and the Company has received formal confirmation from the Notified Body that the Company CE Products may continue to be placed on the
market of the CE Mark Countries until December 31, 2028.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company and its Subsidiaries have not received, since January 1, 2021, any written notice, Form FDA-483, warning letters, untitled
letters, or any similar notice or letter from any other Governmental Entity alleging or asserting non-compliance with any Healthcare Laws
or any other communication alleging actual or potential violations of any Healthcare Laws. Company has not entered into any consent decree
or order pursuant to any Healthcare Laws and Company is not party to any judgement, decree, or judicial or administrative order pursuant
to any Healthcare Laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(h)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The preclinical and clinical studies and tests conducted with respect to the Company Products, by or on behalf of, or sponsored
by Company or its Subsidiaries and used to support a regulatory submission, if still pending, are being conducted in accordance with all
applicable Healthcare Laws. To the Knowledge of Company, no investigational device exemption or clinical trial application filed by or
on behalf of Company or its Subsidiaries with the FDA or similar application or Healthcare Permit filed with any other Governmental Entity
has been terminated or suspended by the FDA or such other Governmental Entity due to a safety or non-compliance issue, and neither the
FDA nor any other Governmental Entity has commenced, or threatened to initiate, any action to place a clinical hold order on, or otherwise
terminate, delay, or suspend, any proposed or ongoing clinical investigation conducted or proposed to be conducted by or on behalf of
Company or its Subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Company nor any of its Subsidiaries is the subject of any pending or, to the Knowledge of Company, threatened investigation
by the FDA pursuant to its &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; Final Policy set
forth in 56 Fed. Reg. 46191 (September&#160;10, 1991) and any amendments thereto. Neither Company, its Subsidiaries, nor any of their
respective officers, directors or employees has been (i) debarred, excluded or suspended from any Governmental Health Program, or any
other Government Health Program or human clinical research, including under 21 U.S.C. &#167; 335a or any similar Applicable Laws or (ii)
convicted of any crime or engaged in any conduct that could result in such a debarment, suspension or exclusion. No legal proceeding,
investigation, audit, inquiry, or action that would reasonably be expected to result in such a debarment, suspension or exclusion are
pending or, to the Knowledge of Company, threatened against Company or any of its officers, directors, or employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(j)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>None of Company or its Subsidiaries, and no director, officer, employee, contractor or agent of Company or its Subsidiaries, has
been charged with or convicted of a Governmental Health Program-related offense, or convicted of, or charged with a violation of federal
or state Applicable Laws related to fraud, theft, embezzlement, breach of fiduciary responsibility, financial misconduct, obstruction
of an investigation of controlled substances, or has been debarred, excluded or suspended from participation in a Governmental Health
Program (nor is any such debarment, exclusion or suspension pending), or been subject to any Order or consent decree of, or criminal or
civil fine or penalty imposed by, any Governmental Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(k)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Company nor any of its Subsidiaries (i) participates in, or submits claims to, any Payors; or (ii) has provided Payor coverage
or reimbursement advice to any customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.9</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Corrupt Practices</span>. Since January 1, 2022, (i) none of Company or its Subsidiaries, nor, to the Knowledge of Company, any
director, officer, employee, agent or other person acting on behalf of Company, has directly or indirectly made, offered to make, attempted
to make, or promised any contribution, gift, bribe, rebate, payoff, influence payment, kickback or other payment to or from any person,
private or public, regardless of what form, whether in money, property or services, in violation of any Anti-Corruption Laws, (ii) to
the Knowledge of Company, as of the date of this Agreement, neither Company nor any of its Subsidiaries, directors, officers, employees
or agents is under internal or Governmental Entity investigation for any violation of any Anti-Corruption Laws, has received any written
notice or other communication from any Governmental Entity regarding a violation of, or failure to comply with, any Anti-Corruption Laws,
(iii) Company and its Subsidiaries maintain a system or systems of internal controls as required by applicable Anti-Corruption Laws, and
(iv) since January 1, 2022, neither Company nor any of its Subsidiaries has made any disclosure (voluntary or otherwise) to any Governmental
Entity with respect to any alleged irregularity, misstatement or omission or other potential violation or liability arising under or relating
to any Anti-Corruption Laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 165 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.10</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Sanctions</span>. Neither Company nor any of its Subsidiaries and, to the Knowledge of Company, no director, officer or employee
thereof, (i) is a Sanctioned Person or (ii) as of the date of this Agreement, has pending or, to the Knowledge of Company, threatened
claims against it, him or her with respect to applicable Sanctions or Ex-Im Laws and (iii) each of Company and its Subsidiaries is and,
since January 1, 2022, has been, in compliance in all material respects with all applicable Sanctions and Ex-Im Laws. Neither Company
nor any of its Subsidiaries has, since January 1, 2022, made any voluntary or directed disclosure to any Governmental Entity regarding
any apparent or alleged violation of Sanctions or Ex-Im Laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.11</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Litigation</span>. There is no legal, administrative, arbitral or other action, suit, charge, investigation, inquiries, proceeding,
complaint, audit, indictment or litigation before any court or arbitrator or any Governmental Entity (each, an &#8220;<span style="text-decoration: underline">Action</span>&#8221;)
pending or, to the Knowledge of Company, threatened against Company or any of its Subsidiaries or any of their respective properties or
any of their respective officers or directors, except as, individually or in the aggregate, would not reasonably be expected to (i) be
material to Company and its Subsidiaries, taken as a whole, or (ii) prevent, materially impair or materially delay the ability of Company
to consummate any of the transactions contemplated hereby. To the Knowledge of Company, there are no SEC inquiries or investigations,
other governmental inquiries or investigations, or internal investigations pending or threatened, in each case regarding any accounting
practices of Company or any of its Subsidiaries or any malfeasance by any officer or director of Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.12</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Benefit Plans</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8239;&#8239;<span style="text-decoration: underline">Section 4.12(a)</span> of the Company Disclosure Letter sets forth a complete and correct list of all Company Benefit
Plans. Neither Company nor any ERISA Affiliate has any agreement, arrangement, commitment, or obligation to create, enter into, or contribute
to any Company Benefit Plan not listed on <span style="text-decoration: underline">Section 4.12(a)</span> of the Company Disclosure Letter or to continue, modify or amend any
existing Company Benefit Plan (except for amendments required by Applicable Law with respect to which the amendment deadline has not lapsed).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>With respect to each Company Benefit Plan, Company has provided to Parent complete and correct copies, to the extent applicable,
of (A) the current plan document and all amendments thereto, or, if no written plan document exists, a written summary of the material
terms of such Company Benefit Plan (B) the most recent summary plan description and all summaries of material modifications related thereto,
(C) all contracts related to such Company Benefit Plan, including all trust agreements, insurances policies and contracts, and service
provider agreements, in each case, as currently in effect, (D) the most recent audited financial statements and actuarial or other valuation
reports prepared with respect thereto, (E) the three (3) most recent annual reports (e.g., Form 5500 series) filed with a Governmental
Entity, along with all attachments and schedules related thereto, (F) the most recently received Internal Revenue Service (the &#8220;<span style="text-decoration: underline">IRS</span>&#8221;)
determination, opinion or advisory letter, (G) all year-end compliance testing results for the three most-recently completed plan years,
including, but not limited to, coverage (Code Section 410(b)), annual limits (Code Sections 402(g) and 415), non-discrimination (Actual
Deferral Percentage and Actual Contribution Percentage), and top-heavy testing, as well as all documentation relating to the correction
of any failure with respect to such testing, and (H) for each of three most recently completed three years, if the Company was considered
an Applicable Large Employer under the Affordable Care Act (whether individually or as a member of an aggregated Applicable Large Employer
group) during such years, copies of all Forms 1094-C and a sample Form 1095-C filed with the Internal Revenue Service for each such year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>With respect to each Company Benefit Plan, (A) such Company Benefit Plan has been established, documented, maintained, administered,
operated and funded in all material respects in accordance with its terms and in material compliance with all applicable requirements
of all Applicable Laws, including ERISA and the Code (and the regulations and rulings issued thereunder); (B) Company, each of its Subsidiaries
and each other Person has properly performed in all material respects all of its duties and obligations (whether arising by operation
of law, by contract or otherwise) under or with respect to such Company Benefit Plan; (C) all returns, reports (including all Form 5500
series annual reports, together with all schedules and audit reports required with respect thereto), notices, statements and other disclosures
relating to such Company Benefit Plan required to be filed with any Governmental Entity or provided to any participant in such Company
Benefit Plan (or the beneficiary of any such participant) have been properly prepared and properly filed or provided on or before their
respective due dates and were complete and accurate in all material respects when so filed or provided; (D) none of Company, any of its
Subsidiaries or any other Person has breached any fiduciary duty imposed upon it by ERISA or any other Applicable Law; (E) no prohibited
transaction within the meaning of Section 406 or 407 of ERISA or Section 4975 of the Code (and not otherwise exempt under Section 408
of ERISA or Section 4975(c)(2) or 4975(d) of the Code) has occurred that would reasonably be expected to subject the Company, any of its
Subsidiaries or such Company Benefit Plan to any material liability; (F) all contributions, premiums and other payments due or required
to be paid to (or with respect to) such Company Benefit Plan on or before the Effective Time have been timely paid in accordance with
the terms of such Company Benefit Plan and Applicable Law or, if not due until after the Effective Time, have been accrued as a liability
in accordance with GAAP or paid; (G) neither Company nor any of its Subsidiaries has incurred (whether or not assessed), and there exists
no condition or set of circumstances in connection with which any of Company, the Surviving Corporation, Parent or any of their respective
Subsidiaries or Affiliates could reasonably be expected to incur, directly or indirectly, any material penalty, excise Tax, fine, Lien
or liability under ERISA, the Code or any other Applicable Law; and (H) there is no pending or, to the Knowledge of Company, threatened
or anticipated claim, action, investigation or audit (other than routine claims for benefits) by, on behalf of or against any of the Company
Benefit Plans or any trusts or assets related thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 166 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Company or any of its Subsidiaries nor any ERISA Affiliate has ever maintained, sponsored, participated in, contributed
to or been obligated to contribute to, or has or could have any liability or obligation (including any contingent liability or obligation)
under or with respect to: (i) any employee benefit plan that is, or at any time was, subject to Section 302 or 303 of ERISA, Title IV
of ERISA, or Section 412 or 430 of the Code, (ii) any Multiemployer Plan, (iii) any &#8220;multiple employer welfare arrangement&#8221;
(as such term is defined under Section 3(40) of ERISA), (iv) any &#8220;multiple employer plan&#8221; (within the meaning of Section 210(a)
of ERISA or Section 413(c) of the Code), or (v) any self-funded (or self-insured) group health plan (including any such plan pursuant
to which a stop-loss policy or contract applies).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Each of the Company Benefit Plans intended to be &#8220;qualified&#8221; within the meaning of Section 401(a) of the Code, (A)
is so qualified and its related trust is exempt from taxation under Section 501(a) of the Code, and nothing has occurred or failed to
occur, and there are no facts or circumstances that could adversely affect the qualified status of any such plan or the tax-exempt status
of its related trust, or require the filing of a submission under the IRS&#8217;s Employee Plans Compliance Resolution System (&#8220;<span style="text-decoration: underline">EPCRS</span>&#8221;)
or the taking of any corrective action under EPCRS in order to maintain the qualified status of such Company Benefit Plan, and (B) has
received a favorable IRS determination letter or utilizes a pre-approved plan document that is the subject of an IRS opinion letter upon
which Company can rely as to such plan&#8217;s qualified status.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company is and, at all relevant times, has been in compliance in all material respects with the Patient Protection and Affordable
Care Act, Pub. L. No. 111 148, the Health Care and Education Reconciliation Act of 2010, Pub. L. No.111 152, and all regulations and guidance
issued thereunder (collectively, the &#8220;<span style="text-decoration: underline">Healthcare Reform Laws</span>&#8221;), including the market reform mandates, the employer
shared responsibility provisions relating to the offer of medical coverage that qualifies as &#8220;minimum essential coverage&#8221;
that is &#8220;affordable&#8221; and provides &#8220;minimum value&#8221; to &#8220;full time employees&#8221; and their &#8220;dependents&#8221;
(as those terms are defined in Section 4980H of the Code and the related Treasury Regulations), and the applicable information reporting
requirements under Sections 6055 and 6056 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Each Company Benefit Plan can be amended or terminated by Company at any time (whether before or after the Closing) in accordance
with its written terms, without any other Person&#8217;s consent, and without any penalty, cost, expense or liability to Company, the
Surviving Corporation, Parent, any of their respective Subsidiaries or Affiliates, or such Company Benefit Plan, other than de minimis
administrative expenses of the type typically incurred in connection with the termination of similar employee benefit plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(h)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby (either alone
or in conjunction with any other event) could reasonably be expected to (A) entitle any current or former employee, director or other
individual service provider of Company or any of its Subsidiaries to any payment of compensation, (B) result in the acceleration of vesting,
exercisability, funding or delivery of, or increase in the amount or value of, any payment, right or other benefit to any current or former
employee, director or other individual service provider of Company or any of its Subsidiaries, (C) result in any payment or funding (through
a grantor trust or otherwise) of compensation or benefits under, increase the amount payable or result in any other material obligation
pursuant to, any Company Benefit Plan or otherwise, (D) result in any limitation on the right of Company, the Surviving Corporation, Parent
or any of their respective Subsidiaries or Affiliates to amend, merge, terminate or receive a reversion of assets from any Company Benefit
Plan or related trust on or after the Effective Time, or (E) result in the payment of any amount (whether in cash, in property, the vesting
of property or in the form of benefits) that could, individually or in combination with any other such payment, reasonably be expected
to constitute an &#8220;excess parachute payment&#8221; within the meaning of Section 280G of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Each Company Benefit Plan that provides, in any part, deferred compensation that is subject to Section 409A of the Code satisfies
the documentary and operational requirements of Sections 409A(a)(2), 409A(a)(3) and 409A(a)(4) of the Code and the regulations, rulings
and other guidance issued thereunder (and has satisfied such requirements for the entire period during which Section 409A of the Code
has applied to such Company Benefit Plan), such that no participant therein has been or could reasonably be expected to be subject to
any additional Tax or interest under Section 409A of the Code. No person is entitled to receive any additional payment (including any
Tax gross-up, reimbursement, make-whole or other payment or indemnification) from Company or any of its Subsidiaries as a result of the
imposition of Taxes or related interest or penalties under Section 4999 of the Code or Section 409A of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 167 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(j)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>(A) Each Company Benefit Plan maintained by Company on behalf of current or former directors, officers, managers, employees or
other service providers who reside or work primarily outside of the United States (each, an &#8220;<span style="text-decoration: underline">Company Foreign Plan</span>&#8221;)
required by any Applicable Law to be registered or approved by a Governmental Entity has been so registered or approved and has been maintained
in all material respects in good standing with the applicable Governmental Entity; (B) if such Company Foreign Plan is intended to qualify
for any preferential Tax treatment, such Company Foreign Plan satisfies the requirements for such treatment and has obtained all approvals
of all relevant Governmental Entities that are necessary to qualify for such Tax treatment; (C) each Company Foreign Plan required under
any Applicable Law to be funded, is either (1) funded in all material respects in accordance with such law to an extent sufficient to
provide for accrued benefit obligations with respect to all affected employees or (2) is fully insured, in each case based upon generally
accepted local accounting and actuarial practices and procedures, and none of the transactions contemplated by this Agreement will, or
would reasonably be expected to, cause such funding or insurance obligations to be materially less than such benefit obligations; (D)
no Company Foreign Plan is a &#8220;defined benefit plan&#8221; (as defined in ERISA, whether or not subject to ERISA), seniority premium,
termination indemnity, gratuity or similar plan or arrangement; and (E) no unfunded or underfunded liabilities exist with respect to any
Company Foreign Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.13</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Labor and Employment Matters</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Company nor any of its Subsidiaries are party to, or bound by, any Labor Agreement and no employees of Company or any of
its Subsidiaries are represented by any labor union, works council, or other labor organization with respect to their employment with
Company or any of its Subsidiaries. Except for matters that, individually or in the aggregate, would not reasonably be expected to be
material to Company and its Subsidiaries, taken as a whole, (i) there are no (and have not been since January 1, 2022) strikes or lockouts
with respect to any employees of Company or any of its Subsidiaries, (ii) there is no (and has not been since January 1, 2022) unfair
labor practice, labor dispute (other than routine individual grievances) or labor arbitration proceeding pending or, to the Knowledge
of Company, threatened in writing against Company or any of its Subsidiaries, (iii) there is no (and has not been since January 1, 2022)
slowdown, or work stoppage in effect or, to the Knowledge of Company, threatened in writing, with respect to any employees of Company
or any of its Subsidiaries, and (iv) to the Knowledge of Company, there are no labor union claims or demands to represent any employees
or contractors and there are no organizational campaigns in progress with respect to any of the employees or contractors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company and its Subsidiaries each are, and have been since January 1, 2022, in compliance with all Applicable Laws respecting labor,
employment and employment practices, including all Applicable Laws respecting terms and conditions of employment, health and safety, wages
and hours (including the classification of independent contractors and exempt and non-exempt employees), immigration (including the completion
of Forms I-9 for all U.S. employees and the proper confirmation of employee visas), employment discrimination, harassment, retaliation,
restrictive covenants, pay transparency, disability rights or benefits, equal opportunity, plant closures and layoffs (including the Worker
Adjustment and Retraining Notification Act of 1988, as amended, or any similar Applicable Laws (&#8220;<span style="text-decoration: underline">WARN Act</span>&#8221;)), workers&#8217;
compensation, labor relations, employee leave issues, employee trainings and notices, affirmative action and unemployment insurance. Neither
Company nor any of its Subsidiaries has received notice since January 1, 2022 of the intent of any Governmental Entity responsible for
the enforcement of labor, employment, immigration and workers compensation insurance laws to conduct an investigation of Company or any
of its Subsidiaries and, to the Knowledge of Company, no such investigation is in progress.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>To the Knowledge of Company, no current or former employee or independent contractor of Company or any of its Subsidiaries is in
any material respect in violation of any term of any employment agreement, nondisclosure agreement, common law nondisclosure obligation,
fiduciary duty, noncompetition agreement, restrictive covenant or other obligation (A) owed to Company or any of its Subsidiaries or (B)
owed to any third party with respect to such person&#8217;s right to be employed or engaged by Company or any of its Subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>To the Knowledge of Company, Company and its Subsidiaries have reasonably responded to, and investigated if required by Applicable
Law, all sexual harassment or other harassment, discrimination, or retaliation allegations against officers, directors and Senior Vice
President level employees of Company or any of its Subsidiaries that have been reported to Company or any of its Subsidiaries; and (ii)
to the Knowledge of Company, no allegations of sexual harassment or gender discrimination are pending against any such officers, directors
and senior vice president level employees of Company or any of its Subsidiaries, and therefore, to the Knowledge of Company, no substantial
liability or significant disrepute is expected to arise from any such allegations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 168 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.14</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Taxes</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>All income and other material Tax Returns required to be filed by, or on behalf of, Company or any of its Subsidiaries have been
properly and timely filed (taking into account validly obtained extensions of time to file), and all such Tax Returns are true, complete
and correct in all material respects and have been prepared in material compliance with all Applicable Law. Neither Company nor any of
its Subsidiaries is the beneficiary of any extension of time within which to file any material Tax Return (other than automatic extensions
validly obtained in the ordinary course of business). All Taxes due and payable by Company or any of its Subsidiaries have been properly
and timely paid in full (whether or not such Taxes were reflected on any Tax Return).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>All material Taxes required to be withheld by, or on behalf of, Company or any of its Subsidiaries in respect of any payments to
any employees, officers, managers, directors or other Persons have been properly and timely withheld and remitted to the appropriate Governmental
Entity in accordance with Applicable Law, and each of Company and its Subsidiaries has complied in all material respects with all related
information reporting, withholding and record retention requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The Company Balance Sheet accrues all liabilities for Taxes with respect to all periods through December 31, 2024 in accordance
with GAAP, and neither Company nor any of its Subsidiaries has incurred any liabilities for Taxes since such date, other than in the ordinary
course of business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>No audits, examinations, investigations, claims or other Actions are pending, currently in progress or threatened in writing with
regard to any material Taxes or any material Tax Return of Company or any of its Subsidiaries. There are no material Tax deficiencies
or assessments claimed, proposed or asserted against (or otherwise with respect to) Company or any of its Subsidiaries that have not been
fully paid and finally settled. Neither Company nor any of its Subsidiaries has extended or waived (or requested to extend or waive) any
statute of limitations period for the assessment or collection of any material Tax. No claim has been made by any Governmental Entity
in a jurisdiction where Company or any of its Subsidiaries does not file a particular type of Tax Return or pay a particular type of Tax
that Company or such Subsidiary is or may be required to file such particular type of Tax Return or pay such particular type of Tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Company nor any of its Subsidiaries has, or has ever had, a &#8220;permanent establishment&#8221; (within the meaning of
any applicable income Tax treaty or under any Applicable Law), a fixed place of business or other taxable presence, in each case, in any
jurisdiction other than the country in which Company or such Subsidiary, as applicable, was formed or organized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Company nor any of its Subsidiaries (A) is, or has ever been, a member of any &#8220;affiliated group&#8221; of corporations
within the meaning of Section 1504 of the Code, or any other affiliated, combined, consolidated or unitary group or arrangement for group
relief for any other Tax purposes (other than a group the common parent of which is or was Company), or (B) has any liability for the
Taxes of any person (other than Company or any of its Subsidiaries) under Treasury Regulations Section 1.1502-6 (or any similar provision
of state, local or non-U.S. Applicable Law), as a transferee or successor, by contract or otherwise. Neither Company nor any of its Subsidiaries
is a party to or bound by any contract, agreement or other arrangement regarding the sharing or allocation of, or indemnification or reimbursement
for, either liability for Taxes or payment of Taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>None of the assets of Company or any of its Subsidiaries is subject to any Lien for a material amount of Taxes (other than Liens
for Taxes not yet due and payable).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(h)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Within the past two years or otherwise as part of a &#8220;plan (or series of related transactions)&#8221; within the meaning of
Section 355(e) of the Code of which the Merger is also a part, neither Company nor any of its Subsidiaries has constituted either a &#8220;distributing
corporation&#8221; or a &#8220;controlled corporation&#8221; (within the meaning of Section 355(a)(1)(A) of the Code) in a distribution
of stock qualifying or intending to qualify for tax-free treatment under Section 355 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company currently is not, and has not been at any time during the past five (5) years, a &#8220;United States real property holding
corporation&#8221; within the meaning of Section&#160;897(c)(2) of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 169 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(j)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Company nor any of its Subsidiaries has participated in any &#8220;reportable transaction&#8221; within the meaning of
Treasury Regulations Section 1.6011-4(b)(1) (or any similar provision of state, local or non-U.S. Applicable Law).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(k)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>There are no private letter rulings or gain recognition agreements with respect to any Taxes or Tax Returns of Company or any of
its Subsidiaries that have been requested, issued or executed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(l)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Company nor any of its Subsidiaries will be required to include any material item of income in, or exclude any material
item of deduction from, Taxable income for any Taxable period (or portion thereof) ending after the Closing Date as a result of any (A)
change in method of accounting made, or improper method of accounting used, on or prior to the Closing Date, (B)&#160;closing agreement
described in Section&#160;7121 of the Code (or any similar provision of state, local or non-U.S. Applicable Law) entered into on or prior
to the Closing Date, (C)&#160;&#8220;intercompany transaction&#8221; within the meaning of Treasury Regulations Section&#160;1.1502-13
(or any similar provision of state, local or non-U.S. Applicable Law) occurring on or prior to the Closing Date, (D)&#160;&#8220;excess
loss account&#8221; within the meaning of Treasury Regulations Section&#160;1.1502-19 (or any similar provision of state, local or non-U.S.
Applicable Law) in existence on the Closing Date, (E)&#160;installment sale or open transaction disposition entered into on or prior to
the Closing Date or (F)&#160;prepaid amount received or deferred revenue accrued on or prior to the Closing Date. Neither Company nor
any of its Subsidiaries has made an election under Section 965 of the Code. Company and each of its Subsidiaries has always used the accrual
method of accounting for Tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(m)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Company nor any of its Subsidiaries (A) is a party to any joint venture, partnership or other arrangement or agreement
that could reasonably be expected to, or is, treated as a partnership for any Tax purposes or (B) directly or indirectly owns any interest
in any&#160;&#8220;passive foreign investment company&#8221; within the meaning of Section&#160;1297(a) of the Code or any&#160;&#8220;controlled
foreign corporation&#8221; within the meaning of Section&#160;957(a) of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(n)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Company nor any of its Subsidiaries has requested or claimed any Tax credits (or received any refund or advance payment
thereof) under the CARES Act, the Families First Coronavirus Response Act or Sections 3131, 3132 or 3134 of the Code (or any similar provision
of state, local or non-U.S. Applicable Law).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(o)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Company nor any of its Subsidiaries has taken or agreed to take any action, or is aware of any facts or circumstances,
in each case, that would prevent or impede, or would reasonably be likely to prevent or impede, the Merger from qualifying for the Intended
Tax Treatment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(p)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company and each of its Subsidiaries is in compliance in all material respects with all Applicable Laws with respect to transfer
pricing, including Section 482 of the Code and the Treasury Regulations thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.15</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Intellectual Property</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Section 4.15(a)</span> of the Company Disclosure Letter contains a list of (1) all issuances, registrations, and applications for
registration of all Intellectual Property owned by or filed or registered in the name of Company or its Subsidiaries (&#8220;<span style="text-decoration: underline">Company
Registered IP</span>&#8221;), (2) all material unregistered trademarks owned by Company or any of its Subsidiaries, (3) the jurisdiction
in which any of the foregoing have been issued, registered or filed, and (4) all actions that are required to be taken by Company or any
of its Subsidiaries within two months following the date of this Agreement in order to avoid prejudice to or impairment or abandonment
of any the foregoing ((1) and (2), collectively, and together with all other Intellectual Property owned or purported to be owned by Company
or its Subsidiaries, the &#8220;<span style="text-decoration: underline">Company Owned IP</span>&#8221;). All Company Registered IP is subsisting, valid and, to the Knowledge
of Company, enforceable, and has been obtained and maintained in compliance with all Applicable Laws and applicable rules, policies and
procedures of the applicable Governmental Entity or of the applicable person that maintains domain name registrations (including with
respect to the filing of required certifications or other documents for purposes of prosecuting, maintaining, and perfecting such Company
Registered IP).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 170 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company or one of its Subsidiaries exclusively owns, free and clear of all Liens (except Permitted Liens) all right, title, and
interest in and to the Company Owned IP and either owns all right, title, and interest in and to, free and clear of all Liens (except
Permitted Liens), or has the right to use pursuant to valid licenses, sublicenses, agreements or permissions, all other items of Intellectual
Property necessary for or used in the operation of Company and its Subsidiaries&#8217; businesses, as currently conducted or as proposed
to be conducted (such Intellectual Property, together with the Company Owned IP, the &#8220;<span style="text-decoration: underline">Company IP</span>&#8221;). The Company Owned
IP is fully transferable, alienable, and licensable by Company and its Subsidiaries without restriction and without payment of any kind
to, or approval by, any third party. The execution of this Agreement and the consummation of the transactions contemplated by this Agreement
will not result in (1) the loss or impairment of any Company IP, (2) any right of any person to terminate any rights under or exercise
any new or additional rights under any Company IP, (3) the payment by Parent or Merger Sub of any additional consideration for its right
to own, maintain or continue to use any of the Company IP, or (4) Parent or Merger Sub being bound by or subject to any exclusivity obligations,
non-compete, or other restrictions on the operation or scope of Company&#8217;s or any of its Subsidiaries&#8217; businesses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The conduct of Company, its Subsidiaries, and the conduct of Company&#8217;s and its Subsidiaries&#8217; businesses, including
the use, sale, or offer to sell any Company Products, does not infringe, misappropriate, dilute or otherwise violate, and has not infringed,
misappropriated, diluted or otherwise violated, any of the Intellectual Property or other rights of any third party. There are no past,
pending, or threatened actions, claims, or other proceedings involving any of the Company Owned IP, or alleging that the Company Products,
the conduct of Company or any of its Subsidiaries, or the conduct of its or their businesses infringe, misappropriate, dilute or otherwise
violate the Intellectual Property or other rights of any third party or challenging Company&#8217;s ownership or use of any Company IP
and, to the Knowledge of Company, no facts or circumstances exist that might reasonably serve as the basis for any of the foregoing. To
the Knowledge of Company, no third party is infringing, misappropriating, diluting or otherwise violating or has infringed, misappropriated,
diluted, or otherwise violated any Company Owned IP and no facts or circumstances exist that might reasonably suggest any of the foregoing.
Neither Company nor any of its Subsidiaries has received any notice that it must license or refrain from using any Intellectual Property
or any offer by any other person to license any Intellectual Property to Company or any of its Subsidiaries and, to the Knowledge of Company,
there are no facts or circumstances that would provide a reasonable basis for any such claim or challenge. Neither Company nor any of
its Subsidiaries has sent a notice to any third party alleging infringement, misappropriation, dilution or other violation of any Company
Owned IP or brought any action, claim, or other proceeding for unauthorized use, unauthorized disclosure, infringement, misappropriation,
dilution or other violation of any Company Owned IP. No Company Owned IP has been declared unenforceable or otherwise invalid by any Governmental
Entity nor is or has been involved in any interference, reissuance, reexamination, invalidation, cancellation, opposition or similar action,
claim, or other proceeding and to the Knowledge of Company there are no facts or circumstances that might reasonably serve as the basis
for any of the foregoing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company and its Subsidiaries take commercially reasonable measures to protect and preserve the confidentiality of trade secrets
and any other proprietary or confidential information, including Company Data, owned by or provided to them under conditions of confidentiality
(collectively, &#8220;<span style="text-decoration: underline">Confidential Information</span>&#8221;). There has been no unauthorized disclosure of any such trade secrets or
other Confidential Information by Company or any of its Subsidiaries to any person and Company and each of its Subsidiaries is in compliance
with all contracts relating to third-party trade secrets to which it is a party or is otherwise bound.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 171 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>All employees, contractors or consultants who have independently or jointly contributed to or are currently independently or jointly
contributing to the conception, creation, development, invention, or reduction to practice of any Company Owned IP (each, an &#8220;<span style="text-decoration: underline">Author</span>&#8221;)
have executed a valid and enforceable contract that: (1) presently assigns to Company or one of Company&#8217;s Subsidiaries all of such
person&#8217;s right, title, and interest in and to all such Intellectual Property, developed, invented, or reduced to practice by such
Author in the scope of such Author&#8217;s employment by or engagement with Company or one of its Subsidiaries, unencumbered by any Lien
(other than Permitted Liens) (to the extent such rights are not transferred to Company or one of Company&#8217;s Subsidiaries via operation
of law); and (2) includes confidentiality obligations in favor of Company or the applicable Subsidiary of Company ((1) and (2), collectively,
the &#8220;<span style="text-decoration: underline">Invention Assignment Agreements</span>&#8221;). Other than as set forth in <span style="text-decoration: underline">Section 4.15(e)</span> of the Company Disclosure
Letter, Company has made available to Parent true, correct, and complete copies of all Invention Assignment Agreements and, to the Knowledge
of Company, no Author is in breach of: (x) such Invention Assignment Agreement; or (y) any contract relating to employment, invention
disclosure, invention assignment, non-disclosure, or non-competition or any other contract by virtue of such Author being employed by,
or performing services for, Company or any of its Subsidiaries. To the Knowledge of Company, no Author is subject to any contract or obligation
with any third party that could adversely affect Company&#8217;s or its Subsidiaries&#8217; rights in the Company Owned IP, that restricts
or limits the work in which such Author may be engaged, or that requires such Author to disclose information concerning such Author&#8217;s
work to any person other than Company or its Subsidiaries. No funding, facilities or personnel of any educational institution or Governmental
Entity were used, directly or indirectly, to develop or create, in whole or in part, any Company Owned IP and no Governmental Entity or
other person has any claim of right or license to, ownership of, or other Lien (other than Permitted Liens) on any Company IP. No Author
was employed by or has performed services for any Governmental Entity during the time during which such Author was also performing services
for Company or one of its Subsidiaries or during the twelve (12) month period immediately prior to the same. Neither Company nor any of
its Subsidiaries have made, directly or indirectly, any commitments, promises, submissions, suggestions, statements or declarations to
any standards-setting bodies, industry groups, or other, similar organizations that would obligate Company or any of its Subsidiaries
to grant any rights or licenses to any person or otherwise impair or limit the control of any Company Owned IP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>No software included in the Company Owned IP (&#8220;<span style="text-decoration: underline">Owned Company Software</span>&#8221;) (1) includes any Harmful Code or (2)
is linked to, incorporates, or is otherwise integrated with any Open Source Software or any modification or derivative thereof in a manner
that (x) subjects such Owned Company Software to any obligations to disclose, distribute, or otherwise make the Owned Company Software
or any Company Source Code available to any third party or to be licensed to third parties at no or minimal cost, (y) creates obligations
for Company or any of its Subsidiaries to grant, or purports to grant to any person any rights or immunities under any Company Owned IP,
or (z) that otherwise restricts the ability of Company or any of its Subsidiaries to commercially exploit such Owned Company Software.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company and its Subsidiaries have not disclosed, delivered, or licensed any Company Source Code (and are not obligated to and have
not permitted a third party to disclose, deliver, or license any Company Source Code), nor has there been any unauthorized or inadvertent
disclosure of any Company Source Code, other than disclosures to employees, contractors, consultants, and advisors (A) involved in the
development of Company Products, and (B) subject to a written confidentiality agreement. No circumstance or condition exists (including
the execution and performance of this Agreement and the consummation of the transactions contemplated by this Agreement), that would reasonably
be expected to result in any of the foregoing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(h)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company&#8217;s and its Subsidiaries&#8217; use of AI Technology and practices relating to the operating, training, testing, improvement,
and development of any AI Technology, and any resulting outputs, complies (and all times has complied) in all material respects with (1)
Applicable Laws; (2) the Privacy and Security Requirements; and (3) applicable contractual obligations to which Company or any of its
Subsidiaries is bound. Company and its Subsidiaries do not employ the use of facial recognition with AI Technologies. Other than as set
forth in <span style="text-decoration: underline">Section 4.15(h)</span> of the Company Disclosure Letter, Company owns or has all necessary rights in and to any data that it
uses to operate, train, test, improve, or develop AI Technologies and the Company Products. Company and its Subsidiaries maintain and
adhere to industry standard policies, protocols, and procedures relating to the ethical and responsible use of AI Technologies, including
policies, protocols, and procedures for: (x)&#160;developing and implementing AI Technologies in a way that promotes transparency, accountability,
and human interpretability; (y)&#160;identifying and mitigating bias in AI Technologies and any data used to operate, train, test, improve,
or develop AI Technologies; (z) preventing AI Technologies from hallucinating, reproducing Personal Data or Confidential Information,
or otherwise producing harmful or inaccurate results; and (xx)&#160;requiring management oversight and approval of Company&#8217;s and
its Subsidiaries&#8217; use and implementation of AI Technologies. There has been no actual or, to the Knowledge of Company, alleged non-compliance
with any such policies, protocols, and procedures, and Company and its Subsidiaries have not received any notice or communication from
any Governmental Entity or other person concerning Company&#8217;s or its Subsidiaries&#8217; use of AI Technologies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 172 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.16</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Information Technology; Data Protection</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The IT Assets owned by, controlled by, or otherwise used in the conduct of the businesses of Company and its Subsidiaries are in
good working order and are sufficient for, and operate and perform as needed by, Company and its Subsidiaries to adequately conduct their
respective businesses as currently conducted and as proposed to be conducted and Company and its Subsidiaries own or have a valid right
to access and use all such IT Assets. There have not been, and there are no known vulnerabilities or defects that would reasonably be
expected to result in, any Security Breaches or unauthorized access or disclosure, unauthorized use, failures, or unplanned outages or
other adverse integrity, performance, or security access incidents affecting the IT Assets (or, in each case, Company Data and other information
and transactions stored or contained therein or transmitted thereby). The IT Assets are free of any Harmful Code and Company and its Subsidiaries
have taken all commercially reasonable steps and implemented commercially reasonable safeguards to protect the IT Assets from Harmful
Code. There are no material un-remediated security vulnerabilities in any Company Products or IT Assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company and its Subsidiaries (1) are and at all times have been in material compliance with all Privacy and Security Requirements,
and (2) have implemented and maintained a data security plan with commercially reasonable administrative, technical, and physical safeguards
to protect the IT Assets of Company and its Subsidiaries, and the Personal Data, Company Data, Confidential Information, and other information
and transactions stored or contained therein or transmitted thereby, against unauthorized access, use, loss, and damage. There has been
no (x) unauthorized access, misuse of, or damage to any IT Assets owned by or controlled by, or otherwise used in the conduct of the business
of, Company or any of its Subsidiaries, or (y) unauthorized access, use, misuse of, Processing, or loss of, or damage to, any Company
Data maintained by or on behalf of Company or any of its Subsidiaries (each of (x) and (y), together with any other event qualifying as
a &#8220;breach,&#8221; &#8220;breach of security,&#8221; &#8220;breach of system security,&#8221; &#8220;security incident,&#8221; or
similar event as defined under Applicable Law, including any such incident that would require notification to any Governmental Entity
or other person of such incident under the Privacy and Security Requirements, a &#8220;<span style="text-decoration: underline">Security Breach</span>&#8221;). Neither Company
nor any of its Subsidiaries have sent (or been required to send) or received any notices to or from any person or Governmental Entity
relating to a Security Breach, and no circumstance has arisen in which the Privacy and Security Requirements would require Company or
any of its Subsidiaries to notify a Governmental Entity or any other person of a Security Breach or any violations or potential violations
of any Privacy and Security Requirements. Neither Company and its Subsidiaries nor any person acting on its or their behalf or direction
have: (A) paid any perpetrator of, or party making a threat regarding, any Security Breach; or (B) paid any third party with actual or
alleged information about a Security Breach pursuant to a request for payment from or on behalf of such perpetrator or other third person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>To the extent that Company or any of its Subsidiaries receives, processes, transmits or stores any financial account numbers (such
as credit cards, bank accounts, PayPal accounts and debit cards), passwords, CCV data, cardholder data, or other related data, Company&#8217;s
and its Subsidiaries&#8217; information security procedures, processes and systems have at all times met or exceeded all Applicable Laws
and Privacy and Security Requirements, including those established by applicable Governmental Entities, payment brands, and the Payment
Card Industry Standards Council (including the Payment Card Industry Data Security Standards (&#8220;<span style="text-decoration: underline">PCI DSS&#8221;))</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company and its Subsidiaries are and at all times have (1) maintained privacy and security policies, procedures and safeguards
that comply with applicable HIPAA requirements, (2) conducted training regarding HIPAA for all workforce members upon hire and on at least
an annual basis thereafter; (ii) entered into business associate agreements and subcontractor business associate agreements (as defined
under HIPAA) when required pursuant to HIPAA; (iii) implemented commercially reasonable administrative, physical and technical safeguards
to ensure the confidentiality, integrity and security of electronic protected health information (as defined under HIPAA) in material
compliance with the HIPAA Security Rule as set forth in 45 C.F.R. Part 160 and subparts A and C of 45 C.F.R. Part 164; and (iv) completed
a security &#8220;risk analysis&#8221; (as required by 45 C.F.R. &#167; 164.308(a)(1)(ii)(A)) and updates such risk analysis when reasonably
determined necessary due to changes in the threat environment or technology and on a regular basis as required by HIPAA. Company and its
Subsidiaries are and have been in compliance with the terms of all business associate agreements and subcontractor business associate
agreements. To the Knowledge of Company, no subcontractor of Company has breached any business associate agreement or subcontractor business
associate agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 173 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.17</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Certain Contracts</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Except as set forth on <span style="text-decoration: underline">Section 4.17(a)</span> of the Company Disclosure Letter, as of the date of this Agreement, neither Company
nor any of its Subsidiaries is a party to or bound by (in each case, excluding any Company Benefit Plan):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any &#8220;material contract&#8221; (as such term is defined in Item 601(b)(10) of Regulation S-K of the SEC) with respect to Company
or any of its Subsidiaries that was required to be, but has not been, filed with the SEC with Company&#8217;s Annual Report on Form 10-K
for the fiscal year ended December 31, 2023 or with Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31,
2024, or any Company SEC Documents filed after the date of filing of such Form 10-K until the date of this Agreement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any contract involving payment by or to Company or its Subsidiaries of more than $250,000 in the year ended December 31, 2024 or
that is expected to involve payment by or to Company or its Subsidiaries of more than $250,000 for the year ended December 31, 2025;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>contracts with any Payor involving payment by or to Company or its Subsidiaries of more than $100,000 in the year ended December
31, 2024 or that is expected to involve payment to Company or its Subsidiaries of more than $100,000 for the year ended December 31, 2025;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>contracts with a Governmental Entity, pursuant to which Company or a Subsidiary received payments from any Governmental Entity;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(v)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any loan agreements, credit agreements, notes, debentures, bonds, mortgages, indentures, and other contracts pursuant to which
any indebtedness of Company or any of its Subsidiaries is outstanding or may be incurred and all guarantees of or by Company or any of
its Subsidiaries of any indebtedness of any other person (except for any such indebtedness or guarantees of indebtedness (A) the principal
amount of which does not exceed $100,000 in the aggregate and (B) intercompany indebtedness among Company and its wholly owned Subsidiaries
in the ordinary course of business);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vi)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any Company Real Property Lease;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any contract relating to any swap or hedging transaction, option, warrant, forward purchase or sale transaction, futures transaction,
cap transaction, floor transaction, or collar transaction relating to one or more currencies, commodities, bonds, equity securities, loans,
interest rates, credit related events or conditions or any indexes, or any other similar transaction (including any option with respect
to any of these transactions) or combination of any of these transactions;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(viii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any contract containing a right of first refusal, right of first negotiation or right of first offer with respect to any assets
of Company or any of its Subsidiaries or joint ventures;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ix)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any contract containing any non-compete, exclusivity, &#8220;most favored nation&#8221; provision or any similarly restrictive
provision with respect to any line of business, person, property or geographic area that limits, in any material respect, the business
of Company or any of its Subsidiaries (or, following the Effective Time, Parent and its Subsidiaries);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(x)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any contract with any (A) executive officer or director of Company, or (B) Affiliate (as such term is defined in Rule 12b-2 promulgated
under the Exchange Act) or (C) &#8220;associates&#8221; (or members of any of their &#8220;immediate family&#8221;) (as such terms are
respectively defined in Rule 12b-2 and Rule 16a-1 of the Exchange Act) of any such executive officer, director or Affiliate;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 174 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xi)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any contract involving the settlement of any Action or threatened Action (or series of related Actions) which (A) will involve
payments by Company or any of its Subsidiaries after the date hereof, or involved such payments, in excess of $100,000, (B) will impose
materially burdensome monitoring or reporting obligations on Company or any of its Subsidiaries or material restrictions on Company or
any of its Subsidiaries (or, following the Effective Time, on Parent or any of its Subsidiaries), including any Corporate Integrity Agreements
and similar agreement with a Governmental Entity or (C) creates or could create a Lien (other than a Permitted Lien) on any asset of Company
and its Subsidiaries in excess of $50,000;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any partnership, joint venture, strategic alliance, limited liability company agreement, and any contract that provides for any
sharing of revenues, profits or losses with one or more persons or other similar agreement, in each case other than any such agreement
solely between or among Company and its wholly owned Subsidiaries;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xiii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any acquisition or divestiture contract, including with respect to the acquisition or disposition of any product line, business
or material asset of Company or any of its Subsidiaries, other than contracts solely between or among Company and its wholly owned Subsidiaries;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xiv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any contract under which Company or its Subsidiaries has granted or received any license or other rights with respect to material
Intellectual Property or otherwise restricting their ability to own, enforce, use, license or disclose any material Intellectual Property
(other than (x) licenses to &#8220;off-the-shelf,&#8221; non-customized, commercially available software that are subject to standard,
non-negotiated terms and conditions, (y) non-exclusive licenses to Company Owned IP granted to customers, (z) non-exclusive licenses granted
by vendors or service providers under contracts primarily for the provision of services, where such non-exclusive license is incidental
to the subject matter of the agreement, and (xx) Invention Assignment Agreements entered into with employees of Company or its Subsidiaries,
in each case of (y), (z) and (xx), in the ordinary course of business and consistent with past practice); or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any contract for the development of material Intellectual Property for the benefit of Company or any of its Subsidiaries or intending
to resolve any disputes relating to Intellectual Property (e.g., covenants not to assert, concurrent use agreements, or coexistence agreements)
or restricting Company or any of its Subsidiaries from using or exploiting Company Owned IP any contract relating to clinical research
or retrospective studies (including any sub-agreements, principal investigator agreements, site affiliation agreements, sponsor agreements,
management services agreements, software agreements or other agreements);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xvi)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any contracts granting data sharing rights or involving the sale of data; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xvii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any business associate agreements and subcontractor business associate agreements (as defined under HIPAA); (all contracts of the
types described in clauses (a) through (q), collectively, the &#8220;<span style="text-decoration: underline">Company Material Contracts</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>True, correct and complete copies of each Company Material Contract have been made available to Parent. Except as, individually
or in the aggregate, would not reasonably be expected to be material to Company, (i) neither Company nor any of its Subsidiaries is in
breach of or default under (or, with the giving of notice or lapse of time or both, would be in default under), and has not taken any
action resulting in the termination of, the acceleration of performance required by, or a right of termination or acceleration under,
any Company Material Contract to which it is a party or by which it is bound, (ii) to the Knowledge of Company, no other party to any
Company Material Contract is in breach of or default (or, with the giving of notice or lapse of time or both, would be in default) under,
and has not taken any action resulting in the termination of, the acceleration of performance required by, or a right of termination or
acceleration under, any Company Material Contract and (iii) each Company Material Contract is (A) a valid and binding obligation of Company
or any Subsidiary of Company that is a party thereto, as applicable, and, to the Knowledge of Company, the other parties thereto (subject
to the Enforceability Exceptions) and (B) in full force and effect. Neither Company nor any of its Subsidiaries has knowledge of, or has
received written notice of, any violation or default (nor, to the Knowledge of Company, does there exist any condition that with the passage
of time or the giving of notice or both would result in such a violation or default) under any Company Material Contract, in each case
that, individually or in the aggregate, would reasonably be expected to be material to Company. Neither Company nor any of its Subsidiaries
has received, in the twelve (12) month period prior to the date of this Agreement, any written notice or other written communication from
any person that such person intends to terminate, accelerate maturity or performance, not renew or modify in a manner materially adverse
to Company and its Subsidiaries any Company Material Contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 175 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.18</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Environmental Protection</span>. Except as, individually or in the aggregate, would not reasonably be expected to have a Material
Adverse Effect on Company, (i) Company and each of its Subsidiaries are and have been since January 1, 2022 in compliance with all applicable
Environmental Laws, and neither Company nor any of its Subsidiaries has received any written communication from any person or Governmental
Entity that alleges that Company or any of its Subsidiaries is not in such compliance with, or has any liability under, applicable Environmental
Laws, (ii) Company and each of its Subsidiaries have obtained all permits, licenses, variances, exemptions, registrations, approvals and
authorizations of all Governmental Entities required or necessary for, pursuant to applicable Environmental Law, the construction, occupation
and operation of their facilities and the conduct of their business and operations (&#8220;<span style="text-decoration: underline">Environmental Permits</span>&#8221;), and all
such Environmental Permits are in good standing or, where applicable, a renewal application has been timely filed and is pending agency
approval, and Company and its Subsidiaries are and since January 1, 2022 have been in compliance with all terms and conditions of the
Environmental Permits, (iii) as of the date hereof, there are no Actions under any Environmental Laws pending or, to the Knowledge of
Company, threatened in writing against Company or any of its Subsidiaries, (iv) there has been no Release or disposal of, exposure of
any person to, or contamination by, any Hazardous Material that has given or would be reasonably likely to give rise to liability for
Company or its Subsidiaries under any Environmental Laws and (v) neither Company nor any of its Subsidiaries has assumed, undertaken,
provided an indemnity with respect to, or otherwise become subject to, the liability of any other Person, either contractually or by operation
of law, under any Environmental Laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.19</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Real Property</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company does not, nor do any of its Subsidiaries, own any real property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Section 4.19(b)</span> of the Company Disclosure Letter sets forth a list of all leases, subleases, licenses and other use and
occupancy arrangements of real property for which Company or its Subsidiaries is a tenant or subtenant, licensee or occupant (such real
property, the &#8220;<span style="text-decoration: underline">Company Leased Real Property</span>&#8221; and each underlying lease, a &#8220;<span style="text-decoration: underline">Company Real Property Lease</span>&#8221;)
and the address of the Company Leased Real Property that is the subject of such Company Real Property Lease. Except as, individually or
in the aggregate, would not reasonably be expected to be material to Company, (i) each Company Real Property Lease is valid and in full
force and effect and, to the Knowledge of Company, valid and enforceable against the other parties thereto, (ii) Company has good and
marketable leasehold title to each Company Leased Real Property, (iii) neither Company nor any of its Subsidiaries, nor to the Knowledge
of Company any other party to a Company Real Property Lease, has violated any provision of, or taken or failed to take any act which,
with or without notice, lapse of time, or both, would constitute a default under the provisions of such Company Real Property Lease, and
neither Company nor any of its Subsidiaries has received or given any notice in writing that there is a breach, violation or default under
any Company Real Property Lease where such breach, violation or default remains uncured, (iv) neither Company nor any of its Subsidiaries
has assigned, transferred, subleased or otherwise granted any Person the right to use or occupy any Company Leased Real Property or pledged
any interest in any Company Real Property Lease, (v) all of the land, buildings, structures and other improvements used by Company are
included in the Company Leased Real Property, (vi) Company has not received any written notice of any violation of Applicable Laws with
respect to any Company Leased Real Property or any Company Real Property Lease, and (vii) there is no condemnation proceeding pending
or, to the Knowledge of Company, threatened as to any Company Real Property Lease nor any material casualty which has not been fully restored.
Company&#8217;s possession and quiet enjoyment of the rights and benefits granted to Company under each Company Real Property Lease is
not currently disturbed in any material respect. There are no third party contracts currently in effect to which Company is a party for
the performance of any repairs, work and/or capital improvements at the Company Leased Real Property, and there is currently no ongoing
construction work in, on or about the Company Leased Real Property other than normal, immaterial maintenance and repairs being performed
in the ordinary course of business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.20</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Voting Requirements</span>. The affirmative vote of the holders of a majority of all outstanding shares of Company Common Stock
entitled to vote thereon (the &#8220;<span style="text-decoration: underline">Company Stockholder Approval</span>&#8221;), at the Company Stockholders Meeting, is necessary to
adopt this Agreement. The Company Stockholder Approval is the only vote of holders of any securities of Company necessary to approve the
transactions contemplated by this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 176 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.21</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Opinion of Financial Advisors</span>. The Company Board has received the opinion of Piper Sandler &amp; Co. (the &#8220;<span style="text-decoration: underline">Company
Financial Advisor</span>&#8221;) to the effect that, as of the date of such opinion and based upon and subject to the various assumptions,
limitations, factors, qualifications and other matters set forth therein, the Exchange Ratio is fair, from a financial point of view,
to the holders of Company Common Stock other than Parent or its Affiliates (it being agreed that such opinion is for the benefit of the
Company Board and, for the avoidance of doubt, may not be relied upon by Parent or any of its Affiliates). A true and complete copy of
the signed, written opinion of the Company Financial Advisor will promptly following receipt thereof by Company be made available to Parent
after the date hereof for informational purposes only.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.22</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Brokers</span>. Except for fees payable to the Company Financial Advisor, no broker, investment banker or financial advisor is
entitled to broker&#8217;s, finder&#8217;s, financial advisor&#8217;s or other similar fee or commission in connection with the transactions
contemplated by this Agreement based upon arrangements made by or on behalf of Company. Company has, prior to the execution and delivery
of this Agreement, made available to Parent, a true, correct and complete copy of Company&#8217;s engagement letter with the Company Financial
Advisor related to the Merger and the transactions contemplated hereby as in effect on the date of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 4.23</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Other Representations</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Except for the express written representations and warranties made in this <span style="text-decoration: underline">ARTICLE IV</span> (as qualified by the Company Disclosure
Letter and Company Filed SEC Documents) or any certificate delivered by or at the direction of Company pursuant to this Agreement, neither
Company nor any other person acting on behalf of Company or its Subsidiaries makes any express or implied representation or warranty with
respect to Company or its Subsidiaries, or their respective Affiliates, businesses, operations, assets, liabilities or conditions (financial
or otherwise) in connection with this Agreement or the transactions contemplated hereby, and Company hereby disclaims any such other representations
or warranties. In particular, without limiting the foregoing disclaimer, except as expressly provided in this <span style="text-decoration: underline">ARTICLE IV</span> or any
certificate delivered pursuant to this Agreement, neither Company nor any other person makes or has made any representation or warranty
to Parent or any of its Affiliates or representatives with respect to (A) any financial projection, forecast, estimate, budget or prospect
information relating to Company or any of its Subsidiaries or their respective businesses or (B) except for the express written representations
and warranties made in this <span style="text-decoration: underline">ARTICLE IV</span> (as qualified by the Company Disclosure Letter and the Company Filed SEC Documents) or any
certificate delivered by or at the direction of Company pursuant to this Agreement, any oral or written information presented to Parent
or any of its Affiliates or representatives in the course of their due diligence investigation of Company, the negotiation of this Agreement
or in the course of the transactions contemplated hereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Notwithstanding anything contained in this Agreement to the contrary, Company acknowledges and agrees that neither Parent nor Merger
Sub or any other person acting on behalf of Parent or its Subsidiaries has made, is making or is authorized to make, and Company expressly
disclaims reliance upon, any representations, warranties or statements relating to Parent or its Subsidiaries whatsoever, express or implied,
beyond those expressly given by Parent in writing in <span style="text-decoration: underline">ARTICLE V</span> (as qualified by the Parent Disclosure Letter and the Parent Filed
SEC Documents) or any certificate delivered by or at the direction of Parent pursuant to this Agreement, including any implied representation
or warranty as to the accuracy or completeness of any information regarding Parent or Merger Sub furnished or made available to Company
or any of its representatives. Without limiting the generality of the foregoing, Company acknowledges that, except as expressly provided
in <span style="text-decoration: underline">ARTICLE V</span> (as qualified by the Parent Disclosure Letter and the Parent Filed SEC Documents) or any certificate delivered by
or at the direction of Parent pursuant to this Agreement, no representations or warranties are made with respect to any projections, forecasts,
estimates, budgets or prospect information that may have been made available to Company or any of its representatives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 177 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE V<br/>
REPRESENTATIONS AND WARRANTIES OF PARENT</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Except as set forth in any Parent
SEC Document filed with the SEC since January 1, 2022 and publicly available prior to the date of this Agreement (as amended prior to
the date of this Agreement, the &#8220;<span style="text-decoration: underline">Parent Filed SEC Documents</span>&#8221;) (excluding any disclosures in any risk factors section,
in any section related to forward-looking statements and other disclosures that are predictive or forward-looking in nature other than
historical facts included therein) or as disclosed in the disclosure letter delivered by Parent to Company upon the execution of this
Agreement (the &#8220;<span style="text-decoration: underline">Parent Disclosure Letter</span>&#8221;) and making reference to the particular subsection of this Agreement to which
exception is being taken (<span style="text-decoration: underline">provided</span> that such disclosure shall be deemed to qualify that particular subsection and such other subsections
of this Agreement to the extent that it is reasonably apparent from the face of such disclosure that such disclosure also qualifies or
applies to such other subsections), Parent represents and warrants to Company as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 5.1</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Organization, Standing and Corporate Power</span>. Each of Parent and its Subsidiaries is a corporation or other legal entity duly
organized, validly existing and in good standing (with respect to jurisdictions that recognize such concept) under the laws of the jurisdiction
in which it is organized and has the requisite corporate or other power, as the case may be, and authority to own, lease and operate its
assets ad to carry on its business as now being conducted, except, as to Subsidiaries, for those jurisdictions where the failure to be
so organized, existing or in good standing, individually or in the aggregate, would not reasonably be expected to have a Material Adverse
Effect on Parent. Each of Parent and its Subsidiaries is duly qualified or licensed to do business and is in good standing (with respect
to jurisdictions that recognize such concept) in each jurisdiction in which the nature of its business or the ownership, leasing or operation
of its properties makes such qualification or licensing necessary, except for those jurisdictions where the failure to be so qualified
or licensed or in good standing, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect
on Parent. The Certificate of Incorporation of Parent and the Bylaws of Parent, in each case as amended through the date of this Agreement,
have been filed prior to the date of this Agreement with the Parent Filed SEC Documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 5.2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Corporate Authority; Non-contravention</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Parent has all requisite corporate power and authority to enter into this Agreement and the Merger Sub Stockholder Approval and
to perform its obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement
by Parent, the performance by Parent of its obligations hereunder and the consummation by Parent of the transactions contemplated hereby
have been duly authorized by all necessary corporate action on the part of Parent. The Board of Directors of Parent (at a meeting duly
called and held) has, by the majority vote of all directors of Parent, (A) approved and declared advisable this Agreement and the transactions
contemplated by this Agreement, including the Merger and the Parent Share Issuance, on the terms and subject to the conditions set forth
in this Agreement and (B) determined that this Agreement and the transactions contemplated by this Agreement, including the Merger and
the Parent Share Issuance are fair to, and in the best interests of, Parent and the stockholders of Parent. This Agreement has been duly
executed and delivered by Parent and, assuming the due authorization, execution and delivery of this Agreement by Company, constitutes
the legal, valid and binding obligation of Parent, enforceable against Parent in accordance with its terms, except for the Enforceability
Exceptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The execution and delivery of this Agreement does not, and the consummation of the transactions contemplated hereby shall not,
conflict with, or result in any violation of, or default (with or without notice or lapse of time, or both) under, or give rise to a right
of termination, cancellation or acceleration of any obligation or loss of a benefit under, or result in the creation of any Liens upon
any of the properties or assets of Parent or any of its Subsidiaries under, (A) the Certificate of Incorporation of Parent or the Bylaws
of Parent or the comparable organizational documents of any of its Subsidiaries, (B) any loan or credit agreement, note, bond, mortgage,
indenture, trust document, lease or other agreement, instrument, permit, concession, franchise, license or similar authorization to which
Parent or any of its Subsidiaries is a party or by which Parent, any of its Subsidiaries or their respective properties or assets may
be bound or (C) subject to the governmental filings and other matters referred to in <span style="text-decoration: underline">Section 5.2(c)</span>, any judgment, order, decree,
statute, law, ordinance, rule or regulation applicable to Parent or any of its Subsidiaries or their respective properties or assets,
other than, in the case of clauses (A) (solely with respect to the certificate of incorporation and bylaws or comparable organizational
documents of Parent&#8217;s Subsidiaries), (B) and (C), any such conflicts, violations, defaults, rights, losses or Liens that, individually
or in the aggregate, would not reasonably be expected to (1) have a Material Adverse Effect on Parent or (2) prevent, materially impair
or materially delay the ability of Parent to consummate any of the transactions contemplated hereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 178 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>No consent, approval, order or authorization of, action by or in respect of, or registration, declaration or filing with, any Governmental
Entity is required by or with respect to Parent or any of its Subsidiaries in connection with the execution and delivery of this Agreement
by Parent, the performance by Parent of its obligations hereunder or the consummation by Parent of the transactions contemplated hereby,
except for (A) compliance with any applicable requirements of Antitrust Laws, (B) the filing or submission with the SEC, and if applicable,
effectiveness, of (1) the Form S-4 to be filed with the SEC by Parent in connection with the issuance of shares of Parent Share Issuance,
(2) the Form S-8 to be filed with the SEC by Parent pursuant to <span style="text-decoration: underline">Section 3.1(b)(iii)</span> and (3) such reports under Section 13(a) or
15(d) of the Exchange Act as may be required in connection with this Agreement and the transactions contemplated hereby, (C) the filing
of the Certificate of Merger with the Secretary of State of the State of Delaware and appropriate documents with the relevant authorities
of other states in which Parent or its Subsidiaries are qualified to do business, (D) such filings with and approvals of the NASDAQ to
permit the shares of Parent Common Stock that are to be issued in the Merger to be listed on the NASDAQ, (E) the approvals, orders or
authorizations set forth in <span style="text-decoration: underline">Section 5.2(c)</span> of the Parent Disclosure Letter and (F) such other consents, approvals, orders or authorizations
the failure of which to be made or obtained, individually or in the aggregate, would not reasonably be expected to (1) have a Material
Adverse Effect on Parent or (2) prevent, materially impair or materially delay the ability of Parent to consummate any of the transactions
contemplated hereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 5.3</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Capital Structure</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The authorized capital stock of Parent consists of 200,000,000 shares of common stock, par value $0.0001 per share (the &#8220;<span style="text-decoration: underline">Parent
Common Stock</span>&#8221;). At the close of business on the Measurement Date, (A) 74,945,616 shares of Parent Common Stock were issued and
outstanding (for the avoidance of doubt, excluding shares of Parent Common Stock held by Parent in its treasury), (B) no shares of Parent
Common Stock were held by Parent in its treasury, and (C) 828,961 shares of Parent Common Stock were subject to issuance pursuant to outstanding
and unexercised Parent Options, (D) 686,566 shares of Parent Common Stock were subject to issuance pursuant to outstanding and unvested
Time-Based Parent Stock Awards, and (E) 130,615 shares of Parent Common Stock were subject to issuance pursuant to outstanding and unvested
Performance-Based Parent Stock Awards (assuming satisfaction of any performance vesting conditions at maximum levels).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>All outstanding shares of capital stock of Parent are, and all shares of capital stock of Parent that may be issued as permitted
by this Agreement or otherwise shall be, when issued, duly authorized, validly issued, fully paid and nonassessable and not subject to
preemptive rights. Except as set forth in this <span style="text-decoration: underline">Section 5.3</span> and except for changes since the Measurement Date resulting from the
issuance or grant of any Parent Equity Awards and the exercise or vesting and settlement of Parent Equity Awards outstanding on the date
hereof or issued or granted on or after the date hereof, as of the date of this Agreement (A) there are no issued, reserved for issuance
or outstanding Equity Securities of Parent, and (B) there are no outstanding obligations of Parent or any of its Subsidiaries to repurchase,
redeem or otherwise acquire any Equity Securities of Parent or to issue, deliver or sell, or cause to be issued, delivered or sold, any
Equity Securities of Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>There are no stockholder agreements or voting trusts or other agreements or understandings to which Parent or any of its Subsidiaries
is a party with respect to the voting, or restricting the transfer, of any Equity Securities of Parent or any of its Subsidiaries. Neither
Parent nor its Subsidiaries has granted any preemptive rights, anti-dilutive rights or rights of first refusal, registration rights or
similar rights with respect to any Equity Securities of Parent or any of its Subsidiaries that are in effect. Neither Parent nor any of
its Subsidiaries has any outstanding any bonds, debentures, notes or other debtor obligations the holders of which have the right to vote
(or convertible into or exchangeable or exercisable for securities having the right to vote) with the stockholders of Parent or any of
its Subsidiaries on any matter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>As of the date of this Agreement, there is no stockholder rights plan, &#8220;poison pill&#8221; antitakeover plan or similar device
in effect to which Parent or any of its Subsidiaries is subject, party or otherwise bound.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 179 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 5.4</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Subsidiaries</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Except as, individually or in the aggregate, would not reasonably be expected to be material to Parent and its Subsidiaries, taken
as a whole, all Equity Securities of each Subsidiary of Parent (A) have been validly issued and are fully paid and nonassessable and (B)
are owned by Parent or one of its wholly owned Subsidiaries, directly or indirectly, free and clear of any Lien (other than any restrictions
imposed by Applicable Laws) and free of preemptive rights, rights of first refusal, subscription rights or similar rights of any person
and transfer restrictions (other than transfer restrictions under Applicable Laws or under the organizational documents of such Subsidiary)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Except as, individually or in the aggregate, would not reasonably be expected to be material to Parent and its Subsidiaries, taken
as a whole, there are no outstanding (A) Equity Securities of Parent or any of its Subsidiaries convertible into or exchangeable or exercisable
for, or based upon the value of, shares of capital stock or other voting or equity securities or interests in any Subsidiary of Parent
or (B) warrants, calls, options, preemptive rights or other rights to acquire from Parent or any of its Subsidiaries, or any obligation
of Parent or any of its Subsidiaries to issue, any Equity Securities in any Subsidiary of Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 5.5</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">SEC Documents; Financial Statements; Undisclosed Liabilities</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Parent has timely filed or furnished all required registration statements, prospectuses, reports, schedules, forms, statements,
certifications and other documents (including exhibits and all other information incorporated therein, regardless of when such exhibits
and other information were filed) with the SEC since January 1, 2022 (the &#8220;<span style="text-decoration: underline">Parent SEC Documents</span>&#8221;). As of their respective
dates, the Parent SEC Documents complied in all material respects with the requirements of the Securities Act, the Exchange Act and the
Sarbanes-Oxley Act, as the case may be, and the rules and regulations of the SEC promulgated thereunder applicable to the Parent SEC Documents,
and none of the Parent SEC Documents when filed and at their respective effective times, if applicable, contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading. As of the date of this Agreement, there are no outstanding or
unresolved comments received from the SEC with respect to any of the Parent SEC Documents, and, to the Knowledge of Parent, none of the
Parent SEC Documents is the subject of any outstanding SEC investigation. No Subsidiary of Parent is required to file reports with the
SEC pursuant to the requirements of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The consolidated financial statements (including all related notes and schedules) of Parent and its Subsidiaries included in the
Parent SEC Documents were prepared in all material respects in accordance with GAAP (except, in the case of unaudited statements, as permitted
by the SEC) applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto) and fairly present
in all material respects the consolidated financial position of Parent and its consolidated Subsidiaries as of the dates thereof and the
consolidated results of their operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal
year-end audit adjustments which are not material and to any other adjustments described therein, including the notes thereto). Since
January 1, 2022, there has been no material change in Parent&#8217;s accounting methods or principles that would be required to be disclosed
in Parent&#8217;s financial statements in accordance with GAAP, except as described in the Parent Filed SEC Documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Except (A) as reflected or reserved against in Parent&#8217;s audited balance sheet as of December 31, 2024 (or the notes thereto)
included in Parent&#8217;s Annual Report on Form 10-K filed with the SEC on March 3, 2025, (B) for liabilities and obligations incurred
in the ordinary course of business consistent with past practice since December 31, 2024, and (C) for liabilities and obligations incurred
in connection with or contemplated by this Agreement, neither Parent nor any of its Subsidiaries has any liabilities or obligations of
any nature (whether accrued, absolute, contingent or otherwise) that would be required by GAAP to be reflected on a consolidated balance
sheet of Parent and its Subsidiaries (or in the notes thereto) that, individually or in the aggregate, would reasonably be expected to
have a Material Adverse Effect on Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 180 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Parent maintains a system of &#8220;internal control over financial reporting&#8221; (as defined in Rules 13a-15(f) and 15d-15(f)
of the Exchange Act) sufficient to provide reasonable assurance (A) that transactions are recorded as necessary to permit preparation
of financial statements in conformity with GAAP, consistently applied, (B) that transactions are executed only in accordance with the
authorization of management and (C) regarding prevention or timely detection of the unauthorized acquisition, use or disposition of Parent&#8217;s
properties or assets. Since January 1, 2022, none of Parent, Parent&#8217;s independent accountants, the Board of Directors of Parent
or its audit committee has identified or been made aware of any (1) &#8220;significant deficiency&#8221; in the internal controls over
financial reporting of Parent, (2) &#8220;material weakness&#8221; in the internal controls over financial reporting of Parent, (3) fraud,
whether or not material, that involves management or other employees of Parent who have a significant role in the internal controls over
financial reporting of Parent or (4) any bona fide complaints regarding a material violation of accounting procedures, internal accounting
controls or auditing matters, including from employees of Parent or any of its Subsidiaries regarding questionable accounting, auditing
or legal compliance matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The &#8220;disclosure controls and procedures&#8221; (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) utilized
by Parent are reasonably designed to ensure that all information (both financial and non-financial) required to be disclosed by Parent
in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods
specified in the rules and forms of the SEC and that all such information required to be disclosed is accumulated and communicated to
the management of Parent, as appropriate, to allow timely decisions regarding required disclosure and to enable the chief executive officer
and chief financial officer of Parent to make the certifications required under the Exchange Act with respect to such reports.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Neither Parent nor any of its Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off-balance
sheet partnership or any similar contract (including any contract or arrangement relating to any transaction or relationship between or
among Parent and any of its Subsidiaries, on the one hand, and any unconsolidated Affiliate, including any structured finance, special
purpose or limited purpose entity or person, on the other hand, or any &#8220;off-balance sheet arrangements&#8221;), where the purpose
or intended effect of such contract is to avoid disclosure of any material transaction involving, or material liabilities of, Parent or
any of its Subsidiaries in Parent&#8217;s or such Subsidiary&#8217;s published financial statements or other Parent SEC Documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Since January 1, 2022, each of the principal executive officer and the principal financial officer of Parent (or each former principal
executive officer and each former principal financial officer of Parent, as applicable) has made all certifications required by Rule 13a-14
or 15d-14 under the Exchange Act and Sections 302 and 906 of the Sarbanes-Oxley Act with respect to the Parent SEC Documents, and the
statements contained in such certifications are true and accurate in all material respects. Since January 1, 2022, Parent has been in
material compliance with all of the other applicable provisions of the Sarbanes-Oxley Act and the applicable listing and corporate governance
rules of NASDAQ.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 5.6</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Absence of Certain Changes or Events</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>From December 31, 2024, through the date of this Agreement, other than with respect to or in connection with the transactions contemplated
hereby, the businesses of Parent and its Subsidiaries have been conducted in all material respects in the ordinary course of business
consistent with past practice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Since December 31, 2024, there have been no Changes that, individually or in the aggregate, have had or would reasonably be expected
to have a Material Adverse Effect on Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 5.7</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Compliance with Applicable Laws; Outstanding Orders</span>. Except as, individually or in the aggregate, would not reasonably be
expected to have a Material Adverse Effect on Parent, Parent and its Subsidiaries hold all Permits that are required for the operation
of the businesses of Parent and its Subsidiaries as currently conducted (the &#8220;<span style="text-decoration: underline">Parent Permits</span>&#8221;), and all such Parent
Permits are in good standing or, where applicable, a renewal application has been timely filed and is pending agency approval, in each
case. Parent and its Subsidiaries are in compliance with the terms of the Parent Permits and all Applicable Laws relating to Parent and
its Subsidiaries or their respective businesses or properties, except where the failure to be in compliance with such Parent Permits or
Applicable Laws, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on Parent. Neither
Parent nor any of its Subsidiaries is subject to any outstanding Order that, individually or in the aggregate, would reasonably be expected
to (i) have a Material Adverse Effect on Parent or (ii) prevent, materially impair or materially delay the ability of Parent to consummate
any of the transactions contemplated hereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 181 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 5.8</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Sanctions</span>. Neither Parent nor any of its Subsidiaries, and, to the Knowledge of Parent, no director, officer or employee
thereof, (i) is a Sanctioned Person or (ii) as of the date of this Agreement, has pending or, to the Knowledge of Parent, threatened claims
against it, him or her with respect to applicable Sanctions or Ex-Im Laws and (iii) each of Parent and its Subsidiaries is and, since
January 1, 2022, has been, in compliance in all material respects with all applicable Sanctions and Ex-Im Laws. Neither Company nor any
of its Subsidiaries has, since January 1, 2022, made any voluntary or directed disclosure to any Governmental Entity regarding any apparent
or alleged violation of Sanctions or Ex-Im Laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 5.9</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Litigation</span>. There is no Action pending or, to the Knowledge of Parent, threatened against or affecting Parent or any of
its Subsidiaries or any of their respective properties or any of their respective officers or directors, except as, individually or in
the aggregate, would not reasonably be expected to (i) be material to Parent and its Subsidiaries, taken as a whole, or (ii) prevent,
materially impair or materially delay the ability of Parent to consummate any of the transactions contemplated hereby. To the Knowledge
of Parent, there are no SEC inquiries or investigations, other governmental inquiries or investigations, or internal investigations pending
or threatened, in each case regarding ay accounting practices of the Parent or any of its Subsidiaries or any malfeasance by any officer
or director of Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 5.10</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Brokers</span>. No broker, investment banker or financial advisor is entitled to broker&#8217;s, finder&#8217;s, financial advisor&#8217;s
or other similar fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by
or on behalf of Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 5.11</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Merger Sub</span>. All of the issued and outstanding capital stock of Merger Sub is, and at the Effective Time will be, owned directly
by Parent. Merger Sub was formed solely for the purpose of entering into the transactions contemplated by this Agreement and, since the
date of its formation, has not carried on any business, other than the execution of this Agreement, the performance of its obligations
hereunder and matters ancillary thereto. Merger Sub has all requisite corporate power and authority to enter into this Agreement and to
consummate the transactions contemplated hereby. The execution and delivery of this Agreement by Merger Sub, the performance by Merger
Sub of its obligations hereunder and the consummation by Merger Sub of the transactions contemplated hereby have been duly authorized
by all necessary corporate action on the part of Merger Sub, subject to the Merger Sub Stockholder Approval. This Agreement has been duly
executed and delivered by Merger Sub and, assuming the due authorization, execution and delivery of this Agreement by Company, constitutes
the legal, valid and binding obligation of Merger Sub, enforceable against Merger Sub in accordance with its terms, except for the Enforceability
Exceptions. The affirmative vote by Parent, in its capacity as the sole holder of all the issued and outstanding capital stock of Merger
Sub as of the effective date of the Merger Sub Written Consent in favor of adopting this Agreement (the &#8220;<span style="text-decoration: underline">Merger Sub Stockholder
Approval</span>&#8221;) is the only vote of the holders of any class or series of Merger Sub&#8217;s capital stock prior to the Effective
Time, or any holder of any other security of Merger Sub, necessary to adopt this Agreement and approve the consummation of the Merger
and the other transactions contemplated hereby, and the execution and delivery by Parent, in its capacity as sole holder of all the issued
and outstanding capital stock of Merger Sub as of the effective date of the Merger Sub Written Consent, of the written consent (the &#8220;<span style="text-decoration: underline">Merger
Sub Written Consent</span>&#8221;) will satisfy the Merger Sub Stockholder Approval and will be sufficient to approve this Agreement and
the transactions contemplated hereby, including the Merger, in accordance with the DGCL and Merger Sub&#8217;s organizational documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 5.12</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Other Representations</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Except for the express written representations and warranties made in this <span style="text-decoration: underline">ARTICLE V</span> (as qualified by the Parent Disclosure
Letter or the Parent Filed SEC Documents) or any certificate delivered by or at the direction of Parent pursuant to this Agreement, neither
Parent nor Merger Sub or any other person acting on behalf of Parent or its Subsidiaries makes any express or implied representation or
warranty with respect to Parent or its Subsidiaries or their respective Affiliates, businesses, operations, assets, liabilities or conditions
(financial or otherwise) in connection with this Agreement or the transactions contemplated hereby, and Parent and Merger Sub hereby disclaim
any such other representations or warranties. In particular, without limiting the foregoing disclaimer, except as expressly provided in
this <span style="text-decoration: underline">ARTICLE V</span> or any certificate delivered pursuant to this Agreement, neither Parent nor Merger Sub or any other person makes
or has made any express or implied representation or warranty to Company or any of its Affiliates or representatives with respect to (A)
any financial projection, forecast, estimate, budget or prospect information relating to Parent or any of its Subsidiaries or their respective
businesses or (B) except for the express written representations and warranties made in this <span style="text-decoration: underline">ARTICLE V</span> (as qualified by the Parent
Disclosure Letter or the Parent Filed SEC Documents) or any certificate delivered by or at the direction of Parent pursuant to this Agreement,
any oral or written information presented to Company or any of its Affiliates or representatives in the course of their due diligence
investigation of Parent or Merger Sub, the negotiation of this Agreement or in the course of the transactions contemplated hereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 182 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Notwithstanding anything contained in this Agreement to the contrary, Parent and Merger Sub acknowledge and agree that neither
Company nor any other person acting on behalf of Company or its Subsidiaries has made, is making, or is authorized to make, and Parent
and Merger Sub expressly disclaim reliance upon, any representations, warranties or statements relating to Company or its Subsidiaries
whatsoever, express or implied, beyond those expressly given by Company in writing in <span style="text-decoration: underline">ARTICLE IV</span> (as qualified by the Company Disclosure
Letter or the Company Filed SEC Documents) or any certificate delivered by or at the direction of Company pursuant to this Agreement,
including any implied representation or warranty as to the accuracy or completeness of any information regarding Company or its Subsidiaries
furnished or made available to Parent or Merger Sub or any of their representatives. Without limiting the generality of the foregoing,
Parent and Merger Sub acknowledge that, except as expressly provided in <span style="text-decoration: underline">ARTICLE IV</span> (as qualified by the Company Disclosure Letter
and the Company Filed SEC Documents) or any certificate delivered by or at the direction of Company pursuant to this Agreement, no representations
or warranties are made with respect to any projections, forecasts, estimates, budgets or prospect information that may have been made
available to Parent and Merger Sub or any of their representatives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE VI<br/>
COVENANTS RELATING TO CONDUCT OF BUSINESS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 6.1</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Conduct of Business</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Conduct of Business by Company</span>. Except for matters set forth in <span style="text-decoration: underline">Section 6.1(a)</span> of the Company Disclosure Letter,
as required by Applicable Law, as expressly contemplated or expressly permitted by this Agreement, or as otherwise consented to by Parent
in writing, during the period from the date of this Agreement to the Effective Time, Company (x) shall, and shall cause its Subsidiaries
to, (1) carry on their respective businesses in all material respects in the ordinary course consistent with past practice and (2) preserve
intact its business organization and relationships with customers, suppliers, licensors, licensees and other third parties (<span style="text-decoration: underline">provided</span>
that the failure to take any action prohibited by any specific subclause of <span style="text-decoration: underline">Section 6.1(a)</span> shall not be a breach of the covenant,
and agreements, in this clause (x)) and (y) shall not, and shall not permit any of its Subsidiaries to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>(A) other than dividends and distributions by a direct or indirect Subsidiary wholly owned by Company payable to another direct
or indirect Subsidiary wholly owned by Company or payable to Company, declare, set aside or pay any dividends on, make any other distributions
in respect of, any of its capital stock, (B) split, combine or reclassify any Equity Securities of Company or issue or authorize the issuance
of any other securities in respect of, in lieu of or in substitution for any Equity Securities of Company or (C) purchase, redeem or otherwise
acquire any Equity Securities of Company (other than the acquisition of shares upon the exercise or settlement of Company Options outstanding
on the Measurement Date in accordance with their terms in effect on the Measurement Date or issued as permitted by this Agreement in accordance
with the terms governing the issuance of such type of Company Option in effect on the Measurement Date), in the case of each of clauses
(B) and (C), other than, solely with respect to the capital stock or other securities of Company&#8217;s wholly owned Subsidiaries, actions
or transactions solely between Company and its wholly owned Subsidiaries, or among Company&#8217;s wholly owned Subsidiaries;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>issue, deliver, sell, transfer, pledge or otherwise encumber or subject to any Lien, or otherwise authorize the issuance, delivery,
sale, transfer, pledge or encumbrance of, any Equity Securities (other than (A) in connection with the settlement or exercise of Company
Options outstanding as of the Measurement Date in accordance with their terms in effect on Measurement Date or issued as permitted by
this Agreement in accordance with the terms governing the issuance of such type of Company Options in effect on the Measurement Date,
(B) as required under the terms of any Company Benefit Plan in effect on the date of this Agreement, as permitted by this Agreement, or
pursuant to <span style="text-decoration: underline">Section 3.1(b)</span> of this Agreement and (C) solely with respect to the capital stock or other securities of Company&#8217;s
wholly owned Subsidiaries, transactions solely between Company and its wholly owned Subsidiaries, or among Company&#8217;s wholly owned
Subsidiaries), or enter into any agreement with respect to the voting of, any of Company&#8217;s capital stock;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>other than (including with respect to equipment and inventory) in the ordinary course of business consistent with past practice:
(A)(1) amend or waive any material provision of any Company Material Contract, (2) enter into any contract that would have been a Company
Material Contract had it been in effect as of the date of this Agreement or (3) renew any Company Material Contract (other than on terms
that are no less favorable, in the aggregate, to Company), (B) other than the expiration of any Company Material Contract in accordance
with the terms and conditions contained therein, terminate any Company Material Contract or (C) acquire any material assets;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 183 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>acquire any equity interests in, or make any investment in or any capital contribution to, any person, or acquire a substantial
portion of the assets or business of any person (or any division or line of business thereof), including in each case by merger or consolidation;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(v)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>transfer, assign, sell, lease, license, mortgage, pledge, surrender, encumber (except for Permitted Liens), divest, cancel, abandon,
allow to lapse or otherwise dispose of any material tangible or intangible assets (including any material Intellectual Property) except
(A) for transactions solely between Company and its wholly owned Subsidiaries, or among Company&#8217;s wholly owned Subsidiaries, or
(B) the non-exclusive license of Intellectual Property in the ordinary course of business consistent with past practice;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vi)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>create, incur or assume any indebtedness for borrowed money, or issue any debt securities or any right to acquire debt securities,
assume, guarantee, endorse or otherwise become liable or responsible (whether, directly, contingently or otherwise) for the indebtedness
of another person, enter into any agreement to maintain any financial statement condition of another person or enter into any arrangement
having the economic effect of any of the foregoing, in each case, except (A) for additional indebtedness incurred in the ordinary course
of business consistent with past practice after the date of this Agreement under Company&#8217;s current borrowing agreements that does
not, at any time, exceed $2,000,000 in the aggregate and (B) for any inter-company indebtedness solely between Company and its wholly
owned Subsidiaries, or among Company&#8217;s wholly owned Subsidiaries;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>other than any Action with respect to Taxes (which shall be governed by <span style="text-decoration: underline">Section 6.1(a)(viii)</span>), settle, pay, discharge or
satisfy any Action, other than any settlement, payment, discharge or satisfaction that (A) does not relate to any Transaction Litigation
(with respect to which any settlements, releases, waivers or compromises shall be subject to <span style="text-decoration: underline">Section 7.12</span>) and (B) (1) either (x)
results solely in a monetary obligation involving only the payment of monies by Company or its Subsidiaries of not more than $250,000
individually or $1,000,000 in the aggregate (as well as related non-substantive incidental provisions and other remedies or obligations
that are not material in the context of the applicable resolution), individually or in the aggregate for all such Actions (excluding any
settlements made under the following <span style="text-decoration: underline">clause (y)</span>), or (y) results solely in a monetary obligation that is funded by an indemnity
obligation to, or an insurance policy of, Company or any of its Subsidiaries and the payment of monies by Company and its Subsidiaries
that are not more than $250,000 individually or $1,000,000 in the aggregate (not funded by an indemnity obligation or through insurance
policies) (as well as related non-substantive incidental provisions and other remedies or obligations that are not material in the context
of the applicable resolution), (2) is limited to Actions which arise in the ordinary course of business, consistent with past practice,
and (3) does not involve any admission of guilt or impose any non de-minimis restrictions or non de-minimis limitations upon the operations
or business of or other conduct remedy or injunctive relief applicable to Company or any of its Subsidiaries, whether before, on or after
the Effective Time;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(viii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>(A) make, change or revoke any material Tax election, (B) change any Tax accounting period or adopt or change any material method
of Tax accounting, (C) settle, adjust or compromise, or enter into any closing agreement with respect to, any audit, examination, investigation,
claim or other Action relating to a material amount of Taxes, (D) file any material amended Tax Return, (E) extend or waive (or request
to extend or waive) any statute of limitations period for the assessment or collection of any material Tax, (F) surrender any claim for
a refund of a material amount of Taxes or (G) prepare and file any material Tax Return in a manner materially inconsistent with past practice;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 184 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ix)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>except as set forth on <span style="text-decoration: underline">Section 6.1(a)(ix)</span> of the Company Disclosure Letter or as required under the terms of any Company
Benefit Plan or Labor Agreement applicable to Company or any of its Subsidiaries, in each case, as in effect on the date of this Agreement,
and subject to <span style="text-decoration: underline">Section 6.1(a)(ii)</span>, (A)&#160;(I) increase the compensation or increase the benefits of any current or former officer,
director, employee or other individual service provider, other than in the ordinary course of business consistent with past practice with
respect to individuals whose annualized base compensation is less than $175,000 and which increase is no more than 5% of such individual&#8217;s
current compensation; <span style="text-decoration: underline">provided</span> that such increase does not result in an increase to any such service provider&#8217;s equity or
equity-based compensation or opportunities, or (II) grant or pay any bonus, incentive, change in control, retention, severance, termination,
tax gross-up or profit-sharing award or payment, (B) enter into, adopt, amend, terminate or modify any Company Benefit Plan (or any arrangement
that would be a Company Benefit Plan if in effect on the date hereof), (C) accelerate the vesting or payment of any compensation or benefits
of any current or former officer, director, employee or other individual service provider, (D) provide any funding for any rabbi trust
or similar arrangement, or take any other action to fund or secure the payment of any compensation or benefit, (E) grant to any current
or former officer, director, employee or other individual service provider any right to receive any severance, change-in-control, retention,
termination, transaction or similar compensation or benefits or increases therein, including adding participants to any Company severance
plan maintained for employees at the level of vice president and above, (F) hire, promote or terminate any individual, except for new
hires or terminations in the ordinary course of business consistent with past practice with respect to individuals whose annualized base
compensation is less than $175,000, (G) forgive any loans or advances to any current or former officer, director, employee or other individual
service provider, or any of their respective Affiliates, or change its existing borrowing or lending arrangements for or on behalf of
any of such Persons in accordance with an employee benefit plan or otherwise, except in the ordinary course of business in connection
with relocation activities to any employees of Company or any Subsidiary of Company; or (H)&#160;announce or commit to take any of the
actions set forth in this <span style="text-decoration: underline">Section 6.1(a)(ix)</span>; <span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>, that the foregoing clauses (A) and (H) shall not
restrict Company or any of its Subsidiaries from entering into, in the ordinary course of business, any offer letter with any newly hired
employee to fill a critical vacant position whose annualized base compensation will be less than $175,000, <span style="text-decoration: underline">provided</span> that the compensation
and benefits provided pursuant to such offer letter contains terms substantially similar to the terms provided to similarly situated employees
of Company and does not contain any change in control, equity or severance benefits;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(x)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>change any of its material financial accounting policies or procedures currently in effect, except (A) as required (or with respect
to permitted early adoption of changes required) by GAAP, Regulation S-X of the Exchange Act or a Governmental Entity or quasi-governmental
authority (including the Financial Accounting Standards Board or any similar organization) or (B) as required by Applicable Law;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xi)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>make any payment of, commitment for or accrual of aggregate capital expenditures for any twelve (12)-month period that are greater
than $125,000 individually or $500,000 in the aggregate;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>voluntarily terminate, suspend, abrogate, amend or modify any Company Permit in a manner materially adverse to Company and its
Subsidiaries;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xiii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>(A) amend the Certificate of Incorporation of Company or Bylaws of Company or any similar organizational documents of Company&#8217;s
Subsidiaries, (B) merge or consolidate with any person or (C) adopt or implement any plan of complete or partial liquidation, dissolution,
consolidation, restructuring, recapitalization or other reorganization;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xiv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>(A) amend, modify, extend, terminate, or enter into any material Labor Agreement or (B) recognize or certify any labor union, labor
organization, works council, or group of employees as the bargaining representative for any employees of Company or its Subsidiaries;
or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>authorize, or commit or agree to take, any of the foregoing actions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 185 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Right to Control or Direct Operations</span>. Nothing contained in this Agreement is intended to give Parent or Merger Sub,
directly or indirectly, the right to control or direct the operations of Company or its Subsidiaries prior to the Effective Time, and
nothing contained in this Agreement is intended to give Company, directly or indirectly, the right to control or direct the operations
of Parent or its Subsidiaries prior to the Effective Time, in each case, in violation of Applicable Law. Prior to the Effective Time,
each of Parent, Merger Sub and Company shall exercise, consistent with the terms and conditions of this Agreement, complete control and
supervision over its and its Subsidiaries&#8217; operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 6.2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Solicitation by Company</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company shall not, and shall cause its Affiliates and its and their respective Representatives not to, directly or indirectly,
(i) (A) solicit, initiate or knowingly encourage (including by way of furnishing non-public information), or take any other action to
knowingly facilitate, any inquiries relating to, the submission of, or the making of, any proposal the consummation of which would constitute
an Alternative Transaction or (B) fail to terminate any direct or indirect solicitation, encouragement, discussions or negotiations with
any persons (other than Parent or Merger Sub and their Representatives) that may be ongoing with respect to a proposal for an Alternative
Transaction, including terminating all access granted to any such person or its representatives to any physical or electronic dataroom,
(ii) engage in, participate in or otherwise continue any discussions or negotiations, or cooperate in any way with any person (or group
of persons), with respect to any inquiries relating to, or the making of, any proposal the consummation of which would constitute an Alternative
Transaction, (iii) amend or grant any waiver or release under, or fail to enforce, any standstill or similar agreement with respect to
any class of equity securities of Company or its Subsidiaries (<span style="text-decoration: underline">provided</span> that Company shall be permitted on a confidential non-public
basis to release or waive any explicit or implicit standstill or similar agreement solely to the extent necessary to permit the relevant
party thereto to submit a proposal for an Alternative Transaction to the Company Board on a confidential nonpublic basis and solely to
the extent the Company Board determines in good faith that the failure to do so would be a breach of the Company Board&#8217;s fiduciary
duties under Applicable Law, so long as Company promptly (and in any event within twenty-four (24) hours) notifies Parent in writing of
any such waiver or release) or (iv) approve, authorize, agree or publicly announce an intention to do any of the foregoing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>If, after the date hereof but at any time prior to obtaining the Company Stockholder Approval, Company receives a bona fide written
proposal that did not result from a breach of <span style="text-decoration: underline">Section 6.2(a)</span> the consummation of which would constitute an Alternative Transaction,
and the Company Board determines in good faith (after consultation with its outside counsel and financial advisors) that such proposal
constitutes a Superior Offer, subject to compliance with <span style="text-decoration: underline">Section 6.2(d)</span>, Company and its Representatives may (i) furnish information
with respect to Company and its Subsidiaries to the person (or group of persons) making such proposal (and its Representatives) (<span style="text-decoration: underline">provided</span>
that all such information has previously been provided to Parent or is provided to Parent prior to or concurrently with the time it is
provided to such person) pursuant to a customary confidentiality agreement containing substantive terms that are not less favorable to
Company than those contained in the Confidentiality Agreement (<span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>, that such confidentiality agreement (x)
need not contain any &#8220;standstill&#8221; or similar provision and (y) may not (A) include any provision calling for an exclusive
right to negotiate with Company or (B) provide for the reimbursement by Company or any of its Subsidiaries of any of the counterparty&#8217;s
costs or expenses) and which does not prohibit Company from complying with its obligations under this Agreement, and (ii) participate
in discussions or negotiations regarding such proposal with the person (or group of persons) making such proposal and its Representatives.
For purposes of this Agreement, &#8220;<span style="text-decoration: underline">Alternative Transaction</span>&#8221; means any of (1) a merger, consolidation, share exchange,
tender offer, share issuance or similar transaction pursuant to which any person (or group of persons) other than Parent and its Subsidiaries
(such person (or group of persons), an &#8220;<span style="text-decoration: underline">Company Third Party</span>&#8221;), or the direct or indirect stockholders of such Company
Third Party or the resulting company, acquires or would acquire, directly or indirectly, beneficial ownership (as defined in Rule 13d-3
under the Exchange Act) of, or would otherwise own or control, directly or indirectly, more than 20% of the outstanding shares of Company
Common Stock or other Equity Securities of Company representing 20% or more of the equity or voting power of Company (or the resulting
company), (2) any transaction or series of transactions pursuant to which any Company Third Party acquires or would acquire, directly
or indirectly, control of assets (including for this purpose the outstanding equity securities of Subsidiaries of Company and any entity
surviving any merger or combination including any of them) or businesses of Company or any of its Subsidiaries representing 20% or more
of the revenues, net income, earnings, or assets (in each case on a consolidated basis) of Company and its Subsidiaries taken as a whole,
or (3) any disposition of assets to a Company Third Party representing 20% or more of the revenues, net income, earnings, or assets (in
each case on a consolidated basis) of Company and its Subsidiaries, taken as a whole. Company agrees that any violations of the restrictions
set forth in this <span style="text-decoration: underline">Section 6.2</span> by any of its officers (or its officers&#8217; direct reports) or directors, or any investment banker
or financial advisor, retained by and acting on behalf of Company will be deemed to be a breach of this <span style="text-decoration: underline">Section 6.2</span> by Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 186 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Except as permitted by this <span style="text-decoration: underline">Section 6.2(c)</span> and <span style="text-decoration: underline">Section 6.2(f)</span>, neither the Company Board nor any committee thereof
shall (i) withdraw, qualify or modify, or propose publicly to withdraw, qualify or modify, or fail to make, in each case in a manner adverse
to Parent, the approval or recommendation by such Board of Directors or such committee of the Merger or this Agreement, (ii) approve or
recommend, or propose publicly to approve or recommend, any Alternative Transaction, (iii) fail to include in the Company Proxy Statement/Prospectus
the recommendation of the Company Board in favor of this Agreement and the Merger, (iv) fail to publicly, within five Business Days after
the commencement of a tender or exchange offer relating to shares of Company Common Stock (or, if earlier, at least two Business Days
prior to the Company Stockholders Meeting), recommend the rejection of such tender or exchange offer by the holders of such shares of
Company Common Stock and reaffirm its recommendation of this Agreement and the Merger or (v) fail to publicly reaffirm its recommendation
of this Agreement and the Merger within five Business Days of Parent&#8217;s written request to do so (or, if earlier, at least two Business
Days prior to the Company Stockholders&#8217; Meeting) following the public announcement of any Alternative Transaction (or any material
amendment, including any change to the price or form of consideration); <span style="text-decoration: underline">provided</span> that Parent shall not be entitled to make such
written request, and the Company Board shall not be required to make such reaffirmation, more than once with respect to any particular
Alternative Transaction and each material modification thereof (any action or failure to act in clauses (i), (iii), (iv) and (v) being
referred to as an &#8220;<span style="text-decoration: underline">Company Recommendation Change</span>&#8221;). Notwithstanding the foregoing, in the event that, prior to obtaining
the Company Stockholder Approval, the Company Board determines in good faith, after consultation with its financial advisors and outside
legal counsel, that it has received a Superior Offer, the Company Board may effect a Company Recommendation Change if (A) the Company
Board determines in good faith, after consultation with its financial advisors and outside legal counsel, that the failure to take such
action would be inconsistent with the fiduciary duties of the Company Board under Applicable Law, (B) Company has notified Parent in writing
that it intends to effect a Company Recommendation Change pursuant to this <span style="text-decoration: underline">Section 6.2(c)</span>, (C) Company has provided Parent with
a copy of the proposed definitive agreements and other proposed transaction documentation between Company and the person making such Superior
Offer and the identity of the person making such Superior Offer, (D) for a period of five (5) Business Days following the notice delivered
pursuant to clause (B) of this <span style="text-decoration: underline">Section 6.2(c)</span>, Company shall have discussed and negotiated in good faith and made Company&#8217;s
Representatives available to discuss and negotiate in good faith (in each case to the extent Parent desires to negotiate) with Parent&#8217;s
Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement
so that the proposal no longer constitutes an Superior Offer (it being understood and agreed that any amendment to any material term or
condition of any Superior Offer shall require a new notice and a new negotiation period that shall expire on the later to occur of (I)
three (3) Business Days following delivery of such new notice from Company to Parent and (II) the expiration of the original five (5)
Business Day period described above in this clause (D)), and (E) no earlier than the end of such negotiation period, the Company Board
shall have determined in good faith, after consultation with its financial advisors and outside legal counsel, and after considering the
terms of any proposed amendments or modifications to this Agreement, that (x) the Alternative Transaction that is the subject of the notice
described in clause (B) above still constitutes a Superior Offer and (y) the failure to take such action would still be inconsistent with
the fiduciary duties of the Company Board under Applicable Law. Neither the Company Board nor any committee thereof shall cause or permit
Company or any of its controlled Affiliates to enter into any letter of intent, memorandum of understanding, agreement in principle, acquisition
agreement or other similar agreement related to any Alternative Transaction or requiring, or reasonably likely to cause, Company to terminate,
delay or fail to consummate, or that would otherwise impede, interfere with or be inconsistent with, the consummation of the Merger (other
than a confidentiality agreement referred to in <span style="text-decoration: underline">Section 6.2(a)</span> or a Specified Agreement pursuant to the conditions in <span style="text-decoration: underline">Section
9.1(e)</span>).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>In addition to the obligations of Company set forth in <span style="text-decoration: underline">Section 6.2(a), Section 6.2(b),</span> and <span style="text-decoration: underline">Section 6.2(c)</span>, Company
shall promptly, and in any event within twenty-four hours of receipt by a member of the Company Board or an executive officer of Company
(or if received by another Representative of Company, the time such person became aware thereof), advise Parent orally and in writing
of any request for information, proposal or inquiry relating to an Alternative Transaction, the material terms and conditions of such
request, proposal or inquiry (including any changes thereto) and the identity of the person making such request, proposal or inquiry.
Company shall (i) keep Parent reasonably informed of the status and details (including amendments or proposed amendments) of any such
request, proposal or inquiry on a reasonably current basis and (ii) provide to Parent as soon as reasonably practicable after receipt
or delivery (but in no event later than twenty-four hours after receipt or delivery) thereof copies of all correspondence and other written
materials exchanged between Company or its Subsidiaries or any of their Representatives, on the one hand, and any person making such request
or proposal or any of its Representatives, on the other hand, in each case relating to any such request, proposal or inquiry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 187 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Nothing contained in this <span style="text-decoration: underline">Section 6.2</span> shall prohibit Company from (i) taking and disclosing to its stockholders a position
contemplated by Rule 14d-9 or Rule 14e-2(a) promulgated under the Exchange Act, (ii) making any disclosure to the Company stockholders
that is required by Applicable Law, or (iii) issuing a &#8220;stop, look and listen&#8221; statement or similar communication of the type
contemplated by Rule 14d-9(f) under the Exchange Act pending disclosure of its position thereunder; <span style="text-decoration: underline">provided</span> that any such disclosure
or statement that constitutes or contains a Company Recommendation Change shall be subject to the provisions of <span style="text-decoration: underline">Section 6.2(c)</span>;
<span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">further</span>, that a &#8220;stop, look and listen&#8221; communication by Company pursuant to Rule 14d-9(f) of the
Exchange Act shall not be deemed to be a Company Recommendation Change so long as any such communication states that the recommendation
of the Company Board in favor of this Agreement and the Merger continues to be in effect (unless, prior to the time of such public disclosure,
a Company Recommendation Change has been made in compliance with <span style="text-decoration: underline">Section 6.2(c)</span>).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Notwithstanding anything in this Agreement to the contrary, at any time prior to obtaining the Company Stockholder Approval, the
Company Board may make a Company Recommendation Change with respect to an Intervening Event, if and only if: (i) the Company Board determines
in good faith, after consultation with the Company&#8217;s financial advisors and outside legal counsel, that the failure to make the
Company Recommendation Change would be inconsistent with the fiduciary duties of the Company Board under Applicable Law; (ii) Company
has notified Parent in writing that it intends to effect a Company Recommendation Change pursuant to this <span style="text-decoration: underline">Section 6.2(f)</span>, describing
the Intervening Event in reasonable detail; (iii) for a period of five (5) Business Days following the notice delivered pursuant to clause
(B) of this <span style="text-decoration: underline">Section 6.2(f)</span>, the Company shall have discussed and negotiated in good faith and made Company&#8217;s Representatives
available to discuss and negotiate in good faith (in each case to the extent Parent desires to negotiate) with Parent&#8217;s Representatives,
with respect to any proposed revisions to this Agreement or other proposals made by Parent, if any, that would obviate the requirement
to make a Company Recommendation Change; and (iv) after considering the results of negotiations with Parent and taking into account the
proposals made by Parent, if any, after consultation with its financial advisors and outside legal counsel, the Company Board shall have
determined in good faith that the failure to make the Company Recommendation Change would be inconsistent with the fiduciary duties of
the Company Board under Applicable Law. For the avoidance of doubt, the provisions of this <span style="text-decoration: underline">Section 6.2(f)</span> shall also apply to any
material change to the facts and circumstances relating to such Intervening Event (except that any reference to five (5) Business Days
shall instead be three (3) Business Days).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE VII<br/>
ADDITIONAL AGREEMENTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.1</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Form S-4 and Company Proxy Statement; Stockholders Meetings</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>As soon as reasonably practicable following the date of this Agreement, Company and Parent shall prepare the Form S-4 and the Company
Proxy Statement/Prospectus, and Parent shall file the Form S-4, which shall include the Company Proxy Statement/Prospectus as a prospectus,
with the SEC, with such filing to be within fifteen (15) Business Days, following the date of this Agreement. The parties shall consult
each other in connection with setting a preliminary record date for the Company Stockholders Meeting and shall commence broker searches
pursuant to Section 14a-13 of the Exchange Act in connection therewith. Each of Company and Parent shall use reasonable best efforts to
have the Form S-4 declared effective under the Securities Act as promptly as practicable after such filing. Company and Parent shall,
as promptly as practicable after receipt thereof, provide the other party copies of any written comments and advise the other party of
any oral comments, with respect to the Form S-4 or the Company Proxy Statement/Prospectus received from the SEC. Parent and Company shall
cooperate and provide the other parties with a reasonable opportunity to review and comment on any amendment or supplement to the Form
S-4 or the Company Proxy Statement/Prospectus prior to filing such with the SEC. No filing of, or amendment or supplement to, the Form
S-4 will be made by Parent, and no filing of, or amendment or supplement to, the Company Proxy Statement/Prospectus will be made by Company,
in each case without providing the other with a reasonable opportunity to review and comment (which comments shall be considered by the
applicable party in good faith) thereon if reasonably practicable; <span style="text-decoration: underline">provided</span> that with respect to documents filed by a party that
are incorporated by reference in the Form S-4 or the Company Proxy Statement/Prospectus, this right of review and comment shall apply
only with respect to information relating to the other party or its business, financial condition or results of operations, or the combined
entity or the transactions contemplated hereby; and <span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">further</span>, that this review and comment right shall not apply
with respect to information relating to a Company Recommendation Change. Company shall use reasonable best efforts to cause the Company
Proxy Statement/Prospectus to be mailed to Company&#8217;s stockholders as promptly as practicable after the Form S-4 is declared effective
under the Securities Act. Each party shall advise the other parties, promptly after it receives notice thereof, of the time when the Form
S-4 has become effective, of the time when any supplement or amendment to the Form S-4 has been filed, of the issuance of any stop order
with respect to the Form S-4, or of any request by the SEC for amendment of the Form S-4 or the Company Proxy Statement/Prospectus or
comments on the Form S-4 or the Company Proxy Statement/Prospectus and responses thereto or requests by the SEC for additional information
relating thereto. If at any time prior to the Effective Time any information relating to Company, Parent or any of their respective Affiliates,
officers or directors, should be discovered by Company or Parent that should be set forth in an amendment or supplement to any of the
Form S-4 or the Company Proxy Statement/Prospectus so that any such document would not include any misstatement of a material fact or
omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not
misleading, the party that discovers such information shall promptly notify the other party and an appropriate amendment or supplement
describing such information shall be promptly filed with the SEC and, to the extent required by Applicable Law, disseminated to the stockholders
of Company and Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 188 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company shall, as promptly as practicable after the Form S-4 is declared effective under the Securities Act, duly give notice of,
convene and hold a meeting of its stockholders (the &#8220;<span style="text-decoration: underline">Company Stockholders Meeting</span>&#8221;) in accordance with the DGCL and
the rules of the NASDAQ for the purpose of obtaining the Company Stockholder Approval and shall, subject to the provisions of <span style="text-decoration: underline">Section
6.2(c)</span>, through its Board of Directors, recommend to its stockholders the adoption of this Agreement and the Merger. Company may only
postpone or adjourn the Company Stockholders Meeting (i) to solicit additional proxies for the purpose of obtaining the Company Stockholder
Approval, (ii) for the absence of a quorum and (iii) to allow reasonable additional time for the filing or mailing of any supplemental
or amended disclosure that Company has determined after consultation with outside legal counsel is reasonably likely to be required under
Applicable Law and for such supplemental or amended disclosure to be disseminated and reviewed by stockholders of Company prior to the
Company Stockholders Meeting. Company shall use reasonable best efforts to hold the Company Stockholders Meeting as soon as reasonably
practicable after the date of this Agreement; <span style="text-decoration: underline">provided</span>&#160;that, with respect to postponements or adjournments in accordance with
the preceding clauses (i)&#160;and (ii), Company shall not postpone or adjourn the Company Stockholder Meeting without Parent&#8217;s
prior written consent for a period of more than ten (10) Business Days after the date on which the Company Stockholder Meeting was originally
scheduled or (y) ten (10) Business Days before the Outside Date. Company shall, if requested by Parent (to the extent permitted by Applicable
Laws), adjourn or postpone the Company Stockholder Meeting for the absence of quorum or to allow additional solicitation of votes in order
to obtain the Company Stockholder Approval; <span style="text-decoration: underline">provided</span> that Company shall not be required pursuant to this sentence to adjourn the
Company Stockholder Meeting more than two (2)&#160;times or for more than ten (10)&#160;Business Days in the aggregate from the originally
scheduled date of the Company Stockholder Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Subject to the terms and conditions of this Agreement, including <span style="text-decoration: underline">Section 6.2</span>, Company shall use reasonable best efforts
to (i) solicit from Company&#8217;s stockholders proxies in favor of the Company Stockholder Approval, respectively, and (ii) take other
action necessary or advisable to secure the Company Stockholder Approval. Company shall use reasonable best efforts to keep Parent updated
with respect to proxy solicitation efforts and tallies as reasonably requested by Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The only matters to be voted upon at the Company Stockholders Meeting are (i) the Merger, (ii) compensatory arrangements between
Company and its executive officers relating to the Merger (on a non-binding, advisory basis), and (iii) any adjournment or postponement
of the Company Stockholders Meeting for a reasonable period to solicit additional proxies, if deemed necessary by Company, and (iv) any
other matters that are (A) required by Applicable Law or the Bylaws of Company, as applicable, or (B) if so desired and mutually agreed
on, of the type customarily brought before a meeting of stockholders in connection with approval of this Agreement and the transactions
contemplated by this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Without limiting the generality of the foregoing, Company agrees that its obligations pursuant to this <span style="text-decoration: underline">Section 7.1</span> to hold
the Company Stockholders Meeting shall not be affected by the commencement, public proposal, public disclosure or communication to Company
or any other person of any Alternative Transaction or the making of a Company Recommendation Change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Each of Company and Parent agrees that none of the information supplied or to be supplied by such party (or its Subsidiaries) for
inclusion or incorporation by reference in (i) the Form S-4 will, at the time the Form S-4 is filed with the SEC, and at any time it is
amended or supplemented or at the time it becomes effective under the Securities Act, contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances under which they are made, not misleading, or (ii) the Company Proxy Statement/Prospectus will, at the date it is first
mailed to Company&#8217;s stockholders or at the time of the Company Stockholders Meeting, contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of
the circumstances under which they are made, not misleading. Each of Company and Parent will cause the Form S-4 and the Company Proxy
Statement/Prospectus to comply as to form in all material respects with the requirements of the Securities Act and the Exchange Act and
the rules and regulations thereunder. Notwithstanding the foregoing, no covenant is made by either Company or Parent with respect to statements
made or incorporated by reference therein based on information supplied by or on behalf of the other party (or its Subsidiaries) for inclusion
or incorporation by reference in the Form S-4 or the Company Proxy Statement/Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 189 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Access to Information; Confidentiality</span>. Subject to the Confidentiality Agreement and Applicable Law, and solely for the
purposes of furthering the Merger, Company shall, and shall cause its Subsidiaries to, afford to Parent and its officers, employees and
Representatives, reasonable access, during normal business hours during the period from the date of this Agreement to the Effective Time,
to all of its and their respective properties, books, contracts, commitments, personnel and records (<span style="text-decoration: underline">provided</span> that such access
shall not unreasonably interfere with the business or operations of Company), and during such period, Company shall, and shall cause its
Subsidiaries to, furnish promptly to Parent all information concerning its and their business, properties and personnel as Parent or its
Representatives may reasonably request; <span style="text-decoration: underline">provided</span> that the foregoing shall not require Company or Parent to disclose any information
pursuant to this <span style="text-decoration: underline">Section 7.2</span> to the extent that (i) such disclosure contravenes any Applicable Law or Order, (ii) in the reasonable
good faith judgment of such party, the information is subject to confidentiality obligations to a third party or (iii) disclosure of any
such information or document would result in the loss of attorney-client privilege, attorney work product or other relevant legal privilege;
<span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">further</span>, that, with respect to the foregoing clauses (i) through (iii), Company shall use its commercially reasonable
efforts to (A) obtain the required consent of any third party necessary to provide such disclosure, (B) develop an alternative to providing
such information so as to address such matters that is reasonably acceptable to the other party and (C) utilize the procedures of a joint
defense agreement or implement such other techniques if the parties determine that doing so would reasonably permit the disclosure of
such information without violating Applicable Law or jeopardizing such privilege. No review pursuant to this <span style="text-decoration: underline">Section 7.2</span> shall
affect any representation or warranty given by the other party hereto. Any information provided or made available pursuant to this <span style="text-decoration: underline">Section
7.2</span> shall be governed by the terms and conditions of the Confidentiality Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.3</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Reasonable Best Efforts</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Subject to the terms and conditions of this Agreement, Parent and Company will cooperate with each other and use (and will cause
their respective Subsidiaries to use) their respective reasonable best efforts to consummate the transactions contemplated by this Agreement
and cause the conditions to the Merger set forth in <span style="text-decoration: underline">ARTICLE VIII</span> to be satisfied as promptly as reasonably practicable, including
by using their respective reasonable best efforts to accomplish the following (in connection with the consummation of the transactions
contemplated by this Agreement, including the Merger) as promptly as reasonably practicable: (i) obtaining all actions, consents, approvals,
registrations, waivers, permits, authorizations, orders, expirations or terminations of waiting periods and other confirmations from any
Governmental Entity that are necessary in order to consummate and make effective the Merger, (ii) preparing and making all registrations,
filings, forms, notices, petitions, statements, submissions of information, applications and other documents (including filings with Governmental
Entities) that are necessary in order to consummate and make effective the Merger, (iii) defending any lawsuits or other Actions, whether
judicial or administrative, challenging this Agreement or that would otherwise prevent or delay the consummation of the transactions contemplated
by this Agreement, including the Merger, including seeking to have any stay, temporary restraining order or injunction entered by any
court of other Governmental Entity vacated or reversed and (iv) executing and delivering any additional instruments that are reasonably
necessary, proper or advisable to carry out fully the purposes of this Agreement. Each of Parent and Company shall, in consultation and
cooperation with the other make any filings required in connection with the conditions set forth on <span style="text-decoration: underline">Section 8.1(b)</span> as promptly
as reasonably practicable after such determination that any such filings are required. Neither Parent nor Company will withdraw any such
filings or applications without the prior written consent of the other party. Notwithstanding anything to the contrary contained in this
Agreement, neither Parent nor Company, nor any of their respective Subsidiaries, shall be required to (and Company shall not, without
Parent&#8217;s prior written consent (which shall not be unreasonably withheld, conditioned or delayed)), pay any material consent or
other similar fee, payment or consideration, make any other material concession or provide any additional material security (including
a guaranty) to any non-Governmental Entity third party in connection with seeking or obtaining its consent to the transactions contemplated
by this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 190 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="vertical-align: baseline"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span></span>In connection with and without limiting the efforts referenced in <span style="text-decoration: underline">Section 7.3(a)</span>, Parent and Company shall jointly
develop, and Parent and Company shall consult and cooperate in all respects with one another, and consider in good faith the views of
one another, in connection with the form and content of any analyses, appearances, presentations, memoranda, briefs, filings, arguments,
opinions and proposals made or submitted by or on behalf of any party in connection with any Action, or seeking of any consent, approval,
order or authorization, under or relating to any Antitrust Law; <span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>, that if there is any disagreement regarding
the foregoing, Parent shall ultimately control strategy or decisions in connection with any Action, or seeking of any consent, approval,
order or authorization, under or relating to any Antitrust Law. Each of Parent and Company shall (i) furnish to the other such necessary
information and reasonable assistance as the other may request in connection with the preparation of any governmental filings, submissions
or other documents, (ii) promptly inform the other of any such filing, submission or other document and of any communication with or from
any Governmental Entity regarding the transactions contemplated by this Agreement, and permit the other to review and discuss in advance,
and consider in good faith the views of the other in connection with, any such filing, submission, document or communication and (iii)
cooperate in making an appropriate response as promptly as reasonably practicable to any investigation or other inquiry from a Governmental
Entity or any Action initiated by a Governmental Entity or private party, including promptly notifying the other party of any such investigation,
inquiry or Action, and consulting in advance before making any presentations or submissions to a Governmental Entity, or, in connection
with any Action initiated by a private party, to any other person. Each of Parent and Company shall promptly make an appropriate response
to any request for information, documentation, other material, or testimony by any Governmental Entity, including by using reasonable
best efforts to promptly make an appropriate response to any request for additional information, documents or other materials received
by any party or any of their respective Subsidiaries from any Governmental Entity in connection with such filings, submissions or in connection
with any Actions under or relating to any Antitrust Law. Each of Parent and Company shall, in connection with the transactions contemplated
by this Agreement, promptly inform and consult with the other in advance of any meeting, conference or material communication with any
Governmental Entity, or, in connection with any Action by a private party, with any other person, and to the extent not prohibited by
Applicable Law or by the applicable Governmental Entity, reasonably consult with the other party in advance of any such meeting, conference
or material communication, and give the other party a reasonable opportunity to attend and participate therein, and if the other party
does not participate, keep such party apprised with respect thereto. Each party shall furnish to the other copies of all filings (excluding
any Notification and Report Form under the HSR Act and any attachments thereto, if required), submissions, correspondence and communications
between it and its Affiliates and their respective Representatives, on the one hand, and any Governmental Entity (or any other person
in connection with any Action initiated by a private party), on the other hand, with respect to the transactions contemplated by this
Agreement. Each party may, as it deems advisable and necessary, reasonably designate material provided to the other party as &#8220;Outside
Counsel Only Material,&#8221; and also may reasonably redact the material as necessary to (A) remove personally sensitive information,
(B) remove references concerning the valuation of a party and its Subsidiaries conducted in connection with the approval and adoption
of this Agreement and the negotiations and investigations leading thereto, (C) comply with contractual arrangements, (D) prevent the loss
of a legal privilege or (E) comply with Applicable Law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Notwithstanding anything in this Agreement to the contrary, neither Parent nor any of its Subsidiaries or Affiliates shall be required,
either pursuant to this <span style="text-decoration: underline">Section 7.3</span> or otherwise, to (and, without Parent&#8217;s prior written consent, Company shall not, nor
shall it permit any of its Representatives to) (i) negotiate, commit to or effect, by consent decree, hold separate order or otherwise,
the sale, lease, license, divestiture or disposition of any assets, rights, product lines or businesses of Parent, Company or any of their
respective Subsidiaries or Affiliates, (ii) terminate any existing relationships, contractual rights or obligations of Parent, Company
or any of their respective Subsidiaries or Affiliates, (iii) terminate any joint venture or other arrangement of Parent, Company or any
of their respective Subsidiaries or Affiliates, (iv) create any relationship, contractual rights or obligations of Parent, Company or
any of their respective Subsidiaries or Affiliates, (v) effectuate any other change or restructuring of Parent, Company or any of their
respective Subsidiaries or Affiliates and (vi) otherwise take or commit to take any actions, including agreeing to prior approval restrictions,
with respect to the businesses, product lines or assets of Parent, Company or any of their respective Subsidiaries or Affiliates; <span style="text-decoration: underline">provided</span>
that Company shall only be required to take or commit to take any such action, or agree to any such condition or restriction, if such
action, commitment, agreement, condition or restriction is binding on Company only in the event the Closing occurs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company will use commercially reasonable efforts to obtain all third-party consents or approvals, and provide all notices to third-parties,
in each case to the extent reasonably requested by Parent in writing and required in connection with the Merger under any contract of
the Company or any of its Subsidiaries or Affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 191 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.4</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Indemnification, Exculpation and Insurance</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Parent agrees that all rights to indemnification and exculpation from liabilities, including advancement of expenses, for acts
or omissions or other matter occurring at or prior to the Effective Time now existing in favor of the current or former directors, officers,
members, managers, employees or agents of Company or any Subsidiary of Company (determined as of the Effective Time) (the &#8220;<span style="text-decoration: underline">Existing
Indemnified Parties</span>&#8221;) as provided in the organizational documents of Company and any of its Subsidiaries or any indemnification
contract between such directors or officers and Company (in each case, as in effect on, and, in the case of any indemnification contracts,
to the extent made available to Parent prior to, the date of this Agreement) shall survive the Merger and shall continue in full force
and effect. For a period of six years from the Effective Time, the Surviving Corporation shall, and Parent shall cause the Surviving Corporation
to, maintain in effect the exculpation, indemnification and advancement of expenses equivalent to the provisions of the organizational
documents of Company and any of its Subsidiaries as in effect immediately prior to the Effective Time with respect to acts or omissions
or other matters occurring prior to the Effective Time and shall not amend, repeal or otherwise modify any such provisions in any manner
that would adversely affect the rights thereunder of any Existing Indemnified Parties; <span style="text-decoration: underline">provided</span> that all rights to indemnification
in respect of any claim made for indemnification within such period shall continue until the disposition of such action or resolution
of such claim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>From and after the Effective Time, Parent shall, and Parent shall cause the Surviving Corporation to, indemnify, defend and hold
harmless, to the fullest extent permitted under Applicable Law, the current or former directors or officers of Company or any Subsidiary
of Company (the &#8220;<span style="text-decoration: underline">D&amp;O Indemnified Parties</span>&#8221;) against any costs or expenses (including reasonable attorneys&#8217;
fees and expenses), amounts paid in settlement, judgments, fines, losses, claims, damages or liabilities incurred in connection with,
arising out of or otherwise related to any actual or alleged Action, in connection with, arising out of or otherwise related to matters
existing or occurring or alleged to have occurred prior to or at the Effective Time, whether asserted or claimed prior to, at or after
the Effective Time, including actions to enforce this provision or any other indemnification or advancement right of any D&amp;O Indemnified
Party, and Parent shall, and Parent shall cause the Surviving Corporation to, also promptly advance reasonable costs and expenses (including
attorney&#8217;s fees) as incurred to the fullest extent permitted under Applicable Law (subject to the execution of an undertaking by
or on behalf of the D&amp;O Indemnified Party to repay such amount if it shall ultimately be determined, by final judicial decision from
a court of competent jurisdiction which there is no further right to appeal, that the D&amp;O Indemnified Party is not entitled to be
indemnified under this <span style="text-decoration: underline">Section 7.4(b)</span>). In the event of any such actual or alleged Action, Parent and the Surviving Corporation
shall cooperate with the D&amp;O Indemnified Party in the defense of any such actual or alleged Action. None of Parent, the Surviving
Corporation nor any of their respective Affiliates shall settle or otherwise compromise or consent to the entry of any judgment with respect
to, or otherwise seek the termination of, any Action for which indemnification may be sought by an D&amp;O Indemnified Party pursuant
to this Agreement unless such settlement, compromise, consent or termination includes an unconditional release of all D&amp;O Indemnified
Parties from all liability arising out of such Action.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The Surviving Corporation shall (and Parent shall cause the Surviving Corporation to), at its option, (i) during the period commencing
at the Effective Time and ending on the sixth anniversary of the Effective Time, maintain in effect Company&#8217;s current directors&#8217;
and officers&#8217; liability insurance (&#8220;<span style="text-decoration: underline">D&amp;O Insurance</span>&#8221;) in respect of acts or omissions occurring at or prior
to the Effective Time on terms (including with respect to coverage, conditions, retentions, limits and amounts) that are equivalent to
or more favorable than those of the D&amp;O Insurance or (ii) purchase a six (6)-year prepaid &#8220;tail&#8221; policy with respect to
the D&amp;O Insurance from an insurance carrier with a comparable credit rating as Company&#8217;s current directors&#8217; and officers&#8217;
liability insurance carrier (the &#8220;<span style="text-decoration: underline">Tail Policy</span>&#8221;). In satisfying its obligations pursuant to the first sentence of this
<span style="text-decoration: underline">Section 7.4(c)</span>, the Surviving Corporation shall not be obligated to (A) pay an amount per year in excess of 300% of the amount
paid by Company for coverage for its last full fiscal year prior to the date hereof for the D&amp;O Insurance (the &#8220;<span style="text-decoration: underline">Maximum Premiums</span>&#8221;)
or (B) incur an aggregate cost for the Tail Policy in excess of the Maximum Premiums. If the annual premiums of such insurance coverage
for the six-year period exceed the Maximum Premiums or the aggregate cost for such Tail Policy exceeds the Maximum Premiums, then the
Surviving Corporation shall only be obligated to obtain a policy with the greatest coverage available for an annual premium not exceeding
the Maximum Premiums or an aggregate cost for such Tail Policy not exceeding the Maximum Premiums from an insurance carrier with the same
or better credit rating as Company&#8217;s current directors&#8217; and officers&#8217; liability insurance carrier. In lieu of the foregoing
obligations, Company may, prior to the Effective Time, and, at Parent&#8217;s request, shall use reasonable best efforts to, purchase
the Tail Policy; <span style="text-decoration: underline">provided</span> that the aggregate cost for such Tail Policy shall not exceed the Maximum Premiums. If Company purchases
the Tail Policy prior to the Effective Time, the Surviving Corporation shall (and Parent shall cause the Surviving Corporation to) maintain
such Tail Policy in full force and effect for a period of no less than six (6) years after the Effective Time and continue to honor its
obligations thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 192 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The covenants contained in this <span style="text-decoration: underline">Section 7.4</span> are intended to be for the benefit of, and shall be enforceable by, each of
the D&amp;O Indemnified Parties and their respective heirs and shall not be deemed exclusive of any other rights to which any such person
is entitled, whether pursuant to Applicable Law, contract or otherwise. Nothing contained in this <span style="text-decoration: underline">Section 7.4</span> shall be construed
or interpreted to release, waive or impair any other right to director and officer liability insurance claims under any policy that is
or has been in existence with respect to Company and its Subsidiaries and the rights contained in this <span style="text-decoration: underline">Section 7.4</span> shall be deemed
to be additional to, and not in lieu of or in substitution for any claims under any such policies or other rights to indemnification,
advancement or contribution.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>In the event that Parent or the Surviving Corporation or any of their respective successors or assigns (i) consolidates with or
merges into any other person and shall not be the continuing or surviving corporation or entity of such consolidation or merger or (ii)
transfers or conveys all or substantially all of its properties and assets to any person, then, and in each such case, proper provision
shall be made so that the successors or assigns of Parent or the Surviving Corporation, as the case may be, shall assume the obligations
set forth in this <span style="text-decoration: underline">Section 7.4</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.5</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Fees and Expenses</span>. Except as set forth in this <span style="text-decoration: underline">Section 7.5</span> and in <span style="text-decoration: underline">Section 9.2</span>, all fees and expenses incurred
in connection with the Merger, this Agreement and the transactions contemplated by this Agreement shall be paid by the party incurring
such fees or expenses, whether or not the Merger are consummated, except that each of Parent and Company shall bear and pay one-half of
the costs and expenses (other than the fees and expenses of each party&#8217;s attorneys and accountants, which shall be borne by the
party incurring such expenses) incurred by the parties in connection with (a) the filing, printing and mailing of the Form S-4 and the
Company Proxy Statement/Prospectus (including SEC filing fees), (b) the filings of the premerger notification and report forms (including
filing fees) and (c) the filings and notices required to obtain the consents of any Governmental Entity required in connection with the
conditions set forth in <span style="text-decoration: underline">Section 8.1(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.6</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Public Announcements</span>. The initial press release with respect to this Agreement and the transactions contemplated hereby
shall be a release mutually agreed to by Company and Parent. Thereafter, Company and Parent shall consult with each other before issuing
any press release or making any public statement with respect to this Agreement or the transactions contemplated hereby and shall not
issue any such press release or make any such public statement without the prior consent of the other, such consent not to be unreasonably
withheld, conditioned or delayed. Notwithstanding the foregoing, the first and second sentences of this <span style="text-decoration: underline">Section 7.6</span> shall not apply
to (a) any press release or public statement required by Applicable Law or any listing agreement with any national securities exchange,
<span style="text-decoration: underline">provided</span> that the party making the release or statement has used its reasonable best efforts to consult with the other party, (b)
a Company Recommendation Change (or any responses thereto), or any communication regarding an Alternative Transaction in accordance with
<span style="text-decoration: underline">Section 6.2(e)</span>, (c) any disclosure of information concerning this Agreement in connection with any dispute between the parties
regarding this Agreement and (d) any press release or public statement containing content with respect to this Agreement or the transactions
contemplated hereby consistent in all material respects with content included in any press release or public statement that has been previously
consented to by the other party or otherwise exempted from this <span style="text-decoration: underline">Section 7.6</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.7</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">NASDAQ Listing</span>. Company and Parent shall use reasonable best efforts to cause the Parent Common Stock issuable under <span style="text-decoration: underline">ARTICLE
III</span> to be approved for listing on the NASDAQ, subject to official notice of issuance, prior to the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.8</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Takeover Statutes</span>. If any &#8220;control share acquisition,&#8221; &#8220;fair price,&#8221; &#8220;moratorium,&#8221; &#8220;antitakeover,&#8221;
or similar statute or regulation is or may become applicable to the transactions contemplated by this Agreement, each of the parties hereto
and its respective Board of Directors shall (a) grant such approvals and take all such actions as are legally permissible so that the
transactions contemplated hereby may be consummated as promptly as practicable on the terms contemplated hereby and (b) otherwise act
to eliminate or minimize the effects of any such statute or regulation on the transactions contemplated hereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 193 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.9</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Transfer Taxes</span>. Company and Parent shall each use commercially reasonable efforts to cooperate in the preparation, execution
and filing of all Tax Returns regarding any real property transfer, documentary, sales, use, transfer, value added, stock transfer, stamp,
registration or other similar Taxes (collectively, &#8220;<span style="text-decoration: underline">Transfer Taxes</span>,&#8221; which shall exclude, for the avoidance of doubt,
any income, capital gains, payroll or other similar Taxes) that become payable by either Company or Parent in connection with the transactions
contemplated by this Agreement, which are required or permitted to be filed on or before the Effective Time. The payment of any Transfer
Taxes incurred by any direct or indirect holder (prior to the Effective Time) of any share of Company Common Stock in connection with
the Merger and any other transactions contemplated by this Agreement, and the filing of any related Tax Returns, shall be the sole responsibility
of such holder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.10</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Employee Matters</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>With respect to each Continuing U.S. Employee, solely for purposes of determining eligibility to participate, vesting (other than
vesting of future equity awards), future vacation accruals and severance amounts (but not (i) for purposes of benefit accrual, other than
with respect to vacation benefits, or (ii) to the extent that such credit would result in a duplication of compensation or benefits) under
each applicable Parent Benefit Plan, service by such Continuing U.S. Employee with Company or any of its Subsidiaries shall be treated
as service with Parent to the same extent that such service was taken into account for such purposes under the analogous Company Benefit
Plan immediately prior to the Effective Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Nothing in this Agreement shall confer upon any employee, officer, director or consultant of Company or any of its Subsidiaries
any right to continue in the employ or service of the Surviving Corporation, Company, Parent or any Subsidiary or Affiliate thereof, or
shall interfere with or restrict in any way the rights of the Surviving Corporation, Company, Parent or any Subsidiary or Affiliate thereof
to discharge or terminate the services of any employee, officer, director or consultant of Company or any of its Subsidiaries at any time
for any reason whatsoever, with or without cause. Nothing in this Agreement shall be deemed to (i) establish, amend, modify or terminate
any Company Benefit Plan or any other compensation or benefit plan, program, agreement or arrangement, or (ii) alter or limit the ability
of the Surviving Corporation or any of its Subsidiaries or Affiliates to establish, amend, modify or terminate any Company Benefit Plan
or any other benefit or employment plan, program, agreement or arrangement after the Effective Time. Without limiting the generality of
<span style="text-decoration: underline">Section 10.6</span>, nothing in this Agreement, express or implied, is intended to or shall confer upon any person other than the parties
hereto, including any current or former employee, officer, director or consultant of Company or any of its Subsidiaries, any right (including
any third-party right), benefit or remedy of any nature whatsoever under or by reason of this Agreement. If a Parent Benefit Plan replaces
a Company Benefit Plan that is a group health plan providing medical benefits during the twelve (12)-consecutive-month period commencing
on the Closing Date, then Parent shall use commercially reasonable efforts to cause such Parent Benefit Plan to (A) waive any limitations
on benefits relating to preexisting conditions to the same extent such limitations are waived under the Company Benefit Plan that is replaced
by such Parent Benefit Plan prior to the Effective Time and (B) recognize, for purposes of annual deductible and out-of-pocket limits
under its medical and dental plans, deductible and out-of-pocket expenses paid by Continuing U.S. Employees in the calendar year in which
the Effective Time occurs, in the case of each of clause (A) and (B), with respect to the Continuing U.S. Employees who are covered by
such Company Benefit Plan at the time it is replaced; provided, however, that clause (B) shall not apply with respect to any Parent Benefit
Plan that is a high-deductible health plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Prior to the Closing Date, Company shall (a) amend the Company 401(k) Plan (the &#8220;<span style="text-decoration: underline">Company 401(k) Plan</span>&#8221;), with
such amendment to be effective prior to the Closing Date, to eliminate future purchases of Company Common Stock (or, following the Closing,
Parent Common Stock) by participants under the Company 401(k) Plan, (b)&#160;if requested by Parent at least five (5) Business Days prior
the Closing Date, terminate the Company 401(k) Plan and such other Company Benefit Plans as Parent may request effective prior to the
Closing Date, (c) provide Parent with evidence satisfactory to Parent that the Company 401(k) Plan has been so amended and, if requested
by Parent, terminated effective prior to the Closing Date as described above pursuant to resolutions of the Company Board or other applicable
governing body, and (d) provide Parent with evidence satisfactory to Parent that all other Company Benefit Plans that Parent has requested
be terminated have been terminated effective prior to the Closing Date as described above pursuant to resolutions of the Company Board
or other applicable governing body (the form and substance of the resolutions and amendments referred to herein shall be subject to the
prior review and approval of Parent, which approval will not be unreasonably delayed, denied or conditioned).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 194 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Company and its Subsidiaries shall be liable for any accrued but unused personal, sick, vacation time or other paid time off balances
to which any Continuing Employee is entitled pursuant to the policies or individual agreements, or other arrangements applicable to such
Continuing Employee immediately prior to the Effective Time (the &#8220;<span style="text-decoration: underline">PTO Policy</span>&#8221;) and, if required pursuant to such PTO
Policy, or Applicable Law, pay out, prior to the Effective Time, all such amounts accrued and owed to such Continuing Employee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Subject to the terms and conditions under the severance guidelines set forth in <span style="text-decoration: underline">Section 7.10(e)</span> of the Company Disclosure
Letter and this <span style="text-decoration: underline">Section 7.10(e)</span>, Parent shall provide, and shall cause the Surviving Corporation and their respective Affiliates
to provide, cash severance to any applicable Continuing U.S. Employee that experiences a qualifying termination of employment (as defined
in <span style="text-decoration: underline">Section 7.10(e)</span> of the Company Disclosure Letter) within ninety (90) days following the Closing; <span style="text-decoration: underline">provided</span> that (1) there
shall be no duplication of benefits (it being understood that in no event shall the payment of any retention amounts, due under an arrangement
in effect prior to the Closing, be duplicative of the payment of any severance amounts hereunder) and (2) Parent may, in its discretion,
condition any such severance payments on the execution and non-revocation of a release of claims (including by waiting until such release
of claims is effective before initiating any such severance payments).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.11</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Section 16 Matters</span>. Company shall take all such steps as are reasonably necessary to cause the transactions contemplated
by this Agreement, including any dispositions of equity securities of Company (including derivative securities) or acquisitions of equity
securities of Parent (including derivative securities) in connection herewith, by any individual who is a director or officer subject
to the reporting requirement of Section 16(a) of the Exchange Act to be exempt under Rule 16b-3 promulgated under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.12</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Certain Litigation</span>. Company shall promptly notify and cooperate with Parent with respect to, any stockholder demands, litigations,
arbitrations or other similar claims, actions, suits or proceedings (including derivative claims) commenced against it, its Subsidiaries
or its or its Subsidiaries&#8217; respective directors or officers relating to this Agreement or any of the transactions contemplated
hereby or any matters relating thereto (collectively, &#8220;<span style="text-decoration: underline">Transaction Litigation</span>&#8221;); <span style="text-decoration: underline">provided</span> that &#8220;Transaction
Litigation&#8221; shall not include any litigation where the parties are adverse to each other or any litigation related to or arising
out of a proposal with respect to an Alternative Transaction. Company shall (a) give Parent the opportunity to reasonably participate
(at Parent&#8217;s expense) in (but not control) the defense and settlement of any Transaction Litigation, (b) keep Parent reasonably
apprised on a prompt basis of proposed strategy and other significant decisions with respect to any such Transaction Litigation, and provide
Parent with the opportunity to consult with Company regarding the defense of any such litigation, which advice Company shall consider
in good faith, and (c) not, and cause its Subsidiaries not to, settle or offer to settle any Transaction Litigation without the prior
written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed). Following the Effective Time, the
Existing Indemnified Parties shall be entitled to continue to retain Dentons US LLP or such other counsel selected by such Existing Indemnified
Parties prior to the Effective Time to defend any Transaction Litigation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.13</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Stock Exchange Delisting; Deregistration</span>. Prior to the Effective Time, Company shall cooperate with Parent and use its reasonable
best efforts to facilitate the commencement of the delisting of Company and of the shares of Company Common Stock from the NASDAQ as promptly
as practicable after the Effective Time, and in any event no more than ten Business Days after the Effective Time, as well as the deregistration
of Company Common Stock pursuant to the Exchange Act as promptly as practicable after such delisting. Prior to the Effective Time, Company
shall not voluntarily delist the Company Common Stock from the NASDAQ.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.14</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Tax Matters</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>After the Closing Date, the parties hereto will prepare and file all U.S. federal income Tax Returns consistent with the Intended
Tax Treatment, except as otherwise required by a change in Applicable Law after the date hereof or a &#8220;determination&#8221; within
the meaning of Section 1313(a) of the Code. Notwithstanding the foregoing or anything else contained in this Agreement to the contrary,
none of Parent or any Affiliate of Parent (including Company and any of its Subsidiaries after the Closing) shall have any liability or
obligation to any direct or indirect holder of any share of Company Common Stock or any direct or indirect holder of any share of Parent
Common Stock if the Merger fails to qualify for the Intended Tax Treatment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 195 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>If, in connection with the preparation and filing of the Form S-4 or the Company Proxy Statement/Prospectus, the SEC requires that
a tax opinion (such opinion, a &#8220;<span style="text-decoration: underline">Tax Opinion</span>&#8221;) be prepared and submitted, Company shall deliver to Parent a Tax Opinion
of Dentons US LLP (or other counsel as may be reasonably acceptable to Parent), dated as of the Closing Date, to the effect that the Merger
qualifies for the Intended Tax Treatment. Company and Parent will use commercially reasonable efforts to cooperate with one another in
connection with the issuance to Company or Parent of any Tax Opinion regarding the Intended Tax Treatment, including using commercially
reasonable efforts to deliver to the relevant counsel certificates (dated as of the necessary date and signed by an officer of Company
or Parent, as applicable) containing customary representations reasonably necessary or appropriate for such counsel to render such Tax
Opinion. Notwithstanding the foregoing or anything else contained in this Agreement to the contrary, <span style="text-decoration: underline">however</span>, no Tax Opinion by
any party&#8217;s counsel or advisor shall be a condition to any party&#8217;s obligation to effect the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.15</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Merger Sub Stockholder Consent and Other Transaction Consents</span>. Parent, in its capacity as the sole stockholder of Merger
Sub, shall, immediately following the execution and delivery of this Agreement, deliver or cause to be delivered the irrevocable written
consent of the sole stockholder of Merger Sub adopting this Agreement in accordance with the DGCL and the organizational documents of
Merger Sub. Parent shall take all necessary action to cause Merger Sub and the Surviving Corporation to perform their respective obligations
under, and in accordance with the terms of, this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.16</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Notices of Certain Events</span>. Subject to Applicable Law, Company shall promptly notify Parent promptly: (a) any notice or other
communication from any Person alleging that the consent of such Person is or may be required in connection with the transactions contemplated
by this Agreement; (b) any notice or other communication from any Governmental Entity in connection with the transactions contemplated
by this Agreement; (c) any Transaction Litigation commenced, or to Company&#8217;s knowledge, threatened against, relating to, or involving
or otherwise affecting Company or any of its Subsidiaries, which relate to the transactions contemplated by this Agreement; and (d) any
event, change, or effect between the date of this Agreement and the Effective Time which individually or in the aggregate causes or is
reasonably likely to cause or constitute: (i) a material breach of any of its representations, warranties, or covenants contained herein,
or (ii) the failure of any of the conditions set forth in <span style="text-decoration: underline">ARTICLE VIII</span> of this Agreement to be satisfied; <span style="text-decoration: underline">provided</span> that
the delivery of any notice pursuant to this <span style="text-decoration: underline">Section 7.16</span> shall not cure any breach of, or noncompliance with, any other provision
of this Agreement or limit the remedies available to the party receiving such notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.17</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Resignations</span>. At the written request of Parent, Company shall (a) cause each director of the Company or any director of
any of Company&#8217;s Subsidiaries to resign in such capacity, with such resignations to be effective as of the Effective Time and (b)
cause such Persons that do not resign to be removed from such positions so requested pursuant to the applicable governing documents and
Applicable Law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 7.18</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Forms 5500</span>. As soon as possible following the date of this Agreement, but in any event not later than thirty (30) days thereafter,
with respect to the Company Welfare Benefit Plan, the Company Premium Conversion Plan, and the Company Health Flexible Spending Account
Plan, the Company shall have prepared and filed for each such plan a Form 5500 Annual Report (for each year in which such filing was required
due to the relevant plan having 100 or more participants or otherwise) with the U.S. Department of Labor (&#8220;<span style="text-decoration: underline">DOL</span>&#8221;) pursuant
to the DOL&#8217;s Delinquent Filer Voluntary Compliance Program (&#8220;<span style="text-decoration: underline">DFVCP</span>&#8221;).&#160; The Company shall provide Purchaser
with a draft of such DFVCP application and draft Forms 5500 (for each plan and each year in which such filing was required) prior to submission
with the DOL for Parent&#8217;s prior review and approval, which shall not be unreasonably withheld, conditioned or delayed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE VIII<br/>
CONDITIONS PRECEDENT</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 8.1</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Conditions to Each Party&#8217;s Obligation to Effect the Merger</span>. The respective obligation of each party to effect the
Merger is subject to the satisfaction or waiver, in whole or in part (to the extent permitted by Applicable Law), on or prior to the Closing
Date of the following conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Company Stockholder Approval</span>. The Company Stockholder Approval shall have been obtained.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">HSR Act</span>. Any applicable waiting period (including any extensions thereof) under the HSR Act relating to the Merger and the
transactions contemplated hereby shall have expired or been terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 196 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Injunctions or Restraints</span>. No Governmental Entity of competent jurisdiction shall have issued or entered any Order after
the date of this Agreement, and no Applicable Law shall have been enacted or promulgated after the date of this Agreement, in each case,
that (whether temporary, preliminary or permanent) is then in effect and has the effect of enjoining or otherwise prohibiting the consummation
of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Registration Statement</span>. The Form S-4 shall have become effective under the Securities Act and shall not be the subject of
any stop order.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Stock Exchange Listing</span>. The shares of Parent Common Stock to be issued in the Parent Share Issuance shall have been approved
for listing on the NASDAQ, subject to official notice of issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 8.2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Conditions to Obligations of Parent</span>. The obligation of Parent to effect the Merger is further subject to satisfaction or
waiver by Parent, in whole or in part (to the extent permitted by Applicable Law), of the following conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Representations and Warranties</span>. (i) The representations and warranties of Company contained in <span style="text-decoration: underline">Section 4.1</span> (<i>Organization,
Standing and Corporate Power</i>), <span style="text-decoration: underline">Section 4.2(a)</span> (<i>Corporate Authority</i>), <span style="text-decoration: underline">Section 4.2(b)</span> (<i>Non-Contravention</i>),
<span style="text-decoration: underline">Section 4.3</span> (<i>Capital Structure</i>), <span style="text-decoration: underline">Section 4.4</span> (<i>Subsidiaries</i>), <span style="text-decoration: underline">Section 4.20</span> (<i>Voting Requirements</i>),
<span style="text-decoration: underline">Section 4.21</span> (<i>Opinion of Financial Advisors</i>) and <span style="text-decoration: underline">Section 4.22</span> (<i>Brokers</i>) (x) that are qualified by &#8220;materiality&#8221;
or &#8220;Material Adverse Effect&#8221; shall be true and correct as of the Closing Date as though made on the Closing Date (except to
the extent such representations and warranties expressly relate to a specific date or the date of this Agreement, in which case such representations
and warranties shall be true and correct as of such date) and (y) that are not qualified by &#8220;materiality&#8221; or &#8220;Material
Adverse Effect&#8221; shall be true and correct in all material respects as of the Closing Date as though made on the Closing Date (except
to the extent such representations and warranties expressly relate to a specific date or the date of this Agreement, in which case such
representations and warranties shall be true and correct in all material respects as of such date), (ii) the representations and warranties
of Company contained in <span style="text-decoration: underline">Section 4.6(b)</span> (<i>No Material Adverse Effect</i>) shall be true and correct as of the Closing Date as
though made on the Closing Date, and (iii) each of the representations and warranties of Company contained in this Agreement (other than
those contained in the sections set forth in the preceding clauses (i) and (ii)) (without giving effect to any limitation as to &#8220;materiality&#8221;
or &#8220;Material Adverse Effect&#8221; set forth therein) shall be true and correct as of the Closing Date as though made on the Closing
Date (except to the extent such representations and warranties expressly relate to a specific date or the date of this Agreement, in which
case such representations and warranties shall be true and correct as of such date), except where the failure to be so true and correct
has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Performance of Obligations of Company</span>. Company shall have performed in all material respects all covenants and agreements
required to be complied with or performed by it under this Agreement at or prior to the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Material Adverse Effect</span>. No Material Adverse Effect with respect to Company shall have occurred after the date of this
Agreement that is continuing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Officer&#8217;s Certificate</span>. Parent shall have received an officer&#8217;s certificate duly executed by an authorized officer
of Company to the effect that the conditions set forth in <span style="text-decoration: underline">Section 8.2(a)</span>, <span style="text-decoration: underline">Section 8.2(b)</span> and <span style="text-decoration: underline">Section 8.2(c)</span> have
been satisfied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Actions Pending</span>. There shall not be (i) pending or threatened any Action brought by any Governmental Entity, or (ii)
any statute, rule, regulation or Order issued by any court of competent jurisdiction or other Governmental Entity or other legal restraint
or prohibition in effect, in either case: (1) challenging or seeking to restrain or prohibit the consummation of the Merger or other transactions
contemplated by this Agreement, or seeking to obtain any damages in connection therewith; or (2) seeking to prohibit or impose any limitations
on Parent or the Surviving Corporation&#8217;s ownership or operation of all or any portion of Company&#8217;s business or assets or to
compel Parent or any of its Affiliates to dispose of or hold separate all or any material portion of the assets of Company as a result
of the consummation of the Merger or other transactions contemplated by this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 197 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 8.3</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Conditions to Obligations of Company</span>. The obligation of Company to effect the Merger is further subject to satisfaction
or waiver by Company, in whole or in part (to the extent permitted by Applicable Law), of the following conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Representations and Warranties</span>. The representations and warranties of Parent contained in <span style="text-decoration: underline">ARTICLE V</span> shall be true
and correct in all material respects as of the Closing Date as though made on the Closing Date (except to the extent such representations
and warranties expressly relate to a specific date or the date of this Agreement, in which case such representations and warranties shall
be true and correct in all material respects as of such date).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Performance of Obligations of Parent</span>. Parent shall have performed in all material respects all covenants and agreements
required to be complied with or performed by it under this Agreement at or prior to the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Officer&#8217;s Certificate</span>. Company shall have received an officer&#8217;s certificate duly executed by an authorized officer
of Parent to the effect that the conditions set forth in <span style="text-decoration: underline">Section 8.3(a)</span> and <span style="text-decoration: underline">Section 8.3(b)</span> have been satisfied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE IX<br/>
TERMINATION, AMENDMENT AND WAIVER</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 9.1</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Termination</span>. This Agreement may be terminated at any time prior to the Effective Time, and whether before or (except in
the case of <span style="text-decoration: underline">Section 9.1(d)</span>) after receipt of the Company Stockholder Approval:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>by mutual written consent of Company and Parent;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>by either Company or Parent, if:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>the Merger shall not have been consummated by September 30, 2025 (the &#8220;<span style="text-decoration: underline">Outside Date</span>&#8221;); <span style="text-decoration: underline">provided</span> that
if the Closing shall not have occurred by the Outside Date but on that date any of the conditions set forth in <span style="text-decoration: underline">Section 8.1(b)</span> or
<span style="text-decoration: underline">Section 8.1(c)</span> shall not be satisfied or waived but all other conditions shall have been satisfied or waived (other than those
that by their terms are to be fulfilled at the Closing, <span style="text-decoration: underline">provided</span> that each such condition would be capable of being fulfilled if
the Closing were to occur on such date), then the Outside Date shall automatically, without any action on the part of the parties hereto,
be extended to December 31, 2025, and such date shall be the &#8220;Outside Date&#8221; for purposes of this Agreement; <span style="text-decoration: underline">provided</span>,
<span style="text-decoration: underline">further</span>, that the right to terminate this Agreement pursuant to this <span style="text-decoration: underline">Section 9.1(b)(i)</span> shall not be available to any party
if a material breach by such party of any of its obligations under this Agreement has been the principal cause of or principally resulted
in the failure of the Closing to have occurred on or before the Outside Date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>the Company Stockholder Approval shall not have been obtained upon a vote taken thereon at the Company Stockholders Meeting duly
convened therefor or at any adjournment or postponement thereof;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>prior to the Effective Time, any Governmental Entity of competent jurisdiction shall have issued or entered any Order that has
the effect of permanently restraining, enjoining or otherwise prohibiting the Merger, and such Order shall have become final and non-appealable;
<span style="text-decoration: underline">provided</span> that the right to terminate this Agreement under this <span style="text-decoration: underline">Section 9.1(b)(iii)</span> shall not be available to a party if
a material breach by such party of any of its obligations under <span style="text-decoration: underline">Section 7.3</span> has been the principal cause of or principally resulted
in the issuance of such Order or the denial of such expiration, termination, authorization or consent;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>by Parent (<span style="text-decoration: underline">provided</span> that Parent is not then in breach of any representation, warranty, covenant or other agreement contained
in this Agreement, which breach would give rise to the failure of a condition set forth in <span style="text-decoration: underline">Section 8.3(a)</span> or <span style="text-decoration: underline">Section 8.3(b)</span>),
if Company shall have breached or failed to perform any of its representations, warranties, covenants or other agreements contained in
this Agreement, which breach or failure to perform (i) would give rise to the failure of a condition set forth in <span style="text-decoration: underline">Section 8.2(a)</span>
or <span style="text-decoration: underline">Section 8.2(b)</span> and (ii) is incapable of being cured by Company or is not cured by the earlier of (x) the Outside Date and (y)
thirty (30) days of written notice thereof from Parent;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></p>

<!-- Field: Page; Sequence: 198 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>by Company (<span style="text-decoration: underline">provided</span> that Company is not then in breach of any representation, warranty, covenant or other agreement contained
in this Agreement, which breach would give rise to the failure of a condition set forth in <span style="text-decoration: underline">Section 8.2(a)</span> or <span style="text-decoration: underline">Section 8.2(b)</span>),
if Parent shall have breached or failed to perform any of its representations, warranties, covenants or other agreements contained in
this Agreement, which breach or failure to perform (i) would give rise to the failure of a condition set forth in <span style="text-decoration: underline">Section 8.3(a)</span>
or <span style="text-decoration: underline">Section 8.3(b)</span> and (ii) is incapable of being cured by Parent or is not cured by the earlier of (x) the Outside Date and (y)
thirty (30) days of written notice thereof from Company;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>by Company at any time prior to obtaining the Company Stockholder Approval, in order to accept a Superior Offer and enter into
the Specified Agreement relating to such Superior Offer, if (i) such Superior Offer shall not have resulted from any breach of <span style="text-decoration: underline">Section
6.2</span> with respect to such Superior Offer, (ii) the Company Board, after satisfying all of the requirements set forth in <span style="text-decoration: underline">Section
6.2(c)</span>, shall have authorized Company to enter into a binding written definitive acquisition agreement providing for the consummation
of a transaction constituting a Superior Offer (a &#8220;<span style="text-decoration: underline">Specified Agreement</span>&#8221;) and (iii) Company shall have paid the Company
Termination Fee, and have entered into the Specified Agreement, substantially concurrently with the termination of this Agreement pursuant
to this <span style="text-decoration: underline">Section 9.1(e)</span>; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>by Parent, at any time prior to the Company Stockholders Meeting, if the Company Board or any committee thereof shall have made
a Company Recommendation Change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 9.2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Effect of Termination</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>In the event of termination of this Agreement as provided in <span style="text-decoration: underline">Section 9.1</span>, this Agreement shall forthwith become void, and
there shall be no liability or obligation on the part of any of the parties, except (i) the provisions of this <span style="text-decoration: underline">Section 9.2</span>, the
last sentence of <span style="text-decoration: underline">Section 7.2</span>, <span style="text-decoration: underline">Section 7.5</span>, and <span style="text-decoration: underline">ARTICLE X</span> shall survive any such termination of this Agreement and
no such termination shall relieve any party from any liability or obligation under such provisions and (ii) nothing contained herein shall
relieve any party from any claim, liability, or damages for any fraud or Willful Breach of this Agreement prior to such termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>If this Agreement is terminated:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>by Parent pursuant to <span style="text-decoration: underline">Section 9.1(f)</span> (<i>Company Recommendation Change</i>), or by either Parent or Company pursuant to
<span style="text-decoration: underline">Section 9.1(b)(ii)</span> (<i>Company Stockholder No Vote</i>) and, immediately prior to the Company Stockholders Meeting, Parent would
have been entitled to terminate this Agreement pursuant to <span style="text-decoration: underline">Section 9.1(f)</span> (<i>Company Recommendation Change</i>);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>by Company pursuant to <span style="text-decoration: underline">Section 9.1(e)</span> (Specified Agreement)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>by Parent or Company pursuant to <span style="text-decoration: underline">Section 9.1(b)(i)</span> (<i>Outside Date</i>) or <span style="text-decoration: underline">Section 9.1(b)(ii)</span> (<i>Company Stockholder
No Vote</i>) and, in each case,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(A)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>at or prior to the Company Stockholders Meeting, in the case of a termination pursuant to <span style="text-decoration: underline">Section 9.1(b)(ii)</span> (<i>Company
Stockholder No Vote</i>) or at or prior to the time of such termination, in the case of a termination pursuant to <span style="text-decoration: underline">Section 9.1(b)(i)</span>
(<i>Outside Date</i>) there shall have been publicly made to the stockholders of Company generally or shall otherwise have become publicly
known, or any person shall have publicly announced an intention (whether or not conditional) to make, an offer or proposal for an Alternative
Transaction; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(B)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>within twelve (12) months of termination of this Agreement, Company or any of its Subsidiaries enters into a definitive agreement
with any Company Third Party with respect to any Alternative Transaction or any Alternative Transaction is consummated;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"></p>

<!-- Field: Page; Sequence: 199 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">then Company shall pay to Parent,
not later than, in the case of clause (i), two Business Days after the date of termination of this Agreement, in the case of clause (ii)
concurrently with the termination of this Agreement, and in the case of clause (iii), two Business Days after the earlier of the date
the agreement with respect to the Alternative Transaction is entered into and the date the Alternative Transaction is consummated, a termination
fee of (x) one million dollars ($1,000,000), plus (y) the amount of all documented fees and expenses of Parent and its Affiliates incurred
in connection with the negotiation and performance of this Agreement and the transactions contemplated hereby, up to an amount of two
million dollars ($2,000,000) (such aggregate dollar amount contemplated by the foregoing (x) and (y), the &#8220;<span style="text-decoration: underline">Company Termination
Fee</span>&#8221;); <span style="text-decoration: underline">provided</span> that, for purposes of this <span style="text-decoration: underline">Section 9.2(b)</span>, the term &#8220;Alternative Transaction&#8221; shall
have the meaning assigned to the term in <span style="text-decoration: underline">Section 6.2(a)</span>, except that all references to &#8220;20%&#8221; shall be deemed replaced
with &#8220;50%&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The Company Termination Fee payable under <span style="text-decoration: underline">Section 9.2(b)</span> shall be payable in immediately available funds no later than the
applicable date set forth therein. If Company fails to promptly pay to Parent any fee due under such <span style="text-decoration: underline">Section 9.2(b)</span>, Company shall
pay the costs and expenses (including legal fees and expenses) in connection with any action, including the filing of any lawsuit or other
legal action, taken to collect payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>In the event that Parent receives full payment of the Company Termination Fee pursuant to <span style="text-decoration: underline">Section 9.2(b)</span>, then, receipt
of the Company Termination Fee shall be deemed to be liquidated damages for any and all losses or damages suffered or incurred by Parent,
Merger Sub, any of their respective Affiliates or any other Person in connection with this Agreement (and the termination hereof), the
transactions contemplated hereby (and the abandonment thereof) or any matter forming the basis for such termination, and none of Parent,
Merger Sub, any of their respective Affiliates or any other Person shall be entitled to bring or maintain any claim, action or proceeding
against Company or any of its Affiliates for damages or any equitable relief arising out of or in connection with this Agreement, any
of the transactions contemplated by this Agreement or any matters forming the basis for such termination; <span style="text-decoration: underline">provided</span> that the Company
shall not be relieved or released from any liabilities or damages arising out of its Willful Breach prior to the termination of this Agreement.
For purposes of this Agreement, &#8220;<span style="text-decoration: underline">Willful Breach</span>&#8221; means any breach of any of the covenants or agreements set forth in
this Agreement that is the consequence of an action or omission by any party if such party knew that the taking of such action or the
failure to take such action would reasonably be expected to result in a material breach of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE X<br/>
GENERAL PROVISIONS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 10.1</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Amendment</span>. Subject to compliance with Applicable Law, this Agreement may be amended by the parties hereto at any time before
or after the Company Stockholder Approval; <span style="text-decoration: underline">provided</span> that any amendment of this Agreement that requires approval by the stockholders
of Company or approval by the stockholders of Parent under Applicable Law shall be subject to such approval. This Agreement may not be
amended except by an instrument in writing signed on behalf of each of the parties hereto and duly approved by the Parent Board and the
Company Board or a duly authorized committee thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 10.2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Extension; Waiver</span>. At any time prior to the Effective Time, a party may, subject to the first proviso of <span style="text-decoration: underline">Section 10.1</span>
(and for this purpose treating any waiver referred to below as an amendment), (a) extend the time for the performance of any of the obligations
or other acts of the other parties, (b) waive any inaccuracies in the representations and warranties of the other parties contained in
this Agreement or in any document delivered pursuant to this Agreement, (c) waive compliance by the other party with any of the agreements
or conditions for the benefit of such party contained in this Agreement or (d) waive the satisfaction of any of the conditions contained
in this Agreement. No extension or waiver by Company or Parent shall require the approval of the stockholders of Company or Parent, respectively,
unless such approval is required by Applicable Law. Any agreement on the part of a party hereto to any such extension or waiver shall
be valid only if set forth in an instrument in writing signed on behalf of such party. Any extension or waiver given in compliance with
this <span style="text-decoration: underline">Section 10.2</span> or failure to insist on strict compliance with an obligation, covenant, agreement or condition shall not operate
as a waiver of, or estoppel with respect to, any subsequent or other failure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 10.3</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Non-Survival of Representations and Warranties</span>. None of the representations and warranties in this Agreement or in any instrument
delivered pursuant to this Agreement shall survive the Effective Time. This <span style="text-decoration: underline">Section 10.3</span> shall not limit any covenant or agreement
of the parties that, by its terms, contemplates performance after the Effective Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 200 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 10.4</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Notices</span>. All notices, requests, claims, demands and other communications under this Agreement shall be in writing and shall
be deemed given if delivered personally or delivered by electronic mail (which is confirmed) or sent by overnight courier (providing proof
of delivery) to the parties at the following addresses (or at such other address for a party as shall be specified by like notice):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 100%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.05pt">if to Parent or Merger Sub to:</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.05pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt"><br/>
    RadNet, Inc.<br/>
    1510 Cotner Avenue</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">Los Angeles, CA 90025<br/>
    Attention: David J. Katz, EVP and Chief Legal Officer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt"></p></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.05pt">with a copy (which shall not constitute notice) to:</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.05pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">Perkins Coie LLP<br/>
1201 Third Ave<br/>
Seattle, WA 98034<br/>
Attention:&#160;&#160;&#160;Andrew Moore</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;David Martinez</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 125.25pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">Email: AMoore@perkinscoie.com</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;DMartinez@perkinscoie.com</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 107.25pt"></p></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.05pt">if to Company, to:</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.05pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.25pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.25pt">iCAD, Inc.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.25pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.25pt">98 Spit Brook Road, Suite 100</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.25pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.25pt">Nashua, NH 03062</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.25pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.25pt">Attention: Dana Brown, President, Chief Executive Officer
    and Chairman of the Board</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.25pt"></p></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.05pt">with a copy (which shall not constitute notice) to:</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.05pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">Dentons US LLP</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">1221 Avenue of the Americas</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">New York, NY 10020</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">Attention: Jeffrey A. Baumel</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ilan Katz</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 125.3pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">Email: jeffrey.baumel@dentons.com</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ilan.katz@dentons.com</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 125.3pt"></p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 35.05pt; font-size: 10pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 10.5</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Counterparts</span>. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same
agreement and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other
party, it being understood that all parties need not sign the same counterpart. The exchange of a fully executed Agreement (in counterparts
or otherwise) by electronic transmission in .PDF or other electronic format shall be sufficient to bind the parties to the terms and conditions
of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 201 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 10.6</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Entire Agreement; No Third-Party Beneficiaries</span>. This Agreement (including the documents, exhibits, schedules, disclosure
letters and instruments referred to herein), taken together with the Confidentiality Agreement, (a) constitutes the entire agreement,
and supersedes all prior agreements and understandings, both written and oral, among Parent, Merger Sub and Company with respect to the
Merger and the other transactions contemplated by this Agreement, and (b) is not intended to, and does not, confer upon any person other
than the parties hereto any rights or remedies hereunder, other than (i) as provided in <span style="text-decoration: underline">Section 7.4</span>, and (ii) from and after the
Effective Time, the right of the holders of Company Common Stock or Company Options to receive such consideration as provided for in <span style="text-decoration: underline">ARTICLE
III</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 10.7</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Assignment</span>. Neither this Agreement nor any of the rights, interests or obligations under this Agreement shall be assigned,
in whole or in part, by operation of law or otherwise by any of the parties without the prior written consent of the other parties. Any
purported assignment in violation of the preceding sentence shall be void. Subject to the preceding two sentences, this Agreement will
be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 10.8</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">GOVERNING LAW</span>. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE, REGARDLESS
OF THE LAWS THAT MIGHT OTHERWISE GOVERN UNDER ANY APPLICABLE PRINCIPLES OF CONFLICTS OF LAWS THEREOF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 1in; float: left; white-space: nowrap">Section 10.9</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">WAIVER OF JURY TRIAL</span>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY
TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED
BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING
TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH
PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) IT UNDERSTANDS AND HAS CONSIDERED
THE IMPLICATIONS OF SUCH WAIVER, (C) IT MAKES SUCH WAIVER VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG
OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS <span style="text-decoration: underline">SECTION 10.9</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 10.10<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;
</span><span style="text-decoration: underline">Specific Enforcement</span>. The parties acknowledge and agree that irreparable damage would occur in the event that any of the
provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached, and that monetary
damages, even if available, would not be an adequate remedy therefor. It is accordingly agreed that the parties shall be entitled to an
injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the performance of terms and provisions of
this Agreement in any court referred to in <span style="text-decoration: underline">Section 10.11</span>, without proof of actual damages (and each party hereby waives any requirement
for the securing or posting of any bond in connection with such remedy), this being in addition to any other remedy to which they are
entitled at law or in equity. The parties further agree not to assert that a remedy of specific enforcement is unenforceable, invalid,
contrary to law or inequitable for any reason, nor to assert that a remedy of monetary damages would provide an adequate remedy for any
such breach.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 10.11<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;
</span><span style="text-decoration: underline">Jurisdiction</span>. In any action between the parties arising out of or relating to this Agreement or any of the transactions
contemplated hereby, each of the parties (a) irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue
of the Court of Chancery of the State of Delaware in and for New Castle County, Delaware, (b) agrees that it will not attempt to deny
or defeat such jurisdiction by motion or other request for leave from such court and (c) agrees that it will not bring any such action
in any court other than the Court of Chancery for the State of Delaware in and for New Castle County, Delaware, or, if (and only if) such
court finds it lacks subject matter jurisdiction, the federal court of the United States of America sitting in Delaware, and appellate
courts thereof, or, if (and only if) each of such Court of Chancery for the State of Delaware and such federal court finds it lacks subject
matter jurisdiction, any state court within the State of Delaware. Service of process, summons, notice or document to any party&#8217;s
address and in the manner set forth in <span style="text-decoration: underline">Section 10.4</span> shall be effective service of process for any such action.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 10.12<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;
</span><span style="text-decoration: underline">Headings, etc.</span>. The headings, table of contents and index of defined terms contained in this Agreement are for reference
purposes only and shall not affect in any way the meaning or interpretation of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 202 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 10.13<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;
</span><span style="text-decoration: underline">Severability</span>. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any
rule of law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect
so long as either the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse
to any party or such party waives its rights under this <span style="text-decoration: underline">Section 10.13</span> with respect thereto. Upon a determination that any term
or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this
Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by Applicable Law
in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the extent possible.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<i>Remainder of page intentionally left blank.</i>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 203 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Agreement to be executed by their duly authorized representatives as of the date first above written.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RADNET, INC.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%">&#160;</td>
    <td style="width: 2%; font-size: 10pt">By:</td>
    <td style="border-bottom: black 1pt solid; width: 48%; font-size: 10pt">/s/ Howard G. Berger, M.D.</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt">Name:&#160;&#160;Howard G. Berger, M.D.</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt">Title:&#160;&#160;President and Chief Executive Officer</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TRIO MERGER SUB, INC.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%">&#160;</td>
    <td style="width: 2%; font-size: 10pt">By:</td>
    <td style="border-bottom: black 1pt solid; width: 48%; font-size: 10pt">/s/ Howard G. Berger, M.D.</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt">Name:&#160;&#160;Howard G. Berger, M.D.</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt">Title:&#160;&#160;President and Chief Executive Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">iCAD, INC.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%">&#160;</td>
    <td style="width: 3%; font-size: 10pt">By:</td>
    <td style="border-bottom: black 1pt solid; width: 47%; font-size: 10pt">/s/ Dana Brown</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt">Name:&#160;&#160;Dana Brown</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt">Title:&#160;&#160;President and Chief Executive Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 204 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><b><span id="annexb"></span>Annex B<br/>
<br/>
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; padding-left: 8px; width: 58%"><img src="image_003.jpg" alt="" style="height: 33px; width: 218px"/></td>
    <td style="border-right: #3F97B5 1pt solid; text-align: right; width: 42%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #4A4F55">800 NICOLLET MALL, SUITE 900<br/> MINNEAPOLIS, MN 55402<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #4A4F55"></span></span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #4A4F55"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #4A4F55">612 303-6843</span></span></p></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="border-right: #3F97B5 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #4A4F55">Piper Sandler &amp; Co. <br/>
Since 1895. Member SIPC and NYSE.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55"><span style="color: Black">April 15, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">Board
of Directors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">iCAD,
Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">2
Townsend West, Suite 6</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">Nashua,
NH 03062</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">Members
of the Board:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55; text-align: justify; text-indent: 0.75in"><span style="color: Black">You
have requested our opinion as to the fairness, from a financial point of view, to the holders of common stock, par value $0.01 per share
(&#8220;<b>Company Common Stock</b>&#8221;), of iCAD, Inc. (the &#8220;<b>Company</b>&#8221;), of the Exchange Ratio (as defined below)
pursuant to the Agreement and Plan of Merger (the &#8220;<b>Agreement</b>&#8221;) to be entered into among RadNet, Inc. (&#8220;<b>Parent</b>&#8221;),
Trio Merger Sub, Inc. (&#8220;<b>Merger Sub</b>&#8221;), a wholly-owned subsidiary of the Parent, and the Company. The Agreement provides
for, among other things, the merger (the &#8220;<b>Merger</b>&#8221;) of the Merger Sub with and into the Company, pursuant to which
each outstanding share of Company Common Stock, other than shares of Company Common Stock held in treasury or owned by the Parent or
Merger Sub or any of their respective subsidiaries will be converted into the right to receive 0.0677 shares of common stock, par value
$0.0001 per share (&#8220;<b>Parent Common Stock</b>&#8221;), of the Parent (the &#8220;<b>Exchange Ratio</b>&#8221;). The terms and
conditions of the Merger are more fully set forth in the Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55; text-align: justify; text-indent: 0.75in"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55; text-align: justify"><span style="color: Black">In
arriving at our opinion, we have: (i)&#160;reviewed and analyzed the financial terms of a draft labeled &#8220;Execution Copy&#8221;
of the Agreement; (ii)&#160;reviewed and analyzed certain financial and other data with respect to the Company and the Parent which was
publicly available, (iii)&#160;reviewed and analyzed certain information, including financial forecasts, relating to the business, earnings,
cash flow, assets, liabilities and prospects of the Company that were furnished to us by the Company; (iv)&#160;conducted discussions
with members of senior management and representatives of the Company and the Parent concerning the matters described in clauses (ii)
and (iii) above, as well as their respective businesses and prospects of the Company and the Parent before and after giving effect to
the Merger; (v)&#160;reviewed the current and historical reported prices and trading activity of Company Common Stock and Parent Common
Stock; (vi)&#160;compared the financial performance of the Company with that of certain other publicly-traded companies that we deemed
relevant; and (vii)&#160;reviewed the financial terms, to the extent available to Piper Sandler, of certain business combination transactions
that we deemed relevant. In addition, we have conducted such other analyses, examinations and inquiries and considered such other financial,
economic and market criteria as we have deemed necessary in arriving at our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55; text-align: justify"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55; text-align: justify"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">We
have relied upon and assumed, without assuming liability or responsibility for independent verification, the accuracy and completeness
of all information that was publicly available or was furnished, or otherwise made available, to us or discussed with or reviewed by
us. We have further relied upon the assurances of the management of the Company that the financial information provided has been prepared
on a reasonable basis in accordance with industry practice, and that they are not aware of any information or facts that would make any
information provided to us incomplete or misleading. Without limiting the generality of the foregoing, for the purpose of this opinion,
we have assumed that with respect to financial forecasts, estimates and other forward-looking information reviewed by us, that such information
has been reasonably prepared based on assumptions reflecting the best currently available estimates and judgments of the management of
the Company as to the expected future results of operations and financial condition of the Company to which such financial forecasts,
estimates and other forward-looking information relate. We express no opinion as to any such financial forecasts, estimates or forward-looking
information or the assumptions on which they were based. We have relied, with your consent, on advice of the outside counsel and the
independent accountants to the Company, and on the assumptions of the management of the Company, as to all accounting, legal, tax and
financial reporting matters with respect to the Company, the Parent and the Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<!-- Field: Page; Sequence: 205 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;<img src="image_003.jpg" alt="" style="height: 38px; width: 250px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">In
arriving at our opinion, we have assumed that the executed Agreement will be in all material respects identical to the last draft reviewed
by us. We have relied upon and assumed, without independent verification, that (i)&#160;the representations and warranties of all parties
to the Agreement and all other related documents and instruments that are referred to therein are true and correct, (ii)&#160;each party
to such agreements will fully and timely perform all of the covenants and agreements required to be performed by such party, (iii)&#160;the
Merger will be consummated pursuant to the terms of the Agreement without amendments thereto and (iv)&#160;all conditions to the consummation
of the Merger will be satisfied without waiver by any party of any conditions or obligations thereunder. Additionally, we have assumed
that all the necessary regulatory approvals and consents required for the Merger will be obtained in a manner that will not adversely
affect the Company, the Parent or the contemplated benefits of the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">In
arriving at our opinion, we have not performed any appraisals or valuations of any specific assets or liabilities (fixed, contingent
or other) of the Company or the Parent, and have not been furnished or provided with any such appraisals or valuations, nor have we evaluated
the solvency of the Company or the Parent under any state or federal law relating to bankruptcy, insolvency or similar matters. The analyses
performed by us in connection with this opinion were going concern analyses. We express no opinion regarding the liquidation value of
the Company, the Parent or any other entity. Without limiting the generality of the foregoing, we have undertaken no independent analysis
of any pending or threatened litigation, regulatory action, possible unasserted claims or other contingent liabilities, to which the
Company, the Parent or any of their affiliates is a party or may be subject, and at the direction of the Company and with its consent,
our opinion makes no assumption concerning, and therefore does not consider, the possible assertion of claims, outcomes or damages arising
out of any such matters. We have also assumed that neither the Company nor the Parent is party to any material pending transaction, including
without limitation any financing, recapitalization, acquisition or merger, divestiture or spin-off, other than the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">This
opinion is necessarily based upon the information available to us and facts and circumstances as they exist and are subject to evaluation
on the date hereof; events occurring after the date hereof could materially affect the assumptions used in preparing this opinion. We
are not expressing any opinion herein as to the price at which shares of Company Common Stock or Parent Common Stock may trade following
announcement of the Merger or at any future time. We have not undertaken to reaffirm or revise this opinion or otherwise comment upon
any events occurring after the date hereof and do not have any obligation to update, revise or reaffirm this opinion. As you are aware,
the credit, financial and stock markets have been experiencing unusual volatility and we express no opinion or view as to any potential
effects of such volatility on the Company, the Parent or the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">We
have been engaged by the Company to act as its financial advisor and we will receive a fee from the Company for providing our services,
a significant portion of which is contingent upon the consummation of the Merger. We will also receive a fee for rendering this opinion.
Our opinion fee is not contingent upon the consummation of the Merger or the conclusions reached in our opinion. The Company has also
agreed to indemnify us against certain liabilities and reimburse us for certain expenses in connection with our services. In the ordinary
course of our business, we and our affiliates may actively trade securities of the Company and the Parent for our own account or the
account of our customers and, accordingly, may at any time hold a long or short position in such securities. We may also, in the future,
provide investment banking and financial advisory services to the Company, the Parent or entities that are affiliated with the Company
or the Parent, for which we would expect to receive compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">This
opinion is provided to the Board of Directors of the Company in connection with its consideration of the Merger and is not intended to
be and does not constitute a recommendation to any stockholder of the Company as to how such stockholder should act or vote with respect
to the Merger or any other matter. Except with respect to the use of this opinion in connection with the proxy statement relating to
the Merger in accordance with our engagement letter with the Company, this opinion shall not be disclosed, referred to, published or
otherwise used (in whole or in part), nor shall any public references to us be made, without our prior written approval. This opinion
has been approved for issuance by the Piper Sandler Opinion Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<!-- Field: Page; Sequence: 206 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;<img src="image_003.jpg" alt="" style="height: 38px; width: 250px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">This
opinion addresses solely the fairness, from a financial point of view, to holders of Company Common Stock of the proposed Exchange Ratio
set forth in the Agreement and does not address any other terms or agreement relating to the Merger or any other terms of the Agreement.
We were not requested to opine as to, and this opinion does not address, the basic business decision to proceed with or effect the Merger,
the merits of the Merger relative to any alternative transaction or business strategy that may be available to the Company or any other
terms contemplated by the Agreement or the fairness of the Merger to any other class of securities, creditors or other constituency of
the Company. Furthermore, we express no opinion with respect to the amount or nature of compensation to any officer, director or employee
of any party to the Merger, or any class of such persons, relative to the Parent Common Stock to be received by holders of Company Common
Stock in the Merger or with respect to the fairness of any such compensation, including whether such payments are reasonable in the context
of the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">Based
upon and subject to the foregoing and based upon such other factors as we consider relevant, it is our opinion that the Exchange Ratio
is fair, from a financial point of view, to the holders of Company Common Stock who will receive Parent Common Stock in the Merger as
of the date hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">Sincerely,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55"><span style="color: Black">/s/ PIPER SANDLER &amp;
CO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55"><span style="color: Black">PIPER SANDLER &amp; CO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #4A4F55">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<!-- Field: Page; Sequence: 207 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><b><span id="annexc"></span>Annex C<br/>
<br/>
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM OF VOTING AND SUPPORT AGREEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-variant: small-caps">This
Voting and Support Agreement</span> (this &#8220;<span style="text-decoration: underline">Agreement</span>&#8221;) is entered into
as of April 15, 2025, by and among RadNet, Inc., a Delaware corporation (&#8220;<span style="text-decoration: underline">Parent</span>&#8221;),
Trio Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (&#8220;<span style="text-decoration: underline">Merger
Sub</span>&#8221;), and [&#9679;] (&#8220;<span style="text-decoration: underline">Stockholder</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-variant: small-caps"><b>Recitals</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">A.</span></b>Stockholder
is a holder of record and the &#8220;beneficial owner&#8221; (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934,
as amended (the &#8220;<span style="text-decoration: underline">Exchange Act</span>&#8221;)) of certain shares of common stock, par value of $0.01 per share, of iCAD, Inc., a
Delaware corporation (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;) (the &#8220;<span style="text-decoration: underline">Company Common Stock</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">B.</span></b>Parent,
Merger Sub and the Company are entering into an Agreement and Plan of Merger, dated on or about the date hereof (the &#8220;<span style="text-decoration: underline">Merger
Agreement</span>&#8221;), which provides for, among other things, the merger of Merger Sub with and into the Company, with the Company continuing
as the Surviving Corporation and as a wholly owned subsidiary of Parent (the &#8220;<span style="text-decoration: underline">Merger</span>&#8221;) upon the terms and subject to
the conditions set forth in the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">C.</span></b>The
Company Board has unanimously (i) determined that it is in the best interests of the Company and its stockholders, and declared it advisable,
to enter into the Merger Agreement and consummate the Merger upon the terms and subject to the conditions set forth therein; (ii) approved
the execution and delivery of the Merger Agreement by the Company, the performance by the Company of its covenants and other obligations
thereunder, and the consummation of the Merger upon the terms and subject to the conditions set forth therein; (iii) determined that this
Agreement is advisable to, and in the best interests of, the Company and its stockholders and approved this Agreement; and (iv) resolved
to recommend that the Company&#8217;s stockholders adopt the Merger Agreement and approve the Merger in accordance with the DGCL.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">D.</span></b>As
a condition to the willingness of Parent and Merger Sub to enter into the Merger Agreement and as an inducement in consideration therefor,
Stockholder has agreed to enter into this Agreement and vote Stockholder&#8217;s Subject Securities (as defined below) as described herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">AGREEMENT</p>

<p style="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The parties to this Agreement,
intending to be legally bound, hereby agree as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: small-caps bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in">SECTION 1.</td><td>CERTAIN DEFINITIONS</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this Agreement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Capitalized terms used but not defined herein shall have the respective meanings assigned to those terms in the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Contract</span>&#8221; means any note, bond, mortgage, indenture, lease, license, permit, contract, commitment, arrangement,
understanding, agreement or other instrument or obligation of any kind, including any voting agreement, proxy arrangement, pledge agreement,
stockholder agreement or voting trust, to which Stockholder is a party or by which the Subject Securities are bound.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Expiration Date</span>&#8221; means the earliest to occur, without any notice or other action by any Person, of (i) the
valid termination of the Merger Agreement in accordance with its terms or (ii) the Effective Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 208 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Stockholder is deemed to &#8220;<span style="text-decoration: underline">Own</span>&#8221; (or to &#8220;<span style="text-decoration: underline">Beneficially Own</span>&#8221;) or to have acquired &#8220;<span style="text-decoration: underline">Ownership</span>&#8221;
(or &#8220;<span style="text-decoration: underline">Beneficial Ownership</span>&#8221; of a security if Stockholder (i) is the record owner of such security; or (ii) is the &#8220;beneficial
owner&#8221; (within the meaning of Rule 13d-3 under the Exchange Act) of such security.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Subject Securities</span>&#8221; means (i) all Company Common Stock Owned by Stockholder as of the date hereof and (ii)
all additional Company Common Stock of which Stockholder acquires Ownership during the Support Period. For the avoidance of doubt, Company
Options Beneficially Owned by Stockholder shall not be considered Subject Securities, and Company Common Stock issued upon the exercise
of a Company Option during the Support Period shall be Subject Securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Support Period</span>&#8221; means the period commencing on (and including) the date of this Agreement and ending on (and
including) the Expiration Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>A Person is deemed to have effected a &#8220;<span style="text-decoration: underline">Transfer</span>&#8221; of a security if such Person directly or indirectly: (i) sells,
pledges, gifts, hedges, encumbers, grants a Lien (other than any such Lien arising hereunder and any applicable restrictions on transfer
under the Securities Act, collectively, &#8220;<span style="text-decoration: underline">Permitted Liens</span>&#8221;) on or an option with respect to, enters into any derivative
arrangement with respect thereto, transfers or disposes of such security or any interest in such security or right therein to any Person
other than Parent or Merger Sub; (ii) enters into an agreement or commitment contemplating the possible sale of, pledge of, gift, hedge,
encumbrance or Lien of, grant of an option with respect to, a derivative arrangement, transfer of or disposition of such security or any
interest or right therein to any Person other than Parent or Merger Sub; or (iii) reduces such Person&#8217;s Beneficial Ownership of
or interest in or risk relating to such security or enters into a derivative arrangement with respect to such security.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: small-caps bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in">SECTION 2.</td><td>TRANSFER OF SUBJECT SECURITIES AND VOTING RIGHTS</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">2.1</span><span style="font-family: Times New Roman, Times, Serif">
</span>Restriction on Transfer of Subject Securities.</b> Subject to <span style="text-decoration: underline">Section 2.3</span> below, during the Support Period, Stockholder
shall not cause or permit any Transfer of any of the Subject Securities to be effected. Without limiting the generality of the foregoing,
during the Support Period, Stockholder shall not tender, agree to tender or permit to be tendered any of the Subject Securities in response
to or otherwise in connection with any tender or exchange offer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">2.2</span><span style="font-family: Times New Roman, Times, Serif">
</span>Restriction on Transfer of Voting Rights.</b> During the Support Period, Stockholder shall ensure that: (a) none of the Subject
Securities is deposited or otherwise transferred into a voting trust or any voting agreement or arrangement is entered into with respect
to the Subject Securities (other than this Agreement); (b) no proxy, power-of-attorney, consent right or other authorization is granted,
and no voting agreement or similar agreement is entered into, with respect to any of the Subject Securities (other than this Agreement);
and (c) no action is taken or permitted that would in any way restrict, limit or interfere with the performance of Stockholder&#8217;s
obligations hereunder or otherwise make any representation or warranty of Stockholder herein untrue or incorrect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">2.3</span><span style="font-family: Times New Roman, Times, Serif">
</span>Permitted Transfers.</b> <span style="text-decoration: underline">Section 2.1</span> above shall not prohibit a Transfer of Subject Securities by Stockholder: (a) if Stockholder
is an individual (i) to any member of Stockholder&#8217;s immediate family, or to a trust for the benefit of Stockholder or any member
of Stockholder&#8217;s immediate family, <span style="background-color: white">or otherwise for estate planning purposes,</span> or (ii)
by will or under the Applicable Laws of intestacy upon the death of Stockholder; (b) make Transfers or dispositions not involving a change
in Beneficial Ownership; (c) if Stockholder is a trust, to any beneficiary of Stockholder or the estate of any such beneficiary; (d) by
operation of law or to a charitable organization qualified under Section 501(c)(3) of the Code; (e) by exercise of a Company Option (including
a net or cashless exercise of such Company Option to purchase Company Common Stock); (f) to the Company to cover Tax withholding obligations
of Stockholder in connection with any exercise of Company Options, <i>provided</i> that the underlying Subject Securities shall continue
to be subject to the restrictions on Transfer set forth in this Agreement; or (g) pursuant to the Company&#8217;s 10b5-1 Plan up to that
number of Subject Securities as permitted to be sold under such 10b5-1 Plan; <i>provided</i>, <i>however</i>, that a Transfer referred
to in clauses &#8220;(a)&#8221; through &#8220;(d)&#8221; of this sentence shall be permitted only if <span style="background-color: white">(A)
all of the representations and warranties in this Agreement with respect to Stockholder would be true and correct upon such Transfer,
(B) </span>as a precondition to such Transfer, the transferee agrees in a written document, reasonably satisfactory in form and substance
to Parent, to be bound by all of the terms of this Agreement, and (C) such Transfer occurs no later than three (3) Business Days prior
to the Expiration Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 209 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: small-caps bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in">SECTION 3.</td><td>VOTING OF COMPANY <span style="font-family: Times New Roman, Times, Serif; font-variant: normal; text-transform: uppercase">Common
Stock</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">3.1</span><span style="font-family: Times New Roman, Times, Serif">
</span>Voting Covenant.</b> Without in any way limiting Stockholder&#8217;s right to (a) vote in his or her capacity as a director of
the Company or (b) vote his or her Subject Securities in his or her sole discretion on any other matters not set forth in this Section
3 that may be submitted to a stockholder vote, consent or other approval, at any annual, special meeting of stockholders of the Company
<span style="background-color: white">including the Company Stockholder Meeting, however called, including any adjournment or postponement
thereof</span>, during the Support Period, Stockholder hereby irrevocably and unconditionally agrees that, <span style="background-color: white">at
any annual or special meeting of the stockholders of the Company, including the Company Stockholder Meeting, however called, including
any adjournment or postponement thereof, and in connection with any action proposed to be taken by written consent of the stockholders
of the Company, Stockholder shall, in each case to the fullest extent that such Subject Securities are entitled to be voted therein: (1)&#160;appear
at each such meeting or otherwise cause all such Subject Securities to be counted as present thereat for purposes of determining a quorum;
and (2)&#160;be present (in person or by proxy) and vote (or cause to be voted) or deliver (or cause to be delivered) a written consent
with respect to all of the Subject Securities</span>, and unless otherwise directed in writing by Parent:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>in favor of: (i) the Merger, the execution and delivery by the Company of the Merger Agreement and the adoption and approval of
the Merger Agreement and the terms thereof; (ii) any proposal to adjourn or postpone such meeting of stockholders of the Company to a
later date if there are not sufficient votes to approve the Merger Agreement, the Merger and any other matters necessary to effect the
Merger; (iii) each of the other transactions contemplated by the Merger Agreement; and (iv) any other transaction pursuant to which Parent
or any Subsidiary thereof proposes to acquire the Company in which the stockholders of the Company would receive aggregate consideration
per share equal to or greater than the consideration to be received by stockholders of the Company in the Merger;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>against any action or agreement which is intended or would reasonably be expected to impede, delay, postpone, interfere with, nullify,
prevent or adversely affect in any material respect the Merger or this Agreement, including (i) any other extraordinary corporate transaction,
including any proposal of any Person (other than Parent and Merger Sub) to acquire the Company or all or substantially all of the assets
thereof, (ii) any amendment to the certificate of incorporation or bylaws of the Company, (iii) any material change to the capitalization
of the Company, (iv) any change in a majority of the directors of the Company Board and (v) any action, proposal, or agreement that would
reasonably be expected to result in the any breach of any covenant, representation or warranty or any other obligation or agreement under
the Merger Agreement or this Agreement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>against any Alternative Transaction and any action in furtherance of any Alternative Transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">During the Support Period, Stockholder shall not
enter into any agreement or understanding with any Person to vote or give instructions in a manner inconsistent with clauses &#8220;(a)&#8221;,
&#8220;(b)&#8221; or &#8220;(c)&#8221; of this <span style="text-decoration: underline">Section 3.1</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">3.2</span><span style="font-family: Times New Roman, Times, Serif">
</span>Further Assurances. </b>Stockholder shall not, and shall not permit any of its Affiliates to, enter into any tender, voting or
other such agreement, or grant a proxy or power of attorney, with respect to any of the Subject Securities that is inconsistent with this
Agreement or otherwise take any other action with respect to any of the Subject Securities that would restrict, limit or interfere with
the performance of any of Stockholder&#8217;s obligations hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: small-caps bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in">SECTION 4.</td><td>WAIVER OF APPRAISAL RIGHTS</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">4.1</span><span style="font-family: Times New Roman, Times, Serif">
</span></b>During the term of this Agreement, Stockholder hereby (a) irrevocably and unconditionally waives, and agrees not to exercise
or assert, on its own behalf or on behalf of any other holder of Company Common Stock, any rights of appraisal, any dissenters&#8217;
rights or any similar rights relating to the Merger that Stockholder may have by virtue of, or with respect to, any Subject Securities
and (b) agrees not to commence or join in, and agrees to take all actions necessary to opt out of, any class in any class action with
respect to, any claim, derivative or otherwise, against Parent, Merger Sub or the Company or any of their respective successors that challenges
the validity of or seeks to enjoin, any provision of this Agreement or alleges breach of any fiduciary duty of any Person in connection
with the negotiation of and entry into the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 210 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: small-caps bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in">SECTION 5.</td><td>REPRESENTATIONS AND WARRANTIES OF STOCKHOLDER</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholder hereby represents
and warrants to each of Parent and Merger Sub as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">5.1</span><span style="font-family: Times New Roman, Times, Serif">
</span>Authorization, etc.</b> Stockholder has the authority and legal capacity to execute and deliver this Agreement and to perform Stockholder&#8217;s
obligations hereunder. This Agreement has been duly authorized, executed and delivered by Stockholder and, assuming due authorization,
execution and delivery by Parent and Merger Sub, constitutes a legal, valid and binding obligation of Stockholder, enforceable against
Stockholder in accordance with its terms, except as enforcement thereof may be limited by (i) laws of general application relating to
bankruptcy, insolvency and the relief of debtors and (ii)&#160;rules of law governing specific performance, injunctive relief and other
equitable remedies. If Stockholder is a corporation, then Stockholder is a corporation duly organized, validly existing and in good standing
under the Applicable Laws of the jurisdiction in which it was organized. If Stockholder is a general or limited partnership, then Stockholder
is a partnership duly organized, validly existing and in good standing under the Applicable Laws of the jurisdiction in which it was organized.
If Stockholder is married, and any of the Subject Securities constitute community property or otherwise need spousal or other approval
for this Agreement to be legal, valid and binding, this Agreement has been duly executed and delivered by Stockholder&#8217;s spouse and,
assuming due authorization, execution and delivery by Parent and Merger Sub, is enforceable against Stockholder&#8217;s spouse in accordance
with its terms, except as enforcement thereof may be limited by (x) laws of general application relating to bankruptcy, insolvency and
the relief of debtors and (y)&#160;rules of law governing specific performance, injunctive relief and other equitable remedies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">5.2</span><span style="font-family: Times New Roman, Times, Serif">
</span>No Conflicts or Consents.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The execution and delivery of this Agreement by Stockholder does not, and the performance of this Agreement by Stockholder will
not: (a) assuming the compliance of each of the Company, Parent and Merger Sub, with all applicable Antitrust Laws, conflict with or violate
any Applicable Law applicable to Stockholder or by which Stockholder or any of Stockholder&#8217;s properties is or may be bound; (b)
if Stockholder is not an individual, violate, contravene or conflict with or result in any breach of any provision of the certificate
of incorporation or bylaws (or other similar governing documents) of Stockholder; or (c) result in or constitute (with or without notice
or lapse of time) any material breach of or material default under, or give to any other Person (with or without notice or lapse of time)
any right of termination, amendment, acceleration or cancellation of, or result (with or without notice or lapse of time) in the creation
of any Lien on any of the Subject Securities pursuant to, any Contract to which Stockholder is a party or by which Stockholder or any
of Stockholder&#8217;s Affiliates or properties is or may be bound or affected, except, in each case, for any conflict, violation, breach,
default or right which would not adversely affect in any material respect the ability of Stockholder to perform its obligations hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The execution and delivery of this Agreement by Stockholder does not, and the performance of this Agreement by Stockholder will
not, require any filing with or notification of, nor any permit, authorization, consent or approval of, any Person, other than under any
applicable Antitrust Laws or where the failure to make such filings or obtain such permits, authorizations, consents or approvals would
not, individually or in the aggregate, prevent or materially delay the performance by Stockholder of any of its obligations under this
Agreement. Assuming the compliance of each of the Company, Parent and Merger Sub with all applicable Antitrust Laws, no consent or notification
of, or registration, declaration or filing with, any Governmental Entity is required to be obtained or made by or with respect to Stockholder
in connection with the execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby,
other than such reports under Sections 13(d) and 16 of the Exchange Act as may be required in connection with this Agreement, or where
the failure to obtain such consents or make such registrations, declarations or filings would not adversely affect in any material respect
the ability of Stockholder to perform its obligations hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">5.3</span><span style="font-family: Times New Roman, Times, Serif">
</span>Title to Company Common Stock; Full Disclosure.</b> Stockholder Owns, free and clear of any Lien (other than Permitted Liens or
Liens that would not adversely affect in any material respect the ability of Stockholder to perform Stockholder&#8217;s obligations hereunder),
the Subject Securities set forth opposite Stockholder&#8217;s name on <span style="text-decoration: underline">Exhibit A</span> to this Agreement. Except as set forth in <span style="text-decoration: underline">Exhibit
A</span> hereto, neither Stockholder nor any of its Affiliates hold or have any Ownership interest in any other Company Common Stock or any
performance-based stock awards, restricted stock, restricted stock units, options (including any granted pursuant to the Company Stock
Incentive Plans) or warrants to acquire Company Common Stock, or other rights or securities convertible into or exercisable or exchangeable
for Common Stock, Preferred Stock or other Equity Securities of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 211 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">5.4</span><span style="font-family: Times New Roman, Times, Serif">
</span>No Litigation.</b> As of the date of this Agreement, there is no Action pending or, to the knowledge of Stockholder, threatened
against Stockholder or any of Stockholder's properties or assets that would reasonably be expected to impair the ability of Stockholder
to perform Stockholder&#8217;s obligations hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">5.5</span><span style="font-family: Times New Roman, Times, Serif">
</span>Merger Agreement.</b> Stockholder and its Representatives have reviewed and understand the terms of this Agreement and the Merger
Agreement, and Stockholder has had the opportunity to consult with Stockholder&#8217;s counsel in connection with this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">5.6</span><span style="font-family: Times New Roman, Times, Serif">
</span><span style="background-color: white">Voting Power.</span></b><span style="background-color: white"> Stockholder has full voting
power with respect to all the Subject Securities, and full power of disposition, full power to issue instructions with respect to the
matters set forth herein and full power to agree to all of the matters set forth in this Agreement, in each case, with respect to all
the Subject Securities. None of the Subject Securities are subject to any stockholders&#8217; agreement, proxy, voting trust or other
agreement or arrangement with respect to the voting of such Subject Securities, except as provided hereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">5.7</span><span style="font-family: Times New Roman, Times, Serif">
</span>Reliance.</b> <span style="background-color: white">Stockholder understands and acknowledges that Parent and Merger Sub are entering
into the Merger Agreement in reliance upon Stockholder&#8217;s execution, delivery and performance of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: small-caps bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in">SECTION 6.</td><td>COVENANTS OF STOCKHOLDER</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">6.1</span><span style="font-family: Times New Roman, Times, Serif">
</span>Stockholder Information; Disclosure.</b> Stockholder hereby consents to and authorizes the publication and disclosure by Parent,
Merger Sub and the Company (including in any other publicly filed documents relating to the Merger or the transactions contemplated hereby)
of: (a) Stockholder&#8217;s identity; (b) Stockholder&#8217;s Ownership of the Subject Securities; and (c) the nature of Stockholder&#8217;s
commitments, arrangements and understandings under this Agreement, (including filing this Agreement as an exhibit to any publicly filed
documents relating to the Merger or the transactions contemplated hereby), and any other information that Parent, Merger Sub or the Company
determines to be necessary in any SEC disclosure document in connection with the Merger or the transactions contemplated hereby. Stockholder
further agrees, as promptly as practicable, to notify Parent, Merger Sub and the Company of any required corrections with respect to any
written information supplied by Stockholder specifically for use in any such disclosure document.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">6.2</span><span style="font-family: Times New Roman, Times, Serif">
</span>Further Assurances.</b> From time to time and without additional consideration, Stockholder shall (at Parent&#8217;s sole expense)
execute and deliver, or cause to be executed and delivered, such additional transfers, assignments, endorsements, consents and other instruments,
and shall (at Parent&#8217;s sole expense) take such further actions as Parent may reasonably request for the purpose of carrying out
and furthering the intent of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">6.3</span><span style="font-family: Times New Roman, Times, Serif">
</span>Stop Transfer Order; Legends.</b> Stockholder hereby agrees that it will not request that the Company register the Transfer of
any certificated or uncertificated interest representing any of the Subject Securities, unless such Transfer is made in compliance with
this Agreement. In furtherance of this Agreement, concurrently herewith, Stockholder shall, and hereby does, authorize Parent to direct
the Company or its counsel to notify the Company&#8217;s transfer agent that there is a stop transfer order with respect to all of the
Subject Securities (and that this Agreement places limits on the voting and Transfer of such shares). The parties hereto agree that such
stop transfer order shall be removed and shall be of no further force and effect upon the Expiration Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">6.4</span><span style="font-family: Times New Roman, Times, Serif">
</span>Public Announcement.</b> Stockholder shall not, and shall cause its Representatives not to, directly or indirectly, issue any press
release, public announcement or make any other public statement or communication with respect to the transactions contemplated by this
Agreement or the Merger Agreement without the prior written consent of Parent, except as may be required by Applicable Law, <i>provided</i>
that, to the extent feasible, Stockholder shall notify Parent in advance of any public statement it intends to make without Parent approval
because disclosure is required by Applicable Law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">6.5</span><span style="font-family: Times New Roman, Times, Serif">
</span>Waiver of Certain Actions.</b> Stockholder hereby agrees not to commence or participate in, and to take all actions necessary to
opt out of any class in, any class action with respect to any Action or claim, derivative or otherwise, against Parent, Merger Sub or
any of their respective successors (a) challenging the validity of, or seeking to enjoin or delay the operation of, any provision of this
Agreement or the Merger Agreement (including any Action or claim seeking to enjoin or delay the Expiration Date or the Closing) or (b)
alleging a breach of any duty of the Company Board in connection with the Merger Agreement, this Agreement or the transactions contemplated
thereby or hereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 212 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">6.6</span><span style="font-family: Times New Roman, Times, Serif">
</span>No Solicitation.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Stockholder shall not, and shall cause its Representatives not to, directly or indirectly, (i) (A) solicit, initiate, or propose
the making, submission or announcement of, or knowingly encourage (including by way of furnishing non-public information), or take any
other action to knowingly facilitate, any inquiries relating to, the submission of, or the making of, any proposal the consummation of
which would constitute an Alternative Transaction or (B) fail to terminate any direct or indirect solicitation, encouragement, discussions
or negotiations with any persons (other than Parent or Merger Sub and their Representatives) that may be ongoing with respect to a proposal
for an Alternative Transaction, including terminating all access granted to any such person or its representatives to any physical or
electronic dataroom, (ii) engage in, participate in or otherwise continue any discussions or negotiations, or cooperate in any way with
any person (or group of persons), with respect to any inquiries relating to, or the making of, any proposal the consummation of which
would constitute an Alternative Transaction, (iii) amend or grant any waiver or release under, or fail to enforce, any standstill or similar
agreement with respect to any class of equity securities of Company or its Subsidiaries (provided that Company shall be permitted on a
confidential non-public basis to release or waive any explicit or implicit standstill or similar agreement solely to the extent necessary
to permit the relevant party thereto to submit a proposal for an Alternative Transaction to the Company Board on a confidential nonpublic
basis and solely to the extent the Company Board determines in good faith that the failure to do so would be a breach of the Company Board&#8217;s
fiduciary duties under Applicable Law, so long as Company promptly (and in any event within twenty-four (24) hours) notifies Parent in
writing of any such waiver or release) or (iv) approve, authorize, agree or publicly announce an intention to do any of the foregoing..</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>During the Support Period Stockholder shall promptly (and, in any event, within twenty-four (24) hours) notify Parent in writing
of any request for information, proposal or inquiry relating to an Alternative Transaction, the material terms and conditions of such
request, proposal or inquiry (including any changes thereto) and the identity of the person making such request, proposal or inquiry.
Stockholder shall (i) keep Parent reasonably informed of the status and details (including amendments or proposed amendments) of any such
request, proposal or inquiry on a reasonably current basis and (ii) provide to Parent as soon as reasonably practicable after receipt
or delivery (but in no event later than twenty-four hours after receipt or delivery) thereof copies of all correspondence and other written
materials exchanged between Stockholder or any of its Representatives, on the one hand, and any person making such request or proposal
or any of its Representatives, on the other hand, in each case relating to any such request, proposal or inquiry. Notwithstanding the
foregoing, Stockholder shall not be required to notify Parent of any discussions or negotiations to the extent the Company has notified
Parent thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: small-caps bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in">SECTION 7.</td><td>MISCELLANEOUS</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.1</span><span style="font-family: Times New Roman, Times, Serif">
</span>Adjustments.</b> In the event that, between the date of this Agreement and the Effective Time, (a) the outstanding Company Common
Stock are changed into a different number or class of shares by reason of any stock split, division or subdivision of shares, stock dividend,
reverse stock split, consolidation of shares, reclassification, recapitalization or other similar transaction, or (b) Stockholder shall
become the Beneficial Owner of any additional Company Common Stock, then the terms of this Agreement shall apply to the Company Common
Stock held by Stockholder immediately following the effectiveness of the events described in the aforementioned clause (a) or Stockholder
becoming the Beneficial Owner thereof as described in the aforementioned clause (b), as though, in either case, they were Subject Securities
hereunder. In the event that Stockholder shall become the Beneficial Owner of any other Equity Securities entitling the holder thereof
to vote or give consent with respect to the matters set forth in <span style="text-decoration: underline">Section 3</span> hereof, then the terms of <span style="text-decoration: underline">Section 3</span> hereof shall
apply to such other securities as though they were Subject Securities hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.2</span><span style="font-family: Times New Roman, Times, Serif">
</span>Survival of Representations, Warranties and Agreements.</b> All representations, warranties, covenants and agreements in this Agreement,
and all rights and remedies with respect thereto, shall not survive the Expiration Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.3</span><span style="font-family: Times New Roman, Times, Serif">
</span>Expenses.</b> Except as provided in <span style="text-decoration: underline">Section 6.2</span> hereof, all costs and expenses incurred in connection with the negotiation
and execution of this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 213 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.4</span><span style="font-family: Times New Roman, Times, Serif">
</span>Notices.</b> All notices and other communications hereunder shall be in writing and shall be deemed to have been duly delivered
and received hereunder (a) one (1) Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable international
overnight courier service, (b) upon delivery in the case of delivery by hand, (c) if sent by email transmission prior to 6:00 p.m. recipient&#8217;s
local time, upon transmission (<i>provided</i>, that no &#8220;bounce back&#8221; or similar message of non-delivery is received with
respect thereto) or (d) if sent by email transmission after 6:00 p.m. recipient&#8217;s local time and no &#8220;bounce back&#8221; or
similar message of non-delivery is received with respect thereto, the Business Day following the date of transmission; <i>provided,</i>
that in each case the notice or other communication is sent to the physical address or email address set forth beneath the name of such
party below (or to such other physical address or email address as such party shall have specified in a written notice given to the other
parties):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">if to Stockholder:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">at the address set forth on the signature page hereof;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">and if to Parent or Merger
Sub (or following the Effective Time, the Company):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 100%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">RadNet, Inc.<br/>
    1510 Cotner Avenue</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">Los Angeles, CA 90025<br/>
    Attention: David J. Katz, EVP and Chief Legal Officer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt"></p></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.05pt">with a copy (which shall not constitute notice) to:</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.05pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">Perkins Coie LLP<br/>
    1201 Third Ave<br/>
    Seattle, WA 98034<br/>
    Attention:&#160;&#160;&#160;&#160;&#160;&#160;Andrew Moore</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 125.25pt">David Martinez</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 125.25pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt">Email:&#160;&#160;&#160;&#160;&#160;&#160;AMoore@perkinscoie.com</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.05pt"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 107.25pt">DMartinez@perkinscoie.com</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 107.25pt"></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.5</span><span style="font-family: Times New Roman, Times, Serif">
</span>Notification of Certain Matters.</b> During the Support Period Stockholder shall promptly deliver to Parent written notice upon
becoming aware of (a) any injunction, writ or Order of any nature issued and directing that the transactions provided for herein not be
consummated as herein provided or (b) any Action pending or threatened with respect to the transactions contemplated hereby, in each such
case if and only to the extent that such injunction, writ, Order or Action would cause any of the conditions set forth in Article VIII
of the Merger Agreement not to be satisfied at such time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.6</span><span style="font-family: Times New Roman, Times, Serif">
</span>Severability.</b> Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction
shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability
of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction
declares that any term or provision of this Agreement is invalid or unenforceable, the parties agree that the court making such determination
shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a
term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term
or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted
to it in the prior sentence, the parties agree to replace such invalid or unenforceable term or provision with a valid and enforceable
term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable
term or provision.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 214 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.7</span><span style="font-family: Times New Roman, Times, Serif">
</span>Entire Agreement; Counterparts.</b> This Agreement and any other documents delivered by the parties in connection herewith constitute
the entire agreement and supersede all prior agreements and understandings, both written and oral, among or between any of the parties,
with respect to the subject matter hereof and thereof. This Agreement may be executed in several counterparts, each of which shall be
deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts
or otherwise) by PDF shall be sufficient to bind the parties to the terms and conditions of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.8</span><span style="font-family: Times New Roman, Times, Serif">
</span>Assignment; Binding Effect.</b> No party may assign (by merger, operation of law or otherwise) either this Agreement or any of
its rights, interests or obligations hereunder without the prior written approval of the other parties; <i>provided, </i>that each of
Parent or Merger Sub may assign, in its sole discretion, any or all of its rights, interests and obligations under this Agreement to any
one or more direct or indirect wholly owned Subsidiaries of Parent without the consent of Stockholder; <i>provided</i>, <i>however</i>,
that no such assignment shall release Parent or Merger Sub of any of its obligations under this Agreement or enlarge any obligation of
Stockholder hereunder. Any purported assignment in violation of this Agreement will be void <i>ab initio</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.9</span><span style="font-family: Times New Roman, Times, Serif">
</span>Independence of Obligations.</b> The covenants and obligations of Stockholder set forth in this Agreement shall be construed as
independent of any other agreement or arrangement between Stockholder, on the one hand, and the Company or Parent, on the other. The existence
of any claim or cause of action by Stockholder against the Company or Parent shall not constitute a defense to the enforcement of any
of such covenants or obligations against Stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.10</span><span style="font-family: Times New Roman, Times, Serif">
</span>Governing Law; Jurisdiction; Waiver of Jury Trial.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware, regardless of the Laws
that might otherwise govern under applicable principles of conflicts of laws thereof. Subject to <span style="text-decoration: underline">Section 7.10(c)</span>, in any action
or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby: (i) each of the parties irrevocably
and unconditionally consents and submits to the exclusive jurisdiction and venue of the Chancery Court of the State of Delaware and any
state appellate court therefrom or, if such court lacks subject matter jurisdiction, the United States District Court sitting in New Castle
County in the State of Delaware, (it being agreed that the consents to jurisdiction and venue set forth in this <span style="text-decoration: underline">Section 7.10(a)</span>
shall not constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose except as
provided in this paragraph and shall not be deemed to confer rights on any Person other than the parties); and (ii) each of the parties
irrevocably consents to service of process by first class certified mail, return receipt requested, postage prepaid, to the address at
which such party is to receive notice in accordance with <span style="text-decoration: underline">Section 7.4</span>. The parties agree that a final judgment in any such action
or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by
applicable Laws; <i>provided</i>, <i>however</i>, that nothing in the foregoing shall restrict any party&#8217;s rights to seek any post-judgment
relief regarding, or any appeal from, such final trial court judgment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The parties agree that irreparable damage, for which monetary damages, even if available, would not be an adequate remedy, will
occur in the event that the parties do not perform their obligations under the provisions of this Agreement in accordance with its specified
terms or otherwise breach such provisions. Subject to the following sentence, the parties acknowledge and agree that (i) the parties shall
be entitled to seek an injunction or injunctions, specific performance or other equitable relief, to prevent breaches or threatened breaches
of this Agreement and to enforce specifically the terms and provisions hereof in the courts described in <span style="text-decoration: underline">Section 7.10(a)</span> without
proof of damages or otherwise, this being in addition to any other remedy to which they are entitled under this Agreement, and (ii) the
right of specific performance is an integral part of the transactions contemplated hereby and without that right, neither the Company
nor Parent would have entered into this Agreement. Each of the parties agrees that it will not oppose the granting of an injunction, specific
performance or other equitable relief on the basis that the other parties have an adequate remedy at law or an award of specific performance
is not an appropriate remedy for any reason at law or equity. The parties acknowledge and agree that any party seeking an injunction or
injunctions to prevent breaches or threatened breaches of this Agreement and to enforce specifically the terms and provisions of this
Agreement in accordance with this <span style="text-decoration: underline">Section 7.10(b)</span> shall not be required to provide any bond or other security in connection with
any such Order or injunction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES TO THE FULLEST EXTENT PERMISSIBLE UNDER THE LAW ANY AND ALL RIGHT TO TRIAL BY JURY
IN ANY LEGAL PROCEEDING BETWEEN THE PARTIES HERETO ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 215 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.11</span><span style="font-family: Times New Roman, Times, Serif">
</span>Waiver. </b>No failure on the part of any party hereto to exercise any power, right, privilege or remedy under this Agreement,
and no delay on the part of such party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver
of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall preclude
any other or further exercise thereof or of any other power, right, privilege or remedy. No party shall be deemed to have waived any claim
arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of such claim, power,
right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such party; and any
such waiver shall not be applicable or have any effect except in the specific instance in which it is given.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.12</span><span style="font-family: Times New Roman, Times, Serif">
</span>Termination. </b>This Agreement and all rights and obligations of the parties hereunder shall automatically terminate, and no party
shall have any rights or obligations hereunder, and this Agreement shall be revoked, become null and void on and have no further effect
as of the earlier of (a) the Expiration Date or (b) such time as shall be mutually agreed in writing by Parent and Stockholder. If (1)
any change, waiver or amendment to the terms of the Merger Agreement is made without the prior written consent of Stockholder that (i)
reduces the Merger Consideration or any consideration otherwise payable with respect to the Eligible Company Options beneficially owned
by Stockholder, (ii) imposes any restriction on Stockholder&#8217;s right to receive the Merger Consideration or changes the timing of
or the form of consideration payable in the Merger or any consideration otherwise payable with respect to any share of Company Common
Stock beneficially owned by Stockholder or (iii) otherwise materially amends the Merger Agreement in a manner adverse to the stockholders
of the Company; or (2) the Outside Date, is extended without the prior written consent of Stockholder, then in each case of the foregoing
subsections (1) or (2), all obligations of the Stockholder with respect to Sections 2 and 3 hereof shall automatically terminate as of
the occurrence of such event. Nothing in this <span style="text-decoration: underline">Section 7.12</span> shall relieve any party from any liability for any Willful Breach of
this Agreement occurring prior to the termination of this Agreement and the provisions of this <span style="text-decoration: underline">Section 7</span> (other than <span style="text-decoration: underline">Section
7.1</span>) shall survive any termination of this Agreement. For the avoidance of doubt, the representations and warranties herein shall
not survive the termination of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.13</span><span style="font-family: Times New Roman, Times, Serif">
</span>Directors and Officers. </b>Stockholder signs this Agreement solely in Stockholder&#8217;s capacity as a stockholder of the Company,
and not in Stockholder&#8217;s capacity as a director, officer or employee of the Company. Nothing in this Agreement shall be construed
to prohibit Stockholder or any of Stockholder&#8217;s Representatives who is an officer or member of the Company Board from taking any
action (or failure to act) in his or her capacity as an officer or member of the Company Board or from taking any action with respect
to any Alternative Transaction solely in his or her capacity as such an officer or director or in the exercise of his or her fiduciary
duties in his or her capacity as director or officer of the Company, or prevent or be construed to create any obligation on the part of
any director or officer of the Company from taking any action in his or her capacity as such director or officer, and no action taken
solely in any such capacity as an officer or director of the Company shall be deemed to constitute a breach of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.14</span><span style="font-family: Times New Roman, Times, Serif">
</span>Construction.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the
masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and
the neuter gender shall include masculine and feminine genders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The parties agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall
not be applied in the construction or interpretation of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>As used in this Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221; and variations thereof, shall not be deemed
to be terms of limitation, but rather shall be deemed to be followed by the words &#8220;without limitation.&#8221; The words &#8220;hereof&#8221;,
&#8220;herein&#8221; and &#8220;hereunder&#8221; and words of like import used in this Agreement, unless otherwise stated, shall refer
to this Agreement as a whole and not to any particular provision of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Unless otherwise indicated all references in this Agreement to &#8220;Sections&#8221; and &#8220;Exhibits&#8221; are intended to
refer to Sections of this Agreement and Exhibits to this Agreement, as applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 216 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The headings set forth in this Agreement are for convenience of reference purposes only and shall not affect or be deemed to effect
in any way the meaning or interpretation of this Agreement or any term or provision hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>References to &#8220;$&#8221; refer to United States dollars unless otherwise noted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.15</span><span style="font-family: Times New Roman, Times, Serif">
</span>No Ownership Interest</b>. All rights, Ownership and economic benefits of and relating to the Subject Securities at a given time
shall remain vested in and belong to Stockholder as of such time, and neither Parent nor Merger Sub shall have any authority to exercise
any power or authority to direct Stockholder in the voting of any of the Subject Securities, except as otherwise specifically provided
herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.16</span><span style="font-family: Times New Roman, Times, Serif">
</span>No Agreement Until Executed</b>. This Agreement shall not be effective unless and until (i) the Merger Agreement is executed by
all parties thereto and (ii) this Agreement is executed by all parties hereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.17</span><span style="font-family: Times New Roman, Times, Serif">
</span>Amendments and Waivers</b>. Any provision of this Agreement may be amended or waived if such amendment or waiver is in writing
and is signed, (i) in the case of an amendment, by each of (x) Parent and Merger Sub, on the one hand, and (y) Stockholder, on the other
hand, or (ii) in the case of a waiver, by each party against whom such waiver is to be effective. No failure or delay by any party in
exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof
preclude any other or further exercise thereof or the exercise of any other right, power or privilege.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>[Remainder of page intentionally left blank]</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 217 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="text-transform: uppercase">In
Witness Whereof</span>, each of Parent, Merger Sub and Stockholder has caused this Voting and Support Agreement to be executed as of the
date first written above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td colspan="2"><b>RADNET, INC.</b></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="width: 50%">&#160;</td>
  <td style="width: 6%">&#160;</td>
  <td style="width: 44%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="padding-bottom: 1pt">By:</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="padding-bottom: 1pt">Name:</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="padding-bottom: 1pt">TItle:</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td colspan="2"><b>TRIO MERGER SUB, INC.</b></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>By:</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>Name:</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>Title:</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<i>Signature Page to Voting and Support Agreement</i>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 218 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="text-transform: uppercase">In
Witness Whereof</span>, each of Parent, Merger Sub and Stockholder has caused this Voting and Support Agreement to be executed as of the
date first written above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td colspan="2"><b>STOCKHOLDER</b></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td colspan="2">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td colspan="2">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="padding-bottom: 1pt">&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td colspan="2">Signature</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td colspan="2">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td colspan="2">Printed Name</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="width: 50%">&#160;</td>
  <td style="width: 6%">&#160;</td>
  <td style="width: 44%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>Address:</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>Email:</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<i>Signature Page to Voting and Support Agreement</i>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 219 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-variant: small-caps"><b>Exhibit
A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-variant: small-caps"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-variant: small-caps"><b>Subject
Securities and Company <span style="font-family: Times New Roman, Times, Serif">Options</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 53%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stockholder: ___________________________</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="border-bottom: Black 1pt solid; width: 47%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Total Number of Subject Securities</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(<i>by type</i>)</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">Company Common Stock&#160;&#160;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt">&#160;</td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">Company Options&#160;&#160;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<!-- Field: Page; Sequence: 220 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PART II<br/>
INFORMATION NOT REQUIRED IN THE PROSPECTUS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>ITEM 20.</b></td><td><b>INDEMNIFICATION OF DIRECTORS AND OFFICERS</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Delaware Law, Certificate of Incorporation, and Bylaws</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">The following provisions of Delaware law and RadNet&#8217;s
Certificate of Incorporation and Bylaws govern the indemnification of RadNet&#8217;s directors and officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Section 145 of the DGCL permits a corporation to
indemnify any director, officer, employee or agent of the corporation, or other person who is or was serving at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, any such person
we refer to as an indemnitee, against expenses (including attorney&#8217;s fees), judgments, fines and amounts paid in settlement actually
and reasonably incurred in connection with any action, suit or proceeding brought by reason of the fact that the indemnitee is or was
serving the corporation or another entity at the direction of the corporation, provided that the indemnitee acted in good faith and in
a manner that he or she reasonably believed to be in, or not opposed to, the best interests of the corporation, and, with respect to any
criminal action or proceeding, if he or she had no reason to believe his or her conduct was unlawful. In a derivative action (i.e., one
brought by or on behalf of the corporation), indemnification may be provided only for expenses actually and reasonably incurred by the
indemnitee in connection with the defense or settlement of such an action or suit if the indemnitee acted in good faith and in a manner
that he or she reasonably believed to be in, or not opposed to, the best interests of the corporation, except that no indemnification
shall be provided if the indemnitee is adjudged to be liable to the corporation, unless and only to the extent that the court in which
the action or suit was brought determines that the indemnitee is fairly and reasonably entitled to indemnity for his or her expenses despite
the adjudication of liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Section 145(g) of the DGCL also provides that a
corporation may maintain insurance against liabilities even if the corporation would lack the power under the DGCL to indemnify against
those liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Article Ninth of RadNet&#8217;s Certificate of Incorporation
provides that a director is not liable to RadNet or its stockholders for monetary damages for breach of fiduciary duty as a director to
the fullest extent permitted by the DGCL. It further obligates RadNet, with respect to its officers and directors, and permits RadNet,
with respect to its employees and agents, to indemnify, in the manner and to the fullest extent permitted by the DGCL, any person (or
the estate of any person) who is or was a party to, or is threatened to be made a party to, any threatened, pending or completed action,
suit or proceeding, whether or not by or in the right of RadNet, and whether civil, criminal, administrative, investigative or otherwise,
by reason of the fact that the person is or was a director or officer, or employee or agent, as the case may be, of RadNet, or is or was
serving at the request of RadNet as a director or officer, or employee or agent, as the case may be, of another corporation or entity.
RadNet may advance the expenses incurred by any such director, officer, employee or agent in defending any such action, suit or proceeding
prior to its final disposition upon receipt of an undertaking by the recipient to repay the amounts advanced if it is ultimately determined
that he or she is not entitled to be indemnified as authorized by the DGCL and RadNet&#8217;s Certificate of Incorporation. To the fullest
extent permitted by the DGCL, the indemnification provided in the certificate of incorporation includes expenses (including attorneys&#8217;
fees), judgments, fines and amounts paid in settlement and, in the manner provided by the DGCL, RadNet may pay any of these expenses in
advance of the final disposition of such action, suit or proceeding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Except as described in this paragraph, Article VII
of RadNet&#8217;s Bylaws contains provisions substantially similar to Article Ninth of RadNet&#8217;s Certificate of Incorporation. In
addition, RadNet&#8217;s Bylaws obligate RadNet to indemnify each of its officers, directors, employees and agents in any action, suit
or proceeding referred to above to the extent that person has been successful on the merits in defense thereof, or in defense of any claim,
issue or matter therein, against expenses (including attorneys&#8217; fees) actually and reasonably incurred by that person in connection
therewith. RadNet&#8217;s Bylaws obligate RadNet to advance expenses to its officers and directors, and require an undertaking to repay
expenses under the specified conditions if required by applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<!-- Field: Page; Sequence: 221 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><span style="text-decoration: underline">General</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">RadNet also maintains insurance for its officers
and directors against certain liabilities, including liabilities under the Securities Act. The effect of this insurance is to indemnify
any of RadNet&#8217;s officers or directors against expenses, including attorneys&#8217; fees, judgments, fines and amounts paid in settlement,
incurred by an officer or director upon a determination that such person acted in good faith. RadNet pays the premiums for this insurance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">RadNet has also entered into separate indemnification
agreements with its officers and directors, which indemnify the officer or director against all liabilities relating to his or her position
as an officer or director of RadNet, or as an employee, agent, officer or director of any other entity if the officer or director is serving
in that capacity at RadNet&#8217;s request, to the fullest extent permitted under applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to RadNet&#8217;s directors, officers or controlling persons pursuant to the foregoing provisions,
RadNet has been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities
Act and is, therefore, unenforceable. In addition, indemnification for violations of state securities laws may be limited by applicable
laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><span style="font-size: 10pt"><b>ITEM 21.</b></span></td><td><span style="font-size: 10pt"><b>EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</b></span><span style="font-size: 18pt"></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) The following exhibits are filed herewith
or incorporated herein by reference:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="text-align: left; width: 9%; vertical-align: top">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 90%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt"><b>Exhibit<br/>
Number</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">2.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt"><a href="#annexa">Agreement and Plan of Merger, dated as of April 15, 2025, by and among RadNet, Inc., Trio Merger Sub, Inc. and iCAD, Inc. (included as Annex A to the proxy statement/prospectus that forms a part of this Registration Statement).</a></span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt">3.1</span></td>
    <td>&#160;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex301.htm"><span style="font-size: 10pt">Certificate of Incorporation of RadNet, Inc. (incorporated by reference to Exhibit 3.1 to RadNet, Inc.&#8217;s Current Report on Form 8-K, filed on September 4, 2008).</span></a></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt">3.2</span></td>
    <td>&#160;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex302.htm"><span style="font-size: 10pt">Certificate of Amendment to Certificate of Incorporation of RadNet, Inc., dated September 2, 2008 (incorporated by reference to Exhibit 3.2 to RadNet, Inc.&#8217;s Current Report on Form 8-K, filed on September 4, 2008).</span></a></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt">3.3</span></td>
    <td>&#160;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/0000790526/000168316820000383/radnet_ex0301.htm"><span style="font-size: 10pt">Amended and Restated Bylaws of RadNet, Inc. (incorporated by reference to Exhibit 3.1 to RadNet, Inc.&#8217;s Current Report on Form 8-K, filed on February 6, 2020).</span></a></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">5.1**</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/790526/000168316825003180/radnet_ex0501.htm">Opinion of Perkins Coie LLP.</a></span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">8.1</td>
    <td>&#160;</td>
    <td><a href="radnet_ex0801.htm">Opinion of Dentons US LLP, regarding certain U.S. federal income tax matters.</a></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="#annexc">Form of Voting and Support Agreement (included as Annex C to the proxy statement/prospectus that forms as part of this Registration Statement.</a></span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">21.1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/790526/000162828025009481/a10k2024exhibit211.htm"><span style="font-size: 10pt">List of Subsidiaries (incorporated by reference to Exhibit 21.1 to RadNet, Inc.&#8217;s Current Report on Form 8-K, filed March 3, 2025).</span></a></td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">23.1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="radnet_ex2301.htm">Consent of Ernst &amp; Young LLP, Independent Registered Public Accounting Firm of RadNet, Inc.</a></span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">23.2</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="radnet_ex2302.htm">Consent of BDO USA, P.C., Independent Registered Public Accounting Firm of iCAD, Inc.</a></span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">23.3**</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Consent of Perkins Coie LLP (included in <a href="https://www.sec.gov/Archives/edgar/data/790526/000168316825003180/radnet_ex0501.htm">Exhibit 5.1</a>).</span></td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top">23.4</td>
    <td>&#160;</td>
    <td style="vertical-align: top">Consent of Dentons US LLP (included in Exhibit 8.1).</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">24.1**</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/790526/000168316825003180/radnet_s4.htm#poa">Power of Attorney</a> (included in the signature page to this Registration Statement).</span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="radnet_ex9901.htm">Form of Proxy Card of iCAD, Inc.</a></span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">99.2</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="radnet_ex9902.htm">Consent of Piper Sandler &amp; Co.</a></span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">107**</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/790526/000168316825003180/radnet_ex107.htm">Filing Fee Table.</a></span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; width: 5%; font-size: 10pt"><span style="font-size: 10pt">*</span></td>
    <td style="vertical-align: bottom; width: 95%; font-size: 10pt"><span style="font-size: 10pt">The annexes, schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. RadNet agrees to furnish supplementally a copy of such schedules and exhibits, or any section thereof, to the SEC upon request; provided, that RadNet may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any annexes, schedules or exhibits so furnished.</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; font-size: 10pt">**</td>
    <td style="vertical-align: bottom; font-size: 10pt">Previously filed.</td></tr>
  </table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 222 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>ITEM 22.</b></td><td><b>UNDERTAKINGS</b></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">(a) The undersigned registrant hereby undertakes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(1) To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration statement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">(i) To include any prospectus required by Section 10(a)(3)
of the Securities Act of 1933.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">(ii) To reflect in the prospectus any facts or events arising
after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in
the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent
no more than a 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221;
table in the effective registration statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">(iii) To include any material information with respect to
the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration
statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(2) That, for the purpose of determining any liability under
the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(3) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the termination of the offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(4) That, for the purpose of determining liability under
the Securities Act of 1933 to any purchaser, if the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b)
as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses
filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used
after effectiveness. <i>Provided</i>, <i>however</i>, that no statement made in a registration statement or prospectus that is part of
the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus
that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede
or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made
in any such document immediately prior to such date of first use.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(5) That, for the purpose of determining liability of the
registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant
undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless
of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means
of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or
sell such securities to such purchaser:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">(i) Any preliminary prospectus or prospectus of the undersigned
registrant relating to the offering required to be filed pursuant to Rule 424;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">(ii) Any free writing prospectus relating to the offering
prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt"></p>

<!-- Field: Page; Sequence: 223 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">(iii) The portion of any other free writing prospectus relating
to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned
registrant; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">(iv) Any other communication that is an offer in the offering
made by the undersigned registrant to the purchaser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">(b) The undersigned registrant hereby undertakes that, for
purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to
Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s
annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">(c)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(1) The undersigned registrant hereby undertakes as follows:
that prior to any public reoffering of the securities registered hereunder through use of a prospectus which is a part of this registration
statement, by any person or party who is deemed to be an underwriter within the meaning of Rule 145(c), the issuer undertakes that such
reoffering prospectus will contain the information called for by the applicable registration form with respect to reofferings by persons
who may be deemed underwriters, in addition to the information called for by the other items of the applicable form.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(2) The registrant undertakes that every prospectus: (i)
that is filed pursuant to paragraph (1) immediately preceding, or (ii) that purports to meet the requirements of Section 10(a)(3) of the
Securities Act of 1933 and is used in connection with an offering of securities subject to Rule 415, will be filed as a part of an amendment
to the registration statement and will not be used until such amendment is effective, and that, for purposes of determining any liability
under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">(d) Insofar as indemnification for liabilities arising under
the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing
provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification
is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling
person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against
public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">(e) The undersigned registrant hereby undertakes to respond
to requests for information that is incorporated by reference into the proxy statement/prospectus pursuant to Item 4, 10(b), 11 or 13
of this form, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other
equally prompt means. This includes information contained in documents filed subsequent to the effective date of the registration statement
through the date of responding to the request.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">(f) The undersigned registrant hereby undertakes to supply
by means of a post-effective amendment all information concerning a transaction, and the company being acquired involved therein, that
was not the subject of and included in the registration statement when it became effective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"></p>

<!-- Field: Page; Sequence: 224 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="sigs"></span>SIGNATURES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Pursuant to the requirements of the Securities
Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Los Angeles, State of California, on May 19, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; float: right; width: 50%; border-collapse: collapse">
  <tr>
    <td style="width: 10%">&#160;</td>
    <td style="width: 90%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2"><span style="font-size: 10pt"><b>RADNET, INC.</b></span></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="padding-bottom: 1pt; vertical-align: top">By:</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom">/s/ HOWARD G. BERGER, M.D.</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-size: 10pt">Name: Howard G. Berger, M.D.</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-size: 10pt">Title: President, Chief Executive Officer and Director</span></td></tr>
  </table><div style="clear: both"></div>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: left; margin-top: 0; margin-bottom: 0">Pursuant
                                            to the requirements of the Securities Act of 1933, as amended, this registration statement
                                            has been signed by the following persons in the capacities indicated below, on May 19, 2025.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 37%; text-align: center"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 61%; text-align: center"><span style="font-size: 10pt"><b>Title</b></span></td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">/s/ Howard G. Berger, M.D.</span> </td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">President, Chief Executive Officer and Director</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt"><b>Howard G. Berger, M.D.</b></span> </td>
    <td>&#160;</td>
    <td style="text-align: center">(Principal Executive Officer)</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">*</span> </td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">Director</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt"><b>Gregory E. Spurlock</b></span> </td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">Director</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>Alma Gregory Sorensen</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">Director</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>David L. Swartz</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">Director</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>Lawrence L. Levitt</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">Director</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>Laura P. Jacobs</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">Chief Financial Officer</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt"><b>Mark D. Stolper</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">(Principal Financial Officer and Principal Accounting
    Officer)</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    </tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 100%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*By: /s/ Howard G. Berger, M.D.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Howard G. Berger, M.D.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney-in-Fact</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 225; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdsKgkAQhp/Adxj2OnKTLPAyKYksRCS6XXKKJd2R2e30SL1lqxINA3P6v/mFmIiMNrpBhtOqzKHCtmuUQyjxgozmjF6RbncJ+FriVVvHyrhh/IEpeQY9s5jKs98Pyoe2WCcg41DOwyj2TSKXUOxF0N9TMhddo3FaNaBMDQVTxxqd4vf4oVIvMtS+B6cjstVkEphN5Xj+QCRnERzooZ7ENwt5nopgMkQgMqZ751Xrl0PTk7BusPV2dqT/GXwBy+xKXQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>2
<FILENAME>radnet_ex0801.htm
<DESCRIPTION>OPINION OF DENTONS US LLP, REGARDING CERTAIN U.S. FEDERAL INCOME TAX MATTERS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 8.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><IMG SRC="image_017.jpg" ALT=""></TD>
  <TD STYLE="text-indent: 0pt; padding-left: 170pt; text-align: left; width: 50%">Dentons US LLP<BR>
1221 Avenue of the Americas<BR>
New York, NY, 10020-1089<BR>
United States <BR>
<BR>
dentons.com</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 19, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">iCAD, Inc.<BR>
98 Spit Brook Road, Suite 100<BR>
Nashua, NH 03062</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have acted as counsel to iCAD, Inc., a Delaware corporation (&ldquo;Company&rdquo;),
in connection with that certain Agreement and Plan of Merger, dated as of April 15, 2025 (the &ldquo;Agreement&rdquo;) by and among RadNet,
Inc., a Delaware corporation (&ldquo;RadNet&rdquo;), Trio Merger Sub, Inc., a wholly owned subsidiary of RadNet and a Delaware corporation
(&ldquo;Merger Sub&rdquo;), and Company. Pursuant to the Agreement, Merger Sub will be merged with and into Company, with Company surviving
the Merger as a wholly owned subsidiary of RadNet (the &ldquo;Merger&rdquo;) according to the terms and conditions set forth in the Agreement.
The time at which the Merger becomes effective is hereafter referred to as the &ldquo;Effective Time.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This opinion is being delivered in connection with the Registration
Statement (File No. 333-287005) of RadNet on Form S-4, filed on May 6, 2025 with the Securities and Exchange Commission, as amended and
supplemented through the date hereof (the &ldquo;Registration Statement&rdquo;). All section references, unless otherwise indicated, are
to the United States Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;). Capitalized terms not defined herein have the
meanings specified in the Agreement unless otherwise indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In rendering our opinion, we have examined and, with your consent,
are expressly relying upon (without any independent investigation thereof) the truth and accuracy of the statements, covenants, representations
and warranties contained in the following documents (including all schedules and exhibits thereto):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Agreement (including
any amendments, exhibits, and schedules thereto);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A tax representation letter
of RadNet, signed by an authorized officer of RadNet, delivered to us by RadNet for purposes of this opinion and incorporated herein by
reference; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A tax representation letter
of Company, signed by an authorized officer of Company, delivered to us by Company for purposes of this opinion and incorporated herein
by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Such other documents and
corporate records as we have deemed necessary or appropriate for purposes of our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In rendering our opinion, we have assumed, without any independent
investigation or verification, that all of the information as to factual matters contained in the documents referred to herein is true,
correct, and complete and no actions have been taken or will be taken which are inconsistent with such statements, descriptions or representations
or which make any such statements, descriptions or representations untrue, incorrect or incomplete. Any inaccuracy with respect to factual
matters contained in the documents or incompleteness in our understanding of the facts could alter the conclusion reached herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, for purposes of rendering our opinion, we have assumed
with your permission, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</FONT>All signatures on all
documents reviewed by us are genuine, all documents submitted to us as originals are authentic, true and correct, all documents submitted
to us as copies are true and correct copies of the originals thereof, there has been (or will be by the Effective Time) execution and
delivery of all documents where execution and delivery are prerequisites to the effectiveness thereof, and each natural person signing
any document reviewed by us had the legal capacity to do so;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT>Any representation or
statement referred to above made &ldquo;to the knowledge&rdquo; or otherwise similarly qualified is correct without such qualification,
and all statements and representations, whether or not so qualified, are true and will remain true through the Effective Time of the Merger
and thereafter where relevant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT>The parties have complied
with and, if applicable, will continue to comply with, the covenants contained in the Agreement, the Registration Statement, and the Company
Proxy Statement/Prospectus (and no covenants or conditions described therein and affecting this opinion will be waived or modified); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT>The Merger and the transactions
contemplated in the Agreement will be effected in accordance with the terms thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Based on the foregoing documents, materials, and assumptions and information,
and subject to the qualifications and assumptions set forth herein, it is our opinion the Merger will qualify as a &ldquo;reorganization&rdquo;
within the meaning of Section 368(a) of the Code. Additionally, we confirm that the statements set forth in the Registration Statement
under the heading &ldquo;Material U.S. Federal Income Tax Consequences of the Merger,&rdquo; subject to the assumptions, exceptions, limitations
and qualifications set forth herein and described in the Registration Statement, constitute our opinion as to the material U.S. federal
income tax consequences of the Merger to U.S. holders (as defined in the Registration Statement) of Company Common Stock as of the effective
date of the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This opinion is rendered only as of the date hereof, and we undertake
no obligation to supplement, update or revise this opinion after the date hereof to reflect any changes (including changes that have retroactive
effect) in applicable law or factual matters arising subsequent to the date hereof or the impact of any information, document, certificate,
record, statement, representation, covenant, agreement or assumption relied upon herein that becomes untrue, incorrect, or incomplete.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our opinion set forth above is based upon the existing provisions of
the Code, applicable U.S. Treasury Regulations promulgated or proposed under the Code, published administrative rulings and procedures,
judicial decisions and other applicable authorities, all as in effect on the date hereof, which are subject to change (possibly with retroactive
effect) so as to affect the conclusions stated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our opinion is limited to the specific U.S. federal tax consequences
of the Merger presented above. No opinion is expressed as to any transaction other than the Merger as described in the Agreement, including
(i) any transaction undertaken in connection with the Merger and (ii) the Merger, if, to the extent relevant to our opinion, either all
the transactions described in the Agreement are not consummated in accordance with the terms of the Agreement and without waiver or breach
of any provisions thereof or all the factual statements, representations, warranties, and assumptions upon which we have relied are not
true and accurate at all times. In addition, this opinion does not address any estate, gift, state, local or foreign tax consequences
that may result from the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No ruling has been or will be requested from the Internal Revenue Service
(the &ldquo;Service&rdquo;) concerning the U.S. federal income tax consequences of the Merger. In reviewing this opinion, you should be
aware that the opinion set forth above represents our conclusions regarding the application of existing U.S. federal income tax law to
the Merger. Further, if the facts vary from those relied upon (including if any representation, covenant, warranty or assumption upon
which we have relied is inaccurate, incomplete, breached or ineffective), our opinion contained herein could be inapplicable. You should
be aware that an opinion of counsel represents only counsel&rsquo;s best legal judgment, and has no binding effect or official status
of any kind, and that no assurance can be given that contrary positions may not be taken by the Service or that a court considering the
issues would not hold otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This opinion is being delivered solely in connection with the Registration
Statement and in accordance with the terms and conditions of the Agreement. This opinion may not otherwise be relied upon or utilized
for any other purpose or by any other person or entity without our prior written consent. However, we hereby consent to the filing of
this opinion with the Securities and Exchange Commission as an exhibit to the Registration Statement, and to the references therein to
us. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of
the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 340pt">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 340pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 340pt">/s/ Dentons US LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 340pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 340pt">Dentons US LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>radnet_ex2301.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consent of Independent Registered Public Accounting
Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the reference to our firm under
the caption &quot;Experts&quot; in the Registration Statement (Form S-4) and related Prospectus of RadNet, Inc. for the registration of
shares of its common stock and to the incorporation by reference therein of our reports dated March 3, 2025, with respect to the consolidated
financial statements of RadNet, Inc. and subsidiaries, and the effectiveness of internal control over financial reporting of RadNet, Inc.
and subsidiaries, included in its Annual Report (Form 10-K) for the year ended December 31, 2024, filed with the Securities and Exchange
Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Ernst &amp; Young LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Los Angeles, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">May 19, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>radnet_ex2302.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We hereby consent to the incorporation by reference in the proxy statement/prospectus
constituting a part of this Registration Statement of our report dated March 31, 2025, relating to the consolidated financial statements
of iCAD, Inc. (the Company) appearing in the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We also consent to the reference to us under the caption &ldquo;Experts&rdquo;
in the proxy statement/prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">/s/ BDO USA, P.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Boston, Massachusetts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">May 19, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>radnet_ex9901.htm
<DESCRIPTION>FORM OF PROXY CARD OF ICAD, INC.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 99.1</B></P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="pc1.jpg" ALT="" STYLE="height: 879px; width: 650px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0; font-size: 1px; color: White">2025 1 . To adopt the Agreement and Plan of Merger, dated April 15 , 2025 , by and among RadNet, Inc . , a Delaware corporation (&#8220;RadNet&#8221;), Trio Merger Sub, Inc . , a wholly - owned subsidiary of RadNet and a Delaware corporation (&#8220;Merger Sub&#8221;), and iCAD, Inc . (&#8220;iCAD&#8221;) (as it may be amended from time to time, the &#8220;Merger Agreement&#8221;), under which, upon the terms and subject to the conditions set forth therein, Merger Sub will merge with and into iCAD (the &#8220;Merger&#8221;), with iCAD surviving as a wholly - owned subsidiary of RadNet (the &#8220;Merger Agreement Proposal&#8221;) . 2 . To approve, by non - binding advisory vote, the compensation that may be paid or become payable to iCAD&#8217;s named executive officers that is based on or otherwise  related to the Merger  (the &#8220;Advisory Compensation Proposal&#8221;). &#61555; FOLD AND DETACH HERE AND READ THE REVERSE SIDE &#61555; iCAD, INC. PROXY THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED BY THE UNDERSIGNED STOCKHOLDER . IF NO INSTRUCTIONS ARE GIVEN, THIS PROXY WILL BE VOTED FOR THE PROPOSALS LISTED BELOW . THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;FOR&#8221; PROPOSALS 1 , 2 , AND 3 . Please mark like this X your votes Signature Signature if held jointly Date , 2025 . Note : Please sign exactly as name appears hereon . When shares are held by joint tenants, both should sign . When signing as attorney, executor, administrator, trustee or guardian, please give full title as such . If a corporation, please sign in full corporate name by President or other authorized officer . If a partnership, please sign in partnership name by authorized person . 197347 iCAD INC Proxy Card Rev2 Front CONTROL NUMBER INTERNET/MOBILE &#8211; www.cstproxyvote.com Use the Internet to vote your proxy. Have your  proxy card available when you access the above  website. Follow the prompts to vote your shares. PHONE &#8211; 1 (866) 894 - 0536 Use a touch - tone telephone to vote your proxy.  Have your proxy card available when you call.  Follow the voting instructions to vote your shares. MAIL &#8211; Mark, sign and date your proxy card and return it in the postage - paid envelope provided. Your Internet vote authorizes the named proxies to vote your shares in the same manner as if you marked, signed and returned your proxy card . Votes submitted electronically over the Internet must be received by 11 : 59 p . m . , Eastern Time, on July 13 , 2025 . PLEASE DO NOT RETURN THE PROXY CARD IF  YOU ARE VOTING ELECTRONICALLY. YOUR VOTE IS IMPORTANT. PLEASE VOTE TODAY. Vote by Internet, Smartphone or Tablet - QUICK &#61512;&#61512;&#61512; EASY  IMMEDIATE - 24 Hours a Day, 7 Days a Week or by Mail FOR AGAINST ABSTAIN FOR AGAINST ABSTAIN 3. To adjourn the special meeting (the FOR AGAINST ABSTAIN &#8220;Special Meeting&#8221;)  to a later date or dates,  if necessary or appropriate, to solicit additional proxies if  there are  insufficient votes to  adopt the  Merger Agreement at the time of the Special Meeting (the &#8220;Adjournment  Proposal&#8221;).</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="pc2.jpg" ALT="" STYLE="height: 879px; width: 650px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0; font-size: 1px; color: White">2025 &#61555; FOLD AND DETACH HERE AND READ THE REVERSE SIDE &#61555; Important Notice Regarding the Availability of Proxy Materials for the Special Meeting of Stockholders to be  held virtually at https:// www.cstproxy.com/icad/sm2025 at 9:00 a.m., Eastern Time, on July 14, 2025 The Notice and Proxy Statement is available at  https://www.cstproxy.com/icad/sm2025 PROXY iCAD, INC. 2 Townsend West, Suite 6  Nashua, New Hampshire, 03063 PROXY FOR SPECIAL MEETING OF STOCKHOLDERS TO BE HELD VIRTUALLY AT  HTTPS:// WWW.CSTPROXY.COM/ICAD/SM2025 AT 9:00 A.M., EASTERN TIME, ON JULY 14, 2025 THIS PROXY IS SOLICITED  ON BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoints DANA BROWN and ERIC LONNQVIST, and each of them, Proxies, with full power of substitution in each of them, in the name, place and stead of the undersigned, to vote at the Special Meeting of Stockholders of iCAD, Inc . to be held virtually at https : // www . cstproxy . com/icad/sm 2025 at 9 : 00 a . m . , Eastern Time, on July 14 , 2025 or at any postponements or adjournments thereof, according to the number of votes that the undersigned would be entitled to vote if personally present, upon the following matters on the reverse side . 197347 iCAD INC Proxy Card Rev2 Back (Continued, and to be marked, dated and signed, on the other side)</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>radnet_ex9902.htm
<DESCRIPTION>CONSENT OF PIPER SANDLER CO.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>CONSENT OF PIPER SANDLER
&amp; CO.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0">RadNet, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0">1510 Cotner Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0">Los Angeles, CA 90025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0">The Board of Directors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify">We understand that RadNet, Inc. (the
&ldquo;<I><U>Company</U></I>&rdquo;) has determined to include our opinion letter (the &ldquo;<I><U>Opinion</U></I>&rdquo;), dated April
15, 2025, to the Board of Directors of iCAD, Inc. (&ldquo;<I><U>iCAD</U></I>&rdquo;), as part of Amendment No. 1 (the &ldquo;<I><U>Amendment</U></I>&rdquo;)
to the Company&rsquo;s Registration Statement (File No. 333-287005) on Form S-4 (together with the Amendment, the &ldquo;<I><U>Registration
Statement</U></I>&rdquo;) solely because such Opinion is included in the proxy statement/prospectus that forms a part of the Registration
Statement to be delivered to the Company&rsquo;s stockholders in connection with the proposed merger involving the Company and iCAD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify">In connection therewith, we hereby
consent to the inclusion of our Opinion as Annex B to, and references thereto under the headings &ldquo;Summary&mdash;Opinion of iCAD&rsquo;s
Financial Advisor&rdquo; and &ldquo;&mdash;Risk Factors&rdquo;; &ldquo;Risk Factors&mdash;Risks Relating to the Merger&rdquo;; &ldquo;The
Merger&mdash;Background of the Merger&rdquo;, &ldquo;&mdash;Recommendation of the iCAD Board of Directors and Reasons for the Merger&rdquo;,
&ldquo;&mdash;Certain iCAD Unaudited Prospective Financial Information&rdquo;, and &ldquo;&mdash;Opinion of iCAD&rsquo;s Financial Advisor&rdquo;;
and &ldquo;The Merger Agreement&mdash;Representations and Warranties&rdquo;, in the proxy statement/prospectus that forms a part of the
Registration Statement. By giving such consent, we do not thereby admit that we are experts with respect to any part of such Registration
Statement within the meaning of the term &ldquo;expert&rdquo; as used in, or that we come within the category of persons whose consent
is required under, Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission
promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%">&nbsp;</TD>
  <TD STYLE="width: 34%">&nbsp;</TD>
  <TD STYLE="width: 33%">Very truly yours,</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>/s/ PIPER SANDLER
&amp; CO.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>PIPER SANDLER &amp; CO.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-bottom: 0">May 19, 2025</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>icad.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 icad.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !$ .P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z**\\U(
M^(AXQQ#]H\KS1Y>W/E>7[]NG7-:TZ?M&U>QS5ZWL$GRMW=M#T.LSQ1_R+6K?
M]>DW_H!K3K,\4?\ (M:M_P!>DW_H!I4_C7J:5?X<O1GRM^Q_\0-7'BAO#%S>
M37>ESV;30Q3.7\ATV_<ST!!.1TX%?7E?#W[(W_)6[+_L'S_R6ON&OH^(Z<88
MY\JM=)_/4^2X3JSJ9:N=WLVEZ:!16+XO^W_V%/\ V;O^T9&?+^_MSSCWJAX
M.J'3I_[1\[9O'D^?G?C'/7G'_P!>OG53O#GN?4NM:LJ/*]5>_0ZFBBBLCI"B
MBOR;_:C_ ."L_P 0O!/QU\0>&/A_I>BV_A[PYJ$FG2R:I;/--?2Q-LE)(9=B
M;E8 +S@9)YP #]9**\J_9>^.EO\ M(_ SPO\08+$Z7)JD3K<66[<(9XY&BE5
M6[KN0D'T(SS7:>/OB%X;^%OA6^\2^+-9M-!T.R7=/>WDFU%] .[,3P% ))X
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MU^AO_!&'X _;]<\3_%_4[;,-B#HNCLXZS, UQ(/]U"B _P#31QVKQG_@J]\
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M!5AZ$'K0!X#^P$<_L:_"?_L#)_Z&]?/'_!0K_@FX_P <K^[^(_PTCM[;QPR
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M8C%::C=6L1.XI!.Z*3ZX!ZU_3WJ'@KP]JUP)[[0=,O)PH3S+BSCD;:.@R1G
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1** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  I 1$# 2(  A$! Q$!_\0
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MN>,UY /@_JH.?[:@_P"^6KL/&L+V7PSNX"^7AMXD+CC)#(,T ==N7U'YTM>
M>$O!%]XLT^:[@U)(%BE\HJX8D\ YX^M3O-KOPS\30PRWGGV[A9&16)25"<'@
M]#P: />*X3Q)_P E!T?Z1?\ HPUW2L'4,.A&17"^)/\ DH.C_2+_ -&&MZ'Q
M/T?Y')B_@7JOS.[H) !). **\XU5+CQGX_N= ENYK?2M/B#RQQ-M,S<=?^^O
MT]ZP.L]#BN()B1%-'(1U"L#4E<-<_"[2$B+Z5<7=A>+S'.DI;!]QZ?0BNRLH
M);:Q@@GN&N)8T"O,X +D=R!0!,S*B[F8*/4G%+7GGQ+EN=5N-,\+Z>0;FZ8S
MN,_PJ#C/MPQ_X#6YX U<ZOX1M6D)-Q;?Z/*#URO3/X8- '2LZH,NP4>I.*=7
MGWQ?)'A.W(.#]L7_ -!:KOP^\1S:C92:/J8:/5M/^1U?[SH. WN1T/X'O0!V
M3NB#+LJCW.*4L%4LQ  ZDUYW\821X=L,'_E\'_H#5TGC/_D1M5_Z]C0!N?:(
M/^>T?_?0J4$$9!R#7F7A3X?:!JWA:POKN&9IYHRSE9B!G)'2HM3L+GX::A9:
MCIU[<3://,(KFVF;=M]QCV!P?;OF@#U%F5%+,0 .Y.* 0P!!!!Z$5ROQ'.?
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M,KPF-D=&8!<@Y^4CT%;VK:GXN\?R6VGG3#'$C[ML<3*F>FYF8G& 35CX-_\
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MU+XDOK%DE];SBT:=!.3;Q@!-PW<X],UUOQ$_Y$+5?]Q/_0UKF_\ A<VG$_\
M(*NO^^UK>\<W"W?PUO;E5*K-!%( >HRRG'ZT#/+?"7B;Q%H&CW7]E::+BS$A
MDFF:!W"$*,Y(.!P :L:79ZM\3_$OVF_GB6"W"B;;A=D>3\JKUYYY]ZZ[X/1I
M+X7U&*10R/=%64]""BY%<C"TOPZ^([(=WV/?@_[<#]#[D?S6F(]W "J%'0#
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MDG R?T!KCO[4L=)^+^JSW]U';Q-8H@:0X!.(SC]#0!>&I_$;(SH.EX_Z[?\
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>L5S$&W!)4# 'UYJS10!0_L33/^?*+\J*OT4 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>pc1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pc1.jpg
M_]C_X  02D9)1@ ! @$!> %X  #_[@ .061O8F4 9       _]L 0P ," @;
M"ALB$1<D*B0<&R D*R@H("0I)24Q+R4I+BHK*SDK*BXO-#4U-30O.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[_\  "P@0Y Q\ 0 1 /_$ !\   $% 0$! 0$!
M       ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042
M(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V
M-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KA
MXN/DY>;GZ.GJ\?+S]/7V]_CY^O_:  @!    /P#U6BBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBL^
M^U^"PD2WD<"24@*N"2<G Z X!/ )P.OH:T**P]0\:V>GN8I)0&'4*&?&"00=
MH(!!'(/-6M(\26^KY\B0,1U'(;C'.U@#CD<XQGBM*N:_X6-8?\]?_(<G_P 3
M1_PL:P_YZ_\ D.3_ .)H_P"%C6'_ #U_\AR?_$UTM9NK^)+?2,>?(%)Z#DMS
MGG:H)QP><8SQ4&G>,;343LCE7=D !LH26Z !P,GZ9_45LT45E1^*+:2?["L@
M,V2-H#'D#)&[&W( YYX/'7BM"YN5M4:5SA44L3R< #)/'/2N?_X6-8?\]?\
MR')_\31_PL:P_P">O_D.3_XFI;;Q[973K$DN6=@H&R09). .5QUKH**R-7\6
M6VD.(IWVL5W ;7/!)&?E4CJ#6O3)91$"[$!5!)).  .I)]*Y?4?B;9V9V@M(
M<D'RUR!CW8J"#V(R/TR:=\3;.\.TEHSD >8N <^ZE@ .Y.!^N.KHHK#MO&MG
M<R"V24%RVT<-@GT#$;3GMSSVSD5N45S7_"QK#_GK_P"0Y/\ XFC_ (6-8?\
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MJ'2$$L[;5+;0<,>2"<?*">@-9'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\
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MHK*U3Q1:Z6=LTJJP(!4?,PR,C*KD@8[D8Z>HJ#3_ !K9Z@XBCE!8] P9,Y(
M W  DD\ <UN445S]SX]LK5VB>7#(Q4C9(<$'!'"XZU%_PL:P_P">O_D.3_XF
MC_A8UA_SU_\ (<G_ ,36YIVHQZE&+B$[D;.#@CH2#P0#U%6:*********BMK
ME+I1)&P93T*D$'!QU''6I:**************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M*Y3Q5\08=&!BCQ)-@X (*J0<?,0>O7Y1SQ@[<@UYMI\DTFH1-<[O--Q$6W@A
MN67'!Q@8Q@= ,8XKW2N!^*GB,VB+8QDAI1E\<?)R O3HQSG!Z#!X:F^%OAE#
MY:S78+.ZYV990N<$ XPVX=^<#.,<9JMXU\!)IT?VZRRAAP64%B>#]\')(*]3
MSC SQCGK?!NO?VW;),?OK\K_ .\N,GH!R"&XX&<=JQ/^%26G]^7_ +Z3_P"(
MH_X5):?WY?\ OI/_ (BN/T?PK#KUT8;4N+:,99WP6//;"@ M_"#S@%C_ ':]
M+\9:]_8EL\P^^WRI_O-G!Z$< %N>#C'>N$\">"AKFZ^N\LA9@ 2P+MW8MP2
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M,3\H'4<X4 <9!IWA_P#Y#+?]=[C^4E>MT5YQ\3-<-XZ:1!DN77>.F2V-B9)
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M-C#(/^LVB0GD@GOP3QCC'ML4HE =2"K $$'((/0@^E>3_"3_ (^W_P"N#?\
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M3XM_\?:?]<%_]#>O6ZX;XN1 VT;X&X3  XY *-D9]#@9^@]*U/AS_P >$/\
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M'QBGA],##3./D3_V9O\ 9_4G@=R.3\)>#)-<?^T[XDAF#*"!E\$')!! 0@8
MQR.F%QGTZBBO&[#3H]2U9[>8;D:>XR,D=-Y'((/45W__  KFP_YY?^1)/_BJ
MEMO 5E:NLJ189&# [Y#@@Y!Y;'6N@KR3X2?\?;_]<&_]#2O6Z\BT.(2:RP8
MC[1.>1GD;R#]01D>AKUVN&^+D0-M&^!N$P ..0"C9&?0X&?H/2G>'_\ D#-_
MUPN/YR5F_!S_ )>/^V7_ +/7I->2?"3_ (^W_P"N#?\ H:5TGQ;_ ./1/^NZ
M_P#H#UI?#G_CPA_[:?\ HQJZ6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBO)/$'_(97_KO;_RCKUNN/\ B3!<"%;FV=U\HMO$;%<J0/F.".%QZ'@D
M\ &CP9XWAN[=5N)%26,!6\Q@N['1@6/S$C[W?.> ",Y'Q#\6QWZ?V=:L9'=T
MW% &4CDA 1DEMVT\?3.<BNI\$Z$=%M5A< 2$EGP<\GI[9"@ XXR.,]39\4WH
MLK6:7<5(C8 C.0S#:N,<@[B.>W6N-^#]D0)K@J,$JJMQGC)8>H'*D]CQZ<>C
MUS_CJPDO;1U@+[Q@[8S@L.C*1W&TD[>Y Z]#RGPV\9QVR?8+A@H!)1F("X/)
M4GC!SD@D\YQQ@ ]7K/CBUTZ,RK(DC=%2-U8D]NF<#U)Z>YP#QOPTTB34;AM5
MD/"L_/ +2./FX Z ,3VY(QGFNRN? 5E=.TKQ99V+$[Y!DDY)X;'6HO\ A7-A
M_P \O_(DG_Q5>=Z/HL-QJ9LG7,(EF7;EAP@?:,@YXP.]>MZ1HL.D(8H%VJ6W
M$98\D 9^8D] *QOB/>BULI!N*M(548SSD@D<=BH.<\$<=ZH_"BR,%JTI4 RR
M,0>,E5 4>^ P; /N>]=K117DGQ;_ ./M/^N"_P#H;UZW7DFJ0OX,U 7 _P!3
M(Q;"@@;&/S)C(&5[#./NDXZ5Z7HNO0ZR@EA8'@97C<N<\,.QX/L<9!(YJMXD
M\50Z"A:0@R8^6,$;CG...R\'+=..YP#Y_P" -,?6KQM1D4;%=W)VY4NW(49/
M49W9YQ@9Y(-;?Q9UHP1)9*1F4[FY&=JD8&,9P6Y!X^Z1SS70>"=%&DVJ1X(=
MQO?((.Y@."">"HPO;IG&36]7'_$[11?6OG@'? =PP"?E; <<'IT8G!P%[ FI
M?AMK1U&U$;$;X#LZC.T#Y#@ 8&/E'KM)SG-<1\+[Z.RN7>5U13"PR[!1G>G&
M3CGBO4/^$FM/^>\7_?U/\:P_$7Q'M]/1E@82S#  7)3D9R6'! [@'.>..2,O
MX9^&W4MJ=P#ND'[LMRQW<LYR,Y/8YR06[$$^A45Q'Q;_ ./1/^NZ_P#H#UI?
M#G_CPA_[:?\ HQJXGXM_\?:?]<%_]#>O6ZR/%/A]==@:W/WA\R') #@$ GKQ
MS@\'@\<X->(7TLL0^QRDX@=P%)!VDD!P".V5]<9R1U.?=/#/_'I;_P#7"+_T
M 5Y[X\TZ30+M=4AQM=P1@$ ,H&Y6QC(?DGD%LMZ9/>^'_%,&NKNA;YAG*-@.
M,'K@$\<CD9'..N14^M:]#HR&69@.#A>-S8QPH[GD>PSDD#FO+='@?QAJ'VID
M C#JSC&Y0J@!5.<9+;<>_)Q@$#V*BN(^+?\ QZ)_UW7_ - >M+X<_P#'A#_V
MT_\ 1C5TM%9OB;_CTN/^N$O_ * :XCX.?\O'_;+_ -GKT2YMEND:)QE74J1R
M,@C!''/2O)/#EX_@J\:&Z!".NTE22N,_+(!_$!@CU )[@K7H\GC*SC3SC.FW
M . V6Y_V!EL\\C&1WQBO.(XG\;7YF53Y"LFX.QPL:XXR.A;!( [D\X!:O2_$
MGB!-!A-Q("><*H[L02!GL."2?0=S@'SOP5X;/BB62^O,O'D@Y;!9\#CY>0J@
M]L?P@< BJQBE\"7H?!,+$@' ;=&2,C/R_..,].<?PGGUNRO4OD6>)@R.,@C_
M #U]1U!X/->:?%O2?*DCO%'$B[6PO&Y>02W<D' SSA>_:CX/W^)-1^U38)7,
MC 94?)A4 Q_=.WJ>0.2>_L%%%>5^/-.DT"[75(<;7<$8! #*!N5L8R'Y)Y!;
M+>F3WOA_Q3!KJ[H6^89RC8#C!ZX!/'(Y&1SCKD5/K6O0Z,AEF8#@X7C<V,<*
M.YY'L,Y) YKRW1X'\8:A]J9 (PZLXQN4*H 53G&2VW'OR<8! [#XK6S2V891
MD1RJS=. 0RY_-@*K?#GQ%:V]J('=(Y$9MV\JF[<20P)/S<8'J,8Z8S=\4_$"
M#3XV6!P\S+\OED,!G(W%N5XQG')/'&#FN2^$G_'V_P#UP;_T-*/BW_Q]I_UP
M7_T-Z];KSWXLZ$9E2_0#]V-KG/."1LXZ8!)SCGD=0.-3PAXX@O(%6:0)+&JJ
MWFN 6P,;@S8SG&3W!Z]B>2^)'BY-59;2 YCB8EF&,,V,#'?"C/.<'/3 !/;?
M#G_CPA_[:?\ HQJZ6BO)/#__ "&6_P"N]Q_*2O6ZR/%/A]==@:W/WA\R') #
M@$ GKQS@\'@\<X->?_#SQ VBSMIL_"NY7& 2)<A<9'8XQW&<'@9-=SXVT(ZU
M:M"@!D!#)DXY'7VR5) SQD\XZCC?AWXM72@UA=L4 ?Y-X/RDG#(?[HSST !W
M$FNTU#QI9V*&0RHWH(V#L3@G&%)QG'4X&>I%87@'Q+>:X[F4+Y*DG=LQR<8C
M4AAP.N2&..">0:[*^M!>QO V0LB,IQUPPP<=>>:\0T_49-&6ZM&.UG385P&R
MRN%(S@_P%^<X_'%=[\)M+-O;O<G.9GXY&-J9 /J#N+ Y]!QZ]!XM\0#0;=KC
M +DA4!S@L?7'8 $]LXQD$UY?X<N+:\F:^U.7+;LA"KMN/J=JD;1T"^V" HP?
M1/\ A8UA_P ]?_(<G_Q-:>C>(X-9W?9WW;,;OE9<;LX^\!Z&M*BO)/#_ /R&
M6_Z[W'\I*];HHKR3X2?\?;_]<&_]#2O6Z\F\8:=)X=OAJ2*?*:0."K$9/5T)
MYP6^;U!!XZ$#O=/\:6=\@D$J+ZB1@C X!QAB,XSU&1GH37!>-_$ \4RQ6=F&
M< GID!F8#^$XP%&?F.,9;H.3V\VEC2M->VXREM)G!)&XH2Q&><%B3_05S'P<
M_P"7C_ME_P"SUZ37DGPD_P"/M_\ K@W_ *&E=)\6_P#CT3_KNO\ Z ]3_#?5
MX7M(K8.OFJ7!0D!OO,W /)&#G(R.OH:["BBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBN=O/ T%W=#469_,#HV 5VY3&.-N<?+SS714R6(2@HP!5@00
M1D$'J"/2N4U#X86=XYD&^//41L N<DYPRMCZ#  Z"M#0O!-KHI$D:DR $;W.
M6Y]N%!QQD '''<YWJHZUI":O"UK(2%?&2N >&#=P1U'I4'AWP['H$9@B+%6<
MM\Y!.2 .P''%:M%<[KG@*UU<^8RE')R6BPI/4G(P022<DXS[XJC:?"RS@.YM
M\@QT=\#Z_(%.?QQ[5UL40B 10 J@  #  '0 >E/HKG;/P-!:71U%6?S"[M@E
M=N7SGC;G'S<<UT597B+P['K\8@E+!5<-\A .0".X/'-3Z+I":1"MK&253."V
M">6+=@!U/I5ZBBN=\1>!H-?D$\K.&5 OR%0, D]U//-=%5/5-)BU5/)G4,F0
M<'(Y'<$8(/T/3(Z&N)N_@_&YS%,RKCHZASGZ@IQ[8_&I-.^$<,)W3R-( 1@*
M @XZ@\L2#[$$>OIV]E9)8HL$2A408 '^>OJ>I/)YK!UCP%!J\WVJ9I"?E^7<
M-F%_A'RY /4X(Y)(Q72T5%<VRW2-$XRKJ5(Y&01@CCGI6)X<\%Q>'W:2%Y#O
M7!#L"O7(. HY'8^A/K61_P *DM/[\O\ WTG_ ,11_P *DM/[\O\ WTG_ ,16
MAI?PYL[ [BAD8$X,IW=1C&T *1]03GOTQT]%%97B+P['K\8@E+!5<-\A .0"
M.X/'-3Z+I":1"MK&253."V">6+=@!U/I67XB\#0:_()Y6<,J!?D*@8!)[J>>
M:Z*BN:\0> ;?7)/M$A=6V@'RRH!QW.5))QQGT ':MZQM!91I N2L:*HSUPHP
M,].>*+VR2^1H)5#(XP0?\]?0]0>1S7$:C\(X9CN@D:,$G(8!QST Y4@#W))]
M?6.T^#\:',LS,N.B*$.?J2_'MC\:[;2])BTI/)@4*F2<#)Y/<DY)/U/3 Z"K
ME%97B+P['K\8@E+!5<-\A .0".X/'-3Z+I":1"MK&253."V">6+=@!U/I5ZB
MH+ZT%[&\#9"R(RG'7##!QUYYK*\->$8O#V_R2Y\S;G>0?NYQC"CUK<K/UC0(
M-8 6X0.%.1R01GKRI!P>XZ'CT%<U%\)K1"&+2D C@LN#['"@X/L0?>NITO28
MM*3R8%"IDG R>3W).23]3TP.@K)\0>"(M><2S22_*,*JLH4>N 4/)[DDG\
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[encoded data, 8906 characters]
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M?2,>?(%)Z#DMSGG:H)QP><8SQ7-?\+;M/[DO_?*?_%UI:=\0[*^P/,V,V>)
M5QC/5N4&<<?-[=>*Z6BBBN:_X6-8?\]?_(<G_P 3706URMTBRH<JZA@>1D$9
M!YYZ5D:CXTM--D-O-)M=<9&QSU (Y"D=#5;_ (6-8?\ /7_R')_\36YIVHQZ
ME&+B$[D;.#@CH2#P0#U%27-RMJC2N<*BEB>3@ 9)XYZ5S_\ PL:P_P">O_D.
M3_XFI;;Q[973K$DN6=@H&R09). .5QUK;N;E;5&E<X5%+$\G  R3QSTKG_\
MA8UA_P ]?_(<G_Q-'_"QK#_GK_Y#D_\ B:?%\0K&0A1,,D@<HX'/J2H 'N>!
M6[;7*72B2-@RGH5((.#CJ..M2T5AZMXTM-+R)) 6&[Y4^=LKU4XX4YX^8CGZ
M&L3_ (6W:?W)?^^4_P#BZU]&\=6FJD(C[7;HD@VGK@#/W23V )/ZUT%%<_<^
M/;*U=HGEPR,5(V2'!!P1PN.M1?\ "QK#_GK_ .0Y/_B:/^%C6'_/7_R')_\
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MPP_H1V/;W!(/M^DZHFJQ+<Q9V..,C!X."#[@@CT]"17*?%O_ (]$_P"NZ_\
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MHQ<0Q[D;.#O0="0>"P/459_X5S?_ //+_P B1_\ Q5'_  KF_P#^>7_D2/\
M^*KU'P7ITFFVD=O,-KKOR,@]78CD$CH:W**\V^,?_+O_ -M?_9*S?A)_Q]O_
M -<&_P#0TKO_ !EKW]B6SS#[[?*G^\V<'H1P 6YX.,=Z\.^>Z?NSNWNS,S'\
MR2?Q)KK;;X4WDJAF,:$_PLQ)'/\ LJP_(US>LZ-)H\AMYAAAT(Z$=F![@_\
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M*]K\ >)!K-N%8DRP@*^<\]=K9).20.>^0> ,5T]?-M?0'AG_ (]+?_KA%_Z
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M72_"#4,I-:DCY65P/XCN&UN_0;5[<$\]15WXM_\ 'HG_ %W7_P! >N)^'/\
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MN2!PN?4G@>YKP+]YJ<O]Z69_899S^ &2?85O>//#)T.1,8*/&H! "_-&H5^
M3R>&)]6[D$UN_"361&TEBQ^_\Z#@#(&']R2,''/"D\=_3J\K^)WA4VS_ -H1
M [)#^\  PK< 'CLW?C[W4Y8"H/A=X@^Q3&S<_)/TR> XZ=2 -PXZ$D[16;X^
M\0?VQ<MM.8HOE3!X./O-P2.3T(ZJ%S75_"_PJ8!_:,H(9@1&"!]TX^?UR>@Z
M<9ZAA7H5%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9^OZ.-8@>T8E0X'(YP00PX[C(Y'<=QU
MK(\'^"1X<+OO$C2!0#LVD 9R,[FX/&>G05YMXGE&NZ@XA(Q+(B*2?E) 6/.1
MGY21D$=JZ[XP792.&#C:[LQ]<H !^'SG/X5L_#2V6*QC91@R,[-UY(8KG\E
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M17S_ .)O^/NX_P"N\O\ Z&:S:**^DJ**\V^,?_+O_P!M?_9*S?A)_P ?;_\
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MX_ZX2_\ H!KY_KI?^%C7_P#SU_\ (<?_ ,35'5?%EUJJ^7-*67T "@\@\A0
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M_P"VG_HQJZ6BO)/BW_Q]I_UP7_T-ZTO@Y_R\?]LO_9Z])KFOB-_QX3?]L_\
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M*?E)&-RYX8<G@_4X.0>0:N>$?#3:_,(N1&O+L .!V'/&6/ Z]S@@&O<XHA$
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MWT)8@#+CDXY*, /J2<#U->X4R641 NQ 50223@ #J2?2OG"OH#PS_P >EO\
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M@X9OF89'& 20/;N>M>*>)O\ C[N/^N\O_H9KUOX<_P#'A#_VT_\ 1C5G^.O
MJ:BC74"A9D!8A1_K.I(P!]_T/4G@]B/,-&UF31Y!<0G##J#T([J1W!_^N,$
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M_P!<(O\ T 5I5Q'Q;_X]$_Z[K_Z ]<3\.?\ C_A_[:?^BVKVVBBBBN(^+?\
MQZ)_UW7_ - >N \%Z='J5W';S#<C;\C)'1&(Y!!ZBO4?^%<V'_/+_P B2?\
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M$3WK 9E.U>!G:I.3G.<%N"./N@\\5WU>&^/-/^PWLJ@'#MO!;OO&XXX&0&)
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MV  ]/2CXD^),VKH8(U$4;##88LQZY&[ PIXR,9]\$BN?T'17UF9;:,'YC\Q
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MW(%=7\6_^/1/^NZ_^@/7$_#G_C_A_P"VG_HMJ]MKR;XH>&S9R_;D \N8@-C
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M(\"Z,-5NTC891,NXXQA>F0>H+8!'H?QKV#_A&;3_ )X1?]^D_P */^$9M/\
MGA%_WZ3_  KR_P")F@KIEPLD2A8Y4X"[0H9>& 48P,;3[DGGTTOA+K1C=[%B
M-KC>N2!\PP& XR21SUX"GCK4?Q1\-O%*=00$QN%#GKM8#:.,<*0!@\\Y!QD
M\MX?\23:"YEA(^8896R5/ID CD=B"#^!(/:?\+C_ .G?_P B_P#V%<;XA\43
M:^P:8C"9VJHP!D#/J3G'<GVQ75_"KPX7<ZA("%4$1YXR3D,PYZ 9'0@DGNM=
M7\1O^/";_MG_ .C%KQFQNS92).N"T;JPSTRIR,]..*[#_A;=W_<B_P"^7_\
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MWB_]#%?0%%>)?$;_ (_YO^V?_HM:9X=\<SZ!&8(E0JSEOG#$Y( [,..*U?\
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M (372O\ GU_\@0__ !5'_":Z5_SZ_P#D"'_XJC_A-=*_Y]?_ "!#_P#%4?\
M":Z5_P ^O_D"'_XJC_A-=*_Y]?\ R!#_ /%4?\)KI7_/K_Y A_\ BJ/^$UTK
M_GU_\@0__%4?\)KI7_/K_P"0(?\ XJC_ (372O\ GU_\@0__ !5'_":Z5_SZ
M_P#D"'_XJC_A-=*_Y]?_ "!#_P#%4?\ ":Z5_P ^O_D"'_XJC_A-=*_Y]?\
MR!#_ /%4?\)KI7_/K_Y A_\ BJ/^$UTK_GU_\@0__%4?\)KI7_/K_P"0(?\
MXJC_ (372O\ GU_\@0__ !5'_":Z5_SZ_P#D"'_XJC_A-=*_Y]?_ "!#_P#%
M4?\ ":Z5_P ^O_D"'_XJC_A-=*_Y]?\ R!#_ /%4?\)KI7_/K_Y A_\ BJ/^
M$UTK_GU_\@0__%4?\)KI7_/K_P"0(?\ XJC_ (372O\ GU_\@0__ !5'_":Z
M5_SZ_P#D"'_XJC_A-=*_Y]?_ "!#_P#%4?\ ":Z5_P ^O_D"'_XJC_A-=*_Y
M]?\ R!#_ /%4?\)KI7_/K_Y A_\ BJ/^$UTK_GU_\@0__%4?\)KI7_/K_P"0
M(?\ XJC_ (372O\ GU_\@0__ !5'_":Z5_SZ_P#D"'_XJC_A-=*_Y]?_ "!#
M_P#%4?\ ":Z5_P ^O_D"'_XJC_A-=*_Y]?\ R!#_ /%4?\)KI7_/K_Y A_\
MBJ/^$UTK_GU_\@0__%4?\)KI7_/K_P"0(?\ XJC_ (372O\ GU_\@0__ !5'
M_":Z5_SZ_P#D"'_XJC_A-=*_Y]?_ "!#_P#%4?\ ":Z5_P ^O_D"'_XJC_A-
M=*_Y]?\ R!#_ /%4?\)KI7_/K_Y A_\ BJ/^$UTK_GU_\@0__%4?\)KI7_/K
M_P"0(?\ XJC_ (372O\ GU_\@0__ !5'_":Z5_SZ_P#D"'_XJC_A-=*_Y]?_
M "!#_P#%4?\ ":Z5_P ^O_D"'_XJC_A-=*_Y]?\ R!#_ /%4?\)KI7_/K_Y
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MI7_/K_Y A_\ BJ/^$UTK_GU_\@0__%4?\)KI7_/K_P"0(?\ XJC_ (372O\
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M (372O\ GU_\@0__ !5'_":Z5_SZ_P#D"'_XJC_A-=*_Y]?_ "!#_P#%4?\
M":Z5_P ^O_D"'_XJC_A-=*_Y]?\ R!#_ /%4?\)KI7_/K_Y A_\ BJ/^$UTK
M_GU_\@0__%4?\)KI7_/K_P"0(?\ XJC_ (372O\ GU_\@0__ !5'_":Z5_SZ
M_P#D"'_XJC_A-=*_Y]?_ "!#_P#%4?\ ":Z5_P ^O_D"'_XJC_A-=*_Y]?\
MR!#_ /%4?\)KI7_/K_Y A_\ BJ/^$UTK_GU_\@0__%4?\)KI7_/K_P"0(?\
MXJC_ (372O\ GU_\@0__ !5'_":Z5_SZ_P#D"'_XJC_A-=*_Y]?_ "!#_P#%
M4?\ ":Z5_P ^O_D"'_XJC_A-=*_Y]?\ R!#_ /%4?\)KI7_/K_Y A_\ BJ/^
M$UTK_GU_\@0__%4?\)KI7_/K_P"0(?\ XJC_ (372O\ GU_\@0__ !5'_":Z
M5_SZ_P#D"'_XJC_A-=*_Y]?_ "!#_P#%4?\ ":Z5_P ^O_D"'_XJC_A-=*_Y
M]?\ R!#_ /%4?\)KI7_/K_Y A_\ BJ/^$UTK_GU_\@0__%4?\)KI7_/K_P"0
M(?\ XJC_ (372O\ GU_\@0__ !5'_":Z5_SZ_P#D"'_XJC_A-=*_Y]?_ "!#
M_P#%4?\ ":Z5_P ^O_D"'_XJC_A-=*_Y]?\ R!#_ /%4?\)KI7_/K_Y A_\
MBJ/^$UTK_GU_\@0__%4?\)KI7_/K_P"0(?\ XJC_ (372O\ GU_\@0__ !5'
M_":Z5_SZ_P#D"'_XJC_A-=*_Y]?_ "!#_P#%4?\ ":Z5_P ^O_D"'_XJC_A-
M=*_Y]?\ R!#_ /%4?\)KI7_/K_Y A_\ BJ/^$UTK_GU_\@0__%4?\)KI7_/K
M_P"0(?\ XJC_ (372O\ GU_\@0__ !5'_":Z5_SZ_P#D"'_XJC_A-=*_Y]?_
M "!#_P#%4?\ ":Z5_P ^O_D"'_XJC_A-=*_Y]?\ R!#_ /%4?\)KI7_/K_Y
MA_\ BJ/^$UTK_GU_\@0__%4?\)KI7_/K_P"0(?\ XJC_ (372O\ GU_\@0__
M !5'_":Z5_SZ_P#D"'_XJC_A-=*_Y]?_ "!#_P#%4?\ ":Z5_P ^O_D"'_XJ
MC_A-=*_Y]?\ R!#_ /%4?\)KI7_/K_Y A_\ BJ/^$UTK_GU_\@0__%5M^$?$
M-EJ4K1VL/EN$))\N-/ERH(RI)ZD<=.*ZZBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBF2Q"4%& *L""",@@]01Z50_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]
M^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_Y
MX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1
MFT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]
M^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_Y
MX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1
MFT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]
M^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_Y
MX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1
MFT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]
M^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_Y
MX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1
MFT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]
M^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_Y
MX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1
MFT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]
M^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_Y
MX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1
MFT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]
M^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_Y
MX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1
MFT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]
M^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_Y
MX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1
MFT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]
M^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_Y
MX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1
MFT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]
M^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_Y
MX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1
MFT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]
M^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_Y
MX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1
MFT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]
M^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_Y
MX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1
MFT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_PH_X1FT_YX1?]^D_P
MH_X1FT_YX1?]^D_PJ:TT>"R.^*-$8C&415./3( XXJY11111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111117'^*_'Y\/S?9S$'!0,"),<$D<C8<'(/<\8^@TO"'BH>(HVEVA&1\%=
M^XXP"&Z# /(''8UO4R641 NQ 50223@ #J2?2O.?^%Q_].__ )%_^PKT:(D@
M%@ V!D Y /?!P,CWP/H*?1165KGB:WT49F<!L9"#ESUQA?0XQDX&>I%7-,O/
MMT4=QC'F(K8SG&X XSQG&:LT44445Q'B/XE?V-.]IY.[9M^;S-N=RANFP^OK
M72^'-9_MF!+O;MW[OESNQM8KUP/3TK2HHHHHHHKD?%WC[_A'I5M_*W[D#9W[
M>I88QM/I6EX1\2_\)#$UQLV;7*XW;N@4YS@>M;E%%%17-REJIDD8*HZEB !D
MXZGCK67H7BF+7'D2#)2()\Q!&2^[H" <#'4]3GC R=FBBBBBBBBBBBBBBF2R
MB(%V("J"22<  =23Z5C:=XNAU.X-G =^U&9G'W<JP7:/7KG(XQC!.>-RBBBJ
M.LZS'H\9N)CA1T ZD]E [D__ %S@ FO/=1^+TC'%O$H4$\R$L2.W"E<'U&6^
MO',%M\7;A6!DCC9>X7<IZ>I9@.?8UW/A?QC#X@!"9610"R-C/;)![KGC/!]0
M,C.]1111111111116"OC.WGN([&%A([ELE3E5"H6^]T8GI@=.<D$8.]1115;
M4[S[#%)<8SY:,V,XSM!.,\XSBN(TSXK?;I8[?R,>8ZKGS<XW$#.-@SC->@44
M4444444444444444444445Y_J?Q6^PRR6_D9\MV7/FXSM)&<;#C.*K?\+C_Z
M=_\ R+_]A1_PN/\ Z=__ "+_ /84?\+C_P"G?_R+_P#85Z!IEY]NBCN,8\Q%
M;&<XW '&>,XS5FBL/Q=XE_X1Z);C9OW.%QNV]0QSG!]*S?"/C[_A(96M_*V;
M4+9W[NA48QM'K7745A^+O$O_  CT2W&S?N<+C=MZACG.#Z5F^$?'W_"0RM;^
M5LVH6SOW="HQC:/6NNHHHK!U'QG;VDJ6BL'E>1$VJ<[=S;22>@*_W>N<< '(
MWJ********X;6OBM#9.8H4,NTD%MP5>,?=.&R.O. ..,@YKG?^%MW?\ <B_[
MY?\ ^+K7T;XMK(0EU'MSU>/)')_N'D #K@L>.!SQW]M<I=*)(V#*>A4@@X..
MHXZU+5;4[S[#%)<8SY:,V,XSM!.,\XSBN(TSXK?;I8[?R,>8ZKGS<XW$#.-@
MSC->@45Y_J?Q6^PRR6_D9\MV7/FXSM)&<;#C.*[?3+S[=%'<8QYB*V,YQN .
M,\9QFK->?ZG\5OL,LEOY&?+=ESYN,[21G&PXSBNWTR\^W11W&,>8BMC.<;@#
MC/&<9JS3)91$"[$!5!)).  .I)]*X#5?BXD9*6\9<8.'<[1GG!VX)*]#R5)Z
M8%8W_"V[O^Y%_P!\O_\ %UTVA_%*WOCY<P,+$\$G<G8#+8&#SW& !DM7:T5R
M/B[Q]_PCTJV_E;]R!L[]O4L,8VGTK2\(^)?^$AB:XV;-KE<;MW0*<YP/6MRN
M-\2_$J/2)/L\:>:RYWD-M"G^[G#9/KZ=.N0#PUX^DU^3RH[?"C!=S+PH_P"^
M.2>P[^P!([*BBBBBL_7]8&CP/=L"P0#@<9)(4<]AD\GL.QZ59L;L7L:3KD+(
MBL,]<,,C/7GFIZ****R/$WB-- C$[J6#.JX7&><DGGT /U.!QG(UZ*****R-
M:\1II4D$#*2;E]H(Q@=!DY]V'X9/8 Z]%%%%%%<1XC^)7]C3O:>3NV;?F\S;
MG<H;IL/KZUF_\+C_ .G?_P B_P#V%'_"X_\ IW_\B_\ V%'_  N/_IW_ /(O
M_P!A7H&F7GVZ*.XQCS$5L9SC< <9XSC-6:*YKQ?XU3PYL7;YCOD[=P7"CN>"
M>3TXP<'GBL33?BTES(D4D6Q78 MY@(&>,G*J,9ZG/ YYZ5Z!115'6=9CT>,W
M$QPHZ =2>R@=R?\ ZYP 37GNH_%Z1CBWB4*">9"6)';A2N#ZC+?7CF"V^+MP
MK R1QLO<+N4]/4LP'/L:[GPOXQA\0 A,K(H!9&QGMD@]USQG@^H&1G>K*\2:
MP^D0FYCC,NT_, VW"X.6Z'('&>.G/0&N4TWXM)<R)%)%L5V +>8"!GC)RJC&
M>ISP.>>E>@45Y_J7Q:2VD>*.+>J,0&\P ''&1A6&,]#GD<\=*ZOPWK#ZO"+F
M2,Q;C\H+;LK@8;H, \XXZ<]"*U:*********************************
M************************************************************
M************************************************************
M**************************************X;XLZ6;BW2Y&<POSR,;7P"
M?4G<% QZGCTYOX5:H;:Z-N<[9T/  ^\F6!)ZXQN''<CCN/7:YCXC:H;"S<#(
M:4B,$ '[V2V<]BH(]<D?4><_#W2/[2O$R<"']X?7Y", <'^(C/3C/.:]HN;E
M+53)(P51U+$ #)QU/'6N?_X6-8?\]?\ R')_\36YI^I1ZB@EA8.I[J<XX!P>
MX.#R#R.].N[Z.R&^5U12<9=@HSZ9..>*\&\2W/VJZFDW;@97P<Y!4,0N#Z8Q
MCMCI7L'AG7+?[/;P^;'O\J)=OF+NW;0,8SG.>,=<UT%9&J^++72F\N:4*WH
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MP93T*D$'!QU''6H]0U*/3D,LS!%'=CCL3@=R<#@#D]JQHOB%8R$*)ADD#E'
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MN"1QQ36UR 1M<^8AB3[S*P8#IQQGGD<=3D8ZU1T_QK9Z@XBCE!8] P9,Y(
MW  DD\ <UN5Q]]\+[:]D>=GE#2.S'#)C+')Q\AXYKEO'/@:#0(%GB9RS2!?G
M*D8*L>RCGBLCP-X=CU^=H)2P58RWR$ Y#*.X/'-=S_PJ2T_OR_\ ?2?_ !%=
M!-JEMX=C6&60*(T4 ,<N5'R@[0,GIU QU]*H_P#"QK#_ )Z_^0Y/_B:WK2^C
MO1OB=74'&48,,^F1GGFN/^+?_'HG_7=?_0'KF_A)_P ?;_\ 7!O_ $-*[NY\
M?6-NQ1I@2/[JLXY&?O*"#^!K7T_4H]102PL'4]U.<< X/<'!Y!Y'>N1^+?\
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M\O\ Z&:]N\,_\>EO_P!<(O\ T 5I5\_^)O\ C[N/^N\O_H9KV[PS_P >EO\
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M(N.<88_/N7!X."O/!R/85ZM8W8O8TG7(61%89ZX89&>O/-3T44445XE\1O\
MC_F_[9_^BUK?\)_#NWU>VCNI&D#/NR%*@<.R]U)Z#UK7_P"%26G]^7_OI/\
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MZ;?P\C31;&34)<8<LQ(/)5,JJX.!N+;L>N0,]AP6JZM-XDGY))D?$:%N%W$
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M&;0$1,,_,/F)Z,6]6R,'MQQ\N*V:****XKQEXGOM#<M'&C6Y PY5VQT!#$,
M#D\=B",$G.,:V^,+JH$D 9NY5RHZ^A5B./<US?B_Q<WB-T8KL6-2 N0W)/)S
MM!Y  Q[>]6?"'CIO#J/$4\Q78,!N"X.,$_=).0!],>];-W\8)'&(H55L]78N
M,?0!.??/X5T_@S6[S6,RW$:)#M&TA65F)P01N8Y7'?N2,9YQU->?^*?&5_H4
MC*8H_*+?(^UR"#G )W ;L#D<=,CC!JI%\8B  T +8&2), GO@;#@>V3]:X_Q
M1XA;7YC<L-HVA57(. .V<#.22?QQVK;\+_$9M#A%JT?F!6)4[PN ><?=.><G
M.>^.U7KSXOROCR8D7KG>Q?/IC&S'Z_A7:>$M0N[]&EO(UCR1L4!E;C.XD,3@
M=,=#U.,8)WJ\TUKQ]J&C.8IHHAR<-M?:V,<J=_(Y'N,X(!XIW_"X_P#IW_\
M(O\ ]A7":WJK:M,]T_!D;... .%' &<  9QSUKK=$^*;:="EL\6\QKMW;PO
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M JTT8((R""XR"/2OH*OG_P 3?\?=Q_UWE_\ 0S7L^CWJ6-C#/*P5$MXB2?\
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M&0!W;'... >17L/AKPC#H"_NQF0J SGJ><\#HHSV'H,DD9K<HHHHKQ+XC?\
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MF].SR%1B0%#6ZL6)[ 1A^?RZ\9K7^(,0BT^5% "J(P !@ "1, #TKSGX<_\
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M\)/^/M_^N#?^AI7I/B;_ (]+C_KA+_Z :\1\,_\ 'W;_ /7>+_T,5] 5\_\
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M"B@^C#YCC(. ._."5SP:\V\ :6=0O(QSMB/F$@@8V<CKVW8!QS@_B-7XM_\
M'VG_ %P7_P!#>ND^$G_'H_\ UW;_ - 2NWHHKB/BW_QZ)_UW7_T!ZYOX2?\
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M(&#A>1TKKJ**X@>"7UF[EO+\?NPQ6- QY4<*Q(.5&.< @EB20!P>TBB$0"*
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M[>OG_P 3?\?=Q_UWE_\ 0S4OB33_ +&T3  "6V@<!?= ISQU+*2?7.>M>O\
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MG:1RN0S@%6YR<J<#.23N(P3GKG/0UB>,?B.-*?[-;!7D4_.6R5'^SP1EO7G
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M$7S "BQ@_=(R"26;D]0!T'7DX&S17->+/'$?AXB(J7E9=P4<#&<9+'.,X.,
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M@#CJ0/?!K+M+V;29-T;-'(IP>H/!Y4CN,CD'CU%>Z>&]7_M>WCNL8+KR.@W
ME6QR>,@XYSCK6E5'6]57287NGY$:YQSR3PHX!QDD#...M>)7FH7/B>8!B7=V
M.U!]T9[ $X P.3Z#+'J:[#2_A"2<W,HQD_+$,Y&./F8#!SVVGCOSQYQ7TE16
M;XF_X]+C_KA+_P"@&O$?#/\ Q]V__7>+_P!#%?0%%>!>*-4&J74MP,%6?Y2
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MAB1Z8 ^I[WX?P+I5@)Y,J&WRMN!X XR !G!501USG(ZBO-_$'B6?Q')SG:6
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M@YQQ3?!?Q$71HOLLZLR*6*E-N1D@[<';QG)SG/.,8JCXH^($VJ2!H&>*-00
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M8Z>H+VR2^1H)5#(XP0?\]?0]0>1S7*7/PILY6+*9$!_A5@0./]I6/YFM+1O
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MT%H-SC(\PXV \<J.=W?DX&0#\PKT"BBBBBBBBBBBN8\4^/8=!/DX,DN =JD
M#./O-S@D<@8)]< @U>\'ZH^JVJ7,N-[E\X&!P[  >P  ]?4DULT444444444
M44445@^*/&,/AX /EI&!*HN,]\$GLN>,\GT!P<1^"/$#Z]%)<2 #]\P51V4*
MA SW/))/J>PP!-XTU&33;22XA.UUV8. >KJ#P01T-<3X+\:7>I7<=O-)N1M^
M1L0=$8CD*#U%>I4444444445YW\1/%ESI%PL4#[5,08C:AY+,,_,I/0"MOX=
MZU-J]NTL[;F$I4'"C@*IQ\H ZDUU-%%%%%%%%%%%%%8/BCQC#X> #Y:1@2J+
MC/?!)[+GC/)] <'$?@CQ ^O127$@ _?,%4=E"H0,]SR23ZGL, 3>--1DTVTD
MN(3M==F#@'JZ@\$$=#7$^"_&EWJ5W';S2;D;?D;$'1&(Y"@]17J5%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%8?C349--M)+B$[779@X!ZNH/!!'0UQ/@OQI=ZE=
MQV\TFY&WY&Q!T1B.0H/45ZE111111111111111115'7+EK6WFE0X9(I&!X."
M%)!YXZUY;H?CV]NKB&)Y<J\L:D;(QD%@".%STKV"BBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBJ>K:6FJQ-;2YV..<'!X.
M01[@@'T]017@]S!)HDY0\2P/P<<94Y##<.0>",CD5[EHVOQZI +Q6 7;E\GA
M"!E@2<=/4XR.>AKQCQ;X@.O7#7&"$ "H#C(4>N.Y))[XSC) KU+P!X;&C6X9
M@1+, SYSQUVK@@8(!Y[Y)Y(Q6EKGB:WT49F<!L9"#ESUQA?0XQDX&>I%<;+\
M8@"0L!*Y."9,$CMD;#@^V3]:W/#GQ&M]7(A?,4K' 5N5).< -@<\#J!R<#-=
M77.^(O',&@2""57+,@;Y I&"2.[#GBKOAWQ%'K\9GB#!5<K\X .0 >Q/'-3Z
MUJZ:1"UU("53&0N">6"]R!U/K6)HOQ$M]7F6UC60,^<%@H'"ENS$]!Z5MZUJ
MZ:1"UU("53&0N">6"]R!U/K6%I7Q)MM2D$"AU)#'<X0* JEB2=YP,"LB]^+R
M1.RQ1%T!X8OMS[[=IP/3OCJ >*[;2=2&IQ+<JK*KC(#C#8SP<9/!ZCU!!JY1
M7S;7TE7$?\+;M/[DO_?*?_%UH>*?'L.@GR<&27 .U2 !G'WFYP2.0,$^N 0:
MQM/^+L<KA9HBBG^)6WXY'4;5.,<G&3Z UV]SJ"01-=9W(J%\K@Y4#=QS@Y'3
MG%>,>.?$4>OSK/$&"K&%^< '(9CV)XYK7\#>.8- @:"57+-(6^0*1@JH[L.>
M*]2L;L7L:3KD+(BL,]<,,C/7GFN;\1_$:WT@F%,RRJ<%5X4$8R"V#SR>@/(P
M<5C6WQA1F D@*KW*N&/3T*J#S[BNXTO5HM53SH&#)DC(R.1V(."#]1TP>AIN
MM:NFD0M=2 E4QD+@GE@O<@=3ZUA:5\2;;4I! H=20QW.$"@*I8DG><# K(O?
MB\D3LL41= >&+[<^^W:<#T[XZ@'BNBO/&D5G;1Z@Z2!)6P!M&_G<02"V,$+D
M'/((-1:%X^M]9=HT#KL0N3(%50JD \ACZ_3%8FH?%V.)RL,1=1_$S;,\GH-K
M'&.1G!]0*V?"WCV'7CY.#'+@G:Q!!QG[K<9(')& ?3(!-=/6-X@\6V^@@"9C
MO(R$498C.,]@!]2,X.,D5Q__  N/_IW_ /(O_P!A78>'_%MOKP(A8[P,E&&&
M SC/<$?0G&1G!-,\2^+HO#VSS@Y\S=C8 ?NXSG+#UKPFO:=%^(EOJ\RVL:R!
MGS@L% X4MV8GH/2NIHKG?$7CF#0)!!*KEF0-\@4C!)'=ASQ5WP[XBCU^,SQ!
M@JN5^< '( /8GCFM6N(_X6W:?W)?^^4_^+KMZYKQ!X^MM'RF?,E&?D3G!Y&&
M;H.1@CEAUVUS?_"X_P#IW_\ (O\ ]A78>'_%MOKP(A8[P,E&&& SC/<$?0G&
M1G!-6]:U=-(A:ZD!*IC(7!/+!>Y ZGUKQ+Q9JZ:O<R748(5]N V >$5>Q(ZC
MUKK?"?Q$M](MH[619"R;LE0I'+LW=@>A]*].KBM<^*5O8GRX09F!Y(.U.X.&
MP<GCL,$'(:JFG_%V.5PLT113_$K;\<CJ-JG&.3C)] :[FRO4OD6>)@R.,@C_
M #U]1U!X/-3T45S7B7QY!H3>2P+R[2=J8P./E#$GC/L"0.<<C/-_\+C_ .G?
M_P B_P#V%=)X:\>0:ZWDJ"DNT':^,'CY@I!YQ[@$CG'!QTM<1_PMNT_N2_\
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M @@Y!!Z$'TK-\1>(H] C$\H8JSA?D )R03W(XXK+TKXC6NH%_OH(T+LT@4#
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M8LFTD9VX4@Y&<')/([=*\[\4:.-'N9+5265",$]<,H89]QG&>_7 Z5U/P_\
M T6K1F[N Q7>0J\JI '+9')&3@8(P5.<]!G_ !%\+QZ'(C0C$<JG"Y)(9<9Z
M\X(([DYST&*Z#X/7+,D\1/RJR,!QU8,"?7D*/RK&^*.M/<W)M,D1PA>,\%F7
M=NZ=<-@=<8.,9-:G@?X?0WD(NKI2QDSM7<RC;QACC!R<$CD@J0:R/B!X*30]
MMQ!GRG8@AB#M;J #U((SC.2,<DYKJ?A5K+7D#V[DDP,,$XP$8?*H/7@J>O08
M XX'*?$[6C?77D C9 -HP0?F;!<\#KT4C)P5[$FM?P-\/8[R(7=V"PD'R)EE
MP,_>)&"2>W;'/.>,_P"(?@J/1@MU!Q&[!2A))#8)R"<D@@'.3D'ID' S?AS_
M ,?\/_;3_P!%M7MM%%>)?$;_ (_YO^V?_HM:UO 7@H:ROVJZR84RJ)EAGDDG
M/&%!)^Z>6SG&"#9\>^ H=/A^V6WR"/ ="68'<P ()).<GD="/0CG+^&.M&QN
MO()&R<;3D@?,N2AY'7JH&1DMW(%=7\6_^/1/^NZ_^@/7F6C6$FI2"UA/S2\'
M)P,#YCGV&W/?IP"<5W:?"(Q.C>:'4.N]64IE,_-@AF.<<#I]15'XJ>(&N)OL
M X2+:S<#)<KD'/H%;VY)SGBI? 7@*/4X_MESDJ6(1 < @9!)(.>O0<=.X-7O
M&7PYA@A>ZM05:)<E=V5*C)8_,<@@<]<8& ,G-<Y\//$CZ9<+;Y)BG<*5ZX9N
M%8<C!S@'U'8D#'L5S;+=(T3C*NI4CD9!&"..>E>$^*?#[:%.UN?NGYD.024)
M(!/3GC!X'(XXP:T-<\<2:I:Q61SE0/,;)RQ7(7N<C&"Q/5N0!CG7^&/A4W+_
M -H2@[(S^[! PS<@GGLO;C[W0Y4BO0O$W_'I<?\ 7"7_ - ->(^&?^/NW_Z[
MQ?\ H8KVGQ9JK:5:RW*?>50!TX+$*#R"."<X[XQ7C?AW2'\07*PDD[V+2-R3
MMZL2<'D] 3QN(SUKTN[^%UI+'Y:!D<#[^XL2<8Y!XQGD@!?8@5YIHVH2>';H
M.25,;[9 N"2H;#KUP>GKC."#P#7IOQ/U![.SVH<>:ZH3SG:0S'&#WVX/8@D5
MYOX/LK:\GV7C[(]I(RVT%@0=I8] 1GN#Z'.*[W7?AS;7-N7LE DP&0B1BK#T
MRQ88(Z'CG'(&:RO!O@>]TR9+H[$ ;#*SDED.,_<R#ZC)^\ 2*].HHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKY[URV6UN)HD&%2
M610.3@!B .>>E>V^$;9;>S@5!@&)&[GEQN8\^I)-4?B-_P >$W_;/_T8M>;_
M  Y_X_X?^VG_ *+:O;:XCXM_\>B?]=U_] >N;^$G_'V__7!O_0TH^+?_ !]I
M_P!<%_\ 0WKI/A)_QZ/_ -=V_P#0$K2^(W_'A-_VS_\ 1BUYO\.?^/\ A_[:
M?^BVKTCXC?\ 'A-_VS_]&+7FGP]B$E]"& (RYY&>0C$'Z@C(]#7N%%%%?-M?
M25?-M?25>2?%O_C[3_K@O_H;UTGPD_X]'_Z[M_Z E<W\6_\ C[3_ *X+_P"A
MO72?"3_CT?\ Z[M_Z E9OQC_ .7?_MK_ .R5R7AK4+VSW_80YW;=^R,2=,[<
MY5L=_K6W_P )!K/]V7_P''_QNN:_X1F[_P">$O\ WZ?_  KUOXC?\>$W_;/_
M -&+7FGP]B$E]"& (RYY&>0C$'Z@C(]#7N%<1\6_^/1/^NZ_^@/7-_"3_C[?
M_K@W_H:5ZW7S;7MOQ&_X\)O^V?\ Z,6O(-%N)K>97M<F89V[5WGE2#\N#GC/
M:NI_X2#6?[LO_@./_C=8FHZ7?:E(;B:&5G;&3Y+#H !P% Z"O5O 5L]K911R
M*58;\A@01F1CT//2O#:^DJ**BN;9;I&B<95U*D<C((P1QSTKP2VF?0+H-U:W
MEP=I(!V-AAG&<,,CIT/([5UGQ7UL73Q6T; HJ;R5;*DO]W@<9"C(/HW''7?^
M%6EBVM3<'&Z=SR"?NIE0".F<[CQV(Y[#+^,?_+O_ -M?_9*/@Y_R\?\ ;+_V
M>O2:\D^+?_'VG_7!?_0WKI/A)_QZ/_UW;_T!*XGXC?\ '_-_VS_]%K7I'PY_
MX\(?^VG_ *,:N)^+?_'VG_7!?_0WK*\.ZIJ%I&5L@YC+DG9$'&[ SSM;G&.*
MT+G5]8ND:)UE*NI4C[.!D$8(X3/2L_P]X>N8KF!VAE"K-&23&X  <9)..E>X
M45%<W*VJ-*YPJ*6)Y. !DGCGI7DFO_$VXO69;<^5%R!@#>01C)8YP>XVXQGJ
M< U6MO!VH:ZP>4/Q\N^X8@C SC#9?'/& 1D_6N6KZ2KYMKZ2KR3XM_\ 'VG_
M %P7_P!#>ND^$G_'H_\ UW;_ - 2N;^+?_'VG_7!?_0WKI/A)_QZ/_UW;_T!
M*TOB-_QX3?\ ;/\ ]&+7F_PY_P"/^'_MI_Z+:O;:^?\ Q-_Q]W'_ %WE_P#0
MS7MWAG_CTM_^N$7_ * *^?Z^DJS?$W_'I<?]<)?_ $ UXCX9_P"/NW_Z[Q?^
MABO2?BW_ ,>B?]=U_P#0'KF?A-$'NV) )6%B,CH=RC(]#@D?0FO7:\D^+?\
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M\)O^V?\ Z,6O-_AS_P ?\/\ VT_]%M7MM?/_ (F_X^[C_KO+_P"AFO;O#/\
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M!GN,[LC.,#ID&NI^+?\ QZ)_UW7_ - >N;^$G_'V_P#UP;_T-*];KR3XM_\
M'VG_ %P7_P!#>ND^$G_'H_\ UW;_ - 2N/\ 'OC$:\XBBR(8B<9R-QZ;B/3^
M[QD G/7 E\#26-@1=W<@\T'Y$V.0N/XB0I!;T[#K][[O>_\ "QK#_GK_ .0Y
M/_B:GN9H?%EK+' P=6!4$AE < ,N<@' .#T/X]*\;TG4'T2X6?!#Q/RIX/HR
MG(."1D=,CZU[-_PFUEY?G^<FWTR=_7'W,;_TZ<].:XNT^+4\DFTPJRL<(J%@
M^2?E&?FR>W"C)].E=IXHU.XTVV-S"J%TP74[F&W^+&-I.#SDX&T$D5PGA_XG
MS+/F[;,+Y&%50$R<@\#<0.F,DX.>2,'N=1U?3[D;IW@D" D;BDA'K@<G)QT'
M)KQ*^='D=H@1&7;8#U"Y^4'D\@>Y^M>^Z';-:V\,3C#)%&I'!P0H!'''6KU%
M>2?%O_C[3_K@O_H;UK_"[7(+.W>*61$;S2V'8+P54 C. >0>G3OU%;/CF]2]
MTZ66)@R$J 1T.V55./49!YZ'J.*\]^'/_'_#_P!M/_1;5[;7S_XF_P"/NX_Z
M[R_^AFO;O#/_ !Z6_P#UPB_] %>+>*]&.D7,D&,+N)3KC8W*X)Y.!P>O((R:
M]2\,>.8+^%3-*B3*H#AV"Y/(R,A0<XSA>F<5S^L?%AH9MMLJ/ -O+!@S=VQG
M&WT&0>1GD'%=OX=U5]5A6Y=/+WY(7<6.WL3E5Z]1U&,'/-:5%<1\6_\ CT3_
M *[K_P"@/7-_"3_C[?\ ZX-_Z&E>MU\VU[A\0HC)8S!02<(>!G@.I)^@ R?0
M5Y-X3OX]/NHIYQF-6.>-V,@@-C_9.#QSQD<UZMK_ ([MM.C9HY$>0J=BH=XW
M=L[3@#)YR02,XR:\2KZ2KYMKZ2KQ+XC?\?\ -_VS_P#1:UZ1\.?^/"'_ +:?
M^C&KF_C'_P N_P#VU_\ 9*/@Y_R\?]LO_9ZY_P"(^C'3[MI ,)-\ZGDC)^_R
M>^[)P.@(Z=*[#P%XUA>W6VN)%22(;1O(4%5QM.2 N0#C&23C-5O%'Q0^R2"*
MSV2* =S,&(SDC P5X&,Y!(.>.G/3>$_$+Z]&;AH_+7=A?F+%L=3]U1C/&1GD
M$<8Y\R^(^C'3[MI ,)-\ZGDC)^_R>^[)P.@(Z=*ZOX>^,X?(%I.X1X@<-(P"
MLN>,$]"N<;?0#'&0,_XE^+X[Q!8P-N^8,[(WR< X7CAN2">P('4YQ@?#G_C_
M (?^VG_HMJ]MHHKQ+XC?\?\ -_VS_P#1:UO_  T\7QV:&QG;;\Q9&=ODY RO
M/"\@D=B2>AQG0^(7C.'R#:0.'>4#+1L"JKGG)'4MC&WT)SQ@'E/AQHQU"[60
MC*0_.QY R/N<CONP<'J >O2NR^+?_'HG_7=?_0'KF_A)_P ?;_\ 7!O_ $-*
M];KQWXG:*;&Z\\ ;)QN& !\RX#C@]>C$X&2W<@UT'P]\;1)"+.Y<*Z$A"^0I
M7&0"Q. 5Y S@8V@9-:'C+QW#:PO%;R!IG7"^6=P4-D%MRG (&<<Y!P<8KS_P
M1H#:O<H-N8XV#.2 5P.0ISQ\Q&,>F3@@&O;;FY6U1I7.%12Q/)P ,D\<]*\)
M\4^(&UV=K@_='RH, $("2 >O/.3R>3QQ@5J>(O CZ-:QW39WDD2@'<%W?<Q@
M=.S$DC<1C(-7/AGXH_L^3[%(?W<S?+QDB0X Y'.&''?G'09->D^)O^/2X_ZX
M2_\ H!KQ'PS_ ,?=O_UWB_\ 0Q7L'CK1CJMH\:C+IAT'.<KUP!U)7( ]3^->
M4^#=>_L2Y28_<;Y7_P!UL9/0G@@-QR<8[UZMJ'CFTM8C.LJ.2N556RQ."0"
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MN4]/0*P'/N:T]&^$BQD/=2;L=4CR!P?[YY((ZX"GG@\<^@Q1"(!% "J   ,
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M%%17-RMJC2N<*BEB>3@ 9)XYZ5YL_P 2)-6N8;>$>7$T\0)SEV&_H2. ",9
MSZ;B"17IU%%%%%%%%%%%%%%%%%%%%%%%%%%%9_B&4Q6T[J2&6&0@@X((0X(/
MK7C_ (>\0W,MS C32E6FC!!D<@@N,@C/2O<********************\/\0^
M(;F*YG19I0JS2  2.  '. !GI7L'AZ4RVT#L26:&,DDY))09)/K6A111116#
MXM\6IX=1692[N3M4'&<8W$M@X S[DDCC&2,CX>^))M>>>68CY1$%5<A1]_.
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M JS1DDG  #C))]*[G6?BV58I:Q@@-P\F<,,?W!M(YZ9/3J 3P:-\6RS!+J,
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MDYP#GTW$D"NRKAO$?Q033G>WA0NZ%E+,=JAAQTZL <@_=Z<$@YKG?^%MW?\
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MR1W.T5WU%%<CXH^(L>AR&V5#)(N-PSM49&>N"2<8[8P>N1BN2_X6W=_W(O\
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MF/>H/!_C8>(RZ;!&T84@;]Q(.<G&U>!QGKU%=/7GM]\6Q;R/$L(=4=@&$O#
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M8:9URWF#<%#8(7:PP"!C/&0<C.*S_B%X)B2$WEL@5T(+A,A2N,$A0, KP3C
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MW7_T!ZX+P3H0UJZ6%P3& 6?!QP.GO@L0#CG!XQU'I/B?P?:BTDV1*ABC9E9
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M<$DD+P"#C!X)!/7'#?A'*1<R)D[3"21G@D.N#CU&3CZFG?%VY9KB.(GY5BW
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M?PY_X\(?^VG_ *,:O-_B-_Q_S?\ ;/\ ]%K7I'PY_P"/"'_MI_Z,:N;^,?\
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M!0=IX&1EP?JHX]#X0Z6 );PXR2(UY.1C#-QTP<KCOP>G?HOB-_QX3?\ ;/\
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M9\F1'VXSL8-C/3."<9Q5FBBBBJUYJ<5CCSI$3=G&]@N<=<9(SC-5O^$FM/\
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M/0[V.#Z'!!^A%><_$;_C_F_[9_\ HM:](^'/_'A#_P!M/_1C5T4L0E!1@"K
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M_P#HM:](^'/_ !X0_P#;3_T8U>9>-] ;2+EQMQ'(Q9"  N#R5&./E)QCTP<
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M%M>ME3@+(<9'&,,>X/\ >/(/WB0<KZ=1117COQ.UHWUUY (V0#:,$'YFP7/
MZ]%(R<%>Q)KCZ]$^$FLB-I+%C]_YT' &0,/[DD8..>%)X[^G445Q'Q;_ ./1
M/^NZ_P#H#UY)1115[2M;FTEM\#E">N.0>".5.0<9.,CCM7JW@KQXNN_N)0$G
M&2 ,A6'7C))R!U&>G(XR!UU%%%%%%%<1\6_^/1/^NZ_^@/7DE>V_#G_CPA_[
M:?\ HQJZ6OFVI;:Y:U=94.&1@P/!P0<@\\=:][\.ZXFMPK<IQG(*Y!*L.H./
MS'0D$' S6E17S_XF_P"/NX_Z[R_^AFM/X<_\?\/_ &T_]%M7MM%<-XS^(PTT
MM:6V&E (+_PH?3&/F8<Y[ XSGD#R_4-2DU%S+,Q=CW8YQR3@=@,G@#@=JK45
M9T_4I-.<2PL48=U..X.#V(R.0>#WKUGP-XY&M 6\Q N%'T#@=Q_M>H_$<9"]
MA11111111111111111111111111111111111111111111111111111111111
M111111111111111113)8A*"C %6!!!&00>H(]*X+4/A%'*Y:&4HI_A9=^.3T
M.Y3C' SD^I-:_A'P&GAYVF\PN[*5Z!5VDJ>G)SD=<XQV[UMZKHD.K+LG0.!T
MSP1R#PPP1G S@\]ZXFY^#R,Q,<Y5>P9 QZ>H90>?85?T/X6V]B?,F)F8'@$;
M4[$97)R>.YP0<%:[6BBBL'Q)X-@\0%7E+*R C*;02#V)*G(';TR?6I?#?A2'
MP\&6'<3(1DN03QT'  P,GMGGKTQLTR6(2@HP!5@001D$'J"/2N-USX6V]\?,
MA)A8GD ;D[DX7(P>>QP ,!:H6WP>16!DG++W"H%/3U+,!S[&NXTO28M*3R8%
M"IDG R>3W).23]3TP.@JY7#:U\*8;US+"YBW$DKM#+SC[HRN!UXR1SQ@#%3^
M&/ANFBS"Z:4NR9V@*$'*E3GEB>#Q@C'O71:UH,.LH8IE!X.&XW+G'*GL>!['
M&"".*XNY^#R,Q,<Y5>P9 QZ>H90>?85I:-\+K:Q(>4F5A_>X3.<@[1STXP20
M><CT[*BBF2RB(%V("J"22<  =23Z5\YQ1&4A%!+,0  ,DD] !ZU]!Z1IPTV&
M.V7&(T R!MR0.6QZD\GW-7*K:AIL>HH8IE#J>S#..",CN#@\$<CM7$:A\(HY
M7+0RE%/\++OQR>AW*<8X&<GU)J72OA+#;MNG<RCLH'ECH>N&)/;&".G.:[B*
M(1 (H 50  !@ #H /2B6(2@HP!5@001D$'J"/2N"U#X11RN6AE**?X67?CD]
M#N4XQP,Y/J36SX6\!0Z"?.R9)<$;F  &<_=7G!(X)R3Z8!(K/_X5):?WY?\
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M58 @@Y!!Z$'TI]%<1\6_^/1/^NZ_^@/7DE>I>"_!=IJ5I'<31[G;?D[W'1V
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M<>K8)Z ?49*Y&#7A]=!X3\&R>(6.#LB7[SD9&<<*!D9/KSP.3U /H]I\,;*
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M********************************S?$W_'I<?]<)?_0#7B/AG_C[M_\
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M3A01Z'D'Z5ZE_P )1#]E_M+)\K;GI\V<[=N/7=QUQGG..:\OB^(&H7L@CCD
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M:OJ)U*:2Y;.9')P3NP">%SZ <#V%>[:#HJ:-"MM&!\H^8@8W-CECR>3]3@8
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M<$=U/7CV(/0UV4OQB)!"P -@X)DR >V1L&1[9'U%<58:?-XBG*(-TDC%F)X
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M\0/H,PN(P#QAE/=202,]CP"#ZCN,@]!K?C>X\5 6$$042%<J#O8D'/WB  O
M)XXQDMC(KF-,G_LVXCDD!'DRJ6&/F^1@2,''/'0XYKW+Q-_QZ7'_ %PE_P#0
M#7B/AG_C[M_^N\7_ *&*^@*\2^(W_'_-_P!L_P#T6M>D?#G_ (\(?^VG_HQJ
MX+XD^'#IUP;E0?*G.<]@Y^\N<GD_>'3J0/NFG>&OB5)I$?V>1/-5<;"6VE1_
M=SALCT].G3 %+Q/>7.NI_:<HVP;]D:YXY!)QZ_=^9N,G@<#"Z7PD_P"/M_\
MK@W_ *&E>MT445XE\1O^/^;_ +9_^BUKTCX<_P#'A#_VT_\ 1C5T%S;+=(T3
MC*NI4CD9!&"..>E>$Z]H<OAV;8<_*V4D *@XP00?49&<$X/?O74_\+?E\O;Y
M2>;_ 'MQV=?[G7IQ][KS[5S'AN"XU&X"0.ZR2'YW5CN"D@LQ.1D=^3R<#J17
MNT48C 49P !R23QZDY)/N>37AGC33WL;R97'WW9P><%7)88R!G&<'MD$=JW]
M-^*KV,"6_D@M&@4-O('RC"DKC/3&?F&>V.W0?%71FO($N$!)@8Y Q@(P^9B.
MO!4=.@R3QR//?"_BB3P](94 96 #*20" 0<\'[W4 D'&3Q71:MXLN?%L<D,,
M82&--\A)W'"9;&[ ') P ,DCKMSCEO#/_'W;_P#7>+_T,5[=XF_X]+C_ *X2
M_P#H!KQ'PS_Q]V__ %WB_P#0Q7T!7$?%O_CT3_KNO_H#US?PD_X^W_ZX-_Z&
ME>MU\VU])5X?XT\*MH<QV@^2YRC -M&XG"$G/S#'J21@]\#9T_XL2VT0B>,.
MZK@.6(Z  %@<ECGDG(S[=:YF.\N-6NO.B+?:)7.-A((SV!SD*!QUP%')P*]T
MTVS-G&D)8N54 LQ)+'N>23R>V>.@X%>*>,_#AT.X9 "(G),9[8_NYR>5S@Y.
M>A[BMW1OBO)9QB*:/S67@.7VDCMGY6R??OWYR3@>)?M-WLU"Z_Y>-VP=,*N,
M8'9?FX[GECUR>M^#G_+Q_P!LO_9Z])HHHKF/B-I9O[-R,EHB)  0/NY#9SV"
MDGUR!]#XN920$R=H)(&> 3C)QZG S]!Z5[GX+TG^R[2*(C#%=S97:=S\X(ZY
M487GGCMTK<KQCQWX1?2IGGC0_9W.X%1\JY(RIP %&3\O;& "2#BYH'Q1DTV-
M;>2,2!%"J0VPX'&#PP/& .!TYR3FL;Q)XGF\3R*"H 4D1H@)/S'UZLQX'8<<
M 9->D^ O!QT%#++@S2@9Q@[1UV@^O][G!(&.F33^*NC->0)<("3 QR!C 1A\
MS$=>"HZ=!DGCD>>^%_%$GAZ0RH RL &4D@$ @YX/WNH!(.,GBNBU;Q9<^+8Y
M(88PD,:;Y"3N.$RV-V .2!@ 9)'7;G'+>&?^/NW_ .N\7_H8KV[Q-_QZ7'_7
M"7_T UXCX9_X^[?_ *[Q?^ABOH"BBBBO)/BW_P ?:?\ 7!?_ $-ZQO#>L7'A
M\B^C!,+/L8'[K$ -M/HP!RI^N,C<*U/$OQ*DU>/[/&GE*V=Y#;BP_NYPN!Z^
MO3ID$^&OAHZC,+M_]7 P/0_,_50",#Y3@GGT&,&N[^(W_'A-_P!L_P#T8M>;
M_#G_ (_X?^VG_HMJ]MKC?B1X6;5HUN(5S+%G(&,LAY(Z9)!Y SW;&20*\]\-
M^)YO#$C *"&($B."#\I]>JL.1W'/(.!6SK_Q1DU*-K>.,1AU*L2V\X/&!PH'
M&0>#UXP1FHO /@IM5=;N48@1L@$ [R#TP>-N?O'O]T<Y*^J:MJB:5$US+G8@
MYP,GDX 'N20/3U(%>$WMW+K]P9&P99G4 # &3A5 SVZ#D_4]Z]2D^'ZFP_L]
M2!+D/N))7S,8)[?*1\HXX'."W7RO3K^319A,@VR1,>&'U#*0>>F0>A'L:]XT
MG5$U6);F+.QQQD8/!P0?<$$>GH2*Y+XLZ6;BW2Y&<POSR,;7P"?4G<% QZGC
MT\K7?<%8QEC]U0,D\DG 'N2>!W/O7T#I&G#388[9<8C0#(&W) Y;'J3R?<U<
MHHHKF/'OA8Z]"/+QYL1)7)QD$?,O7 )P,$]QC@$FO+?#_B";PW,64'KB2-LC
M.#R".S#L>H/MD'7\4_$5]<B^S+&(T8C=\V\G!! ^Z,#(R>YXY SFW\,O"S7,
M@OY%_=1YV9Q\S],@$'(7GGCYL8S@XN?%K179DOE!*!-C8'W<,2I//0[L=, @
M<Y(KG_"'CE_#H:+8)(V.<9VD-P,YP>"!R,>F,<Y;K^M7/BTM-L_=VZDX09"J
MQZD]2< 9Z#"D@ !JM_"R[$%YL.<RQNHQZC#\^V%/XXKJ_BW_ ,>B?]=U_P#0
M'KF_A)_Q]O\ ]<&_]#2O6Z\O^*OAPHXU",$JP DQS@C 5CST(P.@ ('=JQO"
M?CZ30%,)7S(NJJ6VE3GG!P>#W&.O(QSF7Q'K-SXIC>[V[+:WV_+G(W,0O7 W
M-\WH J^Y^:M\.?\ C_A_[:?^BVKUWQ#*8K:=U)#+#(00<$$(<$'UKQ_P]XAN
M9;F!&FE*M-&"#(Y!!<9!&>E>X44444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444445A^)?",7B'9YQ<>7NQL('WL9SE3Z5B?\*DM/[\O_?2?_$5V%C:"RC2
M!<E8T51GKA1@9Z<\5/14%W8QWHV2HKJ#G#J&&?7!SSS7,7GPNLKC&T/'C/W'
M)S]=^[I[8]ZK?\*DM/[\O_?2?_$5O:=X.M-..^.)=V006RY!7H07)P?IC]!6
MS16#XD\'Q>(2K3.X$8. A4#GJ>5)R<#OCCIUSC?\*DM/[\O_ 'TG_P 177:;
MIZ:=&EO&,+&H Z9X[G  R3R3W/-6:**S]=T./6HC;2YVD@Y7&X$'J"0<'M]"
M17,?\*DM/[\O_?2?_$5T'ASPTF@(T43.RLV[#E3@XP2,*#R .N>G&.<N\1>'
M8]?C$$I8*KAOD(!R 1W!XYKG?^%26G]^7_OI/_B*/^%26G]^7_OI/_B*/^%2
M6G]^7_OI/_B*=%\)K1"&+2D C@LN#['"@X/L0?>N@TOPO:Z6=T,2JP)(8_,P
MR,'#-D@8[ XZ^IK5HHKS_P 7> [6WCGU!WD#'>^,J5WN?E& F<%B!UZ=^]<M
M\-+9I;Z-E&1&KLW3@%2N?S8"O::***RO$7AV/7XQ!*6"JX;Y" <@$=P>.:YW
M_A4EI_?E_P"^D_\ B*ZG1=(32(5M8R2J9P6P3RQ;L .I]*O5Q'_"I+3^_+_W
MTG_Q%:OAWP-!H$AGB9RS(5^<J1@D'LHYXKHJ*@O;)+Y&@E4,CC!!_P ]?0]0
M>1S7'_\ "I+3^_+_ -])_P#$5>T7X=V^D3+=1M(63. Q4CE2O90>A]:ZFBBL
M_5/#]OJHQ/&K' &2,-@'. PPP&?0^OK7.W/PILY6+*9$!_A5@0./]I6/YFBV
M^%-G$P9C(X'\+, #Q_LJI_(UT6E^'[?2AB"-5.",@9;!.<%CEB,^I]/2M"BH
M+ZT%[&\#9"R(RG'7##!QUYYKC_\ A4EI_?E_[Z3_ .(K;\->$8O#V_R2Y\S;
MG>0?NYQC"CUK<HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHJ*YMDNE,<BAE/4, 0<'/0\=:K6VAV]JPDCB
MC5AT*QJ",C'4#/2KU9O_  C-I_SPB_[])_A6E5&YT.WNF,DD4;,>I:-23@8Z
MD9Z59MK9+51'&H51T"@ #)ST''6J6K^&[?5\>?&&(Z'D-QGC<I!QR>,XSS46
ME>$[72F\R&(*WJ26(X(X+$D<'G&,]ZMW>CP7IWRQH[ 8RZ*QQZ9(/'-2VEC'
M9#9$BHI.<(H49]<#'/%5I?#UM*2[0Q%F)))C0DD]23CK5V*(1 (H 50  !@
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MR(PI/4\EN<<;F)..!QG&>:=+X>MI27:&(LQ)),:$DGJ2<=:NQ1"(!% "J
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MR.^*-$8C&415./3( XXJY6;_ ,(S:?\ /"+_ +])_A6E45S;)=*8Y%#*>H8
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M%%%%%><?%[2P1%>#&03&W)R<Y9>.F!AL]^1U[5/A)JWE226;'B1=RY;C<O!
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MO_0$KMZ***IZQ=FR@EG7!:.-V&>F54D9Z<<5XKI.I2:C>P2S,78SQ\L<X_>
MX'8#)X X':O=J***************X;XI:]-IJ110L4\TON9<AODVX (Z YYQ
MSQC.,@Y_P<_Y>/\ ME_[/7I-%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%9OB32/[7MY+7."Z\'H-P(9<\'C(&>,XZ5X?X?U0Z5<1W
M/.$<9P 3M/# 9XR5)']17T%7FGQ>U0DQ68S@ R-P,'.57GKD8;/;D=>UGX2Z
M*(T>^8'<YV+D$?*,%B.<$$\=."IYZUG^,OB/(TCVUHP$8X\Q>6;@[L$\ 9/!
M'.1D-@USMIX/O=5'VA8V8.<[G8*6SSN^<@D'.<]#ZU)HOBFZ\,N(CNV*1NBD
M!'!R> 1E2<YR.IP2".*]4?65UBSDN+4DDQ2;0N=X?:<+@<A@<=/8C((->+ZO
M]HWC[5YF_;QYV[=MR<?>YQG/MG-6=(^V[#]E\[9NY\GS-N[ S]WC.,>^,5[%
M#J@TJR2YN=V4ACWY!+[B ,'/.XL<<]^I%>4:UXINO$SF(;MC$[8HP3P,'D 9
M8C&<GH<D #BH;SPY>Z!BX9'CQGYT8'';ED)VYSCG&>@KN_ 7CUM4;['<\RG)
M1P  V 200!@$#H>A'O\ >V?'/B0Z%;ED(\V0[4S@X]6P3T ^HR5R,&O*(X[S
MQ0^!OF8$GD_*N[GOA4!QP.!Q@47^@W?ATK/(K1$DA75AUQR-R$X)&?3(SZ&N
M^^'7C5M2_P!!N#F15RKDC+ =CGDL!SGN 2>02>[HHKG?'/B0Z%;ED(\V0[4S
M@X]6P3T ^HR5R,&O*(X[SQ0^!OF8$GD_*N[GOA4!QP.!Q@47^@W?ATK/(K1$
MDA75AUQR-R$X)&?3(SZ&N^^'7C5M2_T&X.9%7*N2,L!V.>2P'.>X!)Y!)ZOQ
M#*8K:=U)#+#(00<$$(<$'UKQ_P />(;F6Y@1II2K31@@R.007&01GI7N%>/^
M/=<N+6]ECCED51LP%D8 9C4] <=:] \!7+W5E%)(Q9COR6)).)&'4\]*\R^(
MW_'_ #?]L_\ T6M%AJEWJT,>DVH.$5RP0X+;F8G<3@!<-C!.">N20!GW^E77
MAUU:0-$Y!*LK?@<,I///(SG!YX->D?#OQD^M!K><@RH-P8#&Y<X.0!@%20.V
M01QP29?BA?265LCQ.R,9E&48J<;'XR,<<5Y_HWC.[M68*[R/(FQ [,^&9AA@
MISEN, >I[C@M\0:+?E?MUVKD''S,02-QR!M!R@R>F  3C@\59\.?$*?1D:(_
MO%V_('8_(0,#'?;C^'CV(YRVZTG4O$*_:Y%>10,C.%XV@Y5.,@C'W1\Q]35'
MPWXJFT%PT9)CS\T9)VG.,\=FX&&Z\=QD'W2VN5ND65#E74,#R,@C(///2O!/
M^$FN_P#GO+_W]?\ QKTGXE?:_P!S]D\W_EIN\G?_ +&,[/QQGWKR2NRT?^TM
MY\S[3CRIOO>;C=Y3[>O?=C'?.,<US>K_ &C>/M7F;]O'G;MVW)Q][G&<^V<U
M9TC[;L/V7SMF[GR?,V[L#/W>,XQ[XQ7M.F7)M;2.6<D%(%:0MDL,("Q/?/7/
M?->5>)/'-QKKF&$LL3':J+]YLY'..26S]T''08)&30G\)WNG(+LQ.H&&#*1N
M7 W9(4[EQCDD#!ZX-=7X%^(3NZV=V2V\A4?'S \ *V.H/][KGKD'*^C7-RMJ
MC2N<*BEB>3@ 9)XYZ5XAXC\9W&N$AV*Q$\1J?EQQC/3<> <GOT Z5/!X<U#1
M5^W(CQA5!)#+G;D'E <X[L",#'S#@UE:]K!UB9KI@%9PN0.F54*<>QQG';ID
M]:]=^'/_ !X0_P#;3_T8U=+117">/?'K:6WV.VXE&"[D A<@$  C!)'4] /?
M[O"6?AR]U_-PJ/)G'SNP&>W#.1NQC'&<=#4VB^*;KPRXB.[8I&Z*0$<')X!&
M5)SG(ZG!((XKV32=4358EN8L[''&1@\'!!]P01Z>A(KQ[XC?\?\ -_VS_P#1
M:UZ1\.?^/"'_ +:?^C&K)\>^/6TMOL=MQ*,%W(!"Y ( !&"2.IZ >_W>$L_#
ME[K^;A4>3./G=@,]N&<C=C&.,XZ&IM%\4W7AEQ$=VQ2-T4@(X.3P",J3G.1U
M."01Q7LFDZHFJQ+<Q9V..,C!X."#[@@CT]"17&_$+QR; FPMR1+@;WZ;01D!
M?]H@]>PZ?-]WA[/PY>Z_FX5'DSCYW8#/;AG(W8QCC..AHT_Q%>>'G$89UV=8
MY =N"0V-C=,^HP<'@\UZ?KVJ-JNGM<V6_<X7;L#"3B0!A\O.1@@XXZ\D5X[J
M/F^8?M&_S>-WF9W]!C.[GIC'M6GIW]H>6/L_VCRN=OE^9LZG.-O'7.?>O5O'
MMR]K92R1L58;,%201F11U'/2O+=&\9W%C*)I)9'"J_RL[,I8HP7(+#(#$$]\
M=.:QKV]>^=IY6+.YR2?\]/0= .!Q7L%]K9\*V*&5B]P4&!*VYBYY;D9RJ9]>
M@ W9(->;7>J7GBN3R_FD.<A$&$7G ..@ W8W-SCJU-O/#E[H&+AD>/&?G1@<
M=N60G;G..<9Z"NX\#?$(WY%I=D>:3\CX #9_A(& &].QZ?>^]UWB&4Q6T[J2
M&6&0@@X((0X(/K7C.F>++B"6.22:5D5U+#S&.5!!(P6P<CL>*UM9@U'Q2#=>
M6_D#E4!P, 9!"D@N2#]X YS@<<#G]*UF?09-T9*LK?,AR =N1M9>,XR1ZCM@
MU[II&HC4H8[E<8D0' .[!(Y7/J#P?<5Y7X]URXM;V6..615&S 61@!F-3T!Q
MUKT#P%<O=644DC%F._)8DDXD8=3STK!^(7CDV!-A;DB7 WOTV@C("_[1!Z]A
MT^;[O#V?AR]U_-PJ/)G'SNP&>W#.1NQC'&<=#1I_B*\\/.(PSKLZQR [<$AL
M;&Z9]1@X/!YKVK2=4358EN8L[''&1@\'!!]P01Z>A(K@/B%XZ='-C;,5V$;W
M4_,3UV@@\ ?Q=\\< '=S%MX+OM347*QEA)\VYG4$Y/7YF!YZY/7KWJII>O7&
MA/B-F78YW1MG:3T(9..>,'N.Q! KV_1-575H4NDX$BYQSP1PPY S@@C..>M>
M9?%O_C[3_K@O_H;UTGPD_P"/1_\ KNW_ * E<W\6_P#C[3_K@O\ Z&]=!\+8
M//LI8\E=TKC*G##,:#(/8CL?6N&B\2W>FS@2RRL89!O0RL0=C?,I.2,'&.X^
MM>XQ2B4!U(*L 00<@@]"#Z5YO\4/$DEO-';0.R%$)8QR$<N>%(7'( R,]F_/
M;^&8FFMVN9W=S(_R[W+C:G&1DD@EL@^N!QZ]A117,>-_&(\/H!'M:9R,*V>%
M[L0,<<8'(R>1G!%>8?Z;XLD_CE8?0(N1^"+G;[9([FB?3KWPLXF(>(G&&4@J
M><[25)4_=R5/4#D8KT;P-XY&M 6\Q N%'T#@=Q_M>H_$<9"YOQ2>XLC'=0RN
MD;#80CE0&&6!X;DL,]N-O7D5/\+-?>^26WF<LZL&!=RS%6&" #SA2/IENW?K
M]7U$:;#)<MC$:$X)VY('"Y]2>![FO&=$U&\U:9+5)Y09&QGS6X Y8\L,X )Q
MGGI7LVK:HFE1-<RYV(.<#)Y. ![DD#T]2!7C>M>*;KQ,YB&[8Q.V*,$\#!Y
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MYPRGLP )&>XY!!]#V.0-6BBO)/BW_P ?:?\ 7!?_ $-ZZ3X2?\>C_P#7=O\
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M_LYE.,HA<$C."GS<>A(!&?0GZ5Y)X-NS:7D#KC)D5>?1_D/XX;CWKT+XM_\
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MSS6-K?@2WUF874N[< H(4A5;:>_&<XXSD' &,8K4TC18=(0Q0+M4MN(RQY(
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M&<\<UD7?Q7M[0>7;Q,P4[0.(TVC@$?>..F 5''ITKSO7]8.L3O=L I<C@<X
M 4<]S@<GN>PZ5Z[\.?\ CPA_[:?^C&KB?BW_ ,?:?]<%_P#0WKI/A)_QZ/\
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MZ$<'V->V^+]%.L6LD"@%\;DR ?F7D 9(P3]W.> 3VKRCP!JAT^\C/.V4^60
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MUVD8QFO2?'5H;NRF1<9";N?1"'/XX7CWKR?P5J":?>132'"AB"> !O4KDDD
M $Y)]*]VKS_XNZ@@BCM<_.S[\<<*H9>><\EN.,'!]*R_A#:%YY9^-J1A3ZY=
M@1^'R'/X5!\6_P#C[3_K@O\ Z&]=)\)/^/1_^N[?^@)5+XPVS,D$H'RJSJ3Q
MU8*0/7D*?RKFO ?AJ#7WDBF9U95#*$(&1G#$Y4C@E?3KW[=A+\*;.(%VDE"J
M"22Z  #J2=G2HK3X96-Z-\4SNH.,I)&PSZ9"'GFNNU75[>S!2X= "A)5R,E>
M0?EZL#R, '/2N/;P18>)5:YLG*?-CY5.S=D,?D8 ]#V(4<8'!%<_K?PPGTY'
MG1T>.-=W=7P!ECM.1QS_ !<@>O%9/@O4'L;R%D/WW5".<%7(4YP1G&<CMD ]
MJ]VHHK/U75[>S!2X= "A)5R,E>0?EZL#R, '/2N/;P18>)5:YLG*?-CY5.S=
MD,?D8 ]#V(4<8'!%<_K?PPGTY'G1T>.-=W=7P!ECM.1QS_%R!Z\5D^"]0>QO
M(60_?=4(YP5<A3G!&<9R.V0#VKV3Q-_QZ7'_ %PE_P#0#7B/AG_C[M_^N\7_
M *&*^@*\/^(4HDOIBI!&4'!SR$4$?4$8/H:]+^'/_'A#_P!M/_1C5YO\1O\
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MV>6=<A9)'89ZX9B1GKSS7M%]:&RTYX&P6CM&4XZ96+!QTXXKQWPS_P ?=O\
M]=XO_0Q7T!7B7Q&_X_YO^V?_ *+6O2/AS_QX0_\ ;3_T8U>;_$;_ (_YO^V?
M_HM:](^'/_'A#_VT_P#1C5XO<VS6KM$XPR,5(X."#@CCCK7T-8W8O8TG7(61
M%89ZX89&>O/-9'B3QE!X?*I*&9G!.$VD@#N06& >WK@^E7-&\1P:SN^SONV8
MW?*RXW9Q]X#T->'Z]K3ZS,US(3\Q^4$YVKGA1P.!]!DY)Y)KTO1OA7;VZ@W&
M9'V_, Q5,YSQC#<=.3SUP.@X+QS%'%>2I"%"*5 " !00B[A@<9SG/OGO7I_P
MY_X\(?\ MI_Z,:N)^+?_ !]I_P!<%_\ 0WKI/A)_QZ/_ -=V_P#0$KF_BW_Q
M]I_UP7_T-ZZ3X2?\>C_]=V_] 2K/Q-TG[;:&4#+0,&X7)VGAAGJ!@[CV^7GU
M'$^#?$']G6]Y&2^3$&3:>%8GR\]1@Y=>1S@>P%0?#G2Q?WB$X*Q R$$D?=P%
MQCN&(/I@'Z'VNBBBO!O&5H;2\G1L9,C-QZ/\X_'#<^]>N^"]02^LX60_<14(
MXR&0!3G!.,XR.^"#WK3U+4$TZ-[B0X6-23TSQV&2!DG@#N>*^?;&T-[(D"X#
M2.JC/3+' SUXYKZ+KPOQMHITFZ>/ ".=Z8  VL3P #P%.5[=,XP:/&6N'6)E
ME;;Q#$/DZ9*AV'4\AF(]L8/(->L>"])_LNTBB(PQ7<V5VG<_.".N5&%YYX[=
M*Y?XPVS,D$H'RJSJ3QU8*0/7D*?RKFO ?AJ#7WDBF9U95#*$(&1G#$Y4C@E?
M3KW[=A+\*;.(%VDE"J"22Z  #J2=G2HK3X96-Z-\4SNH.,I)&PSZ9"'GFMGX
MC?\ 'A-_VS_]&+7F_P .?^/^'_MI_P"BVKVVBBBN(^+?_'HG_7=?_0'KF_A)
M_P ?;_\ 7!O_ $-*];KYMKZ2KR3XM_\ 'VG_ %P7_P!#>ND^$G_'H_\ UW;_
M - 2O._%ULUO>3JXP3*[=CPYW*>/4$&NT\/_  XM-5MX[G?+ET&<%0-PX8#*
M9P&!']34]Y\-]/L<>=.Z;LXWR1KG'7&4&<9K>\.^!H- D,\3.69"OSE2,$@]
ME'/%=%117DGQ;_X^T_ZX+_Z&]=)\)/\ CT?_ *[M_P"@)7-_%O\ X^T_ZX+_
M .AO72?"3_CT?_KNW_H"5I?$;_CPF_[9_P#HQ:\W^'/_ !_P_P#;3_T6U>M^
M)O\ CTN/^N$O_H!KQ'PS_P ?=O\ ]=XO_0Q7T!7SE<VS6KM$XPR,5(X."#@C
MCCK7J5M\+;.Z194DE*NH8'<HR",@\IGI44_PWT^!Q"\[J[8PK21ACDX& 4R<
MG@>]=)X:\(Q>'M_DESYFW.\@_=SC&%'K7EWQ&_X_YO\ MG_Z+6O2/AS_ ,>$
M/_;3_P!&-72U\VU])5Y)\6_^/M/^N"_^AO72?"3_ (]'_P"N[?\ H"5QOQ+M
MFBOI&88$BHR].0%"Y_-2*U_!W@.UUVW%PSR;PS*X4J "#D#E#_"0>IZ_A6I=
M_#*QLAOEF=%)QEY(U&?3)0<\5IZ!\/[;39$O87=B 2N60J0RD9X49&#Q@U@_
M&/\ Y=_^VO\ [)1\'/\ EX_[9?\ L]>DT444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444453U?3AJ4,ELV,2(1DC=@D<-CU!Y'N*^?)8C
M$2C AE)!!&"".H(]:]A^&6D_8K02D8:=BW*X.T<*,]2,#<.WS<>IZZO&/%W@
M2;2G>6)2UODD%<G:.3@C).% ^]TQ@D@G ?I_Q/O+-!&=DF.AD4EL8 QE67/U
M.23U-9L,%WXNFSS(YP"Q&$4<XS@84<$\#DYP"3S[#X;\/IH,(MXR3SEF/=B
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M%B<'C"T'Q_<Z+']G38R#[H=>F22<%2IY)[Y]L5F$7'B.8M@R3/C.U0.F%!.
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M'/ !KS_PWXKF\/%FAVD2 9#@D<=#P0<C)[XYZ=,>J> _$$FNPO<38R)2H"C
M "(<<Y/4D\D]?3 KI:******************************************
M************************************************************
M************************************************************
M************************************************************
M***************SY?#UM*2[0Q%F)))C0DD]23CK5NVMDM5$<:A5'0*  ,G/
M0<=:EHK-_P"$9M/^>$7_ 'Z3_"M*HKFV2Z4QR*&4]0P!!P<]#QUJM;:';VK"
M2.*-6'0K&H(R,=0,]*O45!=V,=Z-DJ*Z@YPZAAGUP<\\U!;:';VK"2.*-6'0
MK&H(R,=0,]*O44445!=V,=Z-DJ*Z@YPZAAGUP<\\U!;:';VK"2.*-6'0K&H(
MR,=0,]*O45!=V,=Z-DJ*Z@YPZAAGUP<\\TVSTR*QSY,:)NQG8H7..F< 9QFK
M-%%%4;;0[>U821Q1JPZ%8U!&1CJ!GI5ZBBBBBBBBBH+NQCO1LE174'.'4,,^
MN#GGFHK31X+([XHT1B,91%4X],@#CBKE9O\ PC-I_P \(O\ OTG^%:5,EB$H
M*, 58$$$9!!Z@CTJE%X>MHB'6&(,I!!$: @CH0<=:T**BN;9+I3'(H93U# $
M'!ST/'6H[/3(K'/DQHF[&=BA<XZ9P!G&:LT444451N=#M[IC))%&S'J6C4DX
M&.I&>E6;:V2U41QJ%4= H  R<]!QUJ6BBBJ-SH=O=,9)(HV8]2T:DG QU(ST
MJS;6R6JB.-0JCH%  &3GH..M2T51N=#M[IC))%&S'J6C4DX&.I&>E3VEC'9#
M9$BHI.<(H49]<#'/%3TR6(2@HP!5@001D$'J"/2J47AZVB(=88@RD$$1H"".
MA!QUK0HHHJ"[L8[T;)45U!SAU##/K@YYYJ"VT.WM6$D<4:L.A6-01D8Z@9Z5
M>HHHHHHHHJC<Z';W3&22*-F/4M&I)P,=2,]*GM+&.R&R)%12<X10HSZX&.>*
MGJ*YMDNE,<BAE/4, 0<'/0\=:@M-'@LCOBC1&(QE$53CTR ..*N444445D:E
MXLM=/5V>5"8\Y165GR#C;M!SG/'MWP,UXE<R-J]PS(OS3RDA<CK(W R<#J<9
MXKWC2-.&FPQVRXQ&@&0-N2!RV/4GD^YJY11115:\TR*^QYT:/MSC>H;&>N,@
MXSBF6FCP61WQ1HC$8RB*IQZ9 ''%7******BN;9+I3'(H93U# $'!ST/'6JU
MMH=O:L)(XHU8="L:@C(QU STJ]11111115&YT.WNF,DD4;,>I:-23@8ZD9Z5
M9MK9+51'&H51T"@ #)ST''6I:****IW>CP7IWRQH[ 8RZ*QQZ9(/'-2VEC'9
M#9$BHI.<(H49]<#'/%3T44444444456O-,BOL>=&C[<XWJ&QGKC(.,XHL],B
ML<^3&B;L9V*%SCIG &<9JS5&YT.WNF,DD4;,>I:-23@8ZD9Z59MK9+51'&H5
M1T"@ #)ST''6I:********K7FF17V/.C1]N<;U#8SUQD'&<46>F16.?)C1-V
M,[%"YQTS@#.,U9HK/E\/6TI+M#$68DDF-"23U)..M78HA$ B@!5   &  .@
M]*?111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111111111111111117FWB3X937]Q)<0-&J2-NPS/G
M) +'[IZMD]?RZ5I>$?ANNE.+FX(>1?NJ =BG/WLGECC&.!@YZG!';T444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44445GZ=KT.I.\4+!_*";F7!7Y\X (ZD8YQQSC.<@:%%4=:U=-(A:ZD!*IC(
M7!/+!>Y ZGUK$T7XB6^KS+:QK(&?."P4#A2W9B>@]*ZFBBBBBBBBBBBBBBBB
MBBBBBBH+Z[%E&\[9*QHS''7"C)QTYXKEK'XH6U[(D"I*&D=5&53&6.!GYSQS
M7844444444445SOB+QS!H$@@E5RS(&^0*1@DCNPYXJ[X=\11Z_&9X@P57*_.
M #D 'L3QS6K17+:U\1+?2)FM9%D+)C)4*1RH;NP/0^E;>BZNFKPK=1@A7S@-
M@'ABO8D=1ZU>HHHHHHHHHKC['XH6U[(D"I*&D=5&53&6.!GYSQS7845E>(O$
M4>@1B>4,59POR $Y()[D<<5!X:\71>(=_DAQY>W.\ ?>SC&&/I6Y1117-?\
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M'-:%%%%%%%%%%%%%%<MK7Q$M](F:UD60LF,E0I'*AN[ ]#Z51_X6W:?W)?\
MOE/_ (NC_A;=I_<E_P"^4_\ BZ/^%MVG]R7_ +Y3_P"+K;_X2Z+[)_:F'\KT
MP-_W]G3=CK[]*I:+\1+?5YEM8UD#/G!8*!PI;LQ/0>E=3111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M115:\U.*QQYTB)NSC>P7..N,D9QFI+:Y2Z421L&4]"I!!P<=1QUIMW?1V0WR
MNJ*3C+L%&?3)QSQ3;/4XK[/DR(^W&=C!L9Z9P3C.*LT444451N=<M[5C')+&
MK#J&D4$9&>A.>E2V>IQ7V?)D1]N,[&#8STS@G&<59KSWXO7KQ)# K$)(7+ =
M]NW;GV&>G3.#U J#X.?\O'_;+_V>O2:*YKXC?\>$W_;/_P!&+7F_PY_X_P"'
M_MI_Z+:O8;O6(+([)9$1B,X=U4X]<$CCBI[:Y2Z421L&4]"I!!P<=1QUJ6BJ
M-SKEO:L8Y)8U8=0TB@C(ST)STJS;7*72B2-@RGH5((.#CJ..M2T445!=WT=D
M-\KJBDXR[!1GTR<<\46E]'>C?$ZNH.,HP89],C//-22RB(%V("J"22<  =23
MZ52B\0VTI"+-$68@ "1"23T &>M:%%,EE$0+L0%4$DDX  ZDGTJE%XAMI2$6
M:(LQ  $B$DGH ,]:T**9+*(@78@*H)))P !U)/I5*+Q#;2D(LT19B  )$))/
M0 9ZUH56U.S^W126^<>8C+G&<;@1G'&<9KB-,^%/V&6.X\_/ENK8\K&=I!QG
M><9Q7H%%%%%,EE$0+L0%4$DDX  ZDGTJE%XAMI2$6:(LQ  $B$DGH ,]:T**
M9+*(@78@*H)))P !U)/I52VURWNF$<<L;,>@6123@9Z YZ5YE\6_^/M/^N"_
M^AO72?"3_CT?_KNW_H"5V]%>)?$;_C_F_P"V?_HM:]&^'THBT^)V("J)"23@
M "1\DGTK9MM<M[IA''+&S'H%D4DX&>@.>E7J******BN;E+53)(P51U+$ #)
MQU/'6O,/'/Q"%^#:6A/E$?.^""V?X0#@A?7N>GW?O<GX9_X^[?\ Z[Q?^ABO
MH"LK7/$UOHHS,X#8R$'+GKC"^AQC)P,]2*\9\2^)9-?D\V3A1D(@/"C^I/<]
M_8  =E\'/^7C_ME_[/7I-%%8WC*[%I9SNV<&-EX]7^0?AEN?:O#].TZ34I!;
MPC<[9P,@= 2>20.@K<_X5S?_ //+_P B1_\ Q5=M\-?#D^C>=]H3;O\ +V_,
MK9V[\_=)]16-\5?$9=QI\9(50#)CC)."JGCH!@]2"2.ZUD>%/A])KR?:"XCC
MR0"5+,2,<@?*-O49SU!&*H>*?"<GAUPLA#*^[:R]]I[@\@X()ZCG@GFO3_A]
MXA.LV_[S'F1$(?FRQ  PYSSD\_4@GV'3T4451_MRWW^3YL>_=MV^8N[=G&,9
MSG/&.N:O44445!=WT=D-\KJBDXR[!1GTR<<\46E]'>C?$ZNH.,HP89],C//-
M.N;E+53)(P51U+$ #)QU/'6H+36(+T[(I$=@,X1U8X]< GCFKE%%%%%%?/\
MXF_X^[C_ *[R_P#H9KKM,^%/VZ*.X\_'F(K8\K.-P!QG>,XS5G_A3G_3Q_Y"
M_P#LZ/\ A3G_ $\?^0O_ +.O2:9+*(@78@*H)))P !U)/I5#_A)K3_GO%_W]
M3_&K\4HE =2"K $$'((/0@^E/J*YN4M5,DC!5'4L0 ,G'4\=:I?\)-:?\]XO
M^_J?XUI45\Z7MZ]\[3RL6=SDD_YZ>@Z <#BOHNBJ=WK$%D=DLB(Q&<.ZJ<>N
M"1QQ4MI?1WHWQ.KJ#C*,&&?3(SSS4]%,EE$0+L0%4$DDX  ZDGTJM::Q!>G9
M%(CL!G".K''K@$\<U<IDLHB!=B J@DDG  '4D^E5+;7+>Z81QRQLQZ!9%).!
MGH#GI5ZBBN(\1_#7^V9WN_.V[]OR^7NQM4+UWCT]*YOQ'\-?[&@>[\[=LV_+
MY>W.Y@O7>?7TKFO#FC?VS.EINV[]WS8W8VJ6Z9'IZUV__"G/^GC_ ,A?_9UT
MG_"'?Z!_97F?\#V?]-/,^[N_#K[^U9OASX:_V-.EWYV[9N^7R]N=RE>N\^OI
M7;T56O-3BL<>=(B;LXWL%SCKC)&<9J2VN4NE$D;!E/0J00<''4<=:;=WT=D-
M\KJBDXR[!1GTR<<\4VSU.*^SY,B/MQG8P;&>F<$XSBK-%9\OB&VB)1IH@RD@
M@R("".H(SUJ[%*)0'4@JP!!!R"#T(/I3Z*****SY?$-M$2C31!E)!!D0$$=0
M1GK5NVN4NE$D;!E/0J00<''4<=:EHHK/E\0VT1*--$&4D$&1 01U!&>M:%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<U\1O^/";
M_MG_ .C%KR#1;^2PF66 9EY"\;CEU*\#N>>.O/8]*Z*]^'E_*C7<N'DQDJ7+
MRG''H03@<#<3C@<\5B>'_$DV@N982/F&&5LE3Z9 (Y'8@@_@2#MVO@V_\3#[
M9*P^894S,1D$D_* #A>X& ,$%>*YN.671YLJ2DL+D<$'!4X([@CL>H(]17NG
MAO5_[7MX[K&"Z\CH-P)5L<GC(..<XZUXCXF_X^[C_KO+_P"AFO;O#/\ QZ6_
M_7"+_P! %<1\8_\ EW_[:_\ LE'P<_Y>/^V7_L]1?%'Q.XD%A$Q4*N9-I(R7
M'"G@9 4Y/)!W<C(K T'P!<ZU']H38J'[I=NN"0<!0QX([X]LUGZWHDWAV812
M$!P%961CZ\$'@@@@]@<CTP:]6\!>*3KT)\S'FQ$!L#&01\K=, G!R!W&> 0*
M\FUGPY/HVW[0FW?G;\RMG;C/W2?44:-X<GUG=]G3=LQN^95QNSC[Q'H:]D\%
MZ=)IMI';S#:Z[\C(/5V(Y!(Z&MRN:^(W_'A-_P!L_P#T8M>/:5JCZ7(+B+ =
M0V"1G&Y2N<>HSD=L]01Q721_#6]O$^TMMWN"Q5V/F$GGG(QN/N>_S8.<8.E:
MS/H,FZ,E65OF0Y .W(VLO&<9(]1VP:]WTW4$U&-+B,Y6101TSSV."1D'@CL>
M*\]^(7CIT<V-LQ781O=3\Q/7:"#P!_%WSQP =W.Z#X N=:C^T)L5#]TNW7!(
M. H8\$=\>V:K0SW?A&;',;C!*DY1ASC.#AAR1P>#G!!''LV@:P-8@2[4%0X/
M!YP02IY[C(X/<=ATK0HKY_\ $W_'W<?]=Y?_ $,U/=3W'B#8J([I!'&@5%+A
M<* 3\HX+%2>>>V2 *ZOX<6RZ1'<ZE.,>5E,'(8;<,ZX.!DDJ!GG(QQWYG6_$
M-QXHF"'.'=0D0;Y02<+UP"W/+'U[# %V[^&5Y;1^=A6.,E$;+CC)XP 2.F%)
M)/3-7/ 'C62SD2RE)>*1E5<G)0G"KC/\/0$=NH[@^I:EJ":=&]Q(<+&I)Z9X
M[#) R3P!W/%>):YKDWBF=<_Q,%C0'@;C@#)P,DXR3C/L  +NH?#>[L8C<L$(
M5=S*K?,H )).0 <8YP3STS4O@'Q>VDRK!*Q,#_+@L-J$G(;G@#).[!'!R<D
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MRO+:/SL*QQDHC9<<9/& "1TPI))Z9JYX \:R6<B64I+Q2,JKDY*$X5<9_AZ
MCMU'<'UB641 NQ 50223@ #J2?2O#/%/BF379&8L?*#?(G0 #."1DC=@\GGK
M@<8%:5M\,+R>,3?(I*Y",Q#^PQMP"?0D8[XYQ@ZSJDU^RBXR9(D\LE@0WRL3
M\V?XAG![\<\Y)]+^$G_'H_\ UW;_ - 2NWHKQ+XC?\?\W_;/_P!%K3-'M+KQ
M,J:?%@10!CSD("Q8Y8C.6.2!QTZ#[QJ'Q'X/GT#:9<%7Z,A)7/\ =.0"#CGI
MR.F<'':?#/Q<]X6LKARS8W1LQRQ_O*23DGN."<;N<  <M\1M+%A>.1@+*!(
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M *X2_P#H!KP:QNS92).N"T;JPSTRIR,]..*ZZ7P+J.M W<Q&\@D+*WSD?>
MP0HR<!25P>H KFM+U2;0IO-CRLB$AE8'GGE6''''(Z@\C! -=!#HE_XT)NF(
M"$MM+L1&.@*JHW''OC!P<DM7.ZC82:+,87.V2)ARI^A5@1STP1T(]C7LG@?Q
M VN6PED_UB,48X !(P<C'J",].<X &*Z"BBBBBOG_P 3?\?=Q_UWE_\ 0S7?
M:/\ %"VLH(H&24M'&BG"IC*J <?...*M_P#"V[3^Y+_WRG_Q=7M%^(EOJ\RV
ML:R!GS@L% X4MV8GH/2NDN;E;5&E<X5%+$\G  R3QSTKP[7-<F\4SKG^)@L:
M \#<< 9.!DG&2<9]@ !J7OPMN[5&E!1]HSM0L6/T!49/MG)[9/%9'A7Q(^@S
M"52?+8@2+URN>>,CYA_"<CGV)!]KUO55TF%[I^1&N<<\D\*. <9) SCCK7AH
M-QXCF"Y,DSYQN8#IEB!D@ #D@# ]*W-2^&5U81O<%HV$:EB%9LX')/*@<#GK
M],GBJW@KQ<^A2!&.8)&&\'.!GC>,9.0.N!\PXZX([;XE>')]9\G[.F[9YF[Y
ME7&[9C[Q'H:\DKT#P7X+N]-NX[B:/:B[\G>AZHP' 8GJ:U_B+XU;3?\ 0;<X
MD9<LX(RH/88Y#$<Y[ @CD@CB-"\(7/B3=.A&-QR\C=6X)'&YB3NSG&/?-1WE
MA=^$I023&QSM9#E6 /Y$9 )5ATQD<UZUX/\ $?\ ;\'GE=K*Q5@.FX '([X(
M(Z\CISC)X#XM_P#'VG_7!?\ T-ZYVUU":X@&FPAB&D9RJ9);Y5P, 9PNTGT[
MX^4&MGP+X==[U%G0KY2F7;(&0G:<*0,#.'(/IP?I6'XF_P"/NX_Z[R_^AFNE
M@TR]\7Q1(@"6\**J[V(5F0!2W ))/.#C:!D9SG/,:YH4NBR>1, &QD8(((R0
M"/8X[X/J!7JGPW\1/J\#)*VZ2%@,D')4CY23T)R",]>,GDY/7445S7Q&_P"/
M";_MG_Z,6O-_AS_Q_P /_;3_ -%M7MM<U\1O^/";_MG_ .C%KS?X<_\ '_#_
M -M/_1;5Z1\1O^/";_MG_P"C%KR#1;^2PF66 9EY"\;CEU*\#N>>.O/8]*Z*
M]^'E_*C7<N'DQDJ7+RG''H03@<#<3C@<\5B>'_$DV@N982/F&&5LE3Z9 (Y'
M8@@_@2#MVO@V_P#$P^V2L/F&5,S$9!)/R@ X7N!@#!!7BN;CEET>;*DI+"Y'
M!!P5.".X(['J"/45[IX;U?\ M>WCNL8+KR.@W E6QR>,@XYSCK7FGCKQT^HN
MUK Q6%"5)4_ZSJ"<@_<]!T(Y/8"GI_PWN[Z(7*A &7<JLWS," 01@$#.>,D<
M]<56TC7+GPG,8SD!6^>)C\ISC)[@$@###MCJO!]KL;L7L:3KD+(BL,]<,,C/
M7GFIZ***\;\9>.I-4D>*!RMOT  VEN""3W(.3P<#&,KFC3_AA>7B"0[(\]!(
MQ#8P#G"JV/H<$'J*S89[OPC-CF-Q@E2<HPYQG!PPY(X/!S@@CCV'PWX@37H1
M<1@CG#*>S  D9[CD$'T/8Y \Y^+?_'VG_7!?_0WJCX:DN]2@;2[1<*SEI'S@
M;6"KM)[#@D@99AP!@$&IXB\%W&@ 22[2C$#<C9&3DXP0#G STQ[YKHOA7XB=
M)/[/=OW;*Q0$$D,.2 >P(R2#QD<8).?4J***************************
M************************************************************
M************************************************************
M************************************************************
M*************************YKXC?\ 'A-_VS_]&+7F7@&V6XOH5<9 9F[C
ME%+*>/0@&O<J^;:^C;:V6U18D&%10H')P , <\]*\7^(W_'_ #?]L_\ T6M>
MD?#G_CPA_P"VG_HQJ\D\3?\ 'W<?]=Y?_0S7MWAG_CTM_P#KA%_Z *XCXQ_\
MN_\ VU_]DH^#G_+Q_P!LO_9ZR_BCHKVUR;O!,<P7G' 95V[>O7"Y'3.3C.#6
M1H7C:ZT4".-@8P2=CC*\^_# 9YP"!GGN<]);_$N"^ %_;JY4'#*JOR2.BOT&
M.IW'D=/3T32]6BU5/.@8,F2,C(Y'8@X(/U'3!Z&N"^,?_+O_ -M?_9*/@Y_R
M\?\ ;+_V>O2:*YKXC?\ 'A-_VS_]&+7F7@&V6XOH5<9 9F[CE%+*>/0@&O<J
M\=^*=H(+S>,YEC1CGU&4X]L*/QS78?"FY:6S*L<B.5E7IP"%;'YL37DU]=F]
MD>=L!I'9CCIECDXZ\<UZA;?%*SM46)(Y0J*% VJ< # '+YZ5R?CWQ3!X@,;P
MJRL@8,7502#C:,@G('/7IGCJ:Z7X/W9>.:#C:CJP]<N"#^'R#'XUZ%17S_XF
M_P"/NX_Z[R_^AFO8O ^G"PLX5&,N@<D#&2_S<^I (&?0#Z5F_%.[,%GL&,2R
M(ISZ#+\>^5'X9KSOP7K,.C7'VF=68*C;=F,AC@9Y*C&W(_'I7>_\+;M/[DO_
M 'RG_P 77ENISI/+))&-J,[%1@#"DD@8' P.PXKTOQ]JCSZ;#+P#<&+> ..4
M+X&<D#<!WSQUKG?A3;++>%F&3'$S+UX)*KG\F(KV"L.S\$V5GG;"AW8^^#)T
M]-Y;'X=>]9?Q3NS!9[!C$LB*<^@R_'OE1^&:\[\%ZS#HUQ]IG5F"HVW9C(8X
M&>2HQMR/QZ5WO_"V[3^Y+_WRG_Q=>6ZG.D\LDD8VHSL5& ,*22!@<# [#BO:
M[Z[-[ISSM@-):,QQTRT63CKQS7COAG_C[M_^N\7_ *&*]YOK07L;P-D+(C*<
M=<,,''7GFO!K:9] N@W5K>7!VD@'8V&&<9PPR.G0\CM7J'Q)UL6]GMC8$W!
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MIPN<.68C/7Y<  =P>O7BL;P_\*&F!>\)08X6-@6SGN<,N,= ,YSU&,&EXW\
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M]I_UP7_T-ZZ#X16RK;R2@?,TNTGGHJJ0/3@L?SK6^(W_ !X3?]L__1BUYO\
M#G_C_A_[:?\ HMJ]MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHKFOB-_QX3?]L_\ T8M>;_#G_C_A_P"VG_HMJ]MKYMKZ2KQ+XC?\
M?\W_ &S_ /1:UZ1\.?\ CPA_[:?^C&KR3Q-_Q]W'_7>7_P!#->U^%91):0%2
M"/)C'!SR% (^H(P?0UPWQAN59X(@?F578CGHQ4 ^G)4_E4OP<_Y>/^V7_L]=
M!K7Q LK/= Y,A#,CHJ$^H;._:I'8\G/TJF/ =AKJ)=Q!HUD!;]VP_B[$'> 5
M.1A< '([<<;XO\!'P]&L_F!U9]I^7:02"1W;(X.>F..O;0^$5RRW$D0/RM%N
M(XZJR@'UX#'\ZO?&/_EW_P"VO_LE'P<_Y>/^V7_L]>DT5S7Q&_X\)O\ MG_Z
M,6O*_!VHC3KN&9L;0^"2=H <%"Q/H,Y_#M7O->-_$_4$O+S:ASY2*A/&-P+,
M<8/;=@]P017:?"RT,%GO.,2R.PQZ#"<^^5/X8KR2^M#92/ V"T;LIQTRIP<=
M..*]=TWP3INHQI<1Q96101^\?//8X<C(/!'8\52O]&T;3Y!;2@+(<<%Y2!NZ
M9(;"^O)'')XKHO#>E6ED&>RVE7(#%)#(,KT&2S8(W?K6S17S_P")O^/NX_Z[
MR_\ H9KV[PS_ ,>EO_UPB_\ 0!6#\4[0SV>\8Q%(C'/H<IQ[Y8?AFO/? ]K;
MWER(+I=RR*0OS%1OX(R00>0"!UR2!BO2Y?A]I\0+M$ J@DDR2  #J2=_2L:S
MT_0[S.TH-N/OR2Q]?3>RY_#IWJW\2M+"6"K'@);O'P2?N@&, =<GYAU[9YS7
M&_#+419WBJV,2HR9)Q@G##ZDE< >I_ ^SUP*_%R$2,C1MY8)VNA!+8/!VL$P
M".>N1TQ5GXE1&_L%G *A7C<JXPP# KC'/S N,CZUP7@>UM[RY$%TNY9%(7YB
MHW\$9((/(! ZY) Q7I<OP^T^(%VB 50229)  !U)._I6-9Z?H=YG:4&W'WY)
M8^OIO9<_AT[UU.N6RVME-$@PJ6TB@<G $9 '//2O%O#/_'W;_P#7>+_T,5]
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M*(@78@*H)))P !U)/I5*+Q#;2D(LT19B  )$))/0 9ZTWQ-_QZ7'_7"7_P!
M->(^&?\ C[M_^N\7_H8KZ KY_P#$W_'W<?\ 7>7_ -#->W>&?^/2W_ZX1?\
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MX)8ACSZC:,C_ &AT[U/BW_Q]I_UP7_T-ZZ3X2?\ 'H__ %W;_P! 2M+XC?\
M'A-_VS_]&+7F_P .?^/^'_MI_P"BVKVVBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBN?\ 'ML]U92QQJ68[,!023B13T'/2O/_  %H
M=Q:WL4DD4BJ-^2T; #,;#J1CK7L%?/\ _P (S=_\\)?^_3_X5] 5X_X]T.XN
MKV62.*1E.S!6-B#B-1U QUKT#P%;/:V44<BE6&_(8$$9D8]#STKB/B/X0DBF
M:^B7=%)RP1>5(7YB0.QP6+>N<XX)P-!\1WMG_H]J[G=T0*).F2<*0V.Y..O4
MUI>(?!5U D4SB2:>7<9-H:3;@*%!89).,Y.<<8' R>D^%.F2V/G^=&Z;O*QO
M4KG&_.,@9QFI?'O@)M4;[9;<RG ="0 V  ""3@$#J.A'O][A+/6;WPUF%2\6
M_#;70?3(#J<9QC(ZXYZ43W%[XK<9WRE, ;5 5=Q[[0%7..2<<#DX''I?@+P<
M=!0RRX,TH&<8.T==H/K_ 'N<$@8Z9,7Q)\-OJ\*RP@M)"6.T=U8#=@8Y88&!
MGIGJ<"O+],UJXT%V\EC&Q^5@0#T/0JP(R#[9'([FO6?A_>W%[ TUUN+O)E2R
M[<KL3! P!M//08)R>N:Z>N?\>VSW5E+'&I9CLP%!).)%/0<]*\OT'P7/?S+#
M-'+&C!LN8V !"DKG( QD#C(STR#5G4=8U+PZ/L+NRHH*J=H((_V9"N< $8P<
MKP.","EX<\&7&N$%%*Q$\R,/EQSG'3<>",#OU(ZU[?;6RVJ+$@PJ*% Y. !@
M#GGI7"?$/P.]^QOK89?;^\7)RVT *5&.N.HR,X& 3UXFS\1WN@9MU=X\8^1U
M!QWX5P=N<YXQGJ:-/\.WGB%Q(%=M_620G;@$+G>W7'H,G X'%>T:)I2Z3"EJ
MG(C7&>>2>6/).,DDXSQTJ]17A_B'P]<RW,[K#*5::0@B-R""YP0<=*]@\/1&
M*V@1@0RPQ@@C!!"#((]:MW-LMTC1.,JZE2.1D$8(XYZ5XSXA\%W&A2>9&&:,
M%F5X\DJ%.06( VL!@YZ>AX.*D_BR]U%!:&5V!PH50-S9&W!*C<V<\@DY/7)K
MHO G@28S)=W"E(XSN56R&9@3CC(( (SSUXX()(]/N;9;I&B<95U*D<C((P1Q
MSTKQOQ3X!FT=F>,&2 <AAR0,$_,!R, <MC;TZ$X%*Y\:WES&;9Y24*[3PN2/
M0L!N.>_//?.36[X,^'DMS(MQ=*4B0@[7 W.0?NE3T7CG(Y'3KD>J7-LMTC1.
M,JZE2.1D$8(XYZ5XSXA\%W&A2>9&&:,%F5X\DJ%.06( VL!@YZ>AX.*D_BR]
MU%!:&5V!PH50-S9&W!*C<V<\@DY/7)KHO G@28S)=W"E(XSN56R&9@3CC((
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[encoded data, 5612 characters]
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M2TTV0V\TFUUQD;'/4 CD*1T-5O\ A8UA_P ]?_(<G_Q-'_"QK#_GK_Y#D_\
MB:EMO'ME=.L22Y9V"@;)!DDX Y7'6MNYN5M4:5SA44L3R< #)/'/2N?_ .%C
M6'_/7_R')_\ $T?\+&L/^>O_ )#D_P#B:?%\0K&0A1,,D@<HX'/J2H 'N>!6
M[;7*72B2-@RGH5((.#CJ..M%S<K:HTKG"HI8GDX &2>.>E<__P +&L/^>O\
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M/%.SQ%8Y$8X9\X5@3CY!SQ7?>)O^/2X_ZX2_^@&O!K&T-[(D"X#2.JC/3+'
MSUXYKL/^%27?]^+_ +Z?_P"(K/UKX=W6E(9B%=%!+&,D[0,<D$*<?0' !)P*
MD^'GB1],N%M\DQ3N%*]<,W"L.1@YP#ZCL2!CU7Q-_P >EQ_UPE_] -?/]>M_
M#/Q1_:$?V*0_O(5^7C ,8P!R.,J>.W&.IR:Z7Q-_QZ7'_7"7_P! ->(^&?\
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M&7Q#O\DH/+VYWDC[V<8PI]*V_P#A4EW_ 'XO^^G_ /B*/^%27?\ ?B_[Z?\
M^(KT_1[0V4$4#8+1QHIQTRJ@''3CBKE%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9/BS_CSN?^O>;_
M - :O%?A;_R$8/\ MI_Z*>OH"BBBBBBBBBBOFKQ9_P ?ES_U\3?^AM7TK111
M1117S_XF_P"/NX_Z[R_^AFO;O#/_ !Z6_P#UPB_] %>(^)O^/NX_Z[R_^AFJ
MEW9/:%1(I7>BLN>ZL,@CV_KD'D&O:? WB0Z[;AG(\V,[7Q@9]&P#T(^@R&P,
M"O(?$W_'W<?]=Y?_ $,U[=X9_P"/2W_ZX1?^@"M*O)/BW_Q]I_UP7_T-ZZ3X
M2?\ 'H__ %W;_P! 2NWKQ+XC?\?\W_;/_P!%K76^"_&EIIMI';S2;77?D;'/
M5V(Y"D=#6W_PL:P_YZ_^0Y/_ (FK.G>-+34I!;PR;G;.!L<= 2>2H'05:\3?
M\>EQ_P!<)?\ T UX;H=RMK<0RN<*DL;$\G # D\<]*]?_P"%C6'_ #U_\AR?
M_$UD^*/B-:R0/!"3(TJ.O"E0-PQDE@#T.1@'.,''6N$\%Z>]]>0J@^XZN3S@
M*A#'. <9Q@=LD#O7LGB;_CTN/^N$O_H!KP2VMFNG6)!EG8*!P,DG '/'6K.G
M7\FBS"9!MDB8\,/J&4@\],@]"/8U[1JFH)J-A+<1G*R6TA'3/*'@X)&0>".Q
MXKQOPS_Q]V__ %WB_P#0Q7K?Q&_X\)O^V?\ Z,6O+O!>HQZ;=QW$QVHN_)P3
MU1@. ">IKU'_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FMS3M1CU*,7$)W
M(V<'!'0D'@@'J*LUQ'Q;_P"/1/\ KNO_ * ]<W\)/^/M_P#K@W_H:5ZW7+?$
MK4/L=DZ@D&5E0%?<[CGGH54@^N<=*P?@_9$":X*C!*JK<9XR6'J!RI/8\>G'
M,_$;_C_F_P"V?_HM:@UJT"6EG/SN=)E/IA)21^/SG/X5Z-\+KS[19!,8\IW7
MKUR=^?;[V/PS7F$1&M7@+ JMQ<#(!R0)'YP<=1GKC\*9XF_X^[C_ *[R_P#H
M9KV33+S[#I\=QC/EVJMC.,[8P<9YQG%>)6T#ZE*L><O,X&6)^\YQDGD]3R>3
M7T);6RVJ+$@PJ*% Y. !@#GGI4M<5\5=+%S:BX&-T#CDD_=?"D =,YVGGL#S
MV/)?"[43;78AY*S(P(S@94;PV.Y&"!Z9/T.S\8_^7?\ [:_^R5F_#7Q'!HWG
M?:'V[_+V_*S9V[\_=!]17;?\+&L/^>O_ )#D_P#B:XOXB>-(M95;:WR45]Q8
MJ1D[<#&3G'S'.0.<8XK7^%?AM[4-?R KYB;4![J2"6(QT.!MYY&3C!!KE/B-
M_P ?\W_;/_T6M>D?#G_CPA_[:?\ HQJXGXM_\?:?]<%_]#>ND^$G_'H__7=O
M_0$KMZ*\V^,?_+O_ -M?_9*S?AKXC@T;SOM#[=_E[?E9L[=^?N@^HKMO^%C6
M'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFNEHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK)\6?\>=S
M_P!>\W_H#5XK\+?^0C!_VT_]%/7T!11111111117S5XL_P"/RY_Z^)O_ $-J
M^E:******^?_ !-_Q]W'_7>7_P!#->W>&?\ CTM_^N$7_H KQ'Q-_P ?=Q_U
MWE_]#-=]X@\*G5]/M[B($S0V\> H!+*57(]<CDCKW !)KAO"WB!M"G6X'W3\
MKC )*$@D#ISQD<CD<\9%0>(91+<SNI!5II""#D$%S@@^E>X>&?\ CTM_^N$7
M_H K2KR3XM_\?:?]<%_]#>ND^$G_ !Z/_P!=V_\ 0$KMZ\2^(W_'_-_VS_\
M1:U)HOP[N-7A6ZC:,*^<!BP/#%>RD=1ZU>_X5)=_WXO^^G_^(K7\)_#NXTBY
MCNI&C*INR%+$\HR]U ZGUKLO$W_'I<?]<)?_ $ UX-8VAO9$@7 :1U49Z98X
M&>O'-=%K/PYNM*C-PVQU7[PC+$@=VP5' [XZ=>@)'/Z;'')(BSL5B+#<RC)
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M_A;=I_<E_P"^4_\ BZ/^%MVG]R7_ +Y3_P"+KHO#OB*/7XS/$&"JY7YP <@
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M-N91@  Y^90!V&1C@<''.":Y:OH#PS_QZ6__ %PB_P#0!6E7DGQ;_P"/M/\
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ML";E$04G<@Y#,<?,P/0BN6_X5S?_ //+_P B1_\ Q5'_  KF_P#^>7_D2/\
M^*J[H?@*]M;B&5XL*DL;$[XS@!@2>&STKJ?B5X<GUGR?LZ;MGF;OF5<;MF/O
M$>AKB?\ A7-__P \O_(D?_Q5'_"N;_\ YY?^1(__ (JC_A7-_P#\\O\ R)'_
M /%5ZCX+TZ33;2.WF&UUWY&0>KL1R"1T-;E%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9/BS_CSN?^
MO>;_ - :O%?A;_R$8/\ MI_Z*>OH"BBBBBBBBBBOFKQ9_P ?ES_U\3?^AM7T
MK11111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111111163XL_X\[G_ *]YO_0&KQ7X6_\ (1@_[:?^
MBGKZ HHHHHHHHHHKYJ\6?\?ES_U\3?\ H;5]*T4444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M445D^+/^/.Y_Z]YO_0&KQ#X<7:6E_#+*RH@\S+.0JC,; 9)XZU[?_P )99_\
M_$/_ '^3_P"*H_X2RS_Y^(?^_P G_P 51_PEEG_S\0_]_D_^*H_X2RS_ .?B
M'_O\G_Q5'_"66?\ S\0_]_D_^*H_X2RS_P"?B'_O\G_Q5'_"66?_ #\0_P#?
MY/\ XJC_ (2RS_Y^(?\ O\G_ ,51_P )99_\_$/_ '^3_P"*H_X2RS_Y^(?^
M_P G_P 51_PEEG_S\0_]_D_^*KY]\3S+-=W#H05:>4@@Y!!<D$$=0:^F****
M*****************************K6VI1W+O%&P9H\;@ISC)(P<<9RIR.H[
M]15FBBBBBBBBBBBBBBBBBBBBBBBBBBBJUMJ4=R[Q1L&:/&X*<XR2,''&<J<C
MJ._459HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHK)\6?\>=S_U[S?\ H#5\UT4444444444
M4 9X%?55%%%%%%%%%%%%%%%%%%%%%%%%,EE$0+L0%4$DDX  ZDGTJE%XAMI2
M$6:(LQ  $B$DGH ,]:T**IW>L061V2R(C$9P[JIQZX)''%%IK$%Z=D4B.P&<
M(ZL<>N 3QS5RO/\ XM:E);)#%&Q59/,W!3C. HP<<XPQR.A[]!5;X.?\O'_;
M+_V>O2:*K7FIQ6./.D1-V<;V"YQUQDC.,U);7*72B2-@RGH5((.#CJ..M2T5
M6O-3BL<>=(B;LXWL%SCKC)&<9JS45S<I:J9)&"J.I8@ 9..IXZU6MM<M[IA'
M'+&S'H%D4DX&>@.>E7J*************IW>L061V2R(C$9P[JIQZX)''%2VE
M]'>C?$ZNH.,HP89],C//-3UY_P#%K4I+9(8HV*K)YFX*<9P%&#CG&&.1T/?H
M*K?!S_EX_P"V7_L]>DU%<W*6JF21@JCJ6( &3CJ>.M06FL07IV12([ 9PCJQ
MQZX!/'-7****K7FIQ6./.D1-V<;V"YQUQDC.,T6>IQ7V?)D1]N,[&#8STS@G
M&<59HJG=ZQ!9'9+(B,1G#NJG'K@D<<5+:7T=Z-\3JZ@XRC!AGTR,\\U/116?
M%XAMI2$6:(LQ  $B$DGH ,]:T*H_VY;[_)\V/?NV[?,7=NSC&,YSGC'7-7J*
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M**9-"LRE' *L""",@@\$$'J#7G-_\$X9G+PRLBD_=*A\>P.0<#MG)]2:K_\
M"C5_Y^#_ -^Q_P#%4?\ "C5_Y^#_ -^Q_P#%4?\ "C5_Y^#_ -^Q_P#%4?\
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M9;=KHGF=N!V"QDJ.W7.[N1C'O67\0O'3HYL;9BNPC>ZGYB>NT$'@#^+OGC@
M[N8\/^![G7%\V,!8^<-(< D'&!@$GZXQP1G(Q4&L:)<>%Y0&)5L95XV(!XP<
M-P<C.".#^!!/IW@+QB=>0Q2X$T0&<8&X=-P'K_>XP"1CK@>5:SX<GT;;]H3;
MOSM^96SMQG[I/J*-&\.3ZSN^SINV8W?,JXW9Q]XCT->H6-TWA/3 9P%E0. I
M(.69V*CAN1SDX.< ^E>;1)=>+;@*27E8#D\*JCN<#"J/8<D]"QYL^(/ EQH:
M">3:R9P3&2=OIG(& >QZ9X."1GL/AOXRDU!FL[EMS!08R< D*,,I.<L<<C@G
M[Q)KT"BN*^(_BTZ4@M86(FD&20/NIR,@]F)&!C.!D\'!K@-!\*7'B4O(F, _
M,\A."QY(S@DMSD_J>1F#7/#\_AR15DX/#(Z$X..X/!R#]".#T()]6\!^)6UV
M M)CS8VVM@C)X!#%>V>1Z$@XQT',_$+QTZ.;&V8KL(WNI^8GKM!!X _B[YXX
M .[F/#_@>YUQ?-C 6/G#2' )!Q@8!)^N,<$9R,5!K&B7'A>4!B5;&5>-B >,
M'#<'(S@C@_@03Z=X"\8G7D,4N!-$!G&!N'3<!Z_WN, D8ZX''_%O_C[3_K@O
M_H;UE>';2ZUR,Z;;X$6\R.3D+D@ !B,\?+P .O)Z96EX@\-S:"XBF ^895ER
M5/K@D#D=P0#^!!.I8ZU?>(E33(V)^]N;<V2I/)=R2=H!QCH>!@G%4O$?@^?0
M-IEP5?HR$E<_W3D @XYZ<CIG!QVGPK\2/=!K"0EO+3<A/900"I.>@R-O' R,
MX %>A4444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444A.*^5J*ZKX7'&HP?]M/_13U] 444444444445X;X\T_[#>R
MJ <.V\%N^\;CC@9 8D#Z8ZBND^(_B)-0M;95QF;$I 8,5PI7:<#U8C/'*D8Z
MXY*YT5HK.*]*X$DLB[LCD +M&,^JOV^O:NMT;Q$D.CRQG&Y-\0&X GS22&QC
M/ 9N.^P\]<9OPKT_[1=^<0<0HQ!'3<WR@$X[@L0.#Q[&NE^+>G^;!'< $F)\
M''0*XY)X]54 ].<=Q69\./$2:?:W*MC,.90"P4ME0NT9'JH&>>6 QTSR7AC1
M6U>5HE7=B*5L9 Y"$(>H_C*_UXS6I\,M1%G>*K8Q*C)DG&"<,/J25P!ZG\#0
M\67G]K7LKQC.YPJ[3NW;0$!&.N[&1CUQS7K&OZ&'L'LEW$)" N.6)B *C@<D
ME1G Y[8KS;X9:B+.\56QB5&3).,$X8?4DK@#U/X&EXHN#K=](8@"9) B88$-
MC"*0>!AL9].>O>FZC%_PC]\?EX@G#*N[^$,'09YZKCKD^O-;_P 6-62[DBA0
MA@B%MRL"/WF,#CV4'KR&'X]=\-=/^QV2,00969R&]SM&..A501ZYSTKJ:XWX
MK7+16853@22JK=.0 S8_-0:Y3X31![MB0"5A8C(Z'<HR/0X)'T)KUJ6(2@HP
M!5@001D$'J"/2H[2QCLALB144G.$4*,^N!CGBN6^)/AM]7A66$%I(2QVCNK
M;L#'+# P,],]3@5Y;I^K7&B.3$S1N#AA[C(PRG@D9/4<'WKI].^+%S!A9E20
M#.3C8YZXY'RC'^[T'KS7>^%_&,/B $)E9% +(V,]LD'NN>,\'U R,\I\8_\
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M*% Y. !@#GGI7-_$NV66QD9ADQLC+UX)8+G\F(KS_P"&ERT5]&JG D5U;IR
MI;'YJ#70?&/_ )=_^VO_ +)1\'/^7C_ME_[/4OQAN65((@?E9G8CCJH4 ^O
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M9/(''!(!/*YKU'2=4358EN8L[''&1@\'!!]P01Z>A(KA-?\ '<VCW[Q,2T"
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MI@8&>YHKS_Q_XCN]!G1HG_<NH.UE0C<I^9>F[&,=\\G!].[MKE;I%E0Y5U#
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MY8A*"C %6!!!&00>H(]*\E\" Z5J9M 0PS+&21CA,MD#/!)0>O&?K6I\8_\
MEW_[:_\ LE=AX-M!:6<"+G!C5N?5_G/X9;CVKEOC!=E(X8.-KNS'UR@ 'X?.
M<_A71>!-*73K.,+R95$C'GJX!]3T&![XSCFN@KQV*U'A_5EABP5$R@ YX68
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M+@X/0[V.#Z'!!^A%6_&FH)8V<S.?OHR <9+."HQDC.,Y/? )[5R7P<_Y>/\
MME_[/1\8_P#EW_[:_P#LE=OX9_X]+?\ ZX1?^@"M*BN(^+?_ !Z)_P!=U_\
M0'J?X7:B+FT$/ :%V!&<G#'>&QV!R0/7!^@ZV641 NQ 50223@ #J2?2O)_
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M+KL+#@AMNU<#G'X9K>JMJ=G]NBDM\X\Q&7.,XW C..,XS7C]KINI>&Y'2!)
M>A,<9D1@.01E2#['&1DCCD5Z[$!J4 $J%1-&-Z$D$;U^92>#D9QV/TKS#5?
M=WH$GVJS)=4;*E.9!T&"N.>N#@$$ D@ XILMWK&K VK++MD!!S$L8QU(+[5P
M#]1GISG%=)X&^'YTEA=W!'F@?*JGA=PP<GNW)&!D#KDY&.YHHKR3QSX7FM[M
MI;5)&652Q,:.0"^5=<C/7DD<<-C&*ZOX9Z"VF6[22J5DE?D-N#!5X4%3C!SN
M/N".?3L*\K\2?#::Q<W-EED!W!03YBD9/'J!CC!W<@8)&3!_;&LW/[K$HW\?
MZD)UX^]L&WZY&.N16IX,^&SVTBW=W@%""J*<G<#P6(XP, @ G/?&"#V7BC1S
MK%M):J0K.!@GIE6##/L<8SVZX/2O,-#.I>'GV1Q2[-X+H(RRMM.#AMK 9'&Y
M>HP><"O6-6TM-5B:VESL<<X.#P<@CW! /IZ@BO*[GP5?^'7,]ME@O1H3R1NX
M!3J>@)&&7U)P:)Y]8U@?9G67#9SF,1 \'(+;5&".Q.#]<5U/@/P&VC,;JX(,
MI7"J,$+D#))Q][MQQC/)SQV]%%>#:_H1M+Q[&,#)D 0 ]GP4&6[X8 Y[]^]>
MY6-H+*-(%R5C15&>N%&!GISQ3KFV6Z1HG&5=2I'(R",$<<]*\IU7P'=Z!)]J
MLR75&RI3F0=!@KCGK@X!! )( .*;+=ZQJP-JRR[9 0<Q+&,=2"^U< _49Z<Y
MQ72>!OA^=)87=P1YH'RJIX7<,')[MR1@9 ZY.1CI/$VAC6K=[8XW$90GLP^Z
M<X.!V..<$BO+;?2=3\,R,L"/EAR8T\Q& )P>C#/ID!@#T&:U?^$3O=85[V^)
M.V*0I&<[BQC^7"+@+S@D=25P5YS6E\*=,EL?/\Z-TW>5C>I7.-^<9 SC-'Q6
MTR6^\CR8W?;YN=BEL9V8S@'&<5V'AZ(Q6T","&6&,$$8((09!'K6A17$?%O_
M (]$_P"NZ_\ H#URFE^&+J&WBU2Q9M[!]ZJ<-\CG&!_$IVC*\DGL0<!TMOJW
MB,BWE$@7OO7RDQD<G 4-@X..3U('6O0O!WA<>'H?+)#2.<NP'?'"@XSM';/<
MD\9P.=^*VF2WWD>3&[[?-SL4MC.S&< XSBNP\/1&*V@1@0RPQ@@C!!"#((]:
MDU;2TU6)K:7.QQS@X/!R"/<$ ^GJ"*\KG\)7_A>3S[;+]0&B&XD'/#(03T&3
MP5!QSG%%R-7U]3;2+(5ZD,BQ X/J0@//.,^^...U\$>"!X?!FD(:9P02I.T+
MG.!G&2< DD>P[D\UXO2[\47"V\44JP*< R(R(3SF0Y48&. #DXZ#+$5Z%HVC
M1Z/&+>$84=2>I/=B>Y/_ -88  KSWQOX1FLK@:A9HS;G#':"[+(#NSMP?E/7
MN,Y!P,"O0-!U%M0A661&23&'5T9,,!S@-_#Z')XZ\Y S?'^EC4+.0<;HAY@)
M)&-G)Z=]N0,\9/XCA/A5I9N;HW!SM@0\@C[SY4 CKC&X\=P.>Q]=KAO VJ:A
M=SLMZ'$8C)&^((-VY<<[5YQGBNYHKG_'ML]U92QQJ68[,!023B13T'/2L_X7
MV,EE;.DJ,C&9CAU*G&Q.<'''%=A17E^AZ//'JS3M&XC\Z<[RC!<$/@[L8P<\
M>M=!X_\ !9UP+/#CSD&.6P&49..A&[)XZ#DY/3'&VEWJ^EC[.BS;5.,>5Y@&
M.,!BK?+QQ@X].M7K+PA?>)W6>^9EC!_CX;'0[8\84G:,D@=FPU.^'.E3Z5>$
M30R*&1TW;#L!!#<MTP=N 03DD8ZUZE7DGCGPO-;W;2VJ2,LJEB8T<@%\JZY&
M>O)(XX;&,5U?PST%M,MVDE4K)*_(;<&"KPH*G&#G<?<$<^G5W-LMTC1.,JZE
M2.1D$8(XYZ5Y3JWP[N](D,UF2ZKN*LC;95&.A'!)()'RYSZ#.*;)JFLWH\DB
M8;B!D1>7W_OA5P/4Y QUXK9\$?#J2RD6\NL IRJ##'=R,L>1QU&"3G!R,8/H
ME%%>3?%G2Q;W"7(QB9.>3G<F 3Z ;2H&/0\>O9?#G2S86:$Y#2DR$$@_>P%Q
MCL5 /KDGZ#IZ\K\2?#::Q<W-EED!W!03YBD9/'J!CC!W<@8)&3!_;&LW/[K$
MHW\?ZD)UX^]L&WZY&.N16IX,^&SVTBW=W@%""J*<G<#P6(XP, @ G/?&"#Z)
M+$)048 JP(((R"#U!'I7D&I^"[SP_,)[8,RJYV-'\[ 9. R@ YP/FXVG.,\X
MJ]#I.J>*!Y=PS1Q \^8HCSRI^XH4L1U&1C(/S T>&O#\MCJFX1.L*23!6*-M
MV[7"_,1TZ8.>:Z3XH6,E[;(D2,["93A%+'&Q^<#/'-:'@*V>ULHHY%*L-^0P
M((S(QZ'GI704444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444445RWB+X@Q:)(UN\<A
M<*". $;(R,,3G&>"<'!!X.*Y'X>Z:VLWCZC*ORJS/D ;/,8Y YR> 21CD$*2
M>F?5Z************XCXM_\ 'HG_ %W7_P! >M+X<_\ 'A#_ -M/_1C5TM%%
M%%%%%%%%17,_D(TF"VU2<*,L<#. .Y/8>M>8>,OB+'J\!M($8!R-QD & I##
M 5CR2.2>@['.1UOP]T$Z3:@NI664EG#8W>BCUQCG!Y!)Z=*Z>BBBBBBBBBBB
MBBBBBBBBBBL;Q)XIC\/A7E5V5R1E%! ([$DC!/;UP?2O-+VZ;QO?($0B/Y5X
MQN$8;+,2<@'D^V<+R>OL,40B 10 J@  #  '0 >E/HHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHK(U?PG;:NXEG3<P7:#N<< DX^5@.I-:%E9)8
MHL$2A408 '^>OJ>I/)YJ>BBBBBBBBBBBBJ.KZ+#JZ"*==RAMP&6'(!&?E(/0
MFI=.TZ/38Q;PC:BYP,D]22>22>IJS111111111116#9>!K.R=9HX@'0Y!+.V
M#ZX9B,CMQP>1S6]11111111111111111111115'5]%AU=!%.NY0VX#+#D C/
MRD'H33='T"#1P5MT"!CD\DDXZ<L2<#L.@Y]36A1111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111117/^/;E[6REDC8JPV8*D@C,BCJ.>E9_P +[Z2]MG>5
MV=A,PR[%CC8G&3GCFNPHHHHHHHHHHHHKAM+TO4(]0,TA?[+YDI ,H*[2&V?)
MN/'(P,<>V*L_%"^DLK9'B=D8S*,HQ4XV/QD8XXK0\!7+W5E%)(Q9COR6)).)
M&'4\]*Z"BBBO+]#UB>35F@:1S'YTXV%V*X ? VYQ@8X]*]0HKG_'MR]K92R1
ML58;,%201F11U'/2L_X7WTE[;.\KL["9AEV+'&Q.,G/'-=A11111111117E_
MPOUB>]N7261W40L<.[,,[TYP2>>:]0HHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHK#\8>(_[ @\\+N9F"J#TW$$Y/?  /3D].,Y#_!^J/JM
MJES+C>Y?.!@<.P 'L  /7U)-<Q\5M3EL?(\F1TW>;G8Q7.-F,X(SC-=AX>E,
MMM [$EFAC)).224&23ZUH44444444445G^(93%;3NI(989""#@@A#@@^M<?\
M*=3EOO/\Z1WV^5C>Q;&=^<9)QG%>@4444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444444444444444444444444444444444445R.H>/
MOL=Z--\K.7C7?OQ_K ISMV]MWKS6%K7Q:97*VJ*44GYI-QW=.0H*X'7KDD8X
M!XJSX;^*@NG$-VJIN/#KD*.F 02<#K\V<#C( R:]"KBG^):0RW$$B!?LXDVD
MO]]D8*% V\%OQP,D\ FL2R^*MQ<S+&(D97?"J"5;YCA1O)(SDC)VX/MV[OQ!
MXDAT%!+,3\QPJK@L?7 )' [DD#\2 > N_B].YS%$BKCHY9SGZ@IQ[8_&KNA_
M%H.=EV@ )^_%G Z=5))P.22"3V"UWUS<MY9E@ D.W*C>%#=^&P1R.G8^H'-<
MQX6^(J:Y+]F:,QNP.WYMX. 21]T8.!D=CSR#C/6RRB(%V("J"22<  =23Z5Q
MMI\13J=Q]DM(#(,\.S[!@=7(V'"_J>.,G%3^)O'W]@3BW>+<K*K;E?G:20?E
M*XR"#QNP>.1GCKJQO%?B0>'X?M!4N2X4 '')!/)YP, ]CSCZAWA?7&UR$731
M^6&8A1N#9 XST&.<C&.V>]:]%<#XC^*B6A,-JHD93C>W^KXQT .6'49R!W&X
M5C6WQ=N%8&2.-E[A=RGIZEF Y]C7H'AKQ+'K\?FQ\,,!T)Y4_P!0>Q[^Q! =
MX@\20Z"@EF)^8X55P6/K@$C@=R2!^) / 7?Q>G<YBB15QT<LYS]04X]L?C4F
MG?%Z13BXB4J2.8R5('?ABV3Z#*_7GCTFRO4OD6>)@R.,@C_/7U'4'@\UR+_$
MM(9;B"1 OV<2;27^^R,%"@;>"WXX&2> 36)9?%6XN9EC$2,KOA5!*M\QPHWD
MD9R1D[<'V[>A:SK,>CQFXF.%'0#J3V4#N3_]<X )KSF[^+T[G,42*N.CEG.?
MJ"G'MC\:DU7QZFO6,T$@"3 1\9^5L.F2N>_7Y>2!SD\XV?A)_P >C_\ 7=O_
M $!*[>BN8\4^/8=!/DX,DN =JD #./O-S@D<@8)]< @UQLOQ<N225CB"Y. 0
MY(';)W#)]\#Z"MGP[\55NW6&Z4)NR/,4G9G/&5/*C'!.3SR<#..K\3:T=%@:
M["!PA7(+;>&(7@[6YR1QQQGGL8/"?BE/$49E4;&5L,NX,1W!['!'<@<@CMFM
MRN/U/XA"VNAI\48=BZIN,FU=S$#'"MP,X/<'(QQSM^(/$D.@H)9B?F.%5<%C
MZX!(X'<D@?B0#P%W\7IW.8HD5<='+.<_4%./;'XU)IWQ>D4XN(E*DCF,E2!W
MX8MD^@ROUYX])LKU+Y%GB8,CC((_SU]1U!X/-<QI_C[[9>G3?*QAY%W[\_ZL
M,<[=O?;Z\56^+?\ QZ)_UW7_ - >M+X<_P#'A#_VT_\ 1C5/XH\8P^'@ ^6D
M8$JBXSWP2>RYXSR?0'!QPUS\7;AF)CCC5>P;<QZ>H90>?85>T;XMEF"748 +
M<O'G"C']P[B>>N#TZ D<^C12B4!U(*L 00<@@]"#Z5Y!IEZECJSSRL%1)KDD
MGZ2?KZ#J3P.:T-0^+LI<^1&@3MYF68\GGY64#C''.#W-;OA7XDIJSBVF41R,
M %.[*LW<<CY2?X02<],YQG0^(W_'A-_VS_\ 1BUF_"3_ (]'_P"N[?\ H"5T
MNN>(H=$3S)VQG.T 99B!G ']3@ D9(S7GMW\7IW.8HD5<='+.<_4%./;'XU=
MT/XM!SLNT !/WXLX'3JI).!R202>P6O1(I1* ZD%6 ((.00>A!]*?6-XK\0'
M08?M(C,@W@$ [< @_,3AN,X'U(J3PSKHUR!;H *26!4-NVD$C!.!R1@].A%1
M^*_$@\/P_:"I<EPH ..2">3S@8!['G'U%;P?XP'B0.=A1HRN1NW ALXYP.>#
MD8].?36U?41IL,ERV,1H3@G;D@<+GU)X'N:R?!_BT^(P[^48UC*@'=N!)SD9
MVKR.,]>HKSCX>ZS'H\TEQ,<*(&P!U)WIA0.Y/_US@ FM*Y^+MPS$QQQJO8-N
M8]/4,H//L*ZSP=X]37CY$@"3 =,_*V!R5SWZ_+R0.<GG'5UPWB'XI161\JV
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MV[O^Y%_WR_\ \77:>%O'L.O'R<&.7!.UB"#C/W6XR0.2, ^F0":Z2641 NQ
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M3N"@8]3QZ:7PYU0W]F@.2T1,9) 'W<%<8[!2!ZY!^IX_XJ7YO;F.S0;C$O0
M[M\F#M]^ N,=R?H/2](TX:;#';+C$: 9 VY('+8]2>3[FKE<Q\1M4-A9N!D-
M*1&" #][);.>Q4$>N2/J,3X7^&8S%]OE0,[.?++8( 4CY@.S;@>3SQQ@$Y[G
M4--CU%#%,H=3V89QP1D=P<'@CD=JX_P?X FT*X-PTJE,%<*I)93ZY^Z00IXW
M>F<=3QAX FUVX%PLJA,!<,I!51Z8^\22QYV^F<=.K@MH-$CPH2*)<9)PH[+D
MD]2>!DG)KC?B-J5E>0':T;W'R["A#-PPR"RYP,$\,<$\CD5;^$TI>T8$DA9F
M R>@VJ<#T&23]2:XE-+&J:H]N<%6N9-P)(RJLS,,CG) ('OW'6O9&L8V"H44
MK&04&T84K]T@=B.V.E>6_$R[;4[Q+&/),850#@9>3!X/H05'.,$'ZGTG1=!A
MT9!%"H' RW&YL9Y8]SR?89P !Q7&_%#PS&(OM\2!75QYA7 !#$_,1W;<1R.>
M><@#%OX2?\>C_P#7=O\ T!*[>BO/[#X9NMV;JY=)8]Q<Y4@LQYY4?*!N.>I!
MQC&"<=I<7T&F!4=TC7&%#,J#"XX ..!QTZ5Y7\2KFTN)$:U*%_F\PQ]#G!4Y
M'RD\G)&3V/05Z3ID']I64<<A)\ZV4,<_-\\8!.3GGGJ<\UY[\,[MM,O'L9,@
MR!E(&#AX\GD^@ 8<9R2/J/4KZ[%E&\[9*QHS''7"C)QTYXKRWX9VC:G>/?29
M)C#,2,#+R9'(]""QXQ@@?0]!XP\ 3:[<"X650F N&4@JH],?>))8\[?3..G5
MP6T&B1X4)%$N,DX4=ER2>I/ R3DUQOQ&U*RO(#M:-[CY=A0AFX89!9<X&">&
M.">1R*M_":4O:,"20LS 9/0;5.!Z#))^I-<SX?\ ^0RW_7>X_E)72?%O_CT3
M_KNO_H#UI?#G_CPA_P"VG_HQJQM4^'$FHWGVN216B=PS @JV!T0!>"-H W9!
MZG&>O9/+!I* $I%&#@9*HN3DX'09/)_.O._B=>V=VJM"R-<;P2T?.5VD<LO!
M((& 3D#I@&NN^'LIDL82Q).'')SP'8 ?0 8'H*\ON]*;5M1DM4X,ES(,\< .
MQ8\D9P 3C//2O:=/TV/3D$4*A%'91CL!D]R<#DGD]Z\T^*'AF/3S'=P($5R5
M<+@*"!E<+V) .<<<>IYV]=U0ZIHYN#DLR1[B0!EEE56.!Q@D$CV[#I3OA)_Q
MZ/\ ]=V_] 2N4\5:FFL:@8KB1DMXG*=,[=HPV ,\LPZX)P1D8&*[33_&FF:<
M@BA<(H[+'(.P&3\N2<#DGD]ZQ/&&K:9K,;NKC[0%RK".0$D8X/ !R!M!;.W.
M16A\)M4-Q;O;'.87XX&-KY('J3N#$Y]1SZ=S6?X@TL:K;R6W&70XR2!N'*DX
MYP& /]#7"?"'5"#+9G."!(O P,85N>N3E<=N#T[GQ:NS/)!9)N+8+;1R"6.U
M, =6&&[=^.IJMX"E&E:C+9 L48RHO/>-B06Z#.U3SCJ?0FMOXLZH;>W2V&<S
M/SP,;4P2/4'<5(QZ'GUU_ &EC3[.,<;I1YA().=_(Z]]N <<9'XGR_P/X?77
M+D12?ZM%+L,D$@8&!CU)&>G&<$'%>UQV,<:>0J*(\$; H"X/4;>F#GGUKR*>
MP71M62" E56>+')SA]I*YZXPQ'/4<'-=_P#$'66TJT9HR5>1E167&1GD\]OE
M!&1R#C&.HXOP-=:=IBBXN7!G)X#1LP3!XQA2-QP#NZCH,<Y["Y\>:;=*8Y)
MRGJ&B<@X.>A3'6O/;G4;;2+Z.ZLF)A4J2 K9 ^ZZCS.22,G/'WL#&,UVGQ;_
M ./1/^NZ_P#H#U!\+O#:11#4' ,CE@AZ[5!VGC'#$@Y//& ,9(.]XXT:/4;6
M1I!\T*.Z,.H*KGKZ'&"._P!0".8^#LI(N$R=H,9 SP"=^3CU.!GZ#TKT>BO)
MOB9:-IEXE]'D&0*P)P</'@<#T "GG.23]!ZE8W8O8TG7(61%89ZX89&>O/->
M26BCQ1JF_ ,9DW'Y"5*1#"Y!Z!@H!SW;IVKN_B-JAL+-P,AI2(P0 ?O9+9SV
M*@CUR1]1S_PQ\*)(G]H3*&;?^ZSVVY!;@XSGID9!7(ZBO0+VR2^1H)5#(XP0
M?\]?0]0>1S7C^I6I\'ZBKKD1JX=<8)\MLAE&2>0-RY)!.,\9%=A\6_\ CT3_
M *[K_P"@/6E\.?\ CPA_[:?^C&K3\3?\>EQ_UPE_] -<1\'/^7C_ +9?^SUZ
M317#>,/ $VNW N%E4)@+AE(*J/3'WB26/.WTSCIU<%M!HD>%"11+C).%'9<D
MGJ3P,DY-<;\1M2LKR [6C>X^784(9N&&067.!@GAC@GD<BI?AKJ'V6PEF<DK
M"\AP.2%5%8@ G'7)QP,FN:\ :,/$%T]S<#>J9=LX +NV1E>X/S' XXP>.#ZW
M]F39Y.T;-NW;@;=N,8QTQCC'3%<)?_#-VNQ=6SI%'N#C"DE6'/"GY2-PSU &
M<8P!FI\7M4),5F,X ,C<#!SE5YZY&&SVY'7MUOA'PS'HL*80"8H-['!;) ++
MN'\((X XXSR<DGBWPJFO1,N%$P V.1R,'."1SM.2.X&<X)%8FGZ9+X+L9Y'D
M#,1E0B@A7;Y <MC<#\I.1Q@X![\IX,FL49KK4'W2%CA71G!R,ES@,&))/7IR
M>201WLOQ!T^4%&E!5@008Y""#U!&SI7G?BNYM(9X[K3F (.X@(P"LK;@PWC&
M#G[H&!M]Z]&\63MJ&G2309'F1*_4*=AVLV>?[F<C//3FN)^'/B2UT?S!<#:[
M=),%OEX^3 !(YY]#WZ#/<W1L_%\1B1T=BC;3C]XG.-VTX8#(&>@/ /!J3PEX
M4'AU&C$C.7()SPN1GD+S@D8!Y.<#Z5YEJ\PL-3DDNT,B+,25)SE3RG?! 4@A
M3Q@;3@5Z7!XUL-0S%YJ$%3D2 HI!X(^< '.>GI5&#X=1V]W]NC<HH8,L<8V@
M'C(W9/RGG*@#@X' KKJ*\_\ BKID4%NLR1HKM.,LJ@,<JY.2!DY/)]ZTOASI
MD7V2&X\M/-_>?/M&_P"^P^]C/3CZ<5B?&/\ Y=_^VO\ [)6W\/\ PM'I\$=R
MR@S2J'W'D@,/E"Y Q\IYQU)/)&*C^)^C1W%LUV1^]AV[6'7#. 5/J.<CT/3J
M<L^$TI>T8$DA9F R>@VJ<#T&23]2:XE=3@UV]:XOI&6#)*@@DE0?DC^3.T8.
M21[\Y.:]"MO'FFVJB..0*HZ!8G &3GH$QUKD?'%[INI1F:V8"XW _+&Z[P2=
MV<@+GG<6/)QBNP^'.J&_LT!R6B)C)( ^[@KC'8*0/7(/U/3U%<QM(C*C;6*D
M!L X)'!P>#@\X[UPWACX9#3YFEN2DJ $(N"<Y/WF!XSCM\PR<YR 3V5WK$%D
M=DLB(Q&<.ZJ<>N"1QQ7CWC:YMQ="2Q( 51DQ94!U8C*XP.@'*\'J.<FO6_$W
M_'I<?]<)?_0#7E7PY\.#5[C?( 8H1E@>02<[5(R..">A'&#UKV"2QCD3R&13
M'@#85!7 Z#;TP,<>E>1:M;#PAJ*O&"(E977HQV-PX&?^!*,\]\]ZV?B]JA)B
MLQG !D;@8.<JO/7(PV>W(Z]NI\&>%$T.)6*CSV0>8W4\G.WJ0 .AQPV 3VJ[
MXA\.1:Y'Y4H&X!MC<Y4D8SP1D="1G!P,]*\[^&=VVF7CV,F09 RD#!P\>3R?
M0 ,.,Y)'U%[XO:608KP9P08VY&!C++QUR<MGMP.G?MO"^J'5+6*X.2S)\Q(
MRR_*QP.,$@D>W8=*XGXO:H28K,9P 9&X&#G*KSUR,-GMR.O;2UF5O"VEI"I9
M96"KD$$JSDN_([?> (R1Q@]ZY_P-=:=IBBXN7!G)X#1LP3!XQA2-QP#NZCH,
M<Y["Y\>:;=*8Y) RGJ&B<@X.>A3'6O/;G4;;2+Z.ZLF)A4J2 K9 ^ZZCS.22
M,G/'WL#&,U[7111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111117C_BFY6UU?S7.%26!B>3@!4)/'/2O8*Y;XEW
M*Q6,BL<&1D5>O)#!L?DI-5OA3;-%9EF&!)*S+TY "KG\U(KEO#__ "&6_P"N
M]Q_*2O6Z\BTN066LDR97-Q*!D'_EIN"?@=PP>F#GI7KM9'BZY6WLYV<X!B=>
MYY<;5''J2!7'_!V(@7#X.TF, XX)&_(SZC(S]172^.M?32+=@X#M,"@0G&<@
MY)P0=H'7'.2!D9R/(="O?[)GBNG3*A@V"N<KDJ2,X!((.TYP&'M7O=M<K=(L
MJ'*NH8'D9!&0>>>E0:OIPU*&2V;&)$(R1NP2.&QZ@\CW%>:?#34/[(N9K.8A
M-RMG/9H<DC<#@ #<23QP.?6MX00^(M2-R_0,TI#,21@X0 ]]I*XZ# _"O8**
MXKXLQ%[12 2%F4G Z#:PR?09('U(JY\-+E9;&-5.3&SJW7@EBV/R8&NIK-/B
M2W68V1D F&/E;(^]C !( ).1@ D_K7!^+O%USJ%R=-LB0 VSY.'9ARWS'!4*
M01P0, DDJ>(;3X0SN<2RHJXZH&<Y^A"<>^?PJ+Q%\/(]"MI+EY2S@H$& @)+
M<C!+$G&2,8Q@GD5T7PD_X]'_ .N[?^@)7-^'_P#D,M_UWN/Y25ZW7D7BR066
MK">3*H)(&R0?NJ$R1Z@8/3N".M>NURWQ+N5BL9%8X,C(J]>2&#8_)2:H_"3_
M (]'_P"N[?\ H"5V]17-RMJC2N<*BEB>3@ 9)XYZ5Y(U]>^.I&AC.V(<E<D1
MJ.,!B!EB2.,@\Y( &<:%I\'Y'&99E5L]$4N,?4E.?;'XUB>-/"D?AT11K(7D
M<.7S@< C:0O) /(Y)R0<>E>L^&?^/2W_ .N$7_H KSCXF6C:9>)?1Y!D"L"<
M'#QX' ]  IYSDD_0;?Q(\1![.)$!Q=A6&X=%7:_8\-DKZC&?:M7X<:,-/M%D
M(P\WSL>"<'[G([;<'!Z$GITKFO%WBZYU"Y.FV1( ;9\G#LPY;YC@J%((X(&
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MXB^'D>A6TER\I9P4"# 0$EN1@EB3C)&,8P3R*TO L1ETNZ102S&8  9))B7
M ]:@^#URJO/$3\S*C <]%+ GTX+#\Z].K/U37X-**+.X0RDA<@XXQG) P ,C
MDX%>:?%?]Y<13+RCP+M8<J?F8\'H>"#]"/6O5K:Y6Z194.5=0P/(R",@\\]*
MEKBO%>OP:Y8SK;.'90I*@$-A70LVT@':!U.,>]<OX$\'V_B&-VE=Q)&XR$(
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MU/(SJ6WP>=E!DG"MW"H6'7U+*3Q["N9\9:#'H4RVT;ER(U+DXX8DY&!T&,$
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MH 6P,D28!/? V' ]LGZU@ZU?WOB.%KR8;;>+!  *H26$?RYR6.<YR3MY&1D
M]A\(Y0;:1,C<)B2,\@%%P<>AP<?0^E<[X?\ ^0RW_7>X_E)7K=<1\2/"+ZJJ
MW< S)$I#*,Y9<Y&.V5.>,9.>N0 >?TKXHSZ:OV>YC\QD^7)8H_!((;(;)[=
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M% "J   ,  = !Z5Y%XHLI_"]Z;^/D,[.K%3M_>%LH>V<9'!SCD8/35B^,1
M: %L#)$F 3WP-AP/;)^M8.M7][XCA:\F&VWBP0 "J$EA'\N<ECG.<D[>1D9
M/8?".4&VD3(W"8DC/(!1<''H<''T/I7.^'_^0RW_ %WN/Y25TGQ;_P"/1/\
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MV_\ 0$K/^)/@R2Y?[?;J6) #JH);(X# <Y&, @#C&><DC-T7XK362"*9!+M
M ;<5;C/WCALGIS@'CG).:H^(/&=QXH(M8T(0G(CCRS-@9Y('(&"0  /7) ->
MB^!O#9T*W"N!YLAW/C!QZ+D#H!]1DM@X-=%17G'Q>TL$17@QD$QMR<G.67CI
M@8;/?D=>T'POWW]W<7S8&5.X#/WI7W<#GCY3WSTZU<^,%H7CAGXVH[*?7+@$
M?A\AS^%9OPPM#J5U+?R8+("<]#OE)YP,#& V?J,#T]4KR3X2?\?;_P#7!O\
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MJ=R"$#^8-P*EV/S!@!CY02&ST/0 C..R\>Z&=7M61,EXSO4#N5!R, $DD$X
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M:_\ +OMWCKE6SG([K\O/<<,.F1TTGQ@D*86%1)@?,6)7/?Y< X/8;N/4]X_
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MO;\JKC=OS]T#T%=O1111111111111111111111111145S<K:HTKG"HI8GDX
M&2>.>E<_X1\7_P#"1O-M38D6S;DY8[B_)[#@#CG!SR:Z6BBBBBN63QPMQ?+I
MD2Y 9P[G(Y16)4#V(')]\#H:ZFBBBBBBBBBBBBBN6T#QPNN73VT2_ND1F#G.
M6PR $#C Y/7)/'3D5U-%%%%%%%%%%%%%%%%%%%%%%%%>=ZQXLN;?4Q9(^(3+
M"NW:AX<)N&2N><GO7HE%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%4=:U=-(A:ZD!
M*IC(7!/+!>Y ZGUJ#P[XBCU^,SQ!@JN5^< '( /8GCFK.K:HFE1-<RYV(.<#
M)Y. ![DD#T]2!67X<\;0:^[11!U95W8< 9&<$C!(X)'7'7C/..@KG?#OCF#7
MY#!$KAE0M\X4# ('9CSS6EK6O0Z,AEF8#@X7C<V,<*.YY'L,Y) YKB[GXPHK
M$1P%E[%G"GIZ!6 Y]S6SX<^(UOJY$+YBE8X"MRI)S@!L#G@=0.3@9KJZ\=^&
M-ZEC/+/*P5$MV))_WT_7T'4G@<UO7/QA16(C@++V+.%/3T"L!S[FNH\.>,(-
M?W"+(9.JN &Q_>&"01GCKP>N,C.Y7$:S\58+-C'"IE*M@D$*AXY(;YB>>.F#
MU!QC-2T^,$;G$L+*N.J,'.?H0G'OG\*[NRO4OD6>)@R.,@C_ #U]1U!X/-8E
MGXY@N[HZ<JOY@=UR0NW*9SSNSCY>.*P?B-XNB\N;2\/YO[OG V=5?KNST]NM
M9OPX\71::@L7#EYIQ@J!M^<*HR2P/4<\'BO3Y91$"[$!5!)).  .I)]*XO6?
MBK!9L8X5,I5L$@A4/')#?,3SQTP>H.,9K:?\78Y7"S1%%/\ $K;\<CJ-JG&.
M3C)] :[FRO4OD6>)@R.,@C_/7U'4'@\U/1117DGB#_D,K_UWM_Y1UZW114%[
M>I8HT\K!409)/^>OH.I/ YKB-1^+D,)VP1M( 3DL0@XZ$<,2#[@$>GH_2OBU
M#<-MG0Q#LP/F#H>N%!';& >O.*[B*42@.I!5@""#D$'H0?2O)_#_ /R&6_Z[
MW'\I*[;XC?\ 'A-_VS_]&+6;\)/^/1_^N[?^@)75ZIJT6E)YT[!4R!DY/)[
M#))^@Z9/05Q-W\8(T.(H69<=78(<_0!^/?/X5=T/XI6]\?+F!A8G@D[D[ 9;
M P>>XP ,EJZ#Q%XBCT",3RABK.%^0 G)!/<CCBI]%U=-7A6ZC!"OG ; /#%>
MQ(ZCUJ/Q!X@CT*/[1-G!8* HR23SCG Z GDCIZX%0>&_%</B$,T.X&,C(< '
MGH>"1@X/?/'3IG2OKL64;SMDK&C,<=<*,G'3GBLKPUXNB\0[_)#CR]N=X ^]
MG&,,?2MRL/Q+XNB\/;/.#GS-V-@!^[C.<L/6O*_ WB*/0)VGE#%6C*_( 3DL
MI[D<<5ZOK%V+VQEG7(62V=AGKAHR1GKSS7 _#768]'CN;B8X4>5@#J3^\PH'
M<G_ZYP 36A+\8@"0L!*Y."9,$CMD;#@^V3]:[+P_XDAUY#+"3\IPRM@,/3(!
M/![$$C\00-6N/UWXFV^G$QQ@S. .4(\OGMOYY YX!';.<XR[;XPHS 20%5[E
M7#'IZ%5!Y]Q7<:7JT6JIYT#!DR1D9'([$'!!^HZ8/0U<HK#\2^+HO#VSS@Y\
MS=C8 ?NXSG+#UK-UOXD0:<B%07DD17"9 VA@"-QYP<'. #[X!!K-T_XNQRN%
MFB**?XE;?CD=1M4XQR<9/H#7>Q2B4!U(*L 00<@@]"#Z5B2^,H(KHZ<P8.H)
M+':(P GF$D[LXQ[?IS7-R?&",/A86,>1\Q8!L=_EP1D=ANY]1V[:35$@A^UR
MYC38&.\889'0CGYN<8Y.>!S7&ZC\7(83M@C:0 G)8A!QT(X8D'W (]/1^E?%
MJ&X;;.AB'9@?,'0]<*".V, ]><5W$4HE =2"K $$'((/0@^E8'B+QS!H$@@E
M5RS(&^0*1@DCNPYXJCXD^),.D.8(U,LBG#88*HZY&[!RPXR,8]\@BF^&OB5'
MJ\GV>1/*9L;"6W!C_=SA<'T]>G7 -OQ3X]AT$^3@R2X!VJ0 ,X^\W."1R!@G
MUP"#6-I_Q=CE<+-$44_Q*V_'(ZC:IQCDXR?0&N]BE$H#J058 @@Y!!Z$'TKF
M=*^(UKJ!?[Z"-"[-(% P"!V9B22PP,<]!S6)<_&%%8B. LO8LX4]/0*P'/N:
MZ;POXQA\0 A,K(H!9&QGMD@]USQG@^H&1G/\=>+HM-22Q<.7F@;!4#;\X91D
ME@>HYX/%<3X!\71>'O-\X.?,V8V '[N[.<L/6O8991$"[$!5!)).  .I)]*X
M34?BY#"=L$;2 $Y+$(..A'#$@^X!'IZ&G?%R&8[9XVC!(P5(<<]2>%( ]@2?
M3U[N*42@.I!5@""#D$'H0?2GUE>(O$4>@1B>4,59POR $Y()[D<<5Y)I?B*.
MTU ZBP;RS)*V !NPX;'&<9^;GFO8M%U=-7A6ZC!"OG ; /#%>Q(ZCUK-\0>.
M+;0V\J0EI.,K&,D C.3D@#Z9SR#C!S7+?\+C_P"G?_R+_P#85V'A_P 6V^O
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MSPM*?$6F36!),D0PH!P<??C!+<8W*5[84 <=:/A#J@(ELSC((D7@Y.<*W/3
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MD$\$ =5[GIS7AW2'\8W;R3$[3EI"N>,\*H)# <] ?X0<=*]4B\*VD8"B"+
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M0RO_ %WM_P"4=>MUY%XEE$6L!V("K-;DDG  "QY)/I7KM,EE$0+L0%4$DDX
M ZDGTKR?X2?\?;_]<&_]#2CXM_\ 'VG_ %P7_P!#>O6Z\V^,?_+O_P!M?_9*
M[?PS_P >EO\ ]<(O_0!7-?%O_CT3_KNO_H#UI?#G_CPA_P"VG_HQJX?X32A+
MM@2 6A8#)ZG<IP/4X!/T!KUVO-/C%*";=,C<!(2,\@'9@X]#@X^A]*ZF6(Q:
M648$,MD001@@B+D$>M<Q\'/^7C_ME_[/7H5[9)?(T$JAD<8(/^>OH>H/(YKS
MO5/A"0<VTHQD?+*,8&.?F4')SVVCCOQSS4FE:AX8'GX>-20248,ORGC=M)&,
MG@-P<D<\UZ3X"\4G7H3YF/-B(#8&,@CY6Z8!.#D#N,\ @5T]%>2>'_\ D,M_
MUWN/Y25VWQ&_X\)O^V?_ *,6LOX1R@VTB9&X3$D9Y *+@X]#@X^A]*[FO-/C
M%*";=,C<!(2,\@'9@X]#@X^A]*[GPS_QZ6__ %PB_P#0!6E3)8A*"C %6!!!
M&00>H(]*\E\'W#>'-1-FY.QW,9R&&?\ GFVT'J3C!.0 QYP<U;^*FJF\FCT^
M/),?) SR[XVC;CD@=",_>(XYKLKO2ETG3I+5.1';2#//)*,6/).,DDXSQTKE
M/@[* ;A,C<1&0,\D#?DX]!D9^HKTNN&^+DH%M&F1N,P(&>2 C9./09&?J*U/
MAS_QX0_]M/\ T8U<3\)/^/M_^N#?^AI72?%O_CT3_KNO_H#US/AGX=#7(%NA
M.%)+ J$W;2"1@G>.2,'IT(K4_P"%.?\ 3Q_Y"_\ LZ/^%.?]/'_D+_[.O2:*
MS_$&EC5;>2VXRZ'&20-PY4G'. P!_H:\_P#A1J)M9I;"3(+#(#'&&0X9=I_B
M(//?"\^V?X?SXEU3[2<[0YD_A!"Q_P"K!'3KM4XR??O7=_$;_CPF_P"V?_HQ
M:R_A'*#;2)D;A,21GD HN#CT.#CZ'TKN:\T^,4H)MTR-P$A(SR =F#CT.#CZ
M'TKIO^85_P!N/_M&N;^#G_+Q_P!LO_9Z])KR3P__ ,AEO^N]Q_*2ND^+?_'H
MG_7=?_0'K2^'/_'A#_VT_P#1C5TM%,EB$H*, 58$$$9!!Z@CTKS[6?A(LA+V
MLFW/1),D<G^^.0 .F0QXY//'+7/A6_\ #^Z=0Z@9!>%_X1R3\IW!>,Y( Z9P
M:[CX=^,GUH-;SD&5!N# 8W+G!R , J2!VR".."3S/B#_ )#*_P#7>W_E'7K=
M>;?&/_EW_P"VO_LE=IX>E$5G [$!5MXR23@ !!DD^E>>WWC.]\32&UL047D@
M(0KE1CEG)PO([$#G:2W&6GX?ZCJH#7#C*DX$TK.><9(V[P ?KGCITK&\4^$'
M\.K$9'#-+OR%!P-I'<X)R#Z#'O7IO_,*_P"W'_VC7-_!S_EX_P"V7_L]=OXF
M_P"/2X_ZX2_^@&O(?!_A(>(RZ>:(VC"D#;N)!SDXW+P.,]>HKI_^%.?]/'_D
M+_[.C_A3G_3Q_P"0O_LZ[?PYHW]C0):;MVS=\V-N=S%NF3Z^M<MK_P *H[QF
MEMF\LG)V$93.. ,8*C/7[V,\  8KD;GP+?Z0QEC4G9T>!LGD8X P_?!X]>W-
M=+\.O&\E[)]AN6W$K\C'[WRCE3@<\ G)YR#DG(QZ)1111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111111111111111111117#?%G
M2S<6Z7(SF%^>1C:^ 3ZD[@H&/4\>G+>" =6OXI-@VQ1KD$@X\J(1AN<<[@",
M<@GVS76_%>R,]JLH4$Q2*2>,A6!4^^"Q7('L>U<7X,MFUN^B9AQ$J,=N!@0J
MJH><YR0H./4XQV]IKQ_QKI$WAZ[-_$2%D<LCCG#-RRGC'7. <@KQS\U=!I_Q
M=B*#SXW#]_+PRG@<_,RD<YXYP.YKF_%GCB3Q&1;0J5B+<*.6<Y^7./PPHSSW
M/&/3_#.GR6-NB3LSRD9<NQ8Y/\.2S<+TX.#C/>O%/#\\UI)]JMQEH%+GC(V_
M=;(ZXPW..0.>,9'H4?Q>@*9:)Q)@_*"I7/;YL@X/<[>/0]^6M[>;QS>&4@B/
M*[L$X1!V!(/S'G''+$G &<>D^-M-DU"U=(68.HW (2-P .Y" "2""<#N<=JX
M#P;\1#HJ"UF4M$"=I7&Y<Y)&#@,"?4@C)Y/ &[J'Q=B"'R(W+]O,PJC@\_*S
M$\XXXR.XJI\)=%=6>^8$(4V+D?>RP+$<]!MQTP23SD&L_P /_P#(9;_KO<?R
MDKN?B%$9+&8*"3A#P,\!U)/T &3Z"N*^'GC.+2$-G,"/,E!#@C:-P"G=DC &
M,YYXSP,<]/\ $GPV^KPK+""TD)8[1W5@-V!CEA@8&>F>IP*Y3PC\2&TI!;7
M+QK]U@1O48^[@\,,XQR,#/48 U-:^+2LA6U1@[ _-)M&WIR%!;)Z]< ''!'%
M'PLT^>8O>2,_EDG:"S;7=OO.1NY(QC)!R3URM=EXB\11Z!&)Y0Q5G"_( 3D@
MGN1QQ4^BZNFKPK=1@A7S@-@'ABO8D=1ZU>HKR3Q!_P AE?\ KO;_ ,HZ];HH
MKSWXJ>&WN@M_&"WEIM<#LH)(8#'09.[G@8., FJWA[XJB"/RKM69D"A6CY)
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M^J:C GBFR*QGB= 5.1PP(8 XW=&&& R1R.M>8:#XDN/!\KP.I*Y^>-CCG'#
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M\/V^E#$$:J<$9 RV"<X+'+$9]3Z>E:%9&D>$[;2',L";6*[2=SG@D''S,1U
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MD&%10H')P , <\]*K:OHL.KH(IUW*&W 98<@$9^4@]":ET[3H]-C%O"-J+G
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[encoded data, 4270 characters]
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M(N00G0,!T+'CKP<;B,'(SQ7/_P#"X_\ IW_\B_\ V%;.E?%"UO2(WW1,0.7
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M?+7(&/=BH(/8C(_3+-/^)]G>.(SOCST,B@+G(&,JS8^IP .IKJXI1* ZD%6
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MI(XZ].HR <'%>\12B4!U(*L 00<@@]"#Z4^O-/B=XM$@_LZ%@1G]Z0,\@@A
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M=_X6-8?\]?\ R')_\37G?Q$UJ'5[A98&W*(@I.&'(9CCY@#T(KLOA)_QZ/\
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M'&<8/!(P1SG('K?@>]2QTV.>5@J()"2?^NC?KZ#J3P.:\ZN[BX\;77RJ-Q&
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M2,XXZUTGBSPP]ZPU.S4R0W/S80%F5B,L" 6[YSC@'*\8&>-I\41E(102S$
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M3U)/K7OOAG_CTM_^N$7_ * *\1\3?\?=Q_UWE_\ 0S7MWAG_ (]+?_KA%_Z
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MZLZ9\*?L,L=QY^?+=6QY6,[2#C.\XSBL+XKV0@NEE"D"6-23S@LI*GVR%"Y
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M\/1&*V@1@0RPQ@@C!!"#((]:\?\ $/AZYEN9W6&4JTTA!$;D$%S@@XZ5G_\
M",W?_/"7_OT_^%'_  C-W_SPE_[]/_A1_P (S=_\\)?^_3_X5[AX>B,5M C
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MM ?D20L<KD;DS@C(##AAG'0D=#Z5+I^C77B*0,H=R[8,C[BHP!]YSGH,>^,
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M '!([X.XX/O@_2O0O#7B6/7X_-CX88#H3RI_J#V/?V((%G6=9CT>,W$QPHZ
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MQDI:Q[L='DR!P?[@Y((Z9*GGD<<YEM\7;A6!DCC9>X7<IZ>I9@.?8UZ%X?\
M$D.O(982?E.&5L!AZ9 )X/8@D?B"!JT5Q^F?$(7-T=/EC",'9-PDW+N4D8Y5
M>#C [DX&.>.PK#\6>*4\.QB5AO9FPJ[@I/<GN< =P#R0.^:E\/:]_:MN+UU$
M:G<>7R JD@DDJH'(/MCG/8<EK/Q;6,E+6/=CH\F0.#_<')!'3)4\\CCG,MOB
M[<*P,D<;+W"[E/3U+,!S[&O0O#_B2'7D,L)/RG#*V P],@$\'L02/Q! \Y^(
M/C'^T]UAY>WR9S\V_.=FY.FT8SG/4UI?#GQC_J=*\O\ YZ?/O_WI/N[?PZ^_
MM7>ZIJT6E)YT[!4R!DY/)[ #))^@Z9/05YWJ/Q>D8XMXE"@GF0EB1VX4K@^H
MRWUXY=I7Q=<-BZC!4]XL@C@]F8@Y..XQSUKT>RO4OD6>)@R.,@C_ #U]1U!X
M/-3U3U>]-A#)<*H8QH6P6VY"C)YPW..G'7TZUD^#_& \2!SL*-&5R-VX$-G'
M.!SP<C'ISZ=%7'Q_$ SWG]FQPEL2%"Q<+]W[[;<'@8) SD@=B<5T6LZS'H\9
MN)CA1T ZD]E [D__ %S@ FO/=1^+TC'%O$H4$\R$L2.W"E<'U&6^O'+M*^+K
MAL748*GO%D$<'LS$')QW&.>M>CV5ZE\BSQ,&1QD$?YZ^HZ@\'FN8\7>/O^$>
ME6W\K?N0-G?MZEAC&T^E==6'XN\2_P#"/1+<;-^YPN-VWJ&.<X/I5KPYK/\
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MWAG4Q;.3@OY9P!\P?&P]3@$[6/.0./:MGXQ_\N__ &U_]DK>^'GAM-,MUN,
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MULF<I#'LW<9 9N2^!RV%8>_4#KD]%HOBC2M&010N!P,MY;[FQGECLY/)]AG
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M&0H#,!@L1W/4]2<#)QG XKC_ (H>&8Q%]OB0*ZN/,*X (8GYB.[;B.1SSSD
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M'P=HA()QP"77 SZG!Q]#Z4WXM_\ 'VG_ %P7_P!#>O6ZXCXM_P#'HG_7=?\
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M0M7D\(7+&2/+!2C(QP><'@C(Z@$'!!'3J#7JW[OQ99>BSI[G:P/_  '.UQ[
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MV#Y/4GE5(&0$3VSUQT&<MN.3VWQ&_P"/";_MG_Z,6LWX2?\ 'H__ %W;_P!
M2NWKR3X2?\?;_P#7!O\ T-*Z3XD>$7U55NX!F2)2&49RRYR,=LJ<\8R<]<@
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ME48<HO[QF(.[KM!P,9P!ZY)'3N_ 7A8Z#"?,QYLI!;!S@ ?*O7!(R<D=SCD
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M-)&C''3+*"<=>.:N444444444445D>+-7?2+:2ZC +)MP&R1RZKV(/0^M5/
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M=ZC!)( 'REN3GO@>]=%J&I1Z<AEF8(H[L<=B<#N3@< <GM7+7/Q6LXF*J)'
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MU%QDX)ZD < $]346D:U#JZ&6!MRAMI.&'( ./F /0BO,O$'_ "&5_P"N]O\
MRCKUNL;6O%]KHY*RN-X!^1?F;@ XP.A.1C=@'UQ6#_PMNT_N2_\ ?*?_ !==
M/H^OP:P"UNX<*<'@@C/3A@#@]CT//H:YCXM_\>B?]=U_] >CPMXBAT3389)V
MQGS=H RS$.YP!_4X )&2,U/:?%.SG.UM\8QU=,CZ?(6.?PQ[UUL4HE =2"K
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M5)QS@$G'/8X@^(W_ !X3?]L__1BUF_"3_CT?_KNW_H"5S?B#_D,K_P!=[?\
ME'7K=%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%>,>.+LV6IO.N"T;Q,,],JB$9Z<<5<_X6
MW=_W(O\ OE__ (NC_A;=W_<B_P"^7_\ BZRO$7CF?7XQ!*J!5<-\@8'(!'=C
MQS7I?PY_X\(?^VG_ *,:N2\6:)>Z[>B)T=8=V$/#(J9P7R,#)QNP2&Z+Z5U-
MM\-+&)0K(7(_B9V!//\ LE1^0KD?B'X*AT9%NH,J&<*4)W#E2<@GG^$YR3G/
M&,8KK-*C;Q+I823!>2-E!);[R,0C$\G.5!/J<\8XKF/A)JWE226;'B1=RY;C
M<O! 7N2#DXYPO?MZ?+*(@78@*H)))P !U)/I7D7A!#XBU(W+] S2D,Q)&#A
M#WVDKCH,#\*O>.+V3Q'>+I4&,1MC[W!;;EB>WR#(Q@D?-U)Q72:?\,+.W0+(
MID;NS,R]AG 4@ 9Y&<GGJ:Q/&'PUCMHWN[4E?+7<8R=PP,9(8G(P,DY+9Z#%
M=!\.M?;5K;$C;I(FVDD@L1U5CWZ<9.<E2<YS74UG^(-+&JV\EMQET.,D@;AR
MI..<!@#_ $->?_"76C&[V+$;7&]<D#YA@,!QDDCGKP%/'6N[\4:H=+M9;@9#
M*GRD '#-\JG!XP"03[=CTKB?A#I9)EO#G  C7D8.<,W'7(PN.W)Z]F?%C7V+
MK8(WRA0S@$<DGY5(ZC &[&><@XX!K5\/?"^"&/==@R2,%)&2H3CE?D;DYZG.
M#Q@#O1\9_#B*")KJUROE(2R9+ @').6;((&2>N<   ];GPJU]KR-[.1LF'!3
M)&=AXP!UPI'7G&X#@ 5S_B#_ )#*_P#7>W_E'7K=>;?&/_EW_P"VO_LE=OX9
M_P"/2W_ZX1?^@"O&/"FCG6IULR6$;'<^WG 0'!] >=H)Z%N^<'UFQ\"VNGS)
M=0J4:/=P&)!W+MYW9/ /&"/?-=!17BWCRY:UU*25#AD:)@>#@A$(//'6NRT#
MX86\,:FY4O*R@L"Q 4]2!L(SC."23G&1C.*YOQUX,7P]LO+9B%+XP2=RMRRE
M6'. !WY! Y.>/0O"&M'6+6.=B"^-KX(/S+P2< 8)^]C' ([5X_X4T<ZU.MF2
MPC8[GV\X" X/H#SM!/0MWS@^LV/@6UT^9+J%2C1[N Q(.Y=O.[)X!XP1[YKS
MO7+F3Q;?_9D;Y-Y1,$,H5?O..@.0"W7)&!DX%=S9?#.S@14D0R.!RQ9UR?HK
M  >@].I)YKBO''@[_A'66[MV(C9^.Q1@-R@-G)Z'!QD8Y)/)]"\,ZB/$5FK2
MX)=&20 ]^5;.W&"PYQQ@$8]:\]EAD\!WH<9,+<9(!+1D@L!R!N4^XY ) 4X.
MY\0?&\<L(MK5PWGKEF4G*KQ\O&,%NA!Y R".16M\/?"7]C1^?)_KIE4D$8*+
MUV\C.?[W;( QQD\S\3[0Z;=17\> S@'/4[XB.<'(Q@KCZ'(]?2-(U$:E#'<K
MC$B X!W8)'*Y]0>#[BO,OB9=MJ=XEC'DF,*H!P,O)@\'T(*CG&"#]3ZE8V@L
MHT@7)6-%49ZX48&>G/%3URWQ%U]M)ML1MMDE;:"" P'5F'?IQD8P6!SG%<QX
M$^'\6I1"]N"65R=J*2!@$J=Q&#G(X (Z<DYP-G7_ (86\T;&V4I*JDJ Q(8]
M0#O)QG& 01C.3G&*C^&$-W:J\,Z.L/5/,^4JV>0%/S8;.<_=!![DU@R^&;OQ
M%?'[6CHA))/#*J#E45OND\@<9Y)8@G=791?#>Q0!3&20!R7?)]SA@,GV 'M7
M">/?#">&Y(Y;=F D+$#/*E"",-UQ\PQGD8SDYX]$OKLWNG/.V TEHS''3+19
M..O'->9>!/#XUZ;RI2WDQ N0,[220-N?X2V.3U(7 Z9'I^D>#K?2)3<P J2F
MPKN)7D@Y^;)SP.^,=J\YUB=_&&H?95<",.RH<[E"J"688QDMMS[\#. ".WC^
M&-DB>658M@_.7.[GO@87([?+CCD&O-O&.@G09OLH<M&1O3/8,<'(Z;OEP2.H
M /'0>Q>&?^/2W_ZX1?\ H K2JCK<DR0N;9=TVW"#*CD\9^;CY>N#UQCO7FWA
M#P"^JN]Q?"10&'#95G8G+$EOFQZG@DGAL@UV$OPWL7!41D$@\AWR/<98C(]P
M1[5PEE;GPSJBV\3$KYB)\W&5E"\'!&2-WTR <=JV_B]I8(BO!C()C;DY.<LO
M'3 PV>_(Z]NK\%ZM_:EI%*3E@NULMN.Y.,D]<L,-SSSWZUF_$W5OL5H8@<-.
MP7AL':.6..I&!M/;YN?0P?"K2Q;6IN#C=.YY!/W4RH!'3.=QX[$<]AS<OAF[
M\17Q^UHZ(223PRJ@Y5%;[I/('&>26()W5V47PWL4 4QDD <EWR?<X8#)]@![
M5PGCWPPGAN2.6W9@)"Q SRI0@C#=<?,,9Y&,Y.>.R\779O=*,[8#21P,<=,L
MR$XZ\<U!\)/^/1_^N[?^@)7-^(/^0RO_ %WM_P"4=>FZW),D+FV7=-MP@RHY
M/&?FX^7K@]<8[UYMX0\ OJKO<7PD4!APV59V)RQ);YL>IX))X;(-=A+\-[%P
M5$9!(/(=\CW&6(R/<$>U<)96Y\,ZHMO$Q*^8B?-QE90O!P1DC=],@'':NK^+
M?_'HG_7=?_0'KF? 7@\:^#-<%O*B(55!ZG.YE]0HSR !DMD$$&NHUKX76URA
M^S@Q2 ''S,RD\?>W;CCW&,9S@XQ6-\)]?8.U@[?*5+("1P0?F4#J<@[L9XP3
MCDFJ7Q;_ ./M/^N"_P#H;UZ?J^HC389+EL8C0G!.W) X7/J3P/<UY=X:\,/X
MQEDOKAB(RYR5/S%L9"C=NPJ@CKGC '<CMI?AO8N"HC()!Y#OD>XRQ&1[@CVK
MAM7TR3P)=1SQ,6C;)YPI*AOFC/7/&/FP!DY R./78I1* ZD%6 ((.00>A!]*
M?7DWC>(Z!J*7R [7*R84; 2.'7<.I;&6_P![D'OZI]I39YVX;-N[=D;=N,YS
MTQCG/3%> 7>^_P#-OFP,RC<!G[TN]N!SQ\I[YZ=:]VT/4/[1@CN,@F1%)V]-
MQ'S#J>AR,=1T->9?\C1JW]Z)'_ZZ)LB_3:Y'TR_?OI?&/_EW_P"VO_LE-\&?
M#]=2C6]O"S;P-B9(^4#:N3P<8 V@$# ')!P&>/? 4.GP_;+;Y!'@.A+,#N8
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M5Q7Q5TL7-J+@8W0..23]U\*0!TSG:>>P//8VOAMK1U&U$;$;X#LZC.T#Y#@
M8&/E'KM)SG-4?BSJAM[=+89S,_/ QM3!(]0=Q4C'H>?72^'.EFPLT)R&E)D(
M)!^]@+C'8J ?7)/T'!:Y<R>+;_[,C?)O*)@AE"K]YQT!R 6ZY(P,G KN;+X9
MV<"*DB&1P.6+.N3]%8 #T'IU)/-<5XX\'?\ ".LMW;L1&S\=BC ;E ;.3T.#
MC(QR2>3Z/X0UHZQ:QSL07QM?!!^9>"3@#!/WL8X!':O/?A)_Q]O_ -<&_P#0
MTKUNO)/$'_(97_KO;_RCKUNBN$^*NOM9QI9QM@S9+X(SL'&".N&)Z\9VD<@F
MH/"/PV@EA2YN<NTJ!@H)50& *],$MCKSCG&#C-'BWX:1+$T]FK"1 /W8)8,,
M\XW$G=@YX)SC 7)S6O\ #D74=OY5TC*%/[LN<-MY&W;]X!2.,]00!P!7(R^&
M;OQ%?'[6CHA))/#*J#E45OND\@<9Y)8@G=791?#>Q0!3&20!R7?)]SA@,GV
M'M7">/?#">&Y(Y;=F D+$#/*E"",-UQ\PQGD8SDYX[+Q==F]THSM@-)' QQT
MRS(3CKQS4'PD_P"/1_\ KNW_ * E<WX@_P"0RO\ UWM_Y1UZW11111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111117DGB#_D,K_UWM_Y1UZW17$?%O_CT3_KNO_H#UI?#G_CPA_[:
M?^C&K$\4_$AX)&LK--T@;87().[D$*G<@XP3D$Y&TC!.,)-:U8%?WH"D'HL!
M[]_D)'J.1TSVK(\1>'+RTC%Y>DDEP@#R;WZ%ASEAMZ]\Y[=Z]+^'/_'A#_VT
M_P#1C5P_BLGPUJ?VN,##$2  ]0V5<$D'!8ANF< C'H.R^(6O+:69",-UP J%
M=IRK<L?]W;QD9Y(]<U3^%.D?9;=KHGF=N!V"QDJ.W7.[N1C'O7"7FD/J^H2V
ML9 9YYL%L@<%F[ GH/2M?_A4EW_?B_[Z?_XBC_A4EW_?B_[Z?_XBNM\ ^$9?
M#WF^<4/F;,;"3]W=G.5'K7745X_X@SX:U3[2,[2XD_A)*R?ZP =.NY1G!]^]
M;/Q>U0 168QDDR-P<C&57GI@Y;/?@=._5^"])_LNTBB(PQ7<V5VG<_.".N5&
M%YYX[=*X#Q!_R&5_Z[V_\HZ];HKR3X2?\?;_ /7!O_0TH\0?\AE?^N]O_*.O
M6Z\V^,?_ "[_ /;7_P!DKM_#/_'I;_\ 7"+_ - %>;?"3_C[?_K@W_H:5ZW1
M17DGB#_D,K_UWM_Y1UZW7-?$;_CPF_[9_P#HQ:S?A)_QZ/\ ]=V_] 2N;^$G
M_'V__7!O_0TKUNO)/A)_Q]O_ -<&_P#0TKUNN:^(W_'A-_VS_P#1BUF_"3_C
MT?\ Z[M_Z E3_$X6YM?WQ ES^ZP,MGC..1\I'WB>!P<%MH/G_@".&2\C$^>N
M4Y &\<KGIQQP!U; Z9KW"N8^(VEF_LW(R6B(D ! ^[D-G/8*2?7('T.1\,-=
M"VLL<A(6V);.. C MVY)!#$\=QCT&!X M3K5^UY(!A"\A^7*[F/ YZ$$EEZG
MY?Q'KM%>;?&/_EW_ .VO_LE=OX9_X]+?_KA%_P"@"M*BO--:^)DUZYMM/0]3
MAMI=VQ@Y5,<#@]03CG"FJ)CUK5@&_>@*2.JP'MV^0D>AY'7'>L+Q+H%SINR:
M[.7FW=7WO\F!R>1T(Q@GCTZ5ZC_S"O\ MQ_]HUS?P<_Y>/\ ME_[/7I->2?"
M3_C[?_K@W_H:5ZW7FWQC_P"7?_MK_P"R5V_AG_CTM_\ KA%_Z *TJIZMJB:5
M$US+G8@YP,GDX 'N20/3U(%>:7/Q O\ 5V)LXRJIU$:>:>1_$2I'4'& /QQ3
M9-+UJ]/G$RC< <"58^W]P,N#ZC .>O-8UGI#Z1J$5K(062>')7)')5NX!Z'T
MKV+Q!I8U6WDMN,NAQDD#<.5)QS@, ?Z&O/\ X2ZT8W>Q8C:XWKD@?,,!@.,D
MD<]> IXZU6^(=Z=:O8[&)AA"J#.-H=R-W(R<#Y0?0@\>OJ5C:"RC2!<E8T51
MGKA1@9Z<\5YWK7Q,FO7-MIZ'J<-M+NV,'*IC@<'J"<<X4U1,>M:L W[T!21U
M6 ]NWR$CT/(ZX[UA>)= N=-V379R\V[J^]_DP.3R.A&,$\>G2N_\0?\ (&7_
M *X6_P#..CX2?\>C_P#7=O\ T!*YOQ!_R&5_Z[V_\HZ]/U;5$TJ)KF7.Q!S@
M9/)P /<D@>GJ0*\TN?B!?ZNQ-G&55.HC3S3R/XB5(Z@XP!^.*;)I>M7I\XF4
M;@#@2K'V_N!EP?48!SUYK&L](?2-0BM9""R3PY*Y(Y*MW /0^E=W\6_^/1/^
MNZ_^@/6E\.?^/"'_ +:?^C&KI:\D\/\ _(9;_KO<?RDH^+?_ !]I_P!<%_\
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M .(KK? /A&7P]YOG%#YFS&PD_=W9SE1ZUR7A_P#Y#+?]=[C^4E>MUY)\6_\
MC[3_ *X+_P"AO7K=%07UH+V-X&R%D1E..N&&#CKSS7EOPSNVTR\>QDR#(&4@
M8.'CR>3Z !AQG)(^H@\7N?$6I"V3H&6(%5)(P<N2.^TEL]!@?C7KL40B 10
MJ@  #  '0 >E>3_"3_C[?_K@W_H:5ZW7-?$;_CPF_P"V?_HQ:S?A)_QZ/_UW
M;_T!*YOX2?\ 'V__ %P;_P!#2O6Z\D\0?\AE?^N]O_*.O6Z*\D^+?_'VG_7!
M?_0WKUNBBO--:^)DUZYMM/0]3AMI=VQ@Y5,<#@]03CG"FJ)CUK5@&_>@*2.J
MP'MV^0D>AY'7'>L+Q+H%SINR:[.7FW=7WO\ )@<GD=",8)X].E=_X@_Y R_]
M<+?^<='PD_X]'_Z[M_Z E<WX@_Y#*_\ 7>W_ )1UZW111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111117DGB#_D,K_UWM_Y1UZW17$?%O\ X]$_Z[K_ .@/6E\.?^/"'_MI_P"C
M&KS?PSJ(\*W9-U&<HK*0 "RDX.X9X.1QD$95L@D<'T:7XD6* L)"2 > CY/L
M,J!D^Y ]Z\]\9^+W\1XV(4@B8]R<LV=I;' . <#DCYN2*]$^'/\ QX0_]M/_
M $8U9?Q9TLW%NER,YA?GD8VO@$^I.X*!CU/'IY_?:I)K:VUH,LT:>6H(4?,S
MD#!XXVA!SW!]R?<K&T%E&D"Y*QHJC/7"C STYXKROXB:3)I%V-0B&%=E96"C
M"R+U!Z@DD;N1SD]<&NFT7XHVUR@^T$Q2 #/RLRD\_=V[CCV.,9QDXS67XN^)
MJR(;>R)RW!DP5P,?PYYSVR0,8XZ@CI/ +W$]LLUTY8O]P, "$' )^4$ENN23
MD8/<UTM%<-\6=+-Q;I<C.87YY&-KX!/J3N"@8]3QZ<1X?M6\37<4,N2B(@(&
MX@)$H&.ORAL8)R/F;(Y.*]PKS'XL: P=;]%^4J%<@#@@_*Q/4Y!VYQQ@#/(%
M:OA[XH031[;LF.10H)P6#\<M\B\'/48P.,$]J/C/XCQ3Q-:VN6\U"&?!4 $X
M(PRY)(R#TQD$$GI<^%6@-9QO>2+@S8"9 SL'.0>N&)Z<9V@\@BN=^(,4FE:@
M+T $,8W3(.W,84$'ISE>0#T(]:Z^V^)]G)&)78J^W)CVL3D=@P&TY['(]\<X
M\]\9:^^ON+K!6$%DC!/]W!8D9X8[AG'&,#)QFO7O#/\ QZ6__7"+_P! %>;?
M"3_C[?\ ZX-_Z&E>MT45XI\08C+J$J*"68Q@ #)),:8 'K7;:+\4;:Y0?:"8
MI !GY692>?N[=QQ['&,XR<9KF?'7C-?$.RSME)4/G)!W,W*J%4<X(/?DDC@8
MY]&\+Z.='MH[5B&9 <D=,LQ8X]AG&>_7 Z5YS\)/^/M_^N#?^AI7K=>-ZY;2
M>$K_ .THOR;RZ8 52K?>0=0, E>F0,' R*[FR^)EG.BO(YC<CE2KM@_55((]
M#Z=0#Q7%>./&/_"1,MI;J3&K\=R[$;5(7&1U.!G)SR >!Z%X9TX>';-5EP"B
M,\A [\LV=N<E1QGG( QZ5Y[^^\>7G?R$;_="1Y_X$-[ >^3_ +*\:OQ \");
M1B[M%(" !T7D;0/O\G.1CYNN?O'&&)Z+P'XN_MV,I*1Y\?W@."R\8?'3KP<<
M \\ @5U->#:I&_A^>XM$R P*9)^;865QRN!EE S[$@CT])^&.BBQM?/(.^<[
MCD$?*N0@Y/3JP.!D-W %=A17+?$70&U:VS&NZ2)MP  +$=&4=^G.!G)4#&<5
MS'@3X@1:;$+*X!54)VNH)&"2QW 9.<G@@'KR!C)Z#5/BA:6R;H297R,* R?4
MEF7I],G..,9(Y+P9IMQK'VJYW-\\<@(!VK))(K8!& I W$]MI*GI4'@/Q%'X
M<ED6Y0@OA=V/F3!^8$'G'<XYRHX/;N[GXEV,2EE<N1_"J,">?]H*/S->:>+?
M$DGB!UN&4I& 509)7(P6YX!;D9P!QMSZGT__ )A7_;C_ .T:YOX.?\O'_;+_
M -GKTFO'=8@?P?J'VI4!C+LR#&U2K AE&,X*[L>W!Q@@'MX_B=9.GF%F#8/R
M%#NX[9&5R>WS8YY(KS;QCKQUZ;[4$*Q@;$SW"G)R>F[YLD#H"!SU/L7AG_CT
MM_\ KA%_Z *TJX_XI63W5H#&I;RY S8[*%8$_09&?0<] :Q/ ?CFUTR 6DP,
M;*6)<+N5LGC.T$[L''((PHYZ"MG5?BE:VJYAS*Q[ % .1U+#/3I@'ISBO/=/
MNY+W4(IYLAY+B)CG/1F4KC.3MP1M]L=J]TKQ_P 09\-:I]I&=I<2?PDE9/\
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M*EW0MDD']WO&TK]6!YZ%>GI[7X.TXZ=:0PMG<$R01M(+DN5(]1G'X=NE<?\
M&/\ Y=_^VO\ [)7;^&?^/2W_ .N$7_H K,^(W_'A-_VS_P#1BUF_"3_CT?\
MZ[M_Z E<W\1-)DTB[&H1#"NRLK!1A9%Z@]022-W(YR>N#73:+\4;:Y0?:"8I
M !GY692>?N[=QQ['&,XR<9K+\7?$U9$-O9$Y;@R8*X&/X<\Y[9(&,<=01TG@
M%[B>V6:Z<L7^X& !"#@$_*"2W7))R,'N:XGP_P#\AEO^N]Q_*2O6Z\D^+?\
MQ]I_UP7_ -#>O6Z**\H^(]LVDWL=^@SOV.-V"-\1 Q@8.,!?S.#Z2_"O2C>3
M2:A)DF/@$YY=\[CNSR0.H.?O \<5ZE7C>N6TGA*_^THOR;RZ8 52K?>0=0,
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MER/X51@3S_M!1^9KS3Q;XDD\0.MPRE(P"J#)*Y&"W/ +<C. .-N?4][X@_Y
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MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKG;SP-!=W0U%F?S
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M'XQL)KRW*VK.LRLI7RWV$\X()R.,$G&1R!]*XG0_AU<7\WG:AD*,$Y<.[XX
MW D@ #DYSC 'J/4J********************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M****************************************\O\ &'C"\LKQ[2W<A04"
MJ$1CED4X&5)))-5/^$@UG^[+_P" X_\ C='_  D&L_W9?_ <?_&ZZ+P-JFH7
M<[+>AQ&(R1OB"#=N7'.U><9XKN:***\[T?Q9<W&IFR=\PB69=NU!P@?:,A<\
M8'>MOXB:U-I%NLL#;6,H4G"G@JQQ\P(Z@5=\%ZC)J5I'<3'<[;\G '1V X
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MT/XI6]\?+F!A8G@D[D[ 9; P>>XP ,EJ[6O)/#__ "&6_P"N]Q_*2ND^+?\
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MH54'GW%=WIVHQZE&+B$[D;.#@CH2#P0#U%1:SK,>CQFXF.%'0#J3V4#N3_\
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M72=*TU AD@D? W-(\;9(ST!)"CGH.V,DD9J'Q!H>EZDA,<D,<H4[2DJ(N<'
M8#(QD\D#=@=:K?"363(LEBQ^Y\Z#DG!.']@ <'''+$\]O1*9+$)048 JP(((
MR"#U!'I7D7A!SX=U(VS]"S1$LI!.3E"!VW$+CJ,'\:]@KQVT4>*-4WX!C,FX
M_(2I2(87(/0,% .>[=.U7OBGJC7EPEA'DA ,JH;)=^@QT)VXQ@?Q$9[#K?#W
M@&WTR/;(BR2,%W&0!P"!R%RHPN<]LGN>!BCXS\ PW<33VZ!)8T.%C 56P<D%
M54Y;&=N,$D@$XQC+^%NH"]CFTR4Y7:2%^;.UOED&<X R1P,'+$_3G_B)HL.D
M7"Q0+M4Q!B,L>2S#/S$GH!7J^C>'(-&W?9TV[\;OF9L[<X^\3ZFO-O#_ /R&
M6_Z[W'\I*[;XC?\ 'A-_VS_]&+7$_#?PBFJLUW.,QQ, JG&&;&3GOA1CC&#G
MK@$'N]9\#VNHQF)8TC;JKQHJD'MTQD>H/7V.".(^$5RRW$D0/RM%N(XZJR@'
MUX#'\Z?\4]4:\N$L(\D(!E5#9+OT&.A.W&,#^(C/8=EHO@.UTU AC61\#<TB
MALD9Z Y"CGH.V,DD9KD?B/X,BT]!>VZE1OPZJ"5&[)#?[(SQCIR ,=]GX2?\
M>C_]=V_] 2NWHKR3X2?\?;_]<&_]#2ND^+?_ !Z)_P!=U_\ 0'K+^&W@R.Y3
M[?<*&!)"*P!7 X+$<Y.<@ CC&><@C;\9^#+>>W>6-%C>%&<&-0N=HR5(&,@X
MX/4'D<9!R_@]<LR3Q$_*K(P''5@P)]>0H_*L_P"+TCF>)3GRQ&2O'&XL=W/<
MX"Y';CUYZ3P_%I4L4:1B$E@ !,(S,23T(;G=GTX_N\8JCXD^%ZWLBR6NV)23
MY@)..3G*K@\\GC('  QS6KXJ\,0W5N]S./,GAMF DRRY**3G:IV_>R<<^G2N
M-^&OAR#6?.^T)NV>7M^9EQNWY^Z1Z"NV^(W_ !X3?]L__1BUR'PO\,QZ@9+N
M= ZH0J!L%22,ME>Y (QGCGU''HVGZ)#IS.\*!#)MW;>!\H('R]!U[ 9[UYE\
M)/\ C[?_ *X-_P"AI7K=>2>(/^0RO_7>W_E'7=^.M9.E6CR*<.^$0\YRW7!'
M0A<D'U'X5Q_PX\&1:@AO;A2PWX16!"G;@EO]H9XQTX(.>W::AX+L[Y#&8D7T
M,:A&!P1G*@9QGH<C/4&N0\*> ;BVDDBN57[,XVN-Y^?!W*R["#D,!][!P2,<
MFL'6-%AM]3%DBXA,L*[<L>'";ADG/.3WKUO2-%ATA#% NU2VXC+'D@#/S$GH
M!7F7PD_X^W_ZX-_Z&E:_Q;UDQK'8J?O_ #N.0< X3V()R<<\J#QWO^#/ ,-I
M$L]P@>61!E9 &5<G( 5E&&QC=G)!! .,YO>(? -OJ<>V-%CD4-M,8" DC@-A
M3E<X[9'8\G/)?"S5&L[A["3(#@X5@V0Z=1CH#MSG(_A SV,'Q;_X^T_ZX+_Z
M&]=AX5\!P:="//C625P"_F*K;3C[HZ@ =R.IYZ8 YKXG>%8;!5O80$W.$9%
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M1^+>K>5''9J>9&W-AN=J\ %>X).1GC*]^VSX)M%T6P65\ %#*Y&3P1N!QZA
M 0!U'&>I\]\.Z0_C&[>28G:<M(5SQGA5!(8#GH#_  @XZ5ZI%X5M(P%$$6
M.8U)X]2023[GDUYEX[\*#P[(D]ON$;$X.22C@Y #8&!C&W)+<'GBO4O#^J#5
M;>.YXRZ#. 0-PX8#/. P(_J:\T^$G_'V_P#UP;_T-*];KR3Q!_R&5_Z[V_\
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M -<&_P#0TKI/BW_QZ)_UW7_T!ZTOAS_QX0_]M/\ T8U:?B;_ (]+C_KA+_Z
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MR""LF"#Z4[XM_P#'VG_7!?\ T-Z];KB/BW_QZ)_UW7_T!ZTOAS_QX0_]M/\
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MCT&1GZBM3X<_\>$/_;3_ -&-7$_"3_C[?_K@W_H:5ZW7DGB#_D,K_P!=[?\
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M!#,205R>.<>]<AK/PD60E[63;GHDF2.3_?'( '3(8\<GGCEKGPK?^']TZAU
MR"\+_P (Y)^4[@O&<D =,X-=Q\._&3ZT&MYR#*@W!@,;ES@Y & 5) [9!''!
M)[6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBO)/$'_(97_KO;_P HZ];HHKRWXF^'Y+6;^TXL[6V;F!Y1
MUP%/&" 0!@\_-GID9T-+^+D93_28V\S)_P!4 5([?>8$'VY]<\X&#XO\=/XA
MQ:0*1$S+@<^8S>A"DC&2,#DY .>P] \#^'VT.V$4G^L=B[#((!.!@8] !GKS
MG!(Q7">'_P#D,M_UWN/Y25TGQ;_X]$_Z[K_Z ]:7PY_X\(?^VG_HQJX?QCI<
MWAN\_M"/.QY-ZMDXW'ED;&, \\=UXR2#C?LOBY 47SHW$F/FV!2N?;+ X/H>
MG3)ZGEO$GB:;Q?*MM"AV!SY:#.XY'5N=N0 3Z*">2,FO5?#>D?V1;QVN<E%Y
M/4;B2S8X'&2<<9QUKSWXA6YTB_BU  E6*/@D#+1$ J.,@8"\D'DGZ"[\'[(@
M37!48)55;C/&2P]0.5)['CTXJ?$Q6TV\AOD4?=4@G&&>-L\X()P"H^G /'$_
MPATLDRWAS@ 1KR,'.&;CKD87';D]>WI=%<[\0HC)8S!02<(>!G@.I)^@ R?0
M5Q7P\\9Q:0ALY@1YDH(<$;1N 4[LD8 QG//&>!CGLOB-_P >$W_;/_T8M9OP
MD_X]'_Z[M_Z E=O7DGPD_P"/M_\ K@W_ *&E;/Q4\-O=!;^,%O+3:X'9020P
M&.@R=W/ P<8!-4?#?Q4-J@ANU9]HX=<%CTP""1D]?FSD\9!.31XD^*AND,-H
MK)N'+M@,.N0 "<'I\V<CG !P:V?A=I<MO"9Y2^U^(T8G:%ZE@N<?,3QP#@9!
MPU=O17/^.M&.JVCQJ,NF'0<YRO7 '4E<@#U/XUXW+JSRP)9DG;&[L/F./F"@
M#;T&"&/_  (].<^Z>']+&E6\=MQE$&<$D;CRQ&><%B3_ $%<;\5/#;W06_C!
M;RTVN!V4$D,!CH,G=SP,'& 35;P]\51!'Y5VK,R!0K1\D@#&6W,/FXSG/.>@
MQS3\7?$K^TXS;6RE4=<.S\/UZ#:Q ! P<YR"1@=^G^&WAM](A:68%9)BIVGL
MJ@[<C'#')R,],=#D5RWQ<B(N8WP=IA !QP2';(SZC(S]17<^%O&<7B'*H"KH
MJDJQ'?KMP<D ]3@=1QS7">'_ /D,M_UWN/Y25VWQ&_X\)O\ MG_Z,6LWX2?\
M>C_]=V_] 2NWKR3X2?\ 'V__ %P;_P!#2MGXJ>&WN@M_&"WEIM<#LH)(8#'0
M9.[G@8., FHM%^+2J@6Z1BZ@?-'M.[KR5)7!Z=,@G/ '%<_XQ\9OXD'EQH5A
MB.[U8\[0S$#Y1\P&.F3U/&.P^$G_ !Z/_P!=V_\ 0$KMZ*\D^$G_ !]O_P!<
M&_\ 0TKI/BW_ ,>B?]=U_P#0'K2^'/\ QX0_]M/_ $8U:?B;_CTN/^N$O_H!
MKB/@Y_R\?]LO_9Z@^)]M-8W$5\C,4R"N265'7'0$;0& !QSDAL\"M#3_ (NQ
M%!Y\;A^_EX93P.?F92.<\<X'<US_ (S\;?\ "2A;2",A0X(SR[-C: %&0.2>
M,DGCITKN;317T_3&M""9/L\O &3N<,VT8)R03CCK7G_@+Q?'X>,@E5F64+RF
M"05SV)'!W=<\8Z<\>@?$&42Z?*ZD%6$9!!R"#(F"#Z5G_"3_ (]'_P"N[?\
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M@ /8<"MG4=.CU*,V\PW(V,C)'0@CD$'J*BTC18=(0Q0+M4MN(RQY( S\Q)Z
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MJAD<8(/^>OH>H/(YK*T[P7::;(+B&/:ZYP=[GJ"#P6(Z&MRN?N? -C<,7:$
MG^ZS(.!C[JD ?@*T-+\/V^E#$$:J<$9 RV"<X+'+$9]3Z>E:%%%17-LMTC1.
M,JZE2.1D$8(XYZ5D:=X+M--D%Q#'M=<X.]SU!!X+$=#6Y17/W/@&QN&+M" 3
M_=9D' Q]U2 /P%:&E^'[?2AB"-5.",@9;!.<%CEB,^I]/2M"L_6- @U@!;A
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MG+(N3EL\GOZUYM\+[&.]N725%=1"QPZAAG>G.#GGFN[\>:H=%LR(<HS%8T*
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MRL?E.<;.22".F,Y]Z\T\$RJFJ 0$B)GF"X)Y3:Q4'/)' //<#O6S\8_^7?\
M[:_^R5O?#SPVFF6ZW& 99T#%NN%;E5' P,8)]3W( Q!\3]&CN+9KLC][#MVL
M.N&< J?4<Y'H>G4Y9\)I2]HP))"S,!D]!M4X'H,DGZDURGB#/B75/LPSM#B/
M^$$+'_K"#TZ[F&<GV[5ZOI^FQZ<@BA4(H[*,=@,GN3@<D\GO7FGQ0\,QZ>8[
MN! BN2KA<!00,KA>Q(!SCCCU//7_  Y_X\(?^VG_ *,:NEHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKFO!7_ "]_]?T__LM=
M+6?KVEPZG"T5QCR\9+$@;<#[P)Z$>O3&0>,BN$\%^-AIY^Q3L6M][+%,P*CY
M<8!ST7!!]4R ?EQM]+KR_P =^.3?![.T),2C]Y(O<9 P".B9(!/\1.!\OWNR
M\&:/;Z=;J;8AQ( 3)W8_T Y 7^'G/.2=ZN:^(W_'A-_VS_\ 1BUTM%%%%%%?
M/_B;_C[N/^N\O_H9KT#Q79_:-(A?./*2W;IURH3'M][/X8KS^#4C':R6VXC?
M+$VW)P0%?<?3KL^N!Z<>@?""SV137&?ONJXQTV#.<^^_]/>O+:^CY91$"[$!
M5!)).  .I)]*^?-7U$ZE-)<MG,CDX)W8!/"Y] .!["G6VN7%JHCCED51T"R,
M ,G/0''6H+N^DO3OE=G8#&78L<>F3GCFNY^$FK>5))9L>)%W+EN-R\$!>Y(.
M3CG"]^W6_$;_ (\)O^V?_HQ:\W^'/_'_  _]M/\ T6U>M^)O^/2X_P"N$O\
MZ :\1\,_\?=O_P!=XO\ T,5] 4445Y;XT\%W>I7<EQ#'N1MF#O0=$4'@L#U%
M8G_"N;__ )Y?^1(__BJ/^%<W_P#SR_\ (D?_ ,51_P *YO\ _GE_Y$C_ /BJ
M]?T.V:UMX8G&&2*-2.#@A0"...M7J\V^,?\ R[_]M?\ V2NIM=/_ +1TU+?
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M1Q&01_UT7]?4=0>#S75T444445GR^'K:4EVAB+,223&A))ZDG'6KL40B 10
MJ@  #  '0 >E4/\ A&;3_GA%_P!^D_PJ_%$(@$4 *H   P !T 'I5#_A&;3_
M )X1?]^D_P *LWFF17V/.C1]N<;U#8SUQD'&<4RTT>"R.^*-$8C&415./3(
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M$@-7NU%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%,BB$0"*
M%4   8  Z #TI]%%%%%%4=9T:/6(S;S#*GH1U![,#V(_^L<@D5Q-S\'D9B8Y
MRJ]@R!CT]0R@\^PJ_H?PMM[$^9,3,P/ (VIV(RN3D\=S@@X*UVM%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%8/B_P *CQ%&L6X(R/D-LW'&""O48!X)Y["J
MGA/P#'H#&8MYDO16*[0HQS@9/)[G/3@8YSU-%%%%%%%%%%%%5M3L_MT4EOG'
MF(RYQG&X$9QQG&:P_!W@[_A&_,_>>9YNS^#;C;N_VFSG=72T44444444445Y
M_<_"5)Y6E\W:C.6V+&!A2<[0=V!@< XQ[=J[FRLDL46")0J(, #_ #U]3U)Y
M/-3T44444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444444444444444444445@^*/&,/AX /EI&!*HN,]\$GLN>,\
MGT!P<;U%%%%%%%%%%%%<-X&\<SZ_.T$JH%6,M\@8'(91W8\<UU>LZS'H\9N)
MCA1T ZD]E [D_P#US@ FFZ#K UB%;I055RV >N%8J,^YQG';ID]:T**X;5/'
M,]IJ TY53RS)$N2&W8<+GG=C/S<<5W-%%%%%4=9UF/1XS<3'"CH!U)[*!W)_
M^N< $TW0=8&L0K=*"JN6P#UPK%1GW.,X[=,GK6#X^\72^'O*\D(?,WYW@G[N
MW&,,/6NBT>[-[!%.V TD:,<=,LH)QUXYJY1111111111111111116"?&,+7:
MZ;'EI"2&(QM7:K,1GNPP 1T&>N016]1111111111111111111117#:IXYGM-
M0&G*J>69(ER0V[#A<\[L9^;CBNYHHKAM+\<SW>H'3F5/+$DJY ;=A V.=V,_
M+SQ7<T4444444444444445PWCGQS/H$ZP1*A5HPWSAB<EF'9AQQ7<T444444
M44444444444444444445R/C[Q=+X>\KR0A\S?G>"?N[<8PP]:Z+1[LWL$4[8
M#21HQQTRR@G'7CFKE%<-XY\<SZ!.L$2H5:,-\X8G)9AV8<<5W-%%%%%%<-X&
M\<SZ_.T$JH%6,M\@8'(91W8\<UW-%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%4=
M7UJ'2$$L[;5+;0<,>2"<?*">@-9'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R
M')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/
M^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK
M#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU
M_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D
M.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\
M31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6
M'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK
M_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(
M<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_X
MFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_P
ML:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7
M_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0
MY/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q
M-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A
M8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_
MYZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P A
MR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\
MXFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"
MQK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_
MSU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^
M0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\
MQ-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_
M (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_
M )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\
MAR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_
M (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_
M  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-
M8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_
M^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_
M !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC
M_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:
MP_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\
M/7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/
M_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'
M_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8U
MA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ
M_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R
M')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/
M^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK
M#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU
M_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D
M.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\
M31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6
M'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK
M_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(
M<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_X
MFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_P
ML:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7
M_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0
MY/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q
M-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A
M8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_
MYZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P A
MR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\
MXFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"
MQK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_
MSU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^
M0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\
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M=\3%E7;M<\OC:,A<<Y'>M*YN5M4:5SA44L3R< #)/'/2LNT\86EVDDZ2#9"
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M_CT3_KNO_H#UJ^'O#UM+;0.T,19H8R28T))*#))QUK0_X1FT_P">$7_?I/\
M"C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A
M&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_
M )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1
M?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D
M_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P *
M/^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9
MM/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\
MGA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_
MWZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_
M  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_
MX1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT
M_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">
M$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?
MI/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\
M"C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A
M&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_
M )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1
M?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D
M_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P *
M/^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9
MM/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\
MGA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_
MWZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_
M  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_
MX1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT
M_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">
M$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?
MI/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\
M"C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A
M&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_
M )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1
M?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D
M_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P *
M/^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9
MM/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\
MGA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_
MWZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_
M  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_
MX1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT
M_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">
M$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?
MI/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\
M"C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A
M&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_
M )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1
M?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D
M_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P *
M/^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9
MM/\ GA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\
MGA%_WZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_
MWZ3_  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_
M  H_X1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_
MX1FT_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT
M_P">$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">
M$7_?I/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?
MI/\ "C_A&;3_ )X1?]^D_P */^$9M/\ GA%_WZ3_  H_X1FT_P">$7_?I/\
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M<Q?"ZT$0B8,9,#,@8AB<Y.%Y4#MC!X[YYK(^)NL/=2)I,."7*%L-R68D*AY
M Z-SZJ>,<Z6B_"ZVMD'V@&60@9^9E4'G[NW:<>YSG&<#.*A\0?"V&9"]KE'5
M3A<[E8@$@?,<@DX&<X [=Z@^'&IG6+>73)F)VIA3N&[8X*D $=%]3G&X#@ "
MN1\<^'8] G6"(L5:,-\Y!.2S#L!QQ7JGAKPC%X>W^27/F;<[R#]W.,84>M<!
MX@_Y#*_]=[?^4=>MUYM\8_\ EW_[:_\ LE=OX9_X]+?_ *X1?^@"O'[RS>_U
M"6U0D>=<NIV@GY?,R20,9"XW'MQGMFO2X/AU:6YCD165XG1MV\DL4YY!R,$\
MG 'M@5Q?Q;_X^T_ZX+_Z&]=!X:^',4D?GWP,DTN&(9G4KGG!P02QS\V>_ Z$
MGG_B'X*CT8+=0<1NP4H220V"<@G)((!SDY!Z9!P._P#!6H/J%G%-(<L5()Y)
M.QBN22222!DGUK<HKR3X2?\ 'V__ %P;_P!#2K/Q'\(Q::AOD+EYISD,1M^<
M,QP H/4<<GBM+X<^$8O+AU3+^;^\XR-G5DZ;<]/?K7H%%>2>(/\ D,K_ -=[
M?^4=>D^)O^/2X_ZX2_\ H!KQ_P &^''U^0P;BL*X:0C..,A1Z;CDXST&X\XP
M?1[WX9V<Z,D:&-R.&#.V#]&8@CU'IT(/-<;\/I9-*U V1((8R(^"=N8PQ!'3
MG*\$CH3ZUZ[17EOQ'\(Q::AOD+EYISD,1M^<,QP H/4<<GBM+X<^$8O+AU3+
M^;^\XR-G5DZ;<]/?K5;XQ_\ +O\ ]M?_ &2F^#/A^NI1K>WA9MX&Q,D?*!M7
M)X., ;0"!@#D@X#/'O@*'3X?MEM\@CP'0EF!W, ""23G)Y'0CT(YZ#X8:@]Y
M9[7.?*=D!YSM 5AG)[;L#L  *YOQQ>R>([Q=*@QB-L?>X+;<L3V^09&,$CYN
MI.*Z33_AA9VZ!9%,C=V9F7L,X"D #/(SD\]36)XP^&L=M&]W:DKY:[C&3N&!
MC)#$Y&!DG);/08KH/AUK[:M;8D;=)$VTDD%B.JL>_3C)SDJ3G.:ZFBO"=4\P
MWTR0_?DGF0=.?,9D(YXY#8SVZ\5Z1I_PPL[= LBF1N[,S+V&<!2 !GD9R>>I
MKB?%GAYO!\T<]O(<-DH3C>"N P.  0<^G()!'<]_K'BL0V']H1D!I$7:-P.'
M?C R,$H<DC'\)SCG'">!_!W_  D3-=W#$QJ_/<NQ&Y@6SD=1DXR<\$'D=K>_
M#.SG1DC0QN1PP9VP?HS$$>H].A!YKAM#N9/"5_\ 9G;Y-X1\D*I5ONN>H& 0
MW7(&1D9-=M\3]0>SL]J''FNJ$\YVD,QQ@]]N#V()%<_\/O"5GJT)EE_>2;L,
MNYEV=<?=()W#G/3L.0<WO%'PPC:,R62D2#&$W95N>>7.0<'/7&!C&3FM"P\&
MO?V4=C?,08W#+Y;98#!PK%@1D;B.., 8->?Z7X=CN]0.G,6\L22KD$;L(&QS
MC&?EYXKU[3M,&B6_V> %_+5RH9@"Q)+8W8 &2<9QQ7FVB^"KC7;F1[\2*!DL
MQ !9N@"D\8]U!4  #&17;?\ "N;#_GE_Y$D_^*KSOQ)IG_"'WB&W8G:JR+NZ
M]2"I*XR#@YZ<''N?4/%^M'1[62=2 ^-J9('S-P",@Y(^]C'(![5Y[X%\&+XA
MWWERQ*A\8!.YFX9BS'G!![<DD\C'/3:U\+K:Y0_9P8I #CYF92>/O;MQQ[C&
M,YP<8KA_AS_Q_P /_;3_ -%M7:?%+Q";*(6:8W3@[B&PP4$=AV;D9/! 88/:
M+PW\+HHD$EX"\C#E Q"KG&.5P2P[G..< ' )N:K\+;6Z7$.8F'<$N#R.H8YZ
M=,$=><UD?#'5I+6632IC]W<5!8?*RG#J/7/7@X&TD#DFO2:*YKXC?\>$W_;/
M_P!&+7G?@GPX?$;&"1B((<L=NW.Z0 8R>>0F>A'RXX)S7=ZA\,+.X0K&IC;L
MRLS=CC(8D$9Y.,'CJ*Y3P!J;Z+>-ITC#8SNA&["AUX##(ZG&W'&<C/( K>^)
M\-W=*D,".T/5_+^8LV> 5'S87&<_=)([@5)H'PPMX8U-RI>5E!8%B IZD#81
MG&<$DG.,C&<5'XH^'-K' \\(,;1([<,6!VC."&)/08&",9R<]*B^$6H/+'+;
ML<K$RE>N1OW9'7&,KG [DGO6)X@_Y#*_]=[?^4=>A>+]:.CVLDZD!\;4R0/F
M;@$9!R1][&.0#VKSWP+X,7Q#OO+EB5#XP"=S-PS%F/."#VY))Y&.>FUKX76U
MRA^S@Q2 ''S,RD\?>W;CCW&,9S@XQ7$_#Z4RZA$[$EF,A))R23&^23ZU[717
M#?%+Q";*(6:8W3@[B&PP4$=AV;D9/! 88/:+PW\+HHD$EX"\C#E Q"KG&.5P
M2P[G..< ' )N:K\+;6Z7$.8F'<$N#R.H8YZ=,$=><UD?#'5I+6632IC]W<5!
M8?*RG#J/7/7@X&TD#DFLWXM_\?:?]<%_]#>N@\-?#F*2/S[X&2:7#$,SJ5SS
M@X()8Y^;/?@="3S_ ,0_!4>C!;J#B-V"E"22&P3D$Y)! .<G(/3(.!W_ (*U
M!]0LXII#EBI!/))V,5R22220,D^M><VC#POJFS($8DVGYR%"2C*Y)ZA0P)SW
M7KWKV*O(O']T=:OULXR,(4C'S97<QY/'0@D*W4_+^ W_ (DZP-(MTTV# $B8
M.&.Y43  ZYPW3)Z@,.<\'AOX711()+P%Y&'*!B%7.,<K@EAW.<<X . 3<U7X
M6VMTN(<Q,.X)<'D=0QSTZ8(Z\YK(^&.K26LLFE3'[NXJ"P^5E.'4>N>O!P-I
M(')-9OQ;_P"/M/\ K@O_ *&]>GZOJ(TV&2Y;&(T)P3MR0.%SZD\#W->1>&-
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MRDJ0G\(WC(&#@[2.,>U>G^#O% \00^80%D0X=0>^.& SG:>V>X(YQD\%X?\
M^0RW_7>X_E)7JUS<K:HTKG"HI8GDX &2>.>E>9:A\1[O57,5A&5"\_*GF2$
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M1111111111111111111111111111111111111111111111117FW_ #'O\_\
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M%>@>*)!K^GR-:YD#@%< @G9(-V <'/RGCJ>V>*XWX=^,+?15:"<%2[Y\P#/
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M&EY&N3#D/@#.P\Y)ZX4CISC<3P :S_!GQ)2VC6TN\@( %=1D;0. P'.1@ $
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M!##:#@YR.20.G .<CJ_A_H;Z/:A)/O2-YA&""NY5&TYYR .>!@\=LGB?#_\
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M'Z8-.^&5G9G<0TAR"/,;(&/90H(/<'(_7/411"(!% "J   ,  = !Z5@>(/
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MIG!;!/+%NP ZGTJ]7'WWPOMKV1YV>4-([,<,F,L<G'R'CFNMBB$0"* %4
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M<>N0<?=!'8@ _K7045Q]]\+[:]D>=GE#2.S'#)C+')Q\AXYKK8HA$ B@!5
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M4444444444445%<VRW2-$XRKJ5(Y&01@CCGI7ENH?#2[TV0S6;;@&^4J^R4
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M'![@X/(/([U9KC[[XH6UE(\#)*6C=E.%3&5.#CYQQQ4'_"V[3^Y+_P!\I_\
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MW('4^M<M_P +;M/[DO\ WRG_ ,71_P +;M/[DO\ WRG_ ,71_P +;M/[DO\
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M7K=%%>)?$;_C_F_[9_\ HM:9X=\#3Z_&9XF0*KE?G+ Y ![*>.:U?^%27?\
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M^N"_^AO6)X:\(R^(=_DE!Y>W.\D?>SC&%/I6W_PJ2[_OQ?\ ?3__ !%9NO>
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MY](1IU(DC3&=H(<#'+%>1@'K@GCDX&<8?AW7'T29;E.<9!7) 93U!Q^8Z@$
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M&EM<(5\M40.GS# XR0>1@8SC=GG ' KM++Q!:ZN!&DB/Y@8;"1N(YR"C8.,
M]1TYZ5SO_"I+3^_+_P!])_\ $5V%C:"RC2!<E8T51GKA1@9Z<\5Y7\6_^/M/
M^N"_^AO5GX4ZG%8^?YTB)N\K&]@N<;\XR1G&:] _X2:T_P">\7_?U/\ &C_A
M)K3_ )[Q?]_4_P :NVURETHDC8,IZ%2"#@XZCCK4M%<U\1O^/";_ +9_^C%K
MR3PS_P ?=O\ ]=XO_0Q7T!17B7Q!T9=*NV6,!4D5755S@9X/';Y@3@< 8QCH
M.R^$FH>;!);DDF)\C/0*XX Y]58D=.<]S7$>/-0^W7LK G"-L ;ML&TXY. 6
M!(^N>IKM_A/HP@A:\8?-*Q"G@_(O''<9;.?7:..Y[NBO#?'6C#2KMXU&$?#H
M.,8;K@#H V0!Z#\:[OX3ZCY]LUN3DPN<#'17Y'..<MN]3^&*[>BN:^(W_'A-
M_P!L_P#T8M>*Q1&4A%!+,0  ,DD] !ZU)97KV+K/$Q5T.01_GIZCH1P>*]Y\
M.ZXFMPK<IQG(*Y!*L.H./S'0D$' S7B/B;_C[N/^N\O_ *&:];^'/_'A#_VT
M_P#1C5YEX\U#[=>RL"<(VP!NVP;3CDX!8$CZYZFNW^$^C""%KQA\TK$*>#\B
M\<=QELY]=HX[GNZ*\-\=:,-*NWC481\.@XQANN .@#9 'H/QKN_A/J/GVS6Y
M.3"YP,=%?D<XYRV[U/X8KMZYKXC?\>$W_;/_ -&+7DGAG_C[M_\ KO%_Z&*^
M@****\D^+?\ Q]I_UP7_ -#>K/PIU.*Q\_SI$3=Y6-[!<XWYQDC.,UZ!_P )
M-:?\]XO^_J?XUS_C+QO;0P26\;B225"H$9R '!7<6&1QZ=>G !R/)K&T-[(D
M"X#2.JC/3+' SUXYKZ+KY_\ $W_'W<?]=Y?_ $,UZ=X"URWM;**.26-6&_(:
M101F1CT)STKH/^$FM/\ GO%_W]3_ !H_X2:T_P">\7_?U/\ &M*BO-OC'_R[
M_P#;7_V2LWX2?\?;_P#7!O\ T-*];HKY_P#$W_'W<?\ 7>7_ -#->M_#G_CP
MA_[:?^C&KI:\V^,?_+O_ -M?_9*S?A)_Q]O_ -<&_P#0TKMOB-_QX3?]L_\
MT8M>1>'I1%<P.Q 59HR23@ !QDD^E>X?\)-:?\]XO^_J?XU%<^+K.W4NT\9
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MCU&01]0:X?XC?\?\W_;/_P!%K75_"_6(+*V=)9$1C,QP[JIQL3G!(XXKL/\
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M. !]3UP.IKV_PMX?70H%MQ]X_,YR2"Y !(Z<<8' X'/.37&_&/\ Y=_^VO\
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M,IV3[<!OX6QTW#&>G&1R!UR !7G&J> +S3SS&77( ,7SYR,]!\V.V2 ,_AG
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M$SPO_9\GVV,?NYF^;G)$AR3P><,.>_.>@P*Y32=+?595MHL;W/&3@<#))]@
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M_HQJZ6BO$OB-_P ?\W_;/_T6M=M\)/\ CT?_ *[M_P"@)6;\8_\ EW_[:_\
MLE>>VEC)>G9$C.P&<(I8X]<#/'-6_P#A&;O_ )X2_P#?I_\ "M#P]X>N8KF!
MVAE"K-&23&X  <9)..E>X44444445YM_S'O\_P#/O7I-%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%<1\6_P#CT3_KNO\ Z ]=+X9_X]+?_KA%_P"@"M*BBBBO$OB-_P ?
M\W_;/_T6M=7\+]'@O;9WEC1V$S#+HK'&Q.,D'CFNP_X1FT_YX1?]^D_PJ_%$
M(@$4 *H   P !T 'I3Z\V^,?_+O_ -M?_9*S?A)_Q]O_ -<&_P#0TKUNBBO$
MOB-_Q_S?]L__ $6M=M\)/^/1_P#KNW_H"5V]%%<#\6=:,$262D9E.YN1G:I&
M!C&<%N0>/ND<\UY7116SX0UH:/=1SL2$SM?!(^5N"3@'('WL8Y('>O:=?U0Z
M5 ]TJ&0Q@':#CC(!.<'  Y/'05YZ/B[*T@/EHL.Y<CEGV\;L'<H)ZXX ]:]/
MBE$H#J058 @@Y!!Z$'TJ.[L8[T;)45U!SAU##/K@YYYKPOQ981Z?=2P0',:L
M,<[L9 )7/^R<CGGC!YKT;X32E[1@22%F8#)Z#:IP/09)/U)KF?BW_P ?:?\
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M(FYD?!VB$@G' )=<#/J<''T/I7:?$;_CPF_[9_\ HQ:\D\,_\?=O_P!=XO\
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M/6E\6_\ CT3_ *[K_P"@/7$_#G_C_A_[:?\ HMJ]MHHHHHKY_P#$W_'W<?\
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MX_LZ4DLH)C)(^Z,?)ZY'4=>,] HKT*BN(^+?_'HG_7=?_0'KB?AS_P ?\/\
MVT_]%M7MM%%%>5_%K2C',EV -CIM) _B4GJ<8R5( YR0I["HOA3K264SVTA
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M'@CE3D'&3C(X[5T\OQ9NW!4+$"0>0K9'N,L1D>X(]JY;5-6EU5_.G8L^ ,G
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M;> K*U=94BPR,&!WR'!!R#RV.M=!117-?\*YL/\ GE_Y$D_^*K9CTJ..'[&
M?*V%<%F/RD8QDDG&#@<\#@8Q6-_PKFP_YY?^1)/_ (JNEHJCJ^BPZN@BG7<H
M;<!EAR 1GY2#T)K+B^'UC$0ZQ$,I!!$D@((Z$'?UK0UGPY!K.W[0F[9G;\S+
MC=C/W2/05F?\*YL/^>7_ )$D_P#BJ/\ A7-A_P \O_(DG_Q57-.\'6FG'?'$
MN[((+9<@KT(+DX/TQ^@K9HHHK#U'P7::E(;B:/<[8R=[CH !P& Z"KVD:+#I
M"&*!=JEMQ&6/) &?F)/0"H]9\.0:SM^T)NV9V_,RXW8S]TCT%1:1X3MM(<RP
M)M8KM)W.>"0<?,Q'4"M>BBBBBBBBBO-O^8]_G_GWKTFBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBN(^+?_'HG_7=?_0'KI?#/_'I;_P#7"+_T 5I44444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444444444444444444444444444444444445YM_S'
MO\_\^]>DT444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444445Q'Q;_X]$_Z[K_Z ]=+X9_X]+?\
MZX1?^@"M*BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBO-O^8]_G_GWKTFBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN(
M^+?_ !Z)_P!=U_\ 0'KI?#/_ !Z6_P#UPB_] %:5%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%4[O6(+([)9$1B,X=U4X]<$CCBFVVN6]TPCCEC9CT"R*2<#/0'/
M2KU%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9O_"36G_/>+_OZG^-6[2^C
MO1OB=74'&48,,^F1GGFIZ***************BN;E+53)(P51U+$ #)QU/'6J
M7_"36G_/>+_OZG^-7XI1* ZD%6 ((.00>A!]*?111111111111111111116?
M+XAMHB4::(,I((,B @CJ",]:GL]3BOL^3(C[<9V,&QGIG!.,XJS111111111
M11115&YURWM6,<DL:L.H:101D9Z$YZ4ZTUB"].R*1'8#.$=6./7 )XYJY111
M111111115&YURWM6,<DL:L.H:101D9Z$YZ4ZTUB"].R*1'8#.$=6./7 )XYJ
MY1111111111111111111111111111111111111111111111117FW_,>_S_S[
MUZ3111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111111117$?%O_CT3_KNO_H#UTOAG_CTM_P#KA%_Z
M *TJ**********************IZMI::K$UM+G8XYP<'@Y!'N" ?3U!%>"ZM
MI;Z5*UM+C>AYP<CD9!'L00?7U ->N_#WQ*=:@V/_ *V':K'))(Q\K$GN<'/)
MY&>,@5U->/\ Q*\2G49C:)_JX&(ZGYGZ,2#@?*<@<>IS@U+\,_"_]H2?;9!^
M[A;Y><$R#!' YPHY[<XZC(KUB641 NQ 50223@ #J2?2O)?&/Q#DU!_+M6:.
M)#PRDJSGUR,$+Z#\3S@+R-I8R7IV1(SL!G"*6./7 SQS3KS3);''G1NF[.-Z
ME<XZXR!G&:Z#PMX^FT=E20F2 <%3R0, ?*3R, <+G;UZ$Y'L5E>I?(L\3!D<
M9!'^>OJ.H/!YK!^(W_'A-_VS_P#1BUY)X9_X^[?_ *[Q?^ABOH"BOG_Q-_Q]
MW'_7>7_T,UZW\.?^/"'_ +:?^C&KI:**Y3XDZT=.M3&I&^<[.HSM(^<X(.1C
MY3Z;@<YQ7C%>S_#;6CJ-J(V(WP'9U&=H'R'  P,?*/7:3G.:ZNLWQ-_QZ7'_
M %PE_P#0#7S_ $45JZ3XGN-**F*1MJ'A"Q,?/4%<XP<GW[@@\U[1X;\0)KT(
MN(P1SAE/9@ 2,]QR"#Z'L<@<[\6_^/1/^NZ_^@/7DE%%=+\.?^/^'_MI_P"B
MVKVVBO/_ (MZ3YL<=XHYC;:V%YVMR"6[ $8&>,MV[\I\.=4%A>(#@+*#&203
M][!7&.Y8 >F"?J/:Z*\D^*VK_:KA;4#B!>3W+2 ,>_3&WL#G/M5OX2Z*9'>^
M8#:@V+D _,<%B.<@@<=.0QYX-=SXE\2QZ!'YLG+'(1 >6/\ 0#N>WN2 ?%M9
M\13ZPQ:9R06R$!.P<8&%S@8''KZDDFH[;0[BZ421Q2,IZ%8V(.#CJ!CK4$<L
ME@^5+1R(2."58'H1V(/8UZ;X&^(1OR+2[(\TGY'P &S_  D# #>G8]/O?>ZS
MQ-_QZ7'_ %PE_P#0#7S_ $445[;\.?\ CPA_[:?^C&KQ*OH#PS_QZ6__ %PB
M_P#0!7DGQ&_X_P";_MG_ .BUIW@#Q(=&N K$"*8A7SCCKM;)(P 3SVP3P3BO
M:ZXCXM_\>B?]=U_] >N)^'/_ !_P_P#;3_T6U>VUPGC7XB_V:QM;7#2#(=CR
M%.,8'8L#USD#H03D#R^262_?+%I)'(')+,3T [DGL*LR^'KF(%VAE"J"23&X
M  ZDG'2H-/U*33G$L+%&'=3CN#@]B,CD'@]Z]>\!>,3KR&*7 FB SC W#IN
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M/B;_ (^[C_KO+_Z&:];^'/\ QX0_]M/_ $8U;U[>I8HT\K!409)/^>OH.I/
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MI"&*!]JEMQ&U#R0!GYE)Z 5>_P"%C7__ #U_\AQ__$T?\+&O_P#GK_Y#C_\
MB:]?T.Y:ZMX97.6>*-B>!DE02>..M>&^)O\ C[N/^N\O_H9KUOX<_P#'A#_V
MT_\ 1C5TM%%%%>2?%O\ X^T_ZX+_ .AO6E\'/^7C_ME_[/7I-9OB;_CTN/\
MKA+_ .@&OG^NE_X6-?\ _/7_ ,AQ_P#Q-,E^(5]("IF."".$0'GT(4$'W'(K
M)M+*;5I-L:M)(QR>I/)Y8GL,GDGCU->U>#_#G]@0>06W,S%F(Z;B ,#O@ #K
MR>O&<#R[XC?\?\W_ &S_ /1:UVGPCB MI'P-QF()QR0$7 SZ#)Q]37<T5YI\
M8H@#;O@;B) 3CD@;,#/H,G'U-4?A'*1<R)D[3"21G@D.N#CU&3CZFNB^+?\
MQZ)_UW7_ - >O/?!^EIJMTEM+G8X?.#@\(Q!'N" ?3U!%4M6TM]*E:VEQO0\
MX.1R,@CV((/KZ@&O5/AKXE&HPBT?_60*!U'S)T4@#!^48!X]#G)KQ^OH#PS_
M ,>EO_UPB_\ 0!7B/B;_ (^[C_KO+_Z&:];^'/\ QX0_]M/_ $8U>;_$;_C_
M )O^V?\ Z+6NV^$G_'H__7=O_0$KMZ***YWQ[KATBU9TR'D.Q2.Q8')R"""
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MSX;&A7!5 ?*D&Y,Y./5<D=0?J<%<G)K-.M.UO]A8DH)%=<G[N P8#CH=V>N
M0>,DUJ_#G_C_ (?^VG_HMJ[_ .*-G]HLB^<>4Z-TZY.S'M][/X8KS+PEJ']G
MW<,V0 ' );@!7^5CG(Q@$G/3UKWNN&\<^!I]?G6>)D"K&%^<L#D,Q[*>.:X_
M6OAW<:1"UU(T95,9"EB>6"]U ZGUK(\,_P#'W;_]=XO_ $,5] 445XE\1O\
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M!)SQ@@ ?>)JSJ/Q1M+89C+2L0<!5*C(Z9+XP#Z@''ITSY7K.LR:Q(;B8Y8]
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MI_%O_CT3_KNO_H#UYWX3U=-(N8[J0$JF[(7!/*,O<@=3ZUZ)_P +;M/[DO\
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M<C((P1QSTKP+7M%?1IFMI ?E/RDC&Y<\,.3P?J<'(/(-=EX1^)@LT2TNE.U
M%61>P&  5] ,\CG 'RDY)ZF7XD6* L)"2 > CY/L,J!D^Y ]ZXOQ?\1O[8C:
MTA3;$V,L_P!\X*L, ' Y'JV1Z5SOA6(R7< 4$GSHSP,\!@2?H ,GT%>^T45X
ME\1O^/\ F_[9_P#HM:U/ WCF#0(&@E5RS2%OD"D8*J.[#GBNB_X6W:?W)?\
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M\/MH=L(I/]8[%V&00"<# QZ #/7G."1BLCXM_P#'HG_7=?\ T!ZXGX<_\?\
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M (375?\ GU_\@3?_ !5'_":ZK_SZ_P#D";_XJC_A-=5_Y]?_ "!-_P#%4?\
M":ZK_P ^O_D";_XJC_A-=5_Y]?\ R!-_\51_PFNJ_P#/K_Y F_\ BJ/^$UU7
M_GU_\@3?_%4?\)KJO_/K_P"0)O\ XJC_ (375?\ GU_\@3?_ !5'_":ZK_SZ
M_P#D";_XJC_A-=5_Y]?_ "!-_P#%4?\ ":ZK_P ^O_D";_XJC_A-=5_Y]?\
MR!-_\51_PFNJ_P#/K_Y F_\ BJ/^$UU7_GU_\@3?_%4?\)KJO_/K_P"0)O\
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M_P#%4?\ ":ZK_P ^O_D";_XJC_A-=5_Y]?\ R!-_\51_PFNJ_P#/K_Y F_\
MBJ/^$UU7_GU_\@3?_%4?\)KJO_/K_P"0)O\ XJC_ (375?\ GU_\@3?_ !5'
M_":ZK_SZ_P#D";_XJC_A-=5_Y]?_ "!-_P#%4?\ ":ZK_P ^O_D";_XJC_A-
M=5_Y]?\ R!-_\51_PFNJ_P#/K_Y F_\ BJ/^$UU7_GU_\@3?_%4?\)KJO_/K
M_P"0)O\ XJC_ (375?\ GU_\@3?_ !5'_":ZK_SZ_P#D";_XJC_A-=5_Y]?_
M "!-_P#%4?\ ":ZK_P ^O_D";_XJC_A-=5_Y]?\ R!-_\51_PFNJ_P#/K_Y
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M_P#/K_Y F_\ BJ/^$UU7_GU_\@3?_%4?\)KJO_/K_P"0)O\ XJC_ (375?\
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M (375?\ GU_\@3?_ !5'_":ZK_SZ_P#D";_XJC_A-=5_Y]?_ "!-_P#%4?\
M":ZK_P ^O_D";_XJC_A-=5_Y]?\ R!-_\51_PFNJ_P#/K_Y F_\ BJ/^$UU7
M_GU_\@3?_%4?\)KJO_/K_P"0)O\ XJC_ (375?\ GU_\@3?_ !5'_":ZK_SZ
M_P#D";_XJC_A-=5_Y]?_ "!-_P#%4?\ ":ZK_P ^O_D";_XJC_A-=5_Y]?\
MR!-_\51_PFNJ_P#/K_Y F_\ BJ/^$UU7_GU_\@3?_%4?\)KJO_/K_P"0)O\
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M_P#%4?\ ":ZK_P ^O_D";_XJC_A-=5_Y]?\ R!-_\51_PFNJ_P#/K_Y F_\
MBJ/^$UU7_GU_\@3?_%4?\)KJO_/K_P"0)O\ XJC_ (375?\ GU_\@3?_ !5'
M_":ZK_SZ_P#D";_XJJWAR&[OM32^N(73=NW'RW5!B(J.6SC.!WZUZE111111
[encoded data, 8418 characters]
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M#QSSC&,FMGXM_P#'HG_7=?\ T!ZX;P[X&GU^,SQ,@57*_.6!R #V4\<UJ_\
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MKS?P=XQ_X1OS/W?F>;L_CVXV[O\ 9;.=U=)_PN/_ *=__(O_ -A76^$?$O\
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MU 4<],=*ZSP=JECJYWP1)'-&,D;$##(P2I Y7G&>#Z@9&:?Q;_X]$_Z[K_Z
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M+4'U&1[B0Y:1B3UQSV&23@#@#L.*K5J^&=<.BW"7(SM!PX'=3]X8R,GN,\9
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MVA3+@9X!&#E1P.1C&!C'%=!+K>L2@HR2E6!!!ME((/4$>7TK,\(Z@_A^\3S
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MZD9Z5T'_  C-I_SPB_[])_A5^*(1 (H 50  !@ #H /2GUS7Q&_X\)O^V?\
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M)P<<97OVV_B-_P >$W_;/_T8M<E\*=,BOO/\Z-'V^5C>H;&=^<9!QG%>@?\
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M@Y#,<?,P/0BNVT.V:UMX8G&&2*-2.#@A0"...M8GQ$T6;5[=8H%W,)0Q&5'
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M2N?^6H" YQ@DY!.2<'Y^.NHHK-\3?\>EQ_UPE_\ 0#7-?"3_ (]'_P"N[?\
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M:-HT57;<P4 M@#) Y.!P,GG':I:***S?$W_'I<?]<)?_ $ US7PD_P"/1_\
MKNW_ * E=O1116;XBT--;A:V?C."&P"58=",_D>A()&1FO!KVR>Q=H)5*NAP
M0?\ /3T/0CD<5&)2 4R=I()&>"1G!QZC)Q]31%$92$4$LQ   R23T 'K7M_@
MKPT-!@"'_6R89S@9!Q]W(SD+]3SDC&<5T%%%%9OB;_CTN/\ KA+_ .@&LSX<
M_P#'A#_VT_\ 1C5TM%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%8/C:T,]JTJ8$EN1*A/8Q_,3CD$[<@ @C)Y]:;X'MF
M2W^T2##W+O,P&,#S#D8ZX!4 X))YY]*S],NI?"ZFR>"62)7;RG@42$J26^<9
M&&&>N #S@<9.EX9TZ5&FO;A0DMPZ_(&#!5C&U.1_%UR0<'C@<BL;P]=W.CPC
M2Q;N9D9@LA'^CD,Q;>7X( !/ &3C'#' K?V9+_8OV?RW\W^YM.__ %^?NXST
MY^G->@45PVF^%)(KI;9@WV2VD::,ECM)?;L0#=G,;!CGG/.0-_.OK=K+97":
ME"AE C,<J C=LSO#(#C+ YXR<\ #DD5I))?$DL/[EXK>"02,TP"2%T'RJ%Y^
M7GD]^0"".2"=]-OYRT4K)=&#:\:;D&U=I+'/R@'\<#.,8S3N-+72)IGEM?M$
M,S[U=(UEE5GY9"IP=N02".!P"23QI:+;M)YEQ!;QVX*%8Q)&$E9NN7V_=3(
MV\DXW9' .7>SK? Q76GNURP4,41=A;C;^_#9"],G)VC(.<'/1>$["33[6*"<
MYD53GG=C))"Y_P!D8'''&!Q6O1116;XF_P"/2X_ZX2_^@&N:^$G_ !Z/_P!=
MV_\ 0$KMZ****\O^+EK#&\4BX$S@[@,<J,!2>>O8<<C(S\H%>>UV'POM89[K
M][@NJ$Q@XQN!'/7[P'(&#W;@J*]BHHHHK-\3?\>EQ_UPE_\ 0#69\.?^/"'_
M +:?^C&KI:**************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************R/$.BR:NHA68QQG(D"J"74D<;CRO ([@YY!'%:D40B 10 J@
M  #  '0 >E/HHHHHHHHHHHHHHHHHK-\3?\>EQ_UPE_\ 0#7-?"3_ (]'_P"N
M[?\ H"5V]%%%4]6U1-*B:YESL0<X&3R< #W)('IZD"O!=6U1]5E:YEQO<\X&
M!P, #V  'KZDFJ=2VURUJZRH<,C!@>#@@Y!YXZU[MX6\0+KL"W ^\/E<8( <
M $@=>.<CD\'GG(K7HHHK-\3?\>EQ_P!<)?\ T UF?#G_ (\(?^VG_HQJZ6BB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBLCQ#J[Z;Y&P ^=<QQG=G[KYR1@CGCCJ/:KW[WS?X/(V>_F;\_EMQ^.?:J/
MA[5WU+S]X \FYDC&W/W4Q@G)////0>U:]%%9M]K/V6>"TVY^T>9\V<;?+4-T
MQSGZC%1?VN_VW[#@;/LWF9YW;O,VXSG&,>V<]ZUZK0>;YC[]GE?+Y>W._I\V
M[/'7ICMUJS11111116;XF_X]+C_KA+_Z :YKX2?\>C_]=V_] 2NWHHHKQ_XE
M>)3J,QM$_P!7 Q'4_,_1B0<#Y3D#CU.<&N-KU?3OANHLFMY!BXD^?.XX5U#!
M!P,8 8AN#U."?E(\MN;9K5VB<89&*D<'!!P1QQUK;\%>)3H,X<_ZJ3"N,G &
M?O8&<E?H>,@8SFO<J***S?$W_'I<?]<)?_0#69\.?^/"'_MI_P"C&KI:****
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
MYKQK_P NG_7]!_[-1_S%?^W'_P!K5RQ\6G1ENH8N)7OI?G924C#$ ,< Y/RG
M  /0D@XP=?6K5?"EILC<B2XE59;@Y+_-DL^.2< ' !R,Y!W9)QKV^TZU1IK.
M=TN@,A_WI:0CDJ^X;2'(YX SR>,@^CZ9>?;HH[C&/,16QG.-P!QGC.,UR/B?
MPY!=7]MO3/VCSO,^9AN\N,;>AXQ[8SWINH>'UN]0CM S)%'9 %48C<BN5\LG
M.=IR,]<@>O(MZ+8+HM^]E 2('MA+L)+ .'"9&<D9 YYY^@ %*_\ .\W4_LV?
M-VVV-OWL;/FQ[[<XQSGISBLS3SI(Q&#+;3JVS<S.DH/ ))!9%SR#G&.> ,5Z
M=1111116;XF_X]+C_KA+_P"@&N:^$G_'H_\ UW;_ - 2NWHHKE/B#XJ&C0^3
M&1YTH( R0RJ007X[]EY'/(SM(KQBNY^%_ALWDOVYP/+A)"YP<O@8XP>%!SGC
MG;C.#CUFO./BKX;+@:C&!\H"R=!W 1NG)YP>2<;<# ->:5ZI\,?%0N4_L^4C
M?&/W9).67DD<]U[<_=Z#"DUWU%%9OB;_ (]+C_KA+_Z :S/AS_QX0_\ ;3_T
M8U=+1111111111111111111111111111111111111111111111116;_PDUI_
MSWB_[^I_C5^*42@.I!5@""#D$'H0?2GT4444444445GR^(;:(E&FB#*2"#(@
M((Z@C/6K=M<I=*)(V#*>A4@@X..HXZU+1111111111111111111111111111
M11111111114%W?1V0WRNJ*3C+L%&?3)QSQ4%MKEO=,(XY8V8] LBDG ST!ST
MJ]1111111111111111111111111111111113)91$"[$!5!)).  .I)]*I1>(
M;:4A%FB+,0 !(A))Z #/6M"BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBH+N^CLAOE=44G&78*,^F3CGBH+;7+>Z81QRQLQZ!9%).!GH#G
MI5ZBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBJ-SKEO:L8Y)8U8=0TB@C(ST)STJS;7*72B2-@RGH5(
M(.#CJ..M2T44444444444444444444444444444444444444444444444444
M4444451N=<M[5C')+&K#J&D4$9&>A.>E3VE]'>C?$ZNH.,HP89],C//-3T44
M5GR^(;:(E&FB#*2"#(@((Z@C/6K-I?1WHWQ.KJ#C*,&&?3(SSS4]%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%8?BC3I+[[/Y8SY=U$[<@85<Y/)&<9Z#FC^SI/[0
M^UX_=?9=F[(^]YF[&,YZ=\8JIIOADSQ75M<J0EQ<RN,,,[25*L,$X.1G!].1
MBJUOH%S<VILY<++:R*;>4A=I$?\ JR55FYQD'(X!!PS U;^W:A/_ */Y"1D\
M&?S%=!ZN(\;CG^$'N1NXS711(4 4DD@#DXR?<X &3[ #VK \364YFM[RWC$I
M@,N4WA"?,4*#EN,#'/?IQU(=;6,TEZMZZ;5-F$/S*<.9-Q3CDX'?&#4G]G2?
MVA]KQ^Z^R[-V1][S-V,9ST[XQ53^Q[D37LL1$;3"#RG.U@2BX;(YP.V2.^0#
MBJVJI>ZO&;.2UB!((\UI0T8."-ZI@N">=O<9&>]=/IEG]ABCM\Y\M%7.,9V@
M#..<9Q5FBBBBBLWQ-_QZ7'_7"7_T US7PD_X]'_Z[M_Z E=O145S/Y"-)@MM
M4G"C+' S@#N3V'K7BFO6=]K,S7,D$WS'Y08W.U<\*/E' ^@R<D\DU#IO@ZZO
M)$A,4B!F +-&P"CN><#@=L\]!R:]MTW3TTZ-+>,86-0!TSQW. !DGDGN>:LT
MR6(2@HP!5@001D$'J"/2O%?$7@>?3IFBACDDCX*LJ%N#V.W(R#P>F<9P 15.
MRT>^L76>*&970Y!$3_X=/4=".#Q7MNDWQOXEF9&C9ARCC# @X/IQQP<#(P<"
MKE%9OB;_ (]+C_KA+_Z :S/AS_QX0_\ ;3_T8U=+11111111111111111111
M111111111111111117G?Q$\)W.KW"RP)N41!2=R#D,QQ\S ]"*XC5_"=SI""
M6=-JEMH.Y#R03CY6)Z U%HWAR?6=WV=-VS&[YE7&[./O$>AKKO!?@N[TV[CN
M)H]J+OR=Z'JC <!B>IKD?#/_ !]V_P#UWB_]#%?0%>;?&/\ Y=_^VO\ [)6E
M\)/^/1_^N[?^@)7$_$;_ (_YO^V?_HM:];\,_P#'I;_]<(O_ $ 5Y#XM\1R>
M(+AE0LT6\"-!D@XX#!<#YFR3R,C.WM6A_P *IO-F_,>=N=NX[LXSM^[MSVZX
MSWQS67H^L7'A*X((((.)(VZ,/UYYRK#/7N"0?;[:Y6Z194.5=0P/(R",@\\]
M*I>)O^/2X_ZX2_\ H!KPC3M.DU*06\(W.V<#('0$GDD#H*V9?A[?1@L83@ G
MAT)X] &))]AR:CT+Q5<>'Y N6*(2&B<D+U^88/W6SWQD'KD9![OXK2B6SC=2
M"K3(00<@@H^"#Z5YQHWAR?6=WV=-VS&[YE7&[./O$>AK3_X5S?\ _/+_ ,B1
M_P#Q50:%XJN/#\@7+%$)#1.2%Z_,,'[K9[XR#UR,@^U_VC'Y7VO/[K9OW8/W
M<;LXQGIVQFO'?%/C&;Q')Y4>X1$A5C7.6Y&"P'WF)Q@<@=!SDFW;?"F\E4,Q
MC0G^%F)(Y_V58?D:R;RPN_"4H))C8YVLARK '\B,@$JPZ8R.:]6\&^+%\0QE
ML;98\!U&<<YP0?0X/'4=#G@G@OB;X;&G3"[C!\N<DMU.'SD]N W4#)YW8P *
MZ3X7^)!>1?87)\R$$KG)RF1CG)Y4G&..-N,X..(\<^)!KMP60GRHQM3.1GU;
M!/4GZ' 7(R*]%\$^$EL+4I*IWW*?O 21P0<)C@@@'GODGG &/-/$&D2>&+K:
MIQM8/$W#':&^4GC&01R",9'IC/L/AG7!K5NER,;B,.!V8?>&,G [C/."#7&_
M%7Q(4 TZ,CY@&DZ'N"B]>#QD\ XVX.":;\+?"_\ S$I!ZB+GZJ[$#\AD^IQ]
MTUZ317S[?(=)N76(G,$S;"<$_(_RD\8)X],>U?05?/.L78O9Y9UR%DD=AGKA
MF)&>O/->M_#&[$]DJ#.8G=3GU)W\>V&'XYKD_B[<LUQ'$3\JQ;@..K,P)]>0
MH_*MGPO:"#1Y7&<RQW#'/J R<>V%'XYKD/AS_P ?\/\ VT_]%M7MM>2?%O\
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M>7_D2/\ ^*KJ?AWX3N=(N&EG3:IB*@[D/)93CY6)Z UD?%O_ (^T_P"N"_\
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MW$94< @9^8@=2*U_^%<W_P#SR_\ (D?_ ,55W0_ 5[:W$,KQ85)8V)WQG #
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M[JDD_@*U_"/Q'DL7$5VQ>$\;CRZ\YSGJPYY!R0,;>F#ZW7-?$;_CPF_[9_\
MHQ:\@TC19M7<Q0+N8+N(RHX! S\Q ZD5K_\ "N;_ /YY?^1(_P#XJJ=IJMUX
M9E\L%D:-\M&Q.PG&#E<X(([CM@@]#7:^,=,7Q-:)J\ ^=4RPW'&Q<EQR!DHV
M>>,C/7Y165\+_$ALY?L+D>7,25S@8? QSD<,!C'/.W&,G/J&I:@FG1O<2'"Q
MJ2>F>.PR0,D\ =SQ7AO[[Q5==C+.W^ZH '\E4>Y('<]?;])TM-*B6VBSL0<9
M.3R<DGW))/IZ "N4^)7AR?6?)^SINV>9N^95QNV8^\1Z&N U'P7=Z;&;B:/:
MBXR=Z'J0!P&)ZFJ.D:+-J[F*!=S!=Q&5' (&?F('4BNDT/P%>VMQ#*\6%26-
MB=\9P P)/#9Z52^(W_'_ #?]L_\ T6M>M^&?^/2W_P"N$7_H K,^(W_'A-_V
MS_\ 1BUQ/PD_X^W_ .N#?^AI6E\8_P#EW_[:_P#LE<;I'A.YU=#+ FY0VTG<
M@Y !Q\S ]"*O?\*YO_\ GE_Y$C_^*KJ?AWX3N=(N&EG3:IB*@[D/)93CY6)Z
M UZ)7DGQ;_X^T_ZX+_Z&]=M\.?\ CPA_[:?^C&K3\3?\>EQ_UPE_] ->2?#G
M_C_A_P"VG_HMJ[;XM_\ 'HG_ %W7_P! >N&\#>)!H5P&<GRI!M?&3CT; /4'
MZG!; R:]PKQ+XC?\?\W_ &S_ /1:UZWXF_X]+C_KA+_Z :\(T[3I-2D%O"-S
MMG R!T!)Y) Z"MS_ (5S?_\ /+_R)'_\53-%\4W7AEQ$=VQ2-T4@(X.3P",J
M3G.1U."01Q7LFDZHFJQ+<Q9V..,C!X."#[@@CT]"17A?B;_C[N/^N\O_ *&:
MT_\ A7-__P \O_(D?_Q5'_"N;_\ YY?^1(__ (JO4?!>G2:;:1V\PVNN_(R#
MU=B.02.AKPZVMFNG6)!EG8*!P,DG '/'6N@_X5S?_P#/+_R)'_\ %51O-.N_
M#3C?OA9U."CXR,\C<AQUQD9]#Z5ZIX"\4G7H3YF/-B(#8&,@CY6Z8!.#D#N,
M\ @5S'Q1\3N)!81,5"KF3:2,EQPIX&0%.3R0=W(R*Q-&^'-UJL8N%V(K?=$A
M8$CLV IX/;/7KT()S[_2[KPK,K-E'!)1U.5.#@D'T]0><'YA@U[!X2\0#7K=
M;C #@E7 S@,/3/8@@]\9QDD5XQXF_P"/NX_Z[R_^AFO?991$"[$!5!)).  .
MI)]*\9\4>-9O$3FWCR(68!8P,LQ!XSCDDG^$< XZD9,]I\++R<;FV1G/1WR?
MK\@88_'/M6-JFCW/AJ0;\HW.QT;@CH2&'/3MP<$9 S7JG@+Q2=>A/F8\V(@-
M@8R"/E;I@$X.0.XSP"!7%_%O_C[3_K@O_H;UH?"KQ($)TZ0GYB6CZGL2Z]>!
MQD< 9W9.2*]+KQ+X<_\ '_#_ -M/_1;5VWQ;_P"/1/\ KNO_ * ]>;:-X<GU
MG=]G3=LQN^95QNSC[Q'H:T_^%<W_ /SR_P#(D?\ \56WX+\%W>FW<=Q-'M1=
M^3O0]48#@,3U-6?C'_R[_P#;7_V2N-TCPG<ZNAE@3<H;:3N0<@ X^9@>A%3W
M?@^]TH?:&C90ASN1@Q7'.[Y"2 ,9ST'K74^!?B$[NMG=DMO(5'Q\P/ "MCJ#
M_>ZYZY!ROI=%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9OB;_CTN/\ KA+_
M .@&N:^$G_'H_P#UW;_T!*[>BBBBBBBBBBBBLWQ-_P >EQ_UPE_] -9GPY_X
M\(?^VG_HQJZ6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN(^+?_ !Z)
M_P!=U_\ 0'K-^#G_ "\?]LO_ &>O2:^>='NQ93Q3MDK'(C''7"L"<=.>*]/_
M .%MVG]R7_OE/_BZY+Q]XNB\0^5Y(<>7OSO 'WMN,88^E=;\)/\ CT?_ *[M
M_P"@)7$_$;_C_F_[9_\ HM:];\,_\>EO_P!<(O\ T 5XCK.E2:#.86R&1LHP
M^4D _*XP3C..QX/'45UVD_%N2+"W,8<?*-R?*W^T2#D$GK@;1GZ\=/I>LZ=X
MD?A$,S@DB6)=YV\=2""<#. 2<?0XZB*(1 (H 50  !@ #H /2J'B;_CTN/\
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MA_[:?^C&KR3Q-_Q]W'_7>7_T,UZ3_P +;M/[DO\ WRG_ ,71_P +;M/[DO\
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M[L#T/I6O_P +;M/[DO\ WRG_ ,771>'?$4>OQF>(,%5ROS@ Y ![$\<UY/\
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MF)R%Z\EL =?H3@>K>$]*;2K6*V?[RJ2>G!8EB."1P3C/?&:\K\?^&SHUP64
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M .+KL+&[%[&DZY"R(K#/7##(SUYYKP+0[E;6XAE<X5)8V)Y. &!)XYZ5Z_\
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M.-P!QGC.,U9HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK-\3?\>EQ_UPE_\
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M (BMOPUX1B\/;_)+GS-N=Y!^[G&,*/6N ^+?_'VG_7!?_0WKMOAS_P >$/\
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MJ<F.)5;KP26;'Y,#7H'@&V:WL85<8)5F['AV+*>/4$&KWB;_ (]+C_KA+_Z
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MSXA_XD&J&?YPHE63(X)5\,X'0$$EE].Q/6CQ#_Q/]4,'SE3*L>!R0J85R.H
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M7;E5MXXB?F:7<!ST56!/IP6'YU3^#L1 N'P=I,8!QP2-^1GU&1GZBN&\3?\
M'W<?]=Y?_0S7K?Q&_P"/";_MG_Z,6O+O"/AK_A(96M]^S:A;.W=T*C&,CUJW
MXI\!3:"/.R)(L@;E!!&<?>7G )X!R1ZX) K4^&45G/(%D4FY7+*78%/E_NC@
M[L'."&QMW CMZO7SSH]H+V>*!LA9)$4XZX9@#CKSS7I__"I+3^_+_P!])_\
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M2L_P-X&@U^!IY6<,LA7Y"H& JGNIYYKHO^%26G]^7_OI/_B*V_#7A&+P]O\
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M !%:OAWP-!H$AGB9RS(5^<J1@D'LHYXKF/C'_P N_P#VU_\ 9*TOA)_QZ/\
M]=V_] 2NWKPWQ]<K<7TS(<@,J]QRBA6'/H017L7AZ(Q6T","&6&,$$8((09!
M'K6A1111111111111111111111111111111115'7+9KJWFB099XI% X&25(
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MLYP,;/PU\(+'&;V=0QF4A%93PAR"<'CYQ[?=[X8BN-\:^&CH,Y0?ZJ3+(<'
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M]017ATD<WAFZP<"6!P>"2I[]L':P/(X.#@XKU_4-435=/EN8L['MY<9&#PK
M@^X((]/0D5X[X<UG^QITN]N[9N^7.W.Y2O7!]?2NW_X7'_T[_P#D7_["C_A<
M?_3O_P"1?_L*])KY_P##/_'W;_\ 7>+_ -#%?0%%<U\1O^/";_MG_P"C%KR[
MPCXE_P"$>E:XV;]R%<;MO4J<YP?2NM_X7'_T[_\ D7_["C_A<?\ T[_^1?\
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M^N\7_H8KZ KS;XQ_\N__ &U_]DK$\(^/O^$>B:W\K?N<MG?MZA1C&T^E;?\
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M3XC:6+"\<C 64"0 $G[V0V<]RP)],$?05-%MCXAO5#@?OI2[CD#&2[@8R1D
M@<_CWKW:O-OB;X1>1CJ4(R-H\P#.1M&-_P!,8!QC&,\\D9?@WXB'14%K,I:(
M$[2N-RYR2,' 8$^I!&3R> -W4/B[$$/D1N7[>9A5'!Y^5F)YQQQD=Q7$Z'H<
MWBF=L?Q,6D<C@;CDG P,DYP!C/L 2/<;:V6U18D&%10H')P , <\]*I>)O\
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M):GJ]SXLF52-SGA$3A1ZX!)QG&22>G4X QZ[X2\/C0;=;?(+DEG(S@L?3/8
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MZ"F:/X7MM')>WC"LPP3EF./3+$X'KCKQGH*U:YV7X>V,A+&$9))X=P.?0!@
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M(HDVK,NUQN<Y&",<L2.">F*H_P#"N;#_ )Y?^1)/_BJ/^%<V'_/+_P B2?\
MQ5'_  KFP_YY?^1)/_BJZ6LC5_"=MJ[B6=-S!=H.YQP"3CY6 ZDU1_X5S8?\
M\O\ R))_\51_PKFP_P">7_D23_XJMS3]-CTY!%"H11V48[ 9/<G Y)Y/>HM7
MT6'5T$4Z[E#;@,L.0",_*0>A-9'_  KFP_YY?^1)/_BJ/^%<V'_/+_R))_\
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M;V+8SOSC).,XKT"BO'_'NN7%K>RQQRR*HV8"R, ,QJ>@..M9\4NJ2@.INBK
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MO/#9WL'B+#&Y&X.>=NY#C/RYQG/&<5Z=X"\8G7D,4N!-$!G&!N'3<!Z_WN,
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M]< GCFMG0_[2^T0^9]IV>;'NW>;MV[AG.>,8ZYXQ6?XA\0W,5S.BS2A5FD
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MM(JE7=V4ASM/&>HSD>^*]FN;E;5&E<X5%+$\G  R3QSTKP3_ (2:[_Y[R_\
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M@I&-[ ]PI&!@@@@DC(/;/>O<*RO$VAC6K=[8XW$90GLP^Z<X.!V..<$BO(O
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MH ,]:T*YKXC?\>$W_;/_ -&+7D5EHKWL,MS&"?(*;@!GY6#9;KT&T9X/!SP
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M/B'H8U.U9^-\ +J3Z*/F&<$X([<9(7/ KAOA7J'V>[\DDXF1@ .FY?F!(SV
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M')_\34MMX]LKIUB27+.P4#9(,DG '*XZU%\1O^/";_MG_P"C%KB?A)_Q]O\
M]<&_]#2O6Z\D^*NC+9SI<( !.IR!G)=3\S$=.0PZ=3DGGD]E\-=0^V62*228
MF9"6]CN&.>@5@!Z8QTKJ:^?_ !-_Q]W'_7>7_P!#->W?\)-:?\]XO^_J?XTZ
M+Q#;2D(LT19B  )$))/0 9ZUP/Q?U#+PVH)^56<C^$[CM7OU&UNW /'4UJ_"
MK0Q;0&]."\Q('LJDC'3()8'/)! 7N*[FO-/BUH80I?K@%CL?W."5/3DX!!)/
M0*!6A\)-0\V"2W)),3Y&>@5QP!SZJQ(Z<Y[FO.O$W_'W<?\ 7>7_ -#->W?\
M)-:?\]XO^_J?XURWQ&\16MQ:F!'221V7;L*OMVD$L2#\O&1ZG..F<8?PBMF:
MXDE ^58MI/'5F4@>O(4_E7J]%>;?&/\ Y=_^VO\ [)6E\)/^/1_^N[?^@)7;
MU\]Z'<K:W$,KG"I+&Q/)P P)/'/2O7_^%C6'_/7_ ,AR?_$UQ/Q*\1P:SY/V
M=]VSS-WRLN-VS'W@/0UTGPD_X]'_ .N[?^@)7$_$;_C_ )O^V?\ Z+6N[T/Q
M[96MO#$\N&2*-2-DAP0H!'"XZU=_X6-8?\]?_(<G_P 36YIVHQZE&+B$[D;.
M#@CH2#P0#U%6:\2^(W_'_-_VS_\ 1:UZWX9_X]+?_KA%_P"@"N/^+5["\20!
ME,RR9P,%E7:<Y] <KP<9X/..(O@[$0+A\':3& <<$C?D9]1D9^HKAO$W_'W<
M?]=Y?_0S7MW_  DUI_SWB_[^I_C7+?$;Q%:W%J8$=))'9=NPJ^W:02Q(/R\9
M'J<XZ9QA_"*V9KB24#Y5BVD\=692!Z\A3^58GCS4/MU[*P)PC; &[;!M..3@
M%@2/KGJ:]=\,Z&-%MTMAC<!ER.['[QS@9'89YP .U:M>'^/=#&D73(F D@WJ
M!V#$Y&    0< =L=Z]'@U#^T-*:;))-K("6Y)9$96.<G.2"<]?6O._AS_P ?
M\/\ VT_]%M7M4LHB!=B J@DDG  '4D^E>&>-;F.YO)9(""A8<KT)V@,??+9Y
M[]><YKO?%-V=.TF.)MRN\<,?H0=H+ ]"!A2"/?!&,US?PMT,7UP;E\%;< @'
M^\V=IP0>!@GL0=I%>NUS'Q#T,:G:L_&^ %U)]%'S#."<$=N,D+G@5PWPKU#[
M/=^22<3(P '3<OS D9[ , >3S[FH_B?I[V]XTS#Y9E4J><?*H4C.,9!&<#/!
M'K6AX9^*!T^-+:X0LJ# =" P4#Y1M. 2.F<CCU/7IGU'3?%NP2,"RXVJ[-&P
M,F/E'*ACD <%N?KST&D:+#I"&*!=JEMQ&6/) &?F)/0"LOQ_J@T^SD/&Z4>6
M 03G?P>G?;DC/&1^!X3X8:$NI2RR2 %$C*XR0<R@KVQQM# \]QCGD8VBW)\/
M7JER/W,I1SR1C)1R,8)P"2./P[5[M7DGQ;_X^T_ZX+_Z&]=M\.?^/"'_ +:?
M^C&KI:*^>[F"31)RAXE@?@XXRIR&&X<@\$9'(KT32?BW'+A;F,H?E&Y/F7_:
M)!P0!UP-QQ].=5-*TSQ.YN!MDD<9.)'5L+A<E-P(' '0=CWKIK:V6U18D&%1
M0H')P , <\]*EKY_\,_\?=O_ -=XO_0Q7T!17FWQC_Y=_P#MK_[)6E\)/^/1
M_P#KNW_H"5R7Q/T][>\:9A\LRJ5/./E4*1G&,@C.!G@CUK0\,_% Z?&EM<(6
M5!@.A 8*!\HVG )'3.1QZGKTSZCIOBW8)&!9<;5=FC8&3'RCE0QR ."W/UYZ
M#2-%ATA#% NU2VXC+'D@#/S$GH!5ZOG_ ,3?\?=Q_P!=Y?\ T,U] 5Q'Q;_X
M]$_Z[K_Z ]<W\-?$<&C>=]H?;O\ +V_*S9V[\_=!]17;?\+&L/\ GK_Y#D_^
M)J]I'BRVU=S% ^Y@NXC:XX! S\R@=2*XWXQ_\N__ &U_]DK2^$G_ !Z/_P!=
MV_\ 0$KM)8A*"C %6!!!&00>H(]*\'\26!T6[DB0[?+?*;2<@'#)R><@$?CW
M/6O=+&[%[&DZY"R(K#/7##(SUYYJ>BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBF2Q
M"4%& *L""",@@]01Z5PFM?":*<E[9S&<'Y6RRYP,<YW 9ZD[NO XQ7$Z[X)N
MM%!DD4&,$#>ARO/MPP&>,D 9X[C/0?"[Q(\4HT]R3&X8H.NU@-QYSPI .1SS
M@C&23ZI7FWQC_P"7?_MK_P"R5I?"3_CT?_KNW_H"5J_$*(R6,P4$G"'@9X#J
M2?H ,GT%<)\)I0EVP) +0L!D]3N4X'J< GZ UZ[3)91$"[$!5!)).  .I)]*
M\%\*Q&2[@"@D^=&>!G@,"3] !D^@K2^)$12^E)! 8(1D=1L49'J,@CZ@UZIX
M1N5N+.!D.0(D7N.4&UASZ$$5KUGVGB"WNW:!)%,BNRE"<-E?O84X) ]1D=>>
M*YCXM_\ 'HG_ %W7_P! >O,M&T:36)!;PC+'J3T [L3V _\ K#)(%:'C#PN?
M#THBR61D!5B,9(&&'3&<\XR< KDYKT_P+XH_MZ'YS^^BP'XP#G.UAVY YZ<@
M\ 8K3\3?\>EQ_P!<)?\ T UXCX<T;^V9TM-VW?N^;&[&U2W3(]/6NW_X4Y_T
M\?\ D+_[.N2\7>&O^$>E6WW[]R!L[=O4L,8R?2O4?AS_ ,>$/_;3_P!&-7DF
MA_Z+=P^9\NR>/=N^7;M<9SGICOGI7T!17A_Q"E$E],5((R@X.>0B@CZ@C!]#
M74^.HC%I=JC AE,(((P01$V01ZTWX.?\O'_;+_V>O2:*\2^(W_'_ #?]L_\
MT6M>M^&?^/2W_P"N$7_H J_+*(@78@*H)))P !U)/I7@7AG_ (^[?_KO%_Z&
M*[?XQ_\ +O\ ]M?_ &2L3PCX!_X2&)KCS=FURN-F[H%.<[AZUM_\*<_Z>/\
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MW\2?$2TU>WDM=LH+KP<(!N!#+GYCQD#/&<=*Y_X<:R=/NUC)PDWR,.2,G[G
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M_P!<&_\ 0TKTOQ!I8U6WDMN,NAQDD#<.5)QS@, ?Z&O'_ &J'3[R,\[93Y9
M .=_ Z]MV"<<X'X'3^*NJ&YNA;C.V!!P0/O/AB0>N,;1SW!X[GN_ &EC3[.,
M<;I1YA().=_(Z]]N <<9'XGF/C'_ ,N__;7_ -DK$\(^ ?\ A(8FN/-V;7*X
MV;N@4YSN'K6W_P *<_Z>/_(7_P!G72>#O!W_  C?F?O/,\W9_!MQMW?[39SN
MKB?BW_Q]I_UP7_T-ZZ;5/#9UW38%0#S8X8F3.!GY!E<D="/H,A<G KF?A=X@
M^Q3&S<_)/TR> XZ=2 -PXZ$D[16;\.?^/^'_ +:?^BVKVVBBBO-OC'_R[_\
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MO?1$ D*')P.@V,,GT&2!]2*]FN;E;5&E<X5%+$\G  R3QSTKP+7]8.L3O=L
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M9/H,D#ZD5D_!V4 W"9&XB,@9Y(&_)QZ#(S]17I=97BJ41VDY8@#R9!R<<E2
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MWB1]7A:*8EI(2HW'NK [<G/+#!R<=,=3DUV%?/\ XF_X^[C_ *[R_P#H9KZ
MKB/BW_QZ)_UW7_T!ZXGP=X._X23S/WGE^5L_@W9W;O\ :7&-M=)_PIS_ *>/
M_(7_ -G6WX1\ _\ "/2M<>;OW(5QLV]2ISG<?2L3XQ_\N_\ VU_]DK2^$G_'
MH_\ UW;_ - 2NWKP_P"(4HDOIBI!&4'!SR$4$?4$8/H:]>\,_P#'I;_]<(O_
M $ 5I4444444444444444444444444444444444444444444444444444444
M4444444444444444444444444444444445YQ\6H)HPDRNWDN-C(&(7<"64D9
MY)^G&T<]*J> O'L>F1_8[G(4,2C@9 !R2" ,]>AYZ]@*U/%GQ%MI;=X+=B[R
MHR_<8* < YW;3G!.,9Y'/%<W\+M.-S=B;D+"C$G&1EAL"Y[$Y)'K@_A[%7FW
MQC_Y=_\ MK_[)6E\)/\ CT?_ *[M_P"@)787UH+V-X&R%D1E..N&&#CKSS7A
M<]M/X6N1N&V2)@P/.UAZ@C!*L,@].,@X.17ING_$^SN$#2,8V[JRLW89P5!!
M&>!G!XZ"N?\ &_Q%CO8VL[7)#\,YRHV\'"C@\]#D 8R,'.1#\+O#;RRC4'!$
M:!@AZ;F(VGC'*@$Y/'. ,X(&[\2/"+ZJJW< S)$I#*,Y9<Y&.V5.>,9.>N0
M>2\%>/&T+]Q*"\!R0!@LIZ\9(&">HSUY'.0=W6OBTK(5M48.P/S2;1MZ<A06
MR>O7 !QP1Q7)>#/#AURX5""8D(,A[8_NYR.6Q@8.>I[&N]^+?_'HG_7=?_0'
MK-^#G_+Q_P!LO_9Z[+Q3X?778&MS]X?,AR0 X! )Z\<X/!X/'.#7D'A_5Y/#
M%UN88VL4E7ACM#?,!SC((X(.,CTSGU_7+E;JRFE0Y5[:1@>1D&,D'GGI7E/P
MY_X_X?\ MI_Z+:O;:\D^+?\ Q]I_UP7_ -#>NV^'/_'A#_VT_P#1C5Y[\0_#
M;Z9<-<8)BG<L&ZX9N64\#!SDCU'<D''3^%OB;#Y:PW9*NBXWX9@V, $XRVX]
M^,'&<\XJWK7Q1MK9#]G)ED(./E95!X^]NVG'L,YQC(SFO/O#7A^3Q'/MY*[@
MTKD\@$\G)S\QYQUR>3P"1W_Q;_X]$_Z[K_Z ]<EX!\71>'O-\X.?,V8V '[N
M[.<L/6NM_P"%MVG]R7_OE/\ XNKVB_$2WU>9;6-9 SYP6"@<*6[,3T'I7G?Q
M&_X_YO\ MG_Z+6NKT?XH6UE!% R2EHXT4X5,950#CYQQQ6?XI^)XOXVMK9"H
MD7#-)C.#D,H49'([Y]> <&F_"[PV\LHU!P1&@8(>FYB-IXQRH!.3QS@#."!;
M^,?_ "[_ /;7_P!DK/\  WCF#0(&@E5RS2%OD"D8*J.[#GBNB_X6W:?W)?\
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M/^'/_'_#_P!M/_1;5W'Q2@F^SB>)V5$)6158@%9,#)Y&0#QC!^]Z URGP_\
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M &A#82M\Z<Q[CR5QRHX_AQD<DX/ PM>@45YM\8_^7?\ [:_^R5I?"3_CT?\
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MBBBBBBBBBBBBH+VR2^1H)5#(XP0?\]?0]0>1S7$:C\(X9CN@D:,$G(8!QST
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M%NP ZGTJ>]LDOD:"50R.,$'_ #U]#U!Y'-<1J/PCAF.Z"1HP2<A@''/0#E2
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MS#*GH1U![,#V(_\ K'()%8FB_#NWTB9;J-I"R9P&*D<J5[*#T/K732Q"4%&
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M:1V8X9,98Y./D/'-=A7+:_\ #JVU9FF&8Y&R24Z%B.I4\=>3C:3DY.>:Y_\
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MM[+''+(JC9@+(P S&IZ XZUGQ2ZI* ZFZ*L 0092"#T(/I39]2U+3L2R-<(
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MK*YY./NJ23^ K7\%>/Y+.007+EXI& W.V2A/&=S'[OJ">.H[@^MT45X[XO\
M$]Q<WDD4$DJJK^6J(Q7E?E/"GDELX[D8'L-#X:^*I9+@VLSO()E.TNQ8AD!;
MN> 1G/!).VO4J*Y_QU#(]H\D#.KQ8?,;;"0OWLGC("DG'J!]*XCX;^(Y9;L0
MS22.)$8*&<L PPV<$^BD9Z\UZO7G?Q3\126;Q6T+NAVEV*';G)VKR#GC#9'3
MD=>VI\,Q--;M<SN[F1_EWN7&U.,C))!+9!]<#CUP?&OQ'9F-M9-A1D-(,9/&
M,*>P']X<D_=( RW-P>$[_6A]IV.^['S2, 3P,'YV!(QC!Z>G2FF6^\*,$R\7
M)(&<QDD#)QRC'!&>N..A%>I>#O&*>($P<+,@^=/_ &9?]G]0>#V)X'7/[2^T
M3>7]IV>;)MV^;MV[CC&.,8Z8XQ6-=ZQ?61V2R3HQ&<.\BG'K@D<<5/;7.I72
MB2-KEE/0J92#@XZCCK75^%I;R*VO7N3,&6'*&4N""$DR5+=^G3VKB[;7+VZ8
M1QRS,QZ!9)"3@9Z YZ5>_P")K_T]?^1J/^)K_P!/7_D:O;:*XCQ9KUS=W TF
MPX?;F1^ZAAZD?* "#N&3D@+@\'5UO6&\,68>1A)*H5%)##<W8GECG )//)!Y
M&147@NTO &N;V0DS 8C88*XZ' (521U4+GH20<BN&\>ZY<6M[+''+(JC9@+(
MP S&IZ XZUGQ2ZI* ZFZ*L 0092"#T(/I3_^)K_T]?\ D:O2_#%ZUC8I/>LR
ML@<N9=V[[[8SNYSC&!U/ ':O/?$'CZYUB39;EXXRP"+'PY/09*\DG/W0<=.I
M&33B^'M]( PA." >70'GU!8$'V/(I^D^+KSP]((W+E5VAHI<_= X W<IP>,<
M=,@CBO7]&UF/6(Q<0G*GJ#U![J1V(_\ KC((->6^/=<N+6]ECCED51LP%D8
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M$QVHN_)P3U1@. ">IKU'_A8UA_SU_P#(<G_Q-2VWCVRNG6))<L[!0-D@R2<
M<KCK7045XQXZOI++4)GB=D8A!E&*G'EIQD8XXKH/'4IETNU=B2S&$DDY))B;
M))]:G^%.IRWWG^=([[?*QO8MC._.,DXSBN2^(W_'_-_VS_\ 1:UZ7X>\0VT5
MM C31!EAC!!D0$$(,@C/6M#_ (2:T_Y[Q?\ ?U/\:Y;XMZAY4$=N"097R<="
MJ#D'GU92!TXSV%9_PET,.7OVP2IV)[' +'IP<$ $'H6!KTNN&^*NABY@%Z,!
MX2 ?=6(&.F20Q&.0 "W<UE?"#4,/-:DGYE5P/X1M.UN_4[E[<@<]!6!\1O\
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M-Q&4)[,/NG.#@=CCG!(KR+P'J'V&]B8DX=MA"]]XVC/(R Q!/TSU%=3\8_\
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MO>&?^/2W_P"N$7_H K2KP+Q5$8[N<,"#YTAY&."Q(/T(.1ZBO>HI1* ZD%6
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M2UXE\1O^/^;_ +9_^BUKUOPS_P >EO\ ]<(O_0!7%?&*(D6[X.T&0$XX!.S
MSZG!Q]#Z5>^$<H-M(F1N$Q)&>0"BX./0X./H?2NYKF/B1*$L902 6* 9/4[U
M.!ZG )^@-<;\(XB;F1\':(2"<< EUP,^IP<?0^E9?Q&_X_YO^V?_ *+6IHOA
MK=3PK<Q[&#HK!0Q#88 _Q +D \\_3-<[;6R^8(IR8QNPQV%BO;E<@\'KW'H3
MQ7N'A70[?2X0;;)64!M[?>8$97/ X / P,>F2<Z5[9)?(T$JAD<8(/\ GKZ'
MJ#R.:X+6?A(LA+VLFW/1),D<G^^.0 .F0QXY//'$:YX5N-$YG3"EB P(*G'T
MY&1R,@$C/'!QW/PK\2/=!K"0EO+3<A/900"I.>@R-O' R,X %>A5S7Q&_P"/
M";_MG_Z,6O)_#OAV37Y#!$5#*A;YR0, @=@>>:D\0>$KC02#,HV$X#J<J3C.
M.Q!^H&<'&0*WOAUX?M-4?=*Q:5/F\HKA, XR3R&&2./EY!!!%>MU\[:99_;I
M8[?./,=5SC.-Q SCC.,UZ!_PIS_IX_\ (7_V='_"G/\ IX_\A?\ V==/\0HC
M)8S!02<(>!G@.I)^@ R?05P/PIN5BO"K'!DB95Z\D%6Q^2DU[!5/4M6BTP*\
MS!%=PH)SC)SC)[#CJ< =S5;6)1?VDQA(D#PRA=AW9.TC QG)SQQWKR3X>RB.
M^A+$ 9<<G')1@!]23@>IKW"BOG_7/]*NYO+^;?/)MV_-NW.<8QUSVQUKTGXM
M_P#'HG_7=?\ T!ZQ/#5G]LTBZ3.,.[=,_P"K6-\?CMQ[=:K>!/$?]FVUVA?:
M53?'\N?F/R9Z'^(H,'COTS5GX06>^6:XS]Q%7&.N\YSGVV?K[5B?#G_C_A_[
M:?\ HMJ[;XM_\>B?]=U_] >L3PU9_;-(NDSC#NW3/^K6-\?CMQ[=:K>!/$?]
MFVUVA?:53?'\N?F/R9Z'^(H,'COTS5GX06>^6:XS]Q%7&.N\YSGVV?K[5B?#
MG_C_ (?^VG_HMJZ3XQ_\N_\ VU_]DK$\(^ ?^$AB:X\W9M<KC9NZ!3G.X>M;
M?_"G/^GC_P A?_9UTG@[P=_PC?F?O/,\W9_!MQMW?[39SNKB?BW_ ,?:?]<%
M_P#0WKIM4\-G7=-@5 /-CAB9,X&?D&5R1T(^@R%R<"N9^%WB#[%,;-S\D_3)
MX#CIU( W#CH23M%9OPY_X_X?^VG_ *+:NV^+?_'HG_7=?_0'K-^#G_+Q_P!L
MO_9Z])KR+XLRA[M0""5A4'!Z'<QP?0X(/T(KN/AS_P >$/\ VT_]&-3_ !)X
M&M]=)D8%)2/OKWP"!D="/R. !N KA-4^%5U;',)65<C&#L;IR2&.,9XX8GIQ
MUQS6EZI-H4WFQY61"0RL#SSRK#CCCD=0>1@@&O>[&[%[&DZY"R(K#/7##(SU
MYYJ>O._BWK)C6.Q4_?\ G<<@X!PGL03DXYY4'COA^ _%UOX>23S1(7D8?<"E
M=JCCJP.<DY[8Q[U4\=^(H-?D2>$.&5"K;PH& <KC!//)SGVQWKN?A=K)OK8P
M,<M V.^=AY7)/'7(&.@ &/7LJ*\F^+.EBWN$N1C$R<\G.Y, GT VE0,>AX]=
M[0O%!BTEKC)WVZF,'"_>X$9 Z$ ,N<\\'@]^/^'.EB_O$)P5B!D()(^[@+C'
M<,0?3 /T/I/Q"B,EC,%!)PAX&> ZDGZ #)]!7"?":4)=L"0"T+ 9/4[E.!ZG
M )^@->NTR641 NQ 50223@ #J2?2O!?"L1DNX H)/G1G@9X# D_0 9/H*]]K
MR3XM_P#'VG_7!?\ T-Z[;X<_\>$/_;3_ -&-6GXF_P"/2X_ZX2_^@&O$?#FC
M?VS.EINV[]WS8W8VJ6Z9'IZUV_\ PIS_ *>/_(7_ -G5G3/A3]AECN//SY;J
MV/*QG:0<9WG&<5Z!11117B7Q&_X_YO\ MG_Z+6K=C\+[F]C2=7B"R(K#+/G#
M#(S\AYYJ?_A4EW_?B_[Z?_XBM3XQ1$BW?!V@R G' )V8&?4X./H?2KWPCE!M
MI$R-PF)(SR 47!QZ'!Q]#Z5W-<Q\2)0EC*"0"Q0#)ZG>IP/4X!/T!KC?A'$3
M<R/@[1"03C@$NN!GU.#CZ'TK+^(W_'_-_P!L_P#T6M31?#6ZGA6YCV,'16"A
MB&PP!_B 7(!YY^F:YVVME\P13DQC=ACL+%>W*Y!X/7N/0GBO</"NAV^EP@VV
M2LH#;V^\P(RN>!P >!@8],DYV:****^<K:V:Z=8D&6=@H' R2< <\=:Z#_A7
M-_\ \\O_ ")'_P#%5J:'\*I[D[KHB) >@(9STZ8)4 C/.201]TBNR^(,0BT^
M5% "J(P !@ "1, #TKRGP[X=DU^0P1%0RH6^<D# ('8'GFI/$'A*XT$@S*-A
M. ZG*DXSCL0?J!G!QD"M[X=>'[35'W2L6E3YO**X3 .,D\AADCCY>00017<_
M$*(R6,P4$G"'@9X#J2?H ,GT%<)\)I0EVP) +0L!D]3N4X'J< GZ UZ[3)91
M$"[$!5!)).  .I)]*\%\*Q&2[@"@D^=&>!G@,"3] !D^@KM/C'_R[_\ ;7_V
M2N-TCPG<ZNAE@3<H;:3N0<@ X^9@>A%:$7PWOG(4Q@ D<ETP/<X8G ]@3[5Z
M)X+\%CPZ&=F#RR  D# 4#JH/7&>IXS@<#%>=_$B(I?2D@@,$(R.HV*,CU&01
M]0:]6\*RB2T@*D$>3&.#GD* 1]01@^AK5KS3XQ2@FW3(W 2$C/(!V8./0X./
MH?2M;X31%+1B00&F8C(ZC:HR/49!'U!K<\0>$K?7@#,IW@8#J<,!G..X(^H.
M,G&":\_U3X37%N-T#K* !P?D;.>P)*X YR6'?CUY3]]H<W>.:)OQ!_D01]00
M>X->Y>&]7_M>WCNL8+KR.@W E6QR>,@XYSCK7BWBO63J]S)/G*[B$ZXV+PN
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M+BW',L4ZJ^3R<(^UN23R.I/5@V*Z3X2?\>C_ /7=O_0$KB?B-_Q_S?\ ;/\
M]%K7K?AG_CTM_P#KA%_Z *ORRB(%V("J"22<  =23Z5X%X9_X^[?_KO%_P"A
MBOH"BBO+?%OP^30X?MMM(^8F4G>1GE@%*E0,$$_UR,8.I\-/%LNIE[2=B[(@
M96(&<#"D$]SR"#@D\Y/2N^HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKS;XQ_P#+O_VU_P#9*S_
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MY 47SHW$F/FV!2N?;+ X/H>G3)ZGB?%OBU_$3JS*$1 =J@YQG&XEL#)./8
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M7IO_  LNQV;]YSMSMV-NSC.WIMSVZXSWQS7E>OZD==NGG53F5P%4#YB!A5&
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M)/O6KHW@6TTHAT3<Z]'D.X]<@X^Z".Q !_6N@HKEM:^'=OJ\S74C2!GQD*5
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MV<] !SD5Z!J6H)IT;W$APL:DGIGCL,D#)/ '<\5YI;V-UX_9IW<1VZO@+DL
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MGX?^(SRS"RO8O+D9@ 0&7!;&U2C9(SGKGN.,9-=3XBUQ-$A:Y?G& %R 68]
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M<#KC@CDCE3@C.#C(Y[5>HHHHHJCJNMPZ2N^=P@/3/)/('"C).,C.!QWKEO\
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M57 ]SAB<#V!/M74Z7JT6JIYT#!DR1D9'([$'!!^HZ8/0U#_PD<'G_8-_[_\
MN[6_N[^N,=.>OZUAZA\3[.S<QC?)CJ8U!7.2,99ES]1D$=#6EH/C*VUOY8FP
M_P#<?Y7[]!D@\#/RDX'7%;E<[KGCVUT@^6S%W!P5BPQ'4')R "",$9S[8J+1
M?B):ZJXA!9'8@*) !N)SP""PS]2,D@#)KG?@Y_R\?]LO_9Z])HHHHK-\3?\
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M&20!DUT]8WB#Q;;Z" )F.\C(11EB,XSV 'U(S@XR15'1?B):ZJXA!9'8@*)
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M1QWKT'3_  79V*",1(WJ9%#L3@#.6!QG'08&>@%<!\0=#3P]/%=VWR^8Q8*
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M\#K90DWD2-*[GA@LF% P!W .<GCJ",GC N>*O!<5[;NEO%&LPP4*J$.0>1D
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MUQ'PU\.3Z-YWVA-N_P O;\RMG;OS]TGU%=O11115/5WD2&0P F78=@&W[Q&
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M=?T[$$<5C> O#=SH3RI(1Y#,=O/S$J<!PH) ##KD[L@=A61\'/\ EX_[9?\
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M +)72:!X$MM.C59(T>0J-[.-XW=\;A@#)XP 2,9R:XOXAZ*F@3PW5J A8EL
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MPB_[])_A5^*(1 (H 50  !@ #H /2GUYM\'/^7C_ +9?^SU+K_B>[U6[;3;
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MQT'3.?PK(O\ PXGA_4+6W1BV6@8EL?>,A!P!T'' Y/N:ZGXM_P#'HG_7=?\
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M_P! 2NWKS;X.?\O'_;+_ -GH^,?_ "[_ /;7_P!DKTFO-OC'_P N_P#VU_\
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MYYIMGID5CGR8T3=C.Q0N<=,X SC-.N[&.]&R5%=0<X=0PSZX.>>:DBB$0"*
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M(R3A@XXP&'7&<DG-.6VO/',B^>IAM4^88! (.<8+?>8CC=]T#G SAO2XHA$
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M_P '/^7C_ME_[/1_S'O\_P#/O71>/?"QUZ$>7CS8B2N3C((^9>N 3@8)[C'
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M Z9XRO/"RBUNHBR+N";\J?E(X#X(91VP#U&#C INH:E>>.R(8H@L*OG/\(.
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M:/[*UG_GXB_[Y'_QFC^RM9_Y^(O^^1_\9H_LK6?^?B+_ +Y'_P 9H_LK6?\
MGXB_[Y'_ ,9H_LK6?^?B+_OD?_&:/[*UG_GXB_[Y'_QFC^RM9_Y^(O\ OD?_
M !FC^RM9_P"?B+_OD?\ QFC^RM9_Y^(O^^1_\9J"^M=8LHWG:XB*QHS'"KG"
MC)Q^Z'/%:OP[UJ;5[=I9VW,)2H.%' 53CY0!U)KJ:********\T\.WNJZ_&9
MXIT"JY7YU4'( /:,\<UJ?V5K/_/Q%_WR/_C-']E:S_S\1?\ ?(_^,T?V5K/_
M #\1?]\C_P",T?V5K/\ S\1?]\C_ .,T?V5K/_/Q%_WR/_C-']E:S_S\1?\
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M /D7_P"PH_X7'_T[_P#D7_["C_A<?_3O_P"1?_L*/^%Q_P#3O_Y%_P#L*/\
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M/16;_P )-:?\]XO^_J?XUI45GR^(;:(E&FB#*2"#(@((Z@C/6KL4HE =2"K
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MUXF_X]+C_KA+_P"@&N:^$G_'H_\ UW;_ - 2NWHHHHKB/%'Q%2WS:V7[R=L
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MF-OWN>OOUJWXW\4W!G&E66?,8#<5'S98?=!(PH"_,6!X]5P<U/\ A5$O^O\
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M"$Q&APW(."&SZCH.U;XM_P#'VG_7!?\ T-ZZ;XLRE+10"0&F4'!ZC:QP?49
M/U K TCQ5J-G#'%#:@QJ@VD0R\C'WL@X);J2.I.:M_\ ":ZK_P ^O_D";_XJ
MCX<6=Q#=RR2Q/$DB,<;&2/=O4@ 'C@$X'4#/O39(A)KN& (R#R,\B#(/U!&1
MZ&O2Z\V\(?O]6N6?YBOG8+<D8D51@GIA>![<=*])KS'XPVRJ\$H'S,KJ3ST4
MJ0/3@L?SK9^+,I2T4 D!IE!P>HVL<'U&0#]0*P-(\5:C9PQQ0VH,:H-I$,O(
MQ][(."6ZDCJ3FK?_  FNJ_\ /K_Y F_^*H^'%G<0W<LDL3Q)(C'&QDCW;U(
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M JI(W3., *<'MP,< UZWXF_X]+C_ *X2_P#H!KEOA%;*MO)*!\S2[2>>BJI
M]."Q_.N[KS:#]QKI5/E#9R%X!S#N.0.N6Y/OSUILD0DUW# $9!Y&>1!D'Z@C
M(]#7I=>;?&/_ )=_^VO_ +)7;^)O^/2X_P"N$O\ Z :YKX2?\>C_ /7=O_0$
MKMZ*****\V^#G_+Q_P!LO_9Z])K-L_#=M92&XBB17..0.F!C@=%R#SMQGOFM
M*O--=B&DZQ#+$!F8H6!'&9"T3$8QR1SW^8DG/2O2Z******R/$OB6/0(_-DY
M8Y"(#RQ_H!W/;W) /'^'/#,WB.4:M?X*$Y2,@X*X.WC/RH#@@'.[DG@Y;T>O
M-O@Y_P O'_;+_P!GKTFO-OC'_P N_P#VU_\ 9*])KG?&/C%/#Z8&&F<?(G_L
MS?[/ZD\#N1C>#_!LCR?VK?'=*V6"..0>-K'G ('1<?+QT(P.[K-L_#=M92&X
MBB17..0.F!C@=%R#SMQGOFM*O--=B&DZQ#+$!F8H6!'&9"T3$8QR1SW^8DG/
M2O2Z*****XCXM_\ 'HG_ %W7_P! >N@\(VRV]G J# ,2-W/+C<QY]22:U)8A
M*"C %6!!!&00>H(]*\[^#LI(N$R=H,9 SP"=^3CU.!GZ#TJ#QKG0=1BU(9VO
MM+$;2?E^1U /^QCKW/!].E^(^LC3[1HP</-\BC@G!^_P>VW(R.A(Z=:D^'ND
M?V;9IDY,W[P^GS@8 X'\(&>O.><5TM%%%9OB;_CTN/\ KA+_ .@&N:^$G_'H
M_P#UW;_T!*[>BBBBBBBBBBN(U7_D,VW_ %P;^4U=O111111117FWC7_D*VG_
M &P_]'-7I-%%%%%%%%%%9OB;_CTN/^N$O_H!KFOA)_QZ/_UW;_T!*[>BBBBB
MBBBN(^$G_'H__7=O_0$KMZ**********\V\:_P#(5M/^V'_HYJ])HHHHHHHH
MHHHHHHHHHHJ*YN4M5,DC!5'4L0 ,G'4\=:J2QV^O1E3LFCR1P0P!QV(Z, >H
MP1FN6U3X36]P=T#M$21P?G7&.P)#9)YR6/?CTY;1=2N/!=T+6<D1%P7'52#E
M1(IP3@=>,$XVGD8'>_$;_CPF_P"V?_HQ:C^&ELL5C&RC!D9V;KR0Q7/Y*!6I
MXJB$EI.& (\F0\C/(4D'Z@C(]#7/_":4O:,"20LS 9/0;5.!Z#))^I-</X3U
MN[LGDFMHO.=\;V*/(PR2>JD$;CR<]2!Z5TG_  FNJ_\ /K_Y F_^*J#PR+R[
MU);V>)XQ(&#X1T3 C( .[ME1U/7'M4\_[_70K_,%Q@-R!B'<, ],-R/?GK7I
M-1?9DW^=M&_;MW8&[;G.,]<9YQTS7G?_ #'O\_\ /O7<Z]JD.F0M+<8\O&"I
M .[(^Z >I/ITQDG !-<-_P +2>7_ $>SMN>D8R6^5?\ IF@'\(Z!L#U(%8GB
M[5+_ %*)9+J/RX0X &S9\^&(.&)?H3S]WCUKO_\ F%?]N/\ [1K-^$G_ !Z/
M_P!=V_\ 0$KMZ*\D^$G_ !]O_P!<&_\ 0TK0MI!H6LLIR$N"1E@3GS<-QC''
MF#;GD 9!Y&:/'L@UF_@TX9*H5#;0=P\P@MUR,! #G&!SGV=\8_\ EW_[:_\
MLE:FN2F/1E*D@_9X!P<<'8"/H0<'U%<OX9\1WVG0+%;6X>/+'>(9&W$DY)92
M 2.GT ':M3_A-=5_Y]?_ "!-_P#%5;^%5C/9"=)D=%)C*AU91GYMQ ..>!G'
MMGM7(>$];N[)Y)K:+SG?&]BCR,,DGJI!&X\G/4@>E=)_PFNJ_P#/K_Y F_\
MBJ@\,B\N]26]GB>,2!@^$=$P(R #N[94=3UQ[5/\8_\ EW_[:_\ LE>DUYM\
M'/\ EX_[9?\ L]'C7_D*VG_;#_T<U>DUYMXU_P"0K:?]L/\ T<U.^,4I MTR
M=I,A(SP2-F#CU&3CZFO1(HA$ B@!5   &  .@ ]*XGXN1 VT;X&X3  XY *-
MD9]#@9^@]*Z?PS_QZ6__ %PB_P#0!6E17$?%O_CT3_KNO_H#UTOAG_CTM_\
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M*  .@ W=*IZUK^I:O"UK);$*^,E890>&#=R1U'I7<^!HI(K.))@P=0P(<$,
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ME]'>C?$ZNH.,HP89],C//->:/=?\(EJKR2_ZJ?<2V,D+(V[( /\ "XP>Y )
MY%=W_P )=9[/-\^/&W/WQNQC/W?O9]L9SQC-<-',?%VII/"#Y-N4^?;CA"6&
M<GJS9 [XYV\&NB\>>-?["401<SR+D$CA5)(W<\$Y!P.G<\8!QO"6BV=D5O;N
MXB>X)+8,R,JD\Y)S\SCUSC)XR0&KM?\ A)K3_GO%_P!_4_QJ:5AJ4+"&08D1
M@LB'=@D$;@0>H/H>HKA/!OBYM+>2PU%V5PXVM*6;!. 5+$G"]"I^[C)S@BNP
MN?%UG;J7:>,@?W7#GDX^ZN2?P%<7HH?Q=J U$H1;P$!=QQ]T$H/EZMN.\C)
M'!)&,^A7FIQ6./.D1-V<;V"YQUQDC.,U9HHHHKB/BW_QZ)_UW7_T!ZC\$>-X
MTB2RNF\N2-0%+_*K)C*'. !A<#GJ,$$D\6_%WCRWM(7BAD#RNA"^4V=NX$;M
MXX!7K@'.<= <AWPW\.OI$#/*NV29@<$G(4#Y01T!R2<=><'D8!\3=)^VVAE
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MVO\ [)73PZ6-5TU+;C+VT>,D@;@@*DXYP& /]#7+?#_QDFFJ=.NR4*.=I88
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MPV>.!C)[5SND>,YM;OS#;D?9E7G<G.U<9?J#DD[1V ()3(-6?'OB2YT)XGC
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MA2>I.1@@DDY)QGWQ5&T^%EG =S;Y!CH[X'U^0*<_CCVKK8HA$ B@!5   &
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MDXQU)QBM+P]$8K:!&!#+#&"",$$(,@CUK0HHHKG?$7@:#7Y!/*SAE0+\A4#
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M#!AP!VQ[YK9TG31ID2VRLS*@P"YRV,\#.!P.@]  *P-1^&5G>'< T9R2?+;
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MS[FSIMST]^M;E%%8WB#PE;Z\ 9E.\# =3A@,YQW!'U!QDXP35'1?AW:Z4XF
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M_P#HQ:/AS_QX0_\ ;3_T8U=+11111116;XF_X]+C_KA+_P"@&N:^$G_'H_\
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M17$:K_R&;;_K@W\IJ[>BBBBBBBBBBN:^(W_'A-_VS_\ 1BT?#G_CPA_[:?\
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MV,YV@#+,0,X _J< $C)&:XJ7XQ $A8"5R<$R8)';(V'!]LGZUL^'?B1!J[K
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MAB><@\#IQD'-:'A;Q[#KQ\G!CEP3M8@@XS]UN,D#DC /ID FMG6M732(6NI
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M@,GN3@<D\GO7FGQ0\,QZ>8[N! BN2KA<!00,KA>Q(!SCCCU//7_\PK_MQ_\
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M:LB%\''R\@9]1N*\<\X/:JW@GQ;8V\"6H81.!\V\;0S;06??R,$],D'@  #
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M< .%CW  !3U///<DD;UM\(K=5 DDD9NY7:HZ^A5B./<UC:59166M"&# C0L
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MZ/\ ]=V_] 2LWQK_ ,A6T_[8?^CFKTFBBBBLWQ-_QZ7'_7"7_P! -<U\)/\
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M<@1(O<<H-K#GT((H\77*V]G.SG ,3KW/+C:HX]20*Q/A3;-%9EF&!)*S+TY
M"KG\U(K(^#G_ "\?]LO_ &>O2:****@OKL64;SMDK&C,<=<*,G'3GBO*]*T.
MY\=L]U/+MC5B%XW ,0,JJ;A@ 8R<Y/'WCDCI+;X6V=F!+,SL$7+;F")P.3P
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M346&FW!5W<Y"9.X%1NSE>5..F2,C(&1FN8U;X21RY:VD*'YCM?YE_P!D C!
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MD"O5Z***\=GM;S3;^2]A@=B)IBN8G*D,6&>,9&#Q@UL_\)KJO_/K_P"0)O\
MXJJEU9:KXK.V13%$3@JV8D& #RIR[#(&"0P!Z8YQW_AOP^F@PBWC)/.68]V(
M )QV'  'H.YR3!XN\-+K\)BX$B\HQ!X/<<<X8<'KV."0*XNUO]6\.#[)Y1E1
M1A3L:10 2!AD(.#Z-R!C@"FW6GZEXQ9%G3R85;!R"@!QRVQCN8X.!V[9'S&O
M1M)TM-*B6VBSL0<9.3R<DGW))/IZ "N+^%.F2V/G^=&Z;O*QO4KG&_.,@9QF
MJWB?PU=Z3<MJ5ADB3)8(-S MC<"ISN#'YN <'L-H-'_"7ZM/^[6VVEN ?)D&
M"> <LVT8]3QZ\5B>(?!5ZH%W*#++*QWB,%RO (SC\1P-JX !Y KU^VG\]%DP
M5W*#AAAAD9P1V([CUKS+XC>'9VN3/ DCK.B[]@+#*X&TA1G&%4\]3R.G'I=C
M:"RC2!<E8T51GKA1@9Z<\5Y7X:\(3QWJQ2+)Y%O*[!RI53L/##=D?,57.,DC
MO@9'K=>;>)_#5WI-RVI6&2),E@@W,"V-P*G.X,?FX!P>PV@T?\)?JT_[M;;:
M6X!\F08)X!RS;1CU/'KQ6)XA\%7J@7<H,LLK'>(P7*\ C./Q' VK@ 'D"NO^
M(T$FJ6<1BC<LTB-LV$N 4;JHS@C.#Z&NE\/1&*V@1@0RPQ@@C!!"#((]:LWM
MDE\C02J&1Q@@_P">OH>H/(YKS2+2=2\',?LX\Z%FZ*I<$X(!*#YE. "2..@+
M'I3KW5=6U]&M! 8PP^8A&BR.A7=(V,'/(')'MFNP\&^$U\/1E<[I9,%V&<<9
MP /09//4]3C@#H****IZQ:&]@E@7 :2-U&>F64@9Z\<UYW:?#O4;(;(IU12<
MX2651GUP%'/%3_\ "%:K_P _7_D>;_XFC_A"M5_Y^O\ R/-_\31_PA6J_P#/
MU_Y'F_\ B:/^$*U7_GZ_\CS?_$T?\(5JO_/U_P"1YO\ XFC_ (0K5?\ GZ_\
MCS?_ !-'_"%:K_S]?^1YO_B:/^$*U7_GZ_\ (\W_ ,31_P (5JO_ #]?^1YO
M_B:/^$*U7_GZ_P#(\W_Q-'_"%:K_ ,_7_D>;_P")JWX?\$WEI=QWMS*L@C##
MEW=L%6  W+TRWKZUWU%%%%%%%%<1XT\%W&LW"74#HNQ% +,RL&5F;(VJ?48.
M<YK-_P"$*U7_ )^O_(\W_P 31_PA6J_\_7_D>;_XFC_A"M5_Y^O_ "/-_P#$
MT?\ "%:K_P _7_D>;_XFC_A"M5_Y^O\ R/-_\31_PA6J_P#/U_Y'F_\ B:/^
M$*U7_GZ_\CS?_$T?\(5JO_/U_P"1YO\ XFC_ (0K5?\ GZ_\CS?_ !-'_"%:
MK_S]?^1YO_B:/^$*U7_GZ_\ (\W_ ,339? NJ2@HUR"K @@S2D$'J"-O2NI\
M#>'9- @:"4J6:0M\A)&"JCN!SQ71444444445Y?:?#O4;(;(IU12<X2651GU
MP%'/%3_\(5JO_/U_Y'F_^)H_X0K5?^?K_P CS?\ Q-'_  A6J_\ /U_Y'F_^
M)H_X0K5?^?K_ ,CS?_$T?\(5JO\ S]?^1YO_ (FC_A"M5_Y^O_(\W_Q-'_"%
M:K_S]?\ D>;_ .)H_P"$*U7_ )^O_(\W_P 31_PA6J_\_7_D>;_XFC_A"M5_
MY^O_ "/-_P#$T?\ "%:K_P _7_D>;_XFBS^'M[]HBNIY4D\IT)+22,VU6W8&
MY?K@9QFO2:****************S_ !#$9;:=%!+-#(  ,DDH< #UKG_A?8R6
M5LZ2HR,9F.'4J<;$YP<<<5G^+],EGU*VF2-V1?)RRJ2HQ*Q.2!@8')]J] HH
MHHK/\0Q&6VG102S0R  #))*'  ]:Y_X7V,EE;.DJ,C&9CAU*G&Q.<'''%=!X
MAB,MM.B@EFAD  &224. !ZUS_P +[&2RMG25&1C,QPZE3C8G.#CCBL_Q9X*G
M2X&I:?\ ZPMEE!52&QRPS@$-_$#R23U!.*(\4ZO.HA6 JQVC?Y+ YR.26^09
M[D@ >W;>\">#Y-(+W=R09I0.Y8@'YFR>A8G&>O3ACDUI>,?"X\00^6"%D0Y1
MB.^.5)QG:>^.X!YQ@\;:W^K>'!]D\HRHHPIV-(H ) PR$'!]&Y QP!3K3PU>
M^*94N;_Y(5;[C J=N22JH,$9Q@EB&Q@Y; KH_'O@XZ\@EBP)H@<9P-PZ[2?7
M^[S@$G/7(YR#Q#J^EC[.\)D*X^9HV<XP,#?&<-]>3G.35KP[X3N]2N$U+4#]
MS!"MPW !3Y5P% )SCKD$%>2:Z;QCX7'B"'RP0LB'*,1WQRI.,[3WQW /.,'B
M]/UG5="06?D%PG0M&\F!@84,AP0.W7'3M@6;3P[>>*YDNM079 G_ "SR4..<
M@+R1D@;BQ!(/RG &.K\8^%QX@A\L$+(ARC$=\<J3C.T]\=P#SC!XO3]9U70D
M%GY!<)T+1O)@8&%#(<$#MUQT[8%FT\.WGBN9+K4%V0)_RSR4..<@+R1D@;BQ
M!(/RG &-?Q_X2DU4I=VO^OBP,!MI(SE2"2 "IR>V<]<@ XT7BS5Y (1;G<0%
MWF%P<GC<22$![\C:/3%8>N^#+X@7DRM)+*[;P@WLN,;<[<\'G  PH &1G ]"
M\:(^HZ>_EHY:18R$VG?RZG!49.0.H[5+X"MGM;**.12K#?D,"",R,>AYZ5T%
M><?%C33$8M11B&4A.#@@C+H1@=?O9.?3'>N@^'.EFPLT)R&E)D()!^]@+C'8
MJ ?7)/T'3T44456U+3TU&-[>09612#TSSW&01D'D'L>:\VM=/U+P<SK GG0L
MV!@%P3CAMBG<IP,'MVR?E-%UI^I>,619T\F%6P<@H <<ML8[F.#@=NV1\QKT
MG3=/33HTMXQA8U '3/'<X &2>2>YYKB/A3IDMCY_G1NF[RL;U*YQOSC(&<9K
MT"BBBBHKFV6Z1HG&5=2I'(R",$<<]*\PMK/4?!KM' AFB<G&%9U.,?-M4Y5L
M<'/!_P!K (FGM]4\6XBF7R8"P#?+L'R\Y*L=[=>!]TD#H02+GPOT^;2Y)X)X
MG0L%PQ4[/D+ C=T).[C&00"<UB>*-'.L:K):J0K.!@GIE80PS['&,]NN#TK2
MBUW6+0"S,)9P HD*%CST)<-L)&>IXX^;)S6MX(\$/I;F]NB&F<' SNV[N6)8
M_P ?4<'&,\G/&7\8_P#EW_[:_P#LE10#4_".;:*/SX2Q*'8S@=S@(<KG/(/&
M<[<\DSZ5X.NM=N!J&H85<@B,\D@8*KM.0J<\@_-U!&3NKI_'ML]U92QQJ68[
M,!023B13T'/2CP%;/:V44<BE6&_(8$$9D8]#STK7U+3TU&-[>09612#TSSW&
M01D'D'L>:\VM=/U+P<SK GG0LV!@%P3CAMBG<IP,'MVR?E-%UI^I>,619T\F
M%6P<@H <<ML8[F.#@=NV1\QKTG3=/33HTMXQA8U '3/'<X &2>2>YYKQ;PIH
M=Q?;[FS;$UNR$#(!._<#@GCC'(/!!/T/27.I:KXB4V?D^4K_ 'FV/&-N<$%G
M)XYY"_,1ZC(/8>#O"X\/0^62&D<Y=@.^.%!QG:.V>Y)XS@<[_9DO]M?:/+?R
MO[^T[/\ 48^]C'7CZ\5Z!7G_ /9DO]M?:/+?RO[^T[/]1C[V,=>/KQ6SX]\+
M'7H1Y>/-B)*Y.,@CYEZX!.!@GN,< DUS%MXHU:Q40-;ES'QN:*1B<'^\IPWU
M'7KD]:S=<\(ZA>HU]<@O*&5=B[6;;@_, G  .. ,DDL0,9/I?A9B;6$,K(RQ
MJI5QM8%!M/'H<9'MBO.;"UU#PA+(D$1D5^_EEU8*2%;Y#E3C/!/0\CH:[GQ/
MX>'BBW7&4DP'3>N&!(Y1NI /\6.A /.,'C['4M6\/J+8PF10HVY0R!1D\!HS
M^A)P ,8%26GAJ]\4RI<W_P D*M]Q@5.W))54&",XP2Q#8P<M@5Z+J<[P1221
MC<ZHQ48)RP!(&!R<GL.:R/!>NRZS$\DZA725D(4%<;0IY#$G.2<UT%%%%%<5
M\3?#DNK1QRP@LT)?*C&<, 21SR1MQ@ DYXZ5:\%Z_=WY:&\B9"J JYC9 <<-
MDGC<<@@  =?:L'5O"-UH5R;_ $X;D.YB@P,#J4V\;E/\(7D=.H!,%[JNK:^C
M6@@,88?,0C19'0KND;&#GD#DCVS79>#O"X\/0^62&D<Y=@.^.%!QG:.V>Y)X
MS@;U%%%%<1X[\%2:BZWUIQ.NT$ A2<'A@W'S#W/0#!!&#EQ>,]60!3;$D <F
M"7)]S@@9/L /:M3P=X0FBF;4KXYG/W1NR03E6)QQTP% ) !Z @8/'?@J3476
M^M.)UV@@$*3@\,&X^8>YZ 8((P<W_A*-7_X]_L_S_=W^4W7INW9\OKSG[O?I
M6EX$\%2:<[7UWS.VX $AB,GEBW/S'V/0G)).!/\ %"QDO;9$B1G83*<(I8XV
M/S@9XYK0^S/_ &;Y.T[_ +'MVX.[=Y6,8ZYSQCKFL_X7V,EE;.DJ,C&9CAU*
MG&Q.<'''%4?%/@B<7']I6! DR"5R%.[@$C^$AADL&Z\]=V!GCQ3J\ZB%8"K'
M:-_DL#G(Y);Y!GN2 ![=M[P)X/DT@O=W)!FE [EB ?F;)Z%B<9Z].&.36?X0
MTR6#4KF9XW5&\[#,I"G,JD8)&#D<CVJW\3?#DNK1QRP@LT)?*C&<, 21SR1M
MQ@ DYXZ5:\%Z_=WY:&\B9"J JYC9 <<-DGC<<@@  =?:NKHHHKG_ ![;/=64
ML<:EF.S 4$DXD4]!STKEO#GB2[T:!+3[%*VS=\V'7.YBW3RSZ^M:7_">W?\
MSX2_^/\ _P :H_X3V[_Y\)?_ !__ .-4?\)[=_\ /A+_ ./_ /QJC_A/;O\
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M_P"-4?\ ">W?_/A+_P"/_P#QJC_A/;O_ )\)?_'_ /XU1_PGMW_SX2_^/_\
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M/_\ QJC_ (3V[_Y\)?\ Q_\ ^-4?\)[=_P#/A+_X_P#_ !JC_A/;O_GPE_\
M'_\ XU5*PN;C5]2@O)+>2%41E.Y6(^[(<[BJ@9+8KT2BBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN$^(-G<64L>K6Q)
M\M0KJH;[JDR9;;U0]&S@#CKG@MOB[;LH,D<BMW"[6'7U+*3Q["L:_OYOB!,M
MO"IC@B)+,23U. S 8&[ PJC)R6^;&2/48HA$ B@!5   &  .@ ]*?1111111
M11111111111111117/\ C*TDU"..R1"R3RH)&&/E13N)R3P>.#@CJ.I4'H**
M************IZO<O:PR2Q*7D5"54#.3CCC(R/4 Y(Z9.!5;POI9TNUBMSD,
MJ?,"0<,WS,,CC )('MW/6M6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBLWQ!KJ:''
M]HD5V7< ?+ )&>YR0 ,\9]2!WKSK4]3_ .$\NX;:-2L,>22?O;3@N3C<!T 7
MJ,XR><#U2*(1 (H 50  !@ #H /2GT444444444444444445YM_S'O\ /_/O
M7I-%>;?&/_EW_P"VO_LE>DT4444445YM\'/^7C_ME_[/7I-%%%%%%%%%%%%,
ME<H"P!) / QD^PR0,GW('O6)X,LGMX#+,I66XD>5U/8N> !U P!P22#G/H-Z
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBL^7P];2DNT,19B228T))/4DX
MZU=BB$0"* %4   8  Z #TI]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%17-LETICD4,IZA@"#@YZ'CK3;2
MQCLALB144G.$4*,^N!CGBIZ*******************K?V9%YGVCRT\W^_M&_
MIC[V,]./IQ5FBJUYID5]CSHT?;G&]0V,]<9!QG%6:*******K6>F16.?)C1-
MV,[%"YQTS@#.,U9HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHIAE
M (3(W$$@9Y(&,G'H,C/U%-N;E;5&E<X5%+$\G  R3QSTJMI&M0ZNAE@;<H;:
M3AAR #CY@#T(J]1111111113)91$"[$!5!)).  .I)]*K:7JL>J)Y\)+(20"
M59<XZXW 9'N.,Y'4&BTU>&[1IXW5HT+!F!&T;>N3Z=\],8(X(-2V5ZE\BSQ,
M&1QD$?YZ^HZ@\'FLK4?&EIILAMYI-KKC(V.>H!'(4CH:K?\ "QK#_GK_ .0Y
M/_B:?%\0K&0A1,,D@<HX'/J2H 'N>!6[;7*72B2-@RGH5((.#CJ..M2T4444
M5F_\)'!Y_P!@W_O_ .[M;^[OZXQTYZ_K1K/B.#1MOVA]N_.WY6;.W&?N@^HJ
MSIVHQZE&+B$[D;.#@CH2#P0#U%6:R-7\66VD.(IWVL5W ;7/!)&?E4CJ#6O1
M113)91$"[$!5!)).  .I)]*;<W*VJ-*YPJ*6)Y. !DGCGI6;%XLMI86O5?,,
M;;6;:_!..,;<_P 0[5>T[48]2C%Q"=R-G!P1T)!X(!ZBHK76H;J1[9&_>Q?>
M4AE(]QN R/<9'(]1F]11116;K/B.#1MOVA]N_.WY6;.W&?N@^HK,_P"%C6'_
M #U_\AR?_$T?\+&L/^>O_D.3_P")H_X6-8?\]?\ R')_\3706URMTBRH<JZA
M@>1D$9!YYZ5+6;K/B.#1MOVA]N_.WY6;.W&?N@^HK2HHHHHHK#U'QI::;(;>
M:3:ZXR-CGJ 1R%(Z&M/3M1CU*,7$)W(V<'!'0D'@@'J*LU1U?6H=(02SMM4M
MM!PQY()Q\H)Z U6TCQ9;:NYB@?<P7<1M<< @9^90.I%:]%%%%%%%%%%%%%%%
M%%9^L:_!HX#7#A QP."2<=>%!.!W/0<>HKF/^%MVG]R7_OE/_BZZ72/$EOJ^
M?(D#$=1R&XQSM8 XY'.,9XK2HHHK-O?$<%C*EI(^)9-NU=K'.X[1R 0,D=S6
ME1111115;4=1CTV,W$QVHN,G!/4@#@ GJ:BTC6H=70RP-N4-M)PPY !Q\P!Z
M$5>HHHHHHHHHHHHHHHHHHHHHHHK-LO$<%]*]I&^98]VY=K#&T[3R0 <$]C6E
M111116;9>(X+Z5[2-\RQ[MR[6&-IVGD@ X)[&C6?$<&C;?M#[=^=ORLV=N,_
M=!]16E11111111111111111111116;HWB.#6=WV=]VS&[Y67&[./O >AK2HH
MHHHHHHHHHHHHHHHHK-LO$<%]*]I&^98]VY=K#&T[3R0 <$]C6E16;K/B.#1M
MOVA]N_.WY6;.W&?N@^HJSJ.HQZ;&;B8[47&3@GJ0!P 3U-&G:C'J48N(3N1L
MX.".A(/! /45,90"$R-Q!(&>2!C)QZ#(S]1535]:ATA!+.VU2VT'#'D@G'R@
MGH#5FVN5ND65#E74,#R,@C(///2I:********K:CJ,>FQFXF.U%QDX)ZD <
M$]31IVHQZE&+B$[D;.#@CH2#P0#U%6:************HZOK4.D()9VVJ6V@X
M8\D$X^4$] :LVURMTBRH<JZA@>1D$9!YYZ5+11111116;_PD<'G_ &#?^_\
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M^\.$^7'S<\8QS7EOBFV6ZU?RG&5>6!2.1D%4!''/2N[_ .%<V'_/+_R))_\
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MG;]H3=LSM^9EQNQG[I'H*TJ@N[Z.R&^5U12<9=@HSZ9..>*BM-8@O3LBD1V
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M)0'4@JP!!!R"#T(/I3Z**BN;E+53)(P51U+$ #)QU/'6JUMKEO=,(XY8V8]
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M._B_<O&L,:L0K^9N ) ."A&1T.#TSTKT2BBBBBBJ-MKEO=,(XY8V8] LBDG
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MY+XK2B6SC=2"K3(00<@@H^"#Z5T_AG_CTM_^N$7_ * *NW-REJIDD8*HZEB
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M4NG^"9/$^-1OY"#*N42/'"G!7D[@!C/RXSSDG=D5F>+/ S>'%%]:2/M3AB6
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MF<9.5/9S> ;D3(2UK(P!.,Y7^Z1P-X&2IX!^FY1ZO145S/Y"-)@MM4G"C+'
MS@#N3V'K7ENB^')O&4TEW>,51&*$#A@P_@ .=H7/.1G/J22+GB/X6QV<+W$$
MC9B1F(DP<A1G@J!@X![')QTZUTGP[UI]5M0TI)>-RA8G); !!/'7# =R<9)R
M:\_^P3:O?7&GQ,526X<R'!(Q&[$$X[#/ R 6(SS@CM;#X806,T=RCN1&VXJ^
M#DC[I!7;C!Y[YZ5S5LDWCZY?<Y6UC8';G&%Y"X7)&\C.6Y Y[84Z>L_"9%C+
M6KN91R%D*X;VR%7!]">.QQG(UOAUX@DU*-[>XSYMNP4EA@X.0 <\[@5(.0.V
M<G)KKJ*\V^,?_+O_ -M?_9*Z3XC?\>$W_;/_ -&+7)>$_#$GB2WC6=REM"S!
M$08+$EB7R>."V <'HPP#DF+Q?X &@QB]MG<B-ESN(W+D\.&&WOM  &<\Y]/0
M/">JMJMK%<O]YE(/3DJ2I/  Y(SCMG%>=Z'I3>.[F6YG<K&F/E!!8!MVQ <8
M &#DXY/;))%WQ)\-?[,C%S9-(SQL"5^\_48*[%!R#S].<C'/H&B23/"AN5VS
M;<.,J>1QGY>/FZX'3..U<)\'/^7C_ME_[/7I->6_"^S^W17EOG'F(BYQG&X2
M#..,XS6)K?@[^S+N*P\S=YVSYMF,;W*=-QSC&>HK;U/X4_88I+CS\^6C-CRL
M9V@G&=YQG%9OA'P#_P )#$UQYNS:Y7&S=T"G.=P]:V_&O_(5M/\ MA_Z.:NI
M\<>(&T.V,L?^L=@BG (!.3DY] #CKSC((S7(^&OAL-4C^UWCONFPRA&&<-SN
M8D-DMG/MW.3@5M:\.3>#9H[NS8LCL$ /+%C_  $#&X-CC SGT(!.Y\4I_/LH
MI,%=TJ'####,;G!'8CN/6NBT>[%E8Q3MDK';(QQUPL8)QTYXK@="T6;QS(UW
M=N1"K$ *>C$#Y5!R% &,DC)XZG)%SQ!\,38(+BQ9VDC.2I(W<<@J5"_,.N.I
M[<@ ]7X'\0-KEL)9/]8C%&.  2,'(QZ@C/3G. !BO/\ 3HYY]2N(+9MC2O,K
M/@DHGF;F88Z'C /J<9!((Z*3X0P%,+*XDP/F(4KGO\N <'L-W'J>];X7:C+;
MRRZ7+G$88@$@[2K;748SP2<]<9!(ZDUA?$3PU_9,OVC?N^TO*V-N-O(.,Y.?
MO>W2N_\ !W@[_A&_,_>>9YNS^#;C;N_VFSG=72TR6(2@HP!5@001D$'J"/2O
M-_A]<-HUY-I4A.TEMN0PRR="!D@!DR?<!>>F?1KFY6U1I7.%12Q/)P ,D\<]
M*\[^&T+ZM<SZI-R>@R"1N?D[6).-JC;CD[6 SCK6U^2;QC>MIT9VPP,<YX V
M':[D9^8Y.%]B/NY8UJ7OPC@*-Y,CB3'R[RI7/OA0<'U'3K@]"?#77)=TFESY
M+0 [<X. K;60MGD D;>O&1G  KF?B)X:_LF7[1OW?:7E;&W&WD'&<G/WO;I7
M?^#O!W_"-^9^\\SS=G\&W&W=_M-G.ZN-MDF\?7+[G*VL; [<XPO(7"Y(WD9R
MW('/;"G3UGX3(L9:U=S*.0LA7#>V0JX/H3QV.,Y&M\.O$$FI1O;W&?-MV"DL
M,'!R #GG<"I!R!VSDY-<_P",VD\0Z@NDJVQ$QUY&=F]GP ,D*< $]NHW&M"]
M^$<!1O)D<28^7>5*Y]\*#@^HZ=<'H=/X<BZCM_*ND90I_=ESAMO(V[?O *1Q
MGJ" . *ZNBO&_B)X:_LF7[1OW?:7E;&W&WD'&<G/WO;I7?\ @[P=_P (WYG[
MSS/-V?P;<;=W^TV<[JXNWMY?']TSLQ6WB/L"JDG  R?G;')Y QZ!5K5UGX3(
ML9:U=S*.0LA7#>V0JX/H3QV.,Y&I\-O$CZO"T4Q+20E1N/=6!VY.>6&#DXZ8
MZG)KL**X;XE:E<8CL(%8"<A68#"DL<+&'S@$X.X<<8YP2*BLOA' $7SI',F/
MFV%0N?;*DX'J>O7 Z#&TZUD\&:A':A]Z3[ <?*"')4$@YP5;)&#TXR-Q%=OX
MX\0-H=L98_\ 6.P13@$ G)R<^@!QUYQD$9KD?#7PV&J1_:[QWW3890C#.&YW
M,2&R6SGV[G)P,+QCH,OAT_90Y:VE?>F<=5&#D=F ;!(X88/;"^I:/=BRL8IV
MR5CMD8XZX6,$XZ<\5Y_H.@R^.)7OKIR(P=ORXSG&0B@YVJN<DG.<]R21;\2_
M#8:7']KLW?=#EF#L,X7G<I 7!7&??L<C!Z[P/X@;7+82R?ZQ&*,<  D8.1CU
M!&>G.< #%>:21S7-]<VEOC?<23(221A?,WMR.V%YZY&1@DUU=S\(HO+(CD?S
MMO!;&PM] N0#]21[XY=\-=<EW2:7/DM #MS@X"MM9"V>0"1MZ\9&< "LOXH^
M&OL['4M^?-=%V;>F$QG=GG[OIWK;^'W@[^S-M_YF[SH!\NS&-^U^NXYQC'05
MV]%>):WX._LR[BL/,W>=L^;9C&]RG3<<XQGJ*[^W\-?\(]I]S;[]^Y)FSMV]
M8\8QD^E<3X,\,2>(D,3.4MHG#$ ?>=@ <=LA1U.=N1A?F-:WB?X8)8PM<V[N
M3&I8J^TY QD@C;C R>^>@KI_AWK3ZK:AI22\;E"Q.2V "">.N& [DXR3DURV
MN7-QXNO7TV)BD,1(8=!A" S$ _,=WW1]/N_,:TKWX1P%&\F1Q)CY=Y4KGWPH
M.#ZCIUP>A?\ #G5YHWDTFY!WP+E=W4*" 5SGD<@KU&,\XVBN[HKS;XQ_\N__
M &U_]DK/\5Q&QCT_44!++#$.1E,QA70'&.3EN_(''0UZI;7*W2+*ARKJ&!Y&
M01D'GGI7G/A.0:[JDM]SLC#%2H(4\"-,Y[E,G'!R/0$5G_"3_C[?_K@W_H:5
MT'Q&\031/%IMJ2LDN"2IVD[FVHH;(QD@YZ=N<9%,LOA' $7SI',F/FV%0N?;
M*DX'J>O7 Z#-T$7'@V\6QD):"X? ('RDGY58<_*P. P]/7Y36S\6_P#CT3_K
MNO\ Z ]9?A_P$?$*'4+YWWS'("X!QTR=RG@_P@  +C'!P-34%_X06P*1'=*[
MX#[>-S9.XJ6.,(N!U&0"1R:R/#7PV&J1_:[QWW3890C#.&YW,2&R6SGV[G)P
M,+QCH,OAT_90Y:VE?>F<=5&#D=F ;!(X88/;"^I:/=BRL8IVR5CMD8XZX6,$
MXZ<\5P.A:+-XYD:[NW(A5B %/1B!\J@Y"@#&21D\=3DBYX@^&)L$%Q8L[21G
M)4D;N.05*A?F'7'4]N0 >K\#^(&URV$LG^L1BC'  )&#D8]01GISG  Q7G'V
M";5[ZXT^)BJ2W#F0X)&(W8@G'89X&0"Q&><$=K8?#""QFCN4=R(VW%7P<D?=
M(*[<8//?/2NRHHHHHHHHHHHHHHHHHHHHHHHHHHHHK-\3?\>EQ_UPE_\ 0#7-
M?"3_ (]'_P"N[?\ H"5V]%>:?!V($W#X&X", XY ._(SZ' S]!Z5Z77FGQBB
M -N^!N(D!..2!LP,^@R<?4T[XQ_\N_\ VU_]DKTFN(^+?_'HG_7=?_0'KHO"
ML0CM( H 'DQG@8Y*@D_4DY/J:U:\D\!?\>FH?]</_9):Z+X1Q 6TCX&XS$$X
MY("+@9]!DX^IKN:\T\9Q!-6M2  6,!.!U/FD9/J< #Z 4[XQ_P#+O_VU_P#9
M*])K!\6^+4\.HK,I=W)VJ#C.,;B6P< 9]R21QC)'*?\ "7:KJGRV\&P2<HWE
MMPOWA\[G8<COC![ $BLWQ'9:I- \UZ^(H]N5W(-VY@.D?!P<'YNG;O7;?#G_
M (\(?^VG_HQJYOP5_P A6[_[;_\ HY:[?Q-_QZ7'_7"7_P! -<U\)/\ CT?_
M *[M_P"@)67\'8@3</@;@(P#CD [\C/H<#/T'I7I=>:?&*( V[X&XB0$XY(&
MS SZ#)Q]33OC'_R[_P#;7_V2O2:YKXC?\>$W_;/_ -&+1\.?^/"'_MI_Z,:N
MEHHKS;X.?\O'_;+_ -GKTFBBO'_%-LMUJ_E.,J\L"D<C(*H"..>E=W_PKFP_
MYY?^1)/_ (JO/==T >$;A7=%FA8Y0.2.%()!"D?,.G(*D'.WJ!ZSHE_'J$*3
M0#$;+\HQMQCC;CH,$8XXXXXK/\6^+4\.HK,I=W)VJ#C.,;B6P< 9]R21QC)'
M*?\ "7:KJGRV\&P2<HWEMPOWA\[G8<COC![ $BLWQ'9:I- \UZ^(H]N5W(-V
MY@.D?!P<'YNG;O72>'_^0,W_ %PN/YR4?"3_ (]'_P"N[?\ H"5V]>:1Q"/7
M<* !DG@8Y,&2?J2<GU-.^,?_ "[_ /;7_P!DKM/#T0ELX$8 JUO&"",@@H,@
MCTKS+6+23P3>B:+/EL=R@9 *$_-$2<Y(Z=_X6X.,-^).H)J,T-Q&<K);(1TS
MR[\'!(R#P1V/%=_\1O\ CPF_[9_^C%KB?#G]K>0GV3_4?-M_U/\ >.?O\]<]
M?Y5I?\3[_/V>CPYX<O\ [>E_=I_>W-NC_P">90<(?H.!1\8_^7?_ +:_^R5Z
M31117FWP<_Y>/^V7_L]>DT44445Y)\)/^/M_^N#?^AI7K=>;>-?^0K:?]L/_
M $<U>DUYM\8_^7?_ +:_^R5I?%O_ (]$_P"NZ_\ H#UT7A6(1VD 4 #R8SP,
M<E02?J2<GU-:M>:>!8A%JETB@!5$P  P !*N !Z5Z7117DGB#_D,K_UWM_Y1
MUT'Q;T_S8([@ DQ/@XZ!7')/'JJ@'ISCN*-=\4&725N,G?<*(R<+][D2$CH
M0K8QSR.!VTOAKI_V.R1B"#*S.0WN=HQQT*J"/7.>E<;\)/\ C[?_ *X-_P"A
MI1XC\_\ M9_LG^O^7;]W_GB,_?XZ9Z_SK2_XGW^?L]5M1T[6M2C-O,-R-C(S
M .A!'((/45TEAITFFZ2]O,-KK!<9&0>N\CD$CH:K?"3_ (]'_P"N[?\ H"5I
M?$;_ (\)O^V?_HQ:/AS_ ,>$/_;3_P!&-72UYIX%B$6J72* %43  #  $JX
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M^"O^0K=_]M__ $<M>DUYMXU_Y"MI_P!L/_1S4?&/_EW_ .VO_LE>C11"(!%
M"J   ,  = !Z42Q"4%& *L""",@@]01Z5YS\'/\ EX_[9?\ L]'@K_D*W?\
MVW_]'+1\8_\ EW_[:_\ LE>B7-LMTC1.,JZE2.1D$8(XYZ5YS\,KHZ=<3Z9(
M1G)Q\WR[HSM;:#U+#G/!PO(]&:UCQ3JB6G)A@R&^\1\F2_'&W)PF?8$$\"N\
M\1WLMC \UNF^5=NU=I;.6 /"X)P"37$?\)KJO_/K_P"0)O\ XJM*SUN[U.TO
M/M<7E;(&V_(Z9RCY^^3G&!T]:;\(X@+:1\#<9B"<<D!%P,^@R<?4UW->:>,X
M@FK6I  +& G ZGS2,GU. !] *G^*%LUE+;ZF@R48*<XVY0[T&.#S\V?8#IWD
M^)EY_:,5M;PC=]I<,ASC/ "C!QU\SOC&.?:CKULOAW4[>:,;8V6-<OG8 !Y+
M ,<?=3!Y)P3D\'%2^.?^)[?P::O(3&['##?AGY;CA%!'!YR.3Q7;^)O^/2X_
MZX2_^@&N:^$G_'H__7=O_0$KMZ\V\%?\A6[_ .V__HY:Q+?[7_:%S]@_UN^;
M/W/N^9S]_CKCWK;_ .)]_G[/5'5]%UC5T$4Z[E#;@,P#D C/RD'H36GX_MFM
M=-MHG&&1H5(X."(F!'''6NR\,_\ 'I;_ /7"+_T 5?EB$H*, 58$$$9!!Z@C
MTKSGX.?\O'_;+_V>O2:************BN;E;5&E<X5%+$\G  R3QSTKSN3XE
M7=^[?8K?<B]<H\C<DX)V$!<@=.>0>35;4[+6+J*3[2^V)$9F^:-=P4'*_NN3
MD9X/RGOVK;^$G_'H_P#UW;_T!*S?@Y_R\?\ ;+_V>O2:\V\%?\A6[_[;_P#H
MY:/&O_(5M/\ MA_Z.:O2:\V^,?\ R[_]M?\ V2ND^(W_ !X3?]L__1BT?#G_
M (\(?^VG_HQJYOP5_P A6[_[;_\ HY:TOBW_ ,>B?]=U_P#0'K2_YA7_ &X_
M^T:S?A)_QZ/_ -=V_P#0$KMZ\V\%?\A6[_[;_P#HY:/^8]_G_GWKTFO-O^8]
M_G_GWKJ_%OBU/#J*S*7=R=J@XSC&XEL' &?<DD<8R1R47B;5]7 $,03(#!Q'
MM!'LTI*D'.>.?3C-<[XQLKV'RYK]\M)OVKN!V[=H/"_(,\'Y>O?FO2/B-_QX
M3?\ ;/\ ]&+1\.?^/"'_ +:?^C&KI:*\TDB$FNX8 C(/(SR(,@_4$9'H:]+K
MS;QK_P A6T_[8?\ HYJ/C'_R[_\ ;7_V2O2:\V_YCW^?^?>O2:\V^,?_ "[_
M /;7_P!DKTFO+?BM'';3QS1L5N"H)VC PI.U]PP=V1COP!]W SK_  GLX5A:
M92&G+$/Q\RK_  KSV.-V1@$\')7B3XM_\>B?]=U_] >CQ!_R!E_ZX6_\XZYO
MPY_:WD)]D_U'S;?]3_>.?O\ /7/7^5:7_$^_S]GK2^&OAR?1O.^T)MW^7M^9
M6SMWY^Z3ZBG>-_ !UQQ<P,JR8 8-PI Z-E03N'3G.1CICGF?[7U;PU\TP=D'
M)\S]ZGS?*,R DCGH-PY[<\]IX+\:#Q$&1E"2Q@$@'(8'JP'7&>HYQD<G-=/1
M7FW_ #'O\_\ /O72?$;_ (\)O^V?_HQ:/AS_ ,>$/_;3_P!&-72T5YM\8_\
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M?Q-_QZ7'_7"7_P! -<U\)/\ CT?_ *[M_P"@)6;XU_Y"MI_VP_\ 1S4?&/\
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M_P#EW_[:_P#LE=OXF_X]+C_KA+_Z :YKX2?\>C_]=V_] 2NWKS;P5_R%;O\
M[;_^CEKTFBN6\9^.%\/8B5=\SJ2 <A0.0&/KR.@[ Y(XSS_]MZSJ?^JB\K9U
M^0)G/3_7$YQC^'UY[5B7%E<VNH6WVQ]TKO"WWMVT-)]WT&#GA?E':MOXQ_\
M+O\ ]M?_ &2O2:XCXM_\>B?]=U_] >CQ!_R!E_ZX6_\ ..M+X<_\>$/_ &T_
M]&-72UYM\'/^7C_ME_[/3?!D0?5KHD E3.1D=#YH&1Z'!(^A->EUYM_S'O\
M/_/O6E\6_P#CT3_KNO\ Z ]=+X9_X]+?_KA%_P"@"M*BO-O&O_(5M/\ MA_Z
M.:NW\3?\>EQ_UPE_] -<U\)/^/1_^N[?^@)72^)O^/2X_P"N$O\ Z :YKX2?
M\>C_ /7=O_0$KB?!WV_]Y_9_^QO_ -7_ +6W_6?CT_'M72?\3[_/V>CPYX<O
M_MZ7]VG][<VZ/_GF4'"'Z#@5Z317FWQC_P"7?_MK_P"R5I:[IWV[2(\#+1P0
MN.<8VJ-QZC.$+<?ESBH]"\4&+26N,G?;J8P<+][@1D#H0 RYSSP>#WD^$^G>
M1;-<$8,SG!SU5.!QGC#;O0_ABN;^$G_'V_\ UP;_ -#2CQ'Y_P#:S_9/]?\
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M>4_"3_C[?_K@W_H:5L_$73I-.FCUF#&4*A@ 1R"<,Q7JK#Y#DCC YSQJ:?\
M$^SN$#2,8V[JRLW89P5!!&>!G!XZ"L+Q/XYDUAUL--+?,1EURK,>N!G!51_$
M3C\%!W=?JD4D5A*LS;Y!;2;FX +;#G& HQGIQG'7FL3X2?\ 'H__ %W;_P!
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M#M!D!.. 3LP,^IP<?0^E=EH7B:#7 6@8DJ%W J05W9P#D8)X/0D>]<7\'/\
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M_P!L_P#T8M'PY_X\(?\ MI_Z,:CXC?\ 'A-_VS_]&+4?@.-I--C5&VL5E ;
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M7#VHEN79BY)0/R0O8DD;B6.2,DC;MQBN=\%?\A6[_P"V_P#Z.6O2:\V\%?\
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M]TCT%:5>=_%+4/MC0Z9$0TC."5[AB-L8SG SN/!YZ'@'GN-(TX:;#';+C$:
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MBBBN(^)7B.?1O)^SOMW^9N^56SMV8^\#ZFNWHHHHHKFO]/\ M_\ TY?]L_\
MGG_WW]__ #BNEHK#\::C)IMI)<0G:Z[,' /5U!X((Z&CP7J,FI6D=Q,=SMOR
M< ='8#@ #H*K>#OM_P"\_M#_ &-G^K_VMW^K_#K^'>NEHHHHHHHHHHHHHKR\
M^,-0\03.-/!6- .,1],\%F?C<?0'H.,X)/;^%$NUAS?$&4N< ;>%P  =@ SD
M$]^".>PV:\[^(GBRYTBX6*!]JF(,1M0\EF&?F4GH!47_ !/O\_9ZBN;C7;=2
M[9(']U87/)Q]U02?P%:_@KXAG69/LLZA9&R4* [3@9(.22" "<YP1QP0,]O1
M11117$>*/$<]CJ%O:1OB*3RMR[5.=TA4\D$C('8U>^(FM3:1;K+ VUC*%)PI
MX*L<?,".H%9OP\\;OJK-:W+9EY9&^500 ,K@ <CKWR,],<]W7$?$KQ'/HWD_
M9WV[_,W?*K9V[,?>!]374Z'<M=6\,KG+/%&Q/ R2H)/''6KU%%9'B?Q&GA^+
M[0ZELMM 7'WB"1DGH..3R?8U;T>[-[!%.V TD:,<=,LH)QUXYJY111111111
M5'7+EK6WFE0X9(I&!X."%)!YXZUB?#O6IM7MVEG;<PE*@X4<!5./E '4FNIH
MHHHHJCKERUK;S2H<,D4C \'!"D@\\=:\RT;Q'JVL[OL[[MF-WRPKC=G'W@/0
MUI?\3[_/V>C2?B=+:R"WOX]N-H+!2KKQ]YD/7/!XVX&2 >!7HT4HE =2"K $
M$'((/0@^E/HHK#\::C)IMI)<0G:Z[,' /5U!X((Z&CP7J,FI6D=Q,=SMOR<
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MW9 [C'<<^O?Z3JB:K$MS%G8XXR,'@X(/N""/3T)%8GBGQ[#H)\G!DEP#M4@
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M,!:V_!WC'_A)/,_=^7Y6S^/=G=N_V5QC;5SQ-XIB\/IODR78'8H!^8C&><8
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M,>8BMC.<;@#C/&<9JS17EOQ1\2_:&.F[,>4Z-OW=<IG&W''WO7M6W\/O&/\
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M>\&>.%\0YB9=DR*"0,E2. 6'IR>A[$8)YQMZSK,>CQFXF.%'0#J3V4#N3_\
M7. ":X)/B+?7Y,EM; QYQPDDF#@9!92HSWZ#@CZU9E^+R!%98B7);<I?&W&-
MI#;3D'/L00>,8)]"HHIDLHB!=B J@DDG  '4D^E<%\/XSK-Q/J\HY+;4^Z0.
M.1T!RJ[1GC()ZY.-+XB>)?[)B^S[-WVE)5SNQMX SC!S][VZ5R7P^\8_V9ML
M/+W>=./FWXQOVITVG.,9ZBKOC^Y6UU*VE<X5%A8GDX E8D\<]*GE^(MY?$O9
M6Q:($C)1Y#D>I0@ X(XYQZFM+P;\1!K3BUF4+*0=I7.UL9)&#DJ0/4D'!Y'
M/77MZEBC3RL%1!DD_P">OH.I/ YK@KGXE7%^Q%A;EU7J61G/(XX0X7D'N<^U
M6=&^)9,@M;Z/R7Z%CE0">5RK#*@@]<GUX!R.[HHK#\::=)J5I);PC<[;,#('
M1U)Y) Z"L36-.O[ZR@R,W<<X<\QC&TOM/4(<97C\^]==IGF>5'YW^MV+OZ?>
MP-W3CKZ<>E>?_%+4#>R0Z9$<MN!*_+C<WRQC.<@X)X.!A@?H?$+PH+2TADC
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MM@CU4$8Z$XST!$/PRU$WEFJMG,3LF2<Y PP^@ ; 'H/P'+?"/3A--+<G&8D
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MCG[2KC)573( .&R5'S*0 "#G'K@8]0TR\^W11W&,>8BMC.<;@#C/&<9JS17
M_%S43##%;#.)7))!QP@'RD=P2P/L0/PZ[0=%31H5MHP/E'S$#&YL<L>3R?J<
M# ' %<U\4=%2YMC=X DA*\XY*LVW;UZ9;(ZXP<8R:W/!VHG4;2&9L[BF"2=Q
M)0E"Q/J<9_'O7'_!S_EX_P"V7_L]>DT45Q'Q;_X]$_Z[K_Z ]=+X9_X]+?\
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M4W+6KW&GR'#(V[;P<$'9(<CCKM'7Z=Z@\<(=<U&'3E)*J!N P"N[YG()')V
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M7A+,>?4DFI_B7*;^YMM-R55RI)SD9D?8#MXY7!QSW(X[^@65DEBBP1*%1!@
M?YZ^IZD\GFO+?BMHJ64R7,8 \\-N &/F4C+=>IW#/ Y&>237K-%%8/CJ[-I9
M3.N,E-O/HY"'\<-Q[U2^&-H(+)7&<RN['/J#LX]L*/QS6SXF_P"/2X_ZX2_^
M@&N:^$G_ !Z/_P!=V_\ 0$K&^(EH+W4;>!LA9$B4XZX:5@<=>>:]-BB$0"*
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MBV <\@@* 0  /R Y["V^&EC$H5D+D?Q,[ GG_9*C\A7*:5)#)K0-MM\K+ ;
M O$)!QC QD'D<'J*W?BW_P >B?\ 7=?_ $!ZZ7PS_P >EO\ ]<(O_0!7$?\
M,>_S_P ^]-^)9.GWEM?X!50N%S@DQ/N/;@'<,'GOQZ^D12B4!U(*L 00<@@]
M"#Z5B>.-1%A9S,<9="@!.,E_EX]2 2<>@/UK-^%EH8+/><8ED=ACT&$Y]\J?
MPQ6-\'/^7C_ME_[/7I->;?\ ,>_S_P ^]>DT5YM\(OW+W$+\./+^4\-\I<-P
M>>"0#Z$BO2:**\D\/_\ (9;_ *[W'\I*Z+XLZ6;BW2Y&<POSR,;7P"?4G<%
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MO^[^9/8'!P?$V)8K&%(P0BR1A0000!&^ 0W.<>O/KS76>&?^/2W_ .N$7_H
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M&^*VM/90I;1DCSRVX@X^50,KTZ'<,\C@8Y!-&D_"BWA"M<%G<#Y@&VQDGTP
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M[CT<EQ^.&Y]ZY3X.?\O'_;+_ -GKTFBBN(^+?_'HG_7=?_0'KI?#/_'I;_\
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M0H6)X58(/XA)SD]VQC)R3G@G(-=%\6_^/1/^NZ_^@/72^&?^/2W_ .N$7_H
MK2HK-\3?\>EQ_P!<)?\ T UQ'P<_Y>/^V7_L]-N8QH6LJPR$N"#A23GS<KSG
M''F#=CD 8(Y&*/ 48UF_GU$Y*H6*[B=P\PD+TR,! 1C.!QCVS_BW_P ?:?\
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M$ 9ZUZ77FFNRC5M8ABB(S"4#$GC,9:5@,9Y X[?,"#CK3OC'_P N_P#VU_\
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M.>IQ3X? M[K[^;J,A55/W<AF_ASM"_(H('7KD9*GK7HUM;+:HL2#"HH4#DX
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ME2 .P.<#H<DX8L-<G46[,54[1NWQ @ CDNIW_4C)/OFNG\%^"QX=#.S!Y9
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MWJ,' R1\K-SC)YXXZYQ73U!?78LHWG;)6-&8XZX49..G/%<?_P +;M/[DO\
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M>.>E>4Z!8-XWO'N;@GRDY*Y' ).R,'@@8SD@<X/0MFO5K:V2U41QJ%4= H
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M0<@@]"#Z4^JUGJ<5]GR9$?;C.Q@V,],X)QG%6:**\Q^$MREJMS)(P51Y.2Q
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M1GKSS7GOQC_Y=_\ MK_[)7;^&?\ CTM_^N$7_H K2KS3XQ1 &W? W$2 G')
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M&L'X:R/87=QIN=R)O.>1\T;A,@9(&X'GJ>!SQ6I\2?$,EDJ6=OGS9SU1B)
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MC=\\A4X(4#H..#S7I_AWP['H$9@B+%6<M\Y!.2 .P''%<7X*_P"0K=_]M_\
MT<M5/B;(\=]"T6?,$<93 R=PD?;@<Y.>W>NFT_X86=N@613(W=F9E[#. I
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M''FNJ$\YVD,QQ@]]N#V()%9_A'P+97ENDKXE=@"Q#D;20#LPC<%<\YYSSP,
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M7C_ME_[/1\'/^7C_ +9?^SUV_B;_ (]+C_KA+_Z :YKX2?\ 'H__ %W;_P!
M2M+XC?\ 'A-_VS_]&+1\.?\ CPA_[:?^C&KI:**\V\:_\A6T_P"V'_HYJ])K
MS;P5_P A6[_[;_\ HY:/&O\ R%;3_MA_Z.:O2:\V_P"8]_G_ )]Z])KS;P5_
MR%;O_MO_ .CEJM\2('GU"".,[79(PIR1AC(P!R.1@]QS5G_A"M5_Y^O_ "/-
M_P#$TV7P+JDH*-<@JP((,TI!!Z@C;TKJ? WAV30(&@E*EFD+?(21@JH[@<\5
MT5%%>;>"O^0K=_\ ;?\ ]'+6E\6_^/1/^NZ_^@/71>%91):0%2"/)C'!SR%
M(^H(P?0UJUYIX%E$NJ73J0583$$'((,JX(/I7I=%%%%%%%%%%%%%>+?#O18=
M7N&BG7<HB+ 98<AE&?E(/0FO1/\ A7-A_P \O_(DG_Q5:^E:)#I*[($" ]<<
MD\D\L<DXR<9/':H_$W_'I<?]<)?_ $ US7PD_P"/1_\ KNW_ * E'Q;_ ./1
M/^NZ_P#H#UTOAG_CTM_^N$7_ * */$W_ !Z7'_7"7_T US7PD_X]'_Z[M_Z
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M\FCQ!\1FUE#9643DRJ020"^"#N4(N[MWSP,\#@UUW@?P^VAVPBD_UCL789!
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M!R ,'(X/M5;_ (1FT_YX1?\ ?I/\*/\ A&;3_GA%_P!^D_PJ_%$(@$4 *H
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M,=D-D2*BDYPBA1GUP,<\4ZYMDNE,<BAE/4, 0<'/0\=:+:V2U41QJ%4= H
MR<]!QUJ6BBHKFV2Z4QR*&4]0P!!P<]#QUJ.STR*QSY,:)NQG8H7..F< 9QFB
M#3(H',R1HKMG+*H#')R<D#)R>3[T3Z9%.XF>-&=<89E!88.1@D9&#R/>K-5O
M[,B\S[1Y:>;_ ']HW],?>QGIQ].*LU6@TR*!S,D:*[9RRJ QR<G) R<GD^]6
M:IW>CP7IWRQH[ 8RZ*QQZ9(/'-2VEC'9#9$BHI.<(H49]<#'/%3T4456O-,B
MOL>=&C[<XWJ&QGKC(.,XJ2VMDM5$<:A5'0*  ,G/0<=:;=V,=Z-DJ*Z@YPZA
MAGUP<\\U%::/!9'?%&B,1C*(JG'ID <<5<HHHHHHHHHHHHHHJG::/!9'?%&B
M,1C*(JG'ID <<5<HIDL0E!1@"K @@C((/4$>E1VEC'9#9$BHI.<(H49]<#'/
M%3U!=V,=Z-DJ*Z@YPZAAGUP<\\T6EC'9#9$BHI.<(H49]<#'/%3UYMX*_P"0
MK=_]M_\ T<M=['H\$;^>L:"3).\(H;)ZG=C.3GGUJY15&YT.WNF,DD4;,>I:
M-23@8ZD9Z5>HJC<Z';W3&22*-F/4M&I)P,=2,]*LVULEJHCC4*HZ!0 !DYZ#
MCK4M9\7AZVB(=88@RD$$1H"".A!QUJS=V,=Z-DJ*Z@YPZAAGUP<\\T26,<B>
M0R*8\ ;"H*X'0;>F!CCTIUM;):J(XU"J.@4  9.>@XZU+17 ^,6/B&[BT=,[
M$(>4CMQZ[3@A3P>02X!Y%=W%$(@$4 *H   P !T 'I4,&F10.9DC17;.650&
M.3DY(&3D\GWJS11111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111113(XA&,* !DG@8Y)R3]23
MD^II]%%%%%%%%%%%%%%%%9&M>&(M6>.=LK+"P*NF-W!R =P8$9YP1UZ=3G7H
MHHHHHHHHHHHHHHHHHK(G\,17%R-0DRSHH"AL;%QR"  "2"2023@G(Z#&O111
M161!X8BM[DZA'E7=2&"XV-GDD@@D$D D@C)&3U.=>BBBBBBBBBBBBBBBBBBB
MBBBBJVI:>FHQO;R#*R*0>F>>XR",@\@]CS6#HOP[M=*<3 ,[J05,A!VD9Y
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MBBBBBN*\/^))M3U&:W<@1P)*JJN0#ME4!CR<MCCT'8#)RWXM_P#'HG_7=?\
MT!ZZ7PS_ ,>EO_UPB_\ 0!6E1111117->/O$$FAVXEAQN=PF6&<95CD=L@CC
M.1Z@UJ^'I3+;0.Q)9H8R23DDE!DD^M:%%%%%%%%%%%%%%%%%%%%%%%%%>;?!
MS_EX_P"V7_L]>DT444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444444444444444444444444444444444445F^(_/
M\A_LG^O^7;]W^\,_?XZ9Z_SKR31/M_VN7[-_Q\_/YG^K_OC?][Y?O8Z?AQ7J
MUS<S6MDTKG$Z6Q8GY3AQ'DGCY?O?A^%9OP[UJ;5[=I9VW,)2H.%' 53CY0!U
M)KFE\<7B7<]JG[T[W2)"BX!$@ZD;3@(&Y)]SQDTW5M"U:.-KV2<_*FYD25E(
M '/RJ%3('7!YP<9/66S\>7>KPI:VR@W9+;F '"H%(?##8"V<')P". -RX@U#
M1M5T)#>>>7"=0LCR8&#EBKC! []<=>V1W/A+Q ->MUN, ."5<#. P],]B"#W
MQG&2161XV\;'2B+.V >XD&..2A.-ORX.6.3@9XX)!! .)'X3U>Z'FO<%&8DE
M3,XQSZ("H'H < >G2I-!\8W6D3KI^I8"D???[PR/E.Y<AER,$GG))9N"*]'H
MHHKQOXB?:_-_TK_5;Y?)^Y]W(_N\]-OWN?UKO_!WV_\ >?VA_L;/]7_M;O\
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M8?NY<!C\I ZX(88!R&&_Y@2>@KN/!>HR:E:1W$QW.V_)P!T=@.  .@KE]?\
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M4LGA/5[4>:EP792"%$SG//HX"D>H)P1Z]*V? 'BV352]I=?Z^+)R5VDC.&!
M  *G [9STR"3E:_X[FT>_>)B6@0#]V HR3$"/FQD#<<DYX'8]*;_ &)J^L_Z
M0\ODYZ)O:/ /(^5 ?7'S?-Q@U6L?%UYX9G%E?'?'N&6?+$*2?G5QRPYSR">-
MHVG./2=2U!-.C>XD.%C4D],\=AD@9)X [GBO-HM6U+QBQ^SGR85;JK% #@D
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M_EW_ .VO_LE>A7UH+V-X&R%D1E..N&&#CKSS7DEO<W_@4LI4>6Y_B!:(GG#
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MG^%4]7\'V]W#)%'#$KLAVL$"X;'RG*C.,XS[<8(XKC_A)K(C:2Q8_?\ G0<
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MFNPUK7H=&0RS,!P<+QN;&.%'<\CV&<D@<UQOPNTQYVEU64G=*64<8SEMSMC
M&,@ 8.,AACBLWPM>KX4OYK.9BL3G:"VT]\QLS#H"I.>P)Y QQZ?]I39YVX;-
MN[=D;=N,YSTQCG/3%>8>*;U?%=_#9PL6B0[25VCOF1E8]0% QV)' .>=WXM_
M\>B?]=U_] >NE\,_\>EO_P!<(O\ T 4>)O\ CTN/^N$O_H!KFOA)_P >C_\
M7=O_ $!*[>BO-/!DH35KH$@%C.!D]3YH.!ZG )^@-:GQ;_X]$_Z[K_Z ]=+X
M9_X]+?\ ZX1?^@"CQ-_QZ7'_ %PE_P#0#7-?"3_CT?\ Z[M_Z E8WAB['A"]
MELI\I%*?E=_0$^6Q88&T@G)QP>N,''IL4HE =2"K $$'((/0@^E<7=?$4RW:
M65F@E4MM9B2 2>ZD X5>I;!R,XX&3V]%<1\6_P#CT3_KNO\ Z ]=%X5E$EI
M5((\F,<'/(4 CZ@C!]#7#7$__"):HUQ("(+C=\Q&[A\,Q&,?=?J.2%[$D$^D
MVURETHDC8,IZ%2"#@XZCCK7'^)_B(-.F6TME$L@<!QSZXV+C^/\ , \8)R!'
M\5B39QE@ WG)D Y .Q\X.!D>^!]!73^&?^/2W_ZX1?\ H K,^(W_ !X3?]L_
M_1BT?#G_ (\(?^VG_HQJS?BW_P >B?\ 7=?_ $!ZZ7PS_P >EO\ ]<(O_0!7
M$?&/_EW_ .VO_LE=WK>H-IT+W*)O,:[MNX+P/O')!Z#)]\8K&\&^-$UQ LA5
M;@$Y0?+GJ05!))&!SW!!R ,9H^.-!L+>W9W5(I C>7LPC%N,#:OWAG .0< D
MY'6I?A9&Z6>7SM:1RF3GY> <>@W!N..<GO785@^.I'CLIC'G=LP<#/RD@/Z\
M;2<GL.>,5S?PVTJRNH/F"23DDNL@#,H4X&%8<+@C)'4G!/  [#5=9@T&/=(0
MJJORH, G;@;57C.,@>@[X%>?_#>\^W:A/<8QYB2-C.<;I%.,\9QFK/\ S'O\
M_P#/O7I->;?&/_EW_P"VO_LE=)\0=&;5;1EC!9XV5U5<9..#QW^4DX').,9Z
M&I\._$T=[;I:LX\Z,;=K8!(&=NT=P%&#W&,GL3J>*?%,>A1LQ8>:5^1.I).<
M$C(.W(Y/'3 YP*Y+X.?\O'_;+_V>O2:*****************************
M************************************************************
M************************************************************
M************************************************************
M************XKQ'\,H]6E-RDAC9SEAL#+G Y !7!/).<Y)SQ6];Z&R6?]GO
M)N/E-'OV@<$%5^4'^$8'7G'7FHO"/AK_ (1Z)K??OW.6SMV]0HQC)]*K:)X.
M_LR[EO\ S-WG;_EV8QO</UW'.,8Z"NEKFO!W@[_A&_,_>>9YNS^#;C;N_P!I
MLYW5N:G9_;HI+?./,1ESC.-P(SCC.,UF>$?#7_"/1-;[]^YRV=NWJ%&,9/I5
MK7/#L.MIY<ZYQG:0<,I(QD'^AR"0,@XKBI?@Z"25G(7)P#'D@=LG>,GWP/H*
MZ+PUX#@T)O.4EY=H&Y\8''S%0!QGW)('&>3G<U.S^W126^<>8C+G&<;@1G'&
M<9KFOAO9_88I[?.?+NI%SC&=H49QSC.*ZZBL;Q1X7C\0QB)R5922K  D$@C'
M(^[T) (S@<UG^$/!3>''=A-O610"OEA>0>#G<3P"1CW]JD\'>#O^$;\S]YYG
MF[/X-N-N[_:;.=U=+7-?\(=_I_\ :OF?\ V?],_+^]N_'I[>];U[9)?(T$JA
MD<8(/^>OH>H/(YKAM0^$4<KEH92BG^%EWXY/0[E.,<#.3ZDU9T;X506;"29C
M*5;(! 5#QP"OS$\\]<'H1C.>WHHHJMJ=G]NBDM\X\Q&7.,XW C..,XS6'X.\
M'?\ "-^9^\\SS=G\&W&W=_M-G.ZKWBCP\NOPFV8[3N#*V"<$=\9&<@D?CGM5
M;PAX17PXCJ&WM(P);!7@#@8W$<$DY]_:I/%WAK_A(8EM]^S:X;.W=T##&,CU
MJUX<T;^QH$M-V[9N^;&W.YBW3)]?6L_Q)X&M]=)D8%)2/OKWP"!D="/R. !N
M KFHO@Z 06G)7(R!'@D=\'><'WP?I79>'_#<.@H8H0?F.69L%CZ9( X'8  ?
MB23G^,?!W_"2>7^\\ORM_P#!NSNV_P"TN,;:Z6L'Q5K=K9!;:\!,=P'&=N5&
MW!YQ\P.2,$ D'GC&:YW4/A%'*Y:&4HI_A9=^.3T.Y3C' SD^I-9_B+P7;^&[
M.21F+S2%%5F& #OW':!G:2H.22>F 1G![#P#;-;V,*N,$JS=CP[%E/'J"#3?
M$G@:WUTF1@4E(^^O? (&1T(_(X &X"N:B^#H!!:<E<C($>"1WP=YP??!^E=E
MX?\ #<.@H8H0?F.69L%CZ9( X'8  ?B23G^,?!W_  DGE_O/+\K?_!NSNV_[
M2XQMKI:*HZWI[:C"]LC[#(NW=M#<'[PP2.HR/;.:R_!_@\>&PXWEVD*Y.W:
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MXR0. <@^N0 *NZ=\(X83NGD:0 C 4!!QU!Y8D'V((]?3NXHA$ B@!5   &
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MRN!UXR1SQ@#%0:?\(HXG#32EU'\*KLSR.IW,<8X.,'T(KO8HA$ B@!5   &
M .@ ]*?3)8A*"C %6!!!&00>H(]*X+4/A%'*Y:&4HI_A9=^.3T.Y3C' SD^I
M-2Z5\)8;=MT[F4=E \L=#UPQ)[8P1TYS6EI/@8:5=M>PR81]V8]@QAN=H8'@
M!L$8'08]34G_  AW^G_VKYG_  #9_P!,_+^]N_'I[>]=+7->,?!W_"2>7^\\
MORM_\&[.[;_M+C&VNEKC?$'PQ@U)O-A/DL<9"J"G _NC;@].AQQTR2:BT#X7
M1Z;(MQ)(9"C!E 78,CG)Y8GG!'(Z<Y!Q6EX.\'?\(WYG[SS/-V?P;<;=W^TV
M<[JZ6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBF2H
M7!4$@D'D8R/<9!&1[@CVJEH&CC1X$M%)8(#R>,DDL>.PR>!V'<]:T*******
M******************QO%/AE/$$7DMA7!!5\9*\C/&1D$<$9QT/4"N*@TG6M
M*'V>%MR+C!#1L.@&!YOS #IC 'IZU:LO UWK,BW&IR909/EAN>PQA1L4' )*
MG)]B<CT&*(1 (H 50  !@ #H /2GT4444444445R/C'P.=8=;JW81SIWY&[!
M&TEEY!4 X."3P. !C"BCUV,!1G  ')@)X]2<DGW/)K6\+^ 6M)3>WKB68$;>
M68# &&)8 EAT'88SR<;>UHHHHHHHHHHHHHHHHHHHHHHHHKEO&VDW&M^790C;
M"S;I9"1@8Z#;NRWKC&,[>1@XZ2VMEM46)!A44*!R< # '//2J7B'11K4)MF8
MJK,I;: 20K D<@XSCJ.AQU&0=*BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBJ>KV!U"&2W#%/,0KN !QD8Z'MV/0XZ$'D2V-H+*-(%R5C15&>N%&!GISQ4]
M%%%%8?C33I-2M)+>$;G;9@9 Z.I/)('04>"].DTVTCMYAM==^1D'J[$<@D=#
M6Y1111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111117->,?&/_"-^7^[\SS=_P#'MQMV_P"RV<[JZ6BBN:\'
M>,?^$D\S]WY?E;/X]V=V[_97&-M=+1111116?IVO0ZD[Q0L'\H)N9<%?GS@
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M01T-:6@^,K;6_EB;#_W'^5^_09(/ S\I.!UQ6Y7/^(/'%MH;>5(2TG&5C&2
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MH,G)/&.1GI:QO$'BVWT$ 3,=Y&0BC+$9QGL /J1G!QDBL:V^*UG*P5A(@/\
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M?+QWP"6P>WRYYY KL**\H^+MRS7$<1/RK%N XZLS GUY"C\J].TVVCMHTC@
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MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKQWP9);R74C:CCS26(\T 1[B3OW X
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MCR1G !.,\]*]$T_P79V*",1(WJ9%#L3@#.6!QG'08&>@%<%X\T5/#=Q#>6X
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M6FI<\92VCQD$C<4 4''."Q _J*YCP)X135PVIW@WF1V*@X"DALLY ZY;(VD
M8!R"",=;J'@NSOD,9B1?0QJ$8'!&<J!G&>AR,]0:Y3P'</H=W+H\A&TEBO')
M8 $'@G 9!D@GC '!SG/^*5LUU>Q1(,L\2*!P,DR. .>.M=S%X'LTB%L8E( '
MS$?O#SG)<8;)/H0.V,<5RWCRX?7+N+1XR-H*EN.0Q!)/)&0J'( /.2.3C'5Z
M?X+L[%!&(D;U,BAV)P!G+ XSCH,#/0"O._B+X1CT1DF@!$<F01R0K #^(Y/S
M#)P>>#@XX'?0ZH-*TU+GC*6T>,@D;B@"@XYP6(']17,>!/"*:N&U.\&\R.Q4
M' 4D-EG('7+9&T@# .001CK=0\%V=\AC,2+Z&-0C X(SE0,XST.1GJ#7*> [
MA]#NY='D(VDL5XY+  @\$X#(,D$\8 X.<Y/B;2SJNKM;<X=XLX(!VB-2Q&>,
MA03_ $->C)X2M$V;84!B964J,-E>A+#EO?).3R<UKT5S_C+PFOB&,+G;+'DH
MQSCG&01Z' YZCJ,\@^?Q#5/"A,:AS$GS'"^9%M4DDYP=H/)/W6QR<<5JZ7\7
MB#BYB&,GYHCC QQ\K$Y.>^X<=N.?1+*]2^19XF#(XR"/\]?4=0>#S7GOC7_D
M*VG_ &P_]'-7I-<1\6_^/1/^NZ_^@/6E_P PK_MQ_P#:-<)\.O",>ML\TX)C
MCP .0&8@_P 0P?E&#@<\C)QP?1-0\%V=\AC,2+Z&-0C X(SE0,XST.1GJ#7)
M> I'T*]ETF0\-DKUY91D$ $@;DY.>> ,Y&*])JGJ^G#4H9+9L8D0C)&[!(X;
M'J#R/<5Q/PJNS;&?39,!XWW8ZG(^1^1D8!"X^IZCH[XF2_;I;;30V/,<%OES
MC<0B-VSC+< _7M4OPDU#S8)+<DDQ/D9Z!7' '/JK$CISGN:H^.?^)[?P::O(
M3&['##?AGY;CA%!'!YR.3Q71?$&(1:?*B@!5$8  P !(F !Z4[X<_P#'A#_V
MT_\ 1C5S?@K_ )"MW_VW_P#1RT?&/_EW_P"VO_LE>DT5Q'Q;_P"/1/\ KNO_
M * ].\$^$(6MTNKA!)+(G_+7#@+P$ !R -H&.XSC(' YWXCZ2FASPW=L!&6Y
M 50 &B*D-CISD<8QQDYR:[+0/ EMIT:K)&CR%1O9QO&[OC<, 9/& "1C.37)
M:SIZ:%JL'V8;!(T9(&,#S'*, ,< CMVSQCC':>-M=.BVK3(0)"0J9&>3U]LA
M02,\9'.>AY_P)X$A$*7=PH>20;E5L%54@XXR020<\].. 02=S6O =KJ2%!&L
M;X.UHU"X)QU P&''0]LX()S6'\,-4>/S=+FP&@)VC'(^8B09'! 8C'?D\D=,
M#Q-I9U75VMN<.\6<$ [1&I8C/&0H)_H:]&3PE:)LVPH#$RLI48;*]"6'+>^2
M<GDYKB-;C;Q?J/V'=^XM]V2H (Q@2?>ZDOA>X'! (R3VL?@VSC3R1 FW!&2N
M6Y_VSEL\\'.1VQBO*_'GAI="G"QY\J1=RY!P.2"H;OC@^H!&<]3Z?XVUTZ+:
MM,A D)"ID9Y/7VR%!(SQD<YZ'G_ G@2$0I=W"AY)!N56P552#CC)!)!SSTXX
M!!)W-:\!VNI(4$:QO@[6C4+@G'4# 8<=#VS@@G-8?PPU1X_-TN; : G:,<CY
MB)!D<$!B,=^3R1T[ZBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN/
MUSP':Z^7FA8)+O(=HR&7=QN#+G[WT*G)RV:Y2Y^'M]HVZ:V?=C(_<LRR%>O3
MCT'R@L<XQGK76_#KQ1)KD;K,<R1,,M@ %6SCIQD$'L!C'4YK$\%?\A6[_P"V
M_P#Z.6O2:\V\:_\ (5M/^V'_ *.:CXQ_\N__ &U_]DKT:*42@.I!5@""#D$'
MH0?2LOQ=<K;V<[.< Q.O<\N-JCCU) K!^$T12T8D$!IF(R.HVJ,CU&01]0:R
M_@Y_R\?]LO\ V>LWQ5HW]I:JUN[>6)MF&8<?ZL 8R1G+#:.>O'7BM+_A3G_3
MQ_Y"_P#LZBN?A,EJIDDN@JCJ6C  R<=3)CK4_C;0CI.F16H)<139+!<<-YAR
M1DX&6 Z]<>M=EX5E$EI 5((\F,<'/(4 CZ@C!]#6K5'2M;AU9=\#AP.N.".2
M.5.",X.,CGM7"?!S_EX_[9?^SUZ317$?%O\ X]$_Z[K_ .@/72^&?^/2W_ZX
M1?\ H KAO"<@M=7N$DRK2&8*"#SEPX_ J"0>A'U%>EUPGQ=N56WCB)^9I=P'
M/158$^G!8?G75^'HC%;0(P(988P01@@A!D$>M:%<1\6_^/1/^NZ_^@/72^&?
M^/2W_P"N$7_H KB/^8]_G_GWKTFO-OC'_P N_P#VU_\ 9*U/BS$7M%(!(692
M<#H-K#)]!D@?4BL#2/A:-2ACN5N!B1 <"/=@D<KG?U!X/N*M_P#"G/\ IX_\
MA?\ V=:_@OP6FBRO<).)<*T9"J!ALJ2"0S<C'(Z\UV59_B&(RVTZ*"6:&0
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MU)/T &3Z"N$\,_#H:Y MT)PI)8%0F[:02,$[QR1@].A%:G_"G/\ IX_\A?\
MV=7O#'P^32KD3K<!VASN0( 1O0@9^<D<'(R.:H_&/_EW_P"VO_LE=)\1O^/"
M;_MG_P"C%H^'/_'A#_VT_P#1C5TM>;?!S_EX_P"V7_L]>DT45S7Q&_X\)O\
MMG_Z,6LWX2?\>C_]=V_] 2L30O\ B1ZP]O\ (JR,Z\< *X\Q .@!SM7'3L.Q
MHT+_ (GFL/<?(RQL[<<@J@\M".H)SM;/3N.PJS\8_P#EW_[:_P#LE:FN1&31
ME"@D_9X#P,\#82?H ,GT%<OX9^'0UR!;H3A22P*A-VT@D8)WCDC!Z="*U/\
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M #[UZ37FWA#]QJURK_*6\[ ;@G,BL, ]<KR/;GI7I->:?&*4$VZ9&X"0D9Y
M.S!QZ'!Q]#Z5K?%F(O:*0"0LRDX'0;6&3Z#) ^I%8&D?"T:E#'<K<#$B X$>
M[!(Y7._J#P?<5;_X4Y_T\?\ D+_[.M?P7X+3197N$G$N%:,A5 PV5)!(9N1C
MD=>:[*BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBHKFV6Z1HG&5=2I
M'(R",$<<]*\ICGO/ ,C)C?;LPY(.QO<'^%\ @CGU(8!35V?XJ3WX\FU@Q*V<
M8)E/0]%"CD=><CCD&NG\!>%CH,)\S'FRD%L'. !\J]<$C)R1W..0 :Y3Q%HU
MWX=NWU.U!,;,6)'S#YLLZNHP=N0>>@&WYMW2S_PM>6\_=6]OF5ON_,9.G)^5
M54GC/?CK6)<:9-8ZA;&Z;=-,\,C>Q,F-N1QP%[<#H. "=OXQ_P#+O_VU_P#9
M*B3Q/=^"S]CN$\V(;O*8G:2H.!AAN& /X3\PR.<8%1RZG>>/&%O&OE6V[YF&
M2. #AFX#$'D*,=03TW#T;2=+32HEMHL[$'&3D\G))]R23Z>@ K@O@Y_R\?\
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MP>^,=<D@9'C7_D*VG_;#_P!'-7I-<1\6_P#CT3_KNO\ Z ]:]II2ZMIT=J_
MDMHQGG@A%*G@C." <9YZ5PEAK]YX(8VDZ;XMQV@Y /')1\8P202,''HI)JS?
M>/[GQ&ILK6'!D4AL'S#M8@=<*%'."3D<]1UKN?"7A\:#;K;Y!<DLY&<%CZ9[
M  #MG&< FMFL;Q;X?&O6[6^0'!#(3G 8>N.Q!([XSG!(KS_2_&]UX7'V*ZB+
M! =H<E6 S@8;!#(,''!]FP *EOO$]UXT'V&WB"1L5WGEL8)(W/@!5XSC&21@
M$YQ7H6G:#'9VPL.J!"K=1NW9WGJ2-Q)/!XSQ7GH%YX$D<HA>T9\\G<N,C!)&
M-CX(7)&">S8%69?BK-?@P6T!$K [2&,A'<D($&2!GV[D$<5I?#_P<]D3J%UG
MSI <*W+#=R6)/.\_F 2#R2!%\6=*DNHXIT!98B^[ )(# '=P.%&TY)Z9%:?@
MOQR/$):%T"2(@/!)#=F(X^4 XX))Y]C75T5YMX*_Y"MW_P!M_P#T<M=AXM\/
MC7K=K?(#@AD)S@,/7'8@D=\9S@D5PEAXNO/"0%I=Q%D (3<<'L<!QN5E4'IR
M1G&0!BB_\77GBT&TM(BJ$ /M.3W."YVJJL!TX)QC)!Q7=^$O#XT&W6WR"Y)9
MR,X+'TSV  ';.,X!-<?X*_Y"MW_VW_\ 1RUZ37EOB]Y?#^I#4PFY#M(.#MY3
M85+8P&P"1UXP<'I74KXA77].GN5&T^5,K+DG!"'C.!G((/XX[51^$G_'H_\
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MZE2.1D$8(XYZ5Y@!>>!)'*(7M&?/)W+C(P21C8^"%R1@GLV!5F7XJS7X,%M
M1*P.TAC(1W)"!!D@9]NY!'%:7P_\'/9$ZA=9\Z0'"MRPW<EB3SO/Y@$@\D@9
M_P 8_P#EW_[:_P#LE=)\1O\ CPF_[9_^C%H^'/\ QX0_]M/_ $8U=+7FWP<_
MY>/^V7_L]=)_PF/^G_V5Y?\ P/?_ -,_,^[M_#K[^U=+17-?$;_CPF_[9_\
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M-;2YV..<'!X.01[@@'T]017FECJ][X'_ '$\>^#<<<G;SN^ZXR!DC.TC..<
MDFI[WXD7&LHUO:0LLA'+(3(P7H< *,'D#=V[<X(Z7P%X..@H99<&:4#.,':.
MNT'U_O<X) QTR<'_ )CW^?\ GWKTFN$\<>%YA,NJ6(/G+]_:>?E7 (4]>!M*
M\YX&TY-9A^+<L*F.2 "9=P)W%0&!/5"">.XW9]QVYGQ5%=3%;V\!5IBX52""
M F.-I^ZOS<9Y/)/7)]HU;2TU6)K:7.QQS@X/!R"/<$ ^GJ"*\TL=7O? _P"X
MGCWP;CCD[>=WW7&0,D9VD9QS@$DU/>_$BXUE&M[2%ED(Y9"9&"]#@!1@\@;N
MW;G!'2^ O!QT%#++@S2@9Q@[1UV@^O\ >YP2!CID]7111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111116-KGBZVT4^7,Q#[-P4*Q)'(&#C&2
M1CDCWP*Y3X/6S*D\I'RLR*#QU4,2/7@,/SKT2BBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBN:NP;[48D (%I$[EMIP3+\@7) '0$Y!.<$=0<=+1111
M111111117#>/-3NM#GBOHV/D$*C)NX)#%B,$$ LHP& R,'IQG0MOB78RJ&9R
MA/\ "R,2.?\ 9##\C7+>)]<;QI)'I]DI**Q9F8  XX#]R% )Z\G=C;G&?3;:
MV6U18D&%10H')P , <\]*EHHHHHHHJM>:9%?8\Z-'VYQO4-C/7&0<9Q19Z9%
M8Y\F-$W8SL4+G'3. ,XS5FBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO/\ Q)K]
MQX:OA.[%K6;'R @_=4*V WW2"=W& W&3UQLQ?$BQ<!C(02!P4?(]CA2,CV)'
MO7*75TWCR\C6-#]F@P6WX'!(+Y*\@L!M !/3/'./4J******************
M************************************************************
M************************************************************
M************************************************************
M************************************R-7\)VVKN)9TW,%V@[G' )./
ME8#J36A9626*+!$H5$& !_GKZGJ3R>:GHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHIDL0E!1@"K @@C((/4$>E8$OP]L9"6,(R2
M3P[@<^@#  >PX%:VG:1#IHVP(J# !V@ G;TR>I/N<FKE%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%17-LETICD4,IZA@"#@YZ'CK7/\ _"N;#_GE
M_P"1)/\ XJMZTL8[(;(D5%)SA%"C/K@8YXJ>BBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBH+N^CLAOE=44G&78*,^F3CGBI(I1* ZD%6
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MA4C&>L_PMU V4DVF2G#;B0ORXW+\L@SG). .!D84GZ^DUYM\8_\ EW_[:_\
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M8'Z0>#I?^$=U&73W)"2$JNXKR1\T1)XY*DC ZE@,9Z>H5Q'Q;_X]$_Z[K_Z
M]9'A/X=V^KVT=U(T@9]V0I4#AV7NI/0>M:=S\(K=E(CDD5NQ;:PZ^@52>/<5
MS^DZO<>"KD65PV83MR,L4"MSO3(SP2<X&"01UP1ZW11111111111116'_P (
MC%]K_M3+^;Z9&S[FSIMST]^M;E%%97B+P['K\8@E+!5<-\A .0".X/'-7K&T
M%E&D"Y*QHJC/7"C STYXJ>BBBBBBBBBBBBBBBBBBBBBBBBO-O&O_ "%;3_MA
M_P"CFKTFBBBBBO-O&O\ R%;3_MA_Z.:ND^(W_'A-_P!L_P#T8M'PY_X\(?\
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M_P!LO_9Z/C'_ ,N__;7_ -DKT:*(1 (H 50  !@ #H /2N=^(W_'A-_VS_\
M1BT?#G_CPA_[:?\ HQJZ6N?\5>)K71]@N!O;<&50JLPQG#_,0!@\ YSG..AQ
MRW_"TKB_^2UMLN.3RTOR]#\JA3U(YSCVYK$\7:I?ZE$LEU'Y<(< #9L^?#$'
M#$OT)Y^[QZUW_P#S"O\ MQ_]HUE_".("VD? W&8@G') 1<#/H,G'U-=S7FW@
MK_D*W?\ VW_]'+1X0_?ZM<L_S%?.P6Y(Q(JC!/3"\#VXZ5Z37F/QAME5X)0/
MF974GGHI4@>G!8_G7IU%>;?\Q[_/_/O1\8_^7?\ [:_^R5Z-%$(@$4 *H
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MNTL1Z[B#G/.0:Z_PO\18]<D%LR&.1L[1G<IP,]< @XSVQ@=<G%8GQC_Y=_\
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M@L>.!SQZ)17&^(O']KI$K!4\RX10I90H YR4+\GCJ0 1G@X.<9'_  L:]O\
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M_P!<(O\ T 5Y[\*M7AL#.LSJA<1D;R%!V[L\GC/S#CK^1JW\8_\ EW_[:_\
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MG_7!?_0WKU2^M!>QO V0LB,IQUPPP<=>>:\0_M&2PMI]-<X)G3*8!^[N#_,
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MULMJBQ(,*BA0.3@ 8 YYZ5+7#>*_&%QH-W&K@&U(SA!\S C!!9N-RGD!<<$
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MKA1@9Z<\5E:]X-MM;^:5</\ WT^5^W4X(/ Q\P.!TQ63;?"FSB8,QD<#^%F
M!X_V54_D:ZVVMDM5$<:A5'0*  ,G/0<=:R-4\(Q:E<1WSEP\.S 4C;\C%AD%
M2>IYY'%7M:TA-7A:UD)"OC)7 /#!NX(ZCTHT72$TB%;6,DJF<%L$\L6[ #J?
M2LWQY>):V4I< [UV@,0,LQP",YR5^\._R]NHS?A=HQL;8SL,-.V>^=@X7(/'
M7)&.H(.?3LJ*************************************************
M************************************************************
M************************************************************
M************************************************************
M**********************************************9+$)048 JP(((R
M"#U!'I7.^$O#4GA]I8=P:W=MR9.'!Q@Y&W!R,#.?X<A1DXZ6BBBBBBBBBBBB
MBBBBBBBBBBN(\3_#G[?(;RU?RYBP;!X7<,<@J,J>"2<,2WI6;_PK[4+S]U<7
M68F^]^\DDZ<CY6"@\X[\=:[+PUX:CT"/RH^6."[D<L?Z =AV]R23KT444444
M5S&A^%7ANI=3N2K2R$A O*JO ')53N &W( XSG.[CIZHQZ/&D[7O/F,@3EB0
M%!SP.@R<9[<9&"6)O4444444444444444444444444444444444444444444
M44444445C>*/"\?B&,1.2K*258 $@D$8Y'W>A(!&<#FN-C^'^HV@\J&Y C4G
M:!+*G&<_= (!/4@$\]S6SX:^'2Z=)]LN'\V7@C(. YY+9))8YZ$X]<9QCLJ*
M**************************BN8//1H\E=RD94X89&,@]B.Q]:\[C^&MW?
MNOVVXW(O3#O(W)&0-X 7('7GD#@UZ-%$(@$4 *H   P !T 'I3Z*********
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M********************************Y'P#XNE\0^;YP0>7LQL!'WMV<Y8^
ME==11111117(^/O%TOA[RO)"'S-^=X)^[MQC##UKKJ*****YK1-;N[J[EMYH
MML";]C['7=M<!?F)P<CGCKU'%=+17.^.?$4F@0+/$%+-(%^<$C!5CV(YXK6T
M>[-[!%.V TD:,<=,LH)QUXYK&\':W=ZGYGVN+RMFS;\CIG.[/WR<XP.GK72T
M4444444444445P/B'XBRQ7'V.RC$C(6#;E9B67J%52#A<')[]N!D[G@_5[O4
M@[7<0B"E0GRLA/7=PQ)P.,'@=>N..BKD?'WBZ7P]Y7DA#YF_.\$_=VXQAAZU
MA1>.M4E =;8%6 ((AE((/0@[NE$OCK5(@7:V 5022890 !U).[I6MX5^)*:L
MXMIE$<C !3NRK-W'(^4G^$$G/3.<9[6BBBBBN=\<^(I- @6>(*6:0+\X)&"K
M'L1SQ5O^UW^Q?;L#?]F\S'.W=Y>[&,YQGWSCO7)>%OB:]_.MO<JBK)\JF-6S
MO) 4'+'@].G7'09->B5D>+-7?2+:2ZC +)MP&R1RZKV(/0^M5/ WB*37X&GE
M"AED*_("!@*I[D\\UT5%%5M1U&/38S<3':BXR<$]2 . ">IJ#0=8&L0K=*"J
MN6P#UPK%1GW.,X[=,GK6A15;4M033HWN)#A8U)/3/'89(&2> .YXK*\'ZS-K
M41NI5549SY87).T'&2<G)SQT7IG&",2S>*8DNDTU<M*Q.[@@* A<<D<D\8 ]
M\D8P;NL79LH)9UP6CC=AGIE5)&>G'%9/@;Q%)K\#3RA0RR%?D! P%4]R>>:Z
M*BBBBBBL;4==:&ZAL8E#-(&:0G<-J#(!R 1DGI[C!QN! FNM->&QC4%(H]TC
MG<,,V-BCC&<<]>03@Y4@Y7C[Q=+X>\KR0A\S?G>"?N[<8PP]:@\">.9-?D>"
M95#*@9=@(& <-G+'GD8Q[Y[5VM9OB35_[(MY+K&2B\#J-Q(5<\CC)&><XZ5P
M.C_%"YO9XH&2(+)(BG"OG#, <?.>>:]0HHHHHHHHHHHHHHHHK&\6^(!H-NUQ
M@%R0J YP6/KCL ">V<8R":Y_P=X^EU2?[)<HJ,Z;DVAAGC=C!+<%?F!X&!WR
M*[FBBBBBBBBBBBBBBBBBBBBBBBBBL:;Q3$ETFFKEI6)W<$!0$+CDCDGC 'OD
MC&#LT5SOCGQ%)H$"SQ!2S2!?G!(P58]B.>*Y.V\?ZE=*)([<,IZ%892#@XZA
ML=:?+XZU2(%VM@%4$DF&4  =23NZ5TWA/QQ'XA)B"E)57<5/(QG&0PQG&1G(
M'7C.":Z6BBBBBBBBBBBBBBBBBBN=\<^(I- @6>(*6:0+\X)&"K'L1SQ4EWK,
MXL5O84#S-'$P0*S E]N["@YP 3WK(G\87/\ 9\>HQQJTC.V\!7*A5+Y; ;(
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MD]^G0$UO5SOAWQS!K\A@B5PRH6^<*!@$#LQYYK?EE$0+L0%4$DDX  ZDGTK
MTCQS!JD<TZ*X6W3<VX*"1ACQACS\IZXJ!?B-:F#[8=X&\H%(7>Q 4G #8P P
MR21Z=2,X,7QB!(#0$+D9(DR0.^!L&3[9'U%=KH?B*'6T\R!LXQN!&&4D9P1_
M49!(."<59U#4H].0RS,$4=V..Q.!W)P. .3VKA+GXPHK$1P%E[%G"GIZ!6 Y
M]S6SX<^(UOJY$+YBE8X"MRI)S@!L#G@=0.3@9KJZXK7/BE;V)\N$&9@>2#M3
MN#AL')X[#!!R&J/1?BM#>N(ID,6X@!MP9><_>.%P.G.".>< 9K/^#G_+Q_VR
M_P#9Z])HKD?$7Q(@TAV@4&21,9VD! <\J6Y.0.N >>#@YQEVGQ@C<XEA95QU
M1@YS]"$X]\_A7=V5ZE\BSQ,&1QD$?YZ^HZ@\'FLKPUXNB\0[_)#CR]N=X ^]
MG&,,?2MRL/\ X2Z+[7_9>'\WUP-GW-_7=GI[=:Y+XQ_\N_\ VU_]DK0UKXK0
MV3F*%#+M)!;<%7C'W3ALCKS@#CC(.:DT/XI6]\?+F!A8G@D[D[ 9; P>>XP
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M,CC((_SU]1U!X/-9OB#Q;;Z" )F.\C(11EB,XSV 'U(S@XR17'_\+C_Z=_\
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M>)SC=M.& R!GH#P#P:N^&]!&A0BV5V< YRW8D#( [+GG'/)/)KB_@Y_R\?\
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M""",@@]01Z5YA_9D7]M?9_+3RO[FT;/]1G[N,=>?KS7=Z[;):V<\<:A5$$N
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M5V+2SG=LX,;+QZO\@_#+<^U8WPIMFBLRS# DE9EZ<@!5S^:D5D>"O^0K=_\
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M0K=_]M__ $<M4?%&D)=:L(K@E8Y]F"N,G*;%[-C+KCD>_3FN@_X5):?WY?\
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M (BL^_\  >FZ>ZPS3NCN"0&=!P.Y.S 'IDC)X&33_C#;,R02@?*K.I/'5@I
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MDT*YW%,@ ;B2A#A0/4XQ^/?I7+?##09K=Y+NX5U;8L:^9D9'&>&YP J@=L9
MZ<=EXAB,MM.B@EFAD  &224. !ZUS_POL9+*V=)49&,S'#J5.-B<X...*["O
M/_"&F2P:E<S/&ZHWG89E(4YE4C!(P<CD>U;/C?P</$" Q[5F0C#-GE>ZDC/'
M.1P<'@8R37,0>(=7TL?9WA,A7'S-&SG&!@;XSAOKR<YR::/#E]XNF2:]!BA
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M1@0RPQ@@C!!"#((]:T*\T\>>%);:X74;-69F<,0B!MKK@AL <AL9.0><Y/S
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M;X,U&^TETT^6!_(#D%O*8E=Q/1P0I4,<D\\9P<8KTFBO.]8A_LO68;ELE9\
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M(#&&'S$(T61T*[I&Q@YY Y(]LUV'@WPFOAZ,KG=+)@NPSCC. !Z#)YZGJ<<
M<_X0TR6#4KF9XW5&\[#,I"G,JD8)&#D<CVKT"N-\<>"GU1EO+7"SIUY*EL#*
MD,. P(P"<=>6 45AGQ3J\"F%H"S#<-_DL3G)Y!7Y#CL0"#[]^;\5Z'<6.RYO
M&S-<,Y(R"1LV@9(XYSP!P !]![%KVBIK,+6T@'S#Y21G:V.&'(Y'U&1D'@FO
M/;5-5\)?N$3S8CG:%5I$!."2-N'7Z' )R0#UHOWU7Q6HMVB\N,,-V5:(')X)
MWDE@N,X7/J03MKO?#?A]-!A%O&2><LQ[L0 3CL.  /0=SDGE/"&F2P:E<S/&
MZHWG89E(4YE4C!(P<CD>U>@45Y7XDT>X\0ZCM,<HA#JFXIM 1?OD,1C&=Q4G
M.<@>@KU2BO._BGX=DO'BN84=SM*,$&[&#N7@#/.6R>G Z=^D6P_X22R6.Y4K
M(R<^8FUED4%=^T8QSR.F5..A(KC;5-5\)?N$3S8CG:%5I$!."2-N'7Z' )R0
M#UJ#5+74?$B//= Q0PH[[2NP91,X"GYB3_>.0,M@_P )Z+X2?\>C_P#7=O\
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M*W_<DB2%Q(N,[B4!X&.0W/&.X XSD<UHOQ2%F@M[R-_,B 4E>6)7(.X.00W
MSR<G/3I4'B#Q\WB%?[/LHWS-@$L0&ZY*@*2 "!R2<;=P(QS7;^%=#_L2W2V.
M"PR6*C +$Y^IP,#)Y( X'0:]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>;>
M"O\ D*W?_;?_ -'+7I-%%%%%%%%%%%%%%%>?WB_\)5J0AQFWLL[LC@MGD<KW
M8!2#P55B#S7H%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%17-LETICD4,IZA@"#@
MYZ'CK3;2QCLALB144G.$4*,^N!CGBIZ*****************************
M****@M[&.W+.B*K.<L54 L>>21U/)Z^M3T44444444444444444444445F_\
M(S:?\\(O^_2?X5I44444444444453N]'@O3OEC1V QET5CCTR0>.:EM+&.R&
MR)%12<X10HSZX&.>*GHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJM!ID4#F
M9(T5VSEE4!CDY.2!DY/)]ZLT444444444444445!:6,=D-D2*BDYPBA1GUP,
M<\5/11111111111111111111111111111111111111111111111111111111
[encoded data, 6222 characters]
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MZCJ\.FC=.ZH,$C<0"=O7 ZD^PR:R8OB%8R$*)ADD#E' Y]25  ]SP*WXI1*
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M$(X8<@9P01G'/6K>O:*^JZ5 L0)>..%PH&2V(\$#GKAB>Y., 9-8GASXD'2
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MY=N._)7>1@')Q@GD&O6:\V^#G_+Q_P!LO_9Z])HHHHJ*YN5M4:5SA44L3R<
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MQ[_/_/O1_P Q[_/_ #[U+X]MFT.ZBUF(=6"N..2!C'.?O)D<#C&>IJ+X.?\
M+Q_VR_\ 9Z])HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK(\2^)8] C\
MV3ECD(@/+'^@'<]O<D \%X?\/S>,ICJ%X3Y.> ,C=@_<7T0=SU)R =V2/48H
MA$ B@!5   &  .@ ]*?1117DGA__ )#+?]=[C^4E>D^)O^/2X_ZX2_\ H!KF
MOA)_QZ/_ -=V_P#0$KMZ\V\%?\A6[_[;_P#HY:])HHHHIDLHB!=B J@DDG
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M@#N44YP/ND_4<=E!X@&O:;-<8 <0S*X&<!@AZ9[$$'OC.,DBJ?PD_P"/1_\
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M(/\ GKZ'J#R.:K6F@PVD+6:*1$P8%2S'AAA@"22 ?8CG)ZFLK_A7-A_SR_\
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MJ;Q+XNB\/;/.#GS-V-@!^[C.<L/6MRBBO)/#_P#R&6_Z[W'\I*];KR:WN)?
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ML%]&^^#"C8%SM X!!(' Q@C(88/N:-R\WCZY3:A6UC8C=C&%X+9;!&\C&%Y
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M#.<-6SJGBZ+3;B.Q<.7FV8*@;?G8J,DL#U'/!XK<HHHHHKFOB-_QX3?]L_\
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M3D\GWKS_ /YCW^?^?>N]DT>"1_/:-#)D'>44MD=#NQG(QQZ5<KS;XQ_\N_\
MVU_]DKT"\TR*^QYT:/MSC>H;&>N,@XSBIHHA$ B@!5   &  .@ ]*)8A*"C
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ME/\ XNC_ (6W:?W)?^^4_P#BZ/\ A;=I_<E_[Y3_ .+H_P"%MVG]R7_OE/\
MXNC_ (6W:?W)?^^4_P#BZ/\ A;=I_<E_[Y3_ .+H_P"%MVG]R7_OE/\ XNC_
M (6W:?W)?^^4_P#BZ/\ A;=I_<E_[Y3_ .+H_P"%MVG]R7_OE/\ XNI['XH6
MU[(D"I*&D=5&53&6.!GYSQS7844444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444445F^)O\ CTN/^N$O_H!KC_A?H\%[;.\L:.PF89=%8XV)QD@\<UV'_",V
MG_/"+_OTG^%'_",VG_/"+_OTG^%'_",VG_/"+_OTG^%'_",VG_/"+_OTG^%'
M_",VG_/"+_OTG^%'_",VG_/"+_OTG^%'_",VG_/"+_OTG^%'_",VG_/"+_OT
MG^%'_",VG_/"+_OTG^%'_",VG_/"+_OTG^%'_",VG_/"+_OTG^%<G=6,=EK%
MLD2*BF%CA%"C.V7G QSQ7?444444445YIXZB$NJ6J, 580@@C((,K9!'I7<_
M\(S:?\\(O^_2?X4?\(S:?\\(O^_2?X4?\(S:?\\(O^_2?X4?\(S:?\\(O^_2
M?X4?\(S:?\\(O^_2?X4?\(S:?\\(O^_2?X4?\(S:?\\(O^_2?X4?\(S:?\\(
MO^_2?X4?\(S:?\\(O^_2?X4?\(S:?\\(O^_2?X4?\(S:?\\(O^_2?X5G^(?#
MUM%;3NL,0989""(T!!"'!!QUK*^$G_'H_P#UW;_T!*[>BBBBBBBBO/?A?H\%
M[;.\L:.PF89=%8XV)QD@\<UV'_",VG_/"+_OTG^%'_",VG_/"+_OTG^%'_",
MVG_/"+_OTG^%'_",VG_/"+_OTG^%'_",VG_/"+_OTG^%'_",VG_/"+_OTG^%
M'_",VG_/"+_OTG^%'_",VG_/"+_OTG^%'_",VG_/"+_OTG^%'_",VG_/"+_O
MTG^%'_",VG_/"+_OTG^%<#XJL8[+5+5(D5%)A.$4*,^:><#'/%>H44444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444444444444444444444444444444445Q7BSQ)-:WMO81D+'
M(\+,1G<<R$%<Y^Z<#/&3TS@D5VM%%%%%%%<5XL\236M[;V$9"QR/"S$9W',A
M!7.?NG SQD],X)%='XF_X]+C_KA+_P"@&N:^$G_'H_\ UW;_ - 2NWHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHKBO#_B2;4]1FMW($<"2JJKD [95 8\G+
M8X]!V R<]'XCT;^V8'M-VW?M^;&[&U@W3(]/6CPYHW]C0):;MVS=\V-N=S%N
MF3Z^M:5%%%%%%%%<5X?\23:GJ,UNY C@2555<@';*H#'DY;''H.P&3EOQ;_X
M]$_Z[K_Z ]=+X9_X]+?_ *X1?^@"M*BBBBN*\6>))K6]M[",A8Y'A9B,[CF0
M@KG/W3@9XR>F<$BNUHHHHHHHHHHHHHHHHKS;X.?\O'_;+_V>O2:*********
M****P_%WAK_A(8EM]^S:X;.W=T##&,CUK3TRS^PQ1V^<^6BKG&,[0!G'.,XJ
MS6;XF_X]+C_KA+_Z :YKX2?\>C_]=V_] 2NWHHHK-\3?\>EQ_P!<)?\ T US
M7PD_X]'_ .N[?^@)7;T4444444445Q&J_P#(9MO^N#?RFKMZ********\V\:
M_P#(5M/^V'_HYJ])HHHHHHHHHHK-\3?\>EQ_UPE_] -<U\)/^/1_^N[?^@)7
M;T44444445Q'PD_X]'_Z[M_Z E=O11111111117FWC7_ )"MI_VP_P#1S5Z3
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111115/5TD>&00$B78=A&
MW[P&0/F!&">#GL>HZUSOPZ\42:Y&ZS',D3#+8 !5LXZ<9!![ 8QU.:Z>^NQ9
M1O.V2L:,QQUPHR<=.>*Y3X>:U<ZWYMS.V8PP5% 0*">6' W?*-N,GH3U/3(U
M;Q==:[<FPTX[4&Y2XP<CH7W<[5'\)7D]>I $%[I6K: C78G,@4?, [2X'4MM
MD7&!CDCD#VS79>#O% \00^80%D0X=0>^.& SG:>V>X(YQD^8:W]O^UQ?:?\
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MYX#'OSWK-\8:S]CU3SI%\Q;?R]JYV_P!QR!V=MW.<].E:7_"X_\ IW_\B_\
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M=I %  \F,\#')4$GZDG)]37._%O_ (]$_P"NZ_\ H#UTOAG_ (]+?_KA%_Z
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M%%9OB;_CTN/^N$O_ * :YKX2?\>C_P#7=O\ T!*[>BBBBBBBBN(^$G_'H_\
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M/90.Y/\ ]<X )KB?A?;->RW&IN,%V*C&-N7.]QCD\?+CV)Z]H/'4HBU2U=B
MJB$DDX  E;))]*[;Q1I9U2UEMQDLR?* 0,LOS*,GC!( /MW'6N4^&7BF/R18
M2,%=&.S/ 8,V< D\MN)XXR,8SS77:_K\>BQM-(PR%)52<%B.PZGJ1DX.,Y/%
M4?!6ORZY#Y\R!/F(!7.&QU(!' '3.XY(/3%=!1117FGCJ41:I:NQ 51"22<
M 2MDD^E=SXF_X]+C_KA+_P"@&N:^$G_'H_\ UW;_ - 2NE\3?\>EQ_UPE_\
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M?,QPW&1P0:B^+?\ QZ)_UW7_ - >NE\,_P#'I;_]<(O_ $ 5S7Q;_P"/1/\
MKNO_ * ]:]IJ#:=IT=RB;S';1MMW!> B[CD@]!D^^,5%X*\8+K\>'P)TSN4
M@8SPPR22,8!YX/H",X7Q)T&SLX/.55CF) 0)\N[!^8%1Q@ Y)P#G ST!HZK)
M,FBP@[OF<!L@GY-SE.O1>$P>., <&NB\":+9M;1S1JCOP69E#.L@P2,D97:>
M@&.,'G.3G_$OQ5"(6T]"'D<C=M((38P)S_M97&WJ.IQQG9^'/_'A#_VT_P#1
MC5S/@R4)JUT"0"QG R>I\T' ]3@$_0&NF^(W_'A-_P!L_P#T8M0^![07NF)
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M@P /\]?4]2>3S5'Q!X;AUY!%,#\IRK+@,/7!(/![@@C\0".-E^#H))6<A<G
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M444445YMXU_Y"MI_VP_]'-7I-%%%%%%%%%%9OB;_ (]+C_KA+_Z :YKX2?\
M'H__ %W;_P! 2NWHHHHHHHHKB/A)_P >C_\ 7=O_ $!*[>BBBBBBBBBBO-O&
MO_(5M/\ MA_Z.:O2:*******************************************
M************************************************************
M************************************************************
M************************************************************
M*************S8]%"W37Y8DF(1A<# &[<>0,G)QUZ<\D$!=*BBBBBBBBBBB
MBBBBBBBBBBBBBN(^&OAR?1O.^T)MW^7M^96SMWY^Z3ZBNWHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKEO%\>HAT:P;Y2I#+B+@@\'+\G(.
M,#ICWJ#P)X/DT@O=W)!FE [EB ?F;)Z%B<9Z].&.3784444444444445Q'PU
M\.3Z-YWVA-N_R]OS*V=N_/W2?45V]%%%%%%%%%%%%%9OB;_CTN/^N$O_ * :
MYKX2?\>C_P#7=O\ T!*[>BBBBBBBBBBN(U7_ )#-M_UP;^4U=O111111117F
MWC7_ )"MI_VP_P#1S5Z311111111116;XF_X]+C_ *X2_P#H!KFOA)_QZ/\
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M^N#?RFKMZ********\V\:_\ (5M/^V'_ *.:O2:**********S?$W_'I<?\
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MXW?>W8[],X[9XKIM+U:+54\Z!@R9(R,CD=B#@@_4=,'H:LRRB(%V("J"22<
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M8)!^F<\$XP,UKZCJ,>FQFXF.U%QDX)ZD < $]36-?^/K2SC6?>6$@)554[B
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M"+?3X5BDC1Y,9=G4/EB.<%A]WT&!QUYR3R.B6@T76#:09$9# @\\&+S,9/.
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M$D9Y *+@X]#@X^A]*[FO-O G[[4KJ9.4/F_,.5^:4%>1QR 2/4 T?\Q[_/\
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M<.Q!S@=2O'H0*K?#NT%EJ-Q N2L:2J,]<+*H&>G/%2^.I1%JEJ[$!5$)))P
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M(R<D=SCD &L;QWX:GBF75K+/F#;N" E\C@,!SD$84@#IR006Q1/Q;EA4QR0
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M&UJ-;\077B^-A%&8[>)&>0Y)4E!NP6P,GIA0.IR> "O1?"3_ (]'_P"N[?\
MH"5V]%%%9OB;_CTN/^N$O_H!KRWPCX^_X1Z)K?RM^YRV=^WJ%&,;3Z5M_P#"
MX_\ IW_\B_\ V%'_  N/_IW_ /(O_P!A1_PN/_IW_P#(O_V%'_"X_P#IW_\
M(O\ ]A1_PN/_ *=__(O_ -A1_P +C_Z=_P#R+_\ 84?\+C_Z=_\ R+_]A1_P
MN/\ Z=__ "+_ /84?\+C_P"G?_R+_P#84?\ "X_^G?\ \B__ &%'_"X_^G?_
M ,B__856T?Q+_P )#JD%QLV;4=<;MW1)#G.!ZUZE111111117EOQ(O/L.H07
M&,^6D;8SC.V1CC/.,XJS_P +C_Z=_P#R+_\ 84?\+C_Z=_\ R+_]A1_PN/\
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M<?\ T[_^1?\ ["C_ (7'_P!._P#Y%_\ L*/^%Q_]._\ Y%_^PH_X7'_T[_\
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M*******************SY?#UM*2[0Q%F)))C0DD]23CK5NVMDM5$<:A5'0*
M ,G/0<=:EHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHJCJ^BPZN@BG7<H;<!EAR 1GY2#T)JS;6RVJ+$@PJ*% Y. !@#GGI
M4M%%%%89\%69D-R8@79F8[BS ELY.TDKW]..U;E%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%5I]3B@<0
MO(BNV,*S ,<G P"<G)X'O5FBBBBBBBBBBBJ=WK$%D=DLB(Q&<.ZJ<>N"1QQ4
ML=]'(GGJZF/!.\,"N!U.[I@8Y]*K1^(;:0X6:(G!/$B'@#)/7H ,GT%6;2^C
MO1OB=74'&48,,^F1GGFIZ*************K7FIQ6./.D1-V<;V"YQUQDC.,U
M9HHHHHHHHJM/J<4#B%Y$5VQA68!CDX& 3DY/ ]ZLT44456_M.+S/L_F)YO\
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M#S. !@ ?0=<GJ:J?&/\ Y=_^VO\ [)7I-%%%%%<#X8U:6_U2=)6++$DRH.
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M'K'@VY\)#[=;RY5-NXK\C#+="N2&7.,C)R3RN!FNV%S+XET\26[>7-*J\Y*
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MDJ"H)4%6&3GD?,"F0.IP20,5Z7X;U?\ M>WCNL8+KR.@W E6QR>,@XYSCK7
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M:\H\(:[>:9&PM(!(K/\ ,_E.YR /EW*1P.H';)]:WO\ A-=5_P"?7_R!-_\
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M,;V]OO+FO4V*V_RUVA<8VAN#EQG /S?AQ7K^MZ4NK0O:OP)%QGG@CE3P1G!
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M]4Y3ISUW9Z\8[TWP<AUO4YM0R62,MM88'WLI&"" <; >V<@9.>KOC'_R[_\
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MZ.:M?XHZ,;ZV$ZC+0-GOG8>&P!QUP3GH 3GUD\+?$"#4(U6=PDRK\WF$*#C
MW!N%YSG'!'/&!FJ7C7XAI:IY-E(&E+#+* RJN,\$_*2>!QN &<X.*[+36D:-
M#/@2E06"C !/./O-TZ9SSU]JLUQ'Q;_X]$_Z[K_Z ]:7PY_X\(?^VG_HQJ\[
MNKEO#LE]9*=BR*55>&R"Z[1GG_EDS=3WY^;%>B?#S3OL-E'D8:3+GG.=Q^4]
M3C*!>/SYS7$^'_\ D,M_UWN/Y25M_%+3WA,.IQ##0L 6Y)&#NC.,%<!L\GN0
M.>V]HOCRUU) YD6-\#<LC!<$YZ$X##CJ.V,@$XK!\3?$%FEBMM.8.Q?#':"K
M'.U4!.!@GJ1VQANM;/Q!!&GRAB"V(\D# )\Q,X&3@>V3]:=\.?\ CPA_[:?^
MC&J7QUHQU6T>-1ETPZ#G.5ZX ZDKD >I_&L3P#XWBDA6UN'"/"N 7(564<#!
MX&0,#'4CG)YQG_$GQG'<I]@MV# D%V4@K@<A0><G."2#QC'.2!T7@.V6ZTV.
M)QE7652.1D%W!''/2N4\'>(AX4EET^[RJ;R=P!(# 8SC&XJX P?H<8)([C4/
M&EG8H9#*C>@C8.Q."<84G&<=3@9ZD5E_#W7[K6Q+-.5\L/A<+@Y."5&#]U1C
MJ"3G[W%8W_,>_P _\^]>DT44444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4445D:YX5M];YG3+!2 P)##/TX.#R,@@'/')SB6WPILXF#,9' _A9@ >/]E5
M/Y&NKCLU@3R8@(UP<; HQGN!@C.3GH1GJ*QM#\$P:1(URI=Y6S\TI#$9^\1@
M#DYY)R?S.>@KG;3P-!8W'VV!GC8GE$*^7@]5VE3\I],\?PXP,:VJ:3%JJ>3.
MH9,@X.1R.X(P0?H>F1T-<M+\)K1R6#2@$G@,N![#*DX'N2?>NGTK1(=)79 @
M0'KCDGDGECDG&3C)X[5;EB$H*, 58$$$9!!Z@CTKE-0^&%G>.9!OCSU$; +G
M).<,K8^@P .@K2T'P;;:)\T2Y?\ OO\ ,_?H< #@X^4#(ZYK0U328M53R9U#
M)D'!R.1W!&"#]#TR.AKF;;X4V<3!F,C@?PLP /'^RJG\C6I?^#8+V>*[)96@
M"!%3:$Q&Q91C:>.<<$<5LW-LMTC1.,JZE2.1D$8(XYZ5S-E\-[>QF6ZB:561
M]P <;>OW?NYVXX/.2.IJ_JGA&+4KB.^<N'AV8"D;?D8L,@J3U//(XK<K!\2>
M#8/$!5Y2RL@(RFT$@]B2IR!V],GUK5TW3TTZ-+>,86-0!TSQW. !DGDGN>:L
MURFH_#*SO#N :,Y)/EM@'/LP8 #L!@?IBSH?@*UT@^8JEW!R&EPQ'0C P ""
M,@XS[XKHJ*9+$)048 JP(((R"#U!'I7)7?PLLYSN7?&,=$?(^OSACG\<>U;.
MA^%;?1.8$PQ4 L22QQ]>!D\G  )QQP,:%]:"]C>!LA9$93CKAA@XZ\\U1\.^
M'8] C,$18JSEOG()R0!V XXJ#5/",6I7$=\Y</#LP%(V_(Q89!4GJ>>1Q6K?
M6@O8W@;(61&4XZX88..O/-4?#OAV/0(S!$6*LY;YR"<D =@..*GU71(=679.
M@<#IG@CD'AA@C.!G!Y[US$7PFM$(8M*0"."RX/L<*#@^Q!]ZZS3]-CTY!%"H
M11V48[ 9/<G Y)Y/>H-8T"#6 %N$#A3D<D$9Z\J0<'N.AX]!7-1?":T0ABTI
M (X++@^QPH.#[$'WKK-/TV/3D$4*A%'91CL!D]R<#DGD]ZS-4\(Q:E<1WSEP
M\.S 4C;\C%AD%2>IYY'%;E4]4TF+54\F=0R9!P<CD=P1@@_0],CH:Y3_ (5)
M:?WY?^^D_P#B*ZG2M$ATE=D"! >N.2>2>6.2<9.,GCM5ZBN4U7X:VNHR&<[T
M9R2VQA@DDDGY@W)SVP/:K>N>"XM:2*.9Y/W"D AAN.0H)8E3D_+UXYS705A^
M)?",7B'9YQ<>7NQL('WL9SE3Z5LRQ"4%& *L""",@@]01Z5R%S\*;.5BRF1
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M#[UH:A\/K2\C2W"F-8V8@QMS\V-V2V[.<#KR,  @<5T%M!Y"+'DMM4#+'+'
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MQ38O!<4=JVF[Y#$[9R6!8<AL#Y< 9&<8ZD^M:6BZ0FD0K:QDE4S@M@GEBW8
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M444444444444444444444444444444444444444444444444444445C>+?$
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MWB7_ (1Z);C9OW.%QNV]0QSG!]*YN_\ B3+.5BLH?,?8CMUD W*"5 3!^4D
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M5   &  .@ ]*\N\(Z5'-JLP(&V!YF10!M!63:O&.@SD8Q@@>E=_XJB$EI.&
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M*'9AG)W<KDGT4@8Z YQU).?\4=%2YMC=X DA*\XY*LVW;UZ9;(ZXP<8R:?\
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M;G!&2 A'XX(Z9KG_ (.?\O'_ &R_]GH\:_\ (5M/^V'_ *.:O2:**\V\0_\
M$MUB"9.3-Y>=W3YR83C&/X1D=>?;BO2:****************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M***************************\V^$7[E[B%^''E_*>&^4N&X//!(!]"17I
M->;>"O\ D*W?_;?_ -'+6E\6_P#CT3_KNO\ Z ]=+X9_X]+?_KA%_P"@"N:^
M+?\ QZ)_UW7_ - >I]4M#=Z.$7&1;1-SZ(%<_CA>/>L;P%X;L=:M]TD>Z9&(
M?YV!Y)*G"MTQQG R0?3-=!<^ M.M4:5XL*BEB=\IP ,D\-GI3O QLY$>6Q1D
M#$!PV_JN<#+%ES@Y^4G (SVKIZ**Y3XDZT=.M3&I&^<[.HSM(^<X(.1CY3Z;
M@<YQ7.>%?AK%J5NES.TBM)D@+A0%S@?>4DY SG@8(X[G7_X5):?WY?\ OI/_
M (BN4US3#X)O(IH2S)@,-P'/573=C&<=P,@,.,\G>^+<'VB*"Z0@H&89!SGS
M &4C'!&%/.?2N[TW4$U&-+B,Y6101TSSV."1D'@CL>*XCXNZ@@BCM<_.S[\<
M<*H9>><\EN.,'!]*Z[PS_P >EO\ ]<(O_0!7 ^,8O^$=U&+4$!"2$,VT+R1\
MLH XY*D')ZEB<YZ2W<0\2ZOY9 :*W&&XQQ'R00W4>8VTX'(_.NY\3?\ 'I<?
M]<)?_0#7-?"3_CT?_KNW_H"5I6NK67BUGM]HD\M>"Z@$AQ@E,_.,< G P<8[
M&LG6?A/#."ULQC;LK'<G Z<_,,GOEL<\=,1?"+4'ECEMV.5B92O7(W[LCKC&
M5S@=R3WJI\,)1IMQ<6$A'F$X&#\I,18,!G!)YR..@).,5Z77FFC2C5]9>YB(
M*1ACG/4*@BR,9!!)R/;GKQ3O&O\ R%;3_MA_Z.:O2:P_&FD_VI:2Q 98+N7"
M[CN3G '7+#*\<\]^E>:)XB+Z6UE@?),BDX_A<M*._P![<ASQC&._->H>$M/_
M +/M(8<$$("0W!#/\S#&!C!)&.OK6O5'7-/_ +1@DM\ F1& W=-Q'RGH>AP<
M]1U%>?\ PGU#[+)+8R$JS8*JW #)D.,$YW8QQC.%.>E>G5C>+]:.CVLDZD!\
M;4R0/F;@$9!R1][&.0#VJC\/]1N=2MS<73!M[G9\J@X'!^[@8R" , \$Y((Q
MS?PPE&FW%Q82$>83@8/RDQ%@P&<$GG(XZ DXQ7I=>::-*-7UE[F(@I&&.<]0
MJ"+(QD$$G(]N>O%.\:_\A6T_[8?^CFKTFO-O!7_(5N_^V_\ Z.6NW\3?\>EQ
M_P!<)?\ T US7PD_X]'_ .N[?^@)6)J.H)I^M^=(<*&0$\ #?"%R22  "<D^
ME>I5YIKLHU;6(8HB,PE Q)XS&6E8#&>0..WS @XZU9^,%H7CAGXVH[*?7+@$
M?A\AS^%:FF^"=-U&-+B.+*R*"/WCYY['#D9!X(['BJWB#PSIFA1_:)H3@L%
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M,_*2.H-<?K^CC6-7>T8E0X'(YP1 &''<9'([CN.M7HM&UFS LHW'E !0X9,
M'T9AY@"Y[#(Q\O05T7@SP.OA[,K-OF=0"1D*!P2H]>1U/8# '.=W5M+358FM
MI<[''.#@\'((]P0#Z>H(KSN'PCJGA\D6;AD8MPK+CM@E)/E#$ =,D8QG'66'
MP+>Z^_FZC(553]W(9OX<[0OR*"!UZY&2IZUW>L61DMI;>)1DPNJ*, <H0H'0
M =O05C?#O19M(MVBG7:QE+ 94\%5&?E)'4&MO7+9KJWFB099XI% X&25( YX
MZUB?#O19M(MVBG7:QE+ 94\%5&?E)'4&LCQ+X$FBG_M'3VQ(6+%2V#N)Y*D\
M$'))#''4#(.T5)=-UK4P;:5@L;@AB3$!CT)C!;!Z<=<X/&:Z_P -^%(]$A-M
M@.7SO8KC?G. 02> #C'3J>YKC6\&:AX>D9M/;<C\=4S@8(W*^%)&2 1GO]W.
M*E7P=J&OLIU"3;&K<J&7. #R%0;,G)&3R/0@ '0^'GAVYT*2:.9 $<##AU()
M0D# ZX(;.2!C'(R:O?$'PH^O1HT./,B+8!. 0PY'3[V5&,D#KDT>"_[0B+17
MP)0(-C%HR05XP=N220<Y)[>IJG\-?#D^C>=]H3;O\O;\RMG;OS]TGU%7/&_@
M@>( )HR%F0  L3M*YS@XS@C)(('L>Q&#]BUS_CWW_)]W?NBZ=-V[_6=.<_>[
M]:WO!'@@>'P9I"&F<$$J3M"YS@9QDG ))'L.Y-/XE>')]9\G[.F[9YF[YE7&
M[9C[Q'H:[>N(^)7AR?6?)^SINV>9N^95QNV8^\1Z&NWHKB/B5X<GUGR?LZ;M
MGF;OF5<;MF/O$>AKJ=#MFM;>&)QADBC4C@X(4 CCCK5ZBN(\4>')[[4+>[C3
M,4?E;FW*,;9"QX)!. >PKMZY3QOX('B ":,A9D  +$[2N<X.,X(R2"!['L1@
M_8M<_P"/??\ )]W?NBZ=-V[_ %G3G/WN_6M[P1X('A\&:0AIG!!*D[0N<X&<
M9)P"21[#N33^+?\ QZ)_UW7_ - >L33_  K?:6B7>G/D3Q1EE)7()7<>'&T@
M'H?O#.,=2;UCX N-8D%WJ;Y/'R C) S\I*X51T/RYSD_=;FO1*\XO? -UH\S
M7>F. ,<(3\WS'E?F&UE'4;CGCN0"8)_"NJ>(<)>.%1&!^8IWX)"QC!('3<1U
MX/)KT+2=+32HEMHL[$'&3D\G))]R23Z>@ KB_$O@2:*?^T=/;$A8L5+8.XGD
MJ3P0<DD,<=0,@[14ETW6M3!MI6"QN"&),0&/0F,%L'IQUS@\9KK_  WX4CT2
M$VV Y?.]BN-^<X!!)X .,=.I[FN-;P9J'AZ1FT]MR/QU3.!@C<KX4D9(!&>_
MW<XJ5?!VH:^RG4)-L:MRH9<X /(5!LR<D9/(]"  =#X>>';G0I)HYD 1P,.'
M4@E"0,#K@ALY(&,<C)IWBCPY/?:A;W<:9BC\K<VY1C;(6/!()P#V%=O117G?
MAM!K6JSWR_<AR 58$$X\I3[AE#-QTXY]>H\7?:_*7[!_K=XS]S[N&S]_CKCW
MK3TSS/*C\[_6[%W]/O8&[IQU]./2K-%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%<M\0=!?4H1-#GS[=MR;<[L<;@,$<\!AU.5P.3
M6IX9UP:U;I<C&XC#@=F'WAC)P.XSS@@UJT44444444444444444444444444
M4445Q7BWX@/H,K6WD@DH"CE^#D=2H&<!@1C()QVS3?ASH$D)EU"Y4B:9B,,-
MIP3N8XXQN;L0,8R.#7;T44444444444445YM_P Q[_/_ #[UZ31111111111
M1111111111111111111111117$?%O_CT3_KNO_H#UTOAG_CTM_\ KA%_Z *T
MJ*************YWQSKATRW*1Y\Z<[(POWLMU( (.0.A&<,5]:F\&Z#_ &);
M)"?OM\S_ .\V,CJ1P %XX.,]ZW**********************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M****BN;E+53)(P51U+$ #)QU/'6L*7XA6,9*F89!(X1R./0A2"/<<&M+2_$%
MOJHS!(K'!. <-@'&2IPP&?4>GK6A13)91$"[$!5!)).  .I)]*PKGQ]8V[%&
MF!(_NJSCD9^\H(/X&I].\8VFHG9'*N[( #90DMT #@9/TS^HK9HJG=ZQ!9'9
M+(B,1G#NJG'K@D<<59BE$H#J058 @@Y!!Z$'TI]07=]'9#?*ZHI.,NP49],G
M'/%.MKE+I1)&P93T*D$'!QU''6JDOB&VB)1IH@RD@@R("".H(SUIO_"36G_/
M>+_OZG^-'_"36G_/>+_OZG^-'_"36G_/>+_OZG^-:59O_"36G_/>+_OZG^-'
M_"36G_/>+_OZG^-.B\0VTI"+-$68@ "1"23T &>M:%%%96J>*+72SMFE56!
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ME1T&!$I:0<XS@AC[]L\5T'P<_P"7C_ME_P"SUTGQ&_X\)O\ MG_Z,6N \(^
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M49Q^';I6#\6_^/1/^NZ_^@/6E\.?^/"'_MI_Z,:NEHHKR3XM_P#'VG_7!?\
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MCJ>P& .<Z_B;_CTN/^N$O_H!KB/@Y_R\?]LO_9Z])HHKR3X2?\?;_P#7!O\
MT-*[;XC?\>$W_;/_ -&+6;\)/^/1_P#KNW_H"5V]%%%>2?%O_C[3_K@O_H;U
MZ?JVEIJL36TN=CCG!P>#D$>X(!]/4$5YAX4U:3PC=M87)_=LP5L,-H9L;9,G
MMCKT.#D\J!72?%O_ (]$_P"NZ_\ H#UI?#G_ (\(?^VG_HQJS?BW_P >B?\
M7=?_ $!ZTOAS_P >$/\ VT_]&-72UF^)O^/2X_ZX2_\ H!KB/@Y_R\?]LO\
MV>M+XM_\>B?]=U_] >CP]IW]I:.+?&XLDNT9Q\PD8ISD?Q =>/7BLOX0ZH09
M;,YP0)%X&!C"MSUR<KCMP>G?2^+.J&WMTMAG,S\\#&U,$CU!W%2,>AY]9-&T
ML:?I#CC=+;RR$@DYWH2.O?;@''&1^)R_@Y_R\?\ ;+_V>ND^(W_'A-_VS_\
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M_P!M/_1C5TM<U\1O^/";_MG_ .C%K-^$G_'H_P#UW;_T!*[>BO)/A)_Q]O\
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M_P >$W_;/_T8M>:>'?',^@1F")4*LY;YPQ.2 .S#CBM7_A;=W_<B_P"^7_\
MBZHWE[?^,R $+(&. B[8@P7G+'C./[S$\X'7%>H>$O#XT&W6WR"Y)9R,X+'T
MSV  ';.,X!-8/Q;_ ./1/^NZ_P#H#UQNB_$2XTB%;6-8RJ9P6#$\L6[,!U/I
M5[_A;=W_ '(O^^7_ /BZ/^%MW?\ <B_[Y?\ ^+KN? WB*37X&GE"AED*_("!
M@*I[D\\UPWQ;_P"/M/\ K@O_ *&]>MT5YW\5/#0=?[23JNU9!@ $9PK=B2"0
MO?C'0+6_X%\4?V]#\Y_?18#\8!SG:P[<@<].0> ,5TM%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%9\OAZVE)=H8BS$DDQH22>I)QUJW;6R6JB.-0JCH%  &3
MGH..M2T453N]'@O3OEC1V QET5CCTR0>.:EM+&.R&R)%12<X10HSZX&.>*GH
MHHHHHHHHHHHHHHHHJ*YMDNE,<BAE/4, 0<'/0\=:K6VAV]JPDCBC5AT*QJ",
MC'4#/2KU%%%%%%%%%%%%%%9O_",VG_/"+_OTG^%7XHA$ B@!5   &  .@ ]*
M?11111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111111111111111111111111111111111111116'J
M/C2TTV0V\TFUUQD;'/4 CD*1T-5O^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D
M.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\
M31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6
M'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK
M_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(
M<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_X
MFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_P
ML:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7
M_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0
MY/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q
M-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A
M8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_
MYZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P A
MR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\
MXFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"
MQK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_
MSU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^
M0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\
MQ-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_
M (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_
M )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\
MAR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_
M (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_
M  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-
M8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_
M^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_
M !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC
M_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:
MP_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\
M/7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/
M_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'
M_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8U
MA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ
M_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R
M')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/
M^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK
M#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU
M_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D
M.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFC_ (6-8?\ /7_R')_\
M31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6
M'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_XFC_A8UA_SU_\AR?_ !-'_"QK#_GK
M_P"0Y/\ XFC_ (6-8?\ /7_R')_\31_PL:P_YZ_^0Y/_ (FC_A8UA_SU_P#(
M<G_Q-'_"QK#_ )Z_^0Y/_B:/^%C6'_/7_P AR?\ Q-'_  L:P_YZ_P#D.3_X
MFC_A8UA_SU_\AR?_ !-'_"QK#_GK_P"0Y/\ XFM/1O$<&L[OL[[MF-WRLN-V
M<?> ]#6E1111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111117G9T6'5]7N(IUW*(E8#+#D+$,_*0>A-;_\
MPKFP_P">7_D23_XJC_A7-A_SR_\ (DG_ ,51_P *YL/^>7_D23_XJC_A7-A_
MSR_\B2?_ !5'_"N;#_GE_P"1)/\ XJC_ (5S8?\ /+_R))_\51_PKFP_YY?^
M1)/_ (JC_A7-A_SR_P#(DG_Q5'_"N;#_ )Y?^1)/_BJ/^%<V'_/+_P B2?\
MQ5'_  KFP_YY?^1)/_BJ/^%<V'_/+_R))_\ %4?\*YL/^>7_ )$D_P#BJ/\
MA7-A_P \O_(DG_Q5'_"N;#_GE_Y$D_\ BJ/^%<V'_/+_ ,B2?_%4?\*YL/\
MGE_Y$D_^*H_X5S8?\\O_ "))_P#%4?\ "N;#_GE_Y$D_^*H_X5S8?\\O_(DG
M_P 51_PKFP_YY?\ D23_ .*H_P"%<V'_ #R_\B2?_%4?\*YL/^>7_D23_P"*
MH_X5S8?\\O\ R))_\51_PKFP_P">7_D23_XJC_A7-A_SR_\ (DG_ ,51_P *
MYL/^>7_D23_XJC_A7-A_SR_\B2?_ !5'_"N;#_GE_P"1)/\ XJC_ (5S8?\
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M1)/_ (JC_A7-A_SR_P#(DG_Q5'_"N;#_ )Y?^1)/_BJ/^%<V'_/+_P B2?\
MQ5'_  KFP_YY?^1)/_BJ/^%<V'_/+_R))_\ %4?\*YL/^>7_ )$D_P#BJ/\
MA7-A_P \O_(DG_Q5'_"N;#_GE_Y$D_\ BJ/^%<V'_/+_ ,B2?_%4?\*YL/\
MGE_Y$D_^*H_X5S8?\\O_ "))_P#%4?\ "N;#_GE_Y$D_^*H_X5S8?\\O_(DG
M_P 51_PKFP_YY?\ D23_ .*H_P"%<V'_ #R_\B2?_%4?\*YL/^>7_D23_P"*
MH_X5S8?\\O\ R))_\51_PKFP_P">7_D23_XJC_A7-A_SR_\ (DG_ ,51_P *
MYL/^>7_D23_XJC_A7-A_SR_\B2?_ !5'_"N;#_GE_P"1)/\ XJC_ (5S8?\
M/+_R))_\51_PKFP_YY?^1)/_ (JC_A7-A_SR_P#(DG_Q5'_"N;#_ )Y?^1)/
M_BJ/^%<V'_/+_P B2?\ Q5'_  KFP_YY?^1)/_BJ/^%<V'_/+_R))_\ %4?\
M*YL/^>7_ )$D_P#BJ/\ A7-A_P \O_(DG_Q5'_"N;#_GE_Y$D_\ BJ/^%<V'
M_/+_ ,B2?_%4?\*YL/\ GE_Y$D_^*H_X5S8?\\O_ "))_P#%4?\ "N;#_GE_
MY$D_^*H_X5S8?\\O_(DG_P 51_PKFP_YY?\ D23_ .*H_P"%<V'_ #R_\B2?
M_%4?\*YL/^>7_D23_P"*H_X5S8?\\O\ R))_\51_PKFP_P">7_D23_XJC_A7
M-A_SR_\ (DG_ ,51_P *YL/^>7_D23_XJC_A7-A_SR_\B2?_ !5'_"N;#_GE
M_P"1)/\ XJC_ (5S8?\ /+_R))_\51_PKFP_YY?^1)/_ (JC_A7-A_SR_P#(
MDG_Q5'_"N;#_ )Y?^1)/_BJ/^%<V'_/+_P B2?\ Q5'_  KFP_YY?^1)/_BJ
M/^%<V'_/+_R))_\ %4?\*YL/^>7_ )$D_P#BJ/\ A7-A_P \O_(DG_Q5'_"N
M;#_GE_Y$D_\ BJ/^%<V'_/+_ ,B2?_%4?\*YL/\ GE_Y$D_^*H_X5S8?\\O_
M "))_P#%4?\ "N;#_GE_Y$D_^*H_X5S8?\\O_(DG_P 57-_!S_EX_P"V7_L]
M>DT444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444444445Q&E?\AFY_P"N"_RAKMZ*********************
M************************************************************
M**********************************************************\V
M^#G_ "\?]LO_ &>O2:******************************************
M************************************************************
M************************************************************
M************************************************************
M***********************************XC2O^0S<_]<%_E#7;T4444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444445YM\'/^7C_ME_[/7I-%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<1I7_(9N?^N"_R
MAKMZ********************************************************
M************************************************************
M***********************\V^#G_+Q_VR_]GKTFBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN(T
MK_D,W/\ UP7^4-=O11111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111117FWP<_P"7C_ME_P"SUZ311111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111117$:5_P AFY_ZX+_*&NWHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKS;X.?\O'_
M &R_]GKTFBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBN(TK_D,W/_ %P7^4-=O111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11117FWP<_Y>/^V7_L]>DT44444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444445Q&E?\AFY_ZX+_ "AKMZ**
M************************************************************
M************************************************************
M*****************\V^#G_+Q_VR_P#9Z])HHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKB-*_P"0
MS<_]<%_E#7;T444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444444444445YM\'/^7C_ +9?^SUZ311111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111117$:5_R&;G_ *X+_*&NWHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKS;X.?\ +Q_VR_\
M9Z])HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHKB-*_Y#-S_UP7^4-=O111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111111111111111111111117F
MWP<_Y>/^V7_L]>DT44444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444445Q&E?\AFY_ZX+_*&NWHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHKS;X.?\O'_;+_V>O2:*********************************
M************************************************************
M************************************************************
M************************************************************
M********************************************XC2O^0S<_P#7!?Y0
MUV]%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%>;?!S_ )>/^V7_ +/7I-%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<
M1I7_ "&;G_K@O\H:[>BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO-O@Y_R\?\ ;+_V>O2:****
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M*************XC2O^0S<_\ 7!?Y0UV]%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%>;?!S_EX_
M[9?^SUZ31111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111117$:5_R&;G_K@O\ *&NWHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHKS;X.?\O'_;+_ -GKTFBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN(TK_ )#-S_UP7^4-=O11
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111117FWP<_Y>/\ ME_[/7I-%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<1JOA6]
M^V27]I)&GF*J_-DG 501@HPZK1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\
MC-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S
M_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_
M 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_X
MS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E
M:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$
M7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\
MC-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S
M_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_
M 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_X
MS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E
M:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$
M7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\
MC-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S
M_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_
M 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_X
MS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E
M:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$
M7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\
MC-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S
M_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_
M 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_X
MS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E
M:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$
M7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\
MC-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S
M_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_
M 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_X
MS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E
M:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$
M7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\
MC-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S
M_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_
M 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_X
MS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E
M:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$
M7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\
MC-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S
M_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_XS1_96L_\_$7_
M 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E:S_S\1?]\C_X
MS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$7_?(_P#C-']E
M:S_S\1?]\C_XS1_96L_\_$7_ 'R/_C-']E:S_P _$7_?(_\ C-']E:S_ ,_$
M7_?(_P#C-']E:S_S\1?]\C_XS5GP#X1E\/>;YQ0^9LQL)/W=V<Y4>M==1111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1117$>-?B&=&D^RP*&D7!<N#M&1D 8())!!SG ''))QRW_"4ZOL\[]YLV[MW
MD+MVXSG.S&,<YZ8KH/!OQ(;4)$L[D ,W D!"@D 8!4\98YY'<@!:ZGQ9<36]
MM(]KDS#;MVKO/+J#\N#GC/:LCP#J%[>>;]N#C;LV;XQ'UW;L85<]OI774444
M444445RWB[QY'H685&^?;D+_  KGIN.<].<#DCK@$&NIHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKG_ !EXL7P]
M&&QNEDR$4YQQC))]!D<=3T&.2."3QIJFI$RP!MF<8BA#*" .,E6.>_)[^E3:
M1\4+BQ<Q7B[P&P> DB\@$8  .,'@@'/5A7JD4HE =2"K $$'((/0@^E>?>$]
M8U.XN8TNA((3NW;H0@X1B/FV#'..]>B4444444445E>(/$D.@H)9B?F.%5<%
MCZX!(X'<D@?B0">&-8.L6Z7; *7+\#G #LHY[G Y/<]ATK5HHHHHHHHHKSOQ
M9K&IV]S(EJ)#"-NW;"''**3\VPYYSWKM-?U@:/ ]VP+! .!QDDA1SV&3R>P[
M'I7EJ>/=2U)R("<XSLBB#8 P,\JS8SZGJ:]-\+W<UW;1R7(*RD'<"I4\,0"5
M/0D 'TYX %3ZY<M:V\TJ'#)%(P/!P0I(//'6N)^'?BRYU>X:*=]RB(L!M0<A
ME&?E4'H37HE%%%%>=_$3Q9<Z1<+% ^U3$&(VH>2S#/S*3T KMM#N6NK>&5SE
MGBC8G@9)4$GCCK5ZL/QIJ,FFVDEQ"=KKLP< ]74'@@CH:Q/AKXCGUGSOM#[M
MGE[?E5<;M^?N@>@KMZYWQS>75I K608R&0 [$WG;M;/&&XSCFCP->75W S7H
M82"0@;TV';M7'&%XSGFNBHHKG?'-Y=6D"M9!C(9 #L3>=NUL\8;C..:/ UY=
M7<#->AA()"!O38=NU<<87C.>:Z*BBJ.LZS'H\9N)CA1T ZD]E [D_P#US@ F
MJ/A/Q'_;Z23A=JK*54'KM"J<GMDDGIP.G.,GB?&GC2[TV[DMX9-J+LP-B'JB
MD\E2>IKU*BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBO._B)XLN=(N%B@?:IB#$;4/)9AGYE)Z 5C1>)=8E =1*58 @BW4@@]"#Y?2
MB+X@ZAI4@%T"00#LEC$9QGJ"%4YX(!Y'L:](\-^($UZ$7$8(YPRGLP )&>XY
M!!]#V.0-6BBJ.LZS'H\9N)CA1T ZD]E [D__ %S@ FJ/A/Q'_;Z23A=JK*54
M'KM"J<GMDDGIP.G.,G<HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK
ME/&_C<>'P(8P&F< @,#M"YQDXQDG!  /N>P/#+XZU*%5N68F(MP6B4(V"?EW
M!1Z'H<]:]"\%^+1XBC9F4+)&0& )(Y'##(X!(/&21CDT[QEXL7P]&&QNEDR$
M4YQQC))]!D<=3T&.2//_ /A.-3Q]LY\G=G_4CRL;L;=VW.,_+][/OFO0/!OB
MQ?$,9;&V6/ =1G'.<$'T.#QU'0YX)M^)/$":#";B0$\X51W8@D#/8<$D^@[G
M /F1\>ZE?%Y8B0B %A'$&51CJ258@<$\GU[5T_@?X@OJT@L[@#>5.UUR-Q4
MX*X(!(!).0.P%=)XLU5M*M9;E/O*H Z<%B%!Y!'!.<=\8KRG_A8U_P#\]?\
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MXG>(I)Y6TXA?+B=&! .[)C[G.,?,>WI53P+XNETUX[% A2:=<E@=WSE5."&
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M]!U)X'->.^(_$<WBZ9;>%3LW8CC'4G^\W;./P49YZD^F^$?#2Z!"(N#(W+L
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M$'*G'H<$<5UWB/XE+JD1M+6-]\PVY8+GYB!@*-VXL,CL1GC)K/\ A)_Q]O\
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MV6=2T:Y*% -PR<D') ()).<Y!XY!&,;QCXH/B";S "L:#"*3VSRQ&<;CWQV
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M-NM$94E=-C\$HWG. 0>G&58?S'4#D5R^HO\ \))>8MTVB5D5%QP%50H)"@X
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MM--D%Q#'M=<X.]SU!!X+$=#6O<VR72F.10RGJ& (.#GH>.M8UEX&L[)UFCB
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MPV.M1?\ "N;#_GE_Y$D_^*J]I'A.VTAS+ FUBNTG<YX)!Q\S$=0*U)8A*"C
M%6!!!&00>H(]*PO^$!L=_F^2,[L_>;;G.?NYVX]L8QQC%;L40B 10 J@  #
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M /':/^$"N_\ G_E_\?\ _CM'_"!7?_/_ "_^/_\ QVC_ (0*[_Y_Y?\ Q_\
M^.T?\(%=_P#/_+_X_P#_ !VC_A KO_G_ )?_ !__ ..T?\(%=_\ /_+_ ./_
M /QVC_A KO\ Y_Y?_'__ ([1_P (%=_\_P#+_P"/_P#QVC_A KO_ )_Y?_'_
M /X[1_P@5W_S_P O_C__ ,=H_P"$"N_^?^7_ ,?_ /CM'_"!7?\ S_R_^/\
M_P =H_X0*[_Y_P"7_P ?_P#CM'_"!7?_ #_R_P#C_P#\=H_X0*[_ .?^7_Q_
M_P".T?\ "!7?_/\ R_\ C_\ \=H_X0*[_P"?^7_Q_P#^.T?\(%=_\_\ +_X_
M_P#':/\ A KO_G_E_P#'_P#X[1_P@5W_ ,_\O_C_ /\ ':/^$"N_^?\ E_\
M'_\ X[1_P@5W_P _\O\ X_\ _':/^$"N_P#G_E_\?_\ CM'_  @5W_S_ ,O_
M (__ /':/^$"N_\ G_E_\?\ _CM'_"!7?_/_ "_^/_\ QVC_ (0*[_Y_Y?\
MQ_\ ^.T?\(%=_P#/_+_X_P#_ !VC_A KO_G_ )?_ !__ ..T?\(%=_\ /_+_
M ./_ /QVC_A KO\ Y_Y?_'__ ([1_P (%=_\_P#+_P"/_P#QVC_A KO_ )_Y
M?_'_ /X[1_P@5W_S_P O_C__ ,=H_P"$"N_^?^7_ ,?_ /CM'_"!7?\ S_R_
M^/\ _P =H_X0*[_Y_P"7_P ?_P#CM'_"!7?_ #_R_P#C_P#\=H_X0*[_ .?^
M7_Q__P".T?\ "!7?_/\ R_\ C_\ \=H_X0*[_P"?^7_Q_P#^.T?\(%=_\_\
M+_X__P#':/\ A KO_G_E_P#'_P#X[1_P@5W_ ,_\O_C_ /\ ':/^$"N_^?\
ME_\ '_\ X[1_P@5W_P _\O\ X_\ _':/^$"N_P#G_E_\?_\ CM'_  @5W_S_
M ,O_ (__ /':/^$"N_\ G_E_\?\ _CM'_"!7?_/_ "_^/_\ QVC_ (0*[_Y_
MY?\ Q_\ ^.T?\(%=_P#/_+_X_P#_ !VC_A KO_G_ )?_ !__ ..T?\(%=_\
M/_+_ ./_ /QVC_A KO\ Y_Y?_'__ ([1_P (%=_\_P#+_P"/_P#QVC_A KO_
M )_Y?_'_ /X[1_P@5W_S_P O_C__ ,=H_P"$"N_^?^7_ ,?_ /CM'_"!7?\
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M.T?\(%=_\_\ +_X__P#':/\ A KO_G_E_P#'_P#X[1_P@5W_ ,_\O_C_ /\
M':/^$"N_^?\ E_\ '_\ X[1_P@5W_P _\O\ X_\ _':/^$"N_P#G_E_\?_\
MCM'_  @5W_S_ ,O_ (__ /':/^$"N_\ G_E_\?\ _CM'_"!7?_/_ "_^/_\
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M\O\ X_\ _':/^$"N_P#G_E_\?_\ CM'_  @5W_S_ ,O_ (__ /':/^$"N_\
MG_E_\?\ _CM'_"!7?_/_ "_^/_\ QVC_ (0*[_Y_Y?\ Q_\ ^.T?\(%=_P#/
M_+_X_P#_ !VC_A KO_G_ )?_ !__ ..T?\(%=_\ /_+_ ./_ /QVC_A KO\
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M_P#/_+_X_P#_ !VC_A KO_G_ )?_ !__ ..T?\(%=_\ /_+_ ./_ /QVC_A
MKO\ Y_Y?_'__ ([79?9DW^=M&_;MW8&[;G.,]<9YQTS4M%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%9MEXC@OI7M(WS+'NW+M88VG:>2 #@GL:TJHR
MZU#%,MDS8FD7<JX;D#/.<8_A/>KU%%16URETHDC8,IZ%2"#@XZCCK4M%%%17
M-RMJC2N<*BEB>3@ 9)XYZ5S_ /PL:P_YZ_\ D.3_ .)J6V\?6-PP19@"?[RL
M@X&?O, !^)K7U'48]-C-Q,=J+C)P3U( X )ZFI+:Y6Z194.5=0P/(R",@\\]
M*EHHHHHHHHHHHJMJ.HQZ;&;B8[47&3@GJ0!P 3U-26URMTBRH<JZA@>1D$9!
MYYZ5+1111111111111144]RD&-[!=S!1N(&6/0#/4GL.M5M7UJ'2$$L[;5+;
M0<,>2"<?*">@-7J**************************************HW^M0Z>
M\<4K;6F;:@PQR<@8X! Y(ZXJ]111111111111116?JFOP:446=PAE)"Y!QQC
M.2!@ 9')P*T*S=9\1P:-M^T/MWYV_*S9VXS]T'U%7;:Y6Z194.5=0P/(R",@
M\\]*@U35HM*3SIV"ID#)R>3V &23]!TR>@J&P\1P7\GV>)\N$5\;6'RL%(.2
M .C#CKS]:TJ*********HZ1K4.KH98&W*&VDX8<@ X^8 ]"*O44444444444
M4444445%<W*VJ-*YPJ*6)Y. !DGCGI4>G:C'J48N(3N1LX.".A(/! /459HH
MJ*YN5M4:5SA44L3R< #)/'/2H].U&/4HQ<0G<C9P<$="0>" >HJS5'5]:ATA
M!+.VU2VT'#'D@G'R@GH#5ZJ-_K4.GO'%*VUIFVH,,<G(&. 0.2.N*O444451
MBUJ&69K)6S-&NYEPW ..<XQ_$.]7J*HZOK4.D()9VVJ6V@X8\D$X^4$] :O4
M45%]I3?Y.X;]N[;D;MN<9QUQGC/3-2U%/<I!C>P7<P4;B!ECT SU)[#K4M%%
M%%%%%%%,EE$0+L0%4$DDX  ZDGTHBE$H#J058 @@Y!!Z$'TI]%%%4;_6H=/>
M.*5MK3-M088Y.0,< @<D=<5>HHHJ*>Y2#&]@NY@HW$#+'H!GJ3V'6H]1U&/3
M8S<3':BXR<$]2 . ">IJ2VN5ND65#E74,#R,@C(///2I:***HW^M0Z>\<4K;
M6F;:@PQR<@8X! Y(ZXJ]1111115'2-:AU=#+ VY0VTG##D ''S 'H15ZJVHZ
MC'IL9N)CM1<9.">I ' !/4U);7*W2+*ARKJ&!Y&01D'GGI4M%5M1U&/38S<3
M':BXR<$]2 . ">IJ2VN5ND65#E74,#R,@C(///2I:*****K:CJ,>FQFXF.U%
MQDX)ZD < $]33K*]2^19XF#(XR"/\]?4=0>#S3=1U&/38S<3':BXR<$]2 .
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MGDX &2>.>E1Z=J,>I1BXA.Y&S@X(Z$@\$ ]15FBBJ,NM0Q3+9,V)I%W*N&Y
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M *X-_*:NNU#4H].0RS,$4=V..Q.!W)P. .3VKDXOBS:.0I64 D<E5P/<X8G
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M!ZX!/'(Y&1SCKD5+KGB*'1$\R=L9SM &68@9P!_4X )&2,US]M\5K.5@K"1
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MD=,UR_B;QQ;:Y9311DK)\F%D&"0)$.1@D'Z9SP3C S79>&?^/2W_ .N$7_H
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M'H:N5S_B#QQ;:&WE2$M)QE8QD@$9R<D ?3.>0<8.:@T7XB6NJN(061V("B0
M;B<\ @L,_4C)( R:YOXI^(HYQ_9P#>9%(C$D#;@H>ASG/S#MZUMI\4+9XVGV
M2[4=%/RIG+AB/X^GR'/X5SOPX\71::@L7#EYIQ@J!M^<*HR2P/4<\'BN[\0>
M*8-"7=,WS'&$7!<Y/7!(XX/)P.,=<"LO2_B7:7[^42T>0<-*%5>.V0QP?K@=
MLYP#NZUJZ:1"UU("53&0N">6"]R!U/K6-!\0K>YECMHP[O*$^ZH(7<,X;YNJ
MCEL9 YYR#BWJOC"#2IEM9LJ60ONP-@ W=><Y.W  !R2 .M9/_"UK/?LQ)C=C
M=M&W&<;OO;L=^F<=L\5U\4HE =2"K $$'((/0@^E<WK7Q$M=*<PDL[J2&$8!
MVD8X))49^A.""#@U>T3Q9!K2&2 DN Q,9VB3CV+8P<C!SCG!(.<3^'_$$>NQ
M_:(<X#%2&&"".<<9'0@\$]?7(J+7_$T>B;!('9I6PJQKN8XQZD#J0.N23P.N
M->BH+V]2Q1IY6"H@R2?\]?0=2>!S7*?\+6L]^S$F-V-VT;<9QN^]NQWZ9QVS
MQ70:AKR6D)O%!EC'4P[7X&06^\ 0".<9QWX!(LZ;J":C&EQ&<K(H(Z9Y['!(
MR#P1V/%48/$\5Q<G3X\LZ*2Q7&Q<<$$D@D@D @ X)P>APWQ!XMM]! $S'>1D
M(HRQ&<9[ #ZD9P<9(JGH?Q M=8?RE)1N,"7:N[)Q@88@G...ISQGG'12RB(%
MV("J"22<  =23Z5RFH?$^SLW,8WR8ZF-05SDC&69<_49!'0UT6EZM%JJ>= P
M9,D9&1R.Q!P0?J.F#T-5O#OB*/7XS/$&"JY7YP <@ ]B>.:-7\11Z7)# X8M
M</M7: 0#E1SDCCYATS7!>-/%T5Q=P8#_ .ASMOR!SM=<[?FY^Z>N.U=WH7B>
M+68FNDRJ(Q!,F%QM 8G@D8P>N:QKWXI6EJ[1 .^TXW(%*GZ$L,CWQ@]LCFN@
MT77H=902PL#P,KQN7.>&'8\'V.,@D<UFZCX[M].EEMI=P:% Q.!ALA2%7G)8
M[AV X)) &:T/#^NIKD?VB-75=Q \P $X[C!((SQGU!':M*F2RB(%V("J"22<
M  =23Z5R%S\5K.)BJB1P/XE4 'C_ &F4_F*Z#0_$4.MIYD#9QC<",,I(S@C^
MHR"0<$XIFN>)K?11F9P&QD(.7/7&%]#C&3@9ZD5S=Y\1+758)X061VAD"B0
M;B4;@$%AGZD9) &34_A/5TTC2X[J0$JF[(7!/,S+W('4^M3ZA\2K6RV@[V9T
M5BJJ,J'567.2!DANQ/O5N3QU:1P+>%_E?("XR^X#)7:.A'')^7D<X();X?\
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M_0;L8^8=_6O2=*UR/4H!>KE8R&/SX& I()/) ''KTKG;GXK6<3%5$C@?Q*H
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MH&#)DC(R.1V(."#]1TP>AKG=0^)]G9N8QODQU,:@KG)&,LRY^HR".AK5\/\
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M."J8R.0<$G:&)/!P1C:]X_@UJ!X(H'D;8Q^=5P@VD>9QOP5SUXZ]16AX?_Y
MS?\ 7"X_G)5SX9V206:2JH#REBQ[G:[*/P ' Z=3U)KFO%>LPKJ1%ZK/#;HN
MQ$P068*V6#$ CGG&,X4$$9S>U7XC6.J1F"6.4JP/\$9()!&X98X89X/:M3X8
M:@]Y9[7.?*=D!YSM 5AG)[;L#L  *W/$W_'I<?\ 7"7_ - -8/PQTJ."T6Y
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MRDC.UL<,.1R/J,C(/!-<-X*_Y!5W_P!M_P#T2M;/PQTJ."T6Y 'F2E\L0-V
MVW:#C.WY0<>N352YMELM9B\H;?.B9G"Y 8D29)'3DJ"?<9Z\U)I7_(9N?^N"
M_P H:K>)M/34-6MH9!E3$"1P0=AD;!!!!!(P1Z5TGBS38YK.6-E&V.)F0 8"
ME%)4C'3'MVXZ'%<[9:K)9Z*)U)WA&4$DY ,IC&#G(*@_+Z8'85N> ]%33;6-
ME WS(KLV,$[AD#J>%!P.W4X!)KFO&&BI9:A:7,8 \^9-P Q\RNN6Z]3N&>!R
M,\DFO1ZY'Q!%9:5<?VE=.6E"C9&2&Q@<%4QD<@X).T,2>#@C&U[Q_!K4#P10
M/(VQC\ZKA!M(\SC?@KGKQUZBH#HTFJZ-"L(W-&[N5'4@-(#@=SSG'?MDX!N:
M=\380/LEW"8P $(4 H/X6!0X*J/[OS''';G=\%VEI LC64A='8$H6R$Y(X4@
M,N<8^;D@#DXKI:X1-2T_P<[X9YIY&.\Y$D@Y.06^51\PY&=Q."<C&.=\<^*(
M]?C5XH&"JX'G.H!R Q\O(SQSNQN_#O73?%O_ (]$_P"NZ_\ H#UV]<1\)/\
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MG/ &,'/.1R#SUKA/!DI?2;H$DA1.!D]!Y0.!Z#))^I-6=*TM]4T46\6"[!L
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M_P!&+4;:7%J6G01W$ACB$4)8AP@^X  2P(QDCCU K/B^)%AI8%M KF-  I1
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M:Q%  TD:,S8&XEANY( R!N(&>@K"\.6RV&K7-O$-L?E!MHSMR?+.<=."QQZ
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MVVG#E(OWLG\2^H5EZ#@8R>S].>8_BIJ'E+!;N2(97)DV?>*H5X&3C^+.#QD
M]JBMOB386T8MDBD$07;MV(1@]0<OSGOGKWJ/X>ZNDUY<0VX(MY%\Q5; *L"H
M( 4[0/F(]<!>>*]$HHHHHHHHHHHHHHHHHHHHHHHKB/ 7_'WJ'_7?_P!GEKI?
M$6AIK<+6S\9P0V 2K#H1G\CT)!(R,UYUX>O)I]2MXKH$30(\;%CDG"R,#^3
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M% 88&" <EL9)XY &2>-3Q!_R!E_ZX6_\XZZ7PS_QZ6__ %PB_P#0!7-> O\
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M9 -:=[\3+.!&>-S(X'"A77)^K* !ZGTZ GBII+B>YTZ:6Z4)(T$IVJI7 V'
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MC' P2>!@FC?:5TB-[,D2H7. JL6'F/E0&SSSG@$G&!UJ>/QYIVK(K72@,O\
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M#MNR>P )HMOB;:S1JWS^:V!Y2H6?<3C . I]N02.V>*R_AZ)9Y+\,1',SC)
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M?*BD8^0[2#]T9& H5AUP<T:5_P AFY_ZX+_*&NWKG_''A]M<MC%'_K$8.HR
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M!!Z@CTIMM;):J(XU"J.@4  9.>@XZU+45S;)=*8Y%#*>H8 @X.>AXZTZ*(1
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M74'.'4,,^N#GGFBTL8[(;(D5%)SA%"C/K@8YXIMGID5CGR8T3=C.Q0N<=,X
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M./3)!XYI_P#9D7E_9_+3RO[FT;.N?NXQUY^O-<?\5HA%9QHH 59D  &  $?
M ]*ZV[T>"].^6-'8#&716./3)!XYJY7#>!XA+<ZBC %6FP01D$%Y<@CTKL+/
M3(K'/DQHF[&=BA<XZ9P!G&:LU1N=#M[IC))%&S'J6C4DX&.I&>E7JIW>CP7I
MWRQH[ 8RZ*QQZ9(/'-/_ +,B\O[/Y:>5_<VC9US]W&.O/UYITEC'(GD,BF/
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M!RHW <\!NH')_,T)8QHYG"*)&&"X4;B.."W4C@?D*'L8W<3E%,BC <J-P'/
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M (H 50  !@ #H /2H?[,B\S[1Y:>;_?VC?TQ][&>G'TXJ2YMDNE,<BAE/4,
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M^4G..<8(.#@CMU /%4?$'CA=-D%I#&TT^>47(P-N[KM.3@YP >,Y(QS!I/Q
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M'J*LUQ4WQ,2&26W,3&2.0I&J'<7(+#T&T9 '\1^;@'!I^F_$0RSI:7,#P&3
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M>XS@XXP<CH_$>L_V- ]WMW;-ORYVYW,%ZX/KZ5S0^)1N@/LMO),0JE]N<*6
M.,A6)YR,D+TXR*TM \:+K4$L\:'S85),8))/!*@,!SNQCID'MT)XNR\33Q:A
M-=BV<R/& 8ANW*,)\Q^3./E'8=1^/J5C<&XC25E*,Z*2IZJ2,E3P.1TZ"JVN
M:[%HL?GS$A<X& 22<$@#W..^!ZD5R@^)4J*)I+.183M)?)(VL1R"4 .<\<@'
MUKLM.U&/4HQ<0G<C9P<$="0>" >HKDYOB0$DEMEA9Y8Y"B(A+%]I;<W"_* %
MSCD\^@)'4Z3=O>1+-+&8G89*$Y(YXR<#DC!Q@$=#R*GN;E;5&E<X5%+$\G
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MR>G )(%;GA_4Y-2C\Z:(PDL0%8Y.!WY"D<YX([9Z$5I5F^)O^/2X_P"N$O\
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M#TK$\:_\@JT_[8?^B6KT2VMEM46)!A44*!R< # '//2N+^'L0BN;]% "K,
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M -N"2#UK$\<ZY=:I IEMS#")!]\G>7"MZ[3MP?[O4?>[5T7Q;_X]$_Z[K_Z
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MO@D=Z\^U74'N+/3XW!D5G?*#@MY3A$4%1D':2O'/.>3721>.+F(!%T^4*H
M&\  = !Y72HO!!G>]GF:%X8ITW%75L;P1_$RCD[F./?IP*E\!Q WE^^!N$Q
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M1TM]V9)'&!\O\/RD@XR#MSDG!^4#-=_;6RVJ+$@PJ*% Y. !@#GGI7&_%O\
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M'X=^*DB6/2'1UF5I!R!C@LYSD@@CD8P>G7GBSX"_X^]0_P"N_P#[/+1\6_\
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M'O\ Q]Z?_P!=_P#V>*NWKB/A)_QZ/_UW;_T!*Z+P[XBCU^,SQ!@JN5^< '(
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/BBBBBBBBBBBBBBBBO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>pc2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pc2.jpg
M_]C_X  02D9)1@ ! @$ R #(  #_[@ .061O8F4 9       _]L 0P ," @;
M"ALB$1<D*B0<&R D*R@H("0I)24Q+R4I+BHK*SDK*BXO-#4U-30O.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[_\  "P@(_ :D 0 1 /_$ !\   $% 0$! 0$!
M       ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042
M(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V
M-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KA
MXN/DY>;GZ.GJ\?+S]/7V]_CY^O_:  @!    /P#U6BBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBL'Q3XOB\/K\V&E(!6/)!(R 3D X'7&>N
M"!6S<W*VJ-*YPJ*6)Y. !DGCGI7.Q>*[BX GBM': @$,9$$A7N1'R2>NT9^;
MC'6M*+6S>VPO+5#*6 VH2(R?FVL"3P"O/J#C@G(-9_\ ;M__ ,^7_DS'_A4L
M'BP16QOKI/)4,0JAQ(7]"I& =QSCL0-V=O-5E\6W$ 66XM'CA;[SAQ(5&"=Q
M0+N '\6<8^O!Z:*42@.I!5@""#D$'H0?2LOQ+XECT"/S9.6.0B \L?Z =SV]
MR0#%-K<[Q0W%O;^;YR!F'FJFW(4@98<]3Z=/>J5SXFO;93(]E@#_ *>(R>3@
M  #))/  Y)X'-=);2-(BLZ[6*@E<@X)'(R.#@\9[U'//(DB(J;D;=O?<!LP,
MK\IY;<>..G4U6USQ!'HRJTF2SL%1$&YV)/0#C.,_R'4@'*B\27A D:R8)@$X
MF0N!U.$P"6Q_#P<\<&MG1M9CUB,7$)RIZ@]0>ZD=B/\ ZXR"#5'Q/XE_L15V
MIYCOO(7=M^6-2[MG!'  XZG/%:]M<K=(LJ'*NH8'D9!&0>>>E<W'XKN;IY5@
MM?,6&5XRWGHN2A]&&>F#W^M./BZ6R(-[;M#$0?WBN)E!&,;M@X!S@'N>W4CI
MZS?$>L_V- ]WMW;-ORYVYW,%ZX/KZ55\7>)?^$>B6XV;]SA<;MO4,<YP?2M6
MRO4OD6>)@R.,@C_/7U'4'@\U4_MG_2_L&W_EAYN[/^WLVXQ^.<_A5/6?%8LI
M!:0QM-<$ [$Z*"0,LW.T<YZ>F< @U6D\6S6 \R\MFBBR 7619<$G )"X(7WY
MYP "2*Z2*42@.I!5@""#D$'H0?2L;Q!X@DTV2&WAB\UY]^!O"?< )Y((Z'VZ
M56_MV_\ ^?+_ ,F8_P#"M/0_$$>LJS1Y#(Q5T<;74@]".<9Q_,=00-*BBBBB
MBLW7/$$>C*K29+.P5$0;G8D] .,XS_(=2 <J+Q)>$"1K)@F 3B9"X'4X3 );
M'\/!SQP:V=&UF/6(Q<0G*GJ#U![J1V(_^N,@@U>HHHK-L=9^U3SVFW'V?R_F
MSG=YBENF.,?4YJSJ=Y]ABDN,9\M&;&<9V@G&><9Q7/VWB:]ND65++*NH8'[1
M&,@C(/(STJ>R\5L)EM+R$V[R#]V2X=6.<%=P  ;I@=\]B5ST5%%%<Q'XMFOQ
MYEG;-+%D@.TBQ9(."0&R2OOQSD$ @UI>'_$":TA905D0XDC;[R-W!''''![^
MQ! U:Y'3O%UWJ48N(;/<C9P?M"#H2#P5!ZBKEEXK83+:7D)MWD'[LEPZL<X*
M[@  W3 [Y[$KGHJ***S?#FL_VS EWMV[]WRYW8VL5ZX'IZ5I444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444445P/BWPE;Z38S2HI:4E"9)#ND),@R<]B<D' &>^:Z+QK
MI[ZA9RPQC+%00.23L8-@  DD@8 ]:+;QI9SQBX\U%!7)5F <8ZC9G.?89SVS
MD54\!W9NDN'.X#[7-A7X90<-MQV().1ZYJ?7YS?2II2])%WS')!$2D# P5_U
MA^4X)(&<CG-;+6,;!4**5C(*#:,*5^Z0.Q';'2N8\::G=1)+$D'^C[</*&#G
M8RX<B,%3E<]2<<9/'(V;&_M[*U299 ;>.-0')[*-HSP/FXQC&<\8SQ7/RV4U
M[!<:C>*%<V\HBCY_=*4;/_ VXW'&<#' .T='X9_X]+?_ *X1?^@"L^V<:Y=,
M[ &&S<JF<_-+QN8C(YCZ+D'EBP/IT5<_K-R\=[9QJQ"O]HW $@'$8(R.AP>F
M>E5M-@%WJ5S,_)MTA2/@8 D4LW;.<YYST)'3IU-4[328K-Y)HU"O,07(SR1G
M!QT!Y.<#DG)R:P-/M1K%]/=N%:*!/LZY7.3UDSGN,E>F&#<=\R>!0;))--<C
M?:R$# QE'^=&/)&6R> >!@'GJ[P5_P O?_7]/_[+707-LMTC1.,JZE2.1D$8
M(XYZ5B> ;EKBQA9SDA67L.$8JHX]  *B^(W_ !X3?]L__1BT>-?^73_K^@_]
MFHMO^*?N!;]+:Z;]V!PL<@&63GC$AY4 _>R O4T?\Q7_ +<?_:U1_#J &V^U
MGF6Y=W=L $G>1V XXSCL2<=:Z:6(2@HP!5@001D$'J"/2H=.TZ/38Q;PC:BY
MP,D]22>22>IKFO%VHQZ;=V=Q,=J+]HR<$]44#@ GJ:L_\+&L/^>O_D.3_P")
MJE;K(8K_ %,J\1G0[%;Y7 AC*A^N02>W;'!((-.T"R>U@35;F>9V6$N4$F8R
MNPX^4@9;;@G)Y?DD]:-)T6?7(EO+FXF1Y!N"0.(T52<J, ')P<Y)S@@'D59T
M.YEU$7&G73-YL#@>9'B-BK_-&P*'AN,XZ8P#GYJHP>+I-/A:SE"M?1.D2KN)
M\PN!L?)[$'+9(Y')4L )=0BGT**"[EE9VCFS.=S>65E.UCLSR$X"!0 .NWDU
MI>,+UXHA;0,1/<.$0CJ.<NWJ%5<Y8 E<@\=:VXHQ& HS@ #DDGCU)R2?<\FN
M9TV 7>I7,S\FW2%(^!@"12S=LYSGG/0D=.G4UE3Z.+432VBJD\XY8DA=PR Q
M&&&1DGA?F/7KFN4U&"&S5C/J,OG;F!\N3@-D_P#+)-Q '0C(';(R!6O8:S)?
MZ6UVYQ+Y$WS+\IRFX!N.AXSQCGIBH- LGM8$U6YGF=EA+E!)F,KL./E(&6VX
M)R>7Y)/6C2=%GUR);RYN)D>0;@D#B-%4G*C !R<'.2<X(!Y%.\(QR1W=XL[!
MI!]G!91@'"-@X[$C!(' .<<5N>)O^/2X_P"N$O\ Z :YS1_&8LK:(-;W!6.%
M,N(ODPJ#+!MP^7C.?2GB\D\7O!)"ACMH91(7DQN9HSPJJ&/'/+=,Y[KAG:SJ
MWVVZ>R:X%O#"B[R&6.1V?YAM9NBJ,9(P>2""""(+?5%TB:%(KK[1#,^QD>19
M959^%<,,';D $'@<D D\:6E:BUG>S:?*Q(DQ+"78$X(PZ#G@ @[5 X 8GL:;
M.YUB]>T.[R+>$B0!MH=IAP" >5V9(X!# \],]!%&EA&%&%CB0#D\!5'<GL .
MIK!\(JUX\^IE2BW3)L5L9V1KM#]?XL].W8D$&NEKS_P7XH^PVD</V>X?;O\
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MEV5RP^1\;26S]T@?+D@\=.F.2:]"HK(\5ZR-(MI)\X;:0G3.]N%P#P<'D]>
M3@UYE\,M)^VW8E(RL"EN5R-QX49Z Y.X=_EX]11\563:#>N8_EVN)(R%  R=
MPP.00I^7TXZ=J]ITW4$U&-+B,Y6101TSSV."1D'@CL>*\KD\<7VEW'D7,A*Q
M2 .!&@RH/.,JIPPZ'C((->NUY1XD\=W:W<EO:N0JOL5?+1CN&%./E).6!QWY
M_"NR\1>)6\.6J/+A[AE"XR "X7YFQP=H/H!U XSD>>V$VJ>("TT+RL 0"5D$
M:YQT RJYQUP.^3UY:_B+4?#DGE2N^[Y25E/F CV))X/(.TCTSD<>@:SXG:33
M3J-N=K%4(X!P2ZJP^88.#D9QSU%8GP[\67.KW#13ON41%@-J#D,HS\J@]":R
M/BW_ ,?:?]<%_P#0WKMOAS_QX0_]M/\ T8U<;XN\?37TIM+,E4#;08^7=L]0
M5R0"1\NTY(Z]<"I>Z9J]DC32-,$09)$^[ ]<*Y.!WXX')XKH/A_X[EU*4VET
M0S."4; !R!DKA0!C )!XZ$<Y&,;XM_\ 'VG_ %P7_P!#>JVAZY?W<*:?8J0(
MU<,5 R=[,V2[<)QPO(.<\DX BEUK4O#<@,S2 ^DK&1& P2 22#V!*G(SC(KT
MOP=XH'B"'S" LB'#J#WQPP&<[3VSW!'.,GSW0_'M[=7$,3RY5Y8U(V1C(+ $
M<+GI74_%O_CT3_KNO_H#UF_!S_EX_P"V7_L]9&N>/;VUN)HDEPJ2R*!LC. &
M( Y7/2N^\<WEU:0*UD&,AD .Q-YV[6SQAN,XYKQ:QD>.1&BSY@=2F!D[@?EP
M.<G/;O7H%OK.J?99YY"Z/"8V7= HRIW!QRHX'#$X. .P)J[\./%TVKR207#%
MV"!E^55  .&^Z!R=PQUZ'IWZGQ1JATNUEN!D,J?*0 <,WRJ<'C )!/MV/2N-
M^'_B.\UNX*RR$Q1H2P\M,$GA5W!1@\Y'KM(]:]'HKRCQ3\39+EFAM#LBZ;\?
M.W!!(S]T'/'&[C.1G J26FKV2?:V:8(@#',N[ Z\H6)P.X(X&=PQFMOP9\27
MN9%M+O!+D!748.XG@,!Q@Y ! &.^<DC"\=:A>S/)%.'^SK.WE[HPJ\%@N&VC
M/RYQR<CFLWPUJ%[9[_L(<[MN_9&).F=N<JV._P!:]JT>1Y((FESYAC0OD8.X
MJ-V1Q@Y[=JN4444444444444444444444444444444444444444444444444
M444444444444444444444444444444445Q'Q;_X]$_Z[K_Z ]9OP<_Y>/^V7
M_L]<W\1O^/\ F_[9_P#HM:]6\(VRV]G J# ,2-W/+C<QY]22:\I^(W_'_-_V
MS_\ 1:UZMX1MEM[.!4& 8D;N>7&YCSZDDUY3\1O^/^;_ +9_^BUKMO$'_(&7
M_KA;_P XZY;X4VRRWA9ADQQ,R]>"2JY_)B*]@KY_U/\ XEEW)Y/R^3.VSOC8
MYV]<YQCOGWK9^)UV9[UD.,1(BC'H1OY]\L?PQ7I?@O3TL;.%4'WT5R>,EG 8
MYP!G&<#O@ =JS?B?IZ7%FTS#YH64J>,_,P4C.,X(.<#'('I7+?"*Y9;B2('Y
M6BW$<=590#Z\!C^=<MXF_P"/NX_Z[R_^AFO=]-T]-.C2WC&%C4 =,\=S@ 9)
MY)[GFL/XC?\ 'A-_VS_]&+7$_"3_ (^W_P"N#?\ H:5Z?JFK1:4GG3L%3(&3
MD\GL ,DGZ#ID]!7GK?%**Q#1VEL%4\@DA!N(')1!CK_M9('4=N9\4>(;C7!'
M-.H5 &V;5*J>1N())R> #S@8Z YSWOPD_P"/1_\ KNW_ * E>9:';+=7$,3C
M*O+&I'(R"P!''/2OH2OGWQ#$(KF=% "K-(  ,  .< #TKUWXC?\ 'A-_VS_]
M&+7$_"3_ (^W_P"N#?\ H:5ZW17DGQ;_ ./M/^N"_P#H;UV$_A\:]IL-OD!Q
M#"R$YP&"#KCL02.^,YP2*XKX=:\^DW/V.7(25MI4Y^63H#C!()(VGIU!/W:I
M?\Q7_M^_]K5U?Q@NRD<,'&UW9CZY0 #\/G.?PIWPBT]!%)=8^=GV9XX50K<<
M9Y+<\X.!Z5V^I:>FHQO;R#*R*0>F>>XR",@\@]CS7AOA&Y:WO(&0X)E1>QX<
M[6'/J"170?%O_C[3_K@O_H;UVWPY_P"/"'_MI_Z,:O-_B-_Q_P W_;/_ -%K
M7=ZQ<M;Z.&0X)MH5['APBL.?4$BN1^%-LLMX689,<3,O7@DJN?R8BO6[FV6Z
M1HG&5=2I'(R",$<<]*S]+\+VNEG=#$JL"2&/S,,C!PS9(&.P..OJ:\9\77+7
M%Y.SG)$KKV'"':HX]  *["+XO"(!%M@%4  "7  '0 >7TKB-?U0:K.]TJ",2
M$':#GG !.<#))Y/'4U[IH=RUU;PRN<L\4;$\#)*@D\<=:O5XE\1O^/\ F_[9
M_P#HM:LVWPRNKJ);E&C(= X7<P8Y&0.5QG\<9[URWD^6^R3*X;#<?,,'!^4D
M<CT)'/<5[1X*\.6VFQB>W;S#*HS(>I'< ?PC(Y'7/#$X&.-^+MRS7$<1/RK%
MN XZLS GUY"C\JA\,_$4:' MJ( Q!8E@^W<22<D;#R!@=>@%9GC#Q:/$91_*
M$;1A@3NW$@XP,[5X'..O4UO:/J,B:-/@_<<H.!PKE-PZ=][<]>>.@JC\*;99
M;PLPR8XF9>O!)5<_DQ%>P5\\ZQ:"RGE@7)6.1U&>N%8@9Z<\5[CXAUVWTF/-
MR1M<, F-Q;CD;?3L<X'(R1FN$E^*PME,-K;JB@G9D_+C.>44#!/H&X)ZGORG
MB;5I]5D%Q<KM+(NT!2HV<D$9Y()R<Y/MQQ7HGA__ ) S?]<+C^<E<!X*T]-0
MO(H9!E2Q)'!!V*6P00002,$>E>[5\_Z9_P 3.[C\[YO.G7?VSO<;NF,9SVQ[
M5] 5X_\ %:V6*\#*,&2)6;KR067/Y*!74^'_ /D#-_UPN/YR5Q/PY_X_X?\
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M&?\ $GQG'<I]@MV# D%V4@K@<A0><G."2#QC'.2!/\)-&,:R7S#[_P B'D'
M.7]B"<#//*D<=^#\3?\ 'W<?]=Y?_0S7T!7-?$;_ (\)O^V?_HQ:X#X9:E'8
M73-,P0-$R@L<#.Y3C)X' /7Z=2*V?BI>B]B@EA8M"7E!*YV%E(4>Q/#8/<9(
MXJ#X8:A9VH?SBB3ALJ\F -N,85B< Y)R."0>X'%3XF^(XM6DCBA(980^6&<9
M8@$#CD#;G()!SQTKIOA)_P >C_\ 7=O_ $!*\V\,_P#'W;_]=XO_ $,5] 5\
M_P#B;_C[N/\ KO+_ .AFO6_B-_QX3?\ ;/\ ]&+7 ?#+4H["Z9IF"!HF4%C@
M9W*<9/ X!Z_3J17KME>I>J)8F#(2P!'0[25./49!YZ'J.*GKR3XM_P#'VG_7
M!?\ T-Z])\,_\>EO_P!<(O\ T 5YU\4?#0LY!?Q_=F;##  #XSD8Y^8 D\=0
M23R!7,^'I3+>0.Q)9KB,DDY))<9)/K7I'Q2T,WUN+E,EK<DD#^ZV-QP >1@'
ML -Q-<S\-_%R:4S6DYQ'*P*L<85L8.>^&&.<X&.F"2.P\5>/(-.A/D2+)*X(
M3RV5MIQ]X]0 .P/4\=,D<#\.-&.H7:R$92'YV/(&1]SD=]V#@]0#UZ5>^+?_
M !]I_P!<%_\ 0WKIOA_X@MX;.*!I%$@<KL)^;+R';A>I!W#D<#G)X..'^(W_
M !_S?]L__1:UZ,^EG5-+2W&2S6T>T @9955E&3Q@D 'V[CK7FW@O6QX>NMTP
M(4ADDRIW+R.W!R& SU.,\9Q7I/B;QK!8V[O!*CRD80(ZL<G^+ W<+UY&#C'>
ML3X?^++S6)3#)M>-06=RN&&1A5!7"Y)YY&2-W/%<I\0-&;3KN1L'9,Q=6.,'
M=RV"/1B1CJ!C/4$^EZ#XWM]0A6621$DQAU=@F& YP&/W?0Y/'7G('+2_%>4W
M!2*)9(MY5 -PD;LI!]2><;<]NO->D1$D L &P,@'(![X.!D>^!]!3Z\2^(W_
M !_S?]L__1:UZWX9_P"/2W_ZX1?^@"N6^)OA9;F,W\:_O8\;\9^9.F2 #DKQ
MSQ\N<YP,<[\,O$@TZ8VDA/ESD!>IP^<#OP&Z$X/.W. #6I\6]&9C'?*"0%V.
M>,+SE/?DL1GIT'!/,_PV\70Q0?8YW6-HB2I8A5*L<_>)QN!)XXXQC.#3O%GQ
M,-A((;3RY %RS'+#)Z ;2!P.IR>N."#6S.7\5:>Y:,HTJ$HH;).T[DR650 Q
M'TVD'//'FW@O6QX>NMTP(4ADDRIW+R.W!R& SU.,\9Q7J&H>.;2UB,ZRHY*Y
M55;+$X) ( )7/0DC@]:\2N;EKIVE<Y9V+$\#))R3QQUKMOB[O^T1YSL\KCKM
MW;FW8[9QMSWQC/:M7X;:K96L'S%(YP2':0A68,<C#,>5P!D#H1DCD$\IX_UZ
M/6KGS(>41%4-R,]6)P0".6Q^&>]=MX?_ .0,W_7"X_G)7$_#G_C_ (?^VG_H
MMJ]MKP;5+)_#5W@*?W4@:/?SN56RAXQD''.,<Y'!''K=IXXL[F/S_-50!RKG
M:XP,D;>I/^[D$\ FO*_''B!=<N3+'_JT4(IP02!DY.?4DXZ<8R <UW?A_P#Y
M S?]<+C^<E<3\.?^/^'_ +:?^BVK2^+?_'VG_7!?_0WKMOAS_P >$/\ VT_]
M&-7-_&/_ )=_^VO_ +)6E\)/^/1_^N[?^@)7GNJ63^&KO 4_NI T>_G<JME#
MQC(..<8YR."./6[3QQ9W,?G^:J@#E7.UQ@9(V]2?]W()X!->3^,M>_MNY>8?
M<7Y4_P!U<X/0'DDMSR,X[5ZC\.?^/"'_ +:?^C&KI:\V^,?_ "[_ /;7_P!D
MIWPS\06^GVTB32*C+(6PQP2"B]!_$?E/ R?;D9R_BW_Q]I_UP7_T-Z[;X<_\
M>$/_ &T_]&-7-_&/_EW_ .VO_LE:7PD_X]'_ .N[?^@)7GNJ63^&KO 4_NI
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M?S%>:?%C1C!,MXH^650&/)^=>.>PRN,>NT\=S@:KJ,GB>XC!.698HP6 4;B
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MQG>,XS7=W-LMTC1.,JZE2.1D$8(XYZ5P%S\'D9B8YRJ]@R!CT]0R@\^PKM-
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M44444444444445P/BWX:'4Y6NK=U5G(+*XPN<<L"H/)XR".22<]JP(O#6L1
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M11111111111116'XN\2_\(]$MQLW[G"XW;>H8YS@^E<E_P +C_Z=_P#R+_\
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M)))P !U)/I7)7?Q3LX#M7?(,=43 ^GSE3G\,>]7M#\>VNKGRU8HY. LN%)Z
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M3XIV<YVMOC&.KID?3Y"QS^&/>O/_ (@RB6^E=2"K",@@Y!!C3!!]*]>\,_\
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MV[1D^G;/4$<5S/AKP_)XCGV\E=P:5R>0">3DY^8\XZY/)X!(V_BW_P ?:?\
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M_P##^HOX8O,,0 KF.4X+#:&PQ'&>,9&.>.G4'7^+?_'VG_7!?_0WH\&>!?\
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M< #)/'/2O"?"-LUQ>0*@R1*C=APAW,>?0 FO:]>U2'3(6EN,>7C!4@'=D?=
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M62-@RG9@J00<2J.HXZUY)HVC2:Q(+>$98]2>@'=B>P'_ -89) K0267PA>$
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M6H)%)+;L<-*JE>F#LW9'7.<-G [ GM5;XGZ!)#<->A2T4BJ2P'"D )@D9QG
M()QG.!G!J[X!\7W-[+#IY ,4:MDA?FVJA"@GH #M&< DX!)R<Q^/O L@E:[M
M4+I)\SA3N8.3R0O4@YSQG!ST&*S;;XGWD$8A^1B%P'927]CG=@D>I!SWSSF?
MP+X%?476ZG4K"A# ,/\ 6="!@C[GJ>A' [D.^+?_ !]I_P!<%_\ 0WKMOAS_
M ,>$/_;3_P!&-1\1O^/";_MG_P"C%KB?A)_Q]O\ ]<&_]#2K/Q-\+2><;^-2
MR.HWXY*E5QD@#A=H'/.#G..*RM"\=7MO&+& "0X(3Y2\@&.@P>0O49!QTZ#
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M_>*#R=H&U@#U.!@@')XP,Y-<UI?Q"N]%3[(0K>62 )5;<N.-O#+P/0\CIT
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M6#@F)LC(&5."1U&#D<CU%.U+6;WQD5C"%E0CY8E.P%L@,Q).#VR3@#.,<Y]
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MBBBBBBBBBBBBBBBBBBBBBBBBBH+NQCO1LE174'.'4,,^N#GGFL'_ (5S8?\
M/+_R))_\56KI?A^WTH8@C53@C(&6P3G!8Y8C/J?3TK0HHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHKY_P##/_'W;_\ 7>+_ -#%?0%%%%%%?/\ XF_X^[C_ *[R_P#H9KZ
MHHKY_P##/_'W;_\ 7>+_ -#%?0%%%%%>=_$3PG<ZO<++ FY1$%)W(.0S''S,
M#T(KJ/!>G2:;:1V\PVNN_(R#U=B.02.AK<HK&\5^)!X?A^T%2Y+A0 <<D$\G
MG P#V/./J,'X<^(IM;>XDG;./+V@#"J"9#@#^IR2 ,DXKMZ******\D^+?\
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M&NIHHHHHHHHKY_\ $W_'W<?]=Y?_ $,U] 5X_K _X2#5O)P602JA5CCY8_\
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M;T?6IKC3#>NV9A%,V["CE"^TX QQ@=JXC2OB?<VY=IF\SY"$4JBC?D8)*@'
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M)55NG( 9L?FH-<#X/\6CPX7?RA(T@4 [MI &<C.UN#QGIT%:?B;XBC7(&M3
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MY)0/F:7:3ST55('IP6/YU)\6_P#CT3_KNO\ Z ]9OP<_Y>/^V7_L]<W\1O\
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MR^#K02-<&)6>0DL7RX)8Y)VL2 <^@_2I/$.NV^DQYN2-KA@$QN+<<C;Z=CG
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MJKC)QP>._P I)P.2<8ST/ ?#KQ1'H<CK,<1RJ,M@DAESCIS@@GL3G'09KO\
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MA9:7!OA>/ 4E(X\ DD%@-J@E<GJ2!@GGFO)/#/\ Q]V__7>+_P!#%=+\6_\
MC[3_ *X+_P"AO7;?#G_CPA_[:?\ HQJ\D\,_\?=O_P!=XO\ T,5] 5XI=Q'P
MGJ.[!5$DW+M&<QMV&[J=I*Y]0><C-2> [0ZS?B:3!*EI6SQDYX(V]][ XX&,
M_2O9Z*\H^+N_[1'G.SRN.NW=N;=CMG&W/?&,]JU?AMJME:P?,4CG!(=I"%9@
MQR,,QY7 &0.A&2.03RGC_7H]:N?,AY1$50W(SU8G! (Y;'X9[UZ1\.?^/"'_
M +:?^C&KR#0[E;6XAE<X5)8V)Y. &!)XYZ5[Q9:O#?EEA=7*!2=A# ;LXY'&
M?E/'7\Q5RO-OC'_R[_\ ;7_V2M+X2?\ 'H__ %W;_P! 2CXM_P#'HG_7=?\
MT!ZS?@Y_R\?]LO\ V>N;^(W_ !_S?]L__1:UZ7X4\06\T%O LBF0QJNP'YLH
MGS97J -IY/!XP>1GAOBW_P ?:?\ 7!?_ $-ZZ;X?^(+>&SB@:11('*["?FR\
MAVX7J0=PY' YR>#CA_B-_P ?\W_;/_T6M=IX"\:PO;K;7$BI)$-HWD*"JXVG
M) 7(!QC))QFL3XE^+8M3"6D#!U1RS, <9&5 ![CDDG!!XP>M6_!D<GAVREU'
MRBY=E.TMMS&HX<85CU8DYP-HW=.KM ^(ZZJS6VH+$(V P=I*YW#A@VX8[Y.
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M]!^.:S_",1UK45E<'F1I6V#@$9<=<X7=@<^N,YKT_P 2^+HO#VSS@Y\S=C8
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M3Z=Y%LUP1@S.<'/54X'&>,-N]#^&*S?C'_R[_P#;7_V2M+X2?\>C_P#7=O\
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M *X+_P"AO76^"]033M,2XD.%C60GIGB1N!D@9)X [GBO+=9UEM:G-Q,2 S<
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M/J#C)Q@FN/\ ^%.?]/'_ )"_^SKK?#G@^#0-QBR6?JSD%L?W1@  9YZ<GKG
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M'K@D'@]P01^(!'%_\*<_Z>/_ "%_]G7:>'_#<.@H8H0?F.69L%CZ9( X'8
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MRL3T!KT2BBBBBBBBBBLCQ9;S7%M(EKD3';MVML/#J3\V1CC/>O.8OA]J&JR
MW1(  &^602'&>@ 9CGDD#@>XKT_1-*7284M4Y$:XSSR3RQY)QDDG&>.E7J**
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M************************************************************
M***************************************S=<\10Z(GF3MC.=H RS$#
M. /ZG !(R1FM*BH+V]2Q1IY6"H@R2?\ /7T'4G@<UPEW\8(T.(H69<=78(<_
M0!^/?/X5K^'/B-;ZN1"^8I6. K<J2<X ; YX'4#DX&:ZNBBN&UKXK0V3F*%#
M+M)!;<%7C'W3ALCKS@#CC(.:-%^*T-ZXBF0Q;B &W!EYS]XX7 Z<X(YYP!FN
MYK!\4>,8?#P ?+2,"51<9[X)/9<\9Y/H#@XY:+XQ D!H"%R,D29('? V#)]L
MCZBNYT;68]8C%Q"<J>H/4'NI'8C_ .N,@@U>HHHHHHHHHHHHHHHHKB/$?Q*_
ML:=[3R=VS;\WF;<[E#=-A]?6LW_A<?\ T[_^1?\ ["C_ (7'_P!._P#Y%_\
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M!R.E>$^(+T7UQ+.&+*\CE2<_=R=O7G&,8'8<5[7I'BRVU=S% ^Y@NXC:XX!
MS\R@=2*UZ\O^+VHEI(K3D*J%SSP2Q*CCU&TX/^T>G>SX$\"6U_;"ZN 7:0G
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M#=D8'7J0.37L]%8WB#Q;;Z" )F.\C(11EB,XSV 'U(S@XR16#_PMNT_N2_\
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MQ@9J#6OB):Z4YA)9W4D,(P#M(QP22HS]"<$$'!J?P_XXMM<;RHR5DYPL@P2
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MH$AGB9RS(5^<J1@D'LHYXKHJ\V^+>C,QCOE!("['/&%YRGOR6(STZ#@GG/\
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MR"<-*Q9FP2%4?F< 8503CH,BNK^+T0B%LB@!5$H  P !Y> !Z5J?"3_CT?\
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MO_0TKTGQ-_QZ7'_7"7_T UY)\.?^/^'_ +:?^BVKVVHKFY6U1I7.%12Q/)P
M,D\<]*Y_3O']MJ4XLX=[%LX;;A.%+'J0W;'W>OMS6GXF_P"/2X_ZX2_^@&O)
M/AS_ ,?\/_;3_P!%M6E\6_\ C[3_ *X+_P"AO7;?#G_CPA_[:?\ HQJYOXQ_
M\N__ &U_]DK2^$G_ !Z/_P!=V_\ 0$KS;PS_ ,?=O_UWB_\ 0Q7O-]:"]C>!
MLA9$93CKAA@XZ\\UX_X#NSHU^(9, L6B;/.#G@#;WWJ!GD8S]:AN?^*IU$A>
M5EEQE?E/EIQN^;OL7//?MVKVVBBLWQ-_QZ7'_7"7_P! ->2?#G_C_A_[:?\
MHMJV?BY>N9X[?<?+$8;;VW%F&?<X&!Z<XZG.5HWQ"FT>,6\,<04=25?)/=B=
M_)/_ -88  K$UK5WU>9KJ0 ,^,A<@<*%[DGH/6O1/AQXNEU)Q8N$"0P#!4'=
M\A51DEB.AYX'->@445E>)/$":#";B0$\X51W8@D#/8<$D^@[G /D]G9W/C>Y
M+L?3<V/D1>P _/ SDG))^\U>L>'_  W#H*&*$'YCEF;!8^F2 .!V  'XDD\E
M\8+0O'#/QM1V4^N7 (_#Y#G\*D^$-V'@E@YW)(&/IAU 'X_(<_A1\7KL)!%!
MSN>0L/3"*0?Q^<8_&H_@_:%(YI^-KNJCUR@)/X?.,?C4GQ"\<FP)L+<D2X&]
M^FT$9 7_ &B#U[#I\WW<;P5\.O[2475UE8S@HHX+#.<GN%(Z8P3U! P3ZI%$
M(@$4 *H   P !T 'I7&S_$'3[J9(V4N5==DC(NU2Q'S9<AE /4X'3/I7:U\^
MZQ$);F5(0"K3.$$8R""YVA0.WIC\*^@J****************************
M************************************************************
M**X_XD^&WU>%9806DA+':.ZL!NP,<L,# STSU.!7G>@^*[CPT7C3&"?F20'
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M.2.YQR #7E>JZ3-X;GY!!C?,;E>&VD$,.H/8D<XZ&O2?!>NR^*4G%RH\K:J
M("JG<&W\Y)S@C// QTSSPVM>&[KPM,;B(,(T<E)%^;C( W8'!.<$$ ,<@9%.
MUCQ[=:]']C*H!(R\1JVYL'(7EF[XZ<Y_$'KOAUX*;3?].N!B1EPJ$#*@]SGD
M,1QCL"0>20.-^(W_ !_S?]L__1:UZWX9_P"/2W_ZX1?^@"N(^,?_ "[_ /;7
M_P!DK2^$G_'H_P#UW;_T!*/BW_QZ)_UW7_T!ZS?@Y_R\?]LO_9Z])HHKY_\
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M>&VD$,.H/8D<XZ&M#7?B%<:S$;9PBHQ&=BG)P<@?,S<9P>.>.N,UTGPO\*O
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M&=V/NMMSG'WL;<>^<8YSBMNVN4NE$D;!E/0J00<''4<=:EK#U#QK9Z>YBDE
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M8''WAU.TXYST/L<#HOADT\4+6L\;H(F!0NI7(?)(&0,X()SD_>QQ@5E?%/Q
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M<D#N>OJFO>%4&GM8P@GRDW)D;V+*=QQ_M-R./[QP,<5Q/PJU0VUT;<YVSH>
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M%XMP!##YER."2."">,X&"0.<UTOPJU]KR-[.1LF'!3)&=AXP!UPI'7G&X#@
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ME6?C'_R[_P#;7_V2M+X2?\>C_P#7=O\ T!*K>/?'LFF2?8[; 8*"[D9()P0
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M@O\ Z&]=)X?_ .0,W_7"X_G)7FWARREOITAMWV2MNVMN*XPI)Y7)&0"*[?\
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MXI)%)H-QA@/,MY >0=I*G(/8E3U'3(->M^#?&!\2&4[ BQA,#=N)+;\\X''
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ME((.0S*R $=0=Q ]N]=/\8_^7?\ [:_^R5I?"3_CT?\ Z[M_Z E<3\1O^/\
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MZ9+$)048 JP(((R"#U!'I5#_ (1FT_YX1?\ ?I/\*TJ**BN;9+I3'(H93U#
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M,=5T_$LV]5W#_60A5/?;G8#R!V(..E=KX(\;CQ ##( LR DA0=I7.,C.<$9
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MI^76O2:\Q_X6;<W5Q]F@6(J\NR-F5QD%L*3\V>F,\?A7IU%>;>)OBFT;F&S
MPNY2[8;)S@%,'&.X)SG/3CG(G\8ZKI^)9MZKN'^LA"J>^W.P'D#L0<=*[GP7
MXT'B(,C*$EC ) .0P/5@.N,]1SC(Y.:T/$OB6/0(_-DY8Y"(#RQ_H!W/;W)
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M]"3G.=;3M<TG4I?M$T0CF8C/F F,LPP>A*8'=F5?[W7./1(HA$ B@!5   &
M .@ ]*PKGP%973M*\66=BQ.^09).2>&QUKH*\?T<_P#"0:MYV2R"5G#*,?+'
M_J\\<#A0<C//J:].\2:C_9MM+<9VE4.TXS\QX3C!_B(Z\>O%<'\(-/R\UT0?
ME54!_A.X[F[=1M7OP#SU%/\ B]I9!BO!G!!C;D8&,LO'7)RV>W Z=[>A>(/+
MT=Y,ONA5X\@\AF.$(.<X4.OH1C@<"O-H[/?$]QG[CQKC'7>'.<^VS]?:O2?#
M?B5K?27F.=UONC5LACDXV'#<84N!CG@?A6%\*M+-S=&X.=L"'D$?>?*@$=<8
MW'CN!SV)\5=+-M="X&=LZ#DD?>3"D =<8VGGN3SV&[KOB#S-'23+[IE2/)/)
M93AR3G.&"-ZDYY')KS:2SV1)<9^^\BXQTV!#G/OO_3WKTG5?$K'1TE.=\RB+
M)(8G!*N23_>5&]2"?QJI\(=+),MX<X $:\C!SAFXZY&%QVY/7MRTD9\,W^#N
M"P3 \$%BF<]L#+(>1QUP<5TWQ?U#+PVH)^56<C^$[CM7OU&UNW /'4UR$$IT
M&XCF4DE!#)P=N0Z*Y7//&&VGU';M79?%[5"3%9C. #(W P<Y5>>N1AL]N1U[
M=)\.=+-A9H3D-*3(02#][ 7&.Q4 ^N2?H.GKROXO79>>*#C:D98>N78@_A\@
MQ^-=-\,-/2WLUF4?-,S%CQGY6*@9QG  S@YY)]:T/$G@V#Q 5>4LK(",IM!(
M/8DJ<@=O3)]:G?P\EO:R6-N-H=) H9F8 NI'<L0,\\>YQDUXM;3S>'+@/C;-
M"W(89'(P1[@@]0>AR#T-=A'\4DOD^SWL 9'!#E#^(PC=^G._(/(YP*Z7P<VF
MSG_0E42*-Q# ^8NX8/S/DX'0[20,^_-/XM_\>B?]=U_] >LWX.?\O'_;+_V>
MM+XM_P#'HG_7=?\ T!ZQ/A%IZ2R2W##+1*H7I@;]V3TSG"XR.Q([UZ3J6GIJ
M,;V\@RLBD'IGGN,@C(/(/8\UX?X-NS:7D#KC)D5>?1_D/XX;CWK>^+?_ !]I
M_P!<%_\ 0WKIOA=HJ6UL+O ,DQ;G'(56V[>O3*Y/3.1G.!6YXQU$Z=:33+G<
M$P"#M(+D(&!]1G/X=J\M^'>BIJMT%E *1H7*D9#8( !YZ98'N#C!&#7M$L0E
M!1@"K @@C((/4$>E>$^*-/&B7<D,1($;AD(R"N0'4 Y)RN<9SGC->UZ9/_:5
MO')( ?.B4L,?+\Z@D8.>.>ASQ7C?B30Y/"UR-F=H8/$Y YQ@^X)4\'UX. "*
ME\&^&W\23EW.8T8-*6));))V]<Y;!YSQR<YP#[5%$(@$4 *H   P !T 'I7B
M_CW33I%ZSHQ'F'S5(/S L3GD 8(8'&.V.<UZ3KVNE-.:^4$-)"I #8*F7 !#
M8ZKNSVSCM7#?"G2/M5PUT3Q O [EI 5';IC=W!SCWKUNL'QU=FTLIG7&2FWG
MT<A#^.&X]Z\Y^&&GI>7FYQGRD9P.,;@549R.V[([@@&O6]2T]-1C>WD&5D4@
M],\]QD$9!Y!['FLCP_X'M]#;S8MY?GYF<YP1]W"[5([\@\\]ACSWXHZB;F[,
M/(6%% &<C+#>6QV)R ?7 ^@] \!Z*FFVL;*!OF179L8)W#('4\*#@=NIP"36
M9\4=%2YMC=X DA*\XY*LVW;UZ9;(ZXP<8R:POA%J#B62US\C)OQSPRE5XYQR
M&YXR<#TKD?$W_'W<?]=Y?_0S7N^FZ>FG1I;QC"QJ .F>.YP ,D\D]SS7@WB&
M(17,Z* %6:0  8  <X 'I7O.FZ>FG1I;QC"QJ .F>.YP ,D\D]SS7@WB&(17
M,Z* %6:0  8  <X 'I7N'B34?[-MI;C.TJAVG&?F/"<8/\1'7CUXK@_A!I^7
MFNB#\JJ@/\)W'<W;J-J]^ >>HJ7XQ_\ +O\ ]M?_ &2M+X2?\>C_ /7=O_0$
MKSWQE=F[O)W;&1(R\>B?(/QPO/O7N&FZ>FG1I;QC"QJ .F>.YP ,D\D]SS6#
M>_#NUO9VNY Q+G)0$*A.,9^4!LD\GYN3UK9O[: 1@7 0Q)CF;# ?P@DOGGG&
M2<G/O7$VOCC3M #QV<;G/.0.&.. 6=MX Z=..2 <\\GXP\8'Q(4.P(L8; W;
MB2V,\X'' P,>O/IW/PD_X]'_ .N[?^@)7FUM_P 3F[7S./M$XW;>,>8_.,Y]
M>,YKWV*(1 (H 50  !@ #H /2O'OB?IZ6=YN08\U%<CC&XEE.,#OMR>Y))KO
M_AS_ ,>$/_;3_P!&-7":.?\ A(-6\[)9!*SAE&/EC_U>>.!PH.1GGU-=O\1M
M&DU6UVPC<T;ARHZD!6!P.YYSCOVR< ^7^&_%<WAXLT.TB0#(<$CCH>"#D9/?
M'/3ICJY_'MEKV([Z @*PVE6+8SPQ)&Q@.F0,Y],@5V_AH6CQ^99!-API*+@G
M;QAL@,2,_P 7/.>^:\6\3?\ 'W<?]=Y?_0S7N^FZ>FG1I;QC"QJ .F>.YP ,
MD\D]SS7@WB&(17,Z* %6:0  8  <X 'I7O.FZ>FG1I;QC"QJ .F>.YP ,D\D
M]SS7@WB&(17,Z* %6:0  8  <X 'I7T%5'6=9CT>,W$QPHZ =2>R@=R?_KG
M!->,ZQK%QXMN  "23B.->BC].>,LQQT[  #UCPCX:70(1%P9&Y=@#R>PYYPH
MX'3N< DUXWXF_P"/NX_Z[R_^AFOH"O$OB-_Q_P W_;/_ -%K7K?AG_CTM_\
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M<; 2< G?D]2!C<,]!@\UY[X-D>.\@,>=WF*#@9^4\/Z\;2<GL.>,5Z%\6_\
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M&X,-O/8X+8'?GTXY/Q-_Q]W'_7>7_P!#-?0%?/\ XF_X^[C_ *[R_P#H9KZ
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M<U=_X5%<;\>9'LW=?FW;<]=NW&<=MV,\9[UW?A;PG'X=0K&2S/MW,W?:.P'
M&22.IYY)XJ/Q9X-C\0J,G9*OW7 R<9Y4C(R/3G@\CJ0>&E^$=R"0LD17)P27
M!([9&TX/MD_6M+0_A*$.^[<$ _<BS@].K$ X/(( ![AJ]$BB$0"* %4   8
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M8Q2,<MA0RGKD[<C#'C)SCVR2:Y:+X1W)(#21!<C)!<D#O@;1D^V1]179>%O
M4.@GSLF27!&Y@ !G/W5YP2."<D^F 2*;XXT"ZUQ5@@9%B'+AF8%CG@8"'@8S
MUY)Z< U6\#^ SH;-/.4:4\(5R0HQR<D#DYQTX Z\D4>./ 9UQEG@*+*.'+9
M88X.0#R,8Z<@]> *L^!] NM#5H)V1HCR@5F)4YY&"@X.<]>".G)-=!J<"3Q2
M1R':C(P8Y PI!!.3P,#N>*\&\/Z6=5N([;G#N,X(!VCEB,\9"@G^AKW^*(1
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[encoded data, 8784 characters]
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MCU)Q^0ZD  9.*S-2\,/J=ZEU-L-O$A C;+[F(.25("CKUR3\H_"/Q-X)2]C
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M]375^';>Z@C*WKK))O."@P-N!@?=7G.>WXUE^.- NM<58(&18ARX9F!8YX&
MAX&,]>2>G -<;_PJ2[_OQ?\ ?3__ !%=AX$\-W&@!X9F1HV(8;"20W0]4&01
MCOQCIR:ZNBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBN(_P"%MVG]R7_OE/\ XNI[+XI6ETZQ$.FXXW.%"CZD,<#WQ@=\#FNI
MOKL64;SMDK&C,<=<*,G'3GBN/_X6W:?W)?\ OE/_ (NG1?%FT<A2LH!(Y*K@
M>YPQ.![ GVKKK*]2^19XF#(XR"/\]?4=0>#S5;6-?@T<!KAP@8X'!)..O"@G
M [GH./45S47Q9M'(4K* 2.2JX'N<,3@>P)]JZG2]6BU5/.@8,F2,C(Y'8@X(
M/U'3!Z&J7B3Q3'X?"O*KLKDC**" 1V))&">WK@^E7=)U1-5B6YBSL<<9&#P<
M$'W!!'IZ$BL;1_'L&KS?985D)^;YMHV87^(_-D ]!D#D@'%&L>/8-(F^RS+(
M#\OS;1LPW\0^;) Z' /((&:Z**42@.I!5@""#D$'H0?2N;B^(5O/<"RB#R,7
M"AD4%/<YW9VCG)QC )&1S73T444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444444444444444444444444444445X[\+[&.]N725%=1"QPZ
MAAG>G.#GGFM+XI:5:V0C,05)B?N( H*<_,5 QG/ /&>>N.-O0Y3)HS%B2?L\
MXY.>!O 'T &!Z"N9^&OV3]]]K\K_ )9[?.V?[><;_P ,X]JU_'7]G?96\CR?
M-W+L\G9NSGG[G;;GKQG'?%:GPLC=+/+YVM(Y3)S\O ./0;@W''.3WKC])@_X
M3/4&>4DQ#<V&.#Y:G"(,9 Y(S@C^(YSS7H\G@VSD3R3 FW &0N&X_P!L8;/'
M)SD]Z\]T-F\+:G]C#$QNX0@8.0XS'G( R"PR1TYQD'!]-UO2EU:%[5^!(N,\
M\$<J>",X(!QGGI7B\FH7&@K/I9. [ -]X=#U7D<.,9)'S+BO3?A[X:.BP;W_
M -;-M9A@@@8^52#W&3G@<G'. :/B%X:.M0;T_P!;#N91@DD8^90!W.!C@\C'
M&2:XW3/B ;2P:TR?/7Y(SS]QN^[=D%1D#&,?)@$ XZ#X7>&C9QF_D^],N%&"
M"$SG)SQ\Q (XZ $'DBN[HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKPGPCX:_P"$AE:WW[-J%L[=
MW0J,8R/6NVT_X11Q.&FE+J/X579GD=3N8XQP<8/H175^(8A%9SHH 5;>0  8
M  0X 'I7F'@'PC%XA\WSBX\O9C80/O;LYRI]*K7FACPQ<A+R/S8&S@@LN5_O
M#!'S#NI./P(:O9--N8[F-)("#$5&W;P,#C&.V.F.W2O*_A]*-'U!K:4C<0\6
M0?EW!AW..#MP.Y) Q7KM>1/*-;U@/"1M\Y""3P1"HW$$9R#L.WUR.E>HZMJB
M:5$US+G8@YP,GDX 'N20/3U(%>*R:?<:\L^J$9","WWCU/1>#P@QD$_*N*]/
M\ >)!K-N%8DRP@*^<\]=K9).20.>^0> ,5T]>-^(=.C.K&WQ\DD\6X9//F;2
M_.<\ECTZ=L5[)11111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111117#>!O T^@3M/*R%6C*_(6)R64]U''
M%=S5/6+0WL$L"X#21NHSTRRD#/7CFN=\ ^$9?#WF^<4/F;,;"3]W=G.5'K6E
MXN\-+K\)BX$B\HQ!X/<<<X8<'KV."0*J>"-"N=#0VTY1H\DJ59RP)ZKAE VG
MKQC!SUSPWQ9X!CU]A,&\N7HS!=P88XR,CD=CGIP<\8YH?#K4)5%O)<#R?E!7
MS)& 4$=$*@'&.!P..HKKO"?@V/P\IP=\K?><C!QGA0,G ]>>3R>@ H^.O#5U
MK^R*)HUA7YB'+!B_(SPIX /'3DG.>,;FC:!'I< LU4%=N'R.')&&)!SU]#G
MXZ"N6TCP+<:)>&YMVC\AFP5;=N\MB"5Z'D8X.[D@$\$BN[KAM4\#3W>H#459
M/+$D38);=A N>-N,_+QS7<T4444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444444444444444444445Q'B/XE?V-.]IY.[9M^;S-N=RANFP
M^OK77:9>?;HH[C&/,16QG.-P!QGC.,U6USQ%#HB>9.V,YV@#+,0,X _J< $C
M)&:X'4?B](QQ;Q*%!/,A+$CMPI7!]1EOKQS':?%Z=#F6)&7'1"R'/U)?CVQ^
M->A:'XBAUM/,@;.,;@1AE)&<$?U&02#@G%:5<_XO\7+X<1&*[VD8@+DKP!R<
M[2."0,>_M6)HGQ3749DMGBV"1MN[>6Y/W1@(.IP/;.:[NBO-O^%Q_P#3O_Y%
M_P#L*/\ A<?_ $[_ /D7_P"PK0TOXLV]P=LZ-$23R/G7&.Y #9)XP%/;GT[:
M*42@.I!5@""#D$'H0?2GT45A^+O$O_"/1+<;-^YPN-VWJ&.<X/I5;P=XQ_X2
M3S/W?E^5L_CW9W;O]E<8VT>,?&/_  C?E_N_,\W?_'MQMV_[+9SNH\(>-4\1
M[UV^6Z8.W<&RI[C@'@]>,#(YYKI:XCQ'\2O[&G>T\G=LV_-YFW.Y0W38?7UK
MMZQO$'BVWT$ 3,=Y&0BC+$9QGL /J1G!QDBN$N_B].YS%$BKCHY9SGZ@IQ[8
M_&I-.^+TBG%Q$I4D<QDJ0._#%LGT&5^O/'HFEZM%JJ>= P9,D9&1R.Q!P0?J
M.F#T-7******************************************************
M************************************************************
M************************************************************
M**********XCQ'_9/GO]K_U_R[O]=_=&/N<=,=/YUUVF>7Y4?D_ZK8NSK]W
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MT]AD!AUX&2" !U+$UZ/117$?%O\ X]$_Z[K_ .@/6;\'/^7C_ME_[/1\8_\
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MJ]6;XF_X]+C_ *X2_P#H!KB/@Y_R\?\ ;+_V>NP\4>*(_#T8E<%F8D*H(!)
M)SR?N] 2 <9'%<1::WK&M#[3;@",G "K$%XX./,RQ&>^2,Y'; O>'_B!+:S&
MQU(!6!QO("X.<_-CY=I!&&&!C!.0=PI^(?%]WHEZ87D)@#JV!&@)C)!*@D9.
M!E<YY(Z@].I\?Z])HMMYD/#NZJ&X..K$X((/"X_'/:J7PW\3S:TDJSG<T;*0
MV%'#@\84 <%2<]\^U8>H^+[N[OS96TA5#*(P/+1B-N%=NA) (+=>GIVO>._%
M\^B7<:1M^ZV(S)A?F^=@1N*DC(&..G6J.H>(M6N(S?QIY=OMR H1CMR<,0V6
M/'4@ 8&[ '-;GP_\:OKFZWGQYJ*""H(W+T)(Z @XSC .> ,5E>)/'-U/='3[
M #*OMR%W,6&=P^<8"@]3C^'=NQ5*_P#$FKZ"5EN<;"2 &6,J3CH3'@@]QR,X
M[@&O1K;5 \ NY 8P$W.&# K@988(!.,'MSU'6O/9?&]_K\I33U*HI.,*I.".
M-[/E5)P<#CTRQP:='XYO]!D6+4(]REN3M ;&!G:RD(<9![\\$CMT?Q U^33;
M9+BU< O(HW *P*E&/&01@X!S7/VOBO4]>C'V.,#RPH>3Y,LV.?OX4 \$@ D<
M<X.*/"7Q!N&N%L[S!WN5R5VNK= I"@#&1C! ()R3@8KJ_&7BQ?#T8;&Z63(1
M3G'&,DGT&1QU/08Y(X^TUK6;P?:T4F/.[;L0 C[V #AV4C@$$D]CFL)-3?4]
M2BGD78YG@#+SPR%%/!Y'(Z'D=,GK7MM9OB33O[2MI;?&XLAVC./F'*<Y'\0'
M7CUXKBO@_>DB:W+# *LJ\9YR&/J1PH/8<>O-*ZM#XFU.>-<$1QRJ!+T!5/*&
M/O8 D;</SZ\5L_"34/-@DMR23$^1GH%<< <^JL2.G.>YK!T6,ZWJ[2G#HDCM
MD$ ;8_EC(QC(!V=,YZG(S77>-_&X\/@0Q@-,X! 8':%SC)QC)."  ?<]@>:B
MU/6T47)5B@(^4QQ[CSC!0 /@^P!QSG'-=/X'\9_\)"K)( LT?)"G@J3U ))X
MZ'J.ASS@<Q=>.;W6[@V^G@!5+;=J@EE'\3&08 ].%ZX.3BFOXKU31)42Z7?Y
MF,(53YN0,*T8^]VQSC()4Y%=IXIDNY($;3\^874G(4':5/42XP<XXZC\Z\G\
M(_:_-;[!_K=AS]S[N5S]_CKCWKVW3/,\J/SO];L7?T^]@;NG'7TX]*LT5XWJ
M+_\ ".ZHT\Z;E\UI  .JODAAN&"5)^FY<9[UZ)I_CRROL 2A3MR1)E,=.,MA
M21GH"?;(J+3O -OI]Q]NC+A@SD+E0@W@C  4$  \#-9OQ*\1SZ-Y/V=]N_S-
MWRJV=NS'W@?4UU.AW+75O#*YRSQ1L3P,DJ"3QQUKB='\67-QJ9LG?,(EF7;M
M0<('VC(7/&!WJ[\2O$<^C>3]G?;O\S=\JMG;LQ]X'U-7M1N;VZLH);,YG=8F
M<_NQD&,EC\_R_>QT_#BO,O"/VOS6^P?ZW8<_<^[E<_?XZX]Z]!\2>-W\/PQ0
ML UV\:%@P^4<88G;@$D@@!3COTP#B1:GK:*+DJQ0$?*8X]QYQ@H 'P?8 XYS
MCFNG\#^,_P#A(59) %FCY(4\%2>H!)/'0]1T.><#J:\D\?7D=QJ2I,,11>4K
M\GE2=['CD<-CCGC(K2N?BQ'=;H'@)A?*D^9ABAX/ '7';=U_B[UU/@VULQ&;
MBQ7"RXW LQ(*Y^4AB<$9_'.>1@UT%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%<#XY^(1L";2T(\T'YWP"%Q_" <@MZ]AT^]]V/P3X">-UU*[)\S)8(PRV3T
M9B<_-R3CJ#@D@@BO0J*S?$W_ !Z7'_7"7_T UQ'P<_Y>/^V7_L]9_P 7)2;F
M-,G:(00,\ EVR<>IP,_0>E>I6,:1QHL6/+"*$P<C:!\N#SD8[]Z\V^,$:"2%
MACS"C!N>=H(V\=ADM@]^?3B#Q[8&:TL[\G+&)$<DDL<IO7KQUW9/7)'7M2\0
M:D_B!;&VQAV3&YF)RS/Y62<9ZQ[B>3S[9-O2I1X5U&>,*&41S;0&/"A?.49(
M)SA0I]SG)QR[X5V!O;F2\<[C$O4D[M\F1N]^ V<]R/J(_BW_ ,?:?]<%_P#0
MWKUB*(1 (H 50  !@ #H /2O)_A)_P ?;_\ 7!O_ $-*T/$O@"ZBN&O;)B2[
MEN'V2*7R6P?E&W\<\XP<$G/_ .$NU30O]>I*K\@\Z/Y<C_;7:6. >=QR,GGK
M71:UXF&M:5+=1Y1LA6 )./G4$9P,@J1GM@X]:YWP+<W]O$YLH8W4O\S/@-D
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M,GDM<^(%S?7'V+3P/O[0P"NS$9R03E0G?/H-Q(&0&+XSU#P](JZ@NY'YZ)G
MR#M9,*2,@D'/;[N<UZ!<ZS'! ;XG]T$W@]"01D8W8Y.0 #CDXKSVW\3ZKX@+
M2V:A8U., )CN1\TG5L8SC Z' SSI>%O&\XN/[-OP!)D@-@*=W) /\)## 4KU
MXZ[LCI_$OB6/0(_-DY8Y"(#RQ_H!W/;W) /$?VMK5^GVN)=L;+N 58^@'4*^
M7.<9'7.>."*Z7P/XS_X2%620!9H^2%/!4GJ 23QT/4=#GG H^//'C:,PM;<
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MJ7AG_CTM_P#KA%_Z *TJ*\V^,?\ R[_]M?\ V2NM\9:#_;=L\(^^OS)_O+G
MZ@<@E>>!G/:N M/$'VW2I[-S\\'EXR>2AD7'4DG:>.@ &T5J1Q&30L*"3@G@
M9X$^2?H ,GT%9?@6VO[B)Q931HH?YE?!;) ^;[C'! P.>H-:^K^#]4U=!%/-
M$RAMP'3D C/RQ ]":/$7A)[72TB?!EM6+90%LJSMN ) (&&#'C'R_B./O-<,
MUA#9?+A)I#Q][  *D\]"9&[<X&.ASMWMD/"NI6^&7;LBW$KL4 CR78\]3@MG
M/4\YQS'X M3K5^UY(!A"\A^7*[F/ YZ$$EEZGY?Q'KM<U\1O^/";_MG_ .C%
MK"^%^CP7ML[RQH["9AET5CC8G&2#QS70>(?#UM%;3NL,0989""(T!!"'!!QU
MKF/@Y_R\?]LO_9ZLMXZN=;G:TTY4VA?OR<$#(!DP2  "1@88]R/X11\6:+?B
MVDGO+@,L>W"1C ;<ZCYL*@X.",AOP[Z_PD_X]'_Z[M_Z E<W\)/^/M_^N#?^
MAI6E\8_^7?\ [:_^R5V_AG_CTM_^N$7_ * *\V^$G_'V_P#UP;_T-*/BW_Q]
MI_UP7_T-Z]8BE$H#J058 @@Y!!Z$'TKR?6/])UD>7\V)X?N\_<";NG]W!SZ8
M.>E:GB;X?)J5P[6LJ"5CN>)VY&>2W&6 )(X(QSP<8%8US#JOAA3(6<1)\@.X
M2(!G PK9VC@ $J,=.,XKT+P7XB.OV_GN '5V5MHPN1@C&23C!'7OGM7!?"3_
M (^W_P"N#?\ H:5TGQ;_ ./1/^NZ_P#H#T>'_P#D#-_UPN/YR5F_!S_EX_[9
M?^SUF^(/^0RO_7>W_E'7I?B&(RVTZ*"6:&0  9))0X 'K7E'@*&[G,B64J1M
MA2P?!) S@@%&X&>>G45T^H^&-6U*,V\T\3(V,C&.A!'(B!ZBM[P-X=DT"!H)
M2I9I"WR$D8*J.X'/%=%17DGB_P#T#5EN)>$+P/GK\J[03@9/53QUX^E>K7-R
MMJC2N<*BEB>3@ 9)XYZ5Y7\)XRD\MPV!''"0S$@ 98$9SVPI.>@QS7H^C>(X
M-9W?9WW;,;OE9<;LX^\!Z&N1^+MM'Y4<I \[?M!_B*88D>X!Q]">V><W6/,O
MM&@D//EN,G@852\:^F<94>O<]S74_#2Y66QC53DQLZMUX)8MC\F!KC?B9_I]
M\EO%RX2-,=/F9B0,G Z,.>G/UJ3XNVS+<1RD?*T6T'CJK,2/7@,/SKU*VV;%
M\O&S:-NW&W;CC&.,8Z8XQ7D_A.,66K&"/*H))UP"?NJ'P#Z@8'7N >M>D1^*
M+:2?["L@,V2-H#'D#)&[&W( YYX/'7BH/&EM'/9S><!A49E+<8< ["#ZYX'K
MG'.<5R_P>N69)XB?E5D8#CJP8$^O(4?E7HE%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<1_P (
MY/\ VM]OV?N/[VY?^>.SIG/7CI^E=E<VRW2-$XRKJ5(Y&01@CCGI7CMU\.KY
M"8D0O&KMM.] #GC=M+\%@!GOT!Z5Z!XY\('Q$B>6P62(G&[[I#8SG )!X&#^
M&.<CEK+3-:A1;125CQM!+1':#Q]X$N .V.0/N]!48^']WI]S%< &8!TDD8,H
M.X/E@-[@L>,Y.,Y[5J>+OAY)=S&^LV"L?F*YV'>O0J0,98\\D?-SGGBC<V&M
MZ@IMY3A).&.85&"><E/FQZXZCC!Z5UW@WPFOAZ,KG=+)@NPSCC. !Z#)YZGJ
M<< <WH_A.YM]3-ZZ8A,LS;MR'AP^TX#9YR.U=1XTTZ34K22WA&YVV8&0.CJ3
MR2!T%4OAWHLVD6[13KM8RE@,J>"JC/RDCJ#7*:C\/KO2[C[18X*AR4VL%91_
M=.\\CG'4Y ^;&<5)JG@S4=9C^T7+AI4 "1#;W;#9(*H#CG(R2, XP!72Z5X6
M:?31IL^8W(;."&P?,+KT)!'3(STXR#7+6'AO5]!+16V-A()*M&5)QU DP0>Q
MX&<=P!3-7^']_>H+J5O-G9N4W#Y5(+?>8A1ACC:HQSD'%=A=V-R=-6WA#)<+
M'$H =58%"H;#!L8(!/7IQUXJM\+[Z2]MG>5V=A,PR[%CC8G&3GCFNPKB/B5X
M<GUGR?LZ;MGF;OF5<;MF/O$>AKMZ\O\ %_@.YDN));12T<PRV'5>2<LIW-D@
ML WH"0!TKL/"FBM;V*V5RN"5D5UR#P[-QE3W![&N1D\#7^@R-+I\FY2W W -
MC!QN5@$.,D=^>0!VCG\*:IX@<)>-M08Y9DV\'J$C."V"<$@<<%AQ7HT>F*(?
MLC%G0H58NQ9F##!RV<Y.>V,=L#%>9>'_ (>7=M=1O*H$<<@8N&5@=AW# W!L
M,0!TR,Y([5T_Q(\,3:TD30#<T;,"N5'#@<Y8@<%0,=\^U3_#OPR^B0L9E"RR
M/R V?E484'!(SDD\=B,GL.KK#\::=)J5I);PC<[;,#('1U)Y) Z"J7P[T6;2
M+=HIUVL92P&5/!51GY21U!K;URV:ZMYHD&6>*10.!DE2 .>.M<M\-?#D^C>=
M]H3;O\O;\RMG;OS]TGU%8DW@2^T&;SK!MP.0#N4,%..&#X4_AD9&<*<5)<^$
M-2UU&>\DQL4[(\J=S ?+PA"#.2-Q.1W&*Z/X=:/-I$#P7"%&,A8?,K @JH_A
M8\C;SG'48SSC&^'?A.YTBX:6=-JF(J#N0\EE./E8GH#5WXE>')]9\G[.F[9Y
MF[YE7&[9C[Q'H:ZG0[9K6WAB<89(HU(X."% (XXZUQ/P[\)W.D7#2SIM4Q%0
M=R'DLIQ\K$] :R/BW_Q]I_UP7_T-ZT)?#FJZ,#9VCEX"#@@HI&[J!O.Y3GGY
M3CG(()-:G@KP(^G2?;KIMTYR0 Q."P^8L>[<D=QU.22,9NL_#RXLIS>Z>P&&
MW*H(5@2>5' 0J,]"1\ORX/>"[T36-:'V:X($9.26:(+QR,^7EB,]L$9P>V1W
M?AOP^F@PBWC)/.68]V( )QV'  'H.YR3R'P[\)W.D7#2SIM4Q%0=R'DLIQ\K
M$] :V_B)HLVKVZQ0+N82AB,J. K#/S$#J11H^BS6^F&R=<3&*9=N5/+E]HR#
MCG([U1^&OAR?1O.^T)MW^7M^96SMWY^Z3ZBJ6L>$[FXU,7J)F$2PMNW(.$";
MC@MGC![5Z)7FVH_#VYTN4W6FO@<$+NP_4$KS\K*, _,>1P02,FM>:!K&MXAN
M#A.<Y>-4]>1'DGD#'!P?3DUU=]H$UC8&SM7=I@$PV\JW#+G!+850HP%!QCCD
MDDUOA??27ML[RNSL)F&78L<;$XR<\<UV%<MXX\&?\)"JO&0LT? +#@J3T) )
MXZCJ.HQSD<Q)IFM7B?9)"?+8!22T73IRRDN1Z]21G.<UV'A/PDFB0&!\.TG,
MAP,'(QMY&2H'KUR3@9P.4O/ =WHDQNM.8$$D!00&4,3\I#DJR@8Y)SG!QQFF
M+X,U#Q#(K:@VU$XZIG!R3M5,J"< $G';[V,5Z!<Z-'/ ;$C]T4V =2 !@8W9
MY& 03GD9KSVW\,:KX>+16;!HV.<@ICN!\LG1L8SC(Z#)QQI>%O!$YN/[2OR#
M)DD+D,=W(!/\("C!4+TXZ;<'I?%/AE/$$7DMA7!!5\9*\C/&1D$<$9QT/4"N
M(31=9TY3:Q,6CQ@%70\%0,*7PZ@=!C&#R/6NE\$>"!X?!FD(:9P02I.T+G.!
MG&2< DD>P[DY_C#X?/>2?;K,A)."5&5)89.X,#@,3CL!GYBV<UE7>B:QK0^S
M7! C)R2S1!>.1GR\L1GM@C.#VR.[\-^'TT&$6\9)YRS'NQ !..PX  ]!W.2=
M6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBJVI6K7<;Q(YC9E(#KC(]^?_
M *Q]"#@B+1M&CT>,6\(PHZD]2>[$]R?_ *PP !5ZBBBBBBBBBBBBBBBBBBBB
MBBO._B)X3N=7N%E@3<HB"D[D'(9CCYF!Z$5Z)1111111111115;4K5KN-XD<
MQLRD!UQD>_/_ -8^A!P1%HVC1Z/&+>$84=2>I/=B>Y/_ -88  J]11111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111117G?Q$\67.D
M7"Q0/M4Q!B-J'DLPS\RD] *IWM[K=DC329"(,DA8&P/7"@G [\<#D\5T7@/Q
MK_;JF"7B>-<D@<,H(&[C@')&1T[CC('/^*_%E[;WS65L^ 6C5%VQGEU7C++W
M)[FI?^)]_G[/5OP-XYFOIC878'F8;!VE6W*22K #&<9[+C;@Y)K<\8^,4\/I
M@8:9Q\B?^S-_L_J3P.Y')P:MK6JC[1"NU&Q@!8U'0'(\WYB#USDCT]*N>'OB
M/(DOV34%$9PHW%2A!QU<'H&ZY  'I@Y';:M#+-$R6[A)2/E8@, 0<\@@\'IG
M!QG.#7&^ _&LM[*UC>$F4D[,H%.5!WH< 8(QD9'J">@JI_PE]UX@O?LUC)LA
M_O&,'Y5'S.=P)Y/"_='W0<$FND\=375I#]IM'V^5DNNP,2IQR,@XV]3T&,DG
MCEO@+Q2=>A/F8\V(@-@8R"/E;I@$X.0.XSP"!7/^(/&=U=7@T^Q8+M?9G;NR
MW\1.Y3A4YZ#H"V2,8]"MHVC15=MS!0"V ,D#DX' R><=JXWXE>(Y]&\G[.^W
M?YF[Y5;.W9C[P/J:R+:YURZ194.5=0P/^CC((R#SSTKJ?!WV_P#>?VA_L;/]
M7_M;O]7^'7\.]5O&OCQ="_<1 /.<$@Y*J.O."#DCH,].3Q@'GS?ZY.IN%4JI
MW';LB! !/ 1AO^@.2??-:_A/XAG4)#9W:B.7=A< J">A0AB2&ST]>G!QD^)7
MB.?1O)^SOMW^9N^56SMV8^\#ZFLBVN=<ND65#E74,#_HXR",@\\]*;:^.;W1
M+@6^H %6*[MR@%5/\2F,8(]>&Z8&#FO4*IZMJB:5$US+G8@YP,GDX 'N20/3
MU(%>=V_B?5?$!:6S4+&IQ@!,=R/FDZMC&<8'0X&>=#PUX[FBG_L[4%Q(6"A@
MN#N)X# <$'( *C'0G(.X:_Q$UJ;2+=98&VL90I.%/!5CCY@1U KEM.U'6M2C
M%Q"=R-G!Q .A(/! /45;\'?$&5YOL5]DL[[5;:%96SC8R@#@GOC(/7CE=#XE
M>(Y]&\G[.^W?YF[Y5;.W9C[P/J:R+:YURZ194.5=0P/^CC((R#SSTK7\.?VM
MYZ?:_P#4?-N_U/\ =./N<]<=/Y5J^,?&*>'TP,-,X^1/_9F_V?U)X'<CD_[6
MUJ_3[7$NV-EW *L?0#J%?+G.,CKG/'!%:_@KQV^HR?8;I=LXR 0I&2H^8,.S
M<$]AU& 0,GQ*\1SZ-Y/V=]N_S-WRJV=NS'W@?4UU.AW+75O#*YRSQ1L3P,DJ
M"3QQUKC_ !UXKN+6XCL;-@'8#.-C99SA5.X':1UZ\AAGBK/PX\5R:R)(KA@T
MB$,#\H)4\$;5 X4CD_[0'I73ZY<M:V\TJ'#)%(P/!P0I(//'6N6^&OB.?6?.
M^T/NV>7M^55QNWY^Z!Z"NWHK#\::C)IMI)<0G:Z[,' /5U!X((Z&N2\"^,KF
M]N5@NF++*C;/D11E>=V0 <85AQGGCZ=/X\UUM&M3+&2)&=54@ X/WCD-QC:I
M'0\X^M<_\/\ Q/=ZE<O;W3DA(V.THJD,'4<X4'(R1BLJ[\6:C<7DEE;/DB61
M47;$.$+<99>P'<U>_P")]_G[/76^$?M?E-]O_P!;O./N?=PN/N<=<^]>=Z1X
MLU35W,4#[F"[B-L(X! S\R@=2*U_^)]_G[/72?Z?]@_Z??\ MG_ST_[X^Y_G
M-<;J^M:QI""6=MJEMH.(#R03CY03T!J73M1UK4HQ<0G<C9P<0#H2#P0#U%=!
MXRUJYTBRAE#;9RT:R'"'DQL6'0K]X=OPXJSH^M37&F&]=LS"*9MV%'*%]IP!
MCC [5RW@WX@SSW*0W3[DE^4?*HPQQM/RKDY/R^G.3TKMO&FHR:;:27$)VNNS
M!P#U=0>"".AH\%ZC)J5I'<3'<[;\G '1V X  Z"N=\2_$.1)6L+%"\BDJ6VE
MCD [@J <E?4Y'!^4CFL^YN-=MU+MD@?W5A<\G'W5!)_ 5T'@KQXNN_N)0$G&
M2 ,A6'7C))R!U&>G(XR!UU<[XQ\8IX?3 PTSCY$_]F;_ &?U)X'<CDX-6UK5
M1]HA7:C8P L:CH#D>;\Q!ZYR1Z>E7/#WQ'D27[)J"B,X4;BI0@XZN#T#=<@
M#TP<CIO&FHR:;:27$)VNNS!P#U=0>"".AKA-(UK6-70RP-N4-M)Q .0 <?,
M>A%=!X<_M;ST^U_ZCYMW^I_NG'W.>N.G\J[>N?\ &7BQ?#T8;&Z63(13G'&,
MDGT&1QU/08Y(X^/4]:O$^UQ@^6P+ !8NG7A6!<CTZDC&,YKI?!'C<>( 89 %
MF0$D*#M*YQD9S@C(!!/N.X%/Q'_:WGO]D_U'R[?]3_=&?O\ /7/7^5<M;^+-
M4N)OL2/F8,R[=L(Y3.X9*XXP>]=EX1_M/S6^W_ZK8<?ZK[V5Q]SGIGVK+\0_
M$>1Y?LFGJ)#AAN"ER3CJ@'4+UR00?3 R:<^K:UI0^T3+N1<Y!6-AT)R?*^8
M=<Y ]?2NL\'>,4\0)@X69!\Z?^S+_L_J#P>Q)XQ\8IX?3 PTSCY$_P#9F_V?
MU)X'<CD_[6UJ_3[7$NV-EW *L?0#J%?+G.,CKG/'!%:_@KQV^HR?8;I=LXR
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M--1DTVTDN(3M==F#@'JZ@\$$=#7":1K6L:NAE@;<H;:3B <@ X^8 ]"*O?\
M$^_S]GKH/B)K4VD6ZRP-M8RA2<*>"K''S CJ!7+:=J.M:E&+B$[D;.#B ="0
M>" >HIMQXPU/P](OVP!E8?=8( 0",X:/^+ZYQG)7I7HE[KL5I;F_8DQ;%8$
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M.7.[:2NU@R_>0@ #H"><$$$'.1BW\1/&3Z*%MX"!*XW%B,[5S@8!&"6(([X
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MCM_J@VSICIM'UQSGFO6Z\D^)G^@7R7$7#E(WSU^96(!P<CHHXZ<?6M+XQ_\
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MKT[#IVKT7Q-_QZ7'_7"7_P! -<1\'/\ EX_[9?\ L]>DT5S7Q&_X\)O^V?\
MZ,6N"2,Z;#8:J-VU'97VD=!*[  <'+ N#SC'!QWZ3Q_&=6NK73!NPQ+. 0!M
M)QD9XW*JOU'?C.<54\%?\A6[_P"V_P#Z.6N;>]EL=2EFMTWRK//M7:6SDN#P
MN"< DUTG_":ZK_SZ_P#D";_XJNW\.7LM] DUPFR5MVY=I7&&('#9(R #7C?A
M'5+C396DM8_,<H01L9_ERI)PI!Z@<].:ZW_A-=5_Y]?_ "!-_P#%5Z!ID[SQ
M1R2#:[(I88(PQ )&#R,'L>:Y'XM_\>B?]=U_] >M+X<_\>$/_;3_ -&-6;\6
M_P#CT3_KNO\ Z ]'A_\ Y S?]<+C^<E<3:^'_MNG->(/G@G;.!R4*)GH"3M/
M/4 #<:ZW5->_MO1WF/WUV*_^\LB9/0#D$-QP,X[5>\+7+6ND>:APR13L#P<$
M,Y!YXZUA_!ZV5GGE(^9510>>C%B1Z<E1^5=9XB\<P:!(()5<LR!OD"D8)([L
M.>*P_"FN:=/<A+:!DEE+$,RK@85B<?.VT$9&% ';I7?5Y)XO_P!/U9;>7E \
M"8Z?*VTD9&#U8\]>?I7K=>8_&&V57@E ^9E=2>>BE2!Z<%C^=;GBFY:ZTCS7
M.6>*!B>!DED)/''6N-\(^/O^$>B:W\K?N<MG?MZA1C&T^E=MX1\??\)#*UOY
M6S:A;._=T*C&-H]:ZZN1^(OA>37(T:$9DB8X7( *MC/7C(('<#&>IQ7,Z9\0
M[C0$6TN8"=B*$W9B;:,@9RIR., @#ISDUUOA#6+'4RS6D:QR*.1Y:(Y4XY^7
M.5SUYX.,CD9Z>O)/#_\ R&6_Z[W'\I*]-URY:UMYI4.&2*1@>#@A20>>.M>?
M_!ZV5GGE(^9510>>C%B1Z<E1^5>G5Y)X0_T#5FMXN$+SICK\J[B!DY/51SUX
M^M'B_P#T_5EMY>4#P)CI\K;21D8/5CSUY^E>MUE)X7M4F-X(E\UCDD\\Y!W
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MVG_HQJ\N\(ZI<:;*TEK'YCE""-C/\N5).%(/4#GIS76_\)KJO_/K_P"0)O\
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M444444444444444444444444445Y)\6_^/M/^N"_^AO7I/\ PC-I_P \(O\
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M!X(!ZBN1^+?_ !Z)_P!=U_\ 0'K2^'/_ !X0_P#;3_T8U9OQ;_X]$_Z[K_Z
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M1I+V=M5F'!W[6/!+L?F8 8! !8'MD\<@X/B7HTEE.NJPC@;-S#DAU/RL0<@
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M[IGC&.:P?"WQ,B>+9>N5E4GYMI(8$DCA%X(Z$8]#DY..0UV6/5;Q?[,0J3@
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M.?EV8./0;@W''.3WK&^&OB.#1O.^T/MW^7M^5FSMWY^Z#ZBNV_X6-8?\]?\
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M?\32U!#JV9 G'3GS!CD$'KC_ 'N,,3N^ O%)UZ$^9CS8B V!C((^5NF 3@Y
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MZ"*==RAMP&6'(!&?E(/0FI=.TZ/38Q;PC:BYP,D]22>22>IK#_X5S8?\\O\
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MXE;?CD=1M4XQR<9/H#7>Q2B4!U(*L 00<@@]"#Z5RGB+XD0:0[0*#)(F,[2
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MGO7<:3JB:K$MS%G8XXR,'@X(/N""/3T)%7*P_%/BR/PZ@:0%F?=M5>^T=R>
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M_P#R+_\ 859TSXK?;I8[?R,>8ZKGS<XW$#.-@SC-;?C'QC_PC?E_N_,\W?\
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M*****************************************************XCXM_\
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M-PMOF/0=3DYZGJ:J>+KL66JF=LE8Y(&..N%5"<=.>*ZO_A;=I_<E_P"^4_\
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MMW= PQC(]:M>'-&_L:!+3=NV;OFQMSN8MTR?7UK,\8^#O^$D\O\ >>7Y6_\
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M I&"2.[#GBLKXM_\>B?]=U_] >CP_P#\@9O^N%Q_.2LOX.R@&X3(W$1D#/)
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MXK$L]$L;G399H$W824[I-IE#("1DKTZ @# (ZCDYC^#URS)/$3\JLC <=6#
MGUY"C\J]$HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHK@==^%XED-S9N(FR"$P0H;/)#+RH[@ '!Z8&,4C\-+S4"!=W *J#M.
MYY2"<=FVX![G/8<>G>Z-HT>CQBWA&%'4GJ3W8GN3_P#6&  *Y_\ X1&7^T_[
M4RGE>F3O_P!5LZ;<=??I6KXM\/C7K=K?(#@AD)S@,/7'8@D=\9S@D5S_ (&\
M#3Z!.T\K(5:,K\A8G)93W4<<5W-<UXS\&KXA0%2%F3.&()R,'Y#@],X.<''.
M!R:Y:'X8W=RT:74P,,?& [L0N.BAE &< >@ZX.,5Z3;6RVJ+$@PJ*% Y. !@
M#GGI7GNH_"Z6WE\^QE"#)P&9E9<C& ZY)')ZX.."3R:CB^&%S?2![V<,H &0
MSR/@'[H+@8')YYP>QKT:VMEM46)!A44*!R< # '//2O,+3X97UD=\4R(Q&,I
M)(IQZ9"#CBK?_"%:K_S]?^1YO_B:] TR!X(HXY#N=44,<DY8  G)Y.3W/-<?
MI?@:>TU ZBS)Y9DE; +;L.&QQMQGYN>:[FBBN&\#>!I] G:>5D*M&5^0L3DL
MI[J..*[FN&U3P-/=Z@-15D\L21-@EMV$"YXVXS\O'-:7Q"T8ZK;A Z1A)%8M
M*VU<89>N#SEA4OP]B,=C"&!!PYY&."[$'Z$'(]16EX@M)+VWD@AVAY$*C?G;
MAN&Z9.<$X]\=J\T_X5)=_P!^+_OI_P#XBNB\#>!I] G:>5D*M&5^0L3DLI[J
M..*L^,/ AU>07ENXCF4#J, E3PVY>0P'?!Z*.,9JMX;^'LEM.+Z\D$DBG('+
MY( "L6<9R.PQP0"#QBI_'GA&X\0O'Y1C"1J?OE@VYCST4C& ,=\Y]JY;_A4E
MW_?B_P"^G_\ B*[G2O"@2Q&F7.#PV2A/=RX() Y''48R.017)GX7W<>;=)Q]
MG9@2,N,],DQC*DC''S<X'([=SX;\/IH,(MXR3SEF/=B "<=AP !Z#N<DZM%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%5K_38]041S*'4,& 89&5.0?\]1D'@D59HHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJMJ=Y]ABDN,9\M&;&<9V@G&><
M9Q7G_P#PN/\ Z=__ "+_ /84?\+C_P"G?_R+_P#85MW?C[[/91ZEY6?-<KLW
M],%QG=MY^[Z=ZW/#FL_VS EWMV[]WRYW8VL5ZX'IZ5A^+O'W_"/2K;^5OW(&
MSOV]2PQC:?2M+Q=XE_X1Z);C9OW.%QNV]0QSG!]*GT'71JELM\P$:L&)!;(
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M^/?/X5J>'?B1!J[K P,<CYQN(*$YX4-P<D=,@<\#)QGHM6NWLXFFBC,KJ,A
M<$\\X.#R!DXP2>@Y-8WA#QJGB/>NWRW3!V[@V5/<< \'KQ@9'/-5-4^(!@NO
M[/MX3,X(&0X7YNI'1N%[DD8(.< 9JSXO\8/X=*GR2\;C[^_:-W/RXVMSCD>O
M..AK;TG5$U6);F+.QQQD8/!P0?<$$>GH2*YG4/B)Y=R;"VA,SAMOWMGS#.X
M%3P,<DX'!/09/95R/B[Q]_PCTJV_E;]R!L[]O4L,8VGTKH-9UF/1XS<3'"CH
M!U)[*!W)_P#KG !-<-+\8@"0L!*Y."9,$CMD;#@^V3]:[+P_XDAUY#+"3\IP
MRM@,/3(!/![$$C\00-6J.LZS'H\9N)CA1T ZD]E [D__ %S@ FN&E^,0!(6
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M8/'S!2#SCW )'..#@\8^,?\ A&_+_=^9YN_^/;C;M_V6SG=7-_\ "X_^G?\
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M44MM(!;)RQXW85<9)&0%] *U/B]J):2*TY"JA<\\$L2HX]1M.#_M'IW[[0-
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M&D5WOB,1%"BD]6.Y2<>PVX)]>!G!QE^+KL66JF=LE8Y(&..N%5"<=.>*ZO\
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MDTC6H=70RP-N4-M)PPY !Q\P!Z$5>HKR3X2?\?;_ /7!O_0TKMOB-_QX3?\
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M"L05Z=NW5>. UVU3PM>*;23?Y>&Y()# D,C%2/3D<'!P?4^VUS7Q&_X\)O\
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M%X()[[L #!/(  YS7J5>1?%F()=J0 "T*DX'4[F&3ZG  ^@%>M11"(!% "J
M  ,  = !Z4^O)/BW_P ?:?\ 7!?_ $-Z[+Q?XU;PXZ*8=ZR*2&\P+R#R,;2>
M 0<^_M3;OPEIVLQ?:E540ID21'RP #DG'W<]0=RY'0X(XXWX?7)T[4#:1L'C
M<R(2/NL$#,K@ XS\O'7@G'7->NURWB_QJWAQT4P[UD4D-Y@7D'D8VD\ @Y]_
M:FW?A+3M9B^U*JHA3(DB/E@ ')./NYZ@[ER.AP1QQOP^N3IVH&TC8/&YD0D?
M=8(&97 !QGY>.O!..N:+R0>&]6,\F2AD+9((^68')'7(7<>G4J1P>GJT=]'(
MGGJZF/!.\,"N!U.[I@8Y]*\F\6W*^)]02" Y7Y(]ZY8'DEGQQPN3WP0,YP:U
M_C'_ ,N__;7_ -DKM_#/_'I;_P#7"+_T 5I5Y)\)/^/M_P#K@W_H:4V\D'AO
M5C/)DH9"V2"/EF!R1UR%W'IU*D<'IZI<ZE';1FY=@(@N[=G(P>A&.N>V.O:N
M1\*>/I-<N6MO+'E_,P8':RH,X+ E@Q)*CC&"2>1TYOQ!_P AE?\ KO;_ ,HZ
M];KR3P__ ,AEO^N]Q_*2O2?$W_'I<?\ 7"7_ - ->?\ PITR*^\_SHT?;Y6-
MZAL9WYQD'&<5Z!_PC-I_SPB_[])_A7-?%O\ X]$_Z[K_ .@/6E\.?^/"'_MI
M_P"C&KDOBKJ"7\L-K"=[IO!"8;YG(4)P2=V5Y&,\BO1M'M#9010-@M'&BG'3
M*J <=..*I>,=..HVDT*YW%,@ ;B2A#A0/4XQ^/?I7'_"G7XX$>RD8*Q<,NXX
MW;@%VC/&00,#.3G@<&NWU_7X]%C::1AD*2JDX+$=AU/4C)P<9R>*X'X0Z<6D
MEN^0JH$''!+$,>?4;1D?[0Z=Y_!7_(5N_P#MO_Z.6JUXO_"&:D)@,6\^>@X"
ML?F'"_P-A@%YV[1GFK/P<_Y>/^V7_L]>DUX_XIMENM7\IQE7E@4CD9!5 1QS
MTKN9?AO8N"HC()!Y#OD>XRQ&1[@CVKC? E\;#4#90N6@9Y5&6RI"@E7&,+N(
M0<XZ9J/Q+$)=8", 5::W!!&005CR"/2O2_\ A&;3_GA%_P!^D_PJW:6,=D-D
M2*BDYPBA1GUP,<\5Y)\+[&.]N725%=1"QPZAAG>G.#GGFNP\>Z';VME+)'%&
MK#9@K&H(S(HZ@9Z5%\)/^/1_^N[?^@)7"-JDNI7K7T,9E8/O52A)"J0$R(R#
M\HV]\9ZYSS;\6ZI>ZNBM=6Y18B<.(Y%QNP""6)&"<>^<8/7/H'PYU0W]F@.2
MT1,9) 'W<%<8[!2!ZY!^IXOP_P#\AEO^N]Q_*2O6ZXCXM_\ 'HG_ %W7_P!
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MC-U9C;Y:DNA8D%1R6!8DY ZC.".G(PVI\./$T>H(;78L<J#<?+0*KC@;\*
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M2.OW6'I&O^)?[-MA?Q)YJ'8?O;/E?HW()ZD#&,\^QK-TI;+QI'Y\D2>8&^<
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M6KW%U%)"MNBM&S_O2QY5<KR/F7G&>QZ=/75HHHHHHHK*U>XNHI(5MT5HV?\
M>ECRJY7D?,O.,]CTZ>L=YXD%O=Q:;M):5&8MG   8CCG).TYZ8XZ]JU[XBD@
MU"'3@%\N6,L20=V0'Z'.,?*.WK7145Q&C^+KW6Y/,MX4^R^:%+,1O"\;C]\<
MX.> 0.G..>WHKG?#/B*35)[J!PH6WDVKM!!(W..<D\_*.F*/ WB*37X&GE"A
MED*_("!@*I[D\\UT5%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<1JO\
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MEFQ(CF$>[&,_=C4$$@\@.?;GD&O2(HA$ B@!5   &  .@ ]*I7V@07\B7$B
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M>E?\@:Y_Z[K_ #AKTGPS_P >EO\ ]<(O_0!7!^$-*;5=*N+9/O-*2.G)58V
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M6U^OA&]N!<@B*[;>DF"1P68C R>"V/7@'&&R"YOU\77MN+8$Q6C;WDP0.2K
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MU4_X1FT_YX1?]^D_PJ[]F39Y.T;-NW;@;=N,8QTQCC'3%%M;):J(XU"J.@4
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MNH8'D9!&0>>>E<I)\4[-'\L;RN1\X3Y>>^"0V!W^7/' -5OA[*);F_=2"K3
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MC@'K76^'?$4>OQF>(,%5ROS@ Y ![$\<UQ?C_P 3I'=P0_/BUE5Y ,8/W&7
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M\.*MM"L4\*NV.=CA2<X^8J 3DD??P<\D8J2QUJ'4;&[2*(0/''+YD84#!*,
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MT&.B\1Z=:7B+]MV;5;Y2[[.2.@;(/('3/.,]JYBSLDNM:F,BAO+C5ESV8+$
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MN.M<M#_:>D1K;/#%<0)&0=APQ4 @+\V,D#' 0Y''))J+6=7AU32))+=1&H*
MH  %;S$) P ".<Y'7/.#D"'QA<M%I-NJG D6!6Z<@1[L?FH-:6ZY\G[%_9X\
MG;C;]ICQCKZ9SGG/7/.<\UGVFGKI6G>7JR$I%-E$5EW?-TP489.6<X)SC)Z
M5/K%Y>WUJZ?98X8! Q/FL&.U5!4*J@%64<@,, @=".:UO<M;Z%N0X)5E['AY
MBK#GU!(KJ/">FQPV<4:J-LD2LX(R&+J"Q.>N??MQT&*P/AS;+:W%]$@PJ2JH
M')P T@ YYZ59^*URT5F%4X$DJJW3D ,V/S4&ND_L2'R?L6P>3MQM[8Z_7.><
M]<\YSS7FVGW+2Z).K'(CE"KTX!>-L?FQ->B^&?\ CTM_^N$7_H KFOBW_P >
MB?\ 7=?_ $!Z/BW_ ,>B?]=U_P#0'K;US38[6QFMT4"-(),+C(&%)!Y[YYSU
MSSUKA-0N6BT2!5.!)*5;IR \C8_-0:Z7=<^3]B_L\>3MQM^TQXQU],YSSGKG
MG.>:N^ -.GTVV^SW(VE7;:,J?E.#U4G^(MUY_#%9OQ;_ ./1/^NZ_P#H#UTO
MB;_CTN/^N$O_ * :XC_F _Y_Y^*ZWPGIL<-G%&JC;)$K.",ABZ@L3GKGW[<=
M!BO,HKEHM)95.!)>;6Z<@1AL?FH->M_V)#Y/V+8/)VXV]L=?KG/.>N><YYKS
M;0KEK?1[ED."9=O8\.(E8<^H)%;GAV>YM;5(8K$-&Z DF>,!]ZC+$$$_,.QZ
M#CH*BT;2)],M+Y)H_*B=)&C3<KXRC@C<"2< *.?3/K6O\-+98K&-E&#(SLW7
MDABN?R4"J<_A^\T6>:[L2DBSG<T<O#;BQ)P?E&!DXRPX.""0"9]#\0![K[-=
M6XANW0?.,-OP,GY@,XPO'+#@@G(&>6T*Y:WT>Y9#@F7;V/#B)6'/J"17=^$]
M-CALXHU4;9(E9P1D,74%B<]<^_;CH,5@?#FV6UN+Z)!A4E50.3@!I !SSTIG
MPCLD$$EQM'F&0KN[[0JG'L,G)]>,]!BL\AL=1OY(L*R6CL, ?>VQMG'3.>3Z
MGK1X$N+BQM@UO:!Q(23)YR(6PQ X89 7H!TZGN:TO!^CW%E=33-"(()D!V!T
M<!@1C!'('+'& !G'85'\+(A<QS7S@&:29@SXYQA6(] "22<8SQZ#$5Y9):ZU
M"8U"^9&S-CNQ64$_4X&?4\]2:[ZBO._ %RUKIMS*APR-,P/!P1$I!YXZUL_#
M.R2"S255 >4L6/<[791^  X'3J>I-4?#<0L-4NK2(!8C&K;0.,X0\>@^=N!Q
MSTX&.PU+3TU&-[>09612#TSSW&01D'D'L>:X33_$;:?IDT4AQ/;LT./,&_+'
M"D8Y^4$X SPAP0.E76=&&GQZ?IK#Y99095XR7)0'++SP'*C!Z8Y. :[+Q9IL
M<UG+&RC;'$S( ,!2BDJ1CICV[<=#BN7N+EKC0MSG)"JO8<),%4<>@ %'C"Y:
M+2;=5.!(L"MTY CW8_-0:TMUSY/V+^SQY.W&W[3'C'7TSG/.>N><YYJ[X TZ
M?3;;[/<C:5=MHRI^4X/52?XBW7G\,4WQO):P"*2XB,T@<B) >2QP?NYY4D '
MANH&#G%87C:YO;VVD::".*%-A^9Q))N+XRI7@=<'(!P3@G.!%XU_Y!5I_P!L
M/_1+5Z37$>/?^/O3_P#KO_[/%4?Q&MENKBQB<95Y64CD9!:,$<<]*TOB);(N
MGR*% $?E[0 ,+AU7CTX)'';BN:\42-);Z;;!=ZR+&3'D+N(6, ;NHR&(S[Y[
M5KZRMUJD!LVL %VX3$\>$(&%(  Z>@QD<=#70>$[::UM8HK@8D12I'RG !(4
M?+Q]W']>:@UG6;=YETFX4G[0G?&SDG SD$-E>,#.<8.:S9OAK%$6DM)98'8
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MD$DX&U-N=JC&">B\\GC&.2>2>':]X2DEF_M"RE\JX*X;=RC=!SUQ@#T() .
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MY3UQ715RVO>$I)9O[0LI?*N"N&W<HW0<]<8 ]""0#@'FC0?"4D4W]H7LOFW
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MCD\PHP?E"H56!^ZWS D]NAX(YSVGA7PJ^FN]Y<OYES+D,P)VA<C@<#T'8
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MS80<]=V<.W3CTK<HHHHKG?'/B*30(%GB"EFD"_."1@JQ[$<\5K:/=F]@BG;
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MR*YTLWZZF1DM%<"0 $#[KRALY[!23ZY ^A[3Q%XB2336NQC]_$%"[A]Z0;2
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MALYOPLTB24?:Q,PC21P8AG:QV#YC\V,_,.QZ#\.O\8>'/[?@\@-M96#*3TW
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MVYM9 Z7(N+-]Q^=M[@\@889!P0 >0/O?*#6AXM\0#0;=KC +DA4!S@L?7'8
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M"^9)C+#APJJ,CDY/(P1C((/!UX;VZ\,W\5G+,TT<Q3[Q/1R4'WMQ4AN< _,
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M9,602<!@O!R1RRX+  $YX..&Z<[::3>74*W5I>--*!&S1>9]W<,X.7()![,
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M34OC2Y6ZN--E0Y5Y0P/(R"T1!YYZ5)I7_(9N?^N"_P H:/'O_'WI_P#UW_\
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M]<9!QG%311"(!% "J   ,  = !Z5'=V,=Z-DJ*Z@YPZAAGUP<\\U)+$)048
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M@JP!!!R"#T(/I6$WCVR5!*9?E9F4'9)U4*2/NYX##\ZV[FY2U4R2,%4=2Q
MR<=3QUK$MO'UC<,$68 G^\K(.!G[S  ?B:W991$"[$!5!)).  .I)]*QK;QK
M9W,@MDE!<MM'#8)] Q&TY[<\]LY%<;X/BAETN=;IBD)G^9EY(_U6.S=\=J]
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MUJ72/$EOJ^?(D#$=1R&XQSM8 XY'.,9XKFOB;XD-A&MM#(4F9E8[<@[/FYW
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M8/?'0@\T?$S2(=.@CN($6.19@ T8"'E6/\..<J"#U';J:]"KB/BW_P >B?\
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M6KE;R[?RX[=OW,>URQ/!WLRJ1U ^4'J,= 2\NC>(X)-6EN _R3HJ(=K<L?*
M&,9'(/)P*])HKAM:U2;Q2YT^RR(,D2SX.TXQE5/<<] <MGLF28OB=9)8V,4$
M2A4290 /]Q_U]3U)Y/-=]7$> O\ C[U#_KO_ .SRU/XD\037SG3-/!,F<22C
M.V/.>-PZ-P<GJ,87+_=TD\'0BT_LSD(0NYDP&9@02W.[DD>^!P. *K1?#FS
M =6D8 #<\C[B!P!\I48 P!@#@"LWP:7TF\FT<.7AC3>FX?,,[#CZ?/SV)&0!
MDY;<6RZ[JS6]P-T=K$&5>=I)V'+ Y!Y?GID!0<@',7C_ $V/0A#J5LHCECE5
M<(-JD89L$+CTP<8R"0<\8/$VGIJ&K6T,@RIB!(X(.PR-@@@@@D8(]*[NVMDM
M5$<:A5'0*  ,G/0<=:X"$66FO-%%!+>3!CO9HQ+A\L-I8@8R022%.<YRV,!G
M@^$KJ-S;O$(D>'+0[@Z<[/3Y2"&.!C #$#BI_ NF1/=WN8T/E3C9E1\N'DQM
MXXZ#IZ"M+QE!:1RPW%WYCL.(X4&Y7.1GY<8SEAG+#< !@]#R7C.4%%N(;0VP
M24!92!$Y.W=CRU /49#9.,<$$D5TGQ;_ ./1/^NZ_P#H#U<UCP?:V5E*BQ*3
M'"Y#D#S,J"P)?@YR/IVQCBN<>S>YTJWOE),UHQ93@L=HD(Q@\84 'D$ +C@9
MK0\7ZT=<M[>SMR/,O2C%00P51R0Q R K=2!_ V<8(KI]<MEM;*:)!A4MI% Y
M. (R .>>E<[\//#%O+:+<21J[RELF10V-K,H !' XR>Y/4XP!4TJ<^'+F^M(
M/]5% 9E5R2 RHIQU''S8/<@+SQ5WP!X=@NK87<R"66=F+-* YX=AQN!QG&3W
M)/)Z8;X2C&DZA<Z;%GR0@< DG!PG3V^?'<D!<GCFC9V5UX7,JO;"Z65R/-7E
MV#C+!AAVVG'((QNSRV0:V?"KV%^9H88MC,P\V*5>3M)P=A+* &.,#&#C('%9
M_P )K&-X&G**9%F8!RHW ;%X#=0.3^9JI\+O#L%Y$]S*@=MY0!P&4 !6X!&,
MDGKZ#C'.;UO;+H6K+;VXVQW419EYV@C><J!@#E..N 6 P",1> --CUT3:E<J
M))9)67#C<H&%; #9]<#.<  #'.9;>V70M66WMQMCNHBS+SM!&\Y4# '*<=<
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M)J_#F4P-=6 ),=M,0FXY;!9@1Z8^7/ '))[U0^%.BQ31/=.H9Q* "R@[=@#
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M-+%<*RM&ZJN\,&*[XR/O=AD@8XP .U=7X+T6*QMH9$4;WB4E]HWG?AR"P )
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M:9J?AH/:VT4<L9<L'8@$Y '0R*1P.F.N>2,&KOAKPW=:9>M<W!\T2Q$-(I&
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M-I:9>>5\LRLJ[=P&XJ6QQA0HZ')W#'04-&35='C%O#:Q!1U)89)[L3YO)/\
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M!I.H^&LP682> L2HD.&3OCED')/8D$C.%)(.SX4\,OIIDNKEQ)<S'YF'0 =
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MCUQ&EASM1RF6&,X .1WP0>,X/J!4&C>(&NX'NKB)H!&6R'W$[54,6^ZIQUZ
M]*=!XC2ZM&U*-3M"2,%; )\O=QQN R5]ZE\.:S_;,"7>W;OW?+G=C:Q7K@>G
MI6E116'X1\2_\)#$UQLV;7*XW;N@4YS@>M6M6\01Z6\44F2UPX10HSU(&3G
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M>&/$$ZS-IE\!YZ@LCC 5USV'&3Z8'0'(!4YY&RLM0;4)HTE070C&]R!M*X3
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M$&K?B)1JFE1"!E=K9(6D53N8 1E3D#.",Y.<8 /I4]L+.>,7']H7"@KDJUR
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MR6$[A'.,NO*$LT9VAAP2!@G'3([YQ=U7_D,VW_7!OY34?%O_ (]$_P"NZ_\
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M6+!K8HR;X_G /SCJ.,?-V)/RMQQS/X_\1075L;2%Q++.RA5B(<\.IYVDXSC
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M_7"7_P! ->;:K_R!K;_KNW\YJ]/36('0SB1#&IP7#KM!XX+9P#R/S%68I1*
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M!5:+P?:1",+&!Y#EDPS<,2"2>?F/RC[V> !TK9K!/@:S,8M_*&P.6 W/D$@
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M6ZL/+C56.1\P!XW ,.,D@YR0,#&+WA[Q!'H]Y':6LKRVDNU<.#E68D#&=O\
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M4KCY:J?!S_EX_P"V7_L]>DUYQJ7A*%I))]4NAO)+(J. 0F2>%?<V,YPJYQC
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M@ @  #GK7'_"J[%E'=SMDK&B,<=<*)"<=.>*;X>\/-XW:34+R0X#;%6/ (P
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M)X4;1@#IDUV&M:0FKPM:R$A7QDK@'A@W<$=1Z5YA\,_#L>J2-.Y8-;O$R[2
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MN?$;P[)</%J$">:8L!D(W @-N7Y ,D9)#<],<8R:RF\:6,@58K)6E8@;?+C
MR>P(5B3G@?*,^W2M7QGX;.KVD4MM$8VAW$1853M?EOD7(W9 .,@]01NXIEE\
M4#?(L,4+-=N,!1CR]WKG=G;CD^G0MCYJJ?!S_EX_[9?^SUZ!J?F>5)Y/^MV-
MLZ?>P=O7CKZ\>M>0^%[BUTMC#>VSO.'&T;<GY@ %,;%1GN."3GM@5K^ 0;?4
M95D01-)&Q6,D#&]DD"@<<A>V 0 <@8.)_!7_ "%;O_MO_P"CEH^,?_+O_P!M
M?_9*E\9V4FA7BZW&N]. X)Z';Y?8< KC!YPW7J :OBSQP->MI(K:-]@VF5Y
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D%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_017.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  > '<# 2(  A$! Q$!_\0
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>rdnt-20250519.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOauHeaPty552qYkxvmRxfXnK3yAm3AjYoCNXU0EGMQEM -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:RDNT="http://radnet.com/20250519" elementFormDefault="qualified" targetNamespace="http://radnet.com/20250519">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://radnet.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20250519_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20250519_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>rdnt-20250519_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>rdnt-20250519_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://radnet.com/role/Cover" xlink:href="rdnt-20250519.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://radnet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001683168-25-003842-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-25-003842-xbrl.zip
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M-P8Q12L,MWO@*"./N!)* OL7VG\B^_> Q?Z_D/T+V/_@F@7.4X,HQJ-F!R
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M^U5>3"J22K^!2GIH;OPJK=,>0B&C4#*0.3 !V6&X1P8*&J,J* 9VIZA<ILG
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M=H5>[)W*DHLO+J\\J<%W:XJ ^(6"G.%H?NRZ#<[KLX-W#A<;$_ZY]KCLPO<
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M8Y+XB,D*_,2<;YR(ZVJ$!#J_-&"\-F%^MWS0:S?4I-)4YIT^LGR/D(E@C'<
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MD$%@=VHRZA1"X'] 1U-R79E)(WZT1D9!/=SBF(U246GS:>Z!B_(V879@>]W
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MDOYGZEPCO/__)L%??Y/@\"^]2?#-YOH?5>D]^C6[_+R=?@7_7U!+ P04
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MBQU,/G5?I'<>A)$_CW0'%'^.^0502P,$%     @ T(JS6D/RC3@< @  Y@<
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M]!E(55$B&[YS26?/4*I?M9@I6'!>(U_4:4*Y2R%+;//##\B$;"$G9 #*]RC
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M*9"K [HH4/-HX'M1X+OD78[[ *[C17;@V5%W[/<=UZ"H!^RLU^M.7%8YRV!
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MKU$K.-=0T/\NE&AU;A*G:MJHGLTGDH-DM!5&$L"HZ#Q4%4@JF"JBW_,,0NW
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M'R79@PC!T=+P#_C-@[K%1 ,0^63R*ZU\;]60]><GV6*I*CMA3G"AJEZ9>3U
MQQKN9-OC?9 /W7+$FG*$6+GBY>^)E85U-M)R9$XJ)K3HZ*A >20&&80/[@,9
M+6C*#(%7O-&>2/3163LC2^>:D9V=:K")O36-]I.R9R9F3X0.H?9I&#[1KK*
M"[=R:+VY+EFI8OY+-^VB,T?S8HG,'96L7.V'KL<.CI55E.>\L3+.FQ+*-6I0
M!S;^?4FSI,'M"O(48__MH#]*FI2AJ1['-L(?B_%.P8Z.6!4[=UG5+6=N"F=.
M 0>1/?VF(MP4H<EL&6'-&>'"3.DLY@&R[V1+9HY*>@I9GE*RV2X($L(M(F3;
M-I*_A FK"([,/)</4+!T0M%RVO:L26Y(A0Q3<"R.L]DVU7K=^0P.FGSN:H;
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M1Z:AH.26$GV"KWM-"/8B[(.%V9X;Q2"SC*X.7^&3-:'*:MD(#(U_#H)PT/O
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M2.YTA#7O\V@Y1]=&<A(")(C*(3S:73SP%^?<>+>_X6P$FK2P-"A_6\9,V:?
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MYTRO=OX:K\5&7_&!_I<] ^;,'248F*0,+8%DS*]^T B+DA=%MK?=Z;@$"?K
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MY52^E%1ALP:,9E$/NQ-1SR3,\4![2Q=(2Q?#S%"JJ1K>CL!JYM:+:YK;ERP
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MOE+CC<A%>E6NQ6)'-\8LI:?;28Z<+0[1R_PLO'IU@E9@'-X3EEYBH. W^7H
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M1Y3KEH0Y?']6*V\V.U*6M+(7+H @BC&V1R6F<3K57FL!D/4XI#R-C7].)"Y
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MS0N#\;5QO2#1Q0#;][CZW]<SNO%1EBOF?UU$SW_ "-WA#(S/5PDJ@H)>.7I
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MOG92\QPWS;S#J'E]F<&%_1\VE7$CT+>?X<1_1ZM *\&3)_IDKC'IXN4OA1;
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MUGCV:"\8I//08+H^CIE50'!0GC\]?/1GFO!*LS<AC,[G#G)R^,26,?63S [
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M_Y<AC$FI =OGH9WY-P&]P%HAI&MAKP.W5P>>Y7 2"JY:^NA=UP\0RPK&<:&
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MP::->I-FX/!R'VS2=5(A,O!^_O7BHYRM*4><X2 /K6;,G2<9VR^38P@^HJO
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MOAG,=64;>KK</%&9E$)&75L+)^Y]*7/SE[(.-VE\KOCR O*ZR'W7DR[R-W!
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M"8:J>"]T37:Z),+)Y7/HO[P<L[XG8.Y^C[=JCU?SX08AMXL4O3A0RERA-\G
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M1>43+!N![SI <^83/'B@>*&(>YGF7&9.;:<\_;GJ\K%!95(6NCE<J*\;J5<
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MA6.]@,/9VOA8(' VR1%VP^;7;6V_"8'#-AWNO6R??M'PA4/4[9*)&X0^E4U
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M0/AX;DAQ6=55>JOEZ9AJ=<N6QVII)-ESS[UQ8P(DP2):(, &P"JQ?_W9SWP
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M9"(\B45V*<V,'">A/-6D=1X0)EF1G<66]1E4PK<Q_KH>1: 1 PN;\",GY)/
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MI^O&,6^,; \N7<,^4;) 2X3=*>\L,, +^4;@-+:41, .#G8H1X'3XCVGD9'
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MRP)3DPA@:]>,&%0*U.T=#;++,@+ 94[7*5:)J#QS=G\@#N[G;>TS1L#[Q%^
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MRJ<4!.E&6R?_/'USJL4^)C(61DZZ)6E+Y^C3HR?$RM-KVGRN]H/3XE%UHKG
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M;BS?\P!WPN*OJ.<&+HG3I=$;3\1?OLM_.)7*Z:&XH?2NT?,>\$>[2V!KGU(
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M2;E&B""%=-4X7YV\\S%<T@I=1(14P?FN+KF)IPJ2Y^"]IU:KG:NHM)VFV8S
MO%?9@"9!5-,U=F]Y3&SD2Y'[I\C?8=:(NUK+M=0_72F75S6,TFKJ81NMUGR8
MRZ[2M6_<VN==+)HUC;77/<M,Y1KFJ@^3=8'QP@KN8ED@-M_RVOSY[NF#<\R
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M'I6W]'J$5%"+B\3^% 4:/=Y$R1$PW(].(AA^L_G.[>5(--%]4Y^MY?P++LU
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M6:G2)8?%@:DE<$&I.*[%?(FC/J(PC?0+(MR@PK[$*89";6SEC8ZWZ#K T"]
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MDN*C%ES(7 70%"%W@:V+B9\&;2$?<M;NW]@<=U,5,?MQX&N74ZRH*>,(KN(
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MWU!$NX/27W[TGN'@:4=64FT2S< =S=S2#$4@OSH->*"]*)V#AAM!&E;!_4+
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M5ZBN5_S0W7.$/=(1HD)%R&\GO8[R[*19WZ8+VD1HL2!;X[3OOC:SG6=O[4'
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MOHKB)H-IFF(/+5*8E-^I/BJR;4)1BX A/H*.>5&-"4'B(#&T+5[K[+G*!;2
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M81L<0.;CH=>0:@I_X,8ML4\;0TTE4T<@/8/9(4F>#2,-(:_+9$,$1\)HE'2
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M#J(2MT4NK6ZD-9=K;83OIJV2/AN2J+<B"%%*5WK!*$'C@? S["L?8@16C&
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M$8[9#YJ%Y9/#<,VG?_<*:3YD.BEJT^B.UFL2:*BHM,5;?J(+@]3F+POU8[A
M!3J\IGAT+4F#J&%PK1UDSX68G6%@K^9YC&V8+TG;RM?V\'=2'_*IB-]H)H!/
M%)_0M2*A(F(<U"JLHTF_#,D7;QP<+!; >H]A5!0SP<Y-"AU P3?;P]3-<" 3
M!H<KR:*"Z:# $H$)&KX@7-*DK+@"L$((T=+BD- PJ<R#\HC% ZJ!"OY& W8X
MARS\)'V%:Q[@R??)I.3G#D%Y@.6%$>-RBG*#/RH0GSC#JNDPX!]C06@UX*7%
M2$.DOH)ZJ'_#2F!="+%$:?T@ATP*:%CHA3] (?W271%-X*H:@?4MWVC*&+?R
M+W-(@R<<TM8JN2\_I,%JAQ1/CVJ]90A]F*I0V1S':Q-N.9_%1UM<?<7-"QO2
M^FC#EZD.#JY*/O-@UH!],9BR1%#9Y0BD>"A%S?*SV?D9V2_I[ T2IXT,U^HD
MFFE,9.V -9^B%CT%8]?V06P^2ZXT)&&-X.NQ?(PYY,Q<L(YPC/)'E:@R G=J
M-A).QKQE9 LLJF@^_+/W +=+<$M0I%0MBK5_,=?R@42 [W;+(H!:%[2X$RG1
M;'BY$#.2Y\=%-O]E_82_C@0[T<J+\P@O;1)B%@7NSJFP]"$$/D@RQ4_P\M69
MD<Z1A($]?J'&WF^K5O8DT69F[!-5G8+0.T>^S^$XNUXQE+Q_$%>/&+]AXD#1
M\',>AY,DB'/W_:KS"_TYVJYS-)D60W!DB< 4XX!^^T<T)-MEP8':<VX1#19!
MWRP3PY=8WH.V+KW.EXB%3-V05'_(,+:/QO2G-,KVUW<V&O2<W<*LGN-L='^A
M/QO;=3;HE@AU=2F:&N@MDF#<XK\G:3RZJS=,94/A:_'L;*:CC;/:\6J]?4);
MSZK^?_;>O;MM),D3_3\_!4[?KEER#ZR2Y/=XMLYQN535OMM5KK'=MV?_N@<D
M0 EE$F #A&3.I]^,5V8D'B0E2S:EXCUWI\LB">0C,C(>O_A%G0"^O^^5]*)*
M7U?=$ZI/)K3_[>D%0B59J]7<14.SSUDUS7VL,GI'?H'1#+0$&?LUL=HC>GP2
M1Z?'IT_1]YU.K8?KR4YUS9CK30P^=.NG<BFG\.2M00G3_R9^#_5/=AAO=:EC
MC&RU7G;FMFEL,;8;UIZ<*Y4P]$)>?WR@IMH+G[HMIA%WIDX5.YM+!>U^F-'C
M\==2D9OTHNG1B]$MZ,5Q3 (/!8L4^04@I2J6#*:,#C(7[FN+7K]J7TS[PTMN
M 4SQ[ "F^ 9@BF<',,7!%OLF@2I5P]6^[>""7LJU:.\*0#B7U7H\$'R/=@Z^
M6QO@]=A:4,8>@R)UC<[Q<G&A?DQ]U@PE"#X1ZCPR)5HWF7Q(&5,"36 4%7$4
M2?<I]M/4(.PCTR;&;BA^+!:U]D)E[92K_E$&9B/2-8*1XUK^%:550G;!9LEE
M68&LQJ9;-<N!.GMUCWX<*U^.<ZC+O'(U$OUCV&CA$:V^ T@[I@:#()3<RC[E
M@[&.JO?QL IOQH&#Z[Y$Q;@';VR_-$!/+ +1T%F-R36T$5VD%XY^O4)YS]'I
MPH/&5A\* 0> ,;FGZ]81#L)OHGA>0ET0.<5O^%Q)Q7:E4F\S]21[B"H7BZZY
M5&>>%Z'207DM9^.@(28<:2@<G&)<QOH!"SK#7(8-]DMRH'+;/PGU;CK$H<\+
MB1C,,]Q(3JK&P(VR.D\ %DCN/&1A@00AA9^Z ,)(<[QP5 U""-I';-?L&Z?F
MK419P<L 9C,%#0II[HE5FTC- %DXT-!HG(8A"8"SE'76T<OV%)SGL.<8Z';_
MXE.@KF1 ';I?]3(SCR4Y"A&)V;<)0U,R_90H$Z"VED%*]M;E;4*?L6_X-[ E
M3&!+'([M?AU;:D"+&KBIF(P#L+=TCZ39Q)XTHOAPF2/4Z_:#((9"ZAZ]&@SY
M\2W2^E[,CX^C\R:!\N_,VD_V[)=5^R@2/!9;K<TYPV7/IA4L^*>T:-8#I$/+
MJ#&^S@:C)MA>.:=>O5B/)&4^QO5]4]PEG2?W162@FOV<?FGMUY"T(9^Z2-A,
M0C($"; 68]F]]DQ+1X"X(L)N'DX9-ZWR'%TWMO 5(98RGTT/\ A4;A!-LM\K
M'A&/C37*RZIBC(.GXD+;.2VME-A%M!) U5 K1^5EQ__7T_CX^!C^7X>#AF)\
MIV.7442[YQ%"!5LRNH/ZI(C<HT.FX@&I,.5?<9&YB^_K6# TKX@YV@\5PNL8
M>WM?V-FA@JFM65ES_IR>H=-P5%ON4@7X /H/]Q#C'L)#0,&WKK,3_J"'-N1$
MI&60)L%0?BO>TS^"ZQUE.0YE]'GLN)98VG-TD\LB6\')]Z1&UB^]+.>HB<IB
M+CV^J<&*/=_V%Z"X%<RD6T [PT$CFQVNP5]/G\HA#8FC_GHR>'[-R+KF5U9"
M*8E TP2CP[D7B.6;8L-U'4?0\#N@GTWYGM&T3<HM7T7*\)+N\1!Q$V6FX&=V
M!<LY>D#C[218I'B0DI"8!8A+!VTF,?J49'!3=6^<>MP7EU^,UF,*ZMO_V'4S
MA=XKFL&#N:@#E=^B0+R>^B:Q.^''UK3&" *P-R -3"R[;136IV,;;A:57N1;
MN!/7D9A._"0:P3.V3Q2-@*ILSB_:,X6T270]N3-W)7?1D-S!G68W%!&8=/*%
M4HP@[4#?E>UPL\?;@G>H11XK+42*@0RY).6:#WCD>9//"9VV #\(9026+,T>
M07V!_29, 4J?'5*@]3'.1CC5EISW\XQP[8B!2\<)/!\7G(_A'TV! &-C=R_/
M9GHA.< F9F>/',>N%(*BY7%$$C/$_'FXU/?K4H=K$P):L93KH0MP67YJA2OM
MM1YE\XSO:PBW\O>)TNRSYA?B*GTTJ,LE,?OY+[M'+JS<E"F&NH+?QQ(W%1LB
M2?]H:B8(7%C]80] UI>MG3)">C!KR^PX]CI9@4F<+)C1+^90'NN=V-@;)/<H
M)3%U%+&?CIA;F[8A!<ZVS^@G:T7G\W; %X+ZH(#L9*MLU52PCF=CJO51T?X1
M[L"_&CL>X MH?3RF:]">_8;\!ZT)>.'%;8.X25U[<L4Y[U]/W.6S'<O/8Q\B
MXO6$59C!)69'!!<%_G)PYKAOOV#I )07H4+LKH.?/]_"25%D5>09,.&VV*1I
M#RIDOU2(KT+H8/KM/L[PXL^)0@A.*'!PS#-H/*C(JL7FL0+O2PAZT3#1(!K&
M(!H& N#4Z]"C5ZYWH861\:0%V]F6^OKW@W3>1#J/CYX_S8M>Z3P^.H6/-LCG
MQ@G\Y8>RVR8.PG%UQC*Z6&9%[6S=X$,6+2=O$H ID>=J ?F2V<SJI"KFFH,2
MHNO883/SD39EE4=05&5_8+B$M0J<WR^.+[6]<?]B#+0 '+ H@.CZO^'0V5F:
M8/I@65+&"'R*D^=/T:? TC6TE=W:Y&#A*O_CZ7<.^>9?Z9%0O&K!NT9!$:_A
MW_+SE2</?AM1&ZBM*>E=O)B1+*9[(^?NP$; _WH$<TT[>UTN(>'6%!@T16?1
MG$.X5)=Y3,JB0:W T&%G*4FWNG(.N.85,69"Y,/*/$$L)3^,?X=[[[PJZ_I1
MLR2FI-)*UB/ +*/1<@4TXO3>;TR$=WC)+0#&GA\ 8]\ ,/;\ !@[&!??UKCP
M3FE,_F],KI^&"P&*I$REBJP+Z198A\YV*>#6)).ZEA82?.9M5;.#K7J@G+D'
M\I1,[:(@PR;N(<8I(-=0Z= Q0?Q"X^;6;5?3-K<.XK/_XL-[1>GWANIJ),5K
M;]%)'JTJCJ[5N7U%4FFM@V&V55C:+%FW,J*0$!=Y9.UT1ELFC9?)@^#LO^"0
M(R2AU=OR>YWN"'$LP'\A4&?O0'%+GD<YMR5H>5JA>^7Q75J6AY6B]_09(9D7
M"B 9D7 $Q$B&%P,O7C=*NGH%YI)1^%66HHZ8GVH.#8G@5/ B9#7&Q="W1O*I
MPY'8_R-QD4.""S(0Y4IH[A4 W$M[T#L/(/#PRUK_0C.5W1CD=_UP3[0]W',0
MQ/T71"M6YZ(NYV5""=\DO01]5-^=SHY]W-QTZ*D2^_!Y[HC )4BV O:AG&Q6
M#UN#*#TSIBEK@XB^X?\OK**^2.8S!>13U'-U6+AA\!C8I763";PBC7=T!W.'
MH]=3QUQE\W)*9P=.X"6!,FF]C=?YB@2$6F4XZAG^Y)7]Z'#,]OZ82:,G3CTO
M<L\TI="E#E3>SG[EJVRA_TPDD_AA7C/U9+0LK>'P*NHR6CK0*E 7/1*B2M<"
M2@ BV_)91'6'00DX;127V 7M0L^;915GZ^24K>%"FZ_Q2DO]D0-W ,:61-.*
M.]A<)E,P(9<E473L<B,) V?W6HK=$AFW1,%/P9)RUIU;3EW:CAI$3TEJNFK7
M;]95XM@)B@G)6$'ZBM^GTO 7\*NK!H%/71V /%>2S>#W19ZU.<@B^*R%MRYE
M2H=K>;^RW@K1PJ?.(1Q4BW@%BF' '*=^IEG:@$G(ES1!$C,FI%:P=)T#AZB@
MMOC '_%E.AE*(D8<&>,AC<+D 6-(LT.#L#AZGYTWW-SIPZ/_$DUV]IEG]9J*
M%Q-FN5@09!3\+A+/?S5)G3_2'QK?2:[5_O!GMQJO_6I\D!9DT8\EY[WPIN0C
MI_DEL75IFQRC0W-X.![[=3Q<D:0/",5\A^(_V="S!Z0"2Q/,/(=+E1)*H$>&
MVA \*!*S.CE]M+##N!"PDX.(GF.%326WQNE3!KVV\+!/!_#3!P':+P&"W@0%
M]$H%2+VXV5#$6"\QF9),JI*JP%VU?#NE0KIQ"&6F^BP/PJT/0K%?0@%H5=IN
MM*]AV][ F("(G])<;PMI;NJ@Z_S%']?VFJ@WW32 42NG#7FB8K^%V+#1CV.#
MA=)AG31'8E1AMI3^"P VMX:A<"FMV2^=H0%K35&F%:T0)C?/[1V7<E0SS6N!
MLL=A779LT -HIBND"8; *.M-X65V'GV5Z5D>9'J_9)J3PZ2\8L;[QEKG=9'.
MSM1L0QT1.SPMSPO@>^.:;M&)]-VF0%FB?VBYB,U567V"B*-U>?,YOO:\*@&L
M--/Q[)J <795$^J%H'L.7V:>D;0O'-)1L(= R-[)H_ %QBKL(4(F\8^X+P"2
M9K7U_2>^3E:'.+C'QM$!UK:_+]D!UO;B &O[!K"V%P=8V]<Y2K?4*^:IZQ7S
M3A>,1F^@OA4TXP=HB6#O[U^S#.(A]Z]7#%[HN8K(V-FEC76K,"]5E)B>))\?
M"-(R[.-P 1/JF3YRDE;6%H8X&/XWYC>I;[TK),RDD%"J&N&/UGD'IGU:84\J
M 3W)$;&.H7;[[,]K_^GW]M\80&MJ YDQZ(P$UG?L*J>6324$->5DQ7:.\R20
M2QKF EBZ)42$D_D1?03-[K *W/Y\M2R)-#Y)_RBAW*EOYM#R!4+)&!U<:08*
M&'3.@8^;C2FF3BZN'&Q29T+D&_VK*:MF$7&[%QP$4?;X%E69'@W02+@G0:*/
MDGB+A/]3FL(OV<VA3KY2\Z9*?ZC &H8,K:VDIQ90\LXX(@^ ?P(,H5,%A,
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MVJRN2E3$-6,Z-HE!EUY#6I[Y#8_\ANMS]?"TU0=/DC_([QDH%:/;4*ET%ES
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M<I%&;\K% H@A8/:^BI3)27I2."[[#L_"5S RD5_E:4TN2^;"N&K=],$"&EY
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MV7=78]F.226XGIC-5_E+-33U]@G<RG8#Y,WM2[]_:O#SSL,E#-3I=9! 7E]
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M*@W#TG(^+R<0?N%=([9^$-E_''TXXE>LY97SAU#?N3'7'O>J/Q/ X,+03QF
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MGBOJS 5PRRI@ 7.O M85 #\Q&9-BR((OK7HE5LJD( I702@#XF&P5NKG,5N
MPW*OC,ZI*X/."KKQI>46:<N0F:6MAZC21.XC"L6*"AL2MW7GOHRC\/!MNG!A
MXP +X7$ZG%[U<FE0?@,Y#-"N++6> SG# Z"DZB8G-QK500F^H=(>EU>@'S$7
M2P]H$5XXN&24T0$H,>GO!?$SP67=A@(2]86PKL80ZYIA!P1762>X0($HN7(R
MH(+(<*I_-%;64PYP$@C:816+4N@]Z$;#+0' IV:([IF)H9EPU]Q,-91"T@L_
MX^$6BN,C^T 55=4I]:&C'+ ;P+X,&W)MHH/-6^)[=X.([326HTC8>SAV;H8%
M?1/TO9T,))T::B38S JLK4RPY,H>M/]9.5R8:&'3LMGB\($ $77<$E)G0-R
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MMH^"1JQE;8P=XA'.WL0H/V"J)'@-<2M3XC6@9KB-57%S#64KE=GCX7ZL=3C
MAU2<F,;Y6O\?CO_1#'HI5)GF$!4"2ACD(DL*/BH2*7_\[(4*E;\ITX,8[Z48
M]_2.E(*IF8\V7[8#VAW0-I.<M6[NP!^,7?N&LM6ILS:[=]CK=&)0&:RA6]_S
M^6V[Y4TOBJF]#I2VP7F(FQ*R/U(+-\CG3B^R.AHH59'PRBS)Y]B+:,:%-<0
MRBA3S=&T,1-P.&#[>, FF<HGIC[$@H6^/B<9UE;IOTNME>:S">"GA#*V<XP5
M8#FI18[:]#,HT+YLB""I#)1.2T2MT>,X:E-E"PK:P!&EG[B\<%VJZZ\=!?(>
MM_&89L\[S8AC!=[$:O:#$.^A$!/@#R#R&,C)I>MCA^JFI':NHIRD^V+[NG!L
M"9VZ"G=0 J_+Z*: WTH^#B_9*K@[0-J>'2!MWP#2]NP :?LZ9^F6P#2/'9CF
M8XAP[K,C[P^^YOCH]&E>#.!KF!]8U5\1(X+!2IB-E'I8%<"\Z-RB'K@%R#;N
M%L)2/*?NJ4Y(/&GI##BQH8IR\F@"+. K89"M,S#)(_JC?=V\O!IS\ ;;C"_#
M5G 8%H*^ #!9KJ.Z(_R-+.^#,6MX0GU6C<SUIG8-VQ>+!GFZ6WUM@Z ?^<,'
M[VH/=Y"['HOK)!T=9_]^#ZU$/M+T?X^>VZ5IG>Y'VQ=LXXO^\D-)(Z7_:W@]
MU8T"!;)4M<1'H5DL= KD7;,".C$L?.TT;IT%M;'R*-?90N@$D"\82B(E39NZ
MKKHSJ1!SE!/P8(JLJ+(L:@Y*=8Q_- 4'<X0L"%A "20-KZ>Z82Y(968*>+FO
M&?:O,[X&N.]GHX!II:RY-&DB-&Y<.U1E[#?/FKEU?^9TC05%1^'"82"@U:"6
M:,0F<"$M\?!CT1BLJW]J:\&O,GHS+C@LKEOML>(0UCM(7EW26$%.\"P3AS!R
M>^#H2O.3O<^@X5OT^"2.3H]/GPH@53;2<8?YHD[]"F&I&^[GX,4HEIX2JH<$
M&IU8P1J4['=,AS#T .UXZ7)>8K/JH!I/-U%#&AWJY !U<:W G1-90M&I4$S+
MZQV>G2_.)R!G7@#=@10O4@<9]U?L3PN)4(_;59%!M=>FTS9&^)?0\NF<U*^G
MF>Y*$SK7\GY?A3>_";<I]@X"9Y/U&>IYH@GW:NJ#M9+A$/R:9=*[B)G)DO0/
M:Q,7$KI>EO5J61:,\"+^M&]H)=V2N!VD[?K2ML4WZ\_J#'<; O%D9"%D6"#L
MD7%OPBJ5=GWP)9\P!>T,S9F2PGZ=%"F: GC?9L4?)5&4!MUL[&&XR"?4^5MG
MJ3S_"[Z-5#B R+B+DI154\<C$!%_B9GPZHJV7UUR>?A+:_BZNMW+"LK +Y'8
M[4[O,L-WF: U7:,%6E[.@0%M"#&/X&?9YV4N\"!5XQV#N7)15I*#]FV-#HKG
MSZAX6I4.)**4=47= ?83)=VL<F 2'7<J=$T%9E>OD/>$FC+[BBW/BN++MK@4
MS MW-Q=-3"U\.'DH#9GH,A:@Y"1+_QQK/$ I2=^YT/!3>3+/!<&?N>-A#4-<
M!9<E;&5FAC"X2,&98^^[MK=AS4OENM%DX.^TVN"!,3=EHU(V65+-\ZR2<%G@
M<L#['C,E@PJ9(7N'Q& 8X"T61<M=:DU95"*- _T<NR6R[*@%3;C1;I_7?I=[
M-MGO\5 176N/M^XD=K#9L)%*D*^QA?<Q(:85W\MG 1W"_=9\=QGKHGBDX@CV
MO4+1@A<S9M#L1VH9MJ"0FCNSZY9$'QHL"JNB=[.9H/+!Y"(&;^<18/]&;PR,
MD/=LAN>#0^ :8(OZ(GPR@N5 Y?5\YCP2YP [0) _RKV5)>W0?N^+B;D]8*:+
M6?U0I =Q3Q@3$E8U5S[3DR7H* )DEA/+)&-T,O93=>N81).<&M2)FL/5RPFL
MX8OCE0+RK+/2?\J%Y!R5C\(SX:?6LF[P)NCLJ^\FX+;3ST#3;\%JP84 <X!Y
M$1F9?;O.1/V<93TB0+8S_(B-=M.5(:T_F<UNA0RW,'ZF)YZK9E6K[?FO VYD
M3U66D CV:JV>6$,L0<V0(I$:4B^P\ZYG:@<QP^[HD#>%[[_/",B=DK 02.\^
M7H]_FI?L@A=Y?L"+? .\R/,#7F3?SM)FRHVW Q!CZQAY0$4\9$-A$@=#7)=E
MGL:NMX1OA0@.DO-%A,,>?!4%494_H0--V(LVL"+!E\T:"5N9@2N=FB&X%O3#
M$&IM=&HF!.<T0ETIW!+;VDD;;EI=<[#2^[,= @?W<BE,:T$%8NPG'^GN\P+-
MQ7DHBT:CR\^S(JN2N5&SYI;DOB4+/\6:RK!%8#RE/32(O2M%84LRD/7W\1UV
M&?.,>P10!-$9X$,R0)%"BCFZ$3\ GM]>;!*+$Z>D/29VF:R-E"4&JVHE #BN
M$BSQ :_GKR?Q\?$Q_K]H.6]J[Y1P-U[N."X :?"!VE*DBO&%WM1SFIJ\X&S@
M0+U$D9V75H:=W'$82K-)]PK-YKH)9H"(HV9)*57CY_/74YESV/HX="1\'^Q=
M=-B!NFA_+'OI7 XA>-K\7DO\#5KB!P#5'NXC ZA\CRRN6?$T(,-99(ZY[I(_
MWIP\-N+2$?GW$)%XQUD4-F(,O'KPCJ- WYY\T_)K-==!>.^5\.Y71'1K^+-%
M-MG+,#T087QE1WF0P/V3P'[U"<%@Z0%:4LR[DPBSZHJR5W5-3DH8H^Y5N*!M
M^7<!<L?<6/-*,"UFU5L0&A&\M9AZ2:TXK3^HAK6'9R@FK?V;<"FD"Q3,5:@,
M&?4 _8-ZWH;G6E ! 1*@XUFJ3\W0>]NOC6D%/+:!N-+LU8-.H_0\];OA61_8
M79NC7P2_]\@2]J7E6>9345X5L>P'-^[#V+J\3;C94K2A"L#$P/*-I*C!_I1[
M )+.2.9C*;:#O0-V+/J6%16[P<F<&?:CU]!:$18%^F]X(SYVK=-P+JC>:LE4
MZ,S$8*(%9J(>'JF'N[Z!B!ZN-PQ#2 1.3B-LEU?W;?4]C.!N]C%^;K6HHVJ3
MRKIG:-9(UD/<I8&U$VRMK\U<*2J&H"V176%^%B:63U_]5D8?L!\,I<3Y42YH
MX]HJN2X?F'WF9YP>?\<_, +_=8W\4$KX>T^/OSOB+SZ,J$ [ 2:S7R9KO"'S
MH&&Q\=BM65.D8"Q'X#*K9IT*#8!HZJUV #:WQ!,+L )I8T($#DMNC=L:96R"
M: 6;'O6J%5E0G-OS[!ST1SOXT&;=QJW&^V4J"EF>@ *-I;\2'9PG5W63KXS#
M6=!+Y*?4,AH!#E8K6P7#34WN/ROV$U?(=_;9+D\-JO(]-CN]/U5[+L;,#68N
M,^G]S88/87B@K4M#4H9>'6NV]JD!C$[<KI0;.EHIR'W*%17S_%]-GF+4*4T6
MR;GJ(X-D O8G\[*NB9B#OV'J!JY&LK%<A$SE)OF(?6@FL8ICA^R[JG%0T B8
M;_(=^4G,R$73U&S) !O'NX79(O>,9&+_JRRT%3>6T1'K'7:-D^,X2>H<E\MT
M+2D&M&:Z[]LM+(OLH?;')Q49IF8!=3H)=_7&+D1QY*T'J]2F64:]",Z!<WW5
MUWI8O7_F=UR^A!T&4+=B<-OJH2K'2AE(;!!<-2_,;L0R*L%Q;9ZX<%/J'7>E
M4U[EE#@C@SEBGU+A$S9T4J@9"=KGP6%H+T&^JG?,Q[2,\NWIA@>0"'@H[]@E
MR_[BD&7_!EGV%X<L^WVRY9ZV.IR<L65\CRRY4UJL7R1V$:/5U$TT]N<23>N*
MC/OOBIV3ALJ#RMW]R8!N' #<57@SX@BA&$CRZ:85&5$#R6M=NQPZM8(E;5/)
M\D 2BO9B#]$B>W21S&>^++GK,Z&Y8YP[UYNOQ3>&H&YK")15D:V9 VL*9)
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MR6)I=]"NZ_'CXV>/[RB<RK)WJ^+=4^)VJWSCNUV:4LDV=$V2HO]+IT9LFQ6
M5_%5!A<1J9B__  W'4C C_X OH/-;]]JG9^^BGAAW.M.EN'UYD9GYPB*\7_]
MY;1M/.P^TG[5]J,ZR)A%P\&G])^CD_'H=#QZ/&[/I6?@O6O3;U_LYTK\3C4"
M]NZFR=LM?3-/ZOHVYBYU1-L$LB^J5YU/1J>/7\3\_\9=H66Y?_;LNS[3[Z>D
M2*(?*ZMT!NRLT\UEDZZXLN_A&PW(DP$#[O&SE_'CIR=#O[K^B[[Z#$Z.'C_]
M[L;C_Q)I^"?%>-M3[+[PUWQZD63SZ*?2?L&U-=BP2KLN3<]R/'L2OSQ^L>F+
M?0^\H\%LKNC]GZU&#[N]\&[/;\^9K8ZBOV7I97X>_:VRK_ETQVOV]&7\].FS
MPP9^V9$[LUL%Z.#B7Y=YO;KC53HY?AF_>/'DL&>W>NC>)Y^R^B+Z'?"H=[QD
MCT\>QR>GS_=D T^.3IYT;K0].%.OBW0=?;!F6%[<]2UV$C]]_"1^]O+EGFS)
MTZ.G+[_BEMSDR'QH:GOL_UF6Z1VOQ>GIR_CER=,]V9E]TW8#IZG74^F.XO\M
MBP2C-[^4._@Z&RWM'=_8O]#;_+A>'?H\?G%RNI.+MNLP]GW.5E,_ZZB%&PSB
M;G5%>T"G!%K9XHNSSK].],Y'[:+1"PY=UEL#%J=A''V';>4)?-'&XC.BM&PF
M\ZQW;T_CER]?QJ=/MTKT-4=S3Z;_\NA%UPBYT4B^BFWR/__M_WEQ\O+I*XA$
M'Y_(__R=6MQ9?7KRG0_%W_&-M/V+7_%ZO,E@VDP[MQ&(ONNX]AU2MVUC:-N0
M_AV,#S[NI6#3ELOH9+R)>XV?\_+YU@?]*"VR3I_'3YX\C5\\>[FY5+VN&Z8K
MU(FCOE354?1:$E309I*(=E8E\J;UI,$0J&JOD"K'KB (<N<N1:[44BH')>]%
MY #/CJ&2LR;(?SM=AG!AJ4G7?6*I*VS]BI)<T'N1R07LW%=5CNVP, _WBE-:
M5TE52<<N/#_XVTMXLN]$JSI24Q]KFM':?M5^<]E4=9,4KGID65X1Z+G*+LM/
M +3&1O4Q@H&AX[DU^*JUG?^4JM4!R+S( 0J,8SE'8I972')SF7<?GS30]<R*
M740UG X0?*/W'$5G8>J,]LW#K5U87N4U<>==!2G4Q_@. US%P!OA>VC2XB(6
MG#:^/V4:$$ S[00UG$(V_'E'7$:39D60>.Q&)E_!GFWX8OK>F(MJ@8 ''L5"
M@\ID%XG#?F$3H$(0<4M[N<K,KMJA3_EW5?(-=4T_W6.@:TYWTC4OMCZHDZJU
M>X%D1K!<\SR[5"W(I*LO4GM5I#BX9H?4.JZRM;TSH(DBFM54]U"EH]4NV8)T
M,ZLW^^0Y-[VK@RPY<U-9R;!O6]SOK7M\2UOWEFB?ZN PP(K#>L,%PF?8+K%5
M0M,+>ZNH:R1 -8Q:9ZAS;XS#)@QW2?)WR*C_F3/J9UZ6.:%.4GQO\L@OVDG/
MO<TCGSR-CX]OGD=^B'G8%]=-XWWMD/&^IS4?8J;PN.^8[)=8?.7DV^G3X_CE
MR?$>BL973'@]?OPL?GQRS0SD(<7TU46B)T%S5ZK"KL'QBQM*Q!Z'[O;[<;L4
MK3PY%*U\BZ*5)X>BE?TY(%^O%.7$E:*\_>WCV?NS#Q]=Z0D')C]$/[U]?_;F
MX[OW'Z+7O_T4G?W7V9M_?'S[_YV9=S___/8-U*J\_2WZ^+>SZ->S][^<O;_?
M12I2$_2V0'**W&H J3L!!MC%(BM2%P9&HG"@Q/^Q3"KFE>DR7B -N_0CG?SP
M\[OW0!8A!+U2Z*%(/%Z?5QE1AO]>E<NR3N94A/&:*#'6D%%89D5-XY#O0#C)
MT-?^*)NJ:#V@.Z[Z0I@-DZND4K%#E7(N^FI47&8#8XC >0(A_SKD!#+X.&DX
MX(@9(>*+-$>YYR&R6C'FF+(\.1BHXPR]4ZZ=KR-7'Y$LW:\9];(*VC#&FB2*
MR6X6^,5_07("6@GS-XD2!A>,)/ *, )73(:%3V$9IK8,^LTQ4#Y!P@8C]XMD
MM6+:UB@#(M+$Q82+[+Q<Y?AOTRND0K3BJ52 /P7(EH(^R/X7,<>:_8E2O"OV
M=Y"EF&T\&.:Z!R,:.ACW2:20%>FM?<.B<+QB.+FW1=U40+YSBRPT7^<X,/_L
M!<@M;"XK44@S^"Q6'D[9<*^WQAIQG@5-:,'R+" ?3M)+6!C<<Q"JSR ?\!6@
M?R("I"HJ%SG2.*D<&AV(J)P"/ <?A&F]9967%:<'38OPU@KT++DL*Q%: ?;8
MOT I(U#.B6*-5;W?(@-B./B/I+"6"?Q7MEC.RW66X7CLWXJ5U[DE\=3"/U?(
M=&S/=YY4,&UC5]&1G.5%6#N(1Z[U"_XPTL3Q]KRDY;1!VC<YJ*'$09N,"I=.
M*,LQ2>B+$W$)%(0)QST"S0)'>IK4Q%\.?\ 5C$KJ=.%Z;\-7A%I\\.VQ9&FM
M7&%[C22U"N0RR>?<!LNP<,F>Q<Q9O,J&U JS%=K#=)E?ZGXKO@,6O#XO&MKM
MQO[!;NV44CDT&6*;3SSCLJGSS\BY7>NRUPY?,HWN [X:OO&&2;5SS-//Y[07
M/"4:"M)P#?\*9KRP5PB7TQI>;%HR=WKBS@HCF7+_L2'QHJ,"M'A656<^73XD
M1K[NU%HH \(;"H1N?J./7)MCNI.>W':@:W^BS:8'N_V&='<"5U1LW[/,X&K2
M%(V+,L4^#,(<K=:'6\C:4UU('P6BDK9K:P<"4TOPI7BKBK8#]F]B4V3Y/_N<
M$[+"*7Y[N'\'3K.L?M7B--RH-NG"I:42VOYYDB_HX%@Q-NT?<*)1(  @SN$9
M:.S_SMEDK.UUZGKGX4^X"P)RN%DOO0D^Q%?;LP*J&P5.:,1-^U@HD8_5.=Q!
M^&4^Z]B:6#.H0Y9V6O;"J1:03'=*!,ZR-8M$F4"CFWP%/)6T&<([9Q7+/.&:
MZ WZ/=(JL*6YG=2O_;E@+DS<D[(F&79GSO?#,]!^R)XM3!Y;5[@JLK53XK,L
M$X.=?CB.':OG,LGQ1JBSU6K.-M@?37K.6GZ6%W E$H%^3'MC_S=-%LDY74+J
M=H7+%6:>6GD!42BXEPA(BWUC9<4?S,H&I2PX+,AK2% $F*F5CX;.DY7;#!@!
M?=^,ZSS7J.?**<_DU)3Z#E>OLM]%[X4^M']PVJ <:(X0>YYXNTP5T[OC6LG/
M#4@=&0I#M/B!;3)U2?^LH'O$'CBE9-UEST2QX?&$#Y6:QH//)]O\]&_)8OGJ
M74=IK#O72/M,;;J'$ !2ES# Q7(%"HS>'RFY)/G5<FAT+]\^J1V3\N>-V'(@
MH[X#>9^L^(%W_.S:I&D^X#HC)5?S84">V]1%$W+P)TW'(\/%/7D5;?$5<A>$
M0'N().^SU5#2LNQ[^V^\,)KZ/JTP^DFOBP*T2^ 1BK[]2?3TO?.7</C /BHN
M@KIS(-;"3-HH,TT!:M_8TZOB57E%9FM"R\/TVV B.AKGD*>D[UU(9^M6U0K)
M>94L7 L^JQR!+3=LQ8=&SM3>, P25;8UJN Z9J;7.=.,(%(-3+&TJ7P3*/UH
M-'G8F*#GTHT""#1\Y!W+['T[$="\<"46/0K2F37A5^OH]54"K?R"\-W^G@R<
MB]5\[Q1\FH%',(5?F-*9&MCMZR3:F_Z<8\X<ZHR'3!#TH,_F^7EN;SYJ T5S
M#QF,-3P7OQ2&='WP0;HZ(ZJ80)ML&W#T\)(L'>M%(K,TX12CT>NQABJ:)&)Z
M^Z"'35]SH: -FM4<T,L)OCLZ(81YWW/ZNEVY!D^H /I69&<G$KF43NGU9]QD
MQX[=/L/J)$AC0X\B9H;"(68PL!6P1LV[ T9[RHQ^''-;5(]BIJ9$8,EPPP*W
M%C+YP6_VMV:=A9./!B:_R=$%!#LYD$"+M641FF7_$E##61!-F+P8)Z]9I&A
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M=%FHMND,2-[/!XU[7P*5GUGA@\',F[@>SLV%+^/7U([!#JO,^XHN::OSVA=
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MI;@1N.XSRMZ?3+JB7<^M69.8EWD:!5( YL'_;9WNXW=*!\.<#OA@EE19&3)
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MB]9%Y^OE;]=?_F-WVV>77T$+.+^&IUHWU,[OES=M>_).K=(=;*5M[%+&H;5
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MB$J7^_1AXR<JD,FUGY GF."7X^@>!Q?QY<\0H"'L4_Z^D@YZ;N"BSDZKA/O
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M 9OPJR,L;4&)C%28TRB^@M%1*OE:AWCT@XC#=?662-"/1G/OIR0;_YP.X?C
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MFV2:9">WR%KE%BD;AQ+2.#R?PP:LGI2H^FE5%.?SK1#O@5%^\4=PV[/Q+]2
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M4R_9[62^D4^AF*V@^Y#&]\DQEQ& \Z9VC57A,HQYTCW:ZCG(7BUY82<D_K!
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M23K#PPSW*K+T/%2!&U)[2 O-C)%W-S&+FI9/<F$;>XC0\6?FW7+274BW;;D
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M;F*@M3AF7'=:"I28/B;Z0.!",JJ4BIUC\A:9ZRC;,!6!& ^C4%BTQ)24;,#
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M:&#$'*A _6W'VAK1<+>B[;QN L]5/[ZWU\!Z((T#>I(^]N CO4 K6)^*EV/
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MC"(0#I22LZMU25JO]XC2*PH.:FT#%BUDXFD2VP_X6--I6V'N'>LP_)S4-*O
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M&>/ M,D34T\3#&5"/ BV2K*OY1,1TDTR9)HFM)'70\IQ9B.,%F8!(;A+Y%M
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M'Z>5?"?TM ><Z!(Z !_M[X!:BB]9W'^F+4(]N&C5@UV$FXZV*P43KK(R=W=
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MT,O!P.>LEDXUEI4DT<I]HGWS2H'Q#,N>7;_L1SC!ZAWK'7'>5E?9%2[Q6U<
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MPPO23WLY>L"&'#O4D>/?IY]_ZX%^/P+ ]\4S30@\6C>-'6JG\>\LS^=M_N>
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M_,:?$2**H<1DLVN#5>OC-@+!@]L?*-\#*AKU,U9%?1&/G%;[XW4!_[K,ECY
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ME#R0!'>R^#GS*FEAPDG:A;<*,4%E$*98E$2AE+4+UYY-*[/0B(_))8:O'+D
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M4$R?OVP3>\)EQ&P[Z'FN&;9A1@1-5:,95+J]HXN@1(+>&&URS/B 9UUB_4A
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M;%>]61"+20,;%L5]<J*$>23(!>HQQQ110]?#1/WW0\1 ,,,17KT(CLSC\?>
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MA _:J*4A3+9(.M"G=95ISENB>[;><TE.;DV=+?[MCU11#[DV=*8W'TUHS_S
M2K^PGL.-+5!1N90.;R?'U<S-,2YFBV-I?7SL8F]JXH\M86W=W*,C.W^^ F:
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M#M-#CFVP.+2Z0V3A5)0C=6AL&[%[KBE:4#U'X"/.Z &#NZAS@IZ17\\-P1O
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M)6>X7'&27#VR'<0C?_C!QX03LM)VH(B=W QXG.\''AL"'GN!&=^%?)D5);'
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MX"]KY]!E86P16 :ZM;[QV'VG*3H[#%QON&,3/A34]]#!P:"E0R:[0;DO<NE
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M?? B\D%'B4 8WKIC>^Q_+WS*>U]FB-^,'J0RRX(3(M_6_BNDLV&[T3"Z$PX
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MA2BD>'1,3\9J9K?G2J-%R';XUPN(*=YSUQX_K50/W $+)$1B%""!4((MVC4
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MF>NM.6%GU5])W"K#^@=[#,MP=KG,!2I>+-$'"X4'/Z"-*5#M![N\?*D:GR)
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M?6 MJ1X;8U4>90@VPA ,GY(2?9!TBI:)?1.?$^?="1O;@PDP.S$!C\1^?9N
MQH]C> V!:,E"J6IGJ@Z%$N"7+S+,G.^"%9B]\KF/#E9PYX?AC_=_&+[N^5J]
MYM6?DS\4,OL/)*[V8N]?H0?2'"[?[-=?NMNNUB4UKKS'&J!B:W)>N* \ YWL
MZUEOZ[@B1@J+@]Z WZ8]A9^WUYBB^!LWCNC&R+LQ"54H2 Z-F)0DT(T4F7W_
M*K^"G#']%E>A\\"#UB26.H=*'GK)YU! 4YH6K'QM  +[9/<XT0/V?7H\4'.5
MX@W'P+USOYE:YXO\;2.,4A'E+CVYC=+Q<G#2,2GSR/.KN7#/7#>F][A_C:ZY
M%KV/4+#M)T1R6./^7O\J@#4X62;%-06]BN(N>.:U .+#4O2ZUS/NL=WW$-S<
MZ1$W=R^XN=,C;N[[W'-WZ$?_=/]^]$?K&N!1XKSCP^MU![55.NGWU*>B/<['
M=,+4#"<MUO_DB8 W'BM0[ES=1^:<HE,HOA_<<=>C=1>@-YS#?>9E5JQ:X]HT
MX$H%$BM?Y$/E,96-=:.'&;@O)^]6Y.TA( Z$HER18&>;7DL#V<;[G<3337O^
MW.Z^;?A3]$GA$?RC^OEFZ729<#/2]9#&^]M3+B& /'5= GJNV1*"KR%O4)7N
MV&O3NF_)6RH[*LP5J9HYC)U]G_S<7B< 8(V,_R-R@>[2/+VZ?_/T6R'-U,X^
M?5(\K6?TJ#?8\K+7D3H>&_E]77X7X:\SAH,HK8=&'?D4V\#6[XVZ:55?8"QH
M,3>(O,"<7IN:*='43/UHQGRU:":Y3C23?.I-J DF5+$)4/\]9$H<[Y)JQF\E
M>QY(@>_^?..AG.'?9,49#-=E4;GT G78*ENV#:&BE-KNIQ!VA+S\IU56+NV,
MBP0E?9KP5VHYW1?5TG=K!T^?WK\A_*6I/^L<IHTZ9OBKE)<FHI)F6?69'"P%
MM%Q<%BUJ6!"VIV2P(7Y;P"LI?&'1^SF\@(/=.R"+8*>6>4[=E2N1$;UN)6K8
MC*G9V#2:B-R,&6JT@YIJ?F'WQ''%?^T5?WK_*YX%-:T==(O^S ,J%&^HSOX-
M!(+\5>Q74D7FP^D[.)/AR>U0L000D88*,:@'/C_1U[K*6@+=+""#@OEG(6 0
M:-TRP80"/!6R$%YW _B0 +$N$O+ V>#@PQ0<@"<PMYM$^#.@H<%)HFKRSPNM
M?APGYPF4M^J!N+%1?$MV*+ES( %+49;8PD0MP\%@(8A3:,):N_ 4<F5=7_&U
M1!EV2XCC#NFV<-R&NK>U4=[$@6[$Q>'2SS ;_OFC\L_T9P.O-QRE)!PEX1#1
M&M!J> [TA%0YM2=,!6L4QM<WDOGQ%4@JS3X 8,-=D>I<>G>1ZP?[J%00SKB$
M @,9#)6KP\!#&==*I@:85K>Z+L%91?X-X_E-'FK*IM>:*PY=J?/-'G'V"4B4
M%EM=6+<+KS,K^M)+_>'( 9P_)Z)0"1*T$1EVQV&I+D?V.J6XA29&KH7NL*&Z
M(\PO+4<;>!2XD2]1YD;)BJ<B9&CM63:'/<&,:6!L6#4%$;!VUJ]O#7'5^F2*
M)S+S:95@'?QW RUME1UF% 6&9UMFE^1H9@O@)\5I#'6U;E)/C*\](VNO5V 4
M2B[L6L3QXT=7$BX(X2ZSEH"[><,DLOY&#KT;CM6Z*>I&MH0[*5!FT:&?U30X
MOALF?MWV5U70XXEC%K-K5*?,AP8CF!,C-H5-^UX!<"7,%MM2NU?=SA5GKG/^
MWGS%I?*1*_X]RU/?9I69R'WZ"PQ] I*GW!YB''%<V9'H]0G[J>W/NCG$^/>I
MDNA!TI%FW>3-WU__A@\36>AC3-Y'U_GKN,[/[M]UML'A'V@;/N1,<)8%.?Y'
M,=/?)CKT;>A!Y%]@ EMG^)IP0LG@$&-XD7-P?&WYT+,/G]Z]_NUM\D\1#X6^
MT7]M[/ABBR/3]'&6ZHW+XYO?<O#^&;*R@[]L*B>FA^3GH7,(?Z>HC.*ND%4O
M),&,4C9IW(AVK1MU-E,_$WK$)"_:3QXD,=T_Z%>D'C29"_@44^>&TP% &IZ,
MH9;ACEO$,#^NK<NN&8__214#8,J,!VF?@\KK))N)Z@,)B*6B"9J^0.YA!Q,L
M095:UG$?Q2U8^<F*%8)8$'_$I/6]M0Q 3[>4GR3O*@Q7BOG&!I8I/J/U-*A?
M38Y!*'J?U_"3W 0.14^RQU.&1(_(T[&@=/JM=L?.Q7S 6DT.7ZNX^ SW0;H"
MVR$+,7$+T3Z(E/;"#+-?8M2QZ*\ [ S]]3LYF^($*O[+IOZ3%A"R=^?SK 4-
M>&N-5UBFF&T6YWG'D#6Z3MCY/$#$[<Z ]_>("7%QP&^2/W#K:;SU3!Z ]218
M64/6009)SQ$/%V6,;[**A''4H?YI$B'>7]BO 3P39!%5;24TQ_TL3&6W>U>H
MH*AOLV(W?&"0N<?*^O:@Z>:>'6%S]P*;>W:$S7VON^X;:V;ZO>[ Y]'"UD#^
M<AZV%O=.',X0$EE!LTU'/&%K-AP>!1-]< 'J[Y  I@>_VA^SJ.,XRDY+"@T%
M1C!"A0!(,\^XQFPLVH4WO0?W#K0XV."W$?X,:K-$O-'SJU+M5$'>U;=I:Z=O
MQPN8*SLT;9U?DCO?=W>M;YEO:\QJ(F6%>\ASZW14JB( ,P9^#17AKN_3O=OM
MU,E=1F-B^<#7=.ODFKO\NI )Y( @(6ME*5-K_'S+%?UUF0.VI779]-"%%X3+
MKKGT6D&(%X(@YC(K2E%JB3E[$015X%<^2?X[%@Y:=])&QP(]"@+$U.S?F=0T
MLB=Z_ L6$8<&+L]_3ZL(,%6]G6V"&!V!5SBA,3T6'QZV/CYL?8#82H38CH:(
M:"!!U,&7/N%V)K9^>O.Z;P$],/]W!KU_M[P[>6+]F\.=78CZ[G_/FG__/^;U
M'_]\^_O9[Y\^)A_>_G;VZ=WO?T\^_9&\_N/W-__U^E/RQZ_)+__U\=WO;S]^
MO(^'_?Z* C\\>0!PFM?4Z@D[XA?.FQS+ 0^^''";Z55^4+_U>4G(7<3NM#G^
M#$"&:QQN:FW[]Y=3=_1(2TT6<@J%?:=I>.H&F1IH&O'GL6@(Q50<P/2W/MDM
MQ6*&/6HJ278-TZ&^D)<;B[>:#* !"4$#Y,TG7Z8@&UN6Y%SC/Y-Y!K3& _\(
MZ.N !!@@7%M&ZHPV %^7:&.WX ;VJ3R;4IZON8147(><:_:"3K-#%XR9'M.3
MVW&B>&YW7;U"+MMV@XS3#18FK)EO:__/7#0[&)16- M*\H/ZQ,%K3[PQ7G6&
M6*W#[F? LU,/";<(-#6J.=*2P4H$<7C. 0!E(YL-I0MON0%HH@&0-X.>8<@R
M>)*P>6VCDXSRKAP#,J&5!);\'';U$#OK9#OUE]1+">[ 5.'C$KU_>V!.SIW<
M^/3:I_?AAKVX.\,.U/ *FHDM'WFUH.VQ !'58K:AA#6L5W;>*</-_U;*@H'>
MO0I_U]E6W.2L8NU4_+*YYH7 0_?7<G@[NS?*#+@V6U0M @)M^B2N2O]2D"A8
MR8Z4YU#O",98P@=H!E1K.D 4$8N]G5QHT;/1Z:RH<BH[(,C+KHXDKD?=RY<
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MIK=./@\]53XH!?E.)]D^Y#N"WN%M,2Q=(] -H%"HF1VUX@*OR^<;-%)<D]:
M%BQ7+WVDBP5ELG^ATZF^E'ITIH8TS?)Y!FK"5UGCS#]X&'"0JRYI(MJB]Y5
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MW3'P Q8>U<!8D!#FG^T+B-84$2;U4H%S*[+9C*=58Y+G/2EYW(_7I>0MO?E
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MJCE$J@^?,;"#2'^'M7D-<<6C5<;"\RLX=#'=+K^^3#6A/AQ6C5[.:U1B9(5
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MY3P4+CQXSS."5:/XIRFLGTC1ZWR9@]693NL2#7SB!DC!"Y2A\=4,\]:3+[O
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M)<CN5J$':."E1A&S'3SUOM]:;G<JS%F5EA7\!3>@THP&LJI)%#K.SC1*#DE
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M3?9W<O7_0Z_;F7GWWVO3LZ](4%8<&UH&N+\"D;\U,(.T/]*;?327O9SB9HD
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M6Y2+K\:;Q^BC;%U7MD&M\[N5(AL(-J;\2+Q;SWZ$&*17L2EGNCM;>Z2HI5;
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M-2+'ITW0?P2.#7O$%)2#;QJ!MIVJJ>-O4$L#!!0    ( -"*LUKS6YM8_0H
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MIFG2/L04FO @:1KK'5P*M4\D[GB:8?KOY+GS1-PN]H*'U; 5DH8R/%1L]OJ
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M-F/YO)BG'AI7V=QX]+1XQ/( WFZS5,V@TAA\%;PSR/'MA0$-,&XR=$0$A-X
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MWY-!^2)FH16V4/#>$/&DLH6)UP]*QI2ZQR=Z>[0!$B)@!="0(.:G+T*!<[M
MIJE;3"3CI]'<FM;WF<E?7&K[%[QI$"P'#0WF(DZ <:2K(/UCH1=-;M:/=$J5
MFZ8PIBMS8QMZ"E\4 8I#XX/Z1B$PAHHP77:.?-W9#>[=M,4W[I=[_ZK=\C]0
M2P$"% ,4    " #0BK-:"X<9F[,6  "?%P  "               @ $
M:6-A9"YJ<&=02P$"% ,4    " #0BK-:_EH1MQ\-  #4#0  #0
M    @ '9%@  :6UA9V5?,# S+FIP9U!+ 0(4 Q0    ( -"*LUHDY%[3@0\
M  P_   1              "  2,D  !R861N971?97@P.# Q+FAT;5!+ 0(4
M Q0    ( -"*LUH#6@]Q8P(  ,X(   1              "  =,S  !R861N
M971?97@R,S Q+FAT;5!+ 0(4 Q0    ( -"*LUI#\HTX' (  .8'   1
M          "  64V  !R861N971?97@R,S R+FAT;5!+ 0(4 Q0    ( -"*
MLUIQE8O,H0D  %88   1              "  ; X  !R861N971?97@Y.3 Q
M+FAT;5!+ 0(4 Q0    ( -"*LUIJ2:X*$@4  ! 5   1              "
M 8!"  !R861N971?97@Y.3 R+FAT;5!+ 0(4 Q0    ( -"*LUI3%^4=<&\$
M *ON'P /              "  <%'  !R861N971?<S1A,2YH=&U02P$"% ,4
M    " #0BK-:I++89B8#  #<"P  $0              @ %>MP0 <F1N="TR
M,#(U,#4Q.2YX<V102P$"% ,4    " #0BK-:\UN;6/T*  !_A@  %0
M        @ &SN@0 <F1N="TR,#(U,#4Q.5]L86(N>&UL4$L! A0#%     @
MT(JS6M_S4#=3!P  T%<  !4              ( !X\4$ ')D;G0M,C R-3 U
@,3E?<')E+GAM;%!+!08     "P + *X"  !IS00    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>radnet_s4a1_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20250519.xsd" xlink:type="simple"/>
    <context id="AsOf2025-05-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2025-05-19</startDate>
            <endDate>2025-05-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-05-19" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-05-19" id="Fact000004">0000790526</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-05-19" id="Fact000009">S-4</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="AsOf2025-05-19" id="Fact000010">RADNET, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-05-19" id="Fact000011">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-05-19" id="Fact000012">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-05-19" id="Fact000013">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-05-19" id="Fact000014">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-05-19" id="Fact000015">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-05-19" id="Fact000016">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-05-19" id="Fact000017">(310)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-05-19" id="Fact000018">445-2800</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="AsOf2025-05-19" id="Fact000019">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="AsOf2025-05-19" id="Fact000020">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-05-19" id="Fact000021">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 19, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RADNET, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">445-2800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>15</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="radnet_s4a1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://radnet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-4/A" isOnlyDei="true" isUsgaap="true" original="radnet_s4a1.htm">radnet_s4a1.htm</File>
    <File>rdnt-20250519.xsd</File>
    <File>rdnt-20250519_lab.xml</File>
    <File>rdnt-20250519_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>icad.jpg</File>
    <File>image_003.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>30
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "radnet_s4a1.htm": {
   "nsprefix": "RDNT",
   "nsuri": "http://radnet.com/20250519",
   "dts": {
    "inline": {
     "local": [
      "radnet_s4a1.htm"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20250519.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20250519_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20250519_pre.xml"
     ]
    }
   },
   "keyStandard": 15,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 15
   },
   "report": {
    "R1": {
     "role": "http://radnet.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-05-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "radnet_s4a1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "radnet_s4a1.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
